data_2k0d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k0d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.409 HD22 HD12 ' X' ' 18' ' ' LEU . 29.6 mt . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 120.992 0.425 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -95.93 -165.51 1.29 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -109.35 -33.9 6.7 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.112 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 69.6 p -127.17 166.62 17.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.304 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.7 tp -65.36 -18.03 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 110.47 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.5 m -83.6 -9.59 58.81 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.606 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 22.0 t70 -104.44 -1.0 27.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.52 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.29 120.0 31.06 Favored 'General case' 0 CA--C 1.47 -2.112 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.407 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 75.0 p -83.03 170.41 14.89 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 172.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.639 ' O ' HG11 ' X' ' 16' ' ' VAL . 5.8 pt-20 -58.33 -46.11 86.82 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.322 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.495 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.09 -38.24 75.62 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -64.78 -32.91 74.82 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 121.671 -0.643 . . . . 0.0 110.646 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.657 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 29.1 t80 -71.36 -43.64 66.54 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.639 HG11 ' O ' ' X' ' 12' ' ' GLU . 3.5 m -62.79 -28.98 45.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.739 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -61.63 -45.9 92.07 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.575 ' O ' HG13 ' X' ' 22' ' ' ILE . 29.5 tp -61.76 -47.19 86.31 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 123.858 0.724 . . . . 0.0 109.629 175.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -58.23 -37.57 75.13 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.031 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.1 mttm -70.62 -35.67 73.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.42 -36.75 74.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.947 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.575 HG13 ' O ' ' X' ' 18' ' ' LEU . 56.2 mt -63.01 -41.71 93.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -47.57 81.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.495 1.118 . . . . 0.0 108.618 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -61.39 -52.68 63.62 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.32 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -72.22 -25.64 61.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.34 -46.45 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.78 -25.36 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.717 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.31 -26.79 35.38 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.96 68.44 0.63 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.398 1.479 . . . . 0.0 111.682 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.8 p -99.47 -171.66 2.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -131.93 -44.82 0.95 Allowed 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 118.205 -1.398 . . . . 0.0 112.585 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.657 ' O ' HG22 ' X' ' 36' ' ' VAL . 21.7 t70 -64.78 -52.48 56.67 Favored 'General case' 0 CA--C 1.476 -1.894 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.775 -172.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -85.8 -30.41 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 O-C-N 123.714 0.634 . . . . 0.0 110.64 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -59.1 -47.35 85.57 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.59 -26.88 64.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.285 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.657 HG22 ' O ' ' X' ' 32' ' ' ASP . 92.9 t -67.11 -50.26 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 C-N-CA 118.622 -1.231 . . . . 0.0 108.79 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 67.2 mt -68.64 -39.48 80.72 Favored 'General case' 0 N--CA 1.41 -2.436 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.935 -170.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.9 mt -59.26 -49.18 78.82 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 124.253 0.971 . . . . 0.0 110.431 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.57 -39.97 73.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.693 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.51 ' O ' HG12 ' X' ' 44' ' ' ILE . 12.8 t60 -59.62 -46.22 89.64 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.412 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.543 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 56.3 t80 -60.32 -52.99 62.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.649 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.495 HG13 ' O ' ' X' ' 38' ' ' LEU . 7.4 p -66.65 -31.01 51.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -73.0 -33.57 65.87 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.75 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.51 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.1 pt -84.05 -35.74 11.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.238 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 75.8 p -81.72 -34.67 30.43 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 64.96 22.4 12.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.825 1.65 . . . . 0.0 110.338 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 34.1 t-80 -72.61 133.67 82.46 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 34.6 Cg_exo -67.46 -17.94 49.11 Favored 'Trans proline' 0 CA--C 1.499 -1.274 0 C-N-CA 123.119 2.546 . . . . 0.0 111.639 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.464 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 9.4 m-20 -124.13 33.68 5.23 Favored 'General case' 0 N--CA 1.383 -3.788 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.543 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -56.15 6.03 Favored Glycine 0 CA--C 1.457 -3.569 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.839 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.475 ' O ' ' HD1' ' X' ' 55' ' ' TYR 0.369 0.4 OUTLIER -85.85 -18.3 33.21 Favored 'General case' 0 C--N 1.25 -3.719 0 C-N-CA 117.116 -1.834 . . . . 0.0 114.26 -175.883 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.599 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.88 -31.6 72.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.8 mt -66.91 -38.42 86.2 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 123.691 0.619 . . . . 0.0 111.212 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.44 HD11 HG21 ' X' ' 75' ' ' ILE . 21.0 mm -66.57 -48.12 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.244 1.021 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.475 ' HD1' ' O ' ' X' ' 51' ' ' THR . 43.8 m-85 -64.39 -40.74 96.41 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 113.715 -1.584 . . . . 0.0 113.914 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.15 -36.92 72.22 Favored 'General case' 0 C--O 1.194 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.858 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 O-C-N 123.122 0.264 . . . . 0.0 110.553 179.697 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.403 -3.509 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.537 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.5 Cg_endo -57.87 -40.15 80.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.792 2.995 . . . . 0.0 112.887 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.45 0.66 9.67 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.74 -3.98 30.13 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.829 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.537 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.8 mt -78.13 -46.02 26.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.458 HG12 HG12 ' X' ' 16' ' ' VAL . 0.8 OUTLIER -56.47 -44.47 80.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.648 176.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.3 ttmm -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.309 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.51 -38.51 65.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 44.6 mm -67.31 -39.45 82.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.003 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 21.2 ptmt -61.59 -38.28 87.0 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.65 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -72.33 -39.09 68.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.433 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.511 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 59.4 t90 -67.36 -47.14 71.29 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.049 0.452 . . . . 0.0 110.026 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.523 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 10.6 tpt180 -60.83 -45.08 95.88 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.457 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.77 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.363 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.92 95.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.048 0.452 . . . . 0.0 111.513 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -69.04 -28.97 67.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.51 9.12 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.523 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 53.7 mttm -104.8 147.9 35.21 Favored Pre-proline 0 N--CA 1.405 -2.68 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -68.01 122.56 9.67 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 121.856 1.704 . . . . 0.0 109.643 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . 0.428 ' CA ' ' HG2' ' X' ' 83' ' ' ARG . . . -96.82 -129.0 6.02 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.243 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -78.18 158.1 29.14 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.059 -0.57 . . . . 0.0 110.535 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' X' ' 11' ' ' THR . 39.7 pttt -101.89 175.23 5.61 Favored 'General case' 0 N--CA 1.38 -3.968 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -105.75 144.25 32.76 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.417 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 58.3 mt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -103.2 168.0 9.46 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.68 -27.12 34.18 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.582 0.706 . . . . 0.0 110.479 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.4 p -134.18 163.12 30.31 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.484 HD11 ' CE1' ' X' ' 91' ' ' PHE . 6.0 tp -68.0 -18.1 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.155 0.982 . . . . 0.0 109.854 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.0 p -76.45 -16.23 59.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.646 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -104.07 2.66 32.35 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -97.36 120.86 38.5 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.907 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 74.7 p -79.31 163.16 25.12 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 167.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.648 ' O ' HG12 ' X' ' 16' ' ' VAL . 8.6 pt-20 -59.03 -35.65 73.65 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.102 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.453 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.42 -39.37 74.46 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -58.81 -37.16 75.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.934 0.874 . . . . 0.0 109.282 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.623 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 38.1 t80 -74.82 -39.53 61.6 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.475 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.648 HG12 ' O ' ' X' ' 12' ' ' GLU . 8.6 m -62.69 -29.87 47.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.257 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.04 -50.09 75.39 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.666 ' O ' HG13 ' X' ' 22' ' ' ILE . 46.6 tp -59.7 -46.47 89.0 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.799 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 34.4 mt -57.29 -43.28 83.05 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.232 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 98.5 mttt -61.49 -46.54 89.57 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.964 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.09 -39.32 89.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.796 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.666 HG13 ' O ' ' X' ' 18' ' ' LEU . 50.7 mt -60.77 -44.71 97.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 O-C-N 123.337 0.398 . . . . 0.0 110.59 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.446 ' O ' HG23 ' X' ' 27' ' ' VAL . 46.8 mt-10 -57.02 -46.06 82.64 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.398 0.618 . . . . 0.0 109.723 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.15 -46.85 88.29 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.387 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -85.83 -30.39 23.0 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.305 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.65 -44.64 85.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.092 0.157 . . . . 0.0 111.183 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . 0.446 HG23 ' O ' ' X' ' 23' ' ' GLU . 32.4 m -71.11 -22.53 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.57 -24.99 22.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.68 88.9 0.11 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.899 1.68 . . . . 0.0 110.867 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 44.7 p -96.89 -151.88 0.37 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.92 -66.82 0.37 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 112.726 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.576 ' O ' HG22 ' X' ' 36' ' ' VAL . 38.1 t70 -66.98 -46.26 75.14 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.23 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.603 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.8 p -81.66 -28.13 10.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.046 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.607 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.7 tm? -58.73 -52.54 65.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.321 1.049 . . . . 0.0 108.823 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.5 -19.71 62.91 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.576 HG22 ' O ' ' X' ' 32' ' ' ASP . 97.7 t -72.02 -52.11 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.027 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.875 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 41.4 mt -69.42 -43.7 72.87 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.552 -168.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.4 mt -59.72 -46.77 88.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 124.567 1.167 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -71.43 -40.56 70.34 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.585 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.3 t60 -59.71 -45.7 91.35 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.508 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.592 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.22 -52.79 63.81 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.467 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.465 HG12 ' O ' ' X' ' 38' ' ' LEU 0.267 11.8 p -67.67 -31.94 54.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.0 ptmm? -70.59 -33.2 70.81 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.711 -0.618 . . . . 0.0 112.151 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.495 HG12 ' O ' ' X' ' 40' ' ' HIS . 14.5 pt -84.81 -33.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.564 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -84.42 -35.77 22.85 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 120.965 0.412 . . . . 0.0 110.654 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.01 25.73 15.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.952 1.701 . . . . 0.0 110.163 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.424 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 26.3 t-80 -74.02 134.07 78.11 Favored Pre-proline 0 N--CA 1.429 -1.51 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -71.33 -9.71 25.8 Favored 'Trans proline' 0 CA--C 1.496 -1.423 0 C-N-CA 122.989 2.46 . . . . 0.0 112.058 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.0 m-20 -130.31 29.66 4.84 Favored 'General case' 0 N--CA 1.396 -3.145 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -170.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.592 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.59 -59.04 5.61 Favored Glycine 0 CA--C 1.461 -3.298 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.199 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.455 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -74.67 -28.89 61.03 Favored 'General case' 0 C--N 1.247 -3.891 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.547 -172.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.07 -35.74 81.73 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -61.74 -39.07 90.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.605 0.566 . . . . 0.0 111.522 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.43 HD13 HG22 ' X' ' 22' ' ' ILE . 36.8 mt -67.17 -47.05 82.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.411 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.6 m-85 -57.91 -45.7 86.08 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.432 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.0 pt-20 -70.4 -39.94 74.2 Favored 'General case' 0 C--O 1.201 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.737 0 CA-C-N 117.727 0.24 . . . . 0.0 110.883 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.221 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.555 ' O ' HG13 ' X' ' 75' ' ' ILE . 34.0 Cg_endo -71.95 -22.03 23.68 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 123.725 2.95 . . . . 0.0 113.325 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -72.55 0.44 10.47 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.2 -14.06 23.34 Favored Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.889 -1.624 . . . . 0.0 113.275 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.555 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.9 OUTLIER -70.2 -43.39 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.473 HG13 ' H ' ' X' ' 77' ' ' LYS . 1.1 p -59.85 -47.07 92.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.686 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.473 ' H ' HG13 ' X' ' 76' ' ' VAL . 83.5 tttt -60.86 -42.35 97.67 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.24 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.2 -40.6 86.25 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.426 HG12 ' O ' ' X' ' 75' ' ' ILE . 41.0 mm -67.21 -46.43 84.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.928 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -63.82 -35.68 81.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.759 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.57 -41.48 92.89 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.979 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.54 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 84.1 t90 -66.41 -47.99 71.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -61.27 -45.52 94.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.43 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.72 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.219 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.26 -26.5 66.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.978 0.418 . . . . 0.0 111.308 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -85.24 -12.25 52.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.78 37.71 44.23 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.991 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -117.25 137.83 24.36 Favored Pre-proline 0 N--CA 1.392 -3.353 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.7 129.79 27.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.346 2.03 . . . . 0.0 110.42 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.0 -114.6 3.38 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.187 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.484 ' CE1' HD11 ' X' ' 7' ' ' ILE . 72.4 m-85 -83.67 152.22 24.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.095 -0.553 . . . . 0.0 110.958 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -87.73 166.73 14.42 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -105.92 142.21 36.01 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 176.038 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 CA--C 1.493 -1.244 0 CA-C-O 120.693 0.282 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 28.6 mmtt -101.72 -159.45 0.73 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.04 -23.58 8.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -143.14 166.69 23.98 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tp -62.7 -18.67 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -77.52 -4.37 45.29 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.711 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 9.6 t70 -112.34 -3.8 14.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.488 ' CZ ' ' HG2' ' X' ' 4' ' ' LYS . 39.4 m-85 -93.99 116.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.706 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 70.8 p -75.77 173.48 11.06 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 170.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.591 ' O ' HG11 ' X' ' 16' ' ' VAL . 3.9 pt-20 -56.09 -44.54 79.11 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.303 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.408 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.58 -38.57 74.09 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.445 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 32.1 mm-40 -58.89 -36.61 74.94 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.721 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -67.33 -50.09 61.43 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.706 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.591 HG11 ' O ' ' X' ' 12' ' ' GLU . 2.7 m -61.56 -34.55 62.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 O-C-N 123.182 0.301 . . . . 0.0 111.328 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.62 77.18 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.196 0.998 . . . . 0.0 108.678 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.546 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -65.95 -41.2 91.57 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.153 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.3 mt -58.52 -37.59 75.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.226 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 76.7 mttt -66.52 -36.86 83.72 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.535 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.27 -33.11 61.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.688 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.546 HG13 ' O ' ' X' ' 18' ' ' LEU . 48.1 mt -61.97 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.15 -35.02 79.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.57 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -70.21 -52.17 25.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.61 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -70.03 -18.18 63.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.464 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.68 -52.02 20.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.938 0.895 . . . . 0.0 110.26 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.6 -23.56 19.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.857 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.5 -4.23 57.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 0.0 109.616 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 49.36 62.41 2.64 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.693 1.597 . . . . 0.0 112.927 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.616 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 54.8 p -88.34 -177.84 5.75 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.77 -63.42 0.7 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.634 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.581 ' O ' HG21 ' X' ' 36' ' ' VAL . 30.8 m-20 -58.02 -48.59 79.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.625 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 12.0 p -84.56 -32.63 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.362 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.54 -44.71 93.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.82 -32.71 72.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.473 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.581 HG21 ' O ' ' X' ' 32' ' ' ASP . 71.6 t -59.27 -49.13 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-O 121.877 0.846 . . . . 0.0 109.121 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 77.3 mt -68.33 -40.58 81.55 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 113.415 -1.721 . . . . 0.0 110.889 -174.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -58.8 -49.29 78.25 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 124.316 1.01 . . . . 0.0 110.729 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -69.29 -42.09 75.94 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.287 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.609 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 43.2 t60 -61.38 -44.98 96.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.227 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.64 ' O ' HG21 ' X' ' 45' ' ' THR . 42.3 t80 -55.71 -53.08 60.94 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.693 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.416 HG12 ' O ' ' X' ' 38' ' ' LEU 0.293 8.1 p -66.77 -31.6 54.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -74.44 -33.13 62.85 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.055 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.555 HG12 ' O ' ' X' ' 40' ' ' HIS . 30.1 pt -79.9 -36.83 17.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.207 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.64 HG21 ' O ' ' X' ' 41' ' ' PHE . 10.0 t -85.41 -28.26 25.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 61.35 27.8 17.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.213 1.005 . . . . 0.0 110.839 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 47.3 t-80 -82.51 137.58 44.83 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -75.14 0.01 9.48 Favored 'Trans proline' 0 CA--C 1.486 -1.889 0 C-N-CA 123.235 2.624 . . . . 0.0 113.067 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.5 m-20 -139.0 34.01 2.15 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.82 -56.08 9.07 Favored Glycine 0 CA--C 1.461 -3.326 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.091 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.445 HG21 HD22 ' X' ' 38' ' ' LEU 0.332 0.8 OUTLIER -84.01 -20.1 33.34 Favored 'General case' 0 C--N 1.259 -3.345 0 C-N-CA 116.886 -1.926 . . . . 0.0 114.316 -176.574 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.601 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.16 -36.62 82.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 30.3 mt -61.83 -42.82 99.51 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 123.813 0.695 . . . . 0.0 112.236 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.61 -45.96 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.353 1.073 . . . . 0.0 108.831 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.59 -42.7 98.26 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.479 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -69.03 -35.18 76.33 Favored 'General case' 0 C--O 1.206 -1.221 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.402 175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 CA--C 1.501 -0.931 0 C-N-CA 122.704 0.402 . . . . 0.0 111.182 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.729 0 CA-C-O 121.314 0.397 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.507 ' CG ' ' HG2' ' X' ' 20' ' ' LYS . 25.0 Cg_endo -71.98 -56.12 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.497 2.798 . . . . 0.0 114.076 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.01 0.59 1.81 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.39 -31.17 3.1 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.607 -1.758 . . . . 0.0 114.137 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.471 HG13 HD12 ' X' ' 19' ' ' LEU . 9.9 pt -67.11 -34.12 67.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 117.487 0.643 . . . . 0.0 110.602 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 0.2 OUTLIER -59.08 -43.26 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-O 121.997 0.903 . . . . 0.0 110.913 175.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 88.2 tttt -62.16 -47.24 85.4 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.33 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.22 -40.44 90.17 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.465 HD11 ' OG1' ' X' ' 45' ' ' THR . 22.5 mm -61.92 -46.23 96.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.485 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 20.3 pttp -70.41 -35.76 73.63 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.676 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 40.0 mt-10 -68.19 -39.88 82.37 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.209 0.318 . . . . 0.0 111.424 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -67.38 -48.1 68.41 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.173 0.511 . . . . 0.0 110.297 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.575 ' NH1' ' HA ' ' X' ' 45' ' ' THR . 15.9 ttt180 -70.98 -38.31 72.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.73 0.3 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -31.66 69.51 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.327 0.584 . . . . 0.0 110.378 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.497 ' ND2' ' HD3' ' X' ' 88' ' ' LYS . 39.9 t-20 -73.55 -30.71 63.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.201 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.07 26.7 25.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.497 ' HD3' ' ND2' ' X' ' 86' ' ' ASN . 21.7 mtpp -106.88 132.75 20.66 Favored Pre-proline 0 N--CA 1.399 -3.014 0 C-N-CA 123.491 0.717 . . . . 0.0 109.243 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.25 119.19 3.33 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.995 3.13 . . . . 0.0 113.768 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.15 -126.52 4.87 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.944 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.425 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 11.6 m-85 -84.84 165.65 17.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' X' ' 93' ' ' GLN . 19.5 ptmt -86.47 179.33 6.87 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . 0.441 ' O ' ' HE2' ' X' ' 92' ' ' LYS . 2.3 mp0 -96.55 139.3 32.85 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.615 0.722 . . . . 0.0 110.607 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.402 -3.627 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 177.204 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.45 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 83.7 mt . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.479 ' HE3' ' OD2' ' X' ' 9' ' ' ASP . 28.9 mmtt -111.66 -179.15 3.62 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -91.61 -39.26 11.97 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.192 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 64.8 p -127.87 167.23 16.87 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.653 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.06 -14.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.63 0.772 . . . . 0.0 109.836 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -79.08 -17.93 54.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.34 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.479 ' OD2' ' HE3' ' X' ' 4' ' ' LYS . 5.3 t70 -98.36 1.34 46.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.67 119.8 33.13 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.473 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -78.0 159.75 28.59 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.646 ' O ' HG12 ' X' ' 16' ' ' VAL . 10.1 pt-20 -65.64 -30.64 71.37 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.644 -1.622 . . . . 0.0 111.723 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.76 77.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.07 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -58.04 -40.06 79.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.79 0.805 . . . . 0.0 109.092 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.648 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.1 t80 -71.15 -44.92 64.59 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.905 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.646 HG12 ' O ' ' X' ' 12' ' ' GLU . 4.0 m -62.43 -34.81 66.5 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.825 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.39 -45.43 88.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.718 0.807 . . . . 0.0 109.347 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.495 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -66.63 -43.79 83.75 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.228 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.3 mt -58.08 -46.05 86.12 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.773 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 63.6 mtpt -62.02 -35.83 79.73 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.766 0.826 . . . . 0.0 110.0 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -74.52 -35.37 63.16 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.715 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.495 HG13 ' O ' ' X' ' 18' ' ' LEU . 44.1 mt -59.69 -44.41 93.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.921 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.422 ' O ' HG21 ' X' ' 27' ' ' VAL . 42.8 mt-10 -56.93 -44.82 82.85 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.383 0.611 . . . . 0.0 110.475 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -60.31 -46.09 91.08 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.647 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.5 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 3.1 pp20? -84.92 -30.32 24.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.749 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.02 -40.67 98.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.59 0.756 . . . . 0.0 111.698 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . 0.422 HG21 ' O ' ' X' ' 23' ' ' GLU . 34.7 m -80.5 -7.04 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.256 0.55 . . . . 0.0 111.313 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.03 -25.77 13.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.71 85.36 0.13 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.698 1.599 . . . . 0.0 110.297 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 72.7 p -92.07 -24.23 19.22 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 70.41 -50.81 0.66 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.37 1.868 . . . . 0.0 114.358 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.512 ' O ' HG23 ' X' ' 36' ' ' VAL . 14.3 t70 -70.25 -56.79 5.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 118.034 0.379 . . . . 0.0 110.23 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.672 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.5 p -80.87 -25.45 10.87 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.5 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.6 tm? -58.23 -48.31 80.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.779 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.71 -32.46 73.1 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.839 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.512 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.0 t -66.81 -50.69 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.549 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 35.4 mt -68.45 -43.81 76.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.02 -171.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.51 HD12 ' CG2' ' X' ' 51' ' ' THR . 46.4 mt -61.98 -45.67 92.61 Favored 'General case' 0 N--CA 1.419 -2.016 0 O-C-N 124.211 0.944 . . . . 0.0 111.707 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -70.3 -43.28 70.7 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.882 0.372 . . . . 0.0 111.757 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.496 ' O ' HG12 ' X' ' 44' ' ' ILE . 9.6 t60 -59.56 -45.14 92.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.328 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.589 ' O ' HG22 ' X' ' 45' ' ' THR . 27.5 t80 -59.68 -55.75 30.43 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.641 1.213 . . . . 0.0 110.824 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.486 HG12 ' O ' ' X' ' 38' ' ' LEU 0.278 14.7 p -66.87 -31.64 54.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -69.84 -30.53 68.04 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.84 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.496 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.0 pt -85.27 -35.92 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.574 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.589 HG22 ' O ' ' X' ' 41' ' ' PHE . 4.7 t -84.47 -30.86 24.89 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.394 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.58 36.75 13.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 125.041 1.336 . . . . 0.0 110.34 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -81.94 136.21 47.7 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.271 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 22.3 Cg_exo -70.96 -14.33 32.22 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.787 2.324 . . . . 0.0 111.941 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.401 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 22.3 m-20 -128.3 31.98 4.95 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -172.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.08 8.38 Favored Glycine 0 CA--C 1.457 -3.54 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.419 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.51 ' CG2' HD12 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.77 -33.94 58.03 Favored 'General case' 0 C--N 1.251 -3.697 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.055 -174.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.65 -31.88 69.94 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.191 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 mt -62.29 -48.51 79.55 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 123.574 0.546 . . . . 0.0 112.101 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' X' ' 41' ' ' PHE . 4.4 mp -66.81 -40.43 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.742 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.453 ' HD1' ' O ' ' X' ' 51' ' ' THR . 27.1 m-85 -61.62 -43.29 99.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.78 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.9 pt-20 -71.97 -37.04 69.98 Favored 'General case' 0 C--O 1.203 -1.345 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.202 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 122.594 0.358 . . . . 0.0 110.978 178.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 114.429 0.531 . . . . 0.0 114.429 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.498 ' O ' HG13 ' X' ' 75' ' ' ILE . 36.7 Cg_endo -60.05 -53.6 2.96 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 123.694 2.929 . . . . 0.0 114.701 -167.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.88 0.17 9.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . 0.585 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -105.58 -18.58 11.53 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.004 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.498 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.5 OUTLIER -67.26 -44.22 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.469 HG13 HG13 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -60.49 -39.75 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.656 176.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 22.5 ttpp -58.55 -47.67 83.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.856 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 7.2 mm-40 -58.01 -45.08 87.43 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.125 0.964 . . . . 0.0 109.196 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.47 HD13 ' OG1' ' X' ' 45' ' ' THR . 41.9 mm -61.62 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.447 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.1 ptpt -65.89 -38.31 88.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.983 -177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.65 -40.16 76.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.907 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.448 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 63.1 t90 -70.17 -46.77 63.96 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.787 0.327 . . . . 0.0 110.684 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.473 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 8.4 tpt180 -60.55 -45.58 93.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.38 88.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.947 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.33 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.974 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -69.4 -34.99 75.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.68 44.07 1.86 Allowed Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.473 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 54.9 mttm -119.5 146.42 41.17 Favored Pre-proline 0 N--CA 1.4 -2.941 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.78 124.68 15.47 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.634 2.223 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -88.39 -132.43 4.11 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.864 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.4 ' CZ ' HG22 ' X' ' 76' ' ' VAL . 80.8 m-85 -89.54 166.18 13.82 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.32 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -99.28 166.99 10.94 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.21 144.5 25.76 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.673 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 CA--C 1.487 -1.476 0 CA-C-O 121.16 0.505 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.427 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 31.6 mmtt -105.3 -164.43 1.03 Allowed 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.25 -28.36 7.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.357 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -128.97 163.46 25.29 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -67.5 -16.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-O 121.471 0.653 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -79.1 -3.26 44.51 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.55 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.428 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.1 t0 -110.21 1.64 18.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.213 1.006 . . . . 0.0 108.92 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -93.75 121.01 34.74 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.521 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -82.37 176.14 9.67 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.549 ' O ' HG12 ' X' ' 16' ' ' VAL . 4.7 mm-40 -59.23 -51.97 67.7 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.5 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.84 -38.7 76.57 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.879 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.64 -40.97 80.48 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.172 0.51 . . . . 0.0 109.843 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.542 ' O ' HD12 ' X' ' 19' ' ' LEU . 30.2 t80 -75.06 -48.53 23.51 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.095 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.672 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 15.7 m -58.6 -38.58 71.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -66.8 -46.27 75.76 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 122.682 0.393 . . . . 0.0 111.027 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.54 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.4 tm? -62.95 -41.31 99.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.542 HD12 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.31 -36.86 76.4 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.148 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 61.4 mttm -63.58 -40.13 96.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.964 0.888 . . . . 0.0 108.816 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -65.13 -36.06 83.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.966 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.54 HG13 ' O ' ' X' ' 18' ' ' LEU . 19.3 mt -63.74 -39.55 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.285 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -56.87 -46.07 82.07 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.602 0.564 . . . . 0.0 109.915 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -62.93 -43.89 97.56 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.081 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.415 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 6.1 mm-40 -71.08 -33.33 70.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.284 0.564 . . . . 0.0 109.885 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.37 -44.94 57.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.564 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.34 -29.86 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.744 0.307 . . . . 0.0 111.693 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -4.67 57.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.464 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 48.34 64.85 1.51 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.179 1.392 . . . . 0.0 112.256 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.541 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 72.7 p -83.22 -161.07 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -130.42 -71.16 0.6 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.393 -1.323 . . . . 0.0 114.398 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.592 ' O ' HG21 ' X' ' 36' ' ' VAL . 27.6 t70 -56.64 -52.43 64.9 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 68.9 t -86.83 -25.11 6.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.239 -174.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.66 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -58.79 -50.8 72.62 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.7 -19.81 61.33 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.592 HG21 ' O ' ' X' ' 32' ' ' ASP . 59.2 t -71.48 -49.76 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.074 0 C-N-CA 118.289 -1.365 . . . . 0.0 108.471 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 88.5 mt -68.5 -43.54 76.62 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.091 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.5 mt -60.54 -47.09 87.7 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 124.337 1.023 . . . . 0.0 110.457 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -71.03 -43.72 67.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.627 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 39.1 t60 -60.34 -45.58 92.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.223 0.535 . . . . 0.0 110.062 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.621 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 38.4 t80 -59.14 -53.0 63.25 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.191 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.498 HG11 ' O ' ' X' ' 38' ' ' LEU . 13.1 p -67.99 -32.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -67.0 -36.98 83.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 122.07 -0.394 . . . . 0.0 111.502 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.581 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -81.1 -34.1 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.855 0.36 . . . . 0.0 111.378 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 35.2 p -83.84 -42.46 16.4 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.96 74.97 0.42 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 125.173 1.389 . . . . 0.0 109.583 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.535 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -126.11 139.01 33.32 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.164 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.46 -7.89 22.18 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.794 2.329 . . . . 0.0 112.31 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.431 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 16.3 m-20 -135.21 31.9 3.18 Favored 'General case' 0 N--CA 1.391 -3.386 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.621 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.81 -58.2 8.77 Favored Glycine 0 CA--C 1.461 -3.316 0 O-C-N 123.679 0.612 . . . . 0.0 112.704 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.477 ' CG2' HD12 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.23 -28.65 63.3 Favored 'General case' 0 C--N 1.248 -3.82 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.148 -174.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.78 -34.34 77.94 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.323 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.57 -45.4 77.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.905 0.482 . . . . 0.0 110.052 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 23.4 mt -66.84 -44.37 89.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.608 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -59.49 -49.68 76.86 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.754 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.7 pt-20 -66.94 -35.76 80.7 Favored 'General case' 0 C--O 1.188 -2.158 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.634 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.89 0.376 . . . . 0.0 110.763 179.122 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.636 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.664 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.0 Cg_endo -59.12 -38.64 85.6 Favored 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.536 2.824 . . . . 0.0 113.48 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.44 ' C ' HG22 ' X' ' 76' ' ' VAL . 23.3 mt-10 -85.03 1.65 46.74 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 123.212 0.605 . . . . 0.0 109.918 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.05 -36.91 2.08 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.36 -1.4 . . . . 0.0 112.641 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' X' ' 72' ' ' PRO . 5.8 pt -60.71 -34.33 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 172.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.664 HG13 ' O ' ' X' ' 72' ' ' PRO . 16.6 m -56.62 -39.36 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.559 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 23.4 ttmm -68.77 -39.41 80.23 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.041 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -67.08 -32.15 73.13 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.965 0.888 . . . . 0.0 109.155 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.403 ' HA ' HH21 ' X' ' 83' ' ' ARG . 83.0 mt -67.62 -46.35 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.873 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 14.4 ptmm? -67.71 -36.27 80.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 111.105 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.1 mt-10 -70.45 -36.79 74.15 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.899 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -66.8 -41.16 88.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.535 HH22 ' CD2' ' X' ' 47' ' ' HIS . 0.5 OUTLIER -61.87 -46.27 90.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.379 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.65 91.78 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.796 0.685 . . . . 0.0 111.517 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.937 0.398 . . . . 0.0 110.85 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -68.33 -48.54 64.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.486 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.52 4.77 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.91 151.6 37.54 Favored Pre-proline 0 N--CA 1.407 -2.58 0 C-N-CA 123.933 0.893 . . . . 0.0 108.828 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.97 140.96 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.978 1.785 . . . . 0.0 111.617 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.82 -131.3 6.61 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 10.7 m-85 -93.46 159.36 15.28 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 19.7 ptmt -93.94 172.8 8.01 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -96.25 135.69 37.73 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.712 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.203 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.163 178.406 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.428 -1.554 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -105.89 152.53 23.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -80.2 -11.7 59.71 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.138 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 67.5 p -141.88 162.3 35.81 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -69.4 -13.07 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 121.643 0.735 . . . . 0.0 110.676 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -77.98 -17.91 56.6 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -102.43 5.33 39.56 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -94.03 114.32 26.47 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.938 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 53.2 p -77.32 157.11 30.87 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 171.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.462 ' O ' HG12 ' X' ' 16' ' ' VAL . 6.2 pt-20 -64.67 -26.39 68.36 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.734 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.74 69.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.677 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -57.32 -41.65 80.36 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.266 0.555 . . . . 0.0 109.537 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -64.98 -58.27 6.54 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.041 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 13.8 p -63.43 -29.55 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -60.21 -44.73 94.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.52 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.3 tm? -67.22 -40.92 86.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.547 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.2 mt -58.27 -36.63 73.56 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.34 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 54.5 mtpt -66.84 -35.74 80.74 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.327 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 12.0 pt-20 -75.5 -31.43 60.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.851 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.52 HG13 ' O ' ' X' ' 18' ' ' LEU . 49.9 mt -60.3 -39.99 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 123.77 0.669 . . . . 0.0 109.843 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -58.35 -41.21 84.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.559 0.695 . . . . 0.0 109.635 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.44 -47.79 46.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.401 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.702 ' OE2' ' HA ' ' X' ' 34' ' ' LEU 0.274 0.0 OUTLIER -75.47 -19.5 59.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.446 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' X' ' 22' ' ' ILE . 2.2 m-80 -76.77 -42.1 42.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.385 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 -34.51 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.314 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.24 48.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.66 0.267 . . . . 0.0 110.464 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.83 95.77 0.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.173 1.389 . . . . 0.0 111.977 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 38.8 p -107.66 -171.37 1.86 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -136.34 -20.19 1.42 Allowed 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.102 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.538 ' O ' HG21 ' X' ' 36' ' ' VAL . 10.9 m-20 -85.51 -61.85 1.67 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.154 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.581 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.6 p -76.55 -26.93 16.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.007 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.702 ' HA ' ' OE2' ' X' ' 25' ' ' GLU . 3.1 tm? -58.78 -44.66 90.74 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 124.333 1.021 . . . . 0.0 108.701 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.7 t70 -72.42 -36.77 68.69 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.363 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.538 HG21 ' O ' ' X' ' 32' ' ' ASP . 47.2 t -63.66 -49.79 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 O-C-N 124.324 1.015 . . . . 0.0 110.609 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 41.2 mt -68.14 -41.14 82.1 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.991 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 14.4 mt -59.45 -49.66 76.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 O-C-N 124.437 1.085 . . . . 0.0 111.815 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.3 pt-20 -70.98 -42.29 69.87 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.102 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.51 ' O ' HG12 ' X' ' 44' ' ' ILE . 69.9 t60 -60.26 -45.72 92.3 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.014 0.526 . . . . 0.0 110.373 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.643 ' O ' HG21 ' X' ' 45' ' ' THR . 39.4 t80 -57.95 -53.72 55.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 124.265 0.978 . . . . 0.0 110.834 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -66.34 -31.06 51.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -63.38 -47.46 81.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.51 HG12 ' O ' ' X' ' 40' ' ' HIS . 4.9 pt -75.15 -36.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.643 HG21 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.67 -31.58 24.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.509 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 61.91 29.59 17.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.914 0.864 . . . . 0.0 111.319 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.468 ' H ' HG23 ' X' ' 45' ' ' THR . 50.5 t-80 -77.94 135.87 62.77 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 30.3 Cg_exo -66.11 -19.22 57.22 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 123.151 2.567 . . . . 0.0 112.316 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.98 36.22 4.35 Favored 'General case' 0 N--CA 1.393 -3.296 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.587 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.64 -55.91 7.76 Favored Glycine 0 CA--C 1.462 -3.226 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.136 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.449 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -77.0 -26.17 53.55 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.332 -171.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.571 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.14 -36.71 83.86 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.303 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.3 -38.93 85.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 123.504 0.503 . . . . 0.0 111.729 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -66.73 -47.26 83.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.704 0.764 . . . . 0.0 109.416 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -63.67 -46.87 83.59 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.86 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.9 pt-20 -68.53 -36.39 78.78 Favored 'General case' 0 C--O 1.196 -1.758 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.79 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 CA-C-N 118.246 0.475 . . . . 0.0 111.561 -179.485 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.385 -4.764 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.49 ' O ' HG13 ' X' ' 75' ' ' ILE . 2.9 Cg_endo -64.42 -30.94 62.45 Favored 'Trans proline' 0 CA--C 1.497 -1.366 0 C-N-CA 122.854 2.369 . . . . 0.0 111.14 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.04 -4.18 56.21 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.891 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.84 -15.41 14.94 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.284 -1.912 . . . . 0.0 113.007 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.513 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -68.04 -49.2 70.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 p -55.49 -45.57 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.841 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 56.0 tttp -59.8 -47.3 86.27 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.399 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.513 HG12 ' O ' ' X' ' 75' ' ' ILE . 46.7 mm -66.03 -45.42 90.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.873 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.5 ptpt -61.98 -42.17 98.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.905 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.62 -38.75 70.76 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.532 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 85.1 t90 -66.17 -47.92 72.42 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 110.715 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' X' ' 89' ' ' PRO . 3.4 ttt-85 -68.9 -41.6 78.02 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.222 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.41 84.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.2 86.72 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.525 0.202 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.457 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.0 t-20 -63.29 -43.82 96.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.37 18.89 6.45 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 68.5 mttm -99.15 158.64 31.92 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . 0.423 ' O ' ' HD3' ' X' ' 83' ' ' ARG . 36.8 Cg_endo -71.5 130.0 16.58 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.434 1.423 . . . . 0.0 110.819 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -119.41 2.37 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.291 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -96.74 154.52 17.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 120.524 0.202 . . . . 0.0 110.539 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -89.86 176.28 6.88 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.23 137.51 33.32 Favored 'General case' 0 N--CA 1.398 -3.04 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.184 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.26 0 CA-C-O 118.074 -1.403 . . . . 0.0 110.304 177.857 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.493 -1.229 0 CA-C-O 121.18 0.514 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 40.1 mmtt -103.12 -170.3 1.77 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 171.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -112.41 -24.28 9.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.064 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.5 p -134.35 164.88 26.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.03 -12.52 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.617 0.722 . . . . 0.0 111.051 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -76.07 -18.43 59.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.527 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -102.74 2.74 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.239 1.019 . . . . 0.0 108.454 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 12.1 m-85 -96.05 113.41 25.02 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.218 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.528 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 62.2 p -73.53 160.56 31.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.638 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.83 -32.19 71.58 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.566 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.48 ' O ' HG23 ' X' ' 16' ' ' VAL . . . -70.4 -39.04 74.72 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 22.7 mm-40 -58.07 -42.35 85.31 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.552 1.168 . . . . 0.0 108.61 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.33 -47.48 60.87 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 113.137 -1.847 . . . . 0.0 110.492 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.727 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 22.8 m -58.49 -39.41 75.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.394 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.5 -50.57 73.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.251 0.62 . . . . 0.0 111.25 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.489 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.5 tm? -66.52 -40.36 89.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.723 0.773 . . . . 0.0 109.041 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' X' ' 75' ' ' ILE . 9.9 tp -59.66 -42.61 93.22 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.957 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.727 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.5 mttt -61.43 -34.84 76.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.201 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.32 -41.59 85.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.025 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.489 HG13 ' O ' ' X' ' 18' ' ' LEU . 13.0 mt -57.52 -42.49 81.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.23 -44.83 88.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.493 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -67.57 -45.48 75.45 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.054 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.524 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -69.8 -19.04 63.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.418 177.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.06 -46.53 10.39 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.275 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.94 -32.36 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.26 -6.3 57.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.732 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.99 80.4 0.11 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.754 1.622 . . . . 0.0 113.323 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.651 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 64.2 p -91.68 -165.48 1.36 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.23 -73.09 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.089 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.617 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.2 t70 -60.35 -51.21 70.46 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 123.434 0.459 . . . . 0.0 111.449 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.67 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.0 p -73.03 -35.27 47.95 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.363 -175.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.651 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.4 tm? -58.95 -47.6 84.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.703 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.35 -41.5 98.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.319 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.617 HG23 ' O ' ' X' ' 32' ' ' ASP . 77.9 t -56.71 -49.56 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 O-C-N 123.77 0.669 . . . . 0.0 109.927 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 86.1 mt -68.41 -43.79 76.44 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.982 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 29.6 mt -61.21 -48.47 81.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 124.154 0.909 . . . . 0.0 110.637 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -70.72 -41.53 71.79 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.131 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.548 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.9 t60 -61.29 -45.91 92.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.238 0.542 . . . . 0.0 109.846 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.642 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.2 t80 -59.14 -52.6 64.99 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.334 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.439 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.1 p -67.62 -32.15 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 53.1 pttt -68.48 -39.61 81.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.543 HG12 ' O ' ' X' ' 40' ' ' HIS . 27.4 pt -77.67 -31.38 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.5 p -84.07 -39.99 18.88 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 67.07 20.19 10.38 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 123.915 0.886 . . . . 0.0 111.24 -176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 39.7 t-80 -80.73 133.25 55.8 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.2 Cg_exo -71.34 -2.26 10.94 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.488 2.792 . . . . 0.0 113.043 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 15.1 m-20 -130.05 27.65 5.11 Favored 'General case' 0 N--CA 1.394 -3.237 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.642 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -43.73 -60.28 3.41 Favored Glycine 0 CA--C 1.459 -3.407 0 O-C-N 124.388 1.055 . . . . 0.0 112.931 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.47 HG21 HD12 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.35 -29.33 63.7 Favored 'General case' 0 C--N 1.251 -3.711 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.716 -173.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.2 -30.47 70.94 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 97.9 mt -61.05 -41.52 96.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.153 0.502 . . . . 0.0 109.752 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.21 -46.24 84.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.095 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -58.39 -49.52 76.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.645 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.5 pt-20 -68.0 -37.24 81.21 Favored 'General case' 0 C--O 1.207 -1.169 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.693 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.663 0.21 . . . . 0.0 110.81 178.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.372 -5.59 0 CA-C-O 120.795 0.108 . . . . 0.0 112.889 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.574 ' O ' HG11 ' X' ' 76' ' ' VAL . 11.6 Cg_endo -64.31 -48.29 4.88 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 124.645 3.563 . . . . 0.0 112.349 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.474 ' C ' HG23 ' X' ' 76' ' ' VAL . 42.0 mt-10 -77.78 1.92 18.65 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.0 -39.3 2.33 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 118.651 -1.738 . . . . 0.0 112.769 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.565 ' O ' HG13 ' X' ' 79' ' ' ILE . 3.1 pt -62.73 -28.25 44.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 CA-C-N 117.495 0.647 . . . . 0.0 110.94 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.574 HG11 ' O ' ' X' ' 72' ' ' PRO . 21.6 m -60.27 -36.11 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.945 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 83.6 tttt -65.86 -41.93 91.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.653 174.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' X' ' 75' ' ' ILE . 7.8 tp10 -58.07 -44.13 87.35 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.565 HG13 ' O ' ' X' ' 75' ' ' ILE . 82.9 mt -67.42 -46.34 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.618 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.6 ptmt -64.3 -37.77 88.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.38 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.84 -38.38 73.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.428 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 62.8 t90 -65.49 -47.36 76.29 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.797 0.808 . . . . 0.0 109.626 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -61.15 -45.8 93.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.693 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.93 81.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.125 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -32.79 73.67 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.44 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 25.3 t-20 -78.77 -48.81 14.14 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.55 34.3 1.45 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.44 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 66.6 mttm -103.81 141.85 23.38 Favored Pre-proline 0 N--CA 1.392 -3.368 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.39 121.51 9.34 Favored 'Trans proline' 0 CA--C 1.517 -0.34 0 C-N-CA 122.135 1.89 . . . . 0.0 110.956 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.14 -135.6 8.17 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.341 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -78.65 146.9 33.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -85.81 174.51 9.27 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.98 139.12 51.62 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.597 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 CA--C 1.495 -1.17 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 21.2 mmtt -112.47 151.81 29.48 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.95 -9.07 59.69 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.278 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -145.71 160.93 41.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -67.71 -19.05 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.259 0.624 . . . . 0.0 111.037 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -73.75 -12.63 60.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 20.1 t70 -105.22 -0.81 26.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.895 0.855 . . . . 0.0 108.877 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.05 119.03 33.82 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.738 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 30.4 p -77.8 169.01 19.01 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.601 ' O ' HG12 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.639 177.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.427 ' HA ' HG21 ' X' ' 16' ' ' VAL . . . -70.54 -38.69 74.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.6 -40.67 79.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.851 0.75 . . . . 0.0 109.399 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.463 ' O ' HD12 ' X' ' 19' ' ' LEU . 20.5 t80 -70.56 -48.07 57.19 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.874 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.601 HG12 ' O ' ' X' ' 12' ' ' GLU . 6.3 m -59.29 -39.57 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.519 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.19 -48.23 82.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.125 0.97 . . . . 0.0 110.884 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.437 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -66.17 -38.92 89.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.463 HD12 ' O ' ' X' ' 15' ' ' PHE . 7.7 mp -62.47 -36.8 83.62 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.932 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 47.1 mtmt -61.43 -35.12 76.67 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' X' ' 24' ' ' LYS . 10.4 mm-40 -71.87 -34.73 69.44 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.333 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.437 HG13 ' O ' ' X' ' 18' ' ' LEU . 20.8 mt -64.18 -40.26 88.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.004 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -59.83 -46.22 89.92 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.877 0.846 . . . . 0.0 108.789 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' X' ' 21' ' ' GLU . 24.0 tptm -60.54 -52.34 65.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.556 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.414 ' HB3' ' HG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -63.31 -25.63 68.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.272 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -78.72 -47.67 16.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.997 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -71.66 -23.27 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.789 0.328 . . . . 0.0 111.875 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.9 -17.71 30.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.64 67.16 1.0 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.74 1.216 . . . . 0.0 111.026 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.414 ' HG1' ' HB3' ' X' ' 25' ' ' GLU . 77.3 p -81.86 -31.24 31.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.655 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 68.37 -61.65 0.39 Allowed 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.082 1.753 . . . . 0.0 113.56 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.429 ' O ' HG22 ' X' ' 36' ' ' VAL . 6.5 m-20 -57.07 -57.99 10.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.066 0.547 . . . . 0.0 111.579 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.719 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -81.1 -28.9 11.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.202 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.346 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -44.06 92.72 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.84 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.96 -38.45 91.12 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.191 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' X' ' 39' ' ' GLU . 72.2 t -57.64 -48.97 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 O-C-N 124.405 1.066 . . . . 0.0 109.349 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 76.5 mt -65.21 -43.05 92.79 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.53 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.2 mt -59.99 -49.83 76.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.566 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' X' ' 36' ' ' VAL . 0.0 OUTLIER -70.9 -35.07 72.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.332 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.546 ' O ' HG12 ' X' ' 44' ' ' ILE . 24.0 t60 -66.07 -46.17 78.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.585 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.646 ' CD2' HD12 ' X' ' 54' ' ' ILE . 43.4 t80 -58.15 -53.28 60.03 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.43 HG23 ' O ' ' X' ' 47' ' ' HIS . 7.2 p -66.95 -32.6 58.72 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.606 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 42.9 pttt -75.21 -27.73 59.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.546 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.5 pt -84.13 -39.6 14.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.566 HG23 ' O ' ' X' ' 41' ' ' PHE . 15.1 t -85.18 -27.35 26.21 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 61.36 38.35 16.29 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 122.142 0.972 . . . . 0.0 111.238 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.43 ' O ' HG23 ' X' ' 42' ' ' VAL . 44.6 t-80 -94.32 132.94 28.0 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.542 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.7 -16.39 33.62 Favored 'Trans proline' 0 CA--C 1.495 -1.455 0 C-N-CA 123.042 2.494 . . . . 0.0 113.184 -173.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -120.78 30.48 6.88 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.536 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.12 -56.54 6.85 Favored Glycine 1 CA--C 1.447 -4.178 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.083 -177.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.452 HG23 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -79.13 -26.9 42.82 Favored 'General case' 0 C--N 1.249 -3.796 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.512 -170.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -58.38 -46.49 86.26 Favored 'General case' 0 C--O 1.189 -2.109 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -52.58 -46.01 66.73 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.646 HD12 ' CD2' ' X' ' 41' ' ' PHE . 3.9 mp -68.33 -47.15 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.256 -1.378 . . . . 0.0 109.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.01 -45.39 90.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.534 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 12.8 mm-40 -65.49 -44.88 85.71 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 122.765 0.426 . . . . 0.0 111.688 -178.506 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.52 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.418 -2.526 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.609 ' O ' HG12 ' X' ' 76' ' ' VAL . 10.6 Cg_endo -55.52 -50.49 12.59 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 124.154 3.236 . . . . 0.0 113.63 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.23 1.17 19.33 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.14 -39.9 1.9 Allowed Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 118.998 -1.572 . . . . 0.0 112.571 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.52 HG12 ' O ' ' X' ' 71' ' ' GLY . 5.1 pt -61.8 -31.69 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-N 117.164 0.482 . . . . 0.0 110.923 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.609 HG12 ' O ' ' X' ' 72' ' ' PRO . 15.6 m -61.06 -33.08 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 121.086 0.47 . . . . 0.0 112.182 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 60.3 tttm -67.8 -48.01 67.49 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -61.45 -36.59 80.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.646 0.736 . . . . 0.0 109.317 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mm -66.81 -46.62 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.076 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -71.05 -39.61 72.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.101 0.477 . . . . 0.0 111.857 -173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.1 mt-10 -66.59 -32.37 73.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.287 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -66.05 -47.65 73.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.96 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' X' ' 83' ' ' ARG . 0.0 OUTLIER -66.58 -37.3 84.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.192 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.2 99.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 123.987 0.804 . . . . 0.0 110.718 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.06 -32.4 59.26 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.624 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -76.13 -39.84 54.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.753 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.15 32.45 3.75 Favored Glycine 0 C--N 1.318 -0.466 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -110.6 163.07 18.12 Favored Pre-proline 0 N--CA 1.418 -2.06 0 C-N-CA 124.336 1.055 . . . . 0.0 109.481 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.32 141.13 61.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.406 2.071 . . . . 0.0 112.384 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.5 -155.26 19.33 Favored Glycine 0 N--CA 1.42 -2.427 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.18 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -78.18 151.77 33.05 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -81.7 160.39 23.69 Favored 'General case' 0 N--CA 1.382 -3.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.41 133.93 37.46 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.828 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.539 HD21 ' CD2' ' X' ' 40' ' ' HIS . 95.1 mt . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -107.23 156.45 18.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -77.72 -22.24 50.71 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.581 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 58.0 p -143.21 164.58 29.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.151 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.07 -16.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 111.496 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -14.62 61.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.117 0.484 . . . . 0.0 111.61 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -103.51 3.3 34.64 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' X' ' 44' ' ' ILE . 2.5 m-85 -96.91 112.84 24.42 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.904 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' X' ' 14' ' ' GLU . 46.6 p -76.95 155.22 32.88 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 172.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.586 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -56.95 -39.84 75.32 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.6 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.2 73.7 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.404 ' HB2' ' OG1' ' X' ' 11' ' ' THR . 0.7 OUTLIER -57.75 -42.16 83.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.744 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.1 t80 -67.2 -54.01 25.05 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.372 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.586 HG13 ' O ' ' X' ' 12' ' ' GLU . 10.5 m -60.09 -32.82 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.46 -42.95 78.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.652 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.8 tm? -63.24 -40.07 96.41 Favored 'General case' 0 C--O 1.205 -1.237 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 56.5 mt -64.8 -36.44 84.32 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.637 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.449 ' HG2' ' CG ' ' X' ' 72' ' ' PRO . 48.2 mttp -66.18 -37.58 85.94 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.59 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.17 -31.88 66.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.536 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.652 HG13 ' O ' ' X' ' 18' ' ' LEU . 29.9 mt -66.11 -45.54 90.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.04 -42.0 84.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.383 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.55 -47.16 87.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.596 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.557 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -79.65 -24.67 41.69 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.983 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -65.05 -43.77 91.2 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.716 0.293 . . . . 0.0 110.27 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.5 m -76.28 -34.72 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.534 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -29.63 67.67 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.762 0.791 . . . . 0.0 109.097 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 76.49 87.57 0.08 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 127.469 2.307 . . . . 0.0 113.855 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -109.22 175.59 5.4 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -136.31 -4.68 2.1 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.03 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.454 ' O ' HG23 ' X' ' 36' ' ' VAL . 17.7 p-10 -86.14 -62.81 1.43 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.568 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.0 p -81.54 -26.03 10.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.557 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.8 tm? -58.06 -46.27 85.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.626 175.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 37.3 t70 -61.24 -45.83 92.93 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.539 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.454 HG23 ' O ' ' X' ' 32' ' ' ASP . 42.9 t -62.01 -50.01 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 O-C-N 124.4 1.063 . . . . 0.0 110.92 -176.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 91.1 mt -67.9 -41.81 82.12 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.937 -172.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.2 mt -59.36 -50.13 75.16 Favored 'General case' 0 N--CA 1.417 -2.107 0 O-C-N 124.122 0.888 . . . . 0.0 111.72 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.1 pt-20 -71.82 -36.52 70.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.607 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 5.0 t60 -65.78 -38.28 88.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.598 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 31.7 t80 -62.7 -51.66 66.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.14 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.425 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 5.9 p -67.17 -32.57 58.28 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.848 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -68.65 -30.13 68.76 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.999 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.491 HG12 ' O ' ' X' ' 40' ' ' HIS . 9.5 pt -83.96 -42.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 122.146 -0.346 . . . . 0.0 111.635 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.592 HG21 ' O ' ' X' ' 41' ' ' PHE . 6.0 t -84.16 -28.39 27.44 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.608 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 62.91 26.14 15.4 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.415 ' O ' HG22 ' X' ' 42' ' ' VAL . 42.6 t-80 -75.09 134.26 74.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.562 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -69.93 -14.45 35.55 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.831 2.354 . . . . 0.0 112.082 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.18 29.68 6.03 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.598 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.96 -57.88 8.3 Favored Glycine 0 CA--C 1.455 -3.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.107 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.431 ' CG2' HD13 ' X' ' 38' ' ' LEU . 1.4 m -73.34 -29.15 62.47 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.755 -172.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.6 97.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.658 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -57.73 -43.31 85.22 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 123.558 0.536 . . . . 0.0 112.251 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.401 HD12 HG22 ' X' ' 22' ' ' ILE . 64.2 mt -66.59 -42.2 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 121.684 0.754 . . . . 0.0 110.044 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.77 91.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.05 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.24 77.78 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.948 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.443 0 O-C-N 123.222 0.326 . . . . 0.0 110.809 178.234 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.073 0 CA-C-O 121.208 0.338 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.513 ' O ' HG12 ' X' ' 76' ' ' VAL . 18.0 Cg_endo -60.57 -29.05 87.73 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 124.755 3.637 . . . . 0.0 113.9 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.469 ' C ' HG22 ' X' ' 76' ' ' VAL . 84.0 mt-10 -95.66 1.96 53.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.676 0.274 . . . . 0.0 110.326 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.78 -37.47 3.19 Favored Glycine 0 N--CA 1.426 -1.984 0 C-N-CA 118.587 -1.768 . . . . 0.0 111.803 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.517 ' CD1' HD12 ' X' ' 19' ' ' LEU . 9.0 pt -58.33 -32.11 44.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 120.68 0.276 . . . . 0.0 110.927 174.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.513 HG12 ' O ' ' X' ' 72' ' ' PRO . 19.1 m -63.93 -36.65 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -67.14 -38.12 84.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -68.67 -40.59 80.08 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.436 HG23 ' OG1' ' X' ' 45' ' ' THR . 22.0 mm -61.98 -46.57 96.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.771 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -66.95 -41.01 87.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.396 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.46 -31.96 73.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.562 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 91.3 t90 -72.24 -48.94 38.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.196 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' X' ' 88' ' ' LYS . 10.1 ttt85 -71.17 -37.02 72.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.623 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.18 87.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.741 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.23 -26.35 65.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.117 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.38 -22.02 57.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 120.943 0.402 . . . . 0.0 110.162 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 49.91 16.3 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 60.3 tttp -133.6 126.53 19.11 Favored Pre-proline 0 N--CA 1.414 -2.241 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.72 119.42 5.58 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.283 3.322 . . . . 0.0 113.887 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.63 -127.12 4.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.255 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -79.3 151.55 31.01 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 120.555 0.217 . . . . 0.0 110.577 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 20.4 ptmt -93.31 179.1 5.51 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -110.91 142.24 43.25 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 123.031 0.532 . . . . 0.0 109.738 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.119 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 76.5 mt . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 121.887 0.851 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.429 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 26.7 mmtt -104.85 -162.06 0.86 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -119.56 -31.64 4.53 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.201 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.2 p -126.07 166.95 16.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.531 HG23 HH12 ' X' ' 83' ' ' ARG . 7.9 tt -81.1 -0.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.975 0.893 . . . . 0.0 111.275 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.8 m -80.99 -10.13 59.75 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.28 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 18.9 t70 -106.85 1.27 24.58 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.421 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 7.9 m-85 -98.6 114.14 26.48 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.121 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' X' ' 14' ' ' GLU . 76.9 p -79.6 160.54 26.36 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.576 ' O ' HG12 ' X' ' 16' ' ' VAL . 10.9 pt-20 -61.19 -36.94 81.22 Favored 'General case' 0 C--O 1.2 -1.552 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.828 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.475 ' HA ' HG21 ' X' ' 16' ' ' VAL . . . -70.35 -38.7 74.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.43 ' HB2' ' OG1' ' X' ' 11' ' ' THR . 1.0 OUTLIER -59.98 -42.18 93.64 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.111 0.958 . . . . 0.0 108.769 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' X' ' 19' ' ' LEU . 48.1 t80 -68.33 -49.02 63.25 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.534 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.747 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 18.7 m -57.78 -41.73 80.35 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 CA-C-N 117.98 0.355 . . . . 0.0 110.206 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -61.27 -49.4 77.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.698 0.799 . . . . 0.0 110.366 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.491 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -64.18 -41.96 96.89 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.482 HD23 ' CD1' ' X' ' 75' ' ' ILE . 13.9 tp -59.7 -44.27 93.76 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.913 1.285 . . . . 0.0 111.319 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.747 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.7 mttt -61.56 -35.21 77.15 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.904 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.12 -38.31 82.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.491 HG13 ' O ' ' X' ' 18' ' ' LEU . 23.2 mt -61.07 -43.73 96.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -34.97 73.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.81 -50.95 37.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -25.22 68.0 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.461 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -66.94 -55.41 14.71 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.254 1.022 . . . . 0.0 110.132 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 m -73.22 -21.43 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.75 -12.44 51.03 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.5 57.81 6.18 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.754 1.222 . . . . 0.0 110.982 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -78.17 -24.93 47.06 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.474 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 66.89 -64.31 0.24 Allowed 'General case' 0 C--O 1.205 -1.254 0 C-N-CA 126.043 1.737 . . . . 0.0 114.948 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.486 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.7 t70 -57.29 -57.09 14.14 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.252 0.478 . . . . 0.0 111.573 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.678 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -80.26 -30.7 12.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.35 -175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.614 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.22 -45.47 91.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.611 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.81 -36.55 83.81 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.317 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.486 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -57.31 -49.11 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 87.3 mt -67.99 -43.26 79.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.109 -173.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.0 mt -59.24 -43.73 92.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.938 0.774 . . . . 0.0 110.991 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.12 -45.17 70.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.65 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.7 t60 -60.86 -45.7 93.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.018 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.596 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 58.8 t80 -58.65 -51.67 68.94 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.676 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.441 HG13 ' O ' ' X' ' 38' ' ' LEU . 9.8 p -67.59 -34.11 66.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -71.86 -30.46 65.46 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.697 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.65 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.8 pt -84.1 -36.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.689 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -76.2 -42.57 45.8 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.524 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 61.5 30.23 18.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.922 1.289 . . . . 0.0 109.864 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' X' ' 49' ' ' ASP . 61.9 t-80 -89.12 133.38 35.32 Favored Pre-proline 0 N--CA 1.415 -2.222 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 175.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.04 16.67 0.53 Allowed 'Trans proline' 0 CA--C 1.497 -1.352 0 C-N-CA 122.908 2.405 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 3.2 m-20 -142.99 23.06 1.9 Allowed 'General case' 0 N--CA 1.394 -3.255 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.596 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.16 -66.49 1.04 Allowed Glycine 0 CA--C 1.462 -3.255 0 O-C-N 124.724 1.265 . . . . 0.0 113.821 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.454 HG22 HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -71.54 -26.03 62.47 Favored 'General case' 0 C--N 1.258 -3.4 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.842 -173.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.44 -38.3 90.55 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.675 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 96.5 mt -57.83 -46.51 84.64 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 124.202 0.939 . . . . 0.0 111.258 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.14 -46.67 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.843 0.83 . . . . 0.0 109.891 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.23 -38.99 93.34 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.167 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.2 pt-20 -71.82 -36.45 70.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.012 176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.18 177.361 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.401 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.397 -3.911 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.457 ' CG ' ' HG2' ' X' ' 20' ' ' LYS . 3.9 Cg_exo -46.53 -52.36 7.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 125.257 3.971 . . . . 0.0 114.101 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -76.84 1.54 17.13 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.7 -39.28 1.91 Allowed Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.062 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.564 ' O ' HG13 ' X' ' 79' ' ' ILE . 2.5 pt -60.87 -33.0 53.71 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-N 117.261 0.531 . . . . 0.0 111.097 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.418 HG12 ' O ' ' X' ' 72' ' ' PRO . 9.7 m -59.16 -32.29 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.468 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 25.0 ttmm -67.9 -42.38 81.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.078 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.27 -43.25 99.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.564 HG13 ' O ' ' X' ' 75' ' ' ILE . 76.9 mt -64.74 -44.14 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.868 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 19.1 ptpt -66.85 -43.47 83.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.747 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 42.0 mt-10 -67.95 -32.01 72.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.86 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -66.9 -48.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.531 HH12 HG23 ' X' ' 7' ' ' ILE . 1.3 mpp_? -70.77 -37.36 73.37 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.8 92.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.788 0.68 . . . . 0.0 110.498 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.1 -26.33 56.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 111.513 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.568 ' ND2' ' HD3' ' X' ' 88' ' ' LYS . 4.5 t30 -77.33 -31.37 54.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.807 0.337 . . . . 0.0 110.578 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.55 40.06 5.14 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.568 ' HD3' ' ND2' ' X' ' 86' ' ' ASN . 12.7 mtpp -130.74 155.55 81.16 Favored Pre-proline 0 N--CA 1.416 -2.159 0 C-N-CA 123.504 0.722 . . . . 0.0 109.749 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.06 125.86 20.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.262 2.642 . . . . 0.0 112.586 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . 0.418 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -106.7 -95.65 2.42 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.663 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.74 148.83 52.6 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -85.04 164.9 17.95 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.64 136.24 36.29 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.66 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.254 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.444 ' CD2' HD13 ' X' ' 18' ' ' LEU . 40.1 mt . . . . . 0 CA--C 1.499 -1.01 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -97.06 -159.44 0.74 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -116.88 -27.24 6.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.07 0.462 . . . . 0.0 110.487 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 92.7 p -136.56 166.98 22.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt -67.3 -11.92 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 121.52 0.676 . . . . 0.0 110.618 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -75.37 -27.07 58.98 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.35 -170.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.62 -4.72 40.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.525 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -80.53 115.25 19.95 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.415 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 71.0 p -76.3 159.72 30.3 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 169.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.649 ' O ' HG11 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.26 -34.84 74.28 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.032 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.424 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.25 -37.94 75.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -58.55 -39.45 80.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.56 0.695 . . . . 0.0 109.416 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.474 ' O ' HD11 ' X' ' 19' ' ' LEU . 42.5 t80 -71.8 -44.22 64.33 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.156 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.649 HG11 ' O ' ' X' ' 12' ' ' GLU . 7.6 m -61.94 -37.16 77.58 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.442 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.405 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -49.16 78.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.848 0.859 . . . . 0.0 108.778 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.661 ' O ' HG13 ' X' ' 22' ' ' ILE . 16.9 tp -57.53 -48.04 80.38 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.055 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' X' ' 23' ' ' GLU . 8.1 mp -60.36 -40.25 90.1 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.707 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 80.9 mttt -63.41 -35.59 80.93 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.218 0.532 . . . . 0.0 110.034 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -69.43 -42.4 75.06 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.661 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.9 mt -61.23 -42.3 92.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.333 0 O-C-N 124.073 0.858 . . . . 0.0 109.645 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' X' ' 19' ' ' LEU . 51.7 mt-10 -57.33 -46.29 83.41 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.5 -51.8 67.9 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.681 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.431 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 3.0 pp20? -79.38 -21.75 45.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.44 -46.05 64.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.35 -33.08 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 110.557 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.25 -6.44 59.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.389 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.44 83.65 0.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.135 1.774 . . . . 0.0 114.435 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 16.4 p -99.72 -172.67 2.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.15 -29.76 0.88 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.614 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.474 ' O ' HG21 ' X' ' 36' ' ' VAL . 28.1 m-20 -70.68 -62.31 1.44 Allowed 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.336 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.696 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.6 p -78.85 -27.34 13.67 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.941 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.438 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.3 tm? -58.44 -47.07 85.18 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.212 1.005 . . . . 0.0 109.527 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.3 -28.19 62.93 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.474 HG21 ' O ' ' X' ' 32' ' ' ASP . 64.8 t -67.72 -50.72 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.977 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.506 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 51.6 mt -69.66 -43.99 71.44 Favored 'General case' 0 N--CA 1.412 -2.332 0 O-C-N 124.513 1.133 . . . . 0.0 111.711 -170.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.434 HD23 HG22 ' X' ' 51' ' ' THR . 28.4 mt -60.93 -46.41 90.81 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 124.233 0.958 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -70.74 -39.47 73.3 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.039 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.572 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.6 t60 -63.43 -45.44 90.94 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.245 0.545 . . . . 0.0 109.716 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.582 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 37.9 t80 -59.05 -53.46 58.18 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.665 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.433 HG12 ' O ' ' X' ' 38' ' ' LEU 0.252 11.9 p -68.08 -32.29 55.45 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.969 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 50.9 pttt -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.192 -0.317 . . . . 0.0 111.595 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.509 HG12 ' O ' ' X' ' 40' ' ' HIS . 31.5 pt -88.27 -31.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.058 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 47.1 p -85.06 -35.25 21.98 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 120.93 0.395 . . . . 0.0 111.285 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.82 29.53 17.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 125.353 1.461 . . . . 0.0 110.778 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 32.1 t-80 -76.08 138.57 68.75 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 107.861 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.9 Cg_exo -74.26 -6.89 19.06 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 C-N-CA 123.146 2.564 . . . . 0.0 112.151 -176.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.476 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.9 m-20 -130.71 30.63 4.63 Favored 'General case' 0 N--CA 1.389 -3.477 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.582 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.51 -59.82 6.85 Favored Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.617 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.505 ' O ' ' HD2' ' X' ' 55' ' ' TYR . 0.0 OUTLIER -76.97 -28.28 55.09 Favored 'General case' 0 C--N 1.248 -3.828 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.847 -176.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.615 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.74 -42.97 98.41 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.227 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.36 -49.23 76.83 Favored 'General case' 0 C--O 1.208 -1.085 0 O-C-N 123.525 0.515 . . . . 0.0 112.119 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 79.2 mt -67.74 -42.16 85.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.819 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.505 ' HD2' ' O ' ' X' ' 51' ' ' THR . 15.3 m-85 -60.21 -47.0 87.83 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.585 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.615 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 10.4 pt-20 -71.12 -36.43 72.12 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.687 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.063 0 O-C-N 123.305 0.378 . . . . 0.0 110.438 178.883 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.481 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.41 -3.078 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.583 ' O ' HG13 ' X' ' 76' ' ' VAL . 19.3 Cg_endo -61.96 -47.52 10.47 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.081 3.188 . . . . 0.0 112.825 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.414 ' C ' HG21 ' X' ' 76' ' ' VAL . 43.2 mt-10 -77.37 1.24 19.53 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 -35.03 2.82 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 118.526 -1.797 . . . . 0.0 112.651 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.481 HG12 ' O ' ' X' ' 71' ' ' GLY . 3.6 pt -65.36 -29.38 47.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.761 173.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.583 HG13 ' O ' ' X' ' 72' ' ' PRO . 19.6 m -63.38 -35.04 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.7 0 CA-C-O 121.407 0.622 . . . . 0.0 111.419 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 61.9 tttm -66.88 -39.26 87.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.151 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.13 -38.34 90.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.13 -46.56 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.256 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 18.0 ptpt -66.94 -39.98 87.45 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.816 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.61 -35.85 77.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.377 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.51 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.0 t90 -67.66 -48.05 67.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.629 0.728 . . . . 0.0 109.19 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.422 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 18.4 tpt180 -61.34 -45.75 93.1 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.219 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.65 83.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.66 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.96 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.26 0.35 . . . . 0.0 110.852 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.42 ' OD1' ' HE2' ' X' ' 88' ' ' LYS . 17.5 t-20 -69.08 -37.37 78.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.56 29.38 5.36 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.15 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.42 ' HE2' ' OD1' ' X' ' 86' ' ' ASN . 64.0 mttm -106.41 147.53 35.09 Favored Pre-proline 0 N--CA 1.401 -2.904 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.45 130.03 25.55 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.4 2.066 . . . . 0.0 110.751 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.88 -128.51 5.4 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.689 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -88.72 154.85 19.96 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.2 pttt -90.06 163.97 14.68 Favored 'General case' 0 N--CA 1.39 -3.464 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.49 141.18 29.27 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.276 -2.752 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 175.838 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 73.0 mt . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 35.0 mmtt -99.94 -178.77 3.95 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.376 0.607 . . . . 0.0 110.065 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -104.81 -13.67 15.78 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.47 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -142.73 160.04 41.07 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.1 tt -69.1 -22.89 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.378 0.608 . . . . 0.0 110.746 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -84.36 -2.91 57.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.384 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.459 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -98.67 -3.45 35.98 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.43 ' C ' ' HG2' ' X' ' 92' ' ' LYS . 5.9 m-85 -98.62 121.98 41.25 Favored 'General case' 0 CA--C 1.475 -1.941 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.949 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.61 ' O ' HG13 ' X' ' 16' ' ' VAL . 12.9 pt-20 -63.37 -33.79 76.31 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.829 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.455 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.77 -38.25 76.68 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.357 0.123 . . . . 0.0 110.998 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -59.1 -37.51 77.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.643 0.735 . . . . 0.0 109.477 173.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.602 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 33.6 t80 -74.27 -40.88 62.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.483 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.61 HG13 ' O ' ' X' ' 12' ' ' GLU . 6.3 m -62.58 -32.08 54.17 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.214 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.16 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.05 -46.06 82.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.611 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -58.82 -44.33 90.84 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.799 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.8 mt -58.22 -40.24 81.13 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.197 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.62 ' O ' ' HB3' ' X' ' 23' ' ' GLU . 95.7 mttt -70.22 -34.11 72.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.338 0.589 . . . . 0.0 110.224 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.82 -42.2 98.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.898 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.611 HG13 ' O ' ' X' ' 18' ' ' LEU . 17.6 mt -65.13 -39.52 85.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.62 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 12.8 tt0 -57.24 -47.82 80.4 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 124.343 1.057 . . . . 0.0 108.459 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -47.92 81.49 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.146 -178.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.431 ' OE1' ' HB ' ' X' ' 33' ' ' VAL . 28.6 mm-40 -68.72 -31.7 70.95 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.2 -44.07 22.6 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.237 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.97 -25.86 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.51 -4.29 45.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 45.14 78.8 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.744 1.618 . . . . 0.0 112.987 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.525 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 81.8 p -99.58 -160.51 0.81 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.098 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.57 -63.51 0.67 Allowed 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.612 ' O ' HG22 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.64 -60.02 3.85 Favored 'General case' 0 CA--C 1.472 -2.053 0 O-C-N 123.718 0.637 . . . . 0.0 112.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -82.75 -25.9 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.186 -172.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.607 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -59.16 -46.94 87.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 31.0 t70 -66.72 -43.58 83.88 Favored 'General case' 0 CA--C 1.479 -1.766 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.001 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.612 HG22 ' O ' ' X' ' 32' ' ' ASP . 49.8 t -55.95 -50.23 70.46 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 O-C-N 124.114 0.884 . . . . 0.0 110.493 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 77.6 mt -69.23 -39.03 78.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 O-C-N 124.423 1.077 . . . . 0.0 112.123 -173.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.3 mt -60.25 -50.18 74.66 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.0 0.813 . . . . 0.0 110.69 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 2.7 pt-20 -71.41 -33.79 69.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.529 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.546 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 34.9 t60 -61.37 -45.89 92.47 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.534 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 69.6 t80 -60.7 -54.11 49.24 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.841 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.494 HG13 ' O ' ' X' ' 38' ' ' LEU . 4.8 p -67.22 -32.87 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.9 ptmm? -68.12 -42.43 80.24 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.82 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.523 HG12 ' O ' ' X' ' 40' ' ' HIS . 12.2 pt -77.1 -34.49 21.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.721 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 77.1 p -84.32 -39.19 19.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.459 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 58.81 74.81 0.42 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.537 1.16 . . . . 0.0 110.382 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -123.82 132.49 24.29 Favored Pre-proline 0 N--CA 1.405 -2.679 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.3 -18.59 55.7 Favored 'Trans proline' 0 CA--C 1.498 -1.304 0 C-N-CA 122.99 2.46 . . . . 0.0 111.885 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.421 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 15.3 m-20 -126.99 33.89 4.85 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -170.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.534 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.85 -55.81 7.06 Favored Glycine 0 CA--C 1.461 -3.288 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.866 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.424 HG23 HD22 ' X' ' 38' ' ' LEU 0.313 1.9 p -85.25 -17.19 37.73 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 117.208 -1.797 . . . . 0.0 113.618 -176.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.88 -35.52 80.28 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.35 -40.71 96.41 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 123.604 0.565 . . . . 0.0 110.937 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 17.9 mm -66.57 -46.27 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.796 0.808 . . . . 0.0 109.773 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -63.02 -43.39 98.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.415 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -71.39 -37.32 71.57 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.791 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 C-N-CA 122.32 0.248 . . . . 0.0 111.347 179.688 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.093 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.569 ' O ' HG13 ' X' ' 75' ' ' ILE . 9.6 Cg_endo -54.04 -34.59 78.19 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 124.457 3.438 . . . . 0.0 112.131 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.67 0.63 5.2 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.64 -10.78 28.23 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 118.836 -1.649 . . . . 0.0 113.248 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.569 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -74.15 -44.86 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.486 HG11 HG11 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -55.56 -43.07 71.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.266 175.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 21.7 ttmm -60.48 -47.63 85.31 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.869 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.81 -37.87 86.02 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.122 0.963 . . . . 0.0 108.592 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.488 ' HA ' HH21 ' X' ' 83' ' ' ARG . 36.2 mm -65.58 -45.75 91.53 Favored 'Isoleucine or valine' 0 C--O 1.254 1.304 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.086 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.6 ptpt -63.17 -37.68 88.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.282 0.364 . . . . 0.0 110.86 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 35.7 mt-10 -71.28 -43.91 66.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -62.96 -41.02 99.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.488 HH21 ' HA ' ' X' ' 79' ' ' ILE . 0.5 OUTLIER -61.94 -45.33 94.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.504 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -39.58 93.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.678 0.611 . . . . 0.0 111.324 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.79 82.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.449 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 23.1 t-20 -67.57 -46.96 71.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.26 22.87 5.7 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.449 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 61.3 mttm -102.02 144.73 29.16 Favored Pre-proline 0 N--CA 1.403 -2.815 0 C-N-CA 124.396 1.079 . . . . 0.0 108.114 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.15 132.76 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.697 1.598 . . . . 0.0 111.485 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -92.04 -117.81 2.33 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.038 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.403 ' CZ ' HG21 ' X' ' 76' ' ' VAL . 54.6 m-85 -99.61 166.19 11.25 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 21.9 ptmt -94.62 174.43 7.12 Favored 'General case' 0 N--CA 1.387 -3.605 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -120.67 136.12 54.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 CA-C-O 121.242 0.544 . . . . 0.0 110.659 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.737 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.461 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 78.3 mt . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.631 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 10.9 mptt -120.56 -178.4 3.7 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.793 -175.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.97 -46.44 12.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.446 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.3 p -140.42 167.91 21.03 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.549 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -61.59 -19.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.822 0.82 . . . . 0.0 110.542 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.1 m -82.26 -5.01 58.24 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.717 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.623 ' HB3' ' CG ' ' X' ' 4' ' ' LYS . 3.5 t70 -105.42 3.6 29.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.631 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 4.8 m-85 -105.37 118.11 35.72 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.314 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 18.2 p -79.22 163.76 24.73 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.674 ' O ' HG11 ' X' ' 16' ' ' VAL . 10.1 pt-20 -56.58 -42.17 78.2 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.002 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.539 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.86 -38.37 76.41 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.44 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 53.4 mm-40 -60.89 -36.35 79.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.74 0.781 . . . . 0.0 109.213 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 41.7 t80 -75.26 -42.92 53.99 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.517 -177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.674 HG11 ' O ' ' X' ' 12' ' ' GLU . 10.2 m -58.43 -33.61 48.42 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 O-C-N 123.215 0.322 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.69 -49.37 77.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.675 1.19 . . . . 0.0 110.171 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.492 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.5 tm? -61.77 -42.91 99.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.117 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -61.3 -42.66 99.02 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.366 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.0 mttt -63.87 -35.93 82.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.318 0.58 . . . . 0.0 109.975 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -67.56 -34.92 78.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.492 HG13 ' O ' ' X' ' 18' ' ' LEU . 25.5 mt -66.22 -42.25 90.69 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.17 -37.32 71.93 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.927 0.87 . . . . 0.0 110.666 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.1 -52.38 55.81 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.941 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 1.7 pp20? -97.61 -11.42 23.64 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 118.83 -1.148 . . . . 0.0 113.482 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.61 -38.06 83.48 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.074 0.464 . . . . 0.0 110.948 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.93 -20.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.302 0.572 . . . . 0.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -39.79 13.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.495 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.86 75.93 0.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.0 1.72 . . . . 0.0 109.768 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 49.2 p -78.75 -21.34 48.1 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.351 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 t70 72.99 -48.54 0.69 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.435 ' O ' HG22 ' X' ' 36' ' ' VAL . 21.1 t70 -63.07 -52.55 62.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.714 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 15.0 p -94.01 -25.26 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.857 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.663 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.4 tm? -58.02 -46.58 85.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.647 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 35.2 t70 -63.03 -42.5 99.79 Favored 'General case' 0 CA--C 1.473 -1.987 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.016 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.435 HG22 ' O ' ' X' ' 32' ' ' ASP . 39.2 t -61.55 -49.54 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 O-C-N 124.65 1.219 . . . . 0.0 110.837 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.7 mt -65.97 -43.68 87.15 Favored 'General case' 0 N--CA 1.415 -2.223 0 O-C-N 124.13 0.894 . . . . 0.0 110.362 -173.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.558 ' O ' HG11 ' X' ' 42' ' ' VAL . 32.4 mt -63.14 -50.65 69.58 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.73 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 16.7 pt-20 -71.76 -37.37 70.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.31 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.513 ' O ' HG12 ' X' ' 44' ' ' ILE . 8.9 t60 -59.89 -44.85 93.98 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.495 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 28.8 t80 -62.09 -56.93 13.96 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.438 1.086 . . . . 0.0 111.65 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.558 HG11 ' O ' ' X' ' 38' ' ' LEU 0.266 8.9 p -67.36 -31.18 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -67.6 -30.37 69.95 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.663 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.513 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.1 pt -91.4 -32.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.567 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -81.62 -36.8 28.5 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.315 0.578 . . . . 0.0 110.107 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.61 26.98 16.55 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.497 1.519 . . . . 0.0 111.022 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.0 130.74 80.23 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.509 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -67.19 -14.57 43.64 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 123.226 2.617 . . . . 0.0 112.745 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.04 32.46 5.24 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -173.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.495 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.15 -54.55 8.28 Favored Glycine 0 CA--C 1.457 -3.548 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.576 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.439 HG21 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -33.34 59.59 Favored 'General case' 0 C--N 1.257 -3.436 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.639 -172.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.35 -36.11 77.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.409 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 mt -58.02 -43.14 86.56 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 5.0 mp -66.79 -41.42 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.812 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -63.18 -50.27 70.99 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.6 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.1 pt-20 -66.62 -36.61 83.02 Favored 'General case' 0 C--O 1.206 -1.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.199 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.631 0 O-C-N 123.219 0.324 . . . . 0.0 110.63 178.1 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.801 0 CA-C-O 120.824 0.124 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.624 ' O ' HG11 ' X' ' 76' ' ' VAL . 32.5 Cg_endo -66.45 -41.0 12.77 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 124.617 3.544 . . . . 0.0 112.313 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.459 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.1 mt-10 -84.69 2.02 43.74 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.386 0.675 . . . . 0.0 110.182 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.79 -35.78 3.16 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.89 172.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.477 ' CD1' HD13 ' X' ' 19' ' ' LEU . 4.0 pt -64.78 -22.72 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-N 117.712 0.756 . . . . 0.0 111.582 173.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.624 HG11 ' O ' ' X' ' 72' ' ' PRO . 30.7 m -63.06 -39.21 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-O 121.601 0.715 . . . . 0.0 110.534 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 52.2 tttp -64.12 -42.69 96.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.691 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 39.7 mm-40 -58.3 -45.34 88.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.85 0.833 . . . . 0.0 109.526 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -64.46 -46.79 91.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.009 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 13.5 ptmm? -67.87 -36.32 80.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.761 -174.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.0 -36.69 69.82 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.141 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.509 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.4 t90 -62.97 -48.1 80.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 18.0 tpt180 -65.89 -45.89 80.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.913 -174.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.75 -40.93 79.57 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 122.853 0.461 . . . . 0.0 112.064 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.13 82.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.084 0.469 . . . . 0.0 109.962 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.09 -21.74 56.36 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.3 42.78 9.06 Favored Glycine 0 CA--C 1.498 -0.993 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.012 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.9 mtpp -122.44 144.35 41.86 Favored Pre-proline 0 N--CA 1.393 -3.289 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.93 127.69 20.1 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 122.803 2.336 . . . . 0.0 111.543 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.62 -110.08 3.12 Favored Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.578 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.56 161.67 20.1 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.093 0.473 . . . . 0.0 110.687 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' X' ' 11' ' ' THR . 21.3 ptmt -108.26 171.69 7.26 Favored 'General case' 0 N--CA 1.393 -3.305 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -106.93 140.93 38.95 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.498 0 CA-C-O 118.083 -1.399 . . . . 0.0 110.149 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' X' ' 18' ' ' LEU . 48.8 mt . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 120.864 0.364 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.468 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 25.1 mmtt -99.62 -160.34 0.8 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -117.7 -19.68 9.22 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.042 -0.411 . . . . 0.0 110.852 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 83.4 p -135.8 160.87 37.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.06 -21.92 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.613 0.765 . . . . 0.0 110.279 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 8' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 23.7 m -85.64 -1.75 57.47 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 25.6 t0 -101.67 -0.11 35.18 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.74 123.63 46.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.216 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.492 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 70.6 p -78.18 172.11 14.05 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.557 ' O ' HG11 ' X' ' 16' ' ' VAL . 8.0 pt-20 -56.33 -45.09 80.5 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.169 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.487 ' O ' HG23 ' X' ' 16' ' ' VAL . . . -70.44 -37.85 74.44 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.492 ' HB2' ' H ' ' X' ' 11' ' ' THR . 5.3 mm-40 -57.8 -35.94 71.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.385 0.612 . . . . 0.0 110.227 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.645 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 30.1 t80 -75.67 -40.51 55.86 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.9 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.557 HG11 ' O ' ' X' ' 12' ' ' GLU . 4.3 m -62.92 -28.99 46.08 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.923 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' X' ' 21' ' ' GLU . 0.9 OUTLIER -57.63 -48.79 78.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.605 ' O ' HG13 ' X' ' 22' ' ' ILE . 20.3 tp -61.81 -46.99 87.14 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 121.196 0.522 . . . . 0.0 110.655 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 37.2 mt -57.94 -36.88 73.13 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.924 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 95.9 mttt -70.78 -33.97 71.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.128 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' X' ' 17' ' ' GLN . 8.7 mm-40 -67.37 -43.27 81.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.605 HG13 ' O ' ' X' ' 18' ' ' LEU . 35.5 mt -58.81 -42.2 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.095 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.22 -47.84 82.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.695 1.198 . . . . 0.0 110.165 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.92 -52.1 58.28 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.73 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -17.19 64.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.426 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.53 -38.45 14.92 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.121 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.25 -33.25 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.214 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.83 -26.26 37.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 77.27 0.31 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.326 1.451 . . . . 0.0 112.913 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.9 p -98.55 -177.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.2 -56.09 1.44 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.887 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.596 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.2 p-10 -57.68 -55.7 31.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 123.535 0.522 . . . . 0.0 111.921 -175.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.725 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -81.33 -32.52 12.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.375 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.27 -45.81 90.22 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.154 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.76 -24.61 60.97 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.207 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.596 HG23 ' O ' ' X' ' 32' ' ' ASP . 88.7 t -61.01 -49.1 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.187 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 65.4 mt -68.11 -43.05 79.28 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.962 -173.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.1 mt -58.87 -46.57 87.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.292 0.995 . . . . 0.0 110.597 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.85 -40.93 72.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.087 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.6 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 63.9 t60 -62.4 -45.56 92.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.393 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.582 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.8 t80 -58.27 -51.73 68.53 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.752 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -67.86 -32.85 58.23 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.9 ptmt -68.96 -33.44 73.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 122.046 -0.409 . . . . 0.0 111.897 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.511 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.1 pt -85.13 -32.49 7.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.734 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 73.9 p -84.97 -33.62 22.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 56.8 33.59 23.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.664 1.186 . . . . 0.0 110.274 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.412 ' CE1' HD12 ' X' ' 53' ' ' LEU . 41.3 t-80 -80.61 134.46 54.19 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.225 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.459 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -67.77 -12.18 34.59 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 123.18 2.587 . . . . 0.0 112.437 -175.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -130.24 28.56 4.98 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.582 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.68 -62.59 2.84 Favored Glycine 1 CA--C 1.449 -4.049 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.741 -175.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.404 HG21 HD13 ' X' ' 38' ' ' LEU . 2.7 m -77.64 -23.99 49.59 Favored 'General case' 0 C--N 1.249 -3.774 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.24 -173.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.563 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.0 -34.95 78.66 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.03 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . 0.412 HD12 ' CE1' ' X' ' 47' ' ' HIS . 34.8 mt -62.91 -37.67 87.91 Favored 'General case' 0 CA--C 1.486 -1.493 0 O-C-N 123.362 0.414 . . . . 0.0 110.711 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.2 mt -66.46 -44.03 90.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.86 -44.62 95.63 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.261 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.7 pt-20 -68.52 -46.43 69.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.364 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.015 0 O-C-N 123.224 0.328 . . . . 0.0 111.456 -178.544 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.397 -3.904 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.502 ' O ' HG13 ' X' ' 75' ' ' ILE . 10.2 Cg_endo -57.81 -40.92 74.87 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.449 2.766 . . . . 0.0 111.785 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -74.12 0.75 12.9 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.137 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.59 -17.67 10.3 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.807 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.502 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -68.04 -41.96 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.458 HG11 HG12 ' X' ' 16' ' ' VAL . 1.0 OUTLIER -56.43 -44.6 80.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.714 177.051 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.456 ' H ' HG12 ' X' ' 76' ' ' VAL . 23.1 ttpp -57.98 -47.74 82.08 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.338 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.3 -36.24 73.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.456 0.646 . . . . 0.0 109.657 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.8 -45.81 71.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.369 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.2 pttp -64.32 -35.5 81.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.923 0.392 . . . . 0.0 110.48 -176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 49.5 mt-10 -69.22 -39.35 78.63 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.459 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -67.96 -47.29 69.02 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -60.9 -45.28 95.24 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.296 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.6 83.27 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.011 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.31 -33.73 75.89 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.502 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.15 -46.77 48.99 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.42 41.93 1.31 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -117.62 144.79 34.95 Favored Pre-proline 0 N--CA 1.399 -3.017 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.06 124.74 13.47 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 121.991 1.794 . . . . 0.0 109.862 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.55 -121.43 3.48 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.179 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -83.03 161.38 21.72 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.544 -0.828 . . . . 0.0 109.974 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' X' ' 8' ' ' SER . 21.0 ptmt -87.59 167.62 13.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.21 132.03 48.39 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.116 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 178.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.464 ' CD2' HD12 ' X' ' 18' ' ' LEU . 53.5 mt . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.7 mmtt -110.22 148.43 31.87 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.44 -1.21 55.27 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.021 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 53.0 p -147.08 158.46 43.94 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.8 tp -73.03 -12.41 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.241 0.543 . . . . 0.0 111.615 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.27 -14.27 60.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.421 0.629 . . . . 0.0 111.386 -173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.2 t70 -105.28 5.26 31.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -100.18 121.51 41.55 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.737 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 29.8 p -83.57 165.33 19.15 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.6 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.3 pt-20 -56.07 -43.62 78.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.346 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.97 -37.31 75.73 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 17.4 mm-40 -56.83 -39.73 74.75 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.631 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 16.9 t80 -72.81 -43.21 62.99 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.639 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.6 HG13 ' O ' ' X' ' 12' ' ' GLU . 4.3 m -62.74 -29.03 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.89 -44.91 88.09 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.565 ' O ' HG13 ' X' ' 22' ' ' ILE . 27.5 tp -61.42 -46.23 91.01 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.546 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 36.0 mt -57.24 -41.45 79.6 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.678 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.6 mttm -63.58 -35.84 81.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.664 175.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.08 -31.42 50.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.452 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.565 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.4 mt -62.27 -41.86 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -58.56 -40.62 83.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -60.4 -41.84 94.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.71 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -80.21 -32.19 38.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.292 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -61.16 -52.75 63.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.051 0.54 . . . . 0.0 111.646 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -65.91 -27.3 40.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.27 -20.96 26.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.73 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.69 61.57 2.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.737 1.215 . . . . 0.0 111.887 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.9 p -88.21 -164.8 1.17 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.359 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -134.2 -50.89 0.82 Allowed 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.998 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.53 ' O ' HG21 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.29 -63.06 1.27 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.629 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 90.5 t -85.93 -27.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.052 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.451 -173.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.595 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.8 tm? -58.85 -43.29 90.74 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.5 t70 -68.18 -42.06 80.52 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.118 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.53 HG21 ' O ' ' X' ' 32' ' ' ASP . 75.1 t -57.54 -50.23 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 O-C-N 124.058 0.849 . . . . 0.0 110.27 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 75.8 mt -67.98 -40.31 83.15 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.091 -170.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 26.5 mt -64.08 -49.13 73.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 O-C-N 124.328 1.017 . . . . 0.0 111.498 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.21 -36.68 71.96 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.5 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.573 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 77.6 t60 -60.82 -45.93 92.53 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' X' ' 54' ' ' ILE . 56.5 t80 -57.51 -53.63 55.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.778 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.494 HG11 ' O ' ' X' ' 38' ' ' LEU 0.264 4.6 p -67.14 -31.79 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 17.5 ptmt -71.4 -30.03 65.62 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.851 -0.53 . . . . 0.0 112.369 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.537 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.0 pt -88.96 -35.94 8.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.098 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.41 ' HB ' HD13 ' X' ' 79' ' ' ILE . 77.1 p -82.64 -36.91 25.61 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 110.597 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 64.22 31.22 13.25 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.466 1.507 . . . . 0.0 111.404 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.434 ' O ' HG22 ' X' ' 42' ' ' VAL . 43.7 t-80 -80.88 139.17 49.9 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.456 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.8 Cg_exo -70.94 -18.94 31.07 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 122.859 2.372 . . . . 0.0 112.454 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.404 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.1 35.76 4.71 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.502 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.6 -52.74 23.6 Favored Glycine 1 CA--C 1.447 -4.208 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.857 -177.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.478 ' CG2' HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.66 -32.06 57.72 Favored 'General case' 0 C--N 1.248 -3.839 0 C-N-CA 118.498 -1.281 . . . . 0.0 110.791 -172.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.59 -33.99 74.84 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.258 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.01 -43.23 91.53 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.551 HD12 ' CD2' ' X' ' 41' ' ' PHE . 4.8 mp -67.2 -42.43 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.708 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.403 ' HD2' ' O ' ' X' ' 51' ' ' THR . 49.8 m-85 -62.61 -46.13 89.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.686 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.1 pt-20 -71.57 -38.49 70.94 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.46 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-N 117.832 0.287 . . . . 0.0 110.57 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.252 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.476 ' O ' HG13 ' X' ' 75' ' ' ILE . 26.1 Cg_endo -64.51 -39.53 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.591 2.861 . . . . 0.0 111.974 -174.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.33 0.86 20.69 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.77 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.03 -20.97 8.01 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 119.196 -1.478 . . . . 0.0 113.027 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.476 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -63.07 -46.34 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.484 HG12 ' H ' ' X' ' 77' ' ' LYS . 0.9 OUTLIER -56.49 -46.96 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.86 177.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.484 ' H ' HG12 ' X' ' 76' ' ' VAL . 65.7 tttm -58.88 -48.2 82.25 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.632 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -58.46 -37.73 76.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.41 HD13 ' HB ' ' X' ' 45' ' ' THR . 38.6 mm -68.87 -46.83 78.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.765 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -66.81 -36.37 82.21 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.578 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.444 ' CD ' ' HZ2' ' X' ' 77' ' ' LYS . 47.8 mt-10 -72.42 -34.55 67.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.866 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.456 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 89.7 t90 -69.14 -46.15 68.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.57 . . . . 0.0 110.09 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -67.84 -35.99 79.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.065 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.598 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.58 81.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.762 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' X' ' 88' ' ' LYS . 25.7 t-20 -67.0 -41.25 87.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 46.77 4.58 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 106.607 -2.597 . . . . 0.0 106.607 -169.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' X' ' 86' ' ' ASN . 22.9 ttmm -121.33 135.57 25.11 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.54 114.87 2.14 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.348 2.699 . . . . 0.0 112.347 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.52 -116.14 3.78 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.805 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -86.51 155.01 20.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -91.42 -175.65 4.29 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.87 144.18 32.97 Favored 'General case' 0 N--CA 1.399 -2.994 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.153 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.048 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 35.3 mt . . . . . 0 N--CA 1.437 -1.121 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 30.8 mmtt -96.92 -176.2 3.49 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.514 0.673 . . . . 0.0 111.96 -173.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.7 -36.18 11.84 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 61.6 p -135.12 166.68 22.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.323 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.83 -16.52 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.446 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -69.98 -25.66 63.72 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.573 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.431 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 16.0 t0 -94.93 -15.65 23.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 13.2 m-85 -75.64 119.17 19.31 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.473 ' HA ' ' CB ' ' X' ' 92' ' ' LYS . 51.8 p -78.31 167.28 21.59 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.59 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.7 pt-20 -57.75 -41.01 81.04 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.981 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.501 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.68 -37.63 76.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.16 -37.72 83.89 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.581 -0.699 . . . . 0.0 110.264 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.546 ' O ' HD13 ' X' ' 19' ' ' LEU . 33.5 t80 -71.81 -44.51 63.81 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.557 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.642 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 9.9 m -60.5 -35.86 65.99 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -49.78 76.33 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.231 1.012 . . . . 0.0 110.142 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.645 ' O ' HG13 ' X' ' 22' ' ' ILE . 28.4 tp -58.03 -47.16 83.94 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.584 0.707 . . . . 0.0 110.118 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.546 HD13 ' O ' ' X' ' 15' ' ' PHE . 8.1 mp -60.95 -37.0 80.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.169 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 52.9 mtmt -66.5 -35.43 80.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -65.6 -45.07 84.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.825 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.645 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.4 mt -55.92 -39.58 57.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.436 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.26 -47.33 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.087 0.47 . . . . 0.0 110.761 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.25 -51.56 43.85 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.612 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.442 ' HG3' ' HG1' ' X' ' 30' ' ' THR . 0.7 OUTLIER -64.82 -23.25 67.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.305 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -71.6 -55.95 6.8 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.12 -20.77 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.46 -19.73 22.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.63 0.252 . . . . 0.0 110.553 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.6 64.37 1.77 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.275 1.03 . . . . 0.0 111.071 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.442 ' HG1' ' HG3' ' X' ' 25' ' ' GLU . 51.4 p -77.21 -26.23 52.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.369 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.26 22.9 t70 74.36 -68.5 0.21 Allowed 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 125.806 1.643 . . . . 0.0 115.076 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.59 ' O ' HG21 ' X' ' 36' ' ' VAL . 30.2 t70 -57.19 -55.9 28.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.093 0.86 . . . . 0.0 112.284 -174.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.795 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -78.32 -32.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.507 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.869 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.02 -45.89 89.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.3 t70 -65.01 -40.48 94.98 Favored 'General case' 0 CA--C 1.479 -1.788 0 O-C-N 123.369 0.418 . . . . 0.0 110.668 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.59 HG21 ' O ' ' X' ' 32' ' ' ASP . 98.3 t -54.62 -49.57 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.921 0 O-C-N 124.412 1.07 . . . . 0.0 109.193 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 54.9 mt -67.48 -41.05 85.2 Favored 'General case' 0 N--CA 1.405 -2.694 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.259 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.8 mt -60.57 -50.82 71.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.22 0.95 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.65 -36.66 70.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.445 ' O ' HG12 ' X' ' 44' ' ' ILE . 6.5 t60 -59.99 -46.15 90.4 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.601 ' O ' HG22 ' X' ' 45' ' ' THR . 57.4 t80 -59.94 -56.71 18.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.573 1.171 . . . . 0.0 110.948 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.456 HG12 ' O ' ' X' ' 38' ' ' LEU 0.271 8.4 p -66.62 -31.88 55.52 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.771 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -70.25 -28.33 65.16 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.811 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.445 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.7 pt -87.51 -39.0 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.653 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.601 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.77 -32.78 23.23 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.093 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.01 22.6 13.55 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.414 . . . . 0.0 112.306 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' X' ' 49' ' ' ASP . 55.3 t-80 -70.21 135.22 86.97 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.3 Cg_exo -70.22 4.52 2.34 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 123.527 2.818 . . . . 0.0 112.864 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' X' ' 47' ' ' HIS . 27.9 m-20 -136.83 27.25 2.99 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.17 -58.05 5.26 Favored Glycine 0 CA--C 1.476 -2.387 0 O-C-N 124.511 1.132 . . . . 0.0 113.199 -175.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.457 ' O ' ' HD2' ' X' ' 55' ' ' TYR 0.276 0.0 OUTLIER -79.34 -25.61 42.25 Favored 'General case' 0 C--N 1.257 -3.427 0 C-N-CA 118.059 -1.456 . . . . 0.0 113.65 -176.813 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.16 -37.31 87.0 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 65.2 mt -64.76 -37.86 89.02 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.676 0.61 . . . . 0.0 111.249 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.3 mt -66.78 -46.33 85.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.735 0.779 . . . . 0.0 109.461 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.457 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.8 m-85 -63.45 -46.74 84.88 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -64.24 -40.08 95.28 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.76 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . 0.421 ' HB1' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 C--O 1.201 -1.493 0 O-C-N 123.116 0.26 . . . . 0.0 111.387 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.773 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.604 ' O ' HG11 ' X' ' 76' ' ' VAL . 7.9 Cg_endo -57.02 -42.01 68.84 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.632 2.888 . . . . 0.0 110.623 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.512 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.6 mt-10 -78.35 1.93 20.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.205 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.17 -34.86 2.84 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 119.021 -1.561 . . . . 0.0 112.948 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.421 ' CG2' ' HB1' ' X' ' 57' ' ' ALA . 1.1 pt -67.2 -26.18 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-N 117.503 0.652 . . . . 0.0 110.765 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.604 HG11 ' O ' ' X' ' 72' ' ' PRO . 27.8 m -61.4 -34.44 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.141 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 60.6 tttm -61.79 -47.02 87.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.504 174.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.8 -43.71 90.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.567 0.699 . . . . 0.0 109.415 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.516 HG21 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -64.8 -46.54 91.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.22 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 17.4 pttp -67.44 -37.08 82.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.312 -174.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.92 -39.46 72.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.33 0.394 . . . . 0.0 111.35 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.592 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 70.4 t90 -64.79 -47.83 76.66 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.7 0.625 . . . . 0.0 109.443 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.605 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 16.2 tpt180 -61.45 -45.67 93.3 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.223 -176.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.69 -38.73 84.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.232 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.9 78.5 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.903 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -69.02 -36.16 77.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.8 41.94 2.78 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.605 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 55.7 mttm -118.97 147.96 43.62 Favored Pre-proline 0 N--CA 1.396 -3.172 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.79 130.17 32.02 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.229 1.952 . . . . 0.0 111.071 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -100.09 -140.63 11.49 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.302 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.1 m-85 -78.29 150.45 33.33 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.047 0.451 . . . . 0.0 110.945 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' X' ' 11' ' ' THR . 0.7 OUTLIER -72.72 157.37 37.65 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.979 174.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -85.46 1.16 49.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.004 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.261 -3.62 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.212 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.402 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 33.0 mmtt -108.72 160.31 16.05 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.0 -17.38 43.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.679 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.7 p -139.7 163.84 31.53 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.112 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.602 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.6 tp -64.92 -22.61 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.047 0.939 . . . . 0.0 110.023 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -76.32 -11.61 59.93 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.789 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 26.6 t0 -105.31 -7.17 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.882 0.849 . . . . 0.0 108.914 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -83.59 115.33 22.08 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.947 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 16.3 p -76.77 169.02 19.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.421 ' O ' HG11 ' X' ' 16' ' ' VAL . 9.3 pt-20 -60.86 -33.58 73.29 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 119.676 1.125 . . . . 0.0 112.173 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -44.07 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.381 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -57.22 -41.65 79.88 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.414 0.626 . . . . 0.0 109.949 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.553 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.3 t80 -65.75 -55.55 16.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' X' ' 19' ' ' LEU . 14.7 p -63.63 -27.79 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -60.77 -47.38 86.57 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.44 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.3 tm? -62.61 -40.79 98.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.123 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 21.9 mt -57.78 -43.8 85.81 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.787 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -61.32 -38.74 87.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.45 -31.64 70.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.594 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.44 HG13 ' O ' ' X' ' 18' ' ' LEU . 35.1 mt -66.68 -46.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -57.72 -34.53 69.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.807 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.28 -40.69 96.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.42 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.412 ' OE1' HD22 ' X' ' 34' ' ' LEU . 3.1 pp20? -88.57 -30.27 19.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.735 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -50.38 -47.61 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.81 1.244 . . . . 0.0 111.706 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -69.95 -17.14 20.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -105.52 -19.54 13.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.635 0.255 . . . . 0.0 110.565 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.52 87.64 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.436 1.495 . . . . 0.0 110.73 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.2 p -95.26 -164.62 1.18 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.48 -42.33 0.7 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.417 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.672 ' O ' HG23 ' X' ' 36' ' ' VAL . 13.8 t70 -71.1 -62.02 1.55 Allowed 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.527 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.664 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.3 p -75.8 -27.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.228 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.511 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.8 tm? -57.64 -52.84 63.77 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 124.258 1.023 . . . . 0.0 108.565 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.63 -25.51 60.34 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.294 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.672 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.3 t -68.5 -50.74 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.037 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.623 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.1 mt -68.87 -43.36 75.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 O-C-N 124.744 1.278 . . . . 0.0 111.36 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.463 ' O ' HG13 ' X' ' 42' ' ' VAL . 34.6 mt -61.14 -44.83 96.72 Favored 'General case' 0 N--CA 1.415 -2.191 0 O-C-N 124.274 0.984 . . . . 0.0 112.054 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -71.05 -42.95 68.79 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.782 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.531 ' O ' HG12 ' X' ' 44' ' ' ILE . 26.5 t60 -60.22 -45.92 91.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.47 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.545 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 34.2 t80 -62.77 -48.36 79.51 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.463 HG13 ' O ' ' X' ' 38' ' ' LEU . 14.1 p -67.52 -31.23 51.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 52.2 pttt -73.11 -35.08 66.5 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.602 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 21.7 pt -79.03 -32.46 15.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -83.55 -33.9 25.35 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.843 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.9 28.27 17.24 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.091 0.948 . . . . 0.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.514 ' ND1' ' HB2' ' X' ' 49' ' ' ASP . 54.8 t-80 -85.89 145.82 42.01 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.516 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.56 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.5 Cg_exo -77.48 12.97 1.71 Allowed 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.342 2.694 . . . . 0.0 112.643 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.514 ' HB2' ' ND1' ' X' ' 47' ' ' HIS . 0.8 OUTLIER -123.86 -64.38 1.15 Allowed 'General case' 0 N--CA 1.404 -2.743 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.545 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . 58.42 -84.33 0.01 OUTLIER Glycine 1 CA--C 1.428 -5.361 0 O-C-N 125.337 1.648 . . . . 0.0 111.997 177.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.427 ' CG2' HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.4 -37.27 74.45 Favored 'General case' 1 C--N 1.211 -5.44 0 CA-C-N 112.698 -1.751 . . . . 0.0 109.239 -172.138 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.07 -31.08 70.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.071 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.36 -42.19 96.32 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.423 0.452 . . . . 0.0 111.82 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' X' ' 41' ' ' PHE . 5.0 mp -67.27 -42.0 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.096 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -61.88 -41.86 98.38 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.81 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.8 pt-20 -71.74 -37.12 70.61 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.876 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.018 0 C-N-CA 122.943 0.497 . . . . 0.0 111.281 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.048 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.498 ' O ' HG13 ' X' ' 75' ' ' ILE . 20.3 Cg_endo -63.93 -30.92 67.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.026 2.484 . . . . 0.0 112.379 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.89 -11.65 59.91 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -99.8 -29.08 7.08 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 118.2 -1.952 . . . . 0.0 113.063 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.52 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.0 OUTLIER -60.52 -44.02 95.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.494 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 1.7 p -63.13 -43.68 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.996 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.587 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 85.9 tttt -61.71 -44.78 96.27 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 13.5 mm-40 -59.35 -45.13 92.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.481 0.658 . . . . 0.0 110.504 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.52 HG12 ' O ' ' X' ' 75' ' ' ILE . 48.2 mm -61.86 -45.33 98.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.972 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.2 ptmt -63.06 -38.07 89.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.347 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -71.7 -43.81 65.29 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.479 0.487 . . . . 0.0 111.847 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.56 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.3 t90 -63.98 -48.15 77.58 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.457 0.646 . . . . 0.0 110.916 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.409 ' HG2' ' CA ' ' X' ' 90' ' ' GLY . 12.0 tpt180 -60.9 -45.14 95.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.696 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.33 -38.18 81.29 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.199 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.62 88.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.132 0.492 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.454 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.5 t-20 -74.51 -42.2 59.34 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.91 31.77 3.77 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.454 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 63.7 mttm -102.35 146.66 32.74 Favored Pre-proline 0 N--CA 1.405 -2.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.44 126.62 17.28 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.046 1.831 . . . . 0.0 109.701 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . 0.409 ' CA ' ' HG2' ' X' ' 83' ' ' ARG . . . -110.88 -119.8 3.99 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.506 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.69 149.32 29.79 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.383 1.087 . . . . 0.0 113.422 -171.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' X' ' 11' ' ' THR . 28.3 ttpt -88.19 172.81 9.2 Favored 'General case' 1 N--CA 1.365 -4.716 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.148 174.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.06 27.67 1.04 Allowed 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 121.317 0.58 . . . . 0.0 112.198 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.277 -2.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.383 -177.376 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' X' ' 18' ' ' LEU . 37.2 mt . . . . . 0 CA--C 1.501 -0.922 0 CA-C-O 121.632 0.729 . . . . 0.0 111.877 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.54 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 39.4 mmtt -100.59 -161.47 0.87 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.106 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -117.82 -28.63 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.963 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -136.09 167.03 22.0 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.405 HD13 HH12 ' X' ' 83' ' ' ARG . 11.0 tp -66.96 -11.37 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.681 0.753 . . . . 0.0 110.316 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 8' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 8.2 m -70.1 -26.74 64.12 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.89 0.876 . . . . 0.0 111.294 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.477 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 10.2 t70 -105.01 5.74 32.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.652 0.739 . . . . 0.0 109.677 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 12.3 m-85 -95.87 124.98 40.11 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.646 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 45.4 p -89.4 171.67 9.57 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.5 -45.72 80.89 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.131 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.452 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.74 -38.46 73.52 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.84 -34.46 77.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.402 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -71.48 -43.06 67.27 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.723 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.604 HG13 ' O ' ' X' ' 12' ' ' GLU . 5.9 m -62.64 -29.94 48.11 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.468 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -61.74 -45.98 91.61 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.285 0.634 . . . . 0.0 109.865 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.609 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.7 tp -61.95 -48.19 81.51 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.469 HD13 HD13 ' X' ' 22' ' ' ILE . 4.3 mm? -60.46 -36.31 77.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.329 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 64.4 mttm -68.49 -36.93 79.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.85 -35.55 78.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.358 0.599 . . . . 0.0 110.104 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.609 HG13 ' O ' ' X' ' 18' ' ' LEU . 67.7 mt -63.06 -46.28 96.57 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.38 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.727 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -57.82 -45.5 86.06 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 109.802 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.28 -51.85 67.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.126 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.668 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 6.2 mm-40 -82.47 -14.67 54.67 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -69.85 -47.17 63.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 120.835 0.35 . . . . 0.0 110.191 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.4 -19.75 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.39 -18.67 25.05 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.969 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.37 72.76 0.38 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.146 1.378 . . . . 0.0 111.837 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.493 ' HG1' ' HB3' ' X' ' 25' ' ' GLU . 57.2 p -93.84 -168.4 1.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -134.84 -55.7 0.82 Allowed 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.894 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.532 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.0 p-10 -57.53 -48.08 80.25 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.739 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.8 p -87.92 -32.9 6.27 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.608 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.22 -44.56 92.29 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.713 0.805 . . . . 0.0 109.487 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.92 -32.38 69.29 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.924 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.532 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.4 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.142 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 66.2 mt -68.37 -43.03 78.26 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.707 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 15.9 mt -60.22 -45.08 94.45 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 124.265 0.978 . . . . 0.0 110.325 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -70.39 -38.75 74.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.985 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.535 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.6 t60 -64.41 -45.15 88.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.454 0.645 . . . . 0.0 109.627 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.589 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.7 t80 -59.04 -51.13 71.36 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -67.98 -33.03 58.84 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.869 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.1 ptmt -68.96 -36.12 77.53 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.039 0.447 . . . . 0.0 111.687 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.473 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.7 pt -79.17 -33.29 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.106 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -84.66 -39.69 18.3 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.317 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 63.8 31.77 13.92 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.694 1.198 . . . . 0.0 109.991 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' X' ' 49' ' ' ASP . 40.0 t-80 -80.38 135.34 53.81 Favored Pre-proline 0 N--CA 1.424 -1.77 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.117 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.545 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.0 Cg_exo -76.62 9.68 2.51 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 C-N-CA 123.367 2.711 . . . . 0.0 111.904 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' X' ' 47' ' ' HIS . 5.5 m-20 -140.8 19.14 2.33 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -172.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.589 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.88 -69.01 0.68 Allowed Glycine 0 CA--C 1.46 -3.4 0 O-C-N 124.38 1.05 . . . . 0.0 114.512 -173.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.423 ' CG2' HD12 ' X' ' 38' ' ' LEU . 0.6 OUTLIER -74.38 -18.84 60.61 Favored 'General case' 0 C--N 1.253 -3.593 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.026 -173.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -71.32 -34.19 70.35 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.58 -37.9 88.02 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.621 0.576 . . . . 0.0 110.645 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mt -66.94 -47.07 83.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.863 0.839 . . . . 0.0 109.092 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.05 -47.96 80.74 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.07 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.0 pt-20 -65.71 -36.64 84.18 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.217 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.68 0 CA-C-N 118.181 0.446 . . . . 0.0 110.947 178.77 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.026 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.545 ' O ' HG11 ' X' ' 76' ' ' VAL . 15.9 Cg_endo -57.02 -34.51 97.79 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 124.157 3.238 . . . . 0.0 113.664 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.486 ' C ' HG22 ' X' ' 76' ' ' VAL . 41.5 mt-10 -82.73 2.11 35.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.912 0.386 . . . . 0.0 112.024 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.59 -27.76 6.62 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.268 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' X' ' 78' ' ' GLU . 0.0 OUTLIER -66.23 -34.05 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.545 HG11 ' O ' ' X' ' 72' ' ' PRO . 29.2 m -64.7 -34.79 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.254 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.951 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.571 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 41.7 ttmt -64.79 -43.6 92.68 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 7.6 mm-40 -57.79 -45.09 86.54 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.978 0.894 . . . . 0.0 109.084 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 22.6 mm -62.34 -46.62 95.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.787 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -67.17 -35.64 80.09 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.69 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -69.26 -32.04 70.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.545 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.9 t90 -70.08 -48.58 57.13 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.122 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.424 ' HE ' ' HB2' ' X' ' 83' ' ' ARG . 0.0 OUTLIER -65.95 -37.2 85.41 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.591 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.77 90.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.785 0.678 . . . . 0.0 111.652 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.76 -44.88 39.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.95 0.405 . . . . 0.0 110.695 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.5 -33.93 73.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.208 0.528 . . . . 0.0 110.665 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.65 30.86 6.3 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -103.48 163.35 17.61 Favored Pre-proline 0 N--CA 1.405 -2.689 0 C-N-CA 124.042 0.937 . . . . 0.0 109.651 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 36.3 Cg_exo -62.47 131.05 32.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.913 2.409 . . . . 0.0 113.07 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.86 -150.56 24.4 Favored Glycine 0 N--CA 1.429 -1.815 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.529 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -85.42 150.02 25.01 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' X' ' 8' ' ' SER . 20.0 ptmt -77.89 165.14 24.49 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.32 133.02 36.24 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.256 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.604 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.479 ' CD2' HD11 ' X' ' 18' ' ' LEU . 31.9 mt . . . . . 0 CA--C 1.5 -0.944 0 CA-C-O 121.073 0.464 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -96.37 -162.34 0.95 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -115.05 -24.49 8.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.358 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.7 p -134.61 166.81 22.05 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -65.33 -15.18 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.381 0.672 . . . . 0.0 110.725 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 8' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 16.6 t -76.53 -20.64 56.69 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.882 -170.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 6.87 37.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 118.297 -1.361 . . . . 0.0 109.673 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.21 122.63 34.0 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.105 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.0 p -82.87 167.73 17.77 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.616 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.42 -42.92 92.94 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.189 -1.404 . . . . 0.0 111.85 176.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.426 ' O ' HG23 ' X' ' 16' ' ' VAL . . . -67.34 -38.76 85.37 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -59.13 -39.13 81.38 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.643 0.735 . . . . 0.0 110.1 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.662 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -74.78 -42.15 58.7 Favored 'General case' 0 N--CA 1.407 -2.581 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.017 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.616 HG13 ' O ' ' X' ' 12' ' ' GLU . 8.9 m -62.62 -32.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.41 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' X' ' 21' ' ' GLU . 20.5 tp60 -62.33 -43.98 97.56 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.629 ' O ' HG13 ' X' ' 22' ' ' ILE . 36.8 tp -61.71 -46.54 89.25 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-O 121.253 0.549 . . . . 0.0 109.974 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -57.32 -41.93 80.88 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.765 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.4 mttm -64.28 -41.97 96.65 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.22 0.534 . . . . 0.0 109.648 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' X' ' 17' ' ' GLN . 43.5 mt-10 -66.21 -38.1 87.16 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.042 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.629 HG13 ' O ' ' X' ' 18' ' ' LEU . 47.4 mt -60.15 -46.06 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.348 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.27 -43.58 88.03 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.365 0.602 . . . . 0.0 110.23 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . 0.492 ' HG3' ' OE2' ' X' ' 25' ' ' GLU . 26.1 tptp -59.5 -50.42 73.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.846 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.492 ' OE2' ' HG3' ' X' ' 24' ' ' LYS . 16.0 mm-40 -86.15 -5.61 59.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.339 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -79.23 -44.89 20.9 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.53 -32.39 52.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.256 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -19.67 42.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.752 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.83 80.87 0.19 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.343 1.457 . . . . 0.0 112.911 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 77.0 p -106.77 -169.49 1.56 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.47 -26.33 0.76 Allowed 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.098 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.461 ' O ' HG22 ' X' ' 36' ' ' VAL . 16.6 m-20 -67.28 -57.9 5.81 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.621 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.737 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.53 -31.12 7.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.132 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.9 tm? -59.48 -46.03 89.97 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.974 -175.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -32.34 72.98 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.206 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.461 HG22 ' O ' ' X' ' 32' ' ' ASP . 38.3 t -66.33 -49.27 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.574 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 58.0 mt -66.73 -42.65 85.95 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.0 -170.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.3 mt -59.42 -47.84 83.93 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.541 1.151 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.42 -42.55 71.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.56 ' O ' HG12 ' X' ' 44' ' ' ILE . 22.8 t60 -59.46 -45.55 91.3 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.506 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.596 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.12 -55.12 37.84 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.879 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.534 HG13 ' O ' ' X' ' 38' ' ' LEU . 8.3 p -66.76 -31.81 55.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.3 pttp -71.27 -34.32 70.58 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.769 -0.582 . . . . 0.0 111.781 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.56 HG12 ' O ' ' X' ' 40' ' ' HIS . 23.7 pt -88.48 -29.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.511 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.479 ' HB ' HD11 ' X' ' 79' ' ' ILE . 70.1 p -84.46 -37.77 20.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.544 0.688 . . . . 0.0 109.494 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 69.04 21.56 7.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.249 1.82 . . . . 0.0 112.076 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.452 ' O ' HG22 ' X' ' 42' ' ' VAL . 48.7 t-80 -72.23 132.96 83.76 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.507 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 31.5 Cg_exo -66.74 -21.3 51.56 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.149 2.566 . . . . 0.0 112.146 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -122.44 35.69 4.82 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.596 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.12 -55.3 8.79 Favored Glycine 1 CA--C 1.448 -4.124 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.585 -178.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.469 ' CG2' HD12 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.24 -34.51 68.34 Favored 'General case' 0 C--N 1.255 -3.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.208 -173.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.56 -29.37 70.64 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.653 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.4 mt -61.42 -42.68 99.13 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.413 HD12 HG22 ' X' ' 22' ' ' ILE . 10.5 mt -66.59 -42.54 90.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -63.02 -44.67 95.3 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.802 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.9 pt-20 -69.8 -39.3 76.63 Favored 'General case' 0 C--O 1.201 -1.48 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.635 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.391 0 C-N-CA 122.26 0.224 . . . . 0.0 111.279 -179.722 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.552 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.537 ' O ' HG13 ' X' ' 75' ' ' ILE . 29.1 Cg_endo -61.8 -37.5 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.254 2.636 . . . . 0.0 110.992 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.14 0.69 18.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.764 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.27 -8.87 26.59 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.008 174.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.537 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -73.82 -45.43 49.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.489 HG13 HG11 ' X' ' 16' ' ' VAL . 1.2 p -57.71 -42.16 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.966 175.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttp -58.52 -47.86 82.77 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.747 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.4 -39.12 89.58 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' X' ' 45' ' ' THR . 41.8 mm -67.86 -46.34 82.37 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.832 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.6 pttp -63.72 -36.29 83.39 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.384 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.85 -38.82 70.04 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.874 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.507 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 66.7 t90 -69.75 -47.79 61.69 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.016 0.436 . . . . 0.0 110.025 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.572 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 14.5 tpt180 -60.35 -45.52 93.2 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.0 89.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.704 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.28 92.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.163 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -64.67 -32.56 74.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.78 4.84 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.572 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 64.5 mttm -112.83 144.58 31.3 Favored Pre-proline 0 N--CA 1.388 -3.542 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -64.22 139.3 65.52 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.093 1.862 . . . . 0.0 109.31 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -109.38 -125.23 5.03 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.31 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.419 ' CZ ' HG21 ' X' ' 76' ' ' VAL . 76.9 m-85 -82.86 152.53 25.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.665 -0.768 . . . . 0.0 111.2 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' X' ' 8' ' ' SER . 19.8 ptmt -83.59 -179.27 7.29 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.49 140.07 30.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.884 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.405 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 71.2 mt . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -97.83 -174.7 2.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.87 -9.17 14.07 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.237 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -144.47 164.89 29.52 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -70.79 -8.7 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.444 0.64 . . . . 0.0 110.688 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -76.81 -25.82 53.71 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.02 -11.94 21.04 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.406 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.405 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 8.7 m-85 -72.99 118.11 15.53 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.31 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 76.0 p -78.4 162.0 26.73 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 169.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.636 ' O ' HG11 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.05 -45.28 79.27 Favored 'General case' 0 C--N 1.28 -2.42 0 O-C-N 123.571 0.544 . . . . 0.0 111.015 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.427 ' HA ' HG23 ' X' ' 16' ' ' VAL . . . -69.49 -38.23 77.58 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -57.44 -37.5 72.92 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 118.436 0.562 . . . . 0.0 110.107 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.722 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 5.7 t80 -80.0 -45.38 18.51 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.751 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.636 HG11 ' O ' ' X' ' 12' ' ' GLU . 11.7 m -58.82 -31.78 45.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.043 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.86 -47.19 78.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.939 0.896 . . . . 0.0 109.79 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.486 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -62.75 -41.77 99.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.01 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -61.34 -37.77 84.5 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.519 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 56.6 mttp -64.47 -36.0 82.77 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.439 0.638 . . . . 0.0 109.578 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.74 -32.82 73.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.905 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.486 HG13 ' O ' ' X' ' 18' ' ' LEU . 34.1 mt -64.92 -41.49 92.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -57.49 -46.14 84.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.786 0.803 . . . . 0.0 108.841 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -60.06 -45.36 93.13 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.929 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.599 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -85.24 -29.61 24.5 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.178 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.67 -34.88 79.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.781 0.324 . . . . 0.0 111.359 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.7 m -77.27 -12.59 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.07 -22.68 16.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.56 85.72 0.14 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.127 1.771 . . . . 0.0 112.043 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -106.1 172.26 6.9 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -135.91 8.67 3.27 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.642 170.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.446 ' O ' HG21 ' X' ' 36' ' ' VAL . 26.1 m-20 -91.16 -70.66 0.67 Allowed 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.7 p -74.66 -30.69 25.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.978 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.599 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 3.0 tm? -58.3 -46.03 86.87 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.13 -32.8 74.18 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.282 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.446 HG21 ' O ' ' X' ' 32' ' ' ASP . 75.9 t -64.8 -50.12 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 68.6 mt -68.66 -41.77 78.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.858 -171.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 7.0 mt -61.17 -46.64 89.66 Favored 'General case' 0 N--CA 1.418 -2.063 0 O-C-N 124.102 0.876 . . . . 0.0 110.915 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.18 -42.35 72.55 Favored 'General case' 0 N--CA 1.433 -1.283 0 O-C-N 123.418 0.449 . . . . 0.0 110.884 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.472 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 25.3 t60 -59.57 -45.34 92.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 123.68 0.792 . . . . 0.0 110.595 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.406 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 34.2 t80 -61.02 -55.32 34.23 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.156 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.468 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.3 p -67.3 -31.65 53.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 0.0 OUTLIER -69.68 -39.26 77.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 122.232 -0.293 . . . . 0.0 111.772 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.606 HD11 ' CE1' ' X' ' 15' ' ' PHE . 49.9 pt -80.97 -30.63 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.941 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -85.02 -35.09 22.16 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.76 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 61.76 28.15 17.28 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -77.18 139.53 64.96 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.435 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.474 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 20.3 Cg_exo -70.41 -19.3 33.2 Favored 'Trans proline' 0 CA--C 1.495 -1.432 0 C-N-CA 123.087 2.525 . . . . 0.0 112.488 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.423 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 14.4 m-20 -127.23 40.98 3.61 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.406 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -51.22 -51.77 34.69 Favored Glycine 0 CA--C 1.466 -2.976 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.978 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.403 ' O ' ' HD2' ' X' ' 55' ' ' TYR 0.35 0.6 OUTLIER -80.99 -25.06 37.54 Favored 'General case' 0 C--N 1.256 -3.497 0 C-N-CA 117.48 -1.688 . . . . 0.0 114.165 -174.512 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' X' ' 49' ' ' ASP . . . -61.2 -41.12 96.26 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.12 -46.52 88.12 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.292 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 31.1 mt -67.07 -47.54 81.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 CA-C-O 121.344 0.592 . . . . 0.0 110.736 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.403 ' HD2' ' O ' ' X' ' 51' ' ' THR . 14.0 m-85 -59.8 -49.06 79.2 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.359 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.35 -40.7 96.38 Favored 'General case' 0 C--O 1.174 -2.917 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.769 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . 0.422 ' HB1' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 CA--C 1.501 -0.932 0 CA-C-N 118.412 0.551 . . . . 0.0 111.296 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.517 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.42 -24.63 56.87 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.196 3.264 . . . . 0.0 113.316 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.437 ' HA ' ' CG2' ' X' ' 76' ' ' VAL . 33.5 mt-10 -96.32 1.41 51.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.026 0.441 . . . . 0.0 109.937 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -103.34 -31.65 4.88 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.602 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.487 ' CD1' HD13 ' X' ' 19' ' ' LEU . 5.3 pt -65.43 -32.55 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 O-C-N 122.277 -0.543 . . . . 0.0 111.616 175.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' X' ' 19' ' ' LEU . 0.2 OUTLIER -65.56 -32.23 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.469 176.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 59.6 tttm -66.7 -45.67 78.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.84 -44.76 86.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.376 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.45 -46.81 88.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.079 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -69.39 -36.29 76.64 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.472 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.5 mt-10 -71.37 -37.21 71.65 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.474 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.8 t90 -66.55 -47.25 73.43 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.923 0.868 . . . . 0.0 109.719 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -61.28 -46.1 91.73 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.771 -176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.2 81.64 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.79 -45.62 93.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.954 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.409 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 23.5 t-20 -69.25 -39.0 78.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.2 37.68 2.63 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.409 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 67.7 mttm -109.18 147.16 35.39 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.55 131.36 37.67 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.527 2.151 . . . . 0.0 111.785 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.35 -144.14 15.37 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.182 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -78.17 145.82 35.4 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 111.33 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' X' ' 93' ' ' GLN . 5.3 tttt -86.28 163.03 17.96 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . 0.465 ' N ' ' HG3' ' X' ' 92' ' ' LYS 0.251 13.6 mt-30 -88.87 131.01 35.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.633 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.925 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 174.809 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' X' ' 40' ' ' HIS . 66.5 mt . . . . . 0 N--CA 1.433 -1.276 0 CA-C-O 120.979 0.419 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -102.08 -159.16 0.71 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 174.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -116.33 -28.49 6.49 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.703 0.763 . . . . 0.0 109.499 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 65.0 p -132.74 166.83 21.31 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.652 177.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' X' ' 91' ' ' PHE . 10.9 tp -70.81 -15.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.533 0.683 . . . . 0.0 110.68 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -77.74 -9.0 58.77 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.27 3.67 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -94.8 115.51 27.59 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.646 -174.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 76.1 p -76.06 156.86 33.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 167.168 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.649 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.7 pt-20 -60.84 -30.61 70.21 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' X' ' 16' ' ' VAL . . . -70.68 -38.88 73.78 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.113 0.415 . . . . 0.0 111.382 175.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 10.1 mm-40 -57.46 -39.02 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.606 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.4 t80 -71.54 -49.01 44.88 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.584 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.649 HG13 ' O ' ' X' ' 12' ' ' GLU . 5.0 m -62.6 -30.04 48.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.731 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' X' ' 21' ' ' GLU . 6.6 tt0 -63.0 -49.01 76.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.57 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.1 tm? -58.75 -44.71 90.62 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.56 177.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 33.0 mt -58.12 -42.21 85.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.163 176.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.6 mttm -67.78 -35.04 77.96 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.172 176.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' X' ' 17' ' ' GLN . 45.3 mt-10 -67.24 -37.68 83.95 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.681 176.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.57 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.6 mt -62.13 -43.72 98.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 0.9 OUTLIER -58.06 -47.68 82.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.621 1.168 . . . . 0.0 109.883 176.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.61 -52.04 59.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.427 -176.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.03 -25.95 64.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -70.94 -50.35 35.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.51 177.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.45 -11.68 13.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.14 -19.12 21.08 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 76.42 0.28 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.878 1.271 . . . . 0.0 111.275 -176.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -95.79 -25.67 15.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.168 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 66.41 -64.46 0.22 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 126.19 1.796 . . . . 0.0 114.721 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.45 ' O ' HG21 ' X' ' 36' ' ' VAL . 8.1 p-10 -63.97 -48.57 75.95 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -83.13 -29.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.838 -177.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.514 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -41.84 90.14 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.692 175.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.61 -36.19 82.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.45 HG21 ' O ' ' X' ' 32' ' ' ASP . 99.3 t -57.57 -48.42 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.965 0 O-C-N 123.835 0.709 . . . . 0.0 109.218 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 43.9 mt -68.07 -43.12 79.3 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.447 -174.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.8 mt -58.89 -49.5 77.55 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 124.11 0.881 . . . . 0.0 111.173 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -68.47 -39.06 81.55 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.231 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.612 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 46.3 t60 -65.98 -45.26 82.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.094 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.578 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.5 t80 -55.29 -52.1 64.53 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.886 177.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.9 -32.83 58.09 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 21.0 ptmt -71.33 -33.22 69.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.934 -0.479 . . . . 0.0 112.118 -178.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.591 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.3 pt -83.08 -34.58 11.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.283 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 66.7 p -84.32 -38.73 20.02 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 63.97 27.23 14.29 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 109.983 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' X' ' 49' ' ' ASP . 37.4 t-80 -70.75 136.36 85.56 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 113.762 -1.563 . . . . 0.0 106.82 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.421 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 8.8 Cg_exo -76.73 6.03 4.42 Favored 'Trans proline' 0 CA--C 1.482 -2.088 0 C-N-CA 122.89 2.394 . . . . 0.0 112.686 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.482 ' CG ' ' HB2' ' X' ' 52' ' ' ALA . 24.9 t70 -144.76 32.21 1.15 Allowed 'General case' 0 N--CA 1.39 -3.448 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 -173.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.578 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.48 -62.53 3.93 Favored Glycine 1 CA--C 1.449 -4.036 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.43 -176.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.443 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.437 1.6 p -82.72 -13.33 56.54 Favored 'General case' 0 N--CA 1.386 -3.664 0 C-N-CA 116.46 -2.096 . . . . 0.0 115.267 -177.649 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.655 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -72.09 -29.87 64.54 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 117.863 -1.535 . . . . 0.0 108.814 174.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -60.55 -43.52 97.12 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.599 0.562 . . . . 0.0 110.961 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.48 -47.18 81.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.139 0.971 . . . . 0.0 109.672 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -63.57 -44.33 94.41 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.897 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -67.82 -35.77 79.21 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.38 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.973 0 O-C-N 123.059 0.224 . . . . 0.0 111.093 -179.017 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.946 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.421 ' O ' HG12 ' X' ' 75' ' ' ILE . 14.8 Cg_endo -58.98 -48.43 14.36 Favored 'Trans proline' 0 C--O 1.207 -1.052 0 C-N-CA 124.071 3.181 . . . . 0.0 113.57 -176.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.93 0.57 17.91 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.985 -0.447 . . . . 0.0 112.183 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.56 -23.9 5.51 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.776 175.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.451 HG13 HD12 ' X' ' 19' ' ' LEU . 4.1 pt -69.92 -31.91 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 122.09 -0.653 . . . . 0.0 110.313 176.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.507 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 0.5 OUTLIER -61.7 -41.81 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-O 122.257 1.027 . . . . 0.0 110.737 173.852 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.426 ' H ' HG13 ' X' ' 76' ' ' VAL . 53.1 tttm -58.4 -42.29 86.83 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.228 176.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.07 -33.54 76.28 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.629 0.728 . . . . 0.0 109.566 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.401 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.9 mm -70.69 -45.94 71.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.144 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -62.5 -36.44 82.55 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.032 -177.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.56 -44.2 78.8 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.354 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 90.4 t90 -66.8 -48.86 67.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -176.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -71.44 -39.62 70.89 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.558 -174.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.16 -43.37 78.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.862 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -69.45 -30.38 68.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.97 29.53 7.19 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -117.08 141.08 27.87 Favored Pre-proline 0 N--CA 1.393 -3.296 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.53 118.77 5.25 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.476 2.784 . . . . 0.0 112.022 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.16 -124.63 4.33 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.6 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.0 m-85 -85.88 159.02 19.8 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.081 -178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -89.71 172.95 8.56 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -120.82 134.28 55.29 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.248 0.547 . . . . 0.0 111.862 -175.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.317 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 177.879 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.424 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 26.6 mt . . . . . 0 N--CA 1.444 -0.727 0 CA-C-O 121.063 0.459 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.426 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 36.7 mmtt -98.3 -159.57 0.75 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -113.03 -30.88 6.85 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.722 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.1 p -126.2 166.19 17.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.21 -18.72 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.781 0.801 . . . . 0.0 109.763 -177.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -75.09 -17.75 60.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.364 -172.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 36.3 t0 -102.73 5.21 38.76 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 122.255 1.026 . . . . 0.0 108.919 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.424 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 9.3 m-85 -96.46 125.11 40.72 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.632 -176.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.4 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 67.9 p -88.08 172.53 9.46 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.645 ' O ' HG11 ' X' ' 16' ' ' VAL . 8.4 pt-20 -62.02 -41.4 98.04 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.669 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.45 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.75 -37.86 76.59 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' X' ' 11' ' ' THR . 43.5 mm-40 -60.85 -40.19 91.96 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.287 0.565 . . . . 0.0 109.69 174.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.658 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 26.7 t80 -71.74 -45.4 61.86 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.208 -178.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.645 HG11 ' O ' ' X' ' 12' ' ' GLU . 13.6 m -61.88 -28.86 45.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.61 -46.78 86.71 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.614 ' O ' HG13 ' X' ' 22' ' ' ILE . 35.1 tp -60.86 -45.68 93.57 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.587 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 42.1 mt -57.67 -39.54 77.34 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 82.6 mttt -71.68 -38.7 70.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.101 176.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 73.7 mm-40 -60.72 -44.74 96.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.625 176.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.614 HG13 ' O ' ' X' ' 18' ' ' LEU . 48.1 mt -57.83 -46.1 87.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 O-C-N 123.967 0.792 . . . . 0.0 111.328 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.471 ' O ' HG21 ' X' ' 27' ' ' VAL . 44.5 mt-10 -57.61 -47.88 80.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.387 0.613 . . . . 0.0 110.894 -176.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -60.61 -43.03 97.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.766 -174.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 3.0 pp20? -89.02 -34.04 16.95 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.566 -177.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -60.04 -46.7 88.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.747 0.419 . . . . 0.0 111.798 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . 0.471 HG21 ' O ' ' X' ' 23' ' ' GLU . 31.2 m -79.55 0.6 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.164 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.37 0.19 12.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.239 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 44.95 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.067 1.747 . . . . 0.0 113.537 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 74.1 p -98.41 -24.38 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.493 . . . . 0.0 111.659 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 68.01 -59.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.245 1.418 . . . . 0.0 113.985 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.596 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 t70 -58.88 -61.39 2.66 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.699 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -82.24 -25.03 9.1 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.453 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.9 tm? -58.64 -50.09 75.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.352 176.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.47 -33.8 76.51 Favored 'General case' 0 CA--C 1.483 -1.61 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.784 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.596 HG23 ' O ' ' X' ' 32' ' ' ASP . 40.2 t -65.75 -50.23 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.623 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 40.7 mt -69.04 -43.66 74.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 O-C-N 124.442 1.089 . . . . 0.0 111.379 -172.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.489 ' O ' HG12 ' X' ' 42' ' ' VAL . 34.1 mt -61.54 -45.29 94.78 Favored 'General case' 0 N--CA 1.421 -1.878 0 O-C-N 124.163 0.914 . . . . 0.0 111.571 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.49 -41.57 72.49 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.253 177.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.533 ' O ' HG12 ' X' ' 44' ' ' ILE . 16.0 t60 -62.3 -45.9 91.16 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.466 0.478 . . . . 0.0 109.92 -175.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.492 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 43.7 t80 -58.25 -53.18 61.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.295 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.489 HG12 ' O ' ' X' ' 38' ' ' LEU 0.285 14.5 p -67.86 -31.62 52.94 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.891 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.8 pttp -69.14 -32.27 71.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.745 -0.597 . . . . 0.0 111.991 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.533 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.7 pt -85.17 -35.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.869 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 61.1 p -84.22 -35.43 23.47 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 58.25 30.73 19.91 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.195 1.398 . . . . 0.0 111.325 -176.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -77.14 134.66 67.29 Favored Pre-proline 0 N--CA 1.423 -1.788 0 CA-C-N 114.024 -1.444 . . . . 0.0 107.862 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.495 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.1 Cg_exo -71.0 -2.27 10.8 Favored 'Trans proline' 0 CA--C 1.493 -1.541 0 C-N-CA 123.362 2.708 . . . . 0.0 112.805 -175.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -138.21 29.84 2.47 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -173.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.99 -61.05 3.64 Favored Glycine 1 CA--C 1.45 -4.017 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.946 -176.48 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.471 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -28.44 57.65 Favored 'General case' 0 C--N 1.248 -3.837 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.252 -172.5 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.76 -40.47 95.25 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.026 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.3 mt -56.32 -44.5 80.01 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.731 0.644 . . . . 0.0 112.087 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -66.63 -45.24 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.276 -177.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.425 ' HD2' ' O ' ' X' ' 51' ' ' THR . 29.7 m-85 -61.01 -49.31 77.93 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.74 -178.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.5 pt-20 -70.29 -36.28 74.25 Favored 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.638 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.518 0 CA-C-N 117.652 0.206 . . . . 0.0 111.319 179.383 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.406 -3.307 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.471 ' O ' HG11 ' X' ' 76' ' ' VAL . 25.7 Cg_endo -65.0 -50.98 1.81 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 123.085 2.524 . . . . 0.0 110.956 -176.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.85 1.68 6.66 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.55 -29.16 3.48 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.065 174.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.444 ' O ' HG12 ' X' ' 79' ' ' ILE . 5.2 pt -66.3 -32.98 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.248 1.024 . . . . 0.0 111.045 175.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.471 HG11 ' O ' ' X' ' 72' ' ' PRO . 0.5 OUTLIER -59.6 -43.64 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-O 121.998 0.904 . . . . 0.0 110.327 173.177 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 54.4 tttp -58.42 -46.13 87.08 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.551 175.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -67.21 -30.71 70.72 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.444 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.4 mm -68.21 -45.99 81.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 175.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -64.02 -36.11 82.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.726 0.298 . . . . 0.0 110.699 -176.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.31 -32.31 70.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.837 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.495 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 76.2 t90 -72.16 -44.1 63.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.77 -43.08 98.49 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.775 -176.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.44 84.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.821 178.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.22 99.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.359 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.477 ' ND2' ' HE2' ' X' ' 88' ' ' LYS . 3.5 t30 -73.46 -34.1 65.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.59 47.73 2.91 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.477 ' HE2' ' ND2' ' X' ' 86' ' ' ASN . 60.1 mttm -118.77 147.94 43.35 Favored Pre-proline 0 N--CA 1.4 -2.942 0 C-N-CA 123.234 0.614 . . . . 0.0 109.863 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.1 130.83 28.44 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.309 2.006 . . . . 0.0 110.477 175.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.27 -126.59 5.58 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.465 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -81.27 156.7 25.45 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.108 -174.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -94.57 174.28 7.2 Favored 'General case' 0 N--CA 1.389 -3.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.08 141.73 35.71 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.775 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.236 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.421 HD21 HD13 ' X' ' 18' ' ' LEU . 22.6 mt . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.149 0.499 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 37.7 mmtt -102.8 -179.96 4.11 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.203 -175.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.0 -24.79 16.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.325 0.583 . . . . 0.0 109.741 178.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.4 p -142.02 162.93 34.23 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.079 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -67.3 -17.92 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.24 1.016 . . . . 0.0 111.341 -176.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 75.8 m -86.6 -3.09 58.98 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.49 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 25.6 t0 -103.56 4.44 35.78 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 9.7 m-85 -99.0 121.06 40.46 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.6 -177.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 73.7 p -79.18 167.08 21.48 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 169.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.621 ' O ' HG11 ' X' ' 16' ' ' VAL . 6.4 pt-20 -56.52 -42.65 78.78 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.629 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.1 -38.31 75.6 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -59.0 -37.65 77.36 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.363 0.601 . . . . 0.0 110.12 174.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.687 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -73.42 -42.8 61.61 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.621 HG11 ' O ' ' X' ' 12' ' ' GLU . 3.9 m -62.99 -29.05 46.28 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.447 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.978 178.177 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -61.01 -46.75 89.47 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.618 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.1 tp -61.34 -47.23 86.82 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 175.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.1 mt -58.21 -38.54 76.99 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.158 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 68.3 mttm -71.55 -34.83 70.34 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.659 176.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.85 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.618 HG13 ' O ' ' X' ' 18' ' ' LEU . 60.9 mt -62.92 -42.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.429 ' O ' HG21 ' X' ' 27' ' ' VAL . 1.6 tt0 -58.14 -44.45 87.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.242 174.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -59.11 -48.69 80.68 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.384 1.074 . . . . 0.0 109.567 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.8 -26.75 49.85 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.357 -178.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -80.01 -41.41 25.87 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 122.157 -0.34 . . . . 0.0 111.81 -179.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . 0.429 HG21 ' O ' ' X' ' 23' ' ' GLU . 33.0 m -70.52 -20.84 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.845 -179.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.93 -16.85 18.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.39 76.13 0.31 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.161 1.384 . . . . 0.0 111.969 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.8 p -96.37 -168.81 1.8 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.87 -43.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.943 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.486 ' O ' HG21 ' X' ' 36' ' ' VAL . 23.6 t70 -64.89 -53.02 53.19 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.671 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 79.4 t -87.15 -27.12 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.604 -178.106 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.04 -46.53 87.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.05 -20.6 61.65 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.486 HG21 ' O ' ' X' ' 32' ' ' ASP . 54.7 t -70.86 -49.77 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 C-N-CA 118.563 -1.255 . . . . 0.0 108.286 175.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 63.3 mt -68.29 -41.68 80.59 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 113.756 -1.565 . . . . 0.0 112.345 -170.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.5 mt -59.28 -44.57 92.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 124.151 0.907 . . . . 0.0 110.517 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.53 -45.0 63.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.71 177.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.59 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 20.2 t60 -59.33 -45.48 91.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.2 -175.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.587 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 39.6 t80 -60.49 -50.83 72.02 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.877 178.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.87 -32.19 55.38 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.538 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -179.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -69.53 -33.77 73.27 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.998 -0.439 . . . . 0.0 111.925 -178.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.477 HG12 ' O ' ' X' ' 40' ' ' HIS . 11.7 pt -85.07 -31.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 -178.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 53.2 p -84.77 -32.26 23.51 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.255 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 58.45 31.89 21.49 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.652 1.181 . . . . 0.0 109.949 -177.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.416 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 33.8 t-80 -82.52 135.14 46.86 Favored Pre-proline 0 N--CA 1.424 -1.774 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.441 -178.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.51 -12.33 31.29 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 123.068 2.512 . . . . 0.0 112.681 -176.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.416 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 9.0 m-20 -130.51 30.28 4.72 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.587 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.38 -58.69 5.69 Favored Glycine 0 CA--C 1.453 -3.805 0 CA-C-N 114.491 -1.231 . . . . 0.0 113.277 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.45 HG23 HD13 ' X' ' 38' ' ' LEU . 1.5 m -79.09 -23.3 44.23 Favored 'General case' 0 C--N 1.251 -3.707 0 C-N-CA 117.944 -1.502 . . . . 0.0 110.759 -172.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.53 67.15 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 175.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 28.3 mt -66.67 -37.28 84.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.627 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mt -66.37 -42.79 91.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.891 0.853 . . . . 0.0 108.827 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -62.72 -43.35 99.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.083 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.89 -40.09 75.88 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.048 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.078 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.786 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.563 ' O ' HG13 ' X' ' 75' ' ' ILE . 12.8 Cg_endo -54.1 -45.44 41.0 Favored 'Trans proline' 0 C--O 1.212 -0.804 0 C-N-CA 123.959 3.106 . . . . 0.0 114.077 -171.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -74.15 1.35 11.41 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.64 -6.25 25.19 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 119.901 -1.142 . . . . 0.0 112.769 174.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.563 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.0 OUTLIER -77.04 -43.68 31.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.242 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.481 HG12 HG12 ' X' ' 16' ' ' VAL . 1.2 p -58.22 -43.18 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.989 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 87.8 tttt -58.58 -48.15 81.89 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.393 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.35 -39.46 90.68 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.791 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.5 -45.31 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.278 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.9 pttp -62.34 -36.24 81.6 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -70.78 -36.23 72.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.134 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -70.2 -47.86 59.66 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.768 0.794 . . . . 0.0 108.877 178.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 13.6 tpt180 -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.783 -175.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.25 -43.08 78.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.175 0.59 . . . . 0.0 111.723 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -30.85 71.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -78.06 -37.4 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.08 33.63 5.68 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.345 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 20.2 mtpp -113.95 143.34 29.43 Favored Pre-proline 0 N--CA 1.4 -2.957 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -176.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 128.12 22.59 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.972 2.448 . . . . 0.0 111.884 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.36 -112.0 3.64 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.45 -178.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.98 166.18 14.68 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.406 -173.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -99.76 170.72 8.35 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.27 141.14 30.74 Favored 'General case' 0 N--CA 1.391 -3.409 0 CA-C-O 121.678 0.751 . . . . 0.0 109.571 178.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.109 0 N-CA-C 107.374 -2.29 . . . . 0.0 107.374 178.987 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 85.0 mt . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.1 mmtt -104.14 142.33 34.68 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -75.12 -16.01 60.57 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.113 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.5 p -132.2 162.73 30.2 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.959 175.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tp -69.27 -17.84 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.717 0.807 . . . . 0.0 109.679 -177.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -19.61 59.18 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.359 -172.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 17.6 t70 -101.82 5.0 40.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.974 0.892 . . . . 0.0 109.095 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.41 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.2 m-85 -95.01 114.95 26.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.085 -174.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 70.8 p -80.42 162.36 24.49 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.576 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.5 pt-20 -56.56 -44.77 81.27 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.579 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.427 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -39.05 75.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -58.61 -38.46 78.04 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.277 0.49 . . . . 0.0 110.023 175.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -73.49 -43.12 60.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.338 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.611 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 11.0 m -62.58 -36.39 74.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.082 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.513 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -61.52 -49.46 76.63 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 109.649 177.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.482 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -61.19 -43.32 99.07 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.523 HD21 ' O ' ' X' ' 72' ' ' PRO . 3.0 mp -58.41 -36.94 74.35 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.553 -1.203 . . . . 0.0 114.046 176.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 91.4 mttt -66.26 -40.0 89.87 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.188 0.518 . . . . 0.0 109.643 176.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.78 -37.36 87.34 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.595 178.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.482 HG13 ' O ' ' X' ' 18' ' ' LEU . 26.3 mt -61.0 -45.18 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.408 ' CD ' ' HD3' ' X' ' 72' ' ' PRO . 52.6 mt-10 -58.54 -46.22 87.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.551 0.691 . . . . 0.0 110.639 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.01 -49.83 76.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.069 -175.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -71.82 -27.63 63.04 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -70.59 -53.92 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.462 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.62 -20.65 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.38 -13.98 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.543 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.87 70.25 0.6 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.297 1.039 . . . . 0.0 111.071 -176.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p -88.9 -17.56 29.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 110.951 -176.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.394 1.7 m-20 65.3 -59.55 0.27 Allowed 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 178.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.66 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.6 t70 -63.55 -57.01 11.51 Favored 'General case' 0 CA--C 1.478 -1.816 0 CA-C-N 119.817 1.19 . . . . 0.0 111.733 -176.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.719 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 44.0 t -76.42 -32.25 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.067 -177.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 1.8 tm? -58.35 -47.28 84.28 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . 0.614 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 32.8 t70 -65.02 -41.84 94.93 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.66 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.6 t -56.53 -50.03 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 O-C-N 124.224 0.953 . . . . 0.0 110.079 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.2 mt -67.65 -39.92 84.58 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.603 -172.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 43.8 mt -63.21 -49.95 72.21 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 7.3 pt-20 -71.2 -34.45 70.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.889 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.575 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 59.3 t60 -60.21 -45.49 92.98 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.42 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 63.7 t80 -60.63 -52.98 62.83 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.781 178.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.518 HG11 ' O ' ' X' ' 38' ' ' LEU 0.291 2.7 p -67.49 -32.91 59.2 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.915 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.0 ptmm? -67.17 -33.39 75.3 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.924 -0.485 . . . . 0.0 111.876 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.502 HG12 ' O ' ' X' ' 40' ' ' HIS . 17.6 pt -86.23 -36.05 9.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.833 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -84.18 -33.45 24.18 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 120.891 0.377 . . . . 0.0 111.117 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 64.05 19.34 11.71 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.266 1.427 . . . . 0.0 111.392 -176.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.412 ' O ' HG22 ' X' ' 42' ' ' VAL . 47.8 t-80 -73.0 132.22 82.98 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.522 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -70.19 -17.05 35.88 Favored 'Trans proline' 0 CA--C 1.492 -1.613 0 C-N-CA 122.833 2.355 . . . . 0.0 112.662 -172.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.447 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 5.4 m-20 -127.14 36.19 4.46 Favored 'General case' 0 N--CA 1.389 -3.508 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -173.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.42 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.48 -53.52 16.15 Favored Glycine 0 CA--C 1.454 -3.731 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.422 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.496 ' CG2' HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.43 -31.56 57.96 Favored 'General case' 0 C--N 1.247 -3.874 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.731 -173.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.88 -38.08 84.38 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.058 177.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.8 -48.45 75.35 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.477 0.486 . . . . 0.0 112.136 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.404 HG22 HG21 ' X' ' 22' ' ' ILE . 5.1 mp -67.88 -42.17 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 118.272 -1.371 . . . . 0.0 110.079 -178.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.415 ' HD2' ' O ' ' X' ' 51' ' ' THR . 27.0 m-85 -62.55 -45.51 92.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.158 -178.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.8 pt-20 -68.66 -35.92 77.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.283 176.056 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.136 0 C-N-CA 122.482 0.313 . . . . 0.0 110.982 178.22 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.454 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.407 -3.246 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.632 ' O ' HG12 ' X' ' 76' ' ' VAL . 12.8 Cg_endo -61.09 -43.77 27.92 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.541 2.828 . . . . 0.0 112.564 -175.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.89 0.82 16.93 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.2 -40.31 1.41 Allowed Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.381 177.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.473 HG13 ' CD2' ' X' ' 19' ' ' LEU . 3.6 pt -60.52 -29.72 45.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.169 0.485 . . . . 0.0 111.771 176.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.632 HG12 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -65.51 -45.59 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 122.327 1.061 . . . . 0.0 111.088 175.12 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 40.7 ttmt -63.07 -37.72 88.31 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.584 -1.643 . . . . 0.0 109.761 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.91 -43.74 98.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.319 0.581 . . . . 0.0 111.124 174.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.45 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.5 mm -61.24 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.912 176.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 22.3 ptmt -63.59 -36.3 83.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.963 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.6 mt-10 -64.55 -41.64 96.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.415 0.447 . . . . 0.0 110.752 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.522 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.3 t90 -68.12 -45.33 73.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.524 0.678 . . . . 0.0 109.769 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -60.91 -45.28 95.27 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.454 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.11 85.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.59 92.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.951 0.405 . . . . 0.0 110.738 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.458 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 21.7 t-20 -69.63 -41.34 75.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.726 0.774 . . . . 0.0 109.444 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.79 28.75 5.23 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.458 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 67.7 mttm -100.31 150.85 37.28 Favored Pre-proline 0 N--CA 1.402 -2.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.67 128.56 28.63 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.281 2.654 . . . . 0.0 112.152 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.21 -149.47 25.5 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.941 -177.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -79.28 159.66 27.15 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -176.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -98.73 176.31 5.67 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-O 121.723 0.773 . . . . 0.0 110.126 179.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -112.34 141.84 45.58 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.554 174.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.569 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 -179.794 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.239 0.503 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 28.3 mmtt -111.68 -169.84 1.54 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -107.75 -29.18 9.25 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.628 0.727 . . . . 0.0 110.236 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -131.82 163.52 28.08 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.352 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -69.68 -13.4 17.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 CA-C-O 121.549 0.69 . . . . 0.0 110.668 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 10.8 m -72.82 -22.13 60.85 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.636 -174.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 21.9 t70 -100.57 3.4 42.67 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.165 0.983 . . . . 0.0 108.883 177.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -92.49 115.12 27.81 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.473 -176.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 65.2 p -76.53 159.18 30.58 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 171.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.646 ' O ' HG11 ' X' ' 16' ' ' VAL . 6.7 pt-20 -61.13 -35.27 76.61 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.951 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.415 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.44 -38.45 74.53 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.802 177.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.2 -40.99 83.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.12 0.962 . . . . 0.0 109.243 173.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.415 ' O ' HD13 ' X' ' 19' ' ' LEU . 41.4 t80 -69.27 -45.02 70.68 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.057 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.653 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 8.4 m -61.86 -38.75 81.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.46 -36.48 79.06 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 121.487 0.661 . . . . 0.0 111.544 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.457 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -66.92 -46.18 75.61 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.702 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.415 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.3 mp -60.13 -36.97 78.66 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.081 177.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 62.5 mttm -63.11 -35.64 80.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.477 0.656 . . . . 0.0 109.964 176.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -69.38 -33.5 73.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.632 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' X' ' 37' ' ' LEU . 9.5 mt -67.46 -40.84 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' X' ' 72' ' ' PRO . 50.9 mt-10 -57.72 -46.75 84.0 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.55 -42.81 97.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.907 -176.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -77.16 -29.05 54.31 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.164 -0.335 . . . . 0.0 111.493 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -75.42 -46.37 33.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.131 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.44 -35.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.909 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.33 -10.07 56.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 177.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.07 74.51 0.29 Allowed 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.543 1.537 . . . . 0.0 113.431 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 56.6 p -99.24 -166.27 1.33 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.34 -61.84 1.01 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.568 ' O ' HG22 ' X' ' 36' ' ' VAL . 18.5 m-20 -56.96 -50.93 71.14 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 62.0 t -88.59 -29.16 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.607 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.52 -45.65 88.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.64 -30.4 67.02 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.267 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.568 HG22 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -63.29 -49.73 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.493 176.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 77.0 mt -68.47 -43.78 76.25 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.486 -170.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 36.2 mt -61.14 -46.22 91.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 124.099 0.874 . . . . 0.0 110.428 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.44 -43.77 69.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.989 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.499 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.2 t60 -60.12 -45.71 92.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.607 -176.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' X' ' 54' ' ' ILE . 39.5 t80 -61.43 -51.49 68.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.224 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.44 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.9 p -67.7 -32.59 57.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.8 pttt -72.63 -26.59 61.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.47 HG12 ' O ' ' X' ' 40' ' ' HIS . 26.6 pt -87.26 -34.87 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.779 179.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -84.3 -31.97 24.59 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 58.06 31.71 21.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.633 1.173 . . . . 0.0 109.877 -176.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.426 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 40.9 t-80 -82.43 138.52 44.74 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 113.514 -1.675 . . . . 0.0 108.117 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -73.5 -6.42 18.73 Favored 'Trans proline' 0 CA--C 1.492 -1.593 0 C-N-CA 123.1 2.533 . . . . 0.0 112.599 -175.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.426 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 38.0 m-20 -135.63 32.19 3.04 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.584 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.73 -59.99 5.13 Favored Glycine 1 CA--C 1.445 -4.34 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.872 -176.842 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.477 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -75.18 -30.13 60.6 Favored 'General case' 1 C--N 1.242 -4.092 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.019 -172.641 . . . . . . . . 4 4 . 1 . 025 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.15 -28.13 69.85 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 28.1 mt -65.13 -43.1 93.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 175.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.618 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -67.2 -41.66 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.789 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.4 ' HD2' ' O ' ' X' ' 51' ' ' THR . 35.1 m-85 -58.27 -47.28 84.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.685 178.241 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.6 pt-20 -67.67 -36.72 81.23 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.325 175.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 118.125 0.421 . . . . 0.0 111.824 -178.452 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.473 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.407 -3.262 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.634 ' O ' HG13 ' X' ' 76' ' ' VAL . 12.7 Cg_endo -74.46 -46.24 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.353 2.702 . . . . 0.0 112.353 -172.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.471 ' C ' HG21 ' X' ' 76' ' ' VAL . 31.5 mt-10 -73.5 0.86 11.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -177.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.31 -34.3 2.95 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.518 172.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.514 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.8 pt -66.89 -27.11 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 117.647 0.723 . . . . 0.0 110.633 172.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.634 HG13 ' O ' ' X' ' 72' ' ' PRO . 27.6 m -62.16 -37.99 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.889 0 CA-C-O 121.689 0.757 . . . . 0.0 110.992 176.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 39.8 ttmt -65.74 -45.01 84.22 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.788 176.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -58.1 -38.05 75.71 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.57 -46.89 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.412 177.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.465 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 17.9 ptpt -66.82 -38.5 86.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.726 -175.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 46.2 mt-10 -69.69 -32.22 70.7 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.252 -178.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -72.19 -48.28 44.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.559 0.695 . . . . 0.0 109.354 177.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -61.39 -45.45 94.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.415 -174.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.42 84.3 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.04 84.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.862 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.58 -45.74 57.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.645 0.736 . . . . 0.0 109.061 177.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.35 37.5 1.94 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -112.51 143.47 29.0 Favored Pre-proline 0 N--CA 1.391 -3.387 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.51 131.23 27.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.43 2.086 . . . . 0.0 110.314 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -114.59 -115.71 3.12 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.818 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -79.18 145.93 33.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -174.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' X' ' 9' ' ' ASP . 45.8 pttt -97.38 172.4 7.79 Favored 'General case' 0 N--CA 1.384 -3.771 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.97 148.64 22.11 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 177.86 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.475 ' CD2' HD12 ' X' ' 18' ' ' LEU . 35.0 mt . . . . . 0 N--CA 1.427 -1.588 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.421 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 35.1 mmtt -93.09 -166.73 1.58 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -118.16 -0.08 11.65 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 174.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -153.44 158.89 42.08 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.212 176.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' X' ' 10' ' ' TYR . 11.3 tt -67.4 -24.43 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.488 0.661 . . . . 0.0 110.571 -178.422 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -85.44 0.09 53.31 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.951 -174.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 5.6 t70 -104.11 -1.28 27.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' X' ' 7' ' ' ILE . 8.0 m-85 -97.53 124.61 41.83 Favored 'General case' 0 CA--C 1.472 -2.025 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.804 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 47.9 p -78.75 159.4 27.94 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.014 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.618 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.21 -41.11 75.1 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 123.321 0.388 . . . . 0.0 110.383 -179.41 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' X' ' 16' ' ' VAL . . . -69.91 -38.4 76.26 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.48 -38.9 82.05 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.737 0.779 . . . . 0.0 109.682 173.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.444 ' CD2' HG11 ' X' ' 76' ' ' VAL . 22.0 t80 -75.3 -41.73 56.28 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.73 -177.222 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.618 HG13 ' O ' ' X' ' 12' ' ' GLU . 15.1 m -62.87 -32.79 57.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 176.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -64.24 -47.33 80.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 122.912 0.485 . . . . 0.0 109.966 178.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.669 ' O ' HG13 ' X' ' 22' ' ' ILE . 19.9 tp -57.23 -47.59 80.94 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 123.873 0.733 . . . . 0.0 109.292 177.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.94 -36.82 77.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.345 177.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.573 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 97.4 mttt -61.23 -46.47 90.29 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.518 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.469 ' HA ' ' HE3' ' X' ' 24' ' ' LYS . 54.8 mt-10 -64.14 -37.81 88.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.627 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.669 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.4 mt -63.17 -44.61 99.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -65.68 -35.07 79.71 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.143 0.973 . . . . 0.0 109.423 -178.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' X' ' 21' ' ' GLU . 27.8 ttpp -72.29 -52.03 18.11 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.474 -174.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -17.33 64.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.947 0.403 . . . . 0.0 111.305 176.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -81.08 -51.38 8.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.524 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 m -73.09 -26.39 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.24 -22.01 33.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.31 78.82 0.27 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.171 1.388 . . . . 0.0 112.011 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -92.31 -28.04 17.2 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 67.79 -55.15 0.49 Allowed 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.297 1.839 . . . . 0.0 115.374 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -68.36 -47.4 67.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.737 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -85.95 -29.88 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.13 -41.27 87.84 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 177.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.0 -41.69 98.33 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 123.386 0.429 . . . . 0.0 110.02 178.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' X' ' 33' ' ' VAL . 58.2 t -59.29 -48.74 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 O-C-N 124.622 1.201 . . . . 0.0 109.47 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.2 mt -64.64 -43.22 94.37 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.662 -173.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -60.11 -50.69 72.68 Favored 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 124.119 0.887 . . . . 0.0 111.051 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -70.69 -37.5 73.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.697 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.538 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.5 t60 -59.75 -46.26 89.71 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.268 0.627 . . . . 0.0 109.644 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.556 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.9 t80 -61.8 -53.52 54.77 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.259 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.456 HG11 ' O ' ' X' ' 38' ' ' LEU . 8.2 p -67.09 -31.7 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 54.1 pttt -69.63 -38.88 77.35 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 122.089 -0.382 . . . . 0.0 111.948 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.489 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.1 pt -79.63 -31.79 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.795 0.331 . . . . 0.0 110.747 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 54.7 p -84.04 -34.99 24.13 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.81 22.95 13.25 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.65 1.18 . . . . 0.0 109.929 -176.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -79.3 133.31 60.58 Favored Pre-proline 0 N--CA 1.433 -1.305 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.278 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -71.69 -19.48 27.7 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.282 -173.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -118.5 30.37 7.24 Favored 'General case' 0 N--CA 1.4 -2.957 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -171.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.556 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.0 -57.33 6.25 Favored Glycine 0 CA--C 1.461 -3.34 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.9 -178.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.494 HG23 HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -82.26 -22.78 35.61 Favored 'General case' 0 C--N 1.247 -3.867 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.959 -172.206 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.84 -36.69 84.06 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.754 174.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.09 -40.44 97.66 Favored 'General case' 0 C--O 1.207 -1.142 0 O-C-N 123.609 0.568 . . . . 0.0 110.643 175.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 51.1 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.392 0.615 . . . . 0.0 109.864 -179.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -62.17 -44.49 96.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.69 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.6 pt-20 -71.17 -38.38 72.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.924 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.818 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.396 -3.979 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.573 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 24.1 Cg_endo -66.11 -24.64 51.74 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.472 . . . . 0.0 112.805 -175.501 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.418 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.7 mt-10 -85.68 1.96 47.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.964 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -105.44 -32.82 3.82 Favored Glycine 0 N--CA 1.419 -2.441 0 C-N-CA 118.377 -1.868 . . . . 0.0 114.322 176.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.557 ' CD1' ' HA ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -69.95 -28.21 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-N 118.68 1.24 . . . . 0.0 110.204 175.128 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.562 HG13 ' O ' ' X' ' 72' ' ' PRO . 27.5 m -63.61 -38.06 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-O 121.347 0.594 . . . . 0.0 110.489 177.225 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttm -61.28 -48.46 81.29 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.445 173.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.16 -37.45 82.95 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.741 -178.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.403 HG12 ' O ' ' X' ' 75' ' ' ILE . 31.4 mm -68.46 -46.36 80.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.571 177.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -65.09 -38.06 89.51 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.666 -174.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.23 -38.78 75.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.272 -178.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.428 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 71.2 t90 -66.69 -47.88 71.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 109.131 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -61.19 -46.33 90.92 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.071 -175.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.58 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.868 -178.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.05 75.02 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.923 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.41 ' ND2' ' HE2' ' X' ' 88' ' ' LYS . 3.1 t30 -72.82 -42.63 63.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.64 34.99 1.62 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.918 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.41 ' HE2' ' ND2' ' X' ' 86' ' ' ASN . 65.9 mttm -115.43 140.13 25.48 Favored Pre-proline 0 N--CA 1.385 -3.685 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -177.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -61.5 136.31 62.49 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.422 2.082 . . . . 0.0 110.899 176.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.0 -120.33 4.68 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.233 -174.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -86.87 166.42 15.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 124.202 0.59 . . . . 0.0 109.441 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' X' ' 11' ' ' THR . 18.0 ptmt -105.18 162.14 13.65 Favored 'General case' 1 N--CA 1.374 -4.265 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.176 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.83 134.44 49.98 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.489 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.265 -3.379 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.806 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.849 0.833 . . . . 0.0 112.623 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 32.2 mmtt -101.76 -157.52 0.61 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -120.5 -20.37 7.19 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.222 171.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.4 p -141.01 165.7 26.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.464 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.09 -23.11 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.649 1.18 . . . . 0.0 110.393 -179.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.9 m -73.68 -16.33 61.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.798 -173.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.406 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 19.2 t70 -102.97 3.27 36.13 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.508 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.452 ' OH ' HD21 ' X' ' 18' ' ' LEU . 8.6 m-85 -97.04 118.4 33.35 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.39 -175.235 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 23.8 p -80.15 164.62 23.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.601 ' O ' HG11 ' X' ' 16' ' ' VAL . 5.8 pt-20 -59.08 -40.44 85.26 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.403 178.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.63 76.32 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.42 -38.0 79.48 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.707 0.765 . . . . 0.0 110.261 174.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.403 ' O ' HD21 ' X' ' 19' ' ' LEU . 36.3 t80 -72.87 -46.02 55.12 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.617 -179.054 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.601 HG11 ' O ' ' X' ' 12' ' ' GLU . 10.4 m -62.34 -34.42 64.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.848 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.09 -49.69 76.3 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.648 ' O ' HG13 ' X' ' 22' ' ' ILE . 55.3 tp -60.0 -46.78 88.35 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.524 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.409 HD23 ' CD1' ' X' ' 41' ' ' PHE . 4.4 mm? -58.51 -36.86 74.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.619 178.224 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.5 mttt -63.83 -37.23 86.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 110.568 175.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.31 -35.61 66.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.648 HG13 ' O ' ' X' ' 18' ' ' LEU . 17.3 mt -67.64 -42.09 86.2 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.176 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -42.8 84.75 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.917 1.287 . . . . 0.0 109.604 177.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.74 -47.62 74.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.619 -177.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.612 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 7.1 mm-40 -76.97 -15.4 59.66 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.319 178.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.53 -45.93 64.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.16 -26.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.383 179.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.42 50.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.061 176.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.8 77.27 0.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.166 1.386 . . . . 0.0 111.267 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 27.2 p -101.46 -168.73 1.59 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.73 -35.35 0.58 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.126 176.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.453 ' O ' HG22 ' X' ' 36' ' ' VAL . 37.7 m-20 -65.11 -53.02 51.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.729 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 4.8 p -88.52 -31.12 5.49 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.943 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.181 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.25 -45.02 92.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.322 -175.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.76 -29.71 63.54 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.887 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.453 HG22 ' O ' ' X' ' 32' ' ' ASP . 92.4 t -64.46 -48.78 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.063 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.457 176.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 85.9 mt -67.58 -43.57 80.26 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.121 -172.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 44.5 mt -61.81 -45.06 95.5 Favored 'General case' 0 N--CA 1.422 -1.837 0 O-C-N 124.194 0.934 . . . . 0.0 110.786 -179.575 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.24 -47.28 62.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.3 t60 -59.71 -44.2 93.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.594 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 30.9 t80 -59.95 -52.97 63.13 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.884 177.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.509 HG11 ' O ' ' X' ' 38' ' ' LEU . 13.8 p -67.71 -32.55 57.2 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.773 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.0 pttp -70.17 -28.59 65.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.467 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -84.38 -40.77 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.369 -177.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.562 HG21 ' O ' ' X' ' 41' ' ' PHE . 6.4 t -83.64 -32.11 25.85 Favored 'General case' 0 C--O 1.252 1.224 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.653 178.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.56 30.55 12.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 125.908 1.683 . . . . 0.0 111.342 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.43 ' H ' HG23 ' X' ' 45' ' ' THR . 48.0 t-80 -76.65 137.0 67.01 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.85 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.558 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 18.6 Cg_exo -70.99 -13.07 31.35 Favored 'Trans proline' 0 CA--C 1.502 -1.115 0 C-N-CA 123.099 2.533 . . . . 0.0 112.645 -174.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.55 31.45 4.78 Favored 'General case' 0 N--CA 1.398 -3.051 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -173.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.594 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.15 -56.88 7.49 Favored Glycine 0 CA--C 1.457 -3.584 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.921 -178.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.456 ' CG2' HD13 ' X' ' 38' ' ' LEU . 1.3 m -72.08 -32.55 67.14 Favored 'General case' 0 C--N 1.256 -3.479 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.271 -173.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.681 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.32 -37.21 86.39 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.996 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . 0.4 ' HB3' ' CG2' ' X' ' 75' ' ' ILE . 27.6 mt -58.47 -39.02 78.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.766 0.666 . . . . 0.0 112.22 178.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.407 HD13 HG22 ' X' ' 22' ' ' ILE . 67.8 mt -65.89 -44.43 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.638 . . . . 0.0 109.304 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.56 -49.74 74.09 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.274 178.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.8 pt-20 -69.65 -42.43 74.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.187 -179.603 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.109 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.565 ' O ' HG13 ' X' ' 76' ' ' VAL . 18.7 Cg_endo -55.98 -37.71 95.71 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 123.884 3.056 . . . . 0.0 114.126 -176.331 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.44 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.7 mt-10 -86.37 2.39 47.68 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.76 -28.03 5.5 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 118.684 -1.722 . . . . 0.0 112.481 173.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.425 HG21 HD11 ' X' ' 75' ' ' ILE . 0.3 OUTLIER -61.12 -39.69 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 122.326 1.06 . . . . 0.0 108.277 176.349 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.565 HG13 ' O ' ' X' ' 72' ' ' PRO . 29.2 m -59.46 -33.76 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 CA-C-N 113.314 -1.766 . . . . 0.0 112.686 -176.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.459 ' HZ1' ' CD ' ' X' ' 81' ' ' GLU . 51.0 tttp -60.06 -51.64 68.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.773 172.014 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -59.32 -42.29 91.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.419 HG23 ' HG1' ' X' ' 45' ' ' THR . 29.0 mm -62.75 -46.29 96.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.014 177.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.49 -43.36 73.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.621 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.459 ' CD ' ' HZ1' ' X' ' 77' ' ' LYS . 79.7 mt-10 -72.16 -32.21 66.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.156 -175.404 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.558 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 62.0 t90 -66.11 -45.85 79.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.597 1.189 . . . . 0.0 109.133 175.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -66.24 -46.92 75.48 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.169 -177.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -38.35 81.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.489 0.716 . . . . 0.0 112.094 -176.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.24 70.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . 0.581 ' HB3' ' NZ ' ' X' ' 88' ' ' LYS . 56.4 t30 -101.4 6.16 42.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.075 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.43 42.32 49.19 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.004 175.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.581 ' NZ ' ' HB3' ' X' ' 86' ' ' ASN . 36.6 mtmm -105.19 139.44 20.13 Favored Pre-proline 1 N--CA 1.378 -4.042 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.849 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.08 114.7 2.12 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 111.788 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.0 -125.11 4.09 Favored Glycine 0 CA--C 1.489 -1.587 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.659 -179.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.71 152.84 28.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.975 0.417 . . . . 0.0 110.285 -175.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.07 177.71 6.85 Favored 'General case' 0 N--CA 1.391 -3.375 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . 0.433 ' HA ' ' NE2' ' X' ' 93' ' ' GLN . 11.1 mm100 -117.59 143.37 46.18 Favored 'General case' 1 N--CA 1.377 -4.09 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 177.065 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.499 ' CD2' HD13 ' X' ' 18' ' ' LEU . 33.9 mt . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 34.3 mmtt -102.06 -162.45 0.93 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.52 -19.61 8.73 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.447 -0.783 . . . . 0.0 111.34 173.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 60.7 p -135.86 163.61 29.83 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.465 HG12 HH22 ' X' ' 83' ' ' ARG . 3.6 tp -69.81 -14.88 18.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.667 -177.175 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.5 m -71.87 -17.55 62.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.184 -174.036 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 17.2 t70 -106.83 5.06 28.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.791 0.805 . . . . 0.0 108.932 178.409 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.82 121.58 38.84 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.216 -176.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 43.6 p -88.61 179.51 6.25 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.624 ' O ' HG12 ' X' ' 16' ' ' VAL . 8.3 mm-40 -59.16 -52.36 66.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.437 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -69.22 -38.74 78.7 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.741 -171.244 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.56 -36.27 80.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 110.279 175.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.538 ' O ' HD11 ' X' ' 19' ' ' LEU . 44.7 t80 -75.94 -44.66 39.02 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.354 -177.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.624 HG12 ' O ' ' X' ' 12' ' ' GLU . 6.2 m -62.44 -33.25 58.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 116.939 -0.119 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -65.4 -47.84 74.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 123.024 0.53 . . . . 0.0 110.077 178.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.641 ' O ' HG13 ' X' ' 22' ' ' ILE . 17.9 tp -57.64 -47.44 82.22 Favored 'General case' 0 C--O 1.208 -1.09 0 CA-C-O 121.222 0.534 . . . . 0.0 109.789 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.538 HD11 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.48 -39.2 82.95 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.234 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 50.6 mttp -63.73 -38.5 91.33 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.174 0.511 . . . . 0.0 109.997 176.153 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' X' ' 24' ' ' LYS . 42.9 mt-10 -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.198 177.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.641 HG13 ' O ' ' X' ' 18' ' ' LEU . 31.0 mt -67.3 -40.89 85.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.351 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' X' ' 19' ' ' LEU . 52.3 mt-10 -57.89 -42.74 85.27 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.903 0.858 . . . . 0.0 109.728 177.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' X' ' 21' ' ' GLU . 80.1 tttt -60.23 -52.15 66.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.389 -176.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' X' ' 34' ' ' LEU . 1.2 pp20? -83.71 -32.93 25.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -58.3 -45.6 87.66 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.324 0.249 . . . . 0.0 111.503 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . 0.434 HG21 ' O ' ' X' ' 23' ' ' GLU . 31.7 m -76.22 -24.24 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.22 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -21.23 46.33 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.962 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.85 80.92 0.17 Allowed 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.878 1.671 . . . . 0.0 111.796 -178.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 0.7 OUTLIER -98.34 -175.2 3.04 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.139 174.433 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.71 -55.93 0.62 Allowed 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.724 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.658 ' O ' HG21 ' X' ' 36' ' ' VAL . 32.9 t70 -63.12 -57.42 10.65 Favored 'General case' 0 CA--C 1.484 -1.572 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.939 -179.177 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.676 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.8 p -73.08 -30.16 30.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -175.428 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.522 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.4 tm? -61.21 -50.16 74.22 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.493 178.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.59 -24.5 62.77 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.835 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.658 HG21 ' O ' ' X' ' 32' ' ' ASP . 98.8 t -70.57 -51.34 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.98 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.118 177.084 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 44.7 mt -69.29 -43.13 74.46 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.87 -170.336 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.48 ' O ' HG11 ' X' ' 42' ' ' VAL . 25.7 mt -60.98 -43.51 98.72 Favored 'General case' 0 N--CA 1.419 -2.019 0 O-C-N 124.283 0.989 . . . . 0.0 111.226 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.82 -44.05 67.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.987 0.423 . . . . 0.0 111.128 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.545 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 7.8 t60 -59.52 -45.21 92.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.63 -175.733 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.616 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 60.5 t80 -60.16 -51.79 68.09 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.94 178.037 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.48 HG11 ' O ' ' X' ' 38' ' ' LEU 0.258 9.5 p -67.51 -32.28 56.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.494 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.716 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -70.47 -37.49 74.27 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.99 -0.444 . . . . 0.0 112.073 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.526 HG12 ' O ' ' X' ' 40' ' ' HIS . 18.5 pt -78.75 -31.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.248 0.547 . . . . 0.0 110.776 -178.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.411 ' O ' ' HD2' ' X' ' 83' ' ' ARG . 53.7 p -84.36 -42.4 15.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.04 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.57 25.97 6.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.159 1.784 . . . . 0.0 110.446 -176.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 44.8 t-80 -80.35 135.66 53.63 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 114.286 -1.324 . . . . 0.0 107.797 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.434 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -69.45 -15.56 38.31 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 122.933 2.422 . . . . 0.0 112.737 -173.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 20.7 m-20 -127.17 32.85 5.0 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.616 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.09 -59.23 4.04 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.966 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.475 ' O ' ' HD2' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -73.26 -32.39 64.66 Favored 'General case' 0 C--N 1.246 -3.933 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.537 -171.036 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.75 -36.0 79.75 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.494 178.165 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -59.82 -45.55 92.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 176.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 85.2 mt -67.62 -40.73 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.431 179.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.475 ' HD2' ' O ' ' X' ' 51' ' ' THR . 17.0 m-85 -59.34 -46.65 88.03 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.078 177.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.6 pt-20 -67.68 -36.13 80.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.24 176.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.515 0 O-C-N 122.947 0.155 . . . . 0.0 110.757 179.674 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.519 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.404 -3.498 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.703 ' O ' HG11 ' X' ' 76' ' ' VAL . 9.2 Cg_endo -58.3 -43.15 49.16 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.771 2.981 . . . . 0.0 112.403 -176.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.456 ' C ' HG23 ' X' ' 76' ' ' VAL . 37.0 mt-10 -85.5 1.87 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 123.771 0.828 . . . . 0.0 110.796 -176.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -107.98 -29.72 4.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 119.264 -1.446 . . . . 0.0 112.886 173.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.519 HG12 ' O ' ' X' ' 71' ' ' GLY . 1.6 pt -69.64 -28.5 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 CA-C-N 117.576 0.688 . . . . 0.0 110.762 173.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.703 HG11 ' O ' ' X' ' 72' ' ' PRO . 31.4 m -59.89 -35.92 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 121.76 0.79 . . . . 0.0 110.787 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' X' ' 74' ' ' GLY . 40.4 tttp -62.38 -49.11 76.82 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.302 174.293 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.33 -41.2 84.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 23.5 mm -63.0 -45.85 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.067 177.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 61.5 pttt -71.87 -38.58 70.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.993 -176.287 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.1 mt-10 -69.4 -32.32 71.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.839 -178.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.434 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -65.99 -46.15 79.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.228 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.465 HH22 HG12 ' X' ' 7' ' ' ILE . 0.9 OUTLIER -66.26 -39.74 89.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.274 177.205 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.27 86.51 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.817 0.698 . . . . 0.0 111.717 -179.065 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.786 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.23 -40.03 15.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.15 28.71 3.49 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -175.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -93.55 156.46 39.71 Favored Pre-proline 0 N--CA 1.412 -2.328 0 C-N-CA 124.225 1.01 . . . . 0.0 108.779 179.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -63.71 129.57 25.29 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.574 2.183 . . . . 0.0 112.979 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.99 -132.57 7.78 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.945 178.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 42.4 m-85 -96.21 152.75 18.27 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.251 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -88.85 169.55 11.49 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.29 136.0 41.86 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.82 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.926 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -177.695 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . 0.402 HD21 HD13 ' X' ' 18' ' ' LEU . 40.4 mt . . . . . 0 N--CA 1.435 -1.22 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.455 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 35.3 mmtt -95.62 -161.06 0.83 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.177 -173.577 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -108.79 -33.51 6.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -130.69 166.61 20.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.624 -176.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.2 tp -67.65 -25.15 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.595 0.712 . . . . 0.0 109.785 178.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -77.67 -11.54 59.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.261 -173.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -99.28 1.13 44.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.04 121.43 40.97 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.855 -174.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 11' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 80.1 p -79.52 167.94 20.1 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 170.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.581 ' O ' HG11 ' X' ' 16' ' ' VAL . 6.0 pt-20 -59.96 -41.86 92.82 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.031 178.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.434 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.58 -38.5 74.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.47 177.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.72 -36.17 76.0 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.403 0.62 . . . . 0.0 109.973 174.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.715 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 18.8 t80 -70.92 -46.17 62.97 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.867 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.606 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 4.9 m -62.57 -29.97 48.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.523 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -60.76 -49.41 77.61 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.969 0.907 . . . . 0.0 109.697 174.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.645 ' O ' HG13 ' X' ' 22' ' ' ILE . 22.7 tp -57.72 -46.79 83.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.577 0.704 . . . . 0.0 109.677 175.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.1 mt -58.23 -38.71 77.38 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.055 -178.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 97.6 mttt -70.3 -39.21 74.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.957 0.408 . . . . 0.0 110.157 176.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.41 -37.47 87.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 178.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.645 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.5 mt -65.82 -46.74 87.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.98 -39.86 79.24 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.367 1.067 . . . . 0.0 113.053 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . 0.531 ' HG3' ' OE1' ' X' ' 25' ' ' GLU . 24.3 tptp -60.21 -48.67 80.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . 0.531 ' OE1' ' HG3' ' X' ' 24' ' ' LYS . 9.4 mm-40 -92.15 -1.83 56.93 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.484 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -70.84 -53.39 15.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.71 -28.31 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.962 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -23.36 33.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.959 0.409 . . . . 0.0 110.316 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.77 71.21 0.58 Allowed 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.57 1.548 . . . . 0.0 111.935 -176.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 68.9 p -91.25 -164.03 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.34 -38.71 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.716 177.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.492 ' O ' HG22 ' X' ' 36' ' ' VAL . 33.8 t70 -67.78 -55.09 14.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -172.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.661 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.86 -28.88 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 118.711 -1.195 . . . . 0.0 108.267 -177.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.07 -49.73 76.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.92 -176.203 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.52 -16.02 59.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.294 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.492 HG22 ' O ' ' X' ' 32' ' ' ASP . 57.3 t -71.69 -50.4 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 C-N-CA 118.599 -1.24 . . . . 0.0 107.815 172.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 82.3 mt -68.18 -42.44 79.94 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 113.457 -1.702 . . . . 0.0 112.059 -169.395 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.0 mt -59.12 -45.78 90.03 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.352 1.033 . . . . 0.0 110.524 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -70.55 -43.3 69.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.893 178.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.53 ' O ' HG12 ' X' ' 44' ' ' ILE . 19.6 t60 -59.89 -46.37 89.55 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.109 -176.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.616 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.7 t80 -62.45 -50.54 71.07 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.095 -179.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.481 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.5 p -67.08 -30.97 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.549 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.0 pttt -73.08 -35.41 66.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.364 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.53 HG12 ' O ' ' X' ' 40' ' ' HIS . 28.6 pt -81.21 -38.69 16.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.9 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 77.2 p -79.47 -36.15 39.19 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-O 121.227 0.537 . . . . 0.0 110.398 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 65.02 23.82 12.55 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -75.28 134.14 74.08 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . 0.476 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.7 Cg_exo -72.17 -3.09 12.66 Favored 'Trans proline' 0 CA--C 1.493 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.549 -174.428 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.431 ' CG ' ' HB2' ' X' ' 52' ' ' ALA . 24.0 t70 -138.51 32.48 2.29 Favored 'General case' 0 N--CA 1.389 -3.507 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -174.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.616 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.44 -59.72 4.56 Favored Glycine 1 CA--C 1.45 -4.01 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.353 -179.152 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.471 ' CG2' HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.23 -32.4 70.25 Favored 'General case' 0 C--N 1.248 -3.81 0 CA-C-N 114.764 -0.718 . . . . 0.0 111.461 -173.149 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -75.08 -24.07 58.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.037 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.31 -40.48 94.36 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.435 173.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.438 HD13 HG22 ' X' ' 22' ' ' ILE . 11.7 mt -66.23 -46.11 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -57.45 -49.06 77.46 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.437 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.57 -36.11 70.79 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.148 177.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 118.159 0.436 . . . . 0.0 110.335 178.851 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.409 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.46 ' O ' HG13 ' X' ' 75' ' ' ILE . 11.6 Cg_endo -58.31 -44.4 38.61 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.899 -178.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.79 1.05 7.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.03 -22.78 6.72 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.739 176.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.486 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -65.63 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.703 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.497 HG13 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -58.27 -47.2 88.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.291 178.653 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . 0.449 ' H ' HG11 ' X' ' 76' ' ' VAL . 23.9 ttmm -58.26 -44.66 88.45 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.72 -29.73 64.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.285 0.564 . . . . 0.0 110.664 -178.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.486 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.3 mm -69.02 -45.92 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.028 175.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.2 pttp -63.07 -36.29 83.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.186 -174.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.21 -37.6 75.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.144 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . 0.476 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.4 t90 -68.42 -47.38 67.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.192 0.52 . . . . 0.0 110.239 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.473 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 12.3 tpt180 -60.48 -45.66 92.94 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.26 -175.127 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.32 87.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.804 0.335 . . . . 0.0 111.457 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.46 -30.44 64.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.6 34.77 4.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.843 177.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . 0.473 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 58.7 mttm -111.91 148.27 38.62 Favored Pre-proline 0 N--CA 1.403 -2.802 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.01 126.54 14.65 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.512 2.142 . . . . 0.0 110.344 175.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.79 -114.61 3.13 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.096 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . 0.472 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 18.0 m-85 -88.59 158.5 18.25 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 121.114 0.483 . . . . 0.0 110.273 -174.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.6 ptmt -98.45 166.43 11.36 Favored 'General case' 0 N--CA 1.381 -3.881 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.03 136.46 44.46 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 173.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.119 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.39 -177.166 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.242 0.658 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' X' X ' 4' ' ' LYS . . . . . 0.473 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 36.3 mmtt -101.66 -159.84 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.98 -22.55 6.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.134 0.492 . . . . 0.0 110.446 175.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.1 p -140.0 165.95 25.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.559 179.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 7' ' ' ILE . . . . . 0.562 HG12 ' NH1' ' X' ' 83' ' ' ARG . 4.7 tp -70.38 -18.02 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.488 0.661 . . . . 0.0 110.317 -175.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -70.67 -18.89 62.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.851 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 9' ' ' ASP . . . . . 0.483 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.8 t0 -104.09 6.9 36.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.904 0.859 . . . . 0.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 15.4 m-85 -96.3 123.81 40.08 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.57 -176.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.3 p -86.29 172.73 10.24 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 171.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 12' ' ' GLU . . . . . 0.582 ' O ' HG12 ' X' ' 16' ' ' VAL . 4.1 mm-40 -56.05 -52.04 65.67 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.138 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 13' ' ' ALA . . . . . 0.406 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.13 -38.55 75.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.82 -174.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' X' ' 17' ' ' GLN . 5.2 mm-40 -62.35 -33.47 74.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.899 175.562 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 15' ' ' PHE . . . . . 0.651 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 27.1 t80 -71.94 -44.96 62.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 16' ' ' VAL . . . . . 0.582 HG12 ' O ' ' X' ' 12' ' ' GLU . 3.6 m -62.51 -30.43 49.13 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.176 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' X' ' 17' ' ' GLN . 0.3 OUTLIER -59.22 -50.21 74.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.647 0.779 . . . . 0.0 109.023 174.788 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' X' X ' 18' ' ' LEU . . . . . 0.623 ' O ' HG13 ' X' ' 22' ' ' ILE . 26.0 tp -58.62 -45.91 88.2 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.042 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 22.3 mt -57.93 -40.96 81.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.937 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 99.4 mttt -65.22 -37.49 87.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.23 176.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 21' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' X' ' 24' ' ' LYS . 7.9 mm-40 -71.8 -37.37 70.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 22' ' ' ILE . . . . . 0.623 HG13 ' O ' ' X' ' 18' ' ' LEU . 18.5 mt -62.4 -39.61 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.738 178.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.73 -47.05 83.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.356 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' X' ' 21' ' ' GLU . 17.4 pttp -67.42 -36.26 80.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.497 -175.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -71.86 -31.64 66.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.269 0.557 . . . . 0.0 110.038 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -72.46 -50.79 23.59 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.473 177.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.8 m -68.82 -32.35 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -10.06 49.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 109.92 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.62 80.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.701 1.6 . . . . 0.0 113.495 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 30' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 61.7 p -105.16 -168.53 1.48 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -143.01 -29.13 0.55 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.555 177.465 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 32' ' ' ASP . . . . . 0.569 ' O ' HG21 ' X' ' 36' ' ' VAL . 11.0 m-20 -67.87 -57.8 5.65 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.043 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 33' ' ' VAL . . . . . 0.666 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 85.6 t -86.36 -29.02 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.472 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 34' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.01 -44.25 87.13 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 35' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 28.1 t70 -71.7 -35.2 70.15 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.287 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 36' ' ' VAL . . . . . 0.569 HG21 ' O ' ' X' ' 32' ' ' ASP . 80.9 t -57.76 -49.85 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.008 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 37' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 64.9 mt -68.12 -43.21 78.92 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.615 -172.179 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 38' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.5 mt -60.58 -49.09 78.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 124.154 0.909 . . . . 0.0 111.876 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 39' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.6 pt-20 -71.36 -36.39 71.47 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.8 178.549 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 40' ' ' HIS . . . . . 0.528 ' O ' HG12 ' X' ' 44' ' ' ILE . 13.6 t60 -62.72 -46.53 87.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 41' ' ' PHE . . . . . 0.627 ' O ' HG22 ' X' ' 45' ' ' THR . 54.8 t80 -58.02 -56.03 27.24 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 42' ' ' VAL . . . . . 0.456 HG12 ' O ' ' X' ' 38' ' ' LEU . 10.6 p -67.06 -32.87 59.83 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 43' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 9.2 pttp -70.3 -31.99 69.56 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.026 -179.068 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 44' ' ' ILE . . . . . 0.528 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.9 pt -83.24 -37.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.164 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 45' ' ' THR . . . . . 0.627 HG22 ' O ' ' X' ' 41' ' ' PHE . 7.3 t -84.78 -29.59 25.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.22 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 60.44 34.69 20.49 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.418 1.087 . . . . 0.0 111.549 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 47' ' ' HIS . . . . . 0.461 ' H ' HG21 ' X' ' 45' ' ' THR . 45.1 t-80 -85.3 134.26 40.94 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 114.542 -1.208 . . . . 0.0 107.742 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -69.63 -15.55 37.64 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.945 2.43 . . . . 0.0 113.146 -174.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 49' ' ' ASP . . . . . 0.408 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 10.8 m-20 -124.29 29.29 6.41 Favored 'General case' 0 N--CA 1.402 -2.827 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -173.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 50' ' ' GLY . . . . . 0.529 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -58.05 5.12 Favored Glycine 1 CA--C 1.447 -4.186 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.473 -176.73 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' X' X ' 51' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -75.66 -33.23 60.42 Favored 'General case' 1 C--N 1.242 -4.091 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.512 -171.876 . . . . . . . . 4 4 . 1 . 030 nuclear orig core ' X' X ' 52' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.11 -37.03 76.21 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.527 177.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 42.6 mt -57.82 -44.73 86.61 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.774 0.671 . . . . 0.0 112.007 177.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 54' ' ' ILE . . . . . 0.581 HD12 ' CD2' ' X' ' 41' ' ' PHE . 4.0 mp -67.38 -43.46 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.645 -179.651 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 55' ' ' TYR . . . . . 0.519 ' HD1' ' O ' ' X' ' 51' ' ' THR . 29.6 m-85 -55.03 -47.46 74.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.292 177.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 56' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.1 pt-20 -71.53 -36.74 71.1 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 176.079 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 CA-C-N 118.184 0.447 . . . . 0.0 110.784 178.985 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.204 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.523 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.8 Cg_endo -62.87 -38.4 48.24 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.637 2.891 . . . . 0.0 111.845 -179.017 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.8 -0.2 12.69 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.16 -22.3 7.97 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.771 176.066 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 75' ' ' ILE . . . . . 0.523 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -67.19 -42.74 88.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.356 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' X' X ' 76' ' ' VAL . . . . . 0.509 HG13 HG13 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -58.76 -41.3 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.785 177.487 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -60.06 -48.61 80.99 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.809 177.159 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.42 -45.11 84.96 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.888 0.851 . . . . 0.0 110.053 176.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 79' ' ' ILE . . . . . 0.458 HG22 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -61.46 -40.81 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.881 176.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.67 -39.97 69.92 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.458 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.11 -41.97 85.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 57.8 t90 -64.08 -46.85 82.44 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.65 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 83' ' ' ARG . . . . . 0.562 ' NH1' HG12 ' X' ' 7' ' ' ILE . 0.8 OUTLIER -66.28 -39.72 89.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.783 176.874 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.69 96.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.555 0.534 . . . . 0.0 110.864 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.03 83.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.857 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.31 -49.2 15.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.43 0.633 . . . . 0.0 110.381 -176.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.52 27.99 3.92 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -99.04 155.52 36.48 Favored Pre-proline 0 N--CA 1.406 -2.625 0 C-N-CA 123.342 0.657 . . . . 0.0 109.903 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.58 110.89 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.698 2.265 . . . . 0.0 111.947 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 90' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -85.28 -111.22 0.71 Allowed Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.468 -177.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -109.87 164.21 12.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.357 -179.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 92' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 21.1 ptmt -91.45 168.04 11.83 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.014 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.47 139.44 30.71 Favored 'General case' 0 C--N 1.266 -3.053 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.393 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.744 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.512 -0.497 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.409 HD22 HD12 ' X' ' 18' ' ' LEU . 29.6 mt -91.77 129.73 37.68 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.239 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -95.93 -165.51 1.29 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -109.35 -33.9 6.7 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.112 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 69.6 p -127.17 166.62 17.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.304 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.7 tp -65.36 -18.03 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 110.47 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.5 m -83.6 -9.59 58.81 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.606 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 22.0 t70 -104.44 -1.0 27.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.52 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.29 120.0 31.06 Favored 'General case' 0 CA--C 1.47 -2.112 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.407 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 75.0 p -83.03 170.41 14.89 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 172.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.639 ' O ' HG11 ' X' ' 16' ' ' VAL . 5.8 pt-20 -58.33 -46.11 86.82 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.322 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.495 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.09 -38.24 75.62 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -64.78 -32.91 74.82 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 121.671 -0.643 . . . . 0.0 110.646 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.657 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 29.1 t80 -71.36 -43.64 66.54 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.639 HG11 ' O ' ' X' ' 12' ' ' GLU . 3.5 m -62.79 -28.98 45.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.739 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -61.63 -45.9 92.07 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.575 ' O ' HG13 ' X' ' 22' ' ' ILE . 29.5 tp -61.76 -47.19 86.31 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 123.858 0.724 . . . . 0.0 109.629 175.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -58.23 -37.57 75.13 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.031 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.1 mttm -70.62 -35.67 73.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.42 -36.75 74.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.947 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.575 HG13 ' O ' ' X' ' 18' ' ' LEU . 56.2 mt -63.01 -41.71 93.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -47.57 81.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.495 1.118 . . . . 0.0 108.618 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -61.39 -52.68 63.62 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.32 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -72.22 -25.64 61.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.34 -46.45 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.78 -25.36 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.717 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.31 -26.79 35.38 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.96 68.44 0.63 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.398 1.479 . . . . 0.0 111.682 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.8 p -99.47 -171.66 2.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -131.93 -44.82 0.95 Allowed 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 118.205 -1.398 . . . . 0.0 112.585 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.657 ' O ' HG22 ' X' ' 36' ' ' VAL . 21.7 t70 -64.78 -52.48 56.67 Favored 'General case' 0 CA--C 1.476 -1.894 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.775 -172.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -85.8 -30.41 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 O-C-N 123.714 0.634 . . . . 0.0 110.64 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -59.1 -47.35 85.57 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.59 -26.88 64.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.285 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.657 HG22 ' O ' ' X' ' 32' ' ' ASP . 92.9 t -67.11 -50.26 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 C-N-CA 118.622 -1.231 . . . . 0.0 108.79 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 67.2 mt -68.64 -39.48 80.72 Favored 'General case' 0 N--CA 1.41 -2.436 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.935 -170.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.9 mt -59.26 -49.18 78.82 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 124.253 0.971 . . . . 0.0 110.431 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.57 -39.97 73.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.693 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.51 ' O ' HG12 ' X' ' 44' ' ' ILE . 12.8 t60 -59.62 -46.22 89.64 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.412 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.543 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 56.3 t80 -60.32 -52.99 62.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.649 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.495 HG13 ' O ' ' X' ' 38' ' ' LEU . 7.4 p -66.65 -31.01 51.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -73.0 -33.57 65.87 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.75 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.51 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.1 pt -84.05 -35.74 11.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.238 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 75.8 p -81.72 -34.67 30.43 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 64.96 22.4 12.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.825 1.65 . . . . 0.0 110.338 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 34.1 t-80 -72.61 133.67 82.46 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 34.6 Cg_exo -67.46 -17.94 49.11 Favored 'Trans proline' 0 CA--C 1.499 -1.274 0 C-N-CA 123.119 2.546 . . . . 0.0 111.639 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.464 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 9.4 m-20 -124.13 33.68 5.23 Favored 'General case' 0 N--CA 1.383 -3.788 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.543 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -56.15 6.03 Favored Glycine 0 CA--C 1.457 -3.569 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.839 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.475 ' O ' ' HD1' ' X' ' 55' ' ' TYR 0.369 0.4 OUTLIER -85.85 -18.3 33.21 Favored 'General case' 0 C--N 1.25 -3.719 0 C-N-CA 117.116 -1.834 . . . . 0.0 114.26 -175.883 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.599 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.88 -31.6 72.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.8 mt -66.91 -38.42 86.2 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 123.691 0.619 . . . . 0.0 111.212 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.44 HD11 HG21 ' X' ' 75' ' ' ILE . 21.0 mm -66.57 -48.12 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.244 1.021 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.475 ' HD1' ' O ' ' X' ' 51' ' ' THR . 43.8 m-85 -64.39 -40.74 96.41 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 113.715 -1.584 . . . . 0.0 113.914 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.15 -36.92 72.22 Favored 'General case' 0 C--O 1.194 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.858 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.32 77.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.122 0.264 . . . . 0.0 110.553 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.07 -47.91 78.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.523 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.48 91.19 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.706 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.505 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 75.4 mtp180 -64.48 -30.77 71.8 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.315 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.69 54.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.815 0.341 . . . . 0.0 110.49 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.03 91.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.043 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.39 -48.16 17.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.919 0.39 . . . . 0.0 110.082 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 54.86 88.3 0.13 Allowed Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.002 1.721 . . . . 0.0 112.857 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.88 -66.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.285 1.99 . . . . 0.0 111.823 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.69 37.18 2.15 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.184 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 -63.05 2.95 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . 0.461 ' OD1' ' HE3' ' X' ' 77' ' ' LYS . 23.3 m-20 -56.22 125.91 23.86 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . 0.505 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 92.64 -16.62 59.71 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.615 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 69.38 1.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.48 170.12 17.28 Favored Glycine 0 N--CA 1.403 -3.509 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.537 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.5 Cg_endo -57.87 -40.15 80.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.792 2.995 . . . . 0.0 112.887 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.45 0.66 9.67 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.74 -3.98 30.13 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.829 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.537 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.8 mt -78.13 -46.02 26.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.458 HG12 HG12 ' X' ' 16' ' ' VAL . 0.8 OUTLIER -56.47 -44.47 80.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.648 176.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.3 ttmm -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.309 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.51 -38.51 65.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 44.6 mm -67.31 -39.45 82.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.003 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 21.2 ptmt -61.59 -38.28 87.0 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.65 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -72.33 -39.09 68.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.433 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.511 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 59.4 t90 -67.36 -47.14 71.29 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.049 0.452 . . . . 0.0 110.026 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.523 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 10.6 tpt180 -60.83 -45.08 95.88 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.457 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.77 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.363 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.92 95.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.048 0.452 . . . . 0.0 111.513 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -69.04 -28.97 67.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.51 9.12 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.523 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 53.7 mttm -104.8 147.9 35.21 Favored Pre-proline 0 N--CA 1.405 -2.68 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -68.01 122.56 9.67 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 121.856 1.704 . . . . 0.0 109.643 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . 0.428 ' CA ' ' HG2' ' X' ' 83' ' ' ARG . . . -96.82 -129.0 6.02 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.243 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -78.18 158.1 29.14 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.059 -0.57 . . . . 0.0 110.535 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' X' ' 11' ' ' THR . 39.7 pttt -101.89 175.23 5.61 Favored 'General case' 0 N--CA 1.38 -3.968 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -105.75 144.25 32.76 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.417 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.506 -0.745 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 58.3 mt -92.17 128.74 38.12 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -103.2 168.0 9.46 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.68 -27.12 34.18 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.582 0.706 . . . . 0.0 110.479 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.4 p -134.18 163.12 30.31 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.484 HD11 ' CE1' ' X' ' 91' ' ' PHE . 6.0 tp -68.0 -18.1 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.155 0.982 . . . . 0.0 109.854 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.0 p -76.45 -16.23 59.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.646 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -104.07 2.66 32.35 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -97.36 120.86 38.5 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.907 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 74.7 p -79.31 163.16 25.12 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 167.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.648 ' O ' HG12 ' X' ' 16' ' ' VAL . 8.6 pt-20 -59.03 -35.65 73.65 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.102 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.453 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.42 -39.37 74.46 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -58.81 -37.16 75.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.934 0.874 . . . . 0.0 109.282 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.623 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 38.1 t80 -74.82 -39.53 61.6 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.475 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.648 HG12 ' O ' ' X' ' 12' ' ' GLU . 8.6 m -62.69 -29.87 47.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.257 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.04 -50.09 75.39 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.666 ' O ' HG13 ' X' ' 22' ' ' ILE . 46.6 tp -59.7 -46.47 89.0 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.799 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 34.4 mt -57.29 -43.28 83.05 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.232 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 98.5 mttt -61.49 -46.54 89.57 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.964 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.09 -39.32 89.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.796 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.666 HG13 ' O ' ' X' ' 18' ' ' LEU . 50.7 mt -60.77 -44.71 97.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 O-C-N 123.337 0.398 . . . . 0.0 110.59 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.446 ' O ' HG23 ' X' ' 27' ' ' VAL . 46.8 mt-10 -57.02 -46.06 82.64 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.398 0.618 . . . . 0.0 109.723 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.15 -46.85 88.29 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.387 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -85.83 -30.39 23.0 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.305 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.65 -44.64 85.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.092 0.157 . . . . 0.0 111.183 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . 0.446 HG23 ' O ' ' X' ' 23' ' ' GLU . 32.4 m -71.11 -22.53 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.57 -24.99 22.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.68 88.9 0.11 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.899 1.68 . . . . 0.0 110.867 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 44.7 p -96.89 -151.88 0.37 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.92 -66.82 0.37 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 112.726 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.576 ' O ' HG22 ' X' ' 36' ' ' VAL . 38.1 t70 -66.98 -46.26 75.14 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.23 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.603 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.8 p -81.66 -28.13 10.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.046 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.607 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.7 tm? -58.73 -52.54 65.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.321 1.049 . . . . 0.0 108.823 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.5 -19.71 62.91 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.576 HG22 ' O ' ' X' ' 32' ' ' ASP . 97.7 t -72.02 -52.11 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.027 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.875 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 41.4 mt -69.42 -43.7 72.87 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.552 -168.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.4 mt -59.72 -46.77 88.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 124.567 1.167 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -71.43 -40.56 70.34 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.585 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.3 t60 -59.71 -45.7 91.35 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.508 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.592 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.22 -52.79 63.81 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.467 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.465 HG12 ' O ' ' X' ' 38' ' ' LEU 0.267 11.8 p -67.67 -31.94 54.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.0 ptmm? -70.59 -33.2 70.81 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.711 -0.618 . . . . 0.0 112.151 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.495 HG12 ' O ' ' X' ' 40' ' ' HIS . 14.5 pt -84.81 -33.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.564 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -84.42 -35.77 22.85 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 120.965 0.412 . . . . 0.0 110.654 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.01 25.73 15.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.952 1.701 . . . . 0.0 110.163 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.424 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 26.3 t-80 -74.02 134.07 78.11 Favored Pre-proline 0 N--CA 1.429 -1.51 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -71.33 -9.71 25.8 Favored 'Trans proline' 0 CA--C 1.496 -1.423 0 C-N-CA 122.989 2.46 . . . . 0.0 112.058 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.0 m-20 -130.31 29.66 4.84 Favored 'General case' 0 N--CA 1.396 -3.145 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -170.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.592 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.59 -59.04 5.61 Favored Glycine 0 CA--C 1.461 -3.298 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.199 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.455 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -74.67 -28.89 61.03 Favored 'General case' 0 C--N 1.247 -3.891 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.547 -172.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.07 -35.74 81.73 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -61.74 -39.07 90.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.605 0.566 . . . . 0.0 111.522 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.43 HD13 HG22 ' X' ' 22' ' ' ILE . 36.8 mt -67.17 -47.05 82.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.411 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.6 m-85 -57.91 -45.7 86.08 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.432 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.0 pt-20 -70.4 -39.94 74.2 Favored 'General case' 0 C--O 1.201 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.77 -39.52 85.12 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 117.727 0.24 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.31 -42.12 86.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.537 0.523 . . . . 0.0 110.153 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.29 65.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.172 0.51 . . . . 0.0 110.224 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -61.05 -37.53 82.94 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.811 0.844 . . . . 0.0 110.578 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.33 -30.11 42.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.697 0.285 . . . . 0.0 111.018 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.4 82.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 -44.65 20.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 63.7 92.04 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 124.868 1.267 . . . . 0.0 112.049 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.12 -12.51 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.666 1.578 . . . . 0.0 110.271 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.23 -156.36 15.62 Favored Glycine 0 N--CA 1.422 -2.242 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.9 -118.88 15.96 Favored Glycine 0 N--CA 1.433 -1.563 0 O-C-N 124.494 0.761 . . . . 0.0 113.445 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . 0.558 ' OD2' ' HD3' ' X' ' 77' ' ' LYS . 4.6 p-10 -123.3 -27.85 4.06 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 123.447 0.699 . . . . 0.0 110.125 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.23 -7.49 72.14 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.889 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.37 31.95 5.48 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.75 -175.4 44.04 Favored Glycine 0 N--CA 1.408 -3.221 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.555 ' O ' HG13 ' X' ' 75' ' ' ILE . 34.0 Cg_endo -71.95 -22.03 23.68 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 123.725 2.95 . . . . 0.0 113.325 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -72.55 0.44 10.47 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.2 -14.06 23.34 Favored Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.889 -1.624 . . . . 0.0 113.275 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.555 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.9 OUTLIER -70.2 -43.39 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.473 HG13 ' H ' ' X' ' 77' ' ' LYS . 1.1 p -59.85 -47.07 92.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.686 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.558 ' HD3' ' OD2' ' X' ' 68' ' ' ASP . 83.5 tttt -60.86 -42.35 97.67 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.24 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.2 -40.6 86.25 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.426 HG12 ' O ' ' X' ' 75' ' ' ILE . 41.0 mm -67.21 -46.43 84.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.928 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -63.82 -35.68 81.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.759 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.57 -41.48 92.89 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.979 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.54 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 84.1 t90 -66.41 -47.99 71.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -61.27 -45.52 94.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.43 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.72 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.219 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.26 -26.5 66.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.978 0.418 . . . . 0.0 111.308 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -85.24 -12.25 52.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.78 37.71 44.23 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.991 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -117.25 137.83 24.36 Favored Pre-proline 0 N--CA 1.392 -3.353 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.7 129.79 27.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.346 2.03 . . . . 0.0 110.42 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.0 -114.6 3.38 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.187 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.484 ' CE1' HD11 ' X' ' 7' ' ' ILE . 72.4 m-85 -83.67 152.22 24.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.095 -0.553 . . . . 0.0 110.958 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -87.73 166.73 14.42 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -105.92 142.21 36.01 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 176.038 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt -112.47 143.07 44.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 O-C-N 123.501 0.501 . . . . 0.0 110.438 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 28.6 mmtt -101.72 -159.45 0.73 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.04 -23.58 8.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -143.14 166.69 23.98 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tp -62.7 -18.67 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -77.52 -4.37 45.29 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.711 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 9.6 t70 -112.34 -3.8 14.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.488 ' CZ ' ' HG2' ' X' ' 4' ' ' LYS . 39.4 m-85 -93.99 116.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.706 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 70.8 p -75.77 173.48 11.06 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 170.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.591 ' O ' HG11 ' X' ' 16' ' ' VAL . 3.9 pt-20 -56.09 -44.54 79.11 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.303 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.408 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.58 -38.57 74.09 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.445 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 32.1 mm-40 -58.89 -36.61 74.94 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.721 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -67.33 -50.09 61.43 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.706 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.591 HG11 ' O ' ' X' ' 12' ' ' GLU . 2.7 m -61.56 -34.55 62.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 O-C-N 123.182 0.301 . . . . 0.0 111.328 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.62 77.18 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.196 0.998 . . . . 0.0 108.678 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.546 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -65.95 -41.2 91.57 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.153 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.3 mt -58.52 -37.59 75.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.226 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 76.7 mttt -66.52 -36.86 83.72 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.535 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.27 -33.11 61.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.688 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.546 HG13 ' O ' ' X' ' 18' ' ' LEU . 48.1 mt -61.97 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.15 -35.02 79.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.57 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -70.21 -52.17 25.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.61 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -70.03 -18.18 63.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.464 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.68 -52.02 20.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.938 0.895 . . . . 0.0 110.26 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.6 -23.56 19.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.857 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.5 -4.23 57.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 0.0 109.616 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 49.36 62.41 2.64 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.693 1.597 . . . . 0.0 112.927 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.616 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 54.8 p -88.34 -177.84 5.75 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.77 -63.42 0.7 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.634 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.581 ' O ' HG21 ' X' ' 36' ' ' VAL . 30.8 m-20 -58.02 -48.59 79.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.625 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 12.0 p -84.56 -32.63 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.362 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.54 -44.71 93.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.82 -32.71 72.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.473 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.581 HG21 ' O ' ' X' ' 32' ' ' ASP . 71.6 t -59.27 -49.13 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-O 121.877 0.846 . . . . 0.0 109.121 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 77.3 mt -68.33 -40.58 81.55 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 113.415 -1.721 . . . . 0.0 110.889 -174.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -58.8 -49.29 78.25 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 124.316 1.01 . . . . 0.0 110.729 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -69.29 -42.09 75.94 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.287 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.609 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 43.2 t60 -61.38 -44.98 96.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.227 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.64 ' O ' HG21 ' X' ' 45' ' ' THR . 42.3 t80 -55.71 -53.08 60.94 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.693 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.416 HG12 ' O ' ' X' ' 38' ' ' LEU 0.293 8.1 p -66.77 -31.6 54.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -74.44 -33.13 62.85 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.055 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.555 HG12 ' O ' ' X' ' 40' ' ' HIS . 30.1 pt -79.9 -36.83 17.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.207 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.64 HG21 ' O ' ' X' ' 41' ' ' PHE . 10.0 t -85.41 -28.26 25.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 61.35 27.8 17.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.213 1.005 . . . . 0.0 110.839 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 47.3 t-80 -82.51 137.58 44.83 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -75.14 0.01 9.48 Favored 'Trans proline' 0 CA--C 1.486 -1.889 0 C-N-CA 123.235 2.624 . . . . 0.0 113.067 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.5 m-20 -139.0 34.01 2.15 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.82 -56.08 9.07 Favored Glycine 0 CA--C 1.461 -3.326 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.091 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.445 HG21 HD22 ' X' ' 38' ' ' LEU 0.332 0.8 OUTLIER -84.01 -20.1 33.34 Favored 'General case' 0 C--N 1.259 -3.345 0 C-N-CA 116.886 -1.926 . . . . 0.0 114.316 -176.574 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.601 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.16 -36.62 82.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 30.3 mt -61.83 -42.82 99.51 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 123.813 0.695 . . . . 0.0 112.236 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.61 -45.96 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.353 1.073 . . . . 0.0 108.831 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.59 -42.7 98.26 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.479 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -69.03 -35.18 76.33 Favored 'General case' 0 C--O 1.206 -1.221 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.402 175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' X' ' 75' ' ' ILE . . . -56.72 -40.11 75.12 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 122.704 0.402 . . . . 0.0 111.182 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.32 80.91 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.881 0.738 . . . . 0.0 110.235 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.07 96.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.584 0.707 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.63 -30.78 70.44 Favored 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.529 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.77 -41.18 27.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.48 81.81 2.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' X' ' 65' ' ' PRO . 23.0 p30 -78.53 131.65 67.63 Favored Pre-proline 0 CA--C 1.49 -1.333 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.469 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' X' ' 64' ' ' ASN . 62.8 Cg_endo -92.16 0.05 4.16 Favored 'Trans proline' 0 N--CA 1.43 -2.242 0 C-N-CA 122.262 1.975 . . . . 0.0 112.207 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.55 -166.28 12.23 Favored Glycine 0 CA--C 1.485 -1.787 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.75 -115.11 6.98 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 124.207 0.592 . . . . 0.0 112.504 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.54 -12.98 28.33 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.79 -107.79 2.15 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.937 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -159.13 -144.87 4.08 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.02 -156.3 52.08 Favored Glycine 0 N--CA 1.415 -2.729 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.076 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.507 ' CG ' ' HG2' ' X' ' 20' ' ' LYS . 25.0 Cg_endo -71.98 -56.12 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.497 2.798 . . . . 0.0 114.076 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.01 0.59 1.81 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.39 -31.17 3.1 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.607 -1.758 . . . . 0.0 114.137 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.471 HG13 HD12 ' X' ' 19' ' ' LEU . 9.9 pt -67.11 -34.12 67.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 117.487 0.643 . . . . 0.0 110.602 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 0.2 OUTLIER -59.08 -43.26 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-O 121.997 0.903 . . . . 0.0 110.913 175.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 88.2 tttt -62.16 -47.24 85.4 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.33 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.22 -40.44 90.17 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.465 HD11 ' OG1' ' X' ' 45' ' ' THR . 22.5 mm -61.92 -46.23 96.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.485 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 20.3 pttp -70.41 -35.76 73.63 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.676 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 40.0 mt-10 -68.19 -39.88 82.37 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.209 0.318 . . . . 0.0 111.424 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -67.38 -48.1 68.41 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.173 0.511 . . . . 0.0 110.297 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.575 ' NH1' ' HA ' ' X' ' 45' ' ' THR . 15.9 ttt180 -70.98 -38.31 72.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.73 0.3 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -31.66 69.51 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.327 0.584 . . . . 0.0 110.378 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.497 ' ND2' ' HD3' ' X' ' 88' ' ' LYS . 39.9 t-20 -73.55 -30.71 63.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.201 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.07 26.7 25.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.497 ' HD3' ' ND2' ' X' ' 86' ' ' ASN . 21.7 mtpp -106.88 132.75 20.66 Favored Pre-proline 0 N--CA 1.399 -3.014 0 C-N-CA 123.491 0.717 . . . . 0.0 109.243 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.25 119.19 3.33 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.995 3.13 . . . . 0.0 113.768 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.15 -126.52 4.87 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.944 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.425 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 11.6 m-85 -84.84 165.65 17.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' X' ' 93' ' ' GLN . 19.5 ptmt -86.47 179.33 6.87 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . 0.441 ' O ' ' HE2' ' X' ' 92' ' ' LYS . 2.3 mp0 -96.55 139.3 32.85 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.615 0.722 . . . . 0.0 110.607 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.402 -3.627 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 177.204 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.008 0.433 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.45 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 83.7 mt -92.68 140.92 29.04 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.052 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.479 ' HE3' ' OD2' ' X' ' 9' ' ' ASP . 28.9 mmtt -111.66 -179.15 3.62 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -91.61 -39.26 11.97 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.192 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 64.8 p -127.87 167.23 16.87 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.653 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.06 -14.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.63 0.772 . . . . 0.0 109.836 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -79.08 -17.93 54.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.34 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.479 ' OD2' ' HE3' ' X' ' 4' ' ' LYS . 5.3 t70 -98.36 1.34 46.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.67 119.8 33.13 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.473 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -78.0 159.75 28.59 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.646 ' O ' HG12 ' X' ' 16' ' ' VAL . 10.1 pt-20 -65.64 -30.64 71.37 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.644 -1.622 . . . . 0.0 111.723 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.76 77.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.07 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -58.04 -40.06 79.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.79 0.805 . . . . 0.0 109.092 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.648 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.1 t80 -71.15 -44.92 64.59 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.905 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.646 HG12 ' O ' ' X' ' 12' ' ' GLU . 4.0 m -62.43 -34.81 66.5 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.825 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.39 -45.43 88.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.718 0.807 . . . . 0.0 109.347 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.495 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -66.63 -43.79 83.75 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.228 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.3 mt -58.08 -46.05 86.12 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.773 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 63.6 mtpt -62.02 -35.83 79.73 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.766 0.826 . . . . 0.0 110.0 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -74.52 -35.37 63.16 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.715 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.495 HG13 ' O ' ' X' ' 18' ' ' LEU . 44.1 mt -59.69 -44.41 93.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.921 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.422 ' O ' HG21 ' X' ' 27' ' ' VAL . 42.8 mt-10 -56.93 -44.82 82.85 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.383 0.611 . . . . 0.0 110.475 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -60.31 -46.09 91.08 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.647 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.5 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 3.1 pp20? -84.92 -30.32 24.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.749 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.02 -40.67 98.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.59 0.756 . . . . 0.0 111.698 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . 0.422 HG21 ' O ' ' X' ' 23' ' ' GLU . 34.7 m -80.5 -7.04 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.256 0.55 . . . . 0.0 111.313 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.03 -25.77 13.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.71 85.36 0.13 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.698 1.599 . . . . 0.0 110.297 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 72.7 p -92.07 -24.23 19.22 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 70.41 -50.81 0.66 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.37 1.868 . . . . 0.0 114.358 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.512 ' O ' HG23 ' X' ' 36' ' ' VAL . 14.3 t70 -70.25 -56.79 5.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 118.034 0.379 . . . . 0.0 110.23 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.672 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.5 p -80.87 -25.45 10.87 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.5 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.6 tm? -58.23 -48.31 80.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.779 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.71 -32.46 73.1 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.839 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.512 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.0 t -66.81 -50.69 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.549 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 35.4 mt -68.45 -43.81 76.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.02 -171.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.51 HD12 ' CG2' ' X' ' 51' ' ' THR . 46.4 mt -61.98 -45.67 92.61 Favored 'General case' 0 N--CA 1.419 -2.016 0 O-C-N 124.211 0.944 . . . . 0.0 111.707 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -70.3 -43.28 70.7 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.882 0.372 . . . . 0.0 111.757 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.496 ' O ' HG12 ' X' ' 44' ' ' ILE . 9.6 t60 -59.56 -45.14 92.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.328 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.589 ' O ' HG22 ' X' ' 45' ' ' THR . 27.5 t80 -59.68 -55.75 30.43 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.641 1.213 . . . . 0.0 110.824 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.486 HG12 ' O ' ' X' ' 38' ' ' LEU 0.278 14.7 p -66.87 -31.64 54.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -69.84 -30.53 68.04 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.84 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.496 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.0 pt -85.27 -35.92 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.574 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.589 HG22 ' O ' ' X' ' 41' ' ' PHE . 4.7 t -84.47 -30.86 24.89 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.394 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.58 36.75 13.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 125.041 1.336 . . . . 0.0 110.34 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -81.94 136.21 47.7 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.271 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 22.3 Cg_exo -70.96 -14.33 32.22 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.787 2.324 . . . . 0.0 111.941 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.401 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 22.3 m-20 -128.3 31.98 4.95 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -172.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.08 8.38 Favored Glycine 0 CA--C 1.457 -3.54 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.419 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.51 ' CG2' HD12 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.77 -33.94 58.03 Favored 'General case' 0 C--N 1.251 -3.697 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.055 -174.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.65 -31.88 69.94 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.191 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 mt -62.29 -48.51 79.55 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 123.574 0.546 . . . . 0.0 112.101 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' X' ' 41' ' ' PHE . 4.4 mp -66.81 -40.43 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.742 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.453 ' HD1' ' O ' ' X' ' 51' ' ' THR . 27.1 m-85 -61.62 -43.29 99.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.78 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.9 pt-20 -71.97 -37.04 69.98 Favored 'General case' 0 C--O 1.203 -1.345 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.202 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.51 82.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.594 0.358 . . . . 0.0 110.978 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.39 90.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.991 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.6 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.756 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 29.9 mtp180 -63.47 -39.27 94.01 Favored 'General case' 0 C--O 1.199 -1.564 0 C-N-CA 124.488 1.115 . . . . 0.0 112.155 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.87 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.793 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.38 71.68 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.607 0.718 . . . . 0.0 109.227 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.32 89.57 2.74 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 44.1 m-80 -60.86 125.96 84.43 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.043 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.67 6.96 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.707 2.271 . . . . 0.0 110.738 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.43 -126.76 1.91 Allowed Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.66 14.6 1.39 Allowed Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.271 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.0 -41.76 95.09 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.813 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.53 93.26 0.09 OUTLIER Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.66 -70.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.224 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.95 -114.74 2.38 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.317 -0.944 . . . . 0.0 114.429 -173.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.498 ' O ' HG13 ' X' ' 75' ' ' ILE . 36.7 Cg_endo -60.05 -53.6 2.96 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 123.694 2.929 . . . . 0.0 114.701 -167.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.88 0.17 9.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . 0.585 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -105.58 -18.58 11.53 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.004 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.498 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.5 OUTLIER -67.26 -44.22 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.469 HG13 HG13 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -60.49 -39.75 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.656 176.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 22.5 ttpp -58.55 -47.67 83.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.856 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 7.2 mm-40 -58.01 -45.08 87.43 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.125 0.964 . . . . 0.0 109.196 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.47 HD13 ' OG1' ' X' ' 45' ' ' THR . 41.9 mm -61.62 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.447 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.1 ptpt -65.89 -38.31 88.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.983 -177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.65 -40.16 76.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.907 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.448 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 63.1 t90 -70.17 -46.77 63.96 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.787 0.327 . . . . 0.0 110.684 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.473 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 8.4 tpt180 -60.55 -45.58 93.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.38 88.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.947 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.33 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.974 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -69.4 -34.99 75.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.68 44.07 1.86 Allowed Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.473 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 54.9 mttm -119.5 146.42 41.17 Favored Pre-proline 0 N--CA 1.4 -2.941 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.78 124.68 15.47 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.634 2.223 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -88.39 -132.43 4.11 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.864 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.4 ' CZ ' HG22 ' X' ' 76' ' ' VAL . 80.8 m-85 -89.54 166.18 13.82 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.32 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -99.28 166.99 10.94 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.21 144.5 25.76 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.673 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.75 132.98 36.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.16 0.505 . . . . 0.0 110.598 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.427 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 31.6 mmtt -105.3 -164.43 1.03 Allowed 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.25 -28.36 7.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.357 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -128.97 163.46 25.29 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -67.5 -16.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-O 121.471 0.653 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -79.1 -3.26 44.51 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.55 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.428 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.1 t0 -110.21 1.64 18.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.213 1.006 . . . . 0.0 108.92 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -93.75 121.01 34.74 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.521 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -82.37 176.14 9.67 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.549 ' O ' HG12 ' X' ' 16' ' ' VAL . 4.7 mm-40 -59.23 -51.97 67.7 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.5 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.84 -38.7 76.57 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.879 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.64 -40.97 80.48 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.172 0.51 . . . . 0.0 109.843 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.542 ' O ' HD12 ' X' ' 19' ' ' LEU . 30.2 t80 -75.06 -48.53 23.51 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.095 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.672 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 15.7 m -58.6 -38.58 71.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -66.8 -46.27 75.76 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 122.682 0.393 . . . . 0.0 111.027 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.54 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.4 tm? -62.95 -41.31 99.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.542 HD12 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.31 -36.86 76.4 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.148 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 61.4 mttm -63.58 -40.13 96.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.964 0.888 . . . . 0.0 108.816 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -65.13 -36.06 83.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.966 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.54 HG13 ' O ' ' X' ' 18' ' ' LEU . 19.3 mt -63.74 -39.55 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.285 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -56.87 -46.07 82.07 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.602 0.564 . . . . 0.0 109.915 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -62.93 -43.89 97.56 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.081 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.415 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 6.1 mm-40 -71.08 -33.33 70.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.284 0.564 . . . . 0.0 109.885 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.37 -44.94 57.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.564 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.34 -29.86 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.744 0.307 . . . . 0.0 111.693 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -4.67 57.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.464 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 48.34 64.85 1.51 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.179 1.392 . . . . 0.0 112.256 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.541 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 72.7 p -83.22 -161.07 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -130.42 -71.16 0.6 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.393 -1.323 . . . . 0.0 114.398 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.592 ' O ' HG21 ' X' ' 36' ' ' VAL . 27.6 t70 -56.64 -52.43 64.9 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 68.9 t -86.83 -25.11 6.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.239 -174.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.66 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -58.79 -50.8 72.62 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.7 -19.81 61.33 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.592 HG21 ' O ' ' X' ' 32' ' ' ASP . 59.2 t -71.48 -49.76 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.074 0 C-N-CA 118.289 -1.365 . . . . 0.0 108.471 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 88.5 mt -68.5 -43.54 76.62 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.091 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.5 mt -60.54 -47.09 87.7 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 124.337 1.023 . . . . 0.0 110.457 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -71.03 -43.72 67.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.627 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 39.1 t60 -60.34 -45.58 92.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.223 0.535 . . . . 0.0 110.062 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.621 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 38.4 t80 -59.14 -53.0 63.25 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.191 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.498 HG11 ' O ' ' X' ' 38' ' ' LEU . 13.1 p -67.99 -32.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -67.0 -36.98 83.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 122.07 -0.394 . . . . 0.0 111.502 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.581 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -81.1 -34.1 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.855 0.36 . . . . 0.0 111.378 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 35.2 p -83.84 -42.46 16.4 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.96 74.97 0.42 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 125.173 1.389 . . . . 0.0 109.583 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.535 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -126.11 139.01 33.32 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.164 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.46 -7.89 22.18 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.794 2.329 . . . . 0.0 112.31 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.431 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 16.3 m-20 -135.21 31.9 3.18 Favored 'General case' 0 N--CA 1.391 -3.386 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.621 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.81 -58.2 8.77 Favored Glycine 0 CA--C 1.461 -3.316 0 O-C-N 123.679 0.612 . . . . 0.0 112.704 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.477 ' CG2' HD12 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.23 -28.65 63.3 Favored 'General case' 0 C--N 1.248 -3.82 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.148 -174.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.78 -34.34 77.94 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.323 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.57 -45.4 77.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.905 0.482 . . . . 0.0 110.052 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 23.4 mt -66.84 -44.37 89.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.608 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -59.49 -49.68 76.86 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.754 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.7 pt-20 -66.94 -35.76 80.7 Favored 'General case' 0 C--O 1.188 -2.158 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.634 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.27 73.22 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.89 0.376 . . . . 0.0 110.763 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.89 92.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.3 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.03 64.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.892 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' X' ' 56' ' ' GLU . 44.8 mtp180 -61.8 -40.38 95.03 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 123.76 0.824 . . . . 0.0 111.115 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.87 -30.05 58.73 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.998 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.57 47.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -44.58 19.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.912 0.387 . . . . 0.0 110.3 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 54.54 82.93 0.23 Allowed Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.258 1.423 . . . . 0.0 112.755 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.88 -42.57 3.16 Favored 'Trans proline' 0 C--O 1.241 0.668 0 C-N-CA 122.104 1.869 . . . . 0.0 110.372 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.84 126.87 2.7 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.22 -150.23 21.79 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -109.73 0.77 19.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.718 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.34 79.91 0.33 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.216 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.5 -90.59 1.49 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.96 -132.86 6.2 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.181 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.664 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.0 Cg_endo -59.12 -38.64 85.6 Favored 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.536 2.824 . . . . 0.0 113.48 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.44 ' C ' HG22 ' X' ' 76' ' ' VAL . 23.3 mt-10 -85.03 1.65 46.74 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 123.212 0.605 . . . . 0.0 109.918 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.05 -36.91 2.08 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.36 -1.4 . . . . 0.0 112.641 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' X' ' 72' ' ' PRO . 5.8 pt -60.71 -34.33 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 172.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.664 HG13 ' O ' ' X' ' 72' ' ' PRO . 16.6 m -56.62 -39.36 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.559 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 23.4 ttmm -68.77 -39.41 80.23 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.041 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -67.08 -32.15 73.13 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.965 0.888 . . . . 0.0 109.155 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.403 ' HA ' HH21 ' X' ' 83' ' ' ARG . 83.0 mt -67.62 -46.35 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.873 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 14.4 ptmm? -67.71 -36.27 80.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 111.105 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.1 mt-10 -70.45 -36.79 74.15 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.899 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -66.8 -41.16 88.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.535 HH22 ' CD2' ' X' ' 47' ' ' HIS . 0.5 OUTLIER -61.87 -46.27 90.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.379 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.65 91.78 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.796 0.685 . . . . 0.0 111.517 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.937 0.398 . . . . 0.0 110.85 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -68.33 -48.54 64.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.486 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.52 4.77 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.91 151.6 37.54 Favored Pre-proline 0 N--CA 1.407 -2.58 0 C-N-CA 123.933 0.893 . . . . 0.0 108.828 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.97 140.96 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.978 1.785 . . . . 0.0 111.617 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.82 -131.3 6.61 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 10.7 m-85 -93.46 159.36 15.28 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 19.7 ptmt -93.94 172.8 8.01 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -96.25 135.69 37.73 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.712 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.203 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.163 178.406 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 87.3 mt -103.82 127.66 51.3 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -105.89 152.53 23.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -80.2 -11.7 59.71 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.138 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 67.5 p -141.88 162.3 35.81 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -69.4 -13.07 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 121.643 0.735 . . . . 0.0 110.676 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -77.98 -17.91 56.6 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -102.43 5.33 39.56 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -94.03 114.32 26.47 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.938 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 53.2 p -77.32 157.11 30.87 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 171.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.462 ' O ' HG12 ' X' ' 16' ' ' VAL . 6.2 pt-20 -64.67 -26.39 68.36 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.734 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.74 69.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.677 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -57.32 -41.65 80.36 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.266 0.555 . . . . 0.0 109.537 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -64.98 -58.27 6.54 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.041 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 13.8 p -63.43 -29.55 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -60.21 -44.73 94.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.52 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.3 tm? -67.22 -40.92 86.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.547 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.2 mt -58.27 -36.63 73.56 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.34 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 54.5 mtpt -66.84 -35.74 80.74 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.327 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 12.0 pt-20 -75.5 -31.43 60.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.851 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.52 HG13 ' O ' ' X' ' 18' ' ' LEU . 49.9 mt -60.3 -39.99 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 123.77 0.669 . . . . 0.0 109.843 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -58.35 -41.21 84.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.559 0.695 . . . . 0.0 109.635 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.44 -47.79 46.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.401 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.702 ' OE2' ' HA ' ' X' ' 34' ' ' LEU 0.274 0.0 OUTLIER -75.47 -19.5 59.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.446 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' X' ' 22' ' ' ILE . 2.2 m-80 -76.77 -42.1 42.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.385 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 -34.51 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.314 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.24 48.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.66 0.267 . . . . 0.0 110.464 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.83 95.77 0.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.173 1.389 . . . . 0.0 111.977 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 38.8 p -107.66 -171.37 1.86 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -136.34 -20.19 1.42 Allowed 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.102 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.538 ' O ' HG21 ' X' ' 36' ' ' VAL . 10.9 m-20 -85.51 -61.85 1.67 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.154 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.581 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.6 p -76.55 -26.93 16.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.007 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.702 ' HA ' ' OE2' ' X' ' 25' ' ' GLU . 3.1 tm? -58.78 -44.66 90.74 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 124.333 1.021 . . . . 0.0 108.701 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.7 t70 -72.42 -36.77 68.69 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.363 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.538 HG21 ' O ' ' X' ' 32' ' ' ASP . 47.2 t -63.66 -49.79 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 O-C-N 124.324 1.015 . . . . 0.0 110.609 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 41.2 mt -68.14 -41.14 82.1 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.991 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 14.4 mt -59.45 -49.66 76.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 O-C-N 124.437 1.085 . . . . 0.0 111.815 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.3 pt-20 -70.98 -42.29 69.87 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.102 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.51 ' O ' HG12 ' X' ' 44' ' ' ILE . 69.9 t60 -60.26 -45.72 92.3 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.014 0.526 . . . . 0.0 110.373 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.643 ' O ' HG21 ' X' ' 45' ' ' THR . 39.4 t80 -57.95 -53.72 55.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 124.265 0.978 . . . . 0.0 110.834 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -66.34 -31.06 51.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -63.38 -47.46 81.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.51 HG12 ' O ' ' X' ' 40' ' ' HIS . 4.9 pt -75.15 -36.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.643 HG21 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.67 -31.58 24.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.509 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 61.91 29.59 17.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.914 0.864 . . . . 0.0 111.319 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.468 ' H ' HG23 ' X' ' 45' ' ' THR . 50.5 t-80 -77.94 135.87 62.77 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.532 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 30.3 Cg_exo -66.11 -19.22 57.22 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 123.151 2.567 . . . . 0.0 112.316 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.98 36.22 4.35 Favored 'General case' 0 N--CA 1.393 -3.296 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.587 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.64 -55.91 7.76 Favored Glycine 0 CA--C 1.462 -3.226 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.136 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.449 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -77.0 -26.17 53.55 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.332 -171.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.571 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.14 -36.71 83.86 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.303 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.3 -38.93 85.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 123.504 0.503 . . . . 0.0 111.729 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -66.73 -47.26 83.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.704 0.764 . . . . 0.0 109.416 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -63.67 -46.87 83.59 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.86 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.9 pt-20 -68.53 -36.39 78.78 Favored 'General case' 0 C--O 1.196 -1.758 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.79 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.2 76.44 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.246 0.475 . . . . 0.0 111.561 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.021 0.438 . . . . 0.0 110.468 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.74 65.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.716 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 83.6 mtp180 -61.59 -28.35 69.29 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 124.685 1.194 . . . . 0.0 112.546 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . 0.405 ' HB1' ' N ' ' X' ' 71' ' ' GLY . . . -73.91 -39.04 64.12 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.456 174.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.17 -47.28 52.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.723 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.75 76.37 0.97 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.716 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 6.0 t-20 -69.83 120.42 77.54 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.659 -172.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.62 -37.35 97.77 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.227 2.618 . . . . 0.0 111.722 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.72 73.46 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.595 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.12 -53.52 2.52 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.72 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.32 151.93 42.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.786 0.327 . . . . 0.0 110.464 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.53 36.15 87.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.483 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.61 66.13 3.97 Favored Glycine 0 CA--C 1.478 -2.225 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.62 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.405 ' N ' ' HB1' ' X' ' 61' ' ' ALA . . . 65.45 -128.85 33.44 Favored Glycine 1 N--CA 1.385 -4.764 0 CA-C-N 114.416 -0.892 . . . . 0.0 112.513 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.49 ' O ' HG13 ' X' ' 75' ' ' ILE . 2.9 Cg_endo -64.42 -30.94 62.45 Favored 'Trans proline' 0 CA--C 1.497 -1.366 0 C-N-CA 122.854 2.369 . . . . 0.0 111.14 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.04 -4.18 56.21 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.891 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.84 -15.41 14.94 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.284 -1.912 . . . . 0.0 113.007 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.513 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -68.04 -49.2 70.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 p -55.49 -45.57 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.841 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 56.0 tttp -59.8 -47.3 86.27 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.399 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.513 HG12 ' O ' ' X' ' 75' ' ' ILE . 46.7 mm -66.03 -45.42 90.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.873 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.5 ptpt -61.98 -42.17 98.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.905 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.62 -38.75 70.76 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.532 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 85.1 t90 -66.17 -47.92 72.42 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 110.715 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' X' ' 89' ' ' PRO . 3.4 ttt-85 -68.9 -41.6 78.02 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.222 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.41 84.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.2 86.72 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.525 0.202 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.457 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.0 t-20 -63.29 -43.82 96.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.37 18.89 6.45 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 68.5 mttm -99.15 158.64 31.92 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . 0.423 ' O ' ' HD3' ' X' ' 83' ' ' ARG . 36.8 Cg_endo -71.5 130.0 16.58 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.434 1.423 . . . . 0.0 110.819 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -119.41 2.37 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.291 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -96.74 154.52 17.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 120.524 0.202 . . . . 0.0 110.539 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -89.86 176.28 6.88 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.23 137.51 33.32 Favored 'General case' 0 N--CA 1.398 -3.04 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.184 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.26 0 CA-C-O 118.074 -1.403 . . . . 0.0 110.304 177.857 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 76.3 mt -108.64 140.49 41.95 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.554 0.534 . . . . 0.0 111.666 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 40.1 mmtt -103.12 -170.3 1.77 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 171.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -112.41 -24.28 9.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.064 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.5 p -134.35 164.88 26.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.03 -12.52 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.617 0.722 . . . . 0.0 111.051 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -76.07 -18.43 59.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.527 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -102.74 2.74 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.239 1.019 . . . . 0.0 108.454 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 12.1 m-85 -96.05 113.41 25.02 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.218 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.528 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 62.2 p -73.53 160.56 31.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.638 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.83 -32.19 71.58 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.566 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.48 ' O ' HG23 ' X' ' 16' ' ' VAL . . . -70.4 -39.04 74.72 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 22.7 mm-40 -58.07 -42.35 85.31 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.552 1.168 . . . . 0.0 108.61 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.33 -47.48 60.87 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 113.137 -1.847 . . . . 0.0 110.492 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.727 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 22.8 m -58.49 -39.41 75.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.394 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.5 -50.57 73.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.251 0.62 . . . . 0.0 111.25 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.489 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.5 tm? -66.52 -40.36 89.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.723 0.773 . . . . 0.0 109.041 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' X' ' 75' ' ' ILE . 9.9 tp -59.66 -42.61 93.22 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.957 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.727 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.5 mttt -61.43 -34.84 76.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.201 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.32 -41.59 85.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.025 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.489 HG13 ' O ' ' X' ' 18' ' ' LEU . 13.0 mt -57.52 -42.49 81.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.23 -44.83 88.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.493 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -67.57 -45.48 75.45 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.054 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.524 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -69.8 -19.04 63.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.418 177.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.06 -46.53 10.39 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.275 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.94 -32.36 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.26 -6.3 57.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.732 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.99 80.4 0.11 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.754 1.622 . . . . 0.0 113.323 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.651 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 64.2 p -91.68 -165.48 1.36 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.23 -73.09 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.089 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.617 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.2 t70 -60.35 -51.21 70.46 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 123.434 0.459 . . . . 0.0 111.449 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.67 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.0 p -73.03 -35.27 47.95 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.363 -175.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.651 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.4 tm? -58.95 -47.6 84.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.703 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.35 -41.5 98.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.319 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.617 HG23 ' O ' ' X' ' 32' ' ' ASP . 77.9 t -56.71 -49.56 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 O-C-N 123.77 0.669 . . . . 0.0 109.927 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 86.1 mt -68.41 -43.79 76.44 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.982 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 29.6 mt -61.21 -48.47 81.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 124.154 0.909 . . . . 0.0 110.637 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -70.72 -41.53 71.79 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.131 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.548 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.9 t60 -61.29 -45.91 92.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.238 0.542 . . . . 0.0 109.846 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.642 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.2 t80 -59.14 -52.6 64.99 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.334 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.439 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.1 p -67.62 -32.15 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 53.1 pttt -68.48 -39.61 81.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.543 HG12 ' O ' ' X' ' 40' ' ' HIS . 27.4 pt -77.67 -31.38 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.5 p -84.07 -39.99 18.88 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 67.07 20.19 10.38 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 123.915 0.886 . . . . 0.0 111.24 -176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 39.7 t-80 -80.73 133.25 55.8 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.2 Cg_exo -71.34 -2.26 10.94 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.488 2.792 . . . . 0.0 113.043 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 15.1 m-20 -130.05 27.65 5.11 Favored 'General case' 0 N--CA 1.394 -3.237 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.642 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -43.73 -60.28 3.41 Favored Glycine 0 CA--C 1.459 -3.407 0 O-C-N 124.388 1.055 . . . . 0.0 112.931 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.47 HG21 HD12 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.35 -29.33 63.7 Favored 'General case' 0 C--N 1.251 -3.711 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.716 -173.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.2 -30.47 70.94 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 97.9 mt -61.05 -41.52 96.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.153 0.502 . . . . 0.0 109.752 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.21 -46.24 84.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.095 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -58.39 -49.52 76.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.645 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.5 pt-20 -68.0 -37.24 81.21 Favored 'General case' 0 C--O 1.207 -1.169 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.693 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.55 77.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.663 0.21 . . . . 0.0 110.81 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.5 94.59 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.672 0.608 . . . . 0.0 111.496 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.63 62.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.531 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.527 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 74.3 mtp180 -67.91 -44.33 77.15 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.51 64.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.822 0.344 . . . . 0.0 111.411 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.47 96.43 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.221 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -33.24 15.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.563 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.73 87.57 0.12 Allowed Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 125.433 1.493 . . . . 0.0 112.783 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 4.8 Cg_endo -91.04 109.41 0.32 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.827 2.351 . . . . 0.0 109.26 173.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.44 112.56 3.1 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.188 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.94 -115.31 0.65 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -128.44 153.25 47.31 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . 0.527 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 88.86 27.55 23.66 Favored Glycine 0 C--N 1.305 -1.184 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.174 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.06 4.95 Favored Glycine 0 CA--C 1.483 -1.937 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.605 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.64 -142.82 16.13 Favored Glycine 1 N--CA 1.372 -5.59 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.889 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.574 ' O ' HG11 ' X' ' 76' ' ' VAL . 11.6 Cg_endo -64.31 -48.29 4.88 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 124.645 3.563 . . . . 0.0 112.349 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.474 ' C ' HG23 ' X' ' 76' ' ' VAL . 42.0 mt-10 -77.78 1.92 18.65 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.0 -39.3 2.33 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 118.651 -1.738 . . . . 0.0 112.769 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.565 ' O ' HG13 ' X' ' 79' ' ' ILE . 3.1 pt -62.73 -28.25 44.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 CA-C-N 117.495 0.647 . . . . 0.0 110.94 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.574 HG11 ' O ' ' X' ' 72' ' ' PRO . 21.6 m -60.27 -36.11 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.945 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 83.6 tttt -65.86 -41.93 91.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.653 174.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' X' ' 75' ' ' ILE . 7.8 tp10 -58.07 -44.13 87.35 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.565 HG13 ' O ' ' X' ' 75' ' ' ILE . 82.9 mt -67.42 -46.34 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.618 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.6 ptmt -64.3 -37.77 88.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.38 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.84 -38.38 73.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.428 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 62.8 t90 -65.49 -47.36 76.29 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.797 0.808 . . . . 0.0 109.626 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -61.15 -45.8 93.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.693 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.93 81.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.125 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -32.79 73.67 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.44 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 25.3 t-20 -78.77 -48.81 14.14 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.55 34.3 1.45 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.44 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 66.6 mttm -103.81 141.85 23.38 Favored Pre-proline 0 N--CA 1.392 -3.368 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.39 121.51 9.34 Favored 'Trans proline' 0 CA--C 1.517 -0.34 0 C-N-CA 122.135 1.89 . . . . 0.0 110.956 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.14 -135.6 8.17 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.341 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -78.65 146.9 33.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -85.81 174.51 9.27 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.98 139.12 51.62 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.597 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 CA--C 1.505 -0.76 0 CA-C-O 120.631 0.253 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.69 129.95 37.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.611 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 21.2 mmtt -112.47 151.81 29.48 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.95 -9.07 59.69 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.278 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -145.71 160.93 41.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -67.71 -19.05 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.259 0.624 . . . . 0.0 111.037 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -73.75 -12.63 60.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 20.1 t70 -105.22 -0.81 26.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.895 0.855 . . . . 0.0 108.877 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.05 119.03 33.82 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.738 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 30.4 p -77.8 169.01 19.01 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.601 ' O ' HG12 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.639 177.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.427 ' HA ' HG21 ' X' ' 16' ' ' VAL . . . -70.54 -38.69 74.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.6 -40.67 79.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.851 0.75 . . . . 0.0 109.399 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.463 ' O ' HD12 ' X' ' 19' ' ' LEU . 20.5 t80 -70.56 -48.07 57.19 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.874 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.601 HG12 ' O ' ' X' ' 12' ' ' GLU . 6.3 m -59.29 -39.57 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.519 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.19 -48.23 82.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.125 0.97 . . . . 0.0 110.884 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.437 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -66.17 -38.92 89.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.463 HD12 ' O ' ' X' ' 15' ' ' PHE . 7.7 mp -62.47 -36.8 83.62 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.932 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 47.1 mtmt -61.43 -35.12 76.67 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' X' ' 24' ' ' LYS . 10.4 mm-40 -71.87 -34.73 69.44 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.333 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.437 HG13 ' O ' ' X' ' 18' ' ' LEU . 20.8 mt -64.18 -40.26 88.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.004 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -59.83 -46.22 89.92 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.877 0.846 . . . . 0.0 108.789 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' X' ' 21' ' ' GLU . 24.0 tptm -60.54 -52.34 65.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.556 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.414 ' HB3' ' HG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -63.31 -25.63 68.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.272 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -78.72 -47.67 16.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.997 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -71.66 -23.27 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.789 0.328 . . . . 0.0 111.875 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.9 -17.71 30.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.64 67.16 1.0 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.74 1.216 . . . . 0.0 111.026 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.414 ' HG1' ' HB3' ' X' ' 25' ' ' GLU . 77.3 p -81.86 -31.24 31.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.655 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 68.37 -61.65 0.39 Allowed 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.082 1.753 . . . . 0.0 113.56 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.429 ' O ' HG22 ' X' ' 36' ' ' VAL . 6.5 m-20 -57.07 -57.99 10.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.066 0.547 . . . . 0.0 111.579 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.719 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -81.1 -28.9 11.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.202 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.346 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -44.06 92.72 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.84 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.96 -38.45 91.12 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.191 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' X' ' 39' ' ' GLU . 72.2 t -57.64 -48.97 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 O-C-N 124.405 1.066 . . . . 0.0 109.349 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 76.5 mt -65.21 -43.05 92.79 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.53 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.2 mt -59.99 -49.83 76.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.566 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' X' ' 36' ' ' VAL . 0.0 OUTLIER -70.9 -35.07 72.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.332 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.546 ' O ' HG12 ' X' ' 44' ' ' ILE . 24.0 t60 -66.07 -46.17 78.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.585 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.646 ' CD2' HD12 ' X' ' 54' ' ' ILE . 43.4 t80 -58.15 -53.28 60.03 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.43 HG23 ' O ' ' X' ' 47' ' ' HIS . 7.2 p -66.95 -32.6 58.72 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.606 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 42.9 pttt -75.21 -27.73 59.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.546 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.5 pt -84.13 -39.6 14.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.566 HG23 ' O ' ' X' ' 41' ' ' PHE . 15.1 t -85.18 -27.35 26.21 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 61.36 38.35 16.29 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 122.142 0.972 . . . . 0.0 111.238 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.43 ' O ' HG23 ' X' ' 42' ' ' VAL . 44.6 t-80 -94.32 132.94 28.0 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.542 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.7 -16.39 33.62 Favored 'Trans proline' 0 CA--C 1.495 -1.455 0 C-N-CA 123.042 2.494 . . . . 0.0 113.184 -173.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -120.78 30.48 6.88 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.536 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.12 -56.54 6.85 Favored Glycine 1 CA--C 1.447 -4.178 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.083 -177.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.452 HG23 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -79.13 -26.9 42.82 Favored 'General case' 0 C--N 1.249 -3.796 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.512 -170.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -58.38 -46.49 86.26 Favored 'General case' 0 C--O 1.189 -2.109 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -52.58 -46.01 66.73 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.646 HD12 ' CD2' ' X' ' 41' ' ' PHE . 3.9 mp -68.33 -47.15 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.256 -1.378 . . . . 0.0 109.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.01 -45.39 90.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.534 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 12.8 mm-40 -65.49 -44.88 85.71 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.62 -41.48 81.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.765 0.426 . . . . 0.0 111.688 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.37 -46.71 79.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.783 0.325 . . . . 0.0 110.441 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -43.69 60.72 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -62.44 -38.18 88.78 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.948 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.46 -29.47 41.76 Favored 'General case' 0 C--O 1.245 0.868 0 O-C-N 123.071 0.232 . . . . 0.0 111.564 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.56 99.07 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.14 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.26 -70.96 0.61 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t30 44.4 86.81 0.13 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 126.141 1.777 . . . . 0.0 114.076 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.83 -54.28 4.35 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.651 2.234 . . . . 0.0 111.163 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.06 61.22 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.355 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.22 -122.41 2.17 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.64 152.88 46.1 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.344 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 55.76 4.71 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.87 -86.33 0.86 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.52 ' O ' HG12 ' X' ' 75' ' ' ILE . . . -123.17 -136.03 4.71 Favored Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.012 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.609 ' O ' HG12 ' X' ' 76' ' ' VAL . 10.6 Cg_endo -55.52 -50.49 12.59 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 124.154 3.236 . . . . 0.0 113.63 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.23 1.17 19.33 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.14 -39.9 1.9 Allowed Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 118.998 -1.572 . . . . 0.0 112.571 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.52 HG12 ' O ' ' X' ' 71' ' ' GLY . 5.1 pt -61.8 -31.69 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-N 117.164 0.482 . . . . 0.0 110.923 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.609 HG12 ' O ' ' X' ' 72' ' ' PRO . 15.6 m -61.06 -33.08 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 121.086 0.47 . . . . 0.0 112.182 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 60.3 tttm -67.8 -48.01 67.49 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -61.45 -36.59 80.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.646 0.736 . . . . 0.0 109.317 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mm -66.81 -46.62 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.076 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -71.05 -39.61 72.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.101 0.477 . . . . 0.0 111.857 -173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.1 mt-10 -66.59 -32.37 73.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.287 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -66.05 -47.65 73.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.96 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' X' ' 83' ' ' ARG . 0.0 OUTLIER -66.58 -37.3 84.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.192 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.2 99.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 123.987 0.804 . . . . 0.0 110.718 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.06 -32.4 59.26 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.624 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -76.13 -39.84 54.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.753 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.15 32.45 3.75 Favored Glycine 0 C--N 1.318 -0.466 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -110.6 163.07 18.12 Favored Pre-proline 0 N--CA 1.418 -2.06 0 C-N-CA 124.336 1.055 . . . . 0.0 109.481 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.32 141.13 61.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.406 2.071 . . . . 0.0 112.384 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.5 -155.26 19.33 Favored Glycine 0 N--CA 1.42 -2.427 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.18 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -78.18 151.77 33.05 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -81.7 160.39 23.69 Favored 'General case' 0 N--CA 1.382 -3.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.41 133.93 37.46 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.828 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.539 HD21 ' CD2' ' X' ' 40' ' ' HIS . 95.1 mt -94.52 128.45 41.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -107.23 156.45 18.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -77.72 -22.24 50.71 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.581 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 58.0 p -143.21 164.58 29.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.151 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.07 -16.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 111.496 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -14.62 61.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.117 0.484 . . . . 0.0 111.61 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -103.51 3.3 34.64 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' X' ' 44' ' ' ILE . 2.5 m-85 -96.91 112.84 24.42 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.904 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' X' ' 14' ' ' GLU . 46.6 p -76.95 155.22 32.88 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 172.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.586 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -56.95 -39.84 75.32 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.6 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.2 73.7 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.404 ' HB2' ' OG1' ' X' ' 11' ' ' THR . 0.7 OUTLIER -57.75 -42.16 83.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.744 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.1 t80 -67.2 -54.01 25.05 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.372 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.586 HG13 ' O ' ' X' ' 12' ' ' GLU . 10.5 m -60.09 -32.82 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.46 -42.95 78.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.652 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.8 tm? -63.24 -40.07 96.41 Favored 'General case' 0 C--O 1.205 -1.237 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 56.5 mt -64.8 -36.44 84.32 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.637 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.449 ' HG2' ' CG ' ' X' ' 72' ' ' PRO . 48.2 mttp -66.18 -37.58 85.94 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.59 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.17 -31.88 66.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.536 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.652 HG13 ' O ' ' X' ' 18' ' ' LEU . 29.9 mt -66.11 -45.54 90.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.04 -42.0 84.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.383 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.55 -47.16 87.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.596 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.557 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -79.65 -24.67 41.69 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.983 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -65.05 -43.77 91.2 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.716 0.293 . . . . 0.0 110.27 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.5 m -76.28 -34.72 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.534 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -29.63 67.67 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.762 0.791 . . . . 0.0 109.097 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 76.49 87.57 0.08 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 127.469 2.307 . . . . 0.0 113.855 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -109.22 175.59 5.4 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -136.31 -4.68 2.1 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.03 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.454 ' O ' HG23 ' X' ' 36' ' ' VAL . 17.7 p-10 -86.14 -62.81 1.43 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.568 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.0 p -81.54 -26.03 10.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.557 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.8 tm? -58.06 -46.27 85.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.626 175.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 37.3 t70 -61.24 -45.83 92.93 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.539 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.454 HG23 ' O ' ' X' ' 32' ' ' ASP . 42.9 t -62.01 -50.01 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 O-C-N 124.4 1.063 . . . . 0.0 110.92 -176.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 91.1 mt -67.9 -41.81 82.12 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.937 -172.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.2 mt -59.36 -50.13 75.16 Favored 'General case' 0 N--CA 1.417 -2.107 0 O-C-N 124.122 0.888 . . . . 0.0 111.72 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.1 pt-20 -71.82 -36.52 70.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.607 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 5.0 t60 -65.78 -38.28 88.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.598 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 31.7 t80 -62.7 -51.66 66.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.14 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.425 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 5.9 p -67.17 -32.57 58.28 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.848 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -68.65 -30.13 68.76 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.999 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.491 HG12 ' O ' ' X' ' 40' ' ' HIS . 9.5 pt -83.96 -42.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 122.146 -0.346 . . . . 0.0 111.635 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.592 HG21 ' O ' ' X' ' 41' ' ' PHE . 6.0 t -84.16 -28.39 27.44 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.608 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 62.91 26.14 15.4 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.415 ' O ' HG22 ' X' ' 42' ' ' VAL . 42.6 t-80 -75.09 134.26 74.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.562 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -69.93 -14.45 35.55 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.831 2.354 . . . . 0.0 112.082 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.18 29.68 6.03 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.598 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.96 -57.88 8.3 Favored Glycine 0 CA--C 1.455 -3.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.107 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.431 ' CG2' HD13 ' X' ' 38' ' ' LEU . 1.4 m -73.34 -29.15 62.47 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.755 -172.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.6 97.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.658 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -57.73 -43.31 85.22 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 123.558 0.536 . . . . 0.0 112.251 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.401 HD12 HG22 ' X' ' 22' ' ' ILE . 64.2 mt -66.59 -42.2 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 121.684 0.754 . . . . 0.0 110.044 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.77 91.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.05 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.24 77.78 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.948 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.5 -46.86 83.28 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.222 0.326 . . . . 0.0 110.809 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.1 92.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.67 75.13 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.976 0.417 . . . . 0.0 111.364 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -68.29 -31.24 70.54 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.409 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.45 -34.72 65.54 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 121.154 -0.219 . . . . 0.0 110.861 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.51 -42.64 88.16 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.581 0.551 . . . . 0.0 110.613 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.43 72.97 1.49 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.73 122.61 87.41 Favored Pre-proline 0 CA--C 1.478 -1.799 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -81.33 -33.96 0.64 Allowed 'Trans proline' 0 N--CA 1.423 -2.662 0 C-N-CA 121.331 1.354 . . . . 0.0 110.851 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.74 -86.9 1.52 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.99 -31.05 0.9 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.49 -36.1 80.44 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.635 0.731 . . . . 0.0 109.692 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.33 150.51 19.21 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.17 66.59 0.95 Allowed Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.4 162.29 21.37 Favored Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 119.105 -1.522 . . . . 0.0 113.834 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.513 ' O ' HG12 ' X' ' 76' ' ' VAL . 18.0 Cg_endo -60.57 -29.05 87.73 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 124.755 3.637 . . . . 0.0 113.9 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.469 ' C ' HG22 ' X' ' 76' ' ' VAL . 84.0 mt-10 -95.66 1.96 53.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.676 0.274 . . . . 0.0 110.326 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.78 -37.47 3.19 Favored Glycine 0 N--CA 1.426 -1.984 0 C-N-CA 118.587 -1.768 . . . . 0.0 111.803 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.517 ' CD1' HD12 ' X' ' 19' ' ' LEU . 9.0 pt -58.33 -32.11 44.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 120.68 0.276 . . . . 0.0 110.927 174.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.513 HG12 ' O ' ' X' ' 72' ' ' PRO . 19.1 m -63.93 -36.65 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -67.14 -38.12 84.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -68.67 -40.59 80.08 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.436 HG23 ' OG1' ' X' ' 45' ' ' THR . 22.0 mm -61.98 -46.57 96.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.771 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -66.95 -41.01 87.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.396 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.46 -31.96 73.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.562 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 91.3 t90 -72.24 -48.94 38.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.196 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' X' ' 88' ' ' LYS . 10.1 ttt85 -71.17 -37.02 72.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.623 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.18 87.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.741 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.23 -26.35 65.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.117 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.38 -22.02 57.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 120.943 0.402 . . . . 0.0 110.162 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 49.91 16.3 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 60.3 tttp -133.6 126.53 19.11 Favored Pre-proline 0 N--CA 1.414 -2.241 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.72 119.42 5.58 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.283 3.322 . . . . 0.0 113.887 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.63 -127.12 4.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.255 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -79.3 151.55 31.01 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 120.555 0.217 . . . . 0.0 110.577 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 20.4 ptmt -93.31 179.1 5.51 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -110.91 142.24 43.25 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 123.031 0.532 . . . . 0.0 109.738 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.119 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 . . . . . 0 CA--C 1.488 -1.411 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 76.5 mt -91.5 129.58 37.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.887 0.851 . . . . 0.0 112.17 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.429 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 26.7 mmtt -104.85 -162.06 0.86 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -119.56 -31.64 4.53 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.201 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.2 p -126.07 166.95 16.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.531 HG23 HH12 ' X' ' 83' ' ' ARG . 7.9 tt -81.1 -0.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.975 0.893 . . . . 0.0 111.275 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.8 m -80.99 -10.13 59.75 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.28 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 18.9 t70 -106.85 1.27 24.58 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.421 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 7.9 m-85 -98.6 114.14 26.48 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.121 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' X' ' 14' ' ' GLU . 76.9 p -79.6 160.54 26.36 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.576 ' O ' HG12 ' X' ' 16' ' ' VAL . 10.9 pt-20 -61.19 -36.94 81.22 Favored 'General case' 0 C--O 1.2 -1.552 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.828 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.475 ' HA ' HG21 ' X' ' 16' ' ' VAL . . . -70.35 -38.7 74.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.43 ' HB2' ' OG1' ' X' ' 11' ' ' THR . 1.0 OUTLIER -59.98 -42.18 93.64 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.111 0.958 . . . . 0.0 108.769 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' X' ' 19' ' ' LEU . 48.1 t80 -68.33 -49.02 63.25 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.534 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.747 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 18.7 m -57.78 -41.73 80.35 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 CA-C-N 117.98 0.355 . . . . 0.0 110.206 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -61.27 -49.4 77.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.698 0.799 . . . . 0.0 110.366 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.491 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -64.18 -41.96 96.89 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.482 HD23 ' CD1' ' X' ' 75' ' ' ILE . 13.9 tp -59.7 -44.27 93.76 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.913 1.285 . . . . 0.0 111.319 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.747 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.7 mttt -61.56 -35.21 77.15 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.904 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.12 -38.31 82.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.491 HG13 ' O ' ' X' ' 18' ' ' LEU . 23.2 mt -61.07 -43.73 96.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -34.97 73.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.81 -50.95 37.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -25.22 68.0 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.461 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -66.94 -55.41 14.71 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.254 1.022 . . . . 0.0 110.132 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 m -73.22 -21.43 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.75 -12.44 51.03 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.5 57.81 6.18 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.754 1.222 . . . . 0.0 110.982 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -78.17 -24.93 47.06 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.474 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 66.89 -64.31 0.24 Allowed 'General case' 0 C--O 1.205 -1.254 0 C-N-CA 126.043 1.737 . . . . 0.0 114.948 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.486 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.7 t70 -57.29 -57.09 14.14 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.252 0.478 . . . . 0.0 111.573 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.678 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -80.26 -30.7 12.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.35 -175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.614 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.22 -45.47 91.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.611 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.81 -36.55 83.81 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.317 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.486 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -57.31 -49.11 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 87.3 mt -67.99 -43.26 79.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.109 -173.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.0 mt -59.24 -43.73 92.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.938 0.774 . . . . 0.0 110.991 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.12 -45.17 70.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.65 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.7 t60 -60.86 -45.7 93.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.018 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.596 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 58.8 t80 -58.65 -51.67 68.94 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.676 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.441 HG13 ' O ' ' X' ' 38' ' ' LEU . 9.8 p -67.59 -34.11 66.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -71.86 -30.46 65.46 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.697 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.65 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.8 pt -84.1 -36.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.689 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -76.2 -42.57 45.8 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.524 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 61.5 30.23 18.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.922 1.289 . . . . 0.0 109.864 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' X' ' 49' ' ' ASP . 61.9 t-80 -89.12 133.38 35.32 Favored Pre-proline 0 N--CA 1.415 -2.222 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 175.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.04 16.67 0.53 Allowed 'Trans proline' 0 CA--C 1.497 -1.352 0 C-N-CA 122.908 2.405 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 3.2 m-20 -142.99 23.06 1.9 Allowed 'General case' 0 N--CA 1.394 -3.255 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.596 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.16 -66.49 1.04 Allowed Glycine 0 CA--C 1.462 -3.255 0 O-C-N 124.724 1.265 . . . . 0.0 113.821 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.454 HG22 HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -71.54 -26.03 62.47 Favored 'General case' 0 C--N 1.258 -3.4 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.842 -173.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.44 -38.3 90.55 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.675 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 96.5 mt -57.83 -46.51 84.64 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 124.202 0.939 . . . . 0.0 111.258 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.14 -46.67 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.843 0.83 . . . . 0.0 109.891 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.23 -38.99 93.34 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.167 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.2 pt-20 -71.82 -36.45 70.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.012 176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.56 79.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.18 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.05 81.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.475 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.24 -43.58 77.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.824 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 77.6 mtp85 -67.53 -30.01 69.56 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.783 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . 0.488 ' HA ' ' ND2' ' X' ' 64' ' ' ASN . . . -79.74 -31.09 41.01 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.647 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.92 86.42 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.582 0.706 . . . . 0.0 109.804 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.54 95.37 2.81 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' X' ' 61' ' ' ALA . 12.8 m120 -57.79 119.97 37.97 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 123.912 0.757 . . . . 0.0 111.33 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -0.5 10.21 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.641 2.227 . . . . 0.0 111.694 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.54 -128.85 1.15 Allowed Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.56 48.6 0.36 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.876 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -97.57 -31.38 12.34 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.07 86.67 0.21 Allowed Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.049 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.57 104.32 3.1 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.401 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 146.91 -176.86 25.57 Favored Glycine 0 N--CA 1.397 -3.911 0 C-N-CA 120.486 -0.864 . . . . 0.0 110.964 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.457 ' CG ' ' HG2' ' X' ' 20' ' ' LYS . 3.9 Cg_exo -46.53 -52.36 7.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 125.257 3.971 . . . . 0.0 114.101 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -76.84 1.54 17.13 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.7 -39.28 1.91 Allowed Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.062 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.564 ' O ' HG13 ' X' ' 79' ' ' ILE . 2.5 pt -60.87 -33.0 53.71 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-N 117.261 0.531 . . . . 0.0 111.097 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.418 HG12 ' O ' ' X' ' 72' ' ' PRO . 9.7 m -59.16 -32.29 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.468 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 25.0 ttmm -67.9 -42.38 81.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.078 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.27 -43.25 99.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.564 HG13 ' O ' ' X' ' 75' ' ' ILE . 76.9 mt -64.74 -44.14 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.868 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 19.1 ptpt -66.85 -43.47 83.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.747 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 42.0 mt-10 -67.95 -32.01 72.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.86 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -66.9 -48.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.531 HH12 HG23 ' X' ' 7' ' ' ILE . 1.3 mpp_? -70.77 -37.36 73.37 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.8 92.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.788 0.68 . . . . 0.0 110.498 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.1 -26.33 56.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 111.513 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.568 ' ND2' ' HD3' ' X' ' 88' ' ' LYS . 4.5 t30 -77.33 -31.37 54.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.807 0.337 . . . . 0.0 110.578 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.55 40.06 5.14 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.568 ' HD3' ' ND2' ' X' ' 86' ' ' ASN . 12.7 mtpp -130.74 155.55 81.16 Favored Pre-proline 0 N--CA 1.416 -2.159 0 C-N-CA 123.504 0.722 . . . . 0.0 109.749 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.06 125.86 20.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.262 2.642 . . . . 0.0 112.586 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . 0.418 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -106.7 -95.65 2.42 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.663 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.74 148.83 52.6 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -85.04 164.9 17.95 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.64 136.24 36.29 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.66 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.254 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.444 ' CD2' HD13 ' X' ' 18' ' ' LEU . 40.1 mt -91.71 137.79 32.08 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -97.06 -159.44 0.74 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -116.88 -27.24 6.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.07 0.462 . . . . 0.0 110.487 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 92.7 p -136.56 166.98 22.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt -67.3 -11.92 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 121.52 0.676 . . . . 0.0 110.618 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -75.37 -27.07 58.98 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.35 -170.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.62 -4.72 40.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.525 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -80.53 115.25 19.95 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.415 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 71.0 p -76.3 159.72 30.3 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 169.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.649 ' O ' HG11 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.26 -34.84 74.28 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.032 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.424 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.25 -37.94 75.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -58.55 -39.45 80.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.56 0.695 . . . . 0.0 109.416 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.474 ' O ' HD11 ' X' ' 19' ' ' LEU . 42.5 t80 -71.8 -44.22 64.33 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.156 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.649 HG11 ' O ' ' X' ' 12' ' ' GLU . 7.6 m -61.94 -37.16 77.58 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.442 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.405 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -49.16 78.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.848 0.859 . . . . 0.0 108.778 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.661 ' O ' HG13 ' X' ' 22' ' ' ILE . 16.9 tp -57.53 -48.04 80.38 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.055 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' X' ' 23' ' ' GLU . 8.1 mp -60.36 -40.25 90.1 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.707 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 80.9 mttt -63.41 -35.59 80.93 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.218 0.532 . . . . 0.0 110.034 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -69.43 -42.4 75.06 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.661 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.9 mt -61.23 -42.3 92.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.333 0 O-C-N 124.073 0.858 . . . . 0.0 109.645 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' X' ' 19' ' ' LEU . 51.7 mt-10 -57.33 -46.29 83.41 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.5 -51.8 67.9 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.681 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.431 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 3.0 pp20? -79.38 -21.75 45.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.44 -46.05 64.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.35 -33.08 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 110.557 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.25 -6.44 59.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.389 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.44 83.65 0.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.135 1.774 . . . . 0.0 114.435 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 16.4 p -99.72 -172.67 2.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.15 -29.76 0.88 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.614 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.474 ' O ' HG21 ' X' ' 36' ' ' VAL . 28.1 m-20 -70.68 -62.31 1.44 Allowed 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.336 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.696 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.6 p -78.85 -27.34 13.67 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.941 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.438 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.3 tm? -58.44 -47.07 85.18 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.212 1.005 . . . . 0.0 109.527 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.3 -28.19 62.93 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.474 HG21 ' O ' ' X' ' 32' ' ' ASP . 64.8 t -67.72 -50.72 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.977 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.506 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 51.6 mt -69.66 -43.99 71.44 Favored 'General case' 0 N--CA 1.412 -2.332 0 O-C-N 124.513 1.133 . . . . 0.0 111.711 -170.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.434 HD23 HG22 ' X' ' 51' ' ' THR . 28.4 mt -60.93 -46.41 90.81 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 124.233 0.958 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -70.74 -39.47 73.3 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.039 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.572 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.6 t60 -63.43 -45.44 90.94 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.245 0.545 . . . . 0.0 109.716 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.582 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 37.9 t80 -59.05 -53.46 58.18 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.665 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.433 HG12 ' O ' ' X' ' 38' ' ' LEU 0.252 11.9 p -68.08 -32.29 55.45 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.969 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 50.9 pttt -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.192 -0.317 . . . . 0.0 111.595 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.509 HG12 ' O ' ' X' ' 40' ' ' HIS . 31.5 pt -88.27 -31.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.058 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 47.1 p -85.06 -35.25 21.98 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 120.93 0.395 . . . . 0.0 111.285 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.82 29.53 17.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 125.353 1.461 . . . . 0.0 110.778 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 32.1 t-80 -76.08 138.57 68.75 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 107.861 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.9 Cg_exo -74.26 -6.89 19.06 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 C-N-CA 123.146 2.564 . . . . 0.0 112.151 -176.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.476 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.9 m-20 -130.71 30.63 4.63 Favored 'General case' 0 N--CA 1.389 -3.477 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.582 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.51 -59.82 6.85 Favored Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.617 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.505 ' O ' ' HD2' ' X' ' 55' ' ' TYR . 0.0 OUTLIER -76.97 -28.28 55.09 Favored 'General case' 0 C--N 1.248 -3.828 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.847 -176.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.615 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.74 -42.97 98.41 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.227 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.36 -49.23 76.83 Favored 'General case' 0 C--O 1.208 -1.085 0 O-C-N 123.525 0.515 . . . . 0.0 112.119 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 79.2 mt -67.74 -42.16 85.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.819 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.505 ' HD2' ' O ' ' X' ' 51' ' ' THR . 15.3 m-85 -60.21 -47.0 87.83 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.585 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.615 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 10.4 pt-20 -71.12 -36.43 72.12 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.687 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.42 85.1 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 123.305 0.378 . . . . 0.0 110.438 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.93 87.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.156 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.13 76.4 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.058 0.456 . . . . 0.0 111.314 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -68.18 -31.12 70.43 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.332 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.34 44.23 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.484 -0.135 . . . . 0.0 111.33 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.75 87.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.234 0.54 . . . . 0.0 109.624 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.6 84.01 2.21 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -88.34 120.17 70.4 Favored Pre-proline 0 CA--C 1.489 -1.38 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.847 -173.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.15 -16.73 9.61 Favored 'Trans proline' 0 N--CA 1.432 -2.13 0 C-N-CA 121.664 1.576 . . . . 0.0 112.786 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.47 117.61 3.0 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.882 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.7 -140.98 10.26 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -124.5 150.76 45.42 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.87 -48.77 0.94 Allowed Glycine 0 CA--C 1.469 -2.784 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.58 72.13 2.78 Favored Glycine 0 N--CA 1.416 -2.684 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.481 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 157.05 163.11 12.09 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.583 ' O ' HG13 ' X' ' 76' ' ' VAL . 19.3 Cg_endo -61.96 -47.52 10.47 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.081 3.188 . . . . 0.0 112.825 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.414 ' C ' HG21 ' X' ' 76' ' ' VAL . 43.2 mt-10 -77.37 1.24 19.53 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 -35.03 2.82 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 118.526 -1.797 . . . . 0.0 112.651 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.481 HG12 ' O ' ' X' ' 71' ' ' GLY . 3.6 pt -65.36 -29.38 47.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.761 173.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.583 HG13 ' O ' ' X' ' 72' ' ' PRO . 19.6 m -63.38 -35.04 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.7 0 CA-C-O 121.407 0.622 . . . . 0.0 111.419 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 61.9 tttm -66.88 -39.26 87.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.151 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.13 -38.34 90.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.13 -46.56 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.256 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 18.0 ptpt -66.94 -39.98 87.45 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.816 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.61 -35.85 77.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.377 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.51 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.0 t90 -67.66 -48.05 67.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.629 0.728 . . . . 0.0 109.19 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.422 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 18.4 tpt180 -61.34 -45.75 93.1 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.219 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.65 83.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.66 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.96 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.26 0.35 . . . . 0.0 110.852 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.42 ' OD1' ' HE2' ' X' ' 88' ' ' LYS . 17.5 t-20 -69.08 -37.37 78.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.56 29.38 5.36 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.15 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.42 ' HE2' ' OD1' ' X' ' 86' ' ' ASN . 64.0 mttm -106.41 147.53 35.09 Favored Pre-proline 0 N--CA 1.401 -2.904 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.45 130.03 25.55 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.4 2.066 . . . . 0.0 110.751 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.88 -128.51 5.4 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.689 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -88.72 154.85 19.96 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.2 pttt -90.06 163.97 14.68 Favored 'General case' 0 N--CA 1.39 -3.464 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.49 141.18 29.27 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.276 -2.752 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 175.838 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 73.0 mt -94.14 128.61 40.66 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 35.0 mmtt -99.94 -178.77 3.95 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.376 0.607 . . . . 0.0 110.065 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -104.81 -13.67 15.78 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.47 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -142.73 160.04 41.07 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.1 tt -69.1 -22.89 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.378 0.608 . . . . 0.0 110.746 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -84.36 -2.91 57.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.384 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.459 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -98.67 -3.45 35.98 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.43 ' C ' ' HG2' ' X' ' 92' ' ' LYS . 5.9 m-85 -98.62 121.98 41.25 Favored 'General case' 0 CA--C 1.475 -1.941 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.949 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.61 ' O ' HG13 ' X' ' 16' ' ' VAL . 12.9 pt-20 -63.37 -33.79 76.31 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.829 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.455 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.77 -38.25 76.68 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.357 0.123 . . . . 0.0 110.998 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -59.1 -37.51 77.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.643 0.735 . . . . 0.0 109.477 173.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.602 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 33.6 t80 -74.27 -40.88 62.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.483 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.61 HG13 ' O ' ' X' ' 12' ' ' GLU . 6.3 m -62.58 -32.08 54.17 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.214 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.16 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.05 -46.06 82.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.611 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -58.82 -44.33 90.84 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.799 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.8 mt -58.22 -40.24 81.13 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.197 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.62 ' O ' ' HB3' ' X' ' 23' ' ' GLU . 95.7 mttt -70.22 -34.11 72.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.338 0.589 . . . . 0.0 110.224 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.82 -42.2 98.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.898 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.611 HG13 ' O ' ' X' ' 18' ' ' LEU . 17.6 mt -65.13 -39.52 85.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.62 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 12.8 tt0 -57.24 -47.82 80.4 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 124.343 1.057 . . . . 0.0 108.459 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -47.92 81.49 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.146 -178.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.431 ' OE1' ' HB ' ' X' ' 33' ' ' VAL . 28.6 mm-40 -68.72 -31.7 70.95 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.2 -44.07 22.6 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.237 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.97 -25.86 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.51 -4.29 45.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 45.14 78.8 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.744 1.618 . . . . 0.0 112.987 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.525 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 81.8 p -99.58 -160.51 0.81 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.098 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.57 -63.51 0.67 Allowed 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.612 ' O ' HG22 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.64 -60.02 3.85 Favored 'General case' 0 CA--C 1.472 -2.053 0 O-C-N 123.718 0.637 . . . . 0.0 112.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -82.75 -25.9 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.186 -172.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.607 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -59.16 -46.94 87.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 31.0 t70 -66.72 -43.58 83.88 Favored 'General case' 0 CA--C 1.479 -1.766 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.001 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.612 HG22 ' O ' ' X' ' 32' ' ' ASP . 49.8 t -55.95 -50.23 70.46 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 O-C-N 124.114 0.884 . . . . 0.0 110.493 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 77.6 mt -69.23 -39.03 78.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 O-C-N 124.423 1.077 . . . . 0.0 112.123 -173.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.3 mt -60.25 -50.18 74.66 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.0 0.813 . . . . 0.0 110.69 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 2.7 pt-20 -71.41 -33.79 69.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.529 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.546 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 34.9 t60 -61.37 -45.89 92.47 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.534 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 69.6 t80 -60.7 -54.11 49.24 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.841 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.494 HG13 ' O ' ' X' ' 38' ' ' LEU . 4.8 p -67.22 -32.87 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.9 ptmm? -68.12 -42.43 80.24 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.82 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.523 HG12 ' O ' ' X' ' 40' ' ' HIS . 12.2 pt -77.1 -34.49 21.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.721 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 77.1 p -84.32 -39.19 19.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.459 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 58.81 74.81 0.42 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.537 1.16 . . . . 0.0 110.382 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -123.82 132.49 24.29 Favored Pre-proline 0 N--CA 1.405 -2.679 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.3 -18.59 55.7 Favored 'Trans proline' 0 CA--C 1.498 -1.304 0 C-N-CA 122.99 2.46 . . . . 0.0 111.885 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.421 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 15.3 m-20 -126.99 33.89 4.85 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -170.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.534 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.85 -55.81 7.06 Favored Glycine 0 CA--C 1.461 -3.288 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.866 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.424 HG23 HD22 ' X' ' 38' ' ' LEU 0.313 1.9 p -85.25 -17.19 37.73 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 117.208 -1.797 . . . . 0.0 113.618 -176.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.88 -35.52 80.28 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.35 -40.71 96.41 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 123.604 0.565 . . . . 0.0 110.937 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 17.9 mm -66.57 -46.27 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.796 0.808 . . . . 0.0 109.773 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -63.02 -43.39 98.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.415 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -71.39 -37.32 71.57 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.791 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.25 80.44 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 122.32 0.248 . . . . 0.0 111.347 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.25 -46.34 83.13 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.461 0.476 . . . . 0.0 110.49 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.25 -43.53 67.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.383 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' X' ' 65' ' ' PRO . 74.2 mtp180 -60.99 -34.18 74.38 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.133 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.78 -36.49 37.03 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.574 0.226 . . . . 0.0 111.488 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.6 84.42 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 109.976 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.36 -50.53 8.26 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.68 87.57 0.13 Allowed Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.404 1.482 . . . . 0.0 109.561 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 22.8 Cg_exo -64.27 -65.53 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.903 2.402 . . . . 0.0 113.096 -173.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 47.01 1.03 Allowed Glycine 0 CA--C 1.475 -2.424 0 C-N-CA 119.991 -1.099 . . . . 0.0 112.03 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.43 -82.85 1.14 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.246 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.7 120.83 22.41 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 122.92 0.488 . . . . 0.0 109.935 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.28 23.42 9.65 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.07 52.68 0.78 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.91 173.89 42.87 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.569 ' O ' HG13 ' X' ' 75' ' ' ILE . 9.6 Cg_endo -54.04 -34.59 78.19 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 124.457 3.438 . . . . 0.0 112.131 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.67 0.63 5.2 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.64 -10.78 28.23 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 118.836 -1.649 . . . . 0.0 113.248 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.569 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -74.15 -44.86 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.486 HG11 HG11 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -55.56 -43.07 71.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.266 175.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 21.7 ttmm -60.48 -47.63 85.31 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.869 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.81 -37.87 86.02 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.122 0.963 . . . . 0.0 108.592 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.488 ' HA ' HH21 ' X' ' 83' ' ' ARG . 36.2 mm -65.58 -45.75 91.53 Favored 'Isoleucine or valine' 0 C--O 1.254 1.304 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.086 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.6 ptpt -63.17 -37.68 88.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.282 0.364 . . . . 0.0 110.86 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 35.7 mt-10 -71.28 -43.91 66.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -62.96 -41.02 99.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.488 HH21 ' HA ' ' X' ' 79' ' ' ILE . 0.5 OUTLIER -61.94 -45.33 94.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.504 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -39.58 93.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.678 0.611 . . . . 0.0 111.324 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.79 82.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.449 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 23.1 t-20 -67.57 -46.96 71.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.26 22.87 5.7 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.449 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 61.3 mttm -102.02 144.73 29.16 Favored Pre-proline 0 N--CA 1.403 -2.815 0 C-N-CA 124.396 1.079 . . . . 0.0 108.114 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.15 132.76 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.697 1.598 . . . . 0.0 111.485 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -92.04 -117.81 2.33 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.038 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.403 ' CZ ' HG21 ' X' ' 76' ' ' VAL . 54.6 m-85 -99.61 166.19 11.25 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 21.9 ptmt -94.62 174.43 7.12 Favored 'General case' 0 N--CA 1.387 -3.605 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -120.67 136.12 54.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 CA-C-O 121.242 0.544 . . . . 0.0 110.659 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.737 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 121.606 0.717 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.461 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 78.3 mt -91.84 153.5 19.51 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.932 -176.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.631 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 10.9 mptt -120.56 -178.4 3.7 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.793 -175.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.97 -46.44 12.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.446 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.3 p -140.42 167.91 21.03 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.549 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -61.59 -19.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.822 0.82 . . . . 0.0 110.542 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.1 m -82.26 -5.01 58.24 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.717 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.623 ' HB3' ' CG ' ' X' ' 4' ' ' LYS . 3.5 t70 -105.42 3.6 29.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.631 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 4.8 m-85 -105.37 118.11 35.72 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.314 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 18.2 p -79.22 163.76 24.73 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.674 ' O ' HG11 ' X' ' 16' ' ' VAL . 10.1 pt-20 -56.58 -42.17 78.2 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.002 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.539 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.86 -38.37 76.41 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.44 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 53.4 mm-40 -60.89 -36.35 79.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.74 0.781 . . . . 0.0 109.213 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 41.7 t80 -75.26 -42.92 53.99 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.517 -177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.674 HG11 ' O ' ' X' ' 12' ' ' GLU . 10.2 m -58.43 -33.61 48.42 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 O-C-N 123.215 0.322 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.69 -49.37 77.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.675 1.19 . . . . 0.0 110.171 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.492 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.5 tm? -61.77 -42.91 99.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.117 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -61.3 -42.66 99.02 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.366 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.0 mttt -63.87 -35.93 82.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.318 0.58 . . . . 0.0 109.975 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -67.56 -34.92 78.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.492 HG13 ' O ' ' X' ' 18' ' ' LEU . 25.5 mt -66.22 -42.25 90.69 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.17 -37.32 71.93 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.927 0.87 . . . . 0.0 110.666 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.1 -52.38 55.81 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.941 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 1.7 pp20? -97.61 -11.42 23.64 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 118.83 -1.148 . . . . 0.0 113.482 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.61 -38.06 83.48 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.074 0.464 . . . . 0.0 110.948 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.93 -20.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.302 0.572 . . . . 0.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -39.79 13.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.495 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.86 75.93 0.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.0 1.72 . . . . 0.0 109.768 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 49.2 p -78.75 -21.34 48.1 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.351 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 t70 72.99 -48.54 0.69 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.435 ' O ' HG22 ' X' ' 36' ' ' VAL . 21.1 t70 -63.07 -52.55 62.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.714 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 15.0 p -94.01 -25.26 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.857 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.663 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.4 tm? -58.02 -46.58 85.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.647 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 35.2 t70 -63.03 -42.5 99.79 Favored 'General case' 0 CA--C 1.473 -1.987 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.016 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.435 HG22 ' O ' ' X' ' 32' ' ' ASP . 39.2 t -61.55 -49.54 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 O-C-N 124.65 1.219 . . . . 0.0 110.837 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.7 mt -65.97 -43.68 87.15 Favored 'General case' 0 N--CA 1.415 -2.223 0 O-C-N 124.13 0.894 . . . . 0.0 110.362 -173.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.558 ' O ' HG11 ' X' ' 42' ' ' VAL . 32.4 mt -63.14 -50.65 69.58 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.73 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 16.7 pt-20 -71.76 -37.37 70.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.31 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.513 ' O ' HG12 ' X' ' 44' ' ' ILE . 8.9 t60 -59.89 -44.85 93.98 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.495 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 28.8 t80 -62.09 -56.93 13.96 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.438 1.086 . . . . 0.0 111.65 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.558 HG11 ' O ' ' X' ' 38' ' ' LEU 0.266 8.9 p -67.36 -31.18 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -67.6 -30.37 69.95 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.663 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.513 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.1 pt -91.4 -32.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.567 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -81.62 -36.8 28.5 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.315 0.578 . . . . 0.0 110.107 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.61 26.98 16.55 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.497 1.519 . . . . 0.0 111.022 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.0 130.74 80.23 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.509 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -67.19 -14.57 43.64 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 123.226 2.617 . . . . 0.0 112.745 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.04 32.46 5.24 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -173.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.495 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.15 -54.55 8.28 Favored Glycine 0 CA--C 1.457 -3.548 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.576 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.439 HG21 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -33.34 59.59 Favored 'General case' 0 C--N 1.257 -3.436 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.639 -172.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.35 -36.11 77.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.409 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 mt -58.02 -43.14 86.56 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 5.0 mp -66.79 -41.42 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.812 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -63.18 -50.27 70.99 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.6 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.1 pt-20 -66.62 -36.61 83.02 Favored 'General case' 0 C--O 1.206 -1.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.199 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.83 78.4 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 123.219 0.324 . . . . 0.0 110.63 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.87 91.74 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.491 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.41 -42.6 74.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.222 0.534 . . . . 0.0 110.221 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.628 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 72.5 mtp180 -61.22 -35.79 78.15 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.225 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.29 -39.57 28.53 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.57 64.97 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.45 -13.35 23.18 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.513 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 11.0 m120 41.3 75.14 0.64 Allowed Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.98 -27.35 25.5 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 169.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.41 150.09 20.96 Favored Glycine 0 N--CA 1.399 -3.812 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.36 -20.14 75.41 Favored Glycine 0 C--N 1.304 -1.225 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.77 112.17 3.11 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 124.099 0.96 . . . . 0.0 109.726 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . 0.628 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 84.7 5.54 86.46 Favored Glycine 0 CA--C 1.498 -0.98 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.32 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.16 70.14 3.05 Favored Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.54 -178.73 20.81 Favored Glycine 0 N--CA 1.399 -3.801 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.792 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.624 ' O ' HG11 ' X' ' 76' ' ' VAL . 32.5 Cg_endo -66.45 -41.0 12.77 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 124.617 3.544 . . . . 0.0 112.313 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.459 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.1 mt-10 -84.69 2.02 43.74 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.386 0.675 . . . . 0.0 110.182 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.79 -35.78 3.16 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.89 172.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.477 ' CD1' HD13 ' X' ' 19' ' ' LEU . 4.0 pt -64.78 -22.72 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-N 117.712 0.756 . . . . 0.0 111.582 173.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.624 HG11 ' O ' ' X' ' 72' ' ' PRO . 30.7 m -63.06 -39.21 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-O 121.601 0.715 . . . . 0.0 110.534 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 52.2 tttp -64.12 -42.69 96.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.691 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 39.7 mm-40 -58.3 -45.34 88.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.85 0.833 . . . . 0.0 109.526 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -64.46 -46.79 91.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.009 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 13.5 ptmm? -67.87 -36.32 80.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.761 -174.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.0 -36.69 69.82 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.141 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.509 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.4 t90 -62.97 -48.1 80.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 18.0 tpt180 -65.89 -45.89 80.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.913 -174.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.75 -40.93 79.57 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 122.853 0.461 . . . . 0.0 112.064 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.13 82.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.084 0.469 . . . . 0.0 109.962 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.09 -21.74 56.36 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.3 42.78 9.06 Favored Glycine 0 CA--C 1.498 -0.993 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.012 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.9 mtpp -122.44 144.35 41.86 Favored Pre-proline 0 N--CA 1.393 -3.289 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.93 127.69 20.1 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 122.803 2.336 . . . . 0.0 111.543 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.62 -110.08 3.12 Favored Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.578 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.56 161.67 20.1 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.093 0.473 . . . . 0.0 110.687 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' X' ' 11' ' ' THR . 21.3 ptmt -108.26 171.69 7.26 Favored 'General case' 0 N--CA 1.393 -3.305 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -106.93 140.93 38.95 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.498 0 CA-C-O 118.083 -1.399 . . . . 0.0 110.149 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' X' ' 18' ' ' LEU . 48.8 mt -90.79 148.38 22.57 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.483 -174.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.468 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 25.1 mmtt -99.62 -160.34 0.8 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -117.7 -19.68 9.22 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.042 -0.411 . . . . 0.0 110.852 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 83.4 p -135.8 160.87 37.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.06 -21.92 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.613 0.765 . . . . 0.0 110.279 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 8' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 23.7 m -85.64 -1.75 57.47 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 25.6 t0 -101.67 -0.11 35.18 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.74 123.63 46.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.216 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.492 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 70.6 p -78.18 172.11 14.05 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.557 ' O ' HG11 ' X' ' 16' ' ' VAL . 8.0 pt-20 -56.33 -45.09 80.5 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.169 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.487 ' O ' HG23 ' X' ' 16' ' ' VAL . . . -70.44 -37.85 74.44 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.492 ' HB2' ' H ' ' X' ' 11' ' ' THR . 5.3 mm-40 -57.8 -35.94 71.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.385 0.612 . . . . 0.0 110.227 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.645 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 30.1 t80 -75.67 -40.51 55.86 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.9 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.557 HG11 ' O ' ' X' ' 12' ' ' GLU . 4.3 m -62.92 -28.99 46.08 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.923 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' X' ' 21' ' ' GLU . 0.9 OUTLIER -57.63 -48.79 78.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.605 ' O ' HG13 ' X' ' 22' ' ' ILE . 20.3 tp -61.81 -46.99 87.14 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 121.196 0.522 . . . . 0.0 110.655 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 37.2 mt -57.94 -36.88 73.13 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.924 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 95.9 mttt -70.78 -33.97 71.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.128 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' X' ' 17' ' ' GLN . 8.7 mm-40 -67.37 -43.27 81.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.605 HG13 ' O ' ' X' ' 18' ' ' LEU . 35.5 mt -58.81 -42.2 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.095 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.22 -47.84 82.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.695 1.198 . . . . 0.0 110.165 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.92 -52.1 58.28 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.73 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -17.19 64.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.426 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.53 -38.45 14.92 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.121 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.25 -33.25 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.214 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.83 -26.26 37.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 77.27 0.31 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.326 1.451 . . . . 0.0 112.913 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.9 p -98.55 -177.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.2 -56.09 1.44 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.887 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.596 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.2 p-10 -57.68 -55.7 31.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 123.535 0.522 . . . . 0.0 111.921 -175.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.725 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -81.33 -32.52 12.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.375 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.27 -45.81 90.22 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.154 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.76 -24.61 60.97 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.207 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.596 HG23 ' O ' ' X' ' 32' ' ' ASP . 88.7 t -61.01 -49.1 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.187 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 65.4 mt -68.11 -43.05 79.28 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.962 -173.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.1 mt -58.87 -46.57 87.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.292 0.995 . . . . 0.0 110.597 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.85 -40.93 72.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.087 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.6 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 63.9 t60 -62.4 -45.56 92.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.393 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.582 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.8 t80 -58.27 -51.73 68.53 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.752 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -67.86 -32.85 58.23 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.9 ptmt -68.96 -33.44 73.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 122.046 -0.409 . . . . 0.0 111.897 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.511 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.1 pt -85.13 -32.49 7.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.734 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 73.9 p -84.97 -33.62 22.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 56.8 33.59 23.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.664 1.186 . . . . 0.0 110.274 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.412 ' CE1' HD12 ' X' ' 53' ' ' LEU . 41.3 t-80 -80.61 134.46 54.19 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.225 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.459 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -67.77 -12.18 34.59 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 123.18 2.587 . . . . 0.0 112.437 -175.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -130.24 28.56 4.98 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.582 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.68 -62.59 2.84 Favored Glycine 1 CA--C 1.449 -4.049 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.741 -175.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.404 HG21 HD13 ' X' ' 38' ' ' LEU . 2.7 m -77.64 -23.99 49.59 Favored 'General case' 0 C--N 1.249 -3.774 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.24 -173.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.563 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.0 -34.95 78.66 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.03 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . 0.412 HD12 ' CE1' ' X' ' 47' ' ' HIS . 34.8 mt -62.91 -37.67 87.91 Favored 'General case' 0 CA--C 1.486 -1.493 0 O-C-N 123.362 0.414 . . . . 0.0 110.711 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.2 mt -66.46 -44.03 90.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.86 -44.62 95.63 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.261 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.7 pt-20 -68.52 -46.43 69.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.364 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.16 94.19 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.224 0.328 . . . . 0.0 111.456 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.32 94.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.218 0.323 . . . . 0.0 111.551 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.46 84.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.74 0.781 . . . . 0.0 110.016 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 96.8 mtt180 -67.37 -29.23 68.7 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.414 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.32 -37.5 37.48 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.92 83.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 110.035 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . 0.44 ' O ' ' HD3' ' X' ' 65' ' ' PRO . . . -117.64 85.94 2.43 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 28.4 t-20 -78.66 114.66 45.42 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' X' ' 63' ' ' ALA . 30.0 Cg_endo -104.11 27.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.941 2.427 . . . . 0.0 109.889 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.08 -84.57 0.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -169.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.71 -177.09 52.1 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.047 -0.576 . . . . 0.0 114.314 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.35 -53.3 2.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.72 75.95 0.3 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 108.184 -1.967 . . . . 0.0 108.184 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.4 42.76 1.86 Allowed Glycine 0 CA--C 1.49 -1.494 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.403 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.09 169.67 31.86 Favored Glycine 0 N--CA 1.397 -3.904 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.502 ' O ' HG13 ' X' ' 75' ' ' ILE . 10.2 Cg_endo -57.81 -40.92 74.87 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.449 2.766 . . . . 0.0 111.785 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -74.12 0.75 12.9 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.137 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.59 -17.67 10.3 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.807 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.502 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -68.04 -41.96 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.458 HG11 HG12 ' X' ' 16' ' ' VAL . 1.0 OUTLIER -56.43 -44.6 80.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.714 177.051 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.456 ' H ' HG12 ' X' ' 76' ' ' VAL . 23.1 ttpp -57.98 -47.74 82.08 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.338 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.3 -36.24 73.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.456 0.646 . . . . 0.0 109.657 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.8 -45.81 71.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.369 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.2 pttp -64.32 -35.5 81.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.923 0.392 . . . . 0.0 110.48 -176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 49.5 mt-10 -69.22 -39.35 78.63 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.459 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -67.96 -47.29 69.02 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -60.9 -45.28 95.24 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.296 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.6 83.27 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.011 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.31 -33.73 75.89 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.502 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.15 -46.77 48.99 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.42 41.93 1.31 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -117.62 144.79 34.95 Favored Pre-proline 0 N--CA 1.399 -3.017 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.06 124.74 13.47 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 121.991 1.794 . . . . 0.0 109.862 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.55 -121.43 3.48 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.179 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -83.03 161.38 21.72 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.544 -0.828 . . . . 0.0 109.974 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' X' ' 8' ' ' SER . 21.0 ptmt -87.59 167.62 13.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.21 132.03 48.39 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.116 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 178.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.464 ' CD2' HD12 ' X' ' 18' ' ' LEU . 53.5 mt -90.49 146.34 24.19 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.7 mmtt -110.22 148.43 31.87 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.44 -1.21 55.27 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.021 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 53.0 p -147.08 158.46 43.94 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.8 tp -73.03 -12.41 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.241 0.543 . . . . 0.0 111.615 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.27 -14.27 60.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.421 0.629 . . . . 0.0 111.386 -173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.2 t70 -105.28 5.26 31.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -100.18 121.51 41.55 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.737 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 29.8 p -83.57 165.33 19.15 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.6 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.3 pt-20 -56.07 -43.62 78.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.346 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.97 -37.31 75.73 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 17.4 mm-40 -56.83 -39.73 74.75 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.631 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 16.9 t80 -72.81 -43.21 62.99 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.639 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.6 HG13 ' O ' ' X' ' 12' ' ' GLU . 4.3 m -62.74 -29.03 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.89 -44.91 88.09 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.565 ' O ' HG13 ' X' ' 22' ' ' ILE . 27.5 tp -61.42 -46.23 91.01 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.546 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 36.0 mt -57.24 -41.45 79.6 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.678 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.6 mttm -63.58 -35.84 81.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.664 175.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.08 -31.42 50.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.452 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.565 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.4 mt -62.27 -41.86 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -58.56 -40.62 83.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -60.4 -41.84 94.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.71 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -80.21 -32.19 38.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.292 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -61.16 -52.75 63.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.051 0.54 . . . . 0.0 111.646 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -65.91 -27.3 40.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.27 -20.96 26.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.73 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.69 61.57 2.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.737 1.215 . . . . 0.0 111.887 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.9 p -88.21 -164.8 1.17 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.359 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -134.2 -50.89 0.82 Allowed 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.998 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.53 ' O ' HG21 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.29 -63.06 1.27 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.629 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 90.5 t -85.93 -27.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.052 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.451 -173.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.595 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.8 tm? -58.85 -43.29 90.74 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.5 t70 -68.18 -42.06 80.52 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.118 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.53 HG21 ' O ' ' X' ' 32' ' ' ASP . 75.1 t -57.54 -50.23 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 O-C-N 124.058 0.849 . . . . 0.0 110.27 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 75.8 mt -67.98 -40.31 83.15 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.091 -170.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 26.5 mt -64.08 -49.13 73.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 O-C-N 124.328 1.017 . . . . 0.0 111.498 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.21 -36.68 71.96 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.5 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.573 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 77.6 t60 -60.82 -45.93 92.53 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' X' ' 54' ' ' ILE . 56.5 t80 -57.51 -53.63 55.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.778 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.494 HG11 ' O ' ' X' ' 38' ' ' LEU 0.264 4.6 p -67.14 -31.79 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 17.5 ptmt -71.4 -30.03 65.62 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.851 -0.53 . . . . 0.0 112.369 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.537 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.0 pt -88.96 -35.94 8.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.098 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.41 ' HB ' HD13 ' X' ' 79' ' ' ILE . 77.1 p -82.64 -36.91 25.61 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 110.597 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 64.22 31.22 13.25 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.466 1.507 . . . . 0.0 111.404 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.434 ' O ' HG22 ' X' ' 42' ' ' VAL . 43.7 t-80 -80.88 139.17 49.9 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.456 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.8 Cg_exo -70.94 -18.94 31.07 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 122.859 2.372 . . . . 0.0 112.454 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.404 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.1 35.76 4.71 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.502 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.6 -52.74 23.6 Favored Glycine 1 CA--C 1.447 -4.208 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.857 -177.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.478 ' CG2' HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.66 -32.06 57.72 Favored 'General case' 0 C--N 1.248 -3.839 0 C-N-CA 118.498 -1.281 . . . . 0.0 110.791 -172.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.59 -33.99 74.84 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.258 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.01 -43.23 91.53 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.551 HD12 ' CD2' ' X' ' 41' ' ' PHE . 4.8 mp -67.2 -42.43 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.708 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.403 ' HD2' ' O ' ' X' ' 51' ' ' THR . 49.8 m-85 -62.61 -46.13 89.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.686 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.1 pt-20 -71.57 -38.49 70.94 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.46 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.74 76.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.832 0.287 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.78 84.19 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.687 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.77 -40.07 76.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.08 0.466 . . . . 0.0 110.358 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 67.8 mtp180 -62.86 -30.33 71.42 Favored 'General case' 0 C--O 1.207 -1.182 0 C-N-CA 123.691 0.796 . . . . 0.0 110.846 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . 0.526 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -80.64 -46.18 16.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.18 -43.49 78.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.155 0.582 . . . . 0.0 110.63 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.43 86.86 2.43 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.07 121.72 77.34 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.239 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 7.71 3.53 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.385 2.723 . . . . 0.0 113.245 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.42 57.04 1.7 Allowed Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.24 174.77 37.03 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.522 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.27 168.21 13.4 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . 0.498 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 92.28 10.21 61.09 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.04 113.25 4.38 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.526 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 102.18 -179.81 27.26 Favored Glycine 0 N--CA 1.407 -3.252 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.213 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.476 ' O ' HG13 ' X' ' 75' ' ' ILE . 26.1 Cg_endo -64.51 -39.53 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.591 2.861 . . . . 0.0 111.974 -174.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.33 0.86 20.69 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.77 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.03 -20.97 8.01 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 119.196 -1.478 . . . . 0.0 113.027 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.476 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -63.07 -46.34 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.484 HG12 ' H ' ' X' ' 77' ' ' LYS . 0.9 OUTLIER -56.49 -46.96 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.86 177.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.484 ' H ' HG12 ' X' ' 76' ' ' VAL . 65.7 tttm -58.88 -48.2 82.25 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.632 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -58.46 -37.73 76.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.41 HD13 ' HB ' ' X' ' 45' ' ' THR . 38.6 mm -68.87 -46.83 78.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.765 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -66.81 -36.37 82.21 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.578 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.444 ' CD ' ' HZ2' ' X' ' 77' ' ' LYS . 47.8 mt-10 -72.42 -34.55 67.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.866 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.456 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 89.7 t90 -69.14 -46.15 68.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.57 . . . . 0.0 110.09 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -67.84 -35.99 79.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.065 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.598 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.58 81.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.762 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' X' ' 88' ' ' LYS . 25.7 t-20 -67.0 -41.25 87.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 46.77 4.58 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 106.607 -2.597 . . . . 0.0 106.607 -169.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' X' ' 86' ' ' ASN . 22.9 ttmm -121.33 135.57 25.11 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.54 114.87 2.14 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.348 2.699 . . . . 0.0 112.347 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.52 -116.14 3.78 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.805 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -86.51 155.01 20.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -91.42 -175.65 4.29 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.87 144.18 32.97 Favored 'General case' 0 N--CA 1.399 -2.994 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.153 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.048 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.51 -0.573 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 35.3 mt -91.74 128.61 37.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 30.8 mmtt -96.92 -176.2 3.49 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.514 0.673 . . . . 0.0 111.96 -173.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.7 -36.18 11.84 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 61.6 p -135.12 166.68 22.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.323 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.83 -16.52 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.446 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -69.98 -25.66 63.72 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.573 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.431 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 16.0 t0 -94.93 -15.65 23.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 13.2 m-85 -75.64 119.17 19.31 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.473 ' HA ' ' CB ' ' X' ' 92' ' ' LYS . 51.8 p -78.31 167.28 21.59 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.59 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.7 pt-20 -57.75 -41.01 81.04 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.981 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.501 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.68 -37.63 76.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.16 -37.72 83.89 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.581 -0.699 . . . . 0.0 110.264 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.546 ' O ' HD13 ' X' ' 19' ' ' LEU . 33.5 t80 -71.81 -44.51 63.81 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.557 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.642 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 9.9 m -60.5 -35.86 65.99 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -49.78 76.33 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.231 1.012 . . . . 0.0 110.142 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.645 ' O ' HG13 ' X' ' 22' ' ' ILE . 28.4 tp -58.03 -47.16 83.94 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.584 0.707 . . . . 0.0 110.118 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.546 HD13 ' O ' ' X' ' 15' ' ' PHE . 8.1 mp -60.95 -37.0 80.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.169 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 52.9 mtmt -66.5 -35.43 80.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -65.6 -45.07 84.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.825 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.645 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.4 mt -55.92 -39.58 57.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.436 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.26 -47.33 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.087 0.47 . . . . 0.0 110.761 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.25 -51.56 43.85 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.612 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.442 ' HG3' ' HG1' ' X' ' 30' ' ' THR . 0.7 OUTLIER -64.82 -23.25 67.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.305 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -71.6 -55.95 6.8 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.12 -20.77 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.46 -19.73 22.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.63 0.252 . . . . 0.0 110.553 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.6 64.37 1.77 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.275 1.03 . . . . 0.0 111.071 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.442 ' HG1' ' HG3' ' X' ' 25' ' ' GLU . 51.4 p -77.21 -26.23 52.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.369 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.26 22.9 t70 74.36 -68.5 0.21 Allowed 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 125.806 1.643 . . . . 0.0 115.076 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.59 ' O ' HG21 ' X' ' 36' ' ' VAL . 30.2 t70 -57.19 -55.9 28.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.093 0.86 . . . . 0.0 112.284 -174.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.795 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -78.32 -32.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.507 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.869 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.02 -45.89 89.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.3 t70 -65.01 -40.48 94.98 Favored 'General case' 0 CA--C 1.479 -1.788 0 O-C-N 123.369 0.418 . . . . 0.0 110.668 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.59 HG21 ' O ' ' X' ' 32' ' ' ASP . 98.3 t -54.62 -49.57 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.921 0 O-C-N 124.412 1.07 . . . . 0.0 109.193 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 54.9 mt -67.48 -41.05 85.2 Favored 'General case' 0 N--CA 1.405 -2.694 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.259 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.8 mt -60.57 -50.82 71.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.22 0.95 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.65 -36.66 70.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.445 ' O ' HG12 ' X' ' 44' ' ' ILE . 6.5 t60 -59.99 -46.15 90.4 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.601 ' O ' HG22 ' X' ' 45' ' ' THR . 57.4 t80 -59.94 -56.71 18.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.573 1.171 . . . . 0.0 110.948 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.456 HG12 ' O ' ' X' ' 38' ' ' LEU 0.271 8.4 p -66.62 -31.88 55.52 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.771 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -70.25 -28.33 65.16 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.811 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.445 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.7 pt -87.51 -39.0 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.653 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.601 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.77 -32.78 23.23 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.093 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.01 22.6 13.55 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.414 . . . . 0.0 112.306 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' X' ' 49' ' ' ASP . 55.3 t-80 -70.21 135.22 86.97 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.3 Cg_exo -70.22 4.52 2.34 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 123.527 2.818 . . . . 0.0 112.864 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' X' ' 47' ' ' HIS . 27.9 m-20 -136.83 27.25 2.99 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.17 -58.05 5.26 Favored Glycine 0 CA--C 1.476 -2.387 0 O-C-N 124.511 1.132 . . . . 0.0 113.199 -175.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.457 ' O ' ' HD2' ' X' ' 55' ' ' TYR 0.276 0.0 OUTLIER -79.34 -25.61 42.25 Favored 'General case' 0 C--N 1.257 -3.427 0 C-N-CA 118.059 -1.456 . . . . 0.0 113.65 -176.813 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.16 -37.31 87.0 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 65.2 mt -64.76 -37.86 89.02 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.676 0.61 . . . . 0.0 111.249 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.3 mt -66.78 -46.33 85.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.735 0.779 . . . . 0.0 109.461 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.457 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.8 m-85 -63.45 -46.74 84.88 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -64.24 -40.08 95.28 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.76 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . 0.421 ' HB1' ' CG2' ' X' ' 75' ' ' ILE . . . -58.79 -51.04 71.69 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 123.116 0.26 . . . . 0.0 111.387 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.37 80.28 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.733 0.646 . . . . 0.0 111.405 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -44.04 65.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.59 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.31 -38.13 81.28 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.74 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.95 61.97 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 122.974 0.509 . . . . 0.0 111.808 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.02 -22.86 66.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.111 0.481 . . . . 0.0 110.878 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.21 -39.15 6.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 63.94 87.98 0.12 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.885 1.674 . . . . 0.0 113.135 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.48 -18.1 6.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.655 2.237 . . . . 0.0 111.261 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.32 169.54 41.77 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.09 83.93 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.01 138.76 42.43 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -58.51 2.72 Favored Glycine 0 C--O 1.242 0.616 0 CA-C-N 116.205 -0.452 . . . . 0.0 113.837 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.2 62.03 4.56 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.0 161.65 13.53 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.604 ' O ' HG11 ' X' ' 76' ' ' VAL . 7.9 Cg_endo -57.02 -42.01 68.84 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.632 2.888 . . . . 0.0 110.623 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.512 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.6 mt-10 -78.35 1.93 20.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.205 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.17 -34.86 2.84 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 119.021 -1.561 . . . . 0.0 112.948 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.421 ' CG2' ' HB1' ' X' ' 57' ' ' ALA . 1.1 pt -67.2 -26.18 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-N 117.503 0.652 . . . . 0.0 110.765 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.604 HG11 ' O ' ' X' ' 72' ' ' PRO . 27.8 m -61.4 -34.44 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.141 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 60.6 tttm -61.79 -47.02 87.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.504 174.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.8 -43.71 90.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.567 0.699 . . . . 0.0 109.415 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.516 HG21 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -64.8 -46.54 91.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.22 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 17.4 pttp -67.44 -37.08 82.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.312 -174.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.92 -39.46 72.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.33 0.394 . . . . 0.0 111.35 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.592 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 70.4 t90 -64.79 -47.83 76.66 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.7 0.625 . . . . 0.0 109.443 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.605 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 16.2 tpt180 -61.45 -45.67 93.3 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.223 -176.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.69 -38.73 84.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.232 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.9 78.5 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.903 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -69.02 -36.16 77.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.8 41.94 2.78 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.605 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 55.7 mttm -118.97 147.96 43.62 Favored Pre-proline 0 N--CA 1.396 -3.172 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.79 130.17 32.02 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.229 1.952 . . . . 0.0 111.071 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -100.09 -140.63 11.49 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.302 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.1 m-85 -78.29 150.45 33.33 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.047 0.451 . . . . 0.0 110.945 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' X' ' 11' ' ' THR . 0.7 OUTLIER -72.72 157.37 37.65 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.979 174.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -85.46 1.16 49.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.004 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.261 -3.62 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.212 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 CA--C 1.506 -0.736 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt -123.12 148.29 45.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.402 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 33.0 mmtt -108.72 160.31 16.05 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.0 -17.38 43.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.679 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.7 p -139.7 163.84 31.53 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.112 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.602 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.6 tp -64.92 -22.61 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.047 0.939 . . . . 0.0 110.023 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -76.32 -11.61 59.93 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.789 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 26.6 t0 -105.31 -7.17 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.882 0.849 . . . . 0.0 108.914 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -83.59 115.33 22.08 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.947 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 16.3 p -76.77 169.02 19.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.421 ' O ' HG11 ' X' ' 16' ' ' VAL . 9.3 pt-20 -60.86 -33.58 73.29 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 119.676 1.125 . . . . 0.0 112.173 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -44.07 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.381 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -57.22 -41.65 79.88 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.414 0.626 . . . . 0.0 109.949 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.553 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.3 t80 -65.75 -55.55 16.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' X' ' 19' ' ' LEU . 14.7 p -63.63 -27.79 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -60.77 -47.38 86.57 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.44 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.3 tm? -62.61 -40.79 98.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.123 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 21.9 mt -57.78 -43.8 85.81 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.787 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -61.32 -38.74 87.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.45 -31.64 70.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.594 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.44 HG13 ' O ' ' X' ' 18' ' ' LEU . 35.1 mt -66.68 -46.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -57.72 -34.53 69.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.807 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.28 -40.69 96.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.42 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.412 ' OE1' HD22 ' X' ' 34' ' ' LEU . 3.1 pp20? -88.57 -30.27 19.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.735 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -50.38 -47.61 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.81 1.244 . . . . 0.0 111.706 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -69.95 -17.14 20.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -105.52 -19.54 13.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.635 0.255 . . . . 0.0 110.565 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.52 87.64 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.436 1.495 . . . . 0.0 110.73 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.2 p -95.26 -164.62 1.18 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.48 -42.33 0.7 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.417 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.672 ' O ' HG23 ' X' ' 36' ' ' VAL . 13.8 t70 -71.1 -62.02 1.55 Allowed 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.527 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.664 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.3 p -75.8 -27.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.228 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.511 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.8 tm? -57.64 -52.84 63.77 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 124.258 1.023 . . . . 0.0 108.565 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.63 -25.51 60.34 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.294 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.672 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.3 t -68.5 -50.74 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.037 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.623 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.1 mt -68.87 -43.36 75.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 O-C-N 124.744 1.278 . . . . 0.0 111.36 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.463 ' O ' HG13 ' X' ' 42' ' ' VAL . 34.6 mt -61.14 -44.83 96.72 Favored 'General case' 0 N--CA 1.415 -2.191 0 O-C-N 124.274 0.984 . . . . 0.0 112.054 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -71.05 -42.95 68.79 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.782 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.531 ' O ' HG12 ' X' ' 44' ' ' ILE . 26.5 t60 -60.22 -45.92 91.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.47 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.545 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 34.2 t80 -62.77 -48.36 79.51 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.463 HG13 ' O ' ' X' ' 38' ' ' LEU . 14.1 p -67.52 -31.23 51.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 52.2 pttt -73.11 -35.08 66.5 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.602 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 21.7 pt -79.03 -32.46 15.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -83.55 -33.9 25.35 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.843 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.9 28.27 17.24 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.091 0.948 . . . . 0.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.514 ' ND1' ' HB2' ' X' ' 49' ' ' ASP . 54.8 t-80 -85.89 145.82 42.01 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.516 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.56 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.5 Cg_exo -77.48 12.97 1.71 Allowed 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.342 2.694 . . . . 0.0 112.643 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.514 ' HB2' ' ND1' ' X' ' 47' ' ' HIS . 0.8 OUTLIER -123.86 -64.38 1.15 Allowed 'General case' 0 N--CA 1.404 -2.743 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.545 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . 58.42 -84.33 0.01 OUTLIER Glycine 1 CA--C 1.428 -5.361 0 O-C-N 125.337 1.648 . . . . 0.0 111.997 177.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.427 ' CG2' HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.4 -37.27 74.45 Favored 'General case' 1 C--N 1.211 -5.44 0 CA-C-N 112.698 -1.751 . . . . 0.0 109.239 -172.138 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.07 -31.08 70.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.071 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.36 -42.19 96.32 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.423 0.452 . . . . 0.0 111.82 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' X' ' 41' ' ' PHE . 5.0 mp -67.27 -42.0 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.096 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -61.88 -41.86 98.38 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.81 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.8 pt-20 -71.74 -37.12 70.61 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.876 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.23 77.62 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 122.943 0.497 . . . . 0.0 111.281 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.81 86.64 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.332 0.395 . . . . 0.0 111.333 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.19 62.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.797 0.808 . . . . 0.0 109.641 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -61.0 -27.96 68.69 Favored 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.853 1.261 . . . . 0.0 110.404 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.25 -48.12 71.52 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.308 0.643 . . . . 0.0 110.74 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.13 -50.09 62.61 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.673 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.05 71.35 1.12 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' X' ' 65' ' ' PRO . 7.6 p30 -83.42 121.35 76.63 Favored Pre-proline 0 CA--C 1.486 -1.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.979 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' X' ' 64' ' ' ASN . 4.6 Cg_exo -78.61 -66.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.724 0 C-N-CA 120.911 1.074 . . . . 0.0 111.179 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.45 -138.89 3.76 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.46 60.44 4.29 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -148.19 -31.11 0.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 124.357 1.063 . . . . 0.0 108.64 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.41 -129.82 6.79 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.0 -26.28 7.84 Favored Glycine 0 C--N 1.306 -1.135 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.257 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.2 -102.36 1.06 Allowed Glycine 0 N--CA 1.41 -3.048 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.498 ' O ' HG13 ' X' ' 75' ' ' ILE . 20.3 Cg_endo -63.93 -30.92 67.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.026 2.484 . . . . 0.0 112.379 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.89 -11.65 59.91 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -99.8 -29.08 7.08 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 118.2 -1.952 . . . . 0.0 113.063 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.52 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.0 OUTLIER -60.52 -44.02 95.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.494 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 1.7 p -63.13 -43.68 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.996 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.587 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 85.9 tttt -61.71 -44.78 96.27 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 13.5 mm-40 -59.35 -45.13 92.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.481 0.658 . . . . 0.0 110.504 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.52 HG12 ' O ' ' X' ' 75' ' ' ILE . 48.2 mm -61.86 -45.33 98.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.972 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.2 ptmt -63.06 -38.07 89.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.347 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -71.7 -43.81 65.29 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.479 0.487 . . . . 0.0 111.847 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.56 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.3 t90 -63.98 -48.15 77.58 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.457 0.646 . . . . 0.0 110.916 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.409 ' HG2' ' CA ' ' X' ' 90' ' ' GLY . 12.0 tpt180 -60.9 -45.14 95.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.696 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.33 -38.18 81.29 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.199 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.62 88.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.132 0.492 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.454 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.5 t-20 -74.51 -42.2 59.34 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.91 31.77 3.77 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.454 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 63.7 mttm -102.35 146.66 32.74 Favored Pre-proline 0 N--CA 1.405 -2.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.44 126.62 17.28 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.046 1.831 . . . . 0.0 109.701 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . 0.409 ' CA ' ' HG2' ' X' ' 83' ' ' ARG . . . -110.88 -119.8 3.99 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.506 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.69 149.32 29.79 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.383 1.087 . . . . 0.0 113.422 -171.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' X' ' 11' ' ' THR . 28.3 ttpt -88.19 172.81 9.2 Favored 'General case' 1 N--CA 1.365 -4.716 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.148 174.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.06 27.67 1.04 Allowed 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 121.317 0.58 . . . . 0.0 112.198 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.277 -2.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.383 -177.376 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' X' ' 18' ' ' LEU . 37.2 mt -91.87 132.19 36.65 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.632 0.729 . . . . 0.0 111.877 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.54 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 39.4 mmtt -100.59 -161.47 0.87 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.106 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -117.82 -28.63 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.963 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -136.09 167.03 22.0 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.405 HD13 HH12 ' X' ' 83' ' ' ARG . 11.0 tp -66.96 -11.37 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.681 0.753 . . . . 0.0 110.316 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 8' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 8.2 m -70.1 -26.74 64.12 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.89 0.876 . . . . 0.0 111.294 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.477 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 10.2 t70 -105.01 5.74 32.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.652 0.739 . . . . 0.0 109.677 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 12.3 m-85 -95.87 124.98 40.11 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.646 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 45.4 p -89.4 171.67 9.57 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.5 -45.72 80.89 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.131 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.452 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.74 -38.46 73.52 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.84 -34.46 77.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.402 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -71.48 -43.06 67.27 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.723 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.604 HG13 ' O ' ' X' ' 12' ' ' GLU . 5.9 m -62.64 -29.94 48.11 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.468 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -61.74 -45.98 91.61 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.285 0.634 . . . . 0.0 109.865 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.609 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.7 tp -61.95 -48.19 81.51 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.469 HD13 HD13 ' X' ' 22' ' ' ILE . 4.3 mm? -60.46 -36.31 77.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.329 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 64.4 mttm -68.49 -36.93 79.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.85 -35.55 78.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.358 0.599 . . . . 0.0 110.104 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.609 HG13 ' O ' ' X' ' 18' ' ' LEU . 67.7 mt -63.06 -46.28 96.57 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.38 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.727 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -57.82 -45.5 86.06 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 109.802 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.28 -51.85 67.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.126 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.668 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 6.2 mm-40 -82.47 -14.67 54.67 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -69.85 -47.17 63.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 120.835 0.35 . . . . 0.0 110.191 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.4 -19.75 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.39 -18.67 25.05 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.969 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.37 72.76 0.38 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.146 1.378 . . . . 0.0 111.837 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.493 ' HG1' ' HB3' ' X' ' 25' ' ' GLU . 57.2 p -93.84 -168.4 1.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -134.84 -55.7 0.82 Allowed 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.894 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.532 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.0 p-10 -57.53 -48.08 80.25 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.739 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.8 p -87.92 -32.9 6.27 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.608 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.22 -44.56 92.29 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.713 0.805 . . . . 0.0 109.487 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.92 -32.38 69.29 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.924 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.532 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.4 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.142 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 66.2 mt -68.37 -43.03 78.26 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.707 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 15.9 mt -60.22 -45.08 94.45 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 124.265 0.978 . . . . 0.0 110.325 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -70.39 -38.75 74.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.985 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.535 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.6 t60 -64.41 -45.15 88.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.454 0.645 . . . . 0.0 109.627 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.589 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.7 t80 -59.04 -51.13 71.36 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -67.98 -33.03 58.84 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.869 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.1 ptmt -68.96 -36.12 77.53 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.039 0.447 . . . . 0.0 111.687 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.473 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.7 pt -79.17 -33.29 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.106 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -84.66 -39.69 18.3 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.317 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 63.8 31.77 13.92 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.694 1.198 . . . . 0.0 109.991 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' X' ' 49' ' ' ASP . 40.0 t-80 -80.38 135.34 53.81 Favored Pre-proline 0 N--CA 1.424 -1.77 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.117 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.545 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.0 Cg_exo -76.62 9.68 2.51 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 C-N-CA 123.367 2.711 . . . . 0.0 111.904 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' X' ' 47' ' ' HIS . 5.5 m-20 -140.8 19.14 2.33 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -172.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.589 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.88 -69.01 0.68 Allowed Glycine 0 CA--C 1.46 -3.4 0 O-C-N 124.38 1.05 . . . . 0.0 114.512 -173.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.423 ' CG2' HD12 ' X' ' 38' ' ' LEU . 0.6 OUTLIER -74.38 -18.84 60.61 Favored 'General case' 0 C--N 1.253 -3.593 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.026 -173.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -71.32 -34.19 70.35 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.58 -37.9 88.02 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.621 0.576 . . . . 0.0 110.645 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mt -66.94 -47.07 83.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.863 0.839 . . . . 0.0 109.092 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.05 -47.96 80.74 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.07 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.0 pt-20 -65.71 -36.64 84.18 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.217 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.08 83.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.181 0.446 . . . . 0.0 110.947 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.89 99.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 110.877 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.58 -43.71 63.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.36 -40.56 96.81 Favored 'General case' 0 C--O 1.2 -1.529 0 C-N-CA 123.224 0.61 . . . . 0.0 110.477 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.19 69.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -37.9 85.52 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.11 11.29 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.111 0.481 . . . . 0.0 109.934 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 60.58 89.41 0.11 Allowed Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 126.547 1.939 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.51 97.61 0.45 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.773 2.315 . . . . 0.0 111.249 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.5 -93.26 0.36 Allowed Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -157.9 20.5 0.37 Allowed Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -120.58 131.67 54.76 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.212 0.529 . . . . 0.0 110.801 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 6.52 89.28 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.497 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.57 62.16 0.38 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.38 166.47 12.16 Favored Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.724 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.545 ' O ' HG11 ' X' ' 76' ' ' VAL . 15.9 Cg_endo -57.02 -34.51 97.79 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 124.157 3.238 . . . . 0.0 113.664 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.486 ' C ' HG22 ' X' ' 76' ' ' VAL . 41.5 mt-10 -82.73 2.11 35.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.912 0.386 . . . . 0.0 112.024 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.59 -27.76 6.62 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.268 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' X' ' 78' ' ' GLU . 0.0 OUTLIER -66.23 -34.05 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.545 HG11 ' O ' ' X' ' 72' ' ' PRO . 29.2 m -64.7 -34.79 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.254 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.951 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.571 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 41.7 ttmt -64.79 -43.6 92.68 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 7.6 mm-40 -57.79 -45.09 86.54 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.978 0.894 . . . . 0.0 109.084 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 22.6 mm -62.34 -46.62 95.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.787 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -67.17 -35.64 80.09 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.69 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -69.26 -32.04 70.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.545 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.9 t90 -70.08 -48.58 57.13 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.122 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.424 ' HE ' ' HB2' ' X' ' 83' ' ' ARG . 0.0 OUTLIER -65.95 -37.2 85.41 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.591 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.77 90.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.785 0.678 . . . . 0.0 111.652 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.76 -44.88 39.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.95 0.405 . . . . 0.0 110.695 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.5 -33.93 73.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.208 0.528 . . . . 0.0 110.665 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.65 30.86 6.3 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -103.48 163.35 17.61 Favored Pre-proline 0 N--CA 1.405 -2.689 0 C-N-CA 124.042 0.937 . . . . 0.0 109.651 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 36.3 Cg_exo -62.47 131.05 32.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.913 2.409 . . . . 0.0 113.07 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.86 -150.56 24.4 Favored Glycine 0 N--CA 1.429 -1.815 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.529 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -85.42 150.02 25.01 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' X' ' 8' ' ' SER . 20.0 ptmt -77.89 165.14 24.49 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.32 133.02 36.24 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.256 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.604 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 CA--C 1.506 -0.726 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.479 ' CD2' HD11 ' X' ' 18' ' ' LEU . 31.9 mt -91.99 129.81 37.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.073 0.464 . . . . 0.0 110.443 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -96.37 -162.34 0.95 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -115.05 -24.49 8.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.358 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.7 p -134.61 166.81 22.05 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -65.33 -15.18 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.381 0.672 . . . . 0.0 110.725 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 8' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 16.6 t -76.53 -20.64 56.69 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.882 -170.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 6.87 37.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 118.297 -1.361 . . . . 0.0 109.673 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.21 122.63 34.0 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.105 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.0 p -82.87 167.73 17.77 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.616 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.42 -42.92 92.94 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.189 -1.404 . . . . 0.0 111.85 176.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.426 ' O ' HG23 ' X' ' 16' ' ' VAL . . . -67.34 -38.76 85.37 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -59.13 -39.13 81.38 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.643 0.735 . . . . 0.0 110.1 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.662 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -74.78 -42.15 58.7 Favored 'General case' 0 N--CA 1.407 -2.581 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.017 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.616 HG13 ' O ' ' X' ' 12' ' ' GLU . 8.9 m -62.62 -32.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.41 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' X' ' 21' ' ' GLU . 20.5 tp60 -62.33 -43.98 97.56 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.629 ' O ' HG13 ' X' ' 22' ' ' ILE . 36.8 tp -61.71 -46.54 89.25 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-O 121.253 0.549 . . . . 0.0 109.974 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -57.32 -41.93 80.88 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.765 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.4 mttm -64.28 -41.97 96.65 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.22 0.534 . . . . 0.0 109.648 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' X' ' 17' ' ' GLN . 43.5 mt-10 -66.21 -38.1 87.16 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.042 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.629 HG13 ' O ' ' X' ' 18' ' ' LEU . 47.4 mt -60.15 -46.06 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.348 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.27 -43.58 88.03 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.365 0.602 . . . . 0.0 110.23 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . 0.492 ' HG3' ' OE2' ' X' ' 25' ' ' GLU . 26.1 tptp -59.5 -50.42 73.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.846 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.492 ' OE2' ' HG3' ' X' ' 24' ' ' LYS . 16.0 mm-40 -86.15 -5.61 59.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.339 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -79.23 -44.89 20.9 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.53 -32.39 52.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.256 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -19.67 42.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.752 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.83 80.87 0.19 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.343 1.457 . . . . 0.0 112.911 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 77.0 p -106.77 -169.49 1.56 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.47 -26.33 0.76 Allowed 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.098 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.461 ' O ' HG22 ' X' ' 36' ' ' VAL . 16.6 m-20 -67.28 -57.9 5.81 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.621 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.737 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.53 -31.12 7.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.132 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.9 tm? -59.48 -46.03 89.97 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.974 -175.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -32.34 72.98 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.206 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.461 HG22 ' O ' ' X' ' 32' ' ' ASP . 38.3 t -66.33 -49.27 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.574 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 58.0 mt -66.73 -42.65 85.95 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.0 -170.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.3 mt -59.42 -47.84 83.93 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.541 1.151 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.42 -42.55 71.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.56 ' O ' HG12 ' X' ' 44' ' ' ILE . 22.8 t60 -59.46 -45.55 91.3 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.506 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.596 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.12 -55.12 37.84 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.879 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.534 HG13 ' O ' ' X' ' 38' ' ' LEU . 8.3 p -66.76 -31.81 55.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.3 pttp -71.27 -34.32 70.58 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.769 -0.582 . . . . 0.0 111.781 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.56 HG12 ' O ' ' X' ' 40' ' ' HIS . 23.7 pt -88.48 -29.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.511 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.479 ' HB ' HD11 ' X' ' 79' ' ' ILE . 70.1 p -84.46 -37.77 20.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.544 0.688 . . . . 0.0 109.494 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 69.04 21.56 7.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.249 1.82 . . . . 0.0 112.076 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.452 ' O ' HG22 ' X' ' 42' ' ' VAL . 48.7 t-80 -72.23 132.96 83.76 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.507 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 31.5 Cg_exo -66.74 -21.3 51.56 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.149 2.566 . . . . 0.0 112.146 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -122.44 35.69 4.82 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.596 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.12 -55.3 8.79 Favored Glycine 1 CA--C 1.448 -4.124 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.585 -178.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.469 ' CG2' HD12 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.24 -34.51 68.34 Favored 'General case' 0 C--N 1.255 -3.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.208 -173.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.56 -29.37 70.64 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.653 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.4 mt -61.42 -42.68 99.13 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.413 HD12 HG22 ' X' ' 22' ' ' ILE . 10.5 mt -66.59 -42.54 90.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -63.02 -44.67 95.3 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.802 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.9 pt-20 -69.8 -39.3 76.63 Favored 'General case' 0 C--O 1.201 -1.48 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.635 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.51 83.8 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 122.26 0.224 . . . . 0.0 111.279 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.28 -48.05 81.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.756 0.66 . . . . 0.0 110.428 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.95 87.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.293 0.568 . . . . 0.0 110.453 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -63.6 -33.24 75.18 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.143 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -79.39 -30.15 42.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.732 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.06 -39.51 82.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.387 0.613 . . . . 0.0 109.8 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.11 3.46 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 58.26 86.74 0.15 Allowed Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 126.213 1.805 . . . . 0.0 113.055 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.29 -37.97 28.9 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 122.265 1.977 . . . . 0.0 110.118 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.68 175.65 14.2 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.83 -95.99 0.93 Allowed Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.015 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -129.26 16.98 6.06 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 80.37 1.14 Allowed Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 114.807 -1.088 . . . . 0.0 114.079 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.72 -172.61 18.51 Favored Glycine 0 N--CA 1.428 -1.897 0 O-C-N 124.015 0.48 . . . . 0.0 112.391 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 90.25 160.64 36.72 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 124.257 0.622 . . . . 0.0 112.637 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.537 ' O ' HG13 ' X' ' 75' ' ' ILE . 29.1 Cg_endo -61.8 -37.5 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.254 2.636 . . . . 0.0 110.992 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.14 0.69 18.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.764 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.27 -8.87 26.59 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.008 174.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.537 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -73.82 -45.43 49.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.489 HG13 HG11 ' X' ' 16' ' ' VAL . 1.2 p -57.71 -42.16 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.966 175.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttp -58.52 -47.86 82.77 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.747 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.4 -39.12 89.58 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' X' ' 45' ' ' THR . 41.8 mm -67.86 -46.34 82.37 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.832 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.6 pttp -63.72 -36.29 83.39 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.384 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.85 -38.82 70.04 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.874 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.507 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 66.7 t90 -69.75 -47.79 61.69 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.016 0.436 . . . . 0.0 110.025 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.572 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 14.5 tpt180 -60.35 -45.52 93.2 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.0 89.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.704 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.28 92.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.163 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -64.67 -32.56 74.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.78 4.84 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.572 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 64.5 mttm -112.83 144.58 31.3 Favored Pre-proline 0 N--CA 1.388 -3.542 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -64.22 139.3 65.52 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.093 1.862 . . . . 0.0 109.31 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -109.38 -125.23 5.03 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.31 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.419 ' CZ ' HG21 ' X' ' 76' ' ' VAL . 76.9 m-85 -82.86 152.53 25.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.665 -0.768 . . . . 0.0 111.2 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' X' ' 8' ' ' SER . 19.8 ptmt -83.59 -179.27 7.29 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.49 140.07 30.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.884 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.405 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 71.2 mt -91.32 128.29 37.08 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -97.83 -174.7 2.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.87 -9.17 14.07 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.237 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -144.47 164.89 29.52 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -70.79 -8.7 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.444 0.64 . . . . 0.0 110.688 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -76.81 -25.82 53.71 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.02 -11.94 21.04 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.406 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.405 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 8.7 m-85 -72.99 118.11 15.53 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.31 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 76.0 p -78.4 162.0 26.73 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 169.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.636 ' O ' HG11 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.05 -45.28 79.27 Favored 'General case' 0 C--N 1.28 -2.42 0 O-C-N 123.571 0.544 . . . . 0.0 111.015 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.427 ' HA ' HG23 ' X' ' 16' ' ' VAL . . . -69.49 -38.23 77.58 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -57.44 -37.5 72.92 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 118.436 0.562 . . . . 0.0 110.107 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.722 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 5.7 t80 -80.0 -45.38 18.51 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.751 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.636 HG11 ' O ' ' X' ' 12' ' ' GLU . 11.7 m -58.82 -31.78 45.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.043 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.86 -47.19 78.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.939 0.896 . . . . 0.0 109.79 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.486 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -62.75 -41.77 99.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.01 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -61.34 -37.77 84.5 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.519 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 56.6 mttp -64.47 -36.0 82.77 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.439 0.638 . . . . 0.0 109.578 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.74 -32.82 73.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.905 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.486 HG13 ' O ' ' X' ' 18' ' ' LEU . 34.1 mt -64.92 -41.49 92.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -57.49 -46.14 84.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.786 0.803 . . . . 0.0 108.841 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -60.06 -45.36 93.13 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.929 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.599 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -85.24 -29.61 24.5 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.178 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.67 -34.88 79.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.781 0.324 . . . . 0.0 111.359 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.7 m -77.27 -12.59 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.07 -22.68 16.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.56 85.72 0.14 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.127 1.771 . . . . 0.0 112.043 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -106.1 172.26 6.9 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -135.91 8.67 3.27 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.642 170.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.446 ' O ' HG21 ' X' ' 36' ' ' VAL . 26.1 m-20 -91.16 -70.66 0.67 Allowed 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.7 p -74.66 -30.69 25.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.978 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.599 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 3.0 tm? -58.3 -46.03 86.87 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.13 -32.8 74.18 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.282 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.446 HG21 ' O ' ' X' ' 32' ' ' ASP . 75.9 t -64.8 -50.12 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 68.6 mt -68.66 -41.77 78.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.858 -171.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 7.0 mt -61.17 -46.64 89.66 Favored 'General case' 0 N--CA 1.418 -2.063 0 O-C-N 124.102 0.876 . . . . 0.0 110.915 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.18 -42.35 72.55 Favored 'General case' 0 N--CA 1.433 -1.283 0 O-C-N 123.418 0.449 . . . . 0.0 110.884 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.472 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 25.3 t60 -59.57 -45.34 92.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 123.68 0.792 . . . . 0.0 110.595 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.406 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 34.2 t80 -61.02 -55.32 34.23 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.156 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.468 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.3 p -67.3 -31.65 53.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 0.0 OUTLIER -69.68 -39.26 77.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 122.232 -0.293 . . . . 0.0 111.772 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.606 HD11 ' CE1' ' X' ' 15' ' ' PHE . 49.9 pt -80.97 -30.63 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.941 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -85.02 -35.09 22.16 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.76 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 61.76 28.15 17.28 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -77.18 139.53 64.96 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.435 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.474 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 20.3 Cg_exo -70.41 -19.3 33.2 Favored 'Trans proline' 0 CA--C 1.495 -1.432 0 C-N-CA 123.087 2.525 . . . . 0.0 112.488 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.423 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 14.4 m-20 -127.23 40.98 3.61 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.406 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -51.22 -51.77 34.69 Favored Glycine 0 CA--C 1.466 -2.976 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.978 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.403 ' O ' ' HD2' ' X' ' 55' ' ' TYR 0.35 0.6 OUTLIER -80.99 -25.06 37.54 Favored 'General case' 0 C--N 1.256 -3.497 0 C-N-CA 117.48 -1.688 . . . . 0.0 114.165 -174.512 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' X' ' 49' ' ' ASP . . . -61.2 -41.12 96.26 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.12 -46.52 88.12 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.292 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 31.1 mt -67.07 -47.54 81.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 CA-C-O 121.344 0.592 . . . . 0.0 110.736 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.403 ' HD2' ' O ' ' X' ' 51' ' ' THR . 14.0 m-85 -59.8 -49.06 79.2 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.359 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.35 -40.7 96.38 Favored 'General case' 0 C--O 1.174 -2.917 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.769 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . 0.422 ' HB1' ' CG2' ' X' ' 75' ' ' ILE . . . -57.54 -47.96 80.62 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 118.412 0.551 . . . . 0.0 111.296 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.6 85.44 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.651 0.594 . . . . 0.0 110.823 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.7 -43.54 62.91 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.997 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 97.5 mtt180 -66.01 -31.77 72.85 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.099 0.959 . . . . 0.0 111.454 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.46 27.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.098 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.3 27.49 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.243 0.544 . . . . 0.0 110.909 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' X' ' 65' ' ' PRO . . . -109.75 79.57 1.23 Allowed 'General case' 0 CA--C 1.477 -1.863 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 173.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 27.2 t-20 -81.37 112.93 37.66 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.364 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' X' ' 63' ' ' ALA . 66.5 Cg_endo -96.04 10.83 1.42 Allowed 'Trans proline' 0 N--CA 1.437 -1.825 0 C-N-CA 122.35 2.033 . . . . 0.0 110.165 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 143.28 14.62 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.07 -176.44 48.02 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 118.489 -1.815 . . . . 0.0 114.032 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -110.7 -33.94 6.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.045 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -122.9 57.92 0.63 Allowed Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.64 67.72 0.22 Allowed Glycine 0 N--CA 1.415 -2.731 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.44 16.52 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.42 -24.63 56.87 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.196 3.264 . . . . 0.0 113.316 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.437 ' HA ' ' CG2' ' X' ' 76' ' ' VAL . 33.5 mt-10 -96.32 1.41 51.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.026 0.441 . . . . 0.0 109.937 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -103.34 -31.65 4.88 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.602 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.487 ' CD1' HD13 ' X' ' 19' ' ' LEU . 5.3 pt -65.43 -32.55 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 O-C-N 122.277 -0.543 . . . . 0.0 111.616 175.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' X' ' 19' ' ' LEU . 0.2 OUTLIER -65.56 -32.23 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.469 176.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 59.6 tttm -66.7 -45.67 78.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.84 -44.76 86.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.376 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.45 -46.81 88.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.079 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -69.39 -36.29 76.64 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.472 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.5 mt-10 -71.37 -37.21 71.65 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.474 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.8 t90 -66.55 -47.25 73.43 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.923 0.868 . . . . 0.0 109.719 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -61.28 -46.1 91.73 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.771 -176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.2 81.64 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.79 -45.62 93.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.954 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.409 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 23.5 t-20 -69.25 -39.0 78.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.2 37.68 2.63 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.409 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 67.7 mttm -109.18 147.16 35.39 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.55 131.36 37.67 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.527 2.151 . . . . 0.0 111.785 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.35 -144.14 15.37 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.182 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -78.17 145.82 35.4 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 111.33 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' X' ' 93' ' ' GLN . 5.3 tttt -86.28 163.03 17.96 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . 0.465 ' N ' ' HG3' ' X' ' 92' ' ' LYS 0.251 13.6 mt-30 -88.87 131.01 35.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.633 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.925 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 174.809 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' X' ' 40' ' ' HIS . 66.5 mt -100.27 138.78 36.87 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.979 0.419 . . . . 0.0 110.906 -178.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -102.08 -159.16 0.71 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 174.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -116.33 -28.49 6.49 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.703 0.763 . . . . 0.0 109.499 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 65.0 p -132.74 166.83 21.31 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.652 177.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' X' ' 91' ' ' PHE . 10.9 tp -70.81 -15.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.533 0.683 . . . . 0.0 110.68 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -77.74 -9.0 58.77 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.27 3.67 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -94.8 115.51 27.59 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.646 -174.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 76.1 p -76.06 156.86 33.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 167.168 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.649 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.7 pt-20 -60.84 -30.61 70.21 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' X' ' 16' ' ' VAL . . . -70.68 -38.88 73.78 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.113 0.415 . . . . 0.0 111.382 175.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 10.1 mm-40 -57.46 -39.02 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.606 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.4 t80 -71.54 -49.01 44.88 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.584 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.649 HG13 ' O ' ' X' ' 12' ' ' GLU . 5.0 m -62.6 -30.04 48.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.731 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' X' ' 21' ' ' GLU . 6.6 tt0 -63.0 -49.01 76.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.57 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.1 tm? -58.75 -44.71 90.62 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.56 177.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 33.0 mt -58.12 -42.21 85.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.163 176.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.6 mttm -67.78 -35.04 77.96 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.172 176.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' X' ' 17' ' ' GLN . 45.3 mt-10 -67.24 -37.68 83.95 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.681 176.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.57 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.6 mt -62.13 -43.72 98.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 0.9 OUTLIER -58.06 -47.68 82.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.621 1.168 . . . . 0.0 109.883 176.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.61 -52.04 59.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.427 -176.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.03 -25.95 64.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -70.94 -50.35 35.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.51 177.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.45 -11.68 13.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.14 -19.12 21.08 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 76.42 0.28 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.878 1.271 . . . . 0.0 111.275 -176.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -95.79 -25.67 15.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.168 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 66.41 -64.46 0.22 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 126.19 1.796 . . . . 0.0 114.721 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.45 ' O ' HG21 ' X' ' 36' ' ' VAL . 8.1 p-10 -63.97 -48.57 75.95 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -83.13 -29.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.838 -177.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.514 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -41.84 90.14 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.692 175.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.61 -36.19 82.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.45 HG21 ' O ' ' X' ' 32' ' ' ASP . 99.3 t -57.57 -48.42 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.965 0 O-C-N 123.835 0.709 . . . . 0.0 109.218 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 43.9 mt -68.07 -43.12 79.3 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.447 -174.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.8 mt -58.89 -49.5 77.55 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 124.11 0.881 . . . . 0.0 111.173 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -68.47 -39.06 81.55 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.231 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.612 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 46.3 t60 -65.98 -45.26 82.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.094 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.578 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.5 t80 -55.29 -52.1 64.53 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.886 177.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.9 -32.83 58.09 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 21.0 ptmt -71.33 -33.22 69.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.934 -0.479 . . . . 0.0 112.118 -178.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.591 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.3 pt -83.08 -34.58 11.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.283 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 66.7 p -84.32 -38.73 20.02 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 63.97 27.23 14.29 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 109.983 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' X' ' 49' ' ' ASP . 37.4 t-80 -70.75 136.36 85.56 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 113.762 -1.563 . . . . 0.0 106.82 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.421 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 8.8 Cg_exo -76.73 6.03 4.42 Favored 'Trans proline' 0 CA--C 1.482 -2.088 0 C-N-CA 122.89 2.394 . . . . 0.0 112.686 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.482 ' CG ' ' HB2' ' X' ' 52' ' ' ALA . 24.9 t70 -144.76 32.21 1.15 Allowed 'General case' 0 N--CA 1.39 -3.448 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 -173.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.578 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.48 -62.53 3.93 Favored Glycine 1 CA--C 1.449 -4.036 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.43 -176.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.443 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.437 1.6 p -82.72 -13.33 56.54 Favored 'General case' 0 N--CA 1.386 -3.664 0 C-N-CA 116.46 -2.096 . . . . 0.0 115.267 -177.649 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.655 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -72.09 -29.87 64.54 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 117.863 -1.535 . . . . 0.0 108.814 174.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -60.55 -43.52 97.12 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.599 0.562 . . . . 0.0 110.961 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.48 -47.18 81.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.139 0.971 . . . . 0.0 109.672 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -63.57 -44.33 94.41 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.897 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -67.82 -35.77 79.21 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.38 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.27 -42.34 81.46 Favored 'General case' 0 CA--C 1.5 -0.973 0 O-C-N 123.059 0.224 . . . . 0.0 111.093 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.49 93.93 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.74 0.65 . . . . 0.0 110.667 178.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.8 75.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.553 0.692 . . . . 0.0 110.802 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -64.27 -37.3 87.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.948 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.04 61.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.937 0.495 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.31 77.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.157 0.503 . . . . 0.0 109.934 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.78 8.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.233 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 63.65 92.46 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 113.05 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.75 177.59 8.23 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.653 2.235 . . . . 0.0 110.385 173.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.67 175.45 52.1 Favored Glycine 0 CA--C 1.497 -1.047 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.756 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.26 -131.09 19.64 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.22 85.26 6.89 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.43 176.19 48.1 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.474 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.59 136.45 39.01 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.44 171.53 29.8 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.421 ' O ' HG12 ' X' ' 75' ' ' ILE . 14.8 Cg_endo -58.98 -48.43 14.36 Favored 'Trans proline' 0 C--O 1.207 -1.052 0 C-N-CA 124.071 3.181 . . . . 0.0 113.57 -176.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.93 0.57 17.91 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.985 -0.447 . . . . 0.0 112.183 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.56 -23.9 5.51 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.776 175.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.451 HG13 HD12 ' X' ' 19' ' ' LEU . 4.1 pt -69.92 -31.91 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 122.09 -0.653 . . . . 0.0 110.313 176.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.507 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 0.5 OUTLIER -61.7 -41.81 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-O 122.257 1.027 . . . . 0.0 110.737 173.852 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.426 ' H ' HG13 ' X' ' 76' ' ' VAL . 53.1 tttm -58.4 -42.29 86.83 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.228 176.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.07 -33.54 76.28 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.629 0.728 . . . . 0.0 109.566 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.401 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.9 mm -70.69 -45.94 71.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.144 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -62.5 -36.44 82.55 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.032 -177.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.56 -44.2 78.8 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.354 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 90.4 t90 -66.8 -48.86 67.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -176.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -71.44 -39.62 70.89 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.558 -174.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.16 -43.37 78.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.862 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -69.45 -30.38 68.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.97 29.53 7.19 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -117.08 141.08 27.87 Favored Pre-proline 0 N--CA 1.393 -3.296 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.53 118.77 5.25 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.476 2.784 . . . . 0.0 112.022 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.16 -124.63 4.33 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.6 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.0 m-85 -85.88 159.02 19.8 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.081 -178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -89.71 172.95 8.56 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -120.82 134.28 55.29 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.248 0.547 . . . . 0.0 111.862 -175.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.317 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 177.879 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.424 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 26.6 mt -92.28 128.67 38.21 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.063 0.459 . . . . 0.0 111.029 -175.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.426 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 36.7 mmtt -98.3 -159.57 0.75 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -113.03 -30.88 6.85 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.722 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.1 p -126.2 166.19 17.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.21 -18.72 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.781 0.801 . . . . 0.0 109.763 -177.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -75.09 -17.75 60.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.364 -172.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 36.3 t0 -102.73 5.21 38.76 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 122.255 1.026 . . . . 0.0 108.919 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.424 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 9.3 m-85 -96.46 125.11 40.72 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.632 -176.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.4 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 67.9 p -88.08 172.53 9.46 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.645 ' O ' HG11 ' X' ' 16' ' ' VAL . 8.4 pt-20 -62.02 -41.4 98.04 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.669 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.45 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.75 -37.86 76.59 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' X' ' 11' ' ' THR . 43.5 mm-40 -60.85 -40.19 91.96 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.287 0.565 . . . . 0.0 109.69 174.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.658 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 26.7 t80 -71.74 -45.4 61.86 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.208 -178.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.645 HG11 ' O ' ' X' ' 12' ' ' GLU . 13.6 m -61.88 -28.86 45.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.61 -46.78 86.71 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.614 ' O ' HG13 ' X' ' 22' ' ' ILE . 35.1 tp -60.86 -45.68 93.57 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.587 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 42.1 mt -57.67 -39.54 77.34 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 82.6 mttt -71.68 -38.7 70.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.101 176.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 73.7 mm-40 -60.72 -44.74 96.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.625 176.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.614 HG13 ' O ' ' X' ' 18' ' ' LEU . 48.1 mt -57.83 -46.1 87.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 O-C-N 123.967 0.792 . . . . 0.0 111.328 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.471 ' O ' HG21 ' X' ' 27' ' ' VAL . 44.5 mt-10 -57.61 -47.88 80.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.387 0.613 . . . . 0.0 110.894 -176.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -60.61 -43.03 97.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.766 -174.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 3.0 pp20? -89.02 -34.04 16.95 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.566 -177.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -60.04 -46.7 88.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.747 0.419 . . . . 0.0 111.798 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . 0.471 HG21 ' O ' ' X' ' 23' ' ' GLU . 31.2 m -79.55 0.6 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.164 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.37 0.19 12.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.239 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 44.95 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.067 1.747 . . . . 0.0 113.537 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 74.1 p -98.41 -24.38 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.493 . . . . 0.0 111.659 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 68.01 -59.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.245 1.418 . . . . 0.0 113.985 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.596 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 t70 -58.88 -61.39 2.66 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.699 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -82.24 -25.03 9.1 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.453 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.9 tm? -58.64 -50.09 75.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.352 176.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.47 -33.8 76.51 Favored 'General case' 0 CA--C 1.483 -1.61 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.784 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.596 HG23 ' O ' ' X' ' 32' ' ' ASP . 40.2 t -65.75 -50.23 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.623 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 40.7 mt -69.04 -43.66 74.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 O-C-N 124.442 1.089 . . . . 0.0 111.379 -172.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.489 ' O ' HG12 ' X' ' 42' ' ' VAL . 34.1 mt -61.54 -45.29 94.78 Favored 'General case' 0 N--CA 1.421 -1.878 0 O-C-N 124.163 0.914 . . . . 0.0 111.571 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.49 -41.57 72.49 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.253 177.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.533 ' O ' HG12 ' X' ' 44' ' ' ILE . 16.0 t60 -62.3 -45.9 91.16 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.466 0.478 . . . . 0.0 109.92 -175.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.492 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 43.7 t80 -58.25 -53.18 61.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.295 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.489 HG12 ' O ' ' X' ' 38' ' ' LEU 0.285 14.5 p -67.86 -31.62 52.94 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.891 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.8 pttp -69.14 -32.27 71.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.745 -0.597 . . . . 0.0 111.991 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.533 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.7 pt -85.17 -35.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.869 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 61.1 p -84.22 -35.43 23.47 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 58.25 30.73 19.91 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.195 1.398 . . . . 0.0 111.325 -176.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -77.14 134.66 67.29 Favored Pre-proline 0 N--CA 1.423 -1.788 0 CA-C-N 114.024 -1.444 . . . . 0.0 107.862 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.495 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.1 Cg_exo -71.0 -2.27 10.8 Favored 'Trans proline' 0 CA--C 1.493 -1.541 0 C-N-CA 123.362 2.708 . . . . 0.0 112.805 -175.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -138.21 29.84 2.47 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -173.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.99 -61.05 3.64 Favored Glycine 1 CA--C 1.45 -4.017 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.946 -176.48 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.471 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -28.44 57.65 Favored 'General case' 0 C--N 1.248 -3.837 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.252 -172.5 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.76 -40.47 95.25 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.026 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.3 mt -56.32 -44.5 80.01 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.731 0.644 . . . . 0.0 112.087 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -66.63 -45.24 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.276 -177.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.425 ' HD2' ' O ' ' X' ' 51' ' ' THR . 29.7 m-85 -61.01 -49.31 77.93 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.74 -178.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.5 pt-20 -70.29 -36.28 74.25 Favored 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.638 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.652 0.206 . . . . 0.0 111.319 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.25 92.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 178.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -43.52 62.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.88 178.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 63.7 mtp180 -61.0 -30.92 70.58 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.684 1.193 . . . . 0.0 111.363 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.91 -45.78 17.97 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.2 176.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.91 81.55 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.173 -177.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.37 75.24 0.95 Allowed 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 174.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 16.0 t-20 -72.94 118.67 70.3 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.257 -177.024 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -92.56 27.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.122 2.548 . . . . 0.0 111.759 -178.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 45.1 7.65 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -174.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.09 172.66 20.98 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -176.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -128.91 157.78 40.63 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.94 -3.24 31.77 Favored Glycine 0 CA--C 1.494 -1.249 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.613 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.74 83.82 1.61 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.59 170.06 22.0 Favored Glycine 0 N--CA 1.406 -3.307 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.471 ' O ' HG11 ' X' ' 76' ' ' VAL . 25.7 Cg_endo -65.0 -50.98 1.81 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 123.085 2.524 . . . . 0.0 110.956 -176.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.85 1.68 6.66 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.55 -29.16 3.48 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.065 174.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.444 ' O ' HG12 ' X' ' 79' ' ' ILE . 5.2 pt -66.3 -32.98 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.248 1.024 . . . . 0.0 111.045 175.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.471 HG11 ' O ' ' X' ' 72' ' ' PRO . 0.5 OUTLIER -59.6 -43.64 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-O 121.998 0.904 . . . . 0.0 110.327 173.177 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 54.4 tttp -58.42 -46.13 87.08 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.551 175.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -67.21 -30.71 70.72 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.444 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.4 mm -68.21 -45.99 81.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 175.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -64.02 -36.11 82.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.726 0.298 . . . . 0.0 110.699 -176.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.31 -32.31 70.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.837 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.495 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 76.2 t90 -72.16 -44.1 63.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.77 -43.08 98.49 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.775 -176.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.44 84.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.821 178.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.22 99.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.359 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.477 ' ND2' ' HE2' ' X' ' 88' ' ' LYS . 3.5 t30 -73.46 -34.1 65.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.59 47.73 2.91 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.477 ' HE2' ' ND2' ' X' ' 86' ' ' ASN . 60.1 mttm -118.77 147.94 43.35 Favored Pre-proline 0 N--CA 1.4 -2.942 0 C-N-CA 123.234 0.614 . . . . 0.0 109.863 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.1 130.83 28.44 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.309 2.006 . . . . 0.0 110.477 175.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.27 -126.59 5.58 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.465 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -81.27 156.7 25.45 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.108 -174.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -94.57 174.28 7.2 Favored 'General case' 0 N--CA 1.389 -3.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.08 141.73 35.71 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.775 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.236 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.421 HD21 HD13 ' X' ' 18' ' ' LEU . 22.6 mt -91.8 127.82 37.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.149 0.499 . . . . 0.0 110.6 -177.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 37.7 mmtt -102.8 -179.96 4.11 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.203 -175.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.0 -24.79 16.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.325 0.583 . . . . 0.0 109.741 178.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.4 p -142.02 162.93 34.23 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.079 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -67.3 -17.92 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.24 1.016 . . . . 0.0 111.341 -176.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 75.8 m -86.6 -3.09 58.98 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.49 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 25.6 t0 -103.56 4.44 35.78 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 9.7 m-85 -99.0 121.06 40.46 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.6 -177.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 73.7 p -79.18 167.08 21.48 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 169.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.621 ' O ' HG11 ' X' ' 16' ' ' VAL . 6.4 pt-20 -56.52 -42.65 78.78 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.629 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.1 -38.31 75.6 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -59.0 -37.65 77.36 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.363 0.601 . . . . 0.0 110.12 174.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.687 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -73.42 -42.8 61.61 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.621 HG11 ' O ' ' X' ' 12' ' ' GLU . 3.9 m -62.99 -29.05 46.28 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.447 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.978 178.177 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -61.01 -46.75 89.47 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.618 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.1 tp -61.34 -47.23 86.82 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 175.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.1 mt -58.21 -38.54 76.99 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.158 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 68.3 mttm -71.55 -34.83 70.34 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.659 176.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.85 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.618 HG13 ' O ' ' X' ' 18' ' ' LEU . 60.9 mt -62.92 -42.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.429 ' O ' HG21 ' X' ' 27' ' ' VAL . 1.6 tt0 -58.14 -44.45 87.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.242 174.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -59.11 -48.69 80.68 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.384 1.074 . . . . 0.0 109.567 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.8 -26.75 49.85 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.357 -178.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -80.01 -41.41 25.87 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 122.157 -0.34 . . . . 0.0 111.81 -179.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . 0.429 HG21 ' O ' ' X' ' 23' ' ' GLU . 33.0 m -70.52 -20.84 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.845 -179.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.93 -16.85 18.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.39 76.13 0.31 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.161 1.384 . . . . 0.0 111.969 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.8 p -96.37 -168.81 1.8 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.87 -43.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.943 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.486 ' O ' HG21 ' X' ' 36' ' ' VAL . 23.6 t70 -64.89 -53.02 53.19 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.671 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 79.4 t -87.15 -27.12 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.604 -178.106 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.04 -46.53 87.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.05 -20.6 61.65 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.486 HG21 ' O ' ' X' ' 32' ' ' ASP . 54.7 t -70.86 -49.77 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 C-N-CA 118.563 -1.255 . . . . 0.0 108.286 175.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 63.3 mt -68.29 -41.68 80.59 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 113.756 -1.565 . . . . 0.0 112.345 -170.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.5 mt -59.28 -44.57 92.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 124.151 0.907 . . . . 0.0 110.517 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.53 -45.0 63.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.71 177.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.59 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 20.2 t60 -59.33 -45.48 91.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.2 -175.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.587 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 39.6 t80 -60.49 -50.83 72.02 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.877 178.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.87 -32.19 55.38 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.538 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -179.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -69.53 -33.77 73.27 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.998 -0.439 . . . . 0.0 111.925 -178.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.477 HG12 ' O ' ' X' ' 40' ' ' HIS . 11.7 pt -85.07 -31.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 -178.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 53.2 p -84.77 -32.26 23.51 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.255 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 58.45 31.89 21.49 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.652 1.181 . . . . 0.0 109.949 -177.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.416 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 33.8 t-80 -82.52 135.14 46.86 Favored Pre-proline 0 N--CA 1.424 -1.774 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.441 -178.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.51 -12.33 31.29 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 123.068 2.512 . . . . 0.0 112.681 -176.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.416 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 9.0 m-20 -130.51 30.28 4.72 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.587 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.38 -58.69 5.69 Favored Glycine 0 CA--C 1.453 -3.805 0 CA-C-N 114.491 -1.231 . . . . 0.0 113.277 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.45 HG23 HD13 ' X' ' 38' ' ' LEU . 1.5 m -79.09 -23.3 44.23 Favored 'General case' 0 C--N 1.251 -3.707 0 C-N-CA 117.944 -1.502 . . . . 0.0 110.759 -172.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.53 67.15 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 175.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 28.3 mt -66.67 -37.28 84.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.627 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mt -66.37 -42.79 91.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.891 0.853 . . . . 0.0 108.827 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -62.72 -43.35 99.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.083 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.89 -40.09 75.88 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.048 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.67 81.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.97 99.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.595 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.02 68.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.408 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -60.75 -40.19 91.53 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.623 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' CA ' ' X' ' 71' ' ' GLY . . . -75.82 -32.18 59.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.637 0.256 . . . . 0.0 111.188 177.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.23 88.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.1 179.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.13 14.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 61.81 89.1 0.11 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 111.082 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.96 176.16 10.26 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 122.603 2.202 . . . . 0.0 112.048 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.01 72.15 2.65 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.76 172.17 13.24 Favored Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 t70 73.64 -53.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.951 1.3 . . . . 0.0 111.909 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.97 -46.16 1.21 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.72 -46.85 2.09 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.472 ' CA ' ' HB1' ' X' ' 61' ' ' ALA . . . -82.09 -134.93 1.99 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 -172.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.563 ' O ' HG13 ' X' ' 75' ' ' ILE . 12.8 Cg_endo -54.1 -45.44 41.0 Favored 'Trans proline' 0 C--O 1.212 -0.804 0 C-N-CA 123.959 3.106 . . . . 0.0 114.077 -171.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -74.15 1.35 11.41 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.64 -6.25 25.19 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 119.901 -1.142 . . . . 0.0 112.769 174.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.563 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.0 OUTLIER -77.04 -43.68 31.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.242 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.481 HG12 HG12 ' X' ' 16' ' ' VAL . 1.2 p -58.22 -43.18 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.989 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 87.8 tttt -58.58 -48.15 81.89 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.393 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.35 -39.46 90.68 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.791 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.5 -45.31 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.278 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.9 pttp -62.34 -36.24 81.6 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -70.78 -36.23 72.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.134 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -70.2 -47.86 59.66 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.768 0.794 . . . . 0.0 108.877 178.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 13.6 tpt180 -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.783 -175.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.25 -43.08 78.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.175 0.59 . . . . 0.0 111.723 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -30.85 71.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -78.06 -37.4 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.08 33.63 5.68 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.345 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 20.2 mtpp -113.95 143.34 29.43 Favored Pre-proline 0 N--CA 1.4 -2.957 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -176.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 128.12 22.59 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.972 2.448 . . . . 0.0 111.884 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.36 -112.0 3.64 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.45 -178.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.98 166.18 14.68 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.406 -173.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -99.76 170.72 8.35 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.27 141.14 30.74 Favored 'General case' 0 N--CA 1.391 -3.409 0 CA-C-O 121.678 0.751 . . . . 0.0 109.571 178.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.109 0 N-CA-C 107.374 -2.29 . . . . 0.0 107.374 178.987 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 85.0 mt -95.75 127.4 41.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 176.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.1 mmtt -104.14 142.33 34.68 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -75.12 -16.01 60.57 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.113 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.5 p -132.2 162.73 30.2 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.959 175.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tp -69.27 -17.84 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.717 0.807 . . . . 0.0 109.679 -177.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -19.61 59.18 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.359 -172.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 17.6 t70 -101.82 5.0 40.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.974 0.892 . . . . 0.0 109.095 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.41 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.2 m-85 -95.01 114.95 26.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.085 -174.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 70.8 p -80.42 162.36 24.49 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.576 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.5 pt-20 -56.56 -44.77 81.27 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.579 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.427 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -39.05 75.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -58.61 -38.46 78.04 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.277 0.49 . . . . 0.0 110.023 175.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -73.49 -43.12 60.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.338 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.611 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 11.0 m -62.58 -36.39 74.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.082 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.513 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -61.52 -49.46 76.63 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 109.649 177.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.482 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -61.19 -43.32 99.07 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.523 HD21 ' O ' ' X' ' 72' ' ' PRO . 3.0 mp -58.41 -36.94 74.35 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.553 -1.203 . . . . 0.0 114.046 176.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 91.4 mttt -66.26 -40.0 89.87 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.188 0.518 . . . . 0.0 109.643 176.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.78 -37.36 87.34 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.595 178.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.482 HG13 ' O ' ' X' ' 18' ' ' LEU . 26.3 mt -61.0 -45.18 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.408 ' CD ' ' HD3' ' X' ' 72' ' ' PRO . 52.6 mt-10 -58.54 -46.22 87.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.551 0.691 . . . . 0.0 110.639 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.01 -49.83 76.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.069 -175.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -71.82 -27.63 63.04 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -70.59 -53.92 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.462 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.62 -20.65 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.38 -13.98 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.543 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.87 70.25 0.6 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.297 1.039 . . . . 0.0 111.071 -176.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p -88.9 -17.56 29.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 110.951 -176.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.394 1.7 m-20 65.3 -59.55 0.27 Allowed 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 178.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.66 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.6 t70 -63.55 -57.01 11.51 Favored 'General case' 0 CA--C 1.478 -1.816 0 CA-C-N 119.817 1.19 . . . . 0.0 111.733 -176.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.719 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 44.0 t -76.42 -32.25 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.067 -177.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 1.8 tm? -58.35 -47.28 84.28 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . 0.614 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 32.8 t70 -65.02 -41.84 94.93 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.66 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.6 t -56.53 -50.03 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 O-C-N 124.224 0.953 . . . . 0.0 110.079 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.2 mt -67.65 -39.92 84.58 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.603 -172.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 43.8 mt -63.21 -49.95 72.21 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 7.3 pt-20 -71.2 -34.45 70.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.889 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.575 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 59.3 t60 -60.21 -45.49 92.98 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.42 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 63.7 t80 -60.63 -52.98 62.83 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.781 178.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.518 HG11 ' O ' ' X' ' 38' ' ' LEU 0.291 2.7 p -67.49 -32.91 59.2 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.915 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.0 ptmm? -67.17 -33.39 75.3 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.924 -0.485 . . . . 0.0 111.876 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.502 HG12 ' O ' ' X' ' 40' ' ' HIS . 17.6 pt -86.23 -36.05 9.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.833 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -84.18 -33.45 24.18 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 120.891 0.377 . . . . 0.0 111.117 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 64.05 19.34 11.71 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.266 1.427 . . . . 0.0 111.392 -176.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.412 ' O ' HG22 ' X' ' 42' ' ' VAL . 47.8 t-80 -73.0 132.22 82.98 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.522 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -70.19 -17.05 35.88 Favored 'Trans proline' 0 CA--C 1.492 -1.613 0 C-N-CA 122.833 2.355 . . . . 0.0 112.662 -172.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.447 ' HB3' ' HB1' ' X' ' 52' ' ' ALA . 5.4 m-20 -127.14 36.19 4.46 Favored 'General case' 0 N--CA 1.389 -3.508 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -173.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.42 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.48 -53.52 16.15 Favored Glycine 0 CA--C 1.454 -3.731 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.422 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.496 ' CG2' HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.43 -31.56 57.96 Favored 'General case' 0 C--N 1.247 -3.874 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.731 -173.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.88 -38.08 84.38 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.058 177.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.8 -48.45 75.35 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.477 0.486 . . . . 0.0 112.136 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.404 HG22 HG21 ' X' ' 22' ' ' ILE . 5.1 mp -67.88 -42.17 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 118.272 -1.371 . . . . 0.0 110.079 -178.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.415 ' HD2' ' O ' ' X' ' 51' ' ' THR . 27.0 m-85 -62.55 -45.51 92.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.158 -178.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.8 pt-20 -68.66 -35.92 77.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.283 176.056 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' X' ' 70' ' ' GLY . . . -57.48 -39.28 76.05 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 122.482 0.313 . . . . 0.0 110.982 178.22 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.74 87.42 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.41 78.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.834 0.826 . . . . 0.0 110.113 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -64.92 -30.34 71.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.058 178.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.45 58.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.112 0.482 . . . . 0.0 109.746 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.09 94.06 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.94 72.45 0.78 Allowed 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.456 0.646 . . . . 0.0 109.39 174.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -72.02 117.86 61.9 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.498 -177.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -85.74 -14.48 5.37 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.13 1.887 . . . . 0.0 112.181 177.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.89 177.46 14.9 Favored Glycine 0 CA--C 1.485 -1.805 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -177.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.85 -133.52 17.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.52 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -80.05 -50.45 10.34 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 175.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.17 -134.65 20.1 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' X' ' 57' ' ' ALA . . . -103.83 128.08 9.37 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 176.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.454 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 168.96 165.77 26.91 Favored Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.69 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.632 ' O ' HG12 ' X' ' 76' ' ' VAL . 12.8 Cg_endo -61.09 -43.77 27.92 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.541 2.828 . . . . 0.0 112.564 -175.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.89 0.82 16.93 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.2 -40.31 1.41 Allowed Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.381 177.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.473 HG13 ' CD2' ' X' ' 19' ' ' LEU . 3.6 pt -60.52 -29.72 45.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.169 0.485 . . . . 0.0 111.771 176.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.632 HG12 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -65.51 -45.59 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 122.327 1.061 . . . . 0.0 111.088 175.12 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 40.7 ttmt -63.07 -37.72 88.31 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.584 -1.643 . . . . 0.0 109.761 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.91 -43.74 98.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.319 0.581 . . . . 0.0 111.124 174.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.45 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.5 mm -61.24 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.912 176.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 22.3 ptmt -63.59 -36.3 83.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.963 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.6 mt-10 -64.55 -41.64 96.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.415 0.447 . . . . 0.0 110.752 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.522 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.3 t90 -68.12 -45.33 73.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.524 0.678 . . . . 0.0 109.769 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -60.91 -45.28 95.27 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.454 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.11 85.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.59 92.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.951 0.405 . . . . 0.0 110.738 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.458 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 21.7 t-20 -69.63 -41.34 75.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.726 0.774 . . . . 0.0 109.444 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.79 28.75 5.23 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.458 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 67.7 mttm -100.31 150.85 37.28 Favored Pre-proline 0 N--CA 1.402 -2.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.67 128.56 28.63 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.281 2.654 . . . . 0.0 112.152 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.21 -149.47 25.5 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.941 -177.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -79.28 159.66 27.15 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -176.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -98.73 176.31 5.67 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-O 121.723 0.773 . . . . 0.0 110.126 179.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -112.34 141.84 45.58 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.554 174.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.569 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 -179.794 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 CA--C 1.517 -0.303 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -116.94 136.37 53.0 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.503 0.502 . . . . 0.0 110.121 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 28.3 mmtt -111.68 -169.84 1.54 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -107.75 -29.18 9.25 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.628 0.727 . . . . 0.0 110.236 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -131.82 163.52 28.08 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.352 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -69.68 -13.4 17.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 CA-C-O 121.549 0.69 . . . . 0.0 110.668 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 10.8 m -72.82 -22.13 60.85 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.636 -174.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 21.9 t70 -100.57 3.4 42.67 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.165 0.983 . . . . 0.0 108.883 177.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -92.49 115.12 27.81 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.473 -176.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 65.2 p -76.53 159.18 30.58 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 171.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.646 ' O ' HG11 ' X' ' 16' ' ' VAL . 6.7 pt-20 -61.13 -35.27 76.61 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.951 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.415 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.44 -38.45 74.53 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.802 177.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.2 -40.99 83.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.12 0.962 . . . . 0.0 109.243 173.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.415 ' O ' HD13 ' X' ' 19' ' ' LEU . 41.4 t80 -69.27 -45.02 70.68 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.057 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.653 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 8.4 m -61.86 -38.75 81.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.46 -36.48 79.06 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 121.487 0.661 . . . . 0.0 111.544 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.457 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -66.92 -46.18 75.61 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.702 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.415 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.3 mp -60.13 -36.97 78.66 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.081 177.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 62.5 mttm -63.11 -35.64 80.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.477 0.656 . . . . 0.0 109.964 176.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -69.38 -33.5 73.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.632 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' X' ' 37' ' ' LEU . 9.5 mt -67.46 -40.84 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' X' ' 72' ' ' PRO . 50.9 mt-10 -57.72 -46.75 84.0 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.55 -42.81 97.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.907 -176.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -77.16 -29.05 54.31 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.164 -0.335 . . . . 0.0 111.493 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -75.42 -46.37 33.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.131 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.44 -35.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.909 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.33 -10.07 56.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 177.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.07 74.51 0.29 Allowed 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.543 1.537 . . . . 0.0 113.431 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 56.6 p -99.24 -166.27 1.33 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.34 -61.84 1.01 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.568 ' O ' HG22 ' X' ' 36' ' ' VAL . 18.5 m-20 -56.96 -50.93 71.14 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 62.0 t -88.59 -29.16 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.607 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.52 -45.65 88.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.64 -30.4 67.02 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.267 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.568 HG22 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -63.29 -49.73 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.493 176.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 77.0 mt -68.47 -43.78 76.25 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.486 -170.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 36.2 mt -61.14 -46.22 91.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 124.099 0.874 . . . . 0.0 110.428 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.44 -43.77 69.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.989 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.499 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.2 t60 -60.12 -45.71 92.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.607 -176.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' X' ' 54' ' ' ILE . 39.5 t80 -61.43 -51.49 68.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.224 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.44 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.9 p -67.7 -32.59 57.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.8 pttt -72.63 -26.59 61.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.47 HG12 ' O ' ' X' ' 40' ' ' HIS . 26.6 pt -87.26 -34.87 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.779 179.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -84.3 -31.97 24.59 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 58.06 31.71 21.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.633 1.173 . . . . 0.0 109.877 -176.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.426 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 40.9 t-80 -82.43 138.52 44.74 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 113.514 -1.675 . . . . 0.0 108.117 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -73.5 -6.42 18.73 Favored 'Trans proline' 0 CA--C 1.492 -1.593 0 C-N-CA 123.1 2.533 . . . . 0.0 112.599 -175.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.426 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 38.0 m-20 -135.63 32.19 3.04 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.584 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.73 -59.99 5.13 Favored Glycine 1 CA--C 1.445 -4.34 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.872 -176.842 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.477 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -75.18 -30.13 60.6 Favored 'General case' 1 C--N 1.242 -4.092 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.019 -172.641 . . . . . . . . 4 4 . 1 . 025 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.15 -28.13 69.85 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 28.1 mt -65.13 -43.1 93.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 175.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.618 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -67.2 -41.66 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.789 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.4 ' HD2' ' O ' ' X' ' 51' ' ' THR . 35.1 m-85 -58.27 -47.28 84.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.685 178.241 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.6 pt-20 -67.67 -36.72 81.23 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.325 175.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.53 -45.14 85.38 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.125 0.421 . . . . 0.0 111.824 -178.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.9 97.84 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.91 70.56 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.923 179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 52.0 mtp180 -64.85 -30.71 71.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.064 0.946 . . . . 0.0 111.517 177.579 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.18 16.21 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.174 175.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.34 88.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.233 0.54 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 80.23 1.52 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 5.1 t-20 -72.11 112.47 14.65 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.911 -176.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.98 -50.46 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.956 1.77 . . . . 0.0 110.518 178.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.16 172.54 31.42 Favored Glycine 0 CA--C 1.473 -2.575 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.27 52.58 4.54 Favored Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 115.384 -0.408 . . . . 0.0 112.909 -176.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -93.46 -8.81 40.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.153 0.501 . . . . 0.0 109.864 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.99 81.21 0.94 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -177.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.6 88.79 1.47 Allowed Glycine 0 N--CA 1.418 -2.508 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 177.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.473 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 147.09 -143.94 11.96 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 178.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.634 ' O ' HG13 ' X' ' 76' ' ' VAL . 12.7 Cg_endo -74.46 -46.24 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.353 2.702 . . . . 0.0 112.353 -172.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.471 ' C ' HG21 ' X' ' 76' ' ' VAL . 31.5 mt-10 -73.5 0.86 11.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -177.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.31 -34.3 2.95 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.518 172.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.514 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.8 pt -66.89 -27.11 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 117.647 0.723 . . . . 0.0 110.633 172.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.634 HG13 ' O ' ' X' ' 72' ' ' PRO . 27.6 m -62.16 -37.99 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.889 0 CA-C-O 121.689 0.757 . . . . 0.0 110.992 176.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 39.8 ttmt -65.74 -45.01 84.22 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.788 176.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -58.1 -38.05 75.71 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.57 -46.89 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.412 177.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.465 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 17.9 ptpt -66.82 -38.5 86.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.726 -175.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 46.2 mt-10 -69.69 -32.22 70.7 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.252 -178.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -72.19 -48.28 44.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.559 0.695 . . . . 0.0 109.354 177.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -61.39 -45.45 94.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.415 -174.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.42 84.3 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.04 84.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.862 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.58 -45.74 57.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.645 0.736 . . . . 0.0 109.061 177.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.35 37.5 1.94 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -112.51 143.47 29.0 Favored Pre-proline 0 N--CA 1.391 -3.387 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.51 131.23 27.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.43 2.086 . . . . 0.0 110.314 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -114.59 -115.71 3.12 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.818 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -79.18 145.93 33.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -174.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' X' ' 9' ' ' ASP . 45.8 pttt -97.38 172.4 7.79 Favored 'General case' 0 N--CA 1.384 -3.771 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.97 148.64 22.11 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 177.86 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 CA--C 1.487 -1.467 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.475 ' CD2' HD12 ' X' ' 18' ' ' LEU . 35.0 mt -91.65 131.89 36.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.421 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 35.1 mmtt -93.09 -166.73 1.58 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -118.16 -0.08 11.65 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 174.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -153.44 158.89 42.08 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.212 176.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' X' ' 10' ' ' TYR . 11.3 tt -67.4 -24.43 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.488 0.661 . . . . 0.0 110.571 -178.422 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -85.44 0.09 53.31 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.951 -174.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 5.6 t70 -104.11 -1.28 27.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' X' ' 7' ' ' ILE . 8.0 m-85 -97.53 124.61 41.83 Favored 'General case' 0 CA--C 1.472 -2.025 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.804 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 47.9 p -78.75 159.4 27.94 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.014 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.618 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.21 -41.11 75.1 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 123.321 0.388 . . . . 0.0 110.383 -179.41 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' X' ' 16' ' ' VAL . . . -69.91 -38.4 76.26 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.48 -38.9 82.05 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.737 0.779 . . . . 0.0 109.682 173.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.444 ' CD2' HG11 ' X' ' 76' ' ' VAL . 22.0 t80 -75.3 -41.73 56.28 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.73 -177.222 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.618 HG13 ' O ' ' X' ' 12' ' ' GLU . 15.1 m -62.87 -32.79 57.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 176.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -64.24 -47.33 80.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 122.912 0.485 . . . . 0.0 109.966 178.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.669 ' O ' HG13 ' X' ' 22' ' ' ILE . 19.9 tp -57.23 -47.59 80.94 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 123.873 0.733 . . . . 0.0 109.292 177.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.94 -36.82 77.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.345 177.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.573 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 97.4 mttt -61.23 -46.47 90.29 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.518 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.469 ' HA ' ' HE3' ' X' ' 24' ' ' LYS . 54.8 mt-10 -64.14 -37.81 88.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.627 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.669 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.4 mt -63.17 -44.61 99.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -65.68 -35.07 79.71 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.143 0.973 . . . . 0.0 109.423 -178.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' X' ' 21' ' ' GLU . 27.8 ttpp -72.29 -52.03 18.11 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.474 -174.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -17.33 64.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.947 0.403 . . . . 0.0 111.305 176.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -81.08 -51.38 8.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.524 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 m -73.09 -26.39 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.24 -22.01 33.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.31 78.82 0.27 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.171 1.388 . . . . 0.0 112.011 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -92.31 -28.04 17.2 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 67.79 -55.15 0.49 Allowed 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.297 1.839 . . . . 0.0 115.374 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -68.36 -47.4 67.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.737 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -85.95 -29.88 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.13 -41.27 87.84 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 177.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.0 -41.69 98.33 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 123.386 0.429 . . . . 0.0 110.02 178.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' X' ' 33' ' ' VAL . 58.2 t -59.29 -48.74 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 O-C-N 124.622 1.201 . . . . 0.0 109.47 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.2 mt -64.64 -43.22 94.37 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.662 -173.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -60.11 -50.69 72.68 Favored 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 124.119 0.887 . . . . 0.0 111.051 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -70.69 -37.5 73.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.697 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.538 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.5 t60 -59.75 -46.26 89.71 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.268 0.627 . . . . 0.0 109.644 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.556 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.9 t80 -61.8 -53.52 54.77 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.259 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.456 HG11 ' O ' ' X' ' 38' ' ' LEU . 8.2 p -67.09 -31.7 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 54.1 pttt -69.63 -38.88 77.35 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 122.089 -0.382 . . . . 0.0 111.948 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.489 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.1 pt -79.63 -31.79 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.795 0.331 . . . . 0.0 110.747 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 54.7 p -84.04 -34.99 24.13 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.81 22.95 13.25 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.65 1.18 . . . . 0.0 109.929 -176.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -79.3 133.31 60.58 Favored Pre-proline 0 N--CA 1.433 -1.305 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.278 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -71.69 -19.48 27.7 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.282 -173.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -118.5 30.37 7.24 Favored 'General case' 0 N--CA 1.4 -2.957 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -171.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.556 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.0 -57.33 6.25 Favored Glycine 0 CA--C 1.461 -3.34 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.9 -178.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.494 HG23 HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -82.26 -22.78 35.61 Favored 'General case' 0 C--N 1.247 -3.867 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.959 -172.206 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.84 -36.69 84.06 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.754 174.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.09 -40.44 97.66 Favored 'General case' 0 C--O 1.207 -1.142 0 O-C-N 123.609 0.568 . . . . 0.0 110.643 175.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 51.1 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.392 0.615 . . . . 0.0 109.864 -179.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -62.17 -44.49 96.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.69 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.6 pt-20 -71.17 -38.38 72.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.924 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.13 96.46 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.16 80.9 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.328 0.392 . . . . 0.0 110.595 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.17 -44.48 59.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.481 178.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -67.91 -31.31 70.99 Favored 'General case' 0 C--O 1.194 -1.845 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.72 -23.44 42.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.974 -0.454 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.02 69.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.866 178.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.52 85.61 2.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -87.74 112.07 46.36 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.21 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.19 -2.22 11.89 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.247 2.631 . . . . 0.0 113.513 -177.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.72 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.32 -168.06 38.53 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.083 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 64.78 25.42 12.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.743 1.217 . . . . 0.0 111.722 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . 0.406 ' N ' ' HA3' ' X' ' 74' ' ' GLY . . . 173.18 -30.22 0.1 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 -177.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.86 61.3 4.54 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.81 170.14 23.05 Favored Glycine 0 N--CA 1.396 -3.979 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.573 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 24.1 Cg_endo -66.11 -24.64 51.74 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.472 . . . . 0.0 112.805 -175.501 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.418 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.7 mt-10 -85.68 1.96 47.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.964 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . 0.406 ' HA3' ' N ' ' X' ' 69' ' ' GLY . . . -105.44 -32.82 3.82 Favored Glycine 0 N--CA 1.419 -2.441 0 C-N-CA 118.377 -1.868 . . . . 0.0 114.322 176.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.557 ' CD1' ' HA ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -69.95 -28.21 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-N 118.68 1.24 . . . . 0.0 110.204 175.128 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.562 HG13 ' O ' ' X' ' 72' ' ' PRO . 27.5 m -63.61 -38.06 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-O 121.347 0.594 . . . . 0.0 110.489 177.225 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttm -61.28 -48.46 81.29 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.445 173.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.16 -37.45 82.95 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.741 -178.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.403 HG12 ' O ' ' X' ' 75' ' ' ILE . 31.4 mm -68.46 -46.36 80.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.571 177.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -65.09 -38.06 89.51 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.666 -174.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.23 -38.78 75.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.272 -178.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.428 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 71.2 t90 -66.69 -47.88 71.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 109.131 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -61.19 -46.33 90.92 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.071 -175.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.58 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.868 -178.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.05 75.02 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.923 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.41 ' ND2' ' HE2' ' X' ' 88' ' ' LYS . 3.1 t30 -72.82 -42.63 63.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.64 34.99 1.62 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.918 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.41 ' HE2' ' ND2' ' X' ' 86' ' ' ASN . 65.9 mttm -115.43 140.13 25.48 Favored Pre-proline 0 N--CA 1.385 -3.685 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -177.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -61.5 136.31 62.49 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.422 2.082 . . . . 0.0 110.899 176.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.0 -120.33 4.68 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.233 -174.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -86.87 166.42 15.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 124.202 0.59 . . . . 0.0 109.441 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' X' ' 11' ' ' THR . 18.0 ptmt -105.18 162.14 13.65 Favored 'General case' 1 N--CA 1.374 -4.265 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.176 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.83 134.44 49.98 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.489 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.265 -3.379 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.806 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 . . . . . 0 CA--C 1.509 -0.609 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.07 130.4 44.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.849 0.833 . . . . 0.0 112.623 -178.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 32.2 mmtt -101.76 -157.52 0.61 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -120.5 -20.37 7.19 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.222 171.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.4 p -141.01 165.7 26.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.464 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.09 -23.11 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.649 1.18 . . . . 0.0 110.393 -179.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.9 m -73.68 -16.33 61.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.798 -173.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.406 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 19.2 t70 -102.97 3.27 36.13 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.508 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.452 ' OH ' HD21 ' X' ' 18' ' ' LEU . 8.6 m-85 -97.04 118.4 33.35 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.39 -175.235 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 23.8 p -80.15 164.62 23.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.601 ' O ' HG11 ' X' ' 16' ' ' VAL . 5.8 pt-20 -59.08 -40.44 85.26 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.403 178.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.63 76.32 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.42 -38.0 79.48 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.707 0.765 . . . . 0.0 110.261 174.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.403 ' O ' HD21 ' X' ' 19' ' ' LEU . 36.3 t80 -72.87 -46.02 55.12 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.617 -179.054 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.601 HG11 ' O ' ' X' ' 12' ' ' GLU . 10.4 m -62.34 -34.42 64.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.848 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.09 -49.69 76.3 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.648 ' O ' HG13 ' X' ' 22' ' ' ILE . 55.3 tp -60.0 -46.78 88.35 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.524 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.409 HD23 ' CD1' ' X' ' 41' ' ' PHE . 4.4 mm? -58.51 -36.86 74.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.619 178.224 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.5 mttt -63.83 -37.23 86.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 110.568 175.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.31 -35.61 66.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.648 HG13 ' O ' ' X' ' 18' ' ' LEU . 17.3 mt -67.64 -42.09 86.2 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.176 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -42.8 84.75 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.917 1.287 . . . . 0.0 109.604 177.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.74 -47.62 74.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.619 -177.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.612 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 7.1 mm-40 -76.97 -15.4 59.66 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.319 178.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.53 -45.93 64.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.16 -26.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.383 179.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.42 50.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.061 176.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.8 77.27 0.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.166 1.386 . . . . 0.0 111.267 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 27.2 p -101.46 -168.73 1.59 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.73 -35.35 0.58 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.126 176.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.453 ' O ' HG22 ' X' ' 36' ' ' VAL . 37.7 m-20 -65.11 -53.02 51.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.729 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 4.8 p -88.52 -31.12 5.49 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.943 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.181 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.25 -45.02 92.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.322 -175.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.76 -29.71 63.54 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.887 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.453 HG22 ' O ' ' X' ' 32' ' ' ASP . 92.4 t -64.46 -48.78 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.063 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.457 176.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 85.9 mt -67.58 -43.57 80.26 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.121 -172.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 44.5 mt -61.81 -45.06 95.5 Favored 'General case' 0 N--CA 1.422 -1.837 0 O-C-N 124.194 0.934 . . . . 0.0 110.786 -179.575 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.24 -47.28 62.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.3 t60 -59.71 -44.2 93.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.594 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 30.9 t80 -59.95 -52.97 63.13 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.884 177.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.509 HG11 ' O ' ' X' ' 38' ' ' LEU . 13.8 p -67.71 -32.55 57.2 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.773 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.0 pttp -70.17 -28.59 65.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.467 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -84.38 -40.77 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.369 -177.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.562 HG21 ' O ' ' X' ' 41' ' ' PHE . 6.4 t -83.64 -32.11 25.85 Favored 'General case' 0 C--O 1.252 1.224 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.653 178.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.56 30.55 12.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 125.908 1.683 . . . . 0.0 111.342 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.43 ' H ' HG23 ' X' ' 45' ' ' THR . 48.0 t-80 -76.65 137.0 67.01 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.85 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.558 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 18.6 Cg_exo -70.99 -13.07 31.35 Favored 'Trans proline' 0 CA--C 1.502 -1.115 0 C-N-CA 123.099 2.533 . . . . 0.0 112.645 -174.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.55 31.45 4.78 Favored 'General case' 0 N--CA 1.398 -3.051 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -173.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.594 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.15 -56.88 7.49 Favored Glycine 0 CA--C 1.457 -3.584 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.921 -178.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.456 ' CG2' HD13 ' X' ' 38' ' ' LEU . 1.3 m -72.08 -32.55 67.14 Favored 'General case' 0 C--N 1.256 -3.479 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.271 -173.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.681 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.32 -37.21 86.39 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.996 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . 0.4 ' HB3' ' CG2' ' X' ' 75' ' ' ILE . 27.6 mt -58.47 -39.02 78.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.766 0.666 . . . . 0.0 112.22 178.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.407 HD13 HG22 ' X' ' 22' ' ' ILE . 67.8 mt -65.89 -44.43 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.638 . . . . 0.0 109.304 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.56 -49.74 74.09 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.274 178.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.8 pt-20 -69.65 -42.43 74.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.22 92.73 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.187 -179.603 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.26 73.52 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.033 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.93 75.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.701 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.37 -31.07 71.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' X' ' 71' ' ' GLY . . . -74.71 -35.75 62.71 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.063 178.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.97 97.91 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.995 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.53 -48.53 13.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.909 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 60.91 90.9 0.08 OUTLIER Pre-proline 0 C--O 1.241 0.612 0 C-N-CA 125.441 1.497 . . . . 0.0 113.158 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.28 2.99 4.44 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.771 2.314 . . . . 0.0 112.511 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.46 161.11 15.38 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.83 177.42 49.32 Favored Glycine 0 C--O 1.247 0.957 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -178.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -102.85 -169.57 1.67 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.75 -33.11 6.66 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -177.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.71 143.92 21.83 Favored Glycine 0 N--CA 1.414 -2.811 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 176.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' HB3' ' X' ' 61' ' ' ALA . . . 89.56 164.78 40.41 Favored Glycine 0 N--CA 1.424 -2.109 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.947 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.565 ' O ' HG13 ' X' ' 76' ' ' VAL . 18.7 Cg_endo -55.98 -37.71 95.71 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 123.884 3.056 . . . . 0.0 114.126 -176.331 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.44 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.7 mt-10 -86.37 2.39 47.68 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.76 -28.03 5.5 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 118.684 -1.722 . . . . 0.0 112.481 173.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.425 HG21 HD11 ' X' ' 75' ' ' ILE . 0.3 OUTLIER -61.12 -39.69 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 122.326 1.06 . . . . 0.0 108.277 176.349 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.565 HG13 ' O ' ' X' ' 72' ' ' PRO . 29.2 m -59.46 -33.76 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 CA-C-N 113.314 -1.766 . . . . 0.0 112.686 -176.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.459 ' HZ1' ' CD ' ' X' ' 81' ' ' GLU . 51.0 tttp -60.06 -51.64 68.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.773 172.014 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -59.32 -42.29 91.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.419 HG23 ' HG1' ' X' ' 45' ' ' THR . 29.0 mm -62.75 -46.29 96.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.014 177.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.49 -43.36 73.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.621 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.459 ' CD ' ' HZ1' ' X' ' 77' ' ' LYS . 79.7 mt-10 -72.16 -32.21 66.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.156 -175.404 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.558 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 62.0 t90 -66.11 -45.85 79.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.597 1.189 . . . . 0.0 109.133 175.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -66.24 -46.92 75.48 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.169 -177.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -38.35 81.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.489 0.716 . . . . 0.0 112.094 -176.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.24 70.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . 0.581 ' HB3' ' NZ ' ' X' ' 88' ' ' LYS . 56.4 t30 -101.4 6.16 42.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.075 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.43 42.32 49.19 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.004 175.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.581 ' NZ ' ' HB3' ' X' ' 86' ' ' ASN . 36.6 mtmm -105.19 139.44 20.13 Favored Pre-proline 1 N--CA 1.378 -4.042 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.849 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.08 114.7 2.12 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 111.788 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.0 -125.11 4.09 Favored Glycine 0 CA--C 1.489 -1.587 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.659 -179.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.71 152.84 28.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.975 0.417 . . . . 0.0 110.285 -175.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.07 177.71 6.85 Favored 'General case' 0 N--CA 1.391 -3.375 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . 0.433 ' HA ' ' NE2' ' X' ' 93' ' ' GLN . 11.1 mm100 -117.59 143.37 46.18 Favored 'General case' 1 N--CA 1.377 -4.09 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 177.065 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.499 ' CD2' HD13 ' X' ' 18' ' ' LEU . 33.9 mt -103.01 134.32 46.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 34.3 mmtt -102.06 -162.45 0.93 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.52 -19.61 8.73 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.447 -0.783 . . . . 0.0 111.34 173.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 60.7 p -135.86 163.61 29.83 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.465 HG12 HH22 ' X' ' 83' ' ' ARG . 3.6 tp -69.81 -14.88 18.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.667 -177.175 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.5 m -71.87 -17.55 62.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.184 -174.036 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 17.2 t70 -106.83 5.06 28.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.791 0.805 . . . . 0.0 108.932 178.409 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.82 121.58 38.84 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.216 -176.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 43.6 p -88.61 179.51 6.25 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.624 ' O ' HG12 ' X' ' 16' ' ' VAL . 8.3 mm-40 -59.16 -52.36 66.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.437 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -69.22 -38.74 78.7 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.741 -171.244 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.56 -36.27 80.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 110.279 175.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.538 ' O ' HD11 ' X' ' 19' ' ' LEU . 44.7 t80 -75.94 -44.66 39.02 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.354 -177.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.624 HG12 ' O ' ' X' ' 12' ' ' GLU . 6.2 m -62.44 -33.25 58.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 116.939 -0.119 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -65.4 -47.84 74.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 123.024 0.53 . . . . 0.0 110.077 178.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.641 ' O ' HG13 ' X' ' 22' ' ' ILE . 17.9 tp -57.64 -47.44 82.22 Favored 'General case' 0 C--O 1.208 -1.09 0 CA-C-O 121.222 0.534 . . . . 0.0 109.789 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.538 HD11 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.48 -39.2 82.95 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.234 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 50.6 mttp -63.73 -38.5 91.33 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.174 0.511 . . . . 0.0 109.997 176.153 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' X' ' 24' ' ' LYS . 42.9 mt-10 -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.198 177.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.641 HG13 ' O ' ' X' ' 18' ' ' LEU . 31.0 mt -67.3 -40.89 85.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.351 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' X' ' 19' ' ' LEU . 52.3 mt-10 -57.89 -42.74 85.27 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.903 0.858 . . . . 0.0 109.728 177.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' X' ' 21' ' ' GLU . 80.1 tttt -60.23 -52.15 66.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.389 -176.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' X' ' 34' ' ' LEU . 1.2 pp20? -83.71 -32.93 25.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -58.3 -45.6 87.66 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.324 0.249 . . . . 0.0 111.503 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . 0.434 HG21 ' O ' ' X' ' 23' ' ' GLU . 31.7 m -76.22 -24.24 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.22 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -21.23 46.33 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.962 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.85 80.92 0.17 Allowed 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.878 1.671 . . . . 0.0 111.796 -178.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 0.7 OUTLIER -98.34 -175.2 3.04 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.139 174.433 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.71 -55.93 0.62 Allowed 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.724 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.658 ' O ' HG21 ' X' ' 36' ' ' VAL . 32.9 t70 -63.12 -57.42 10.65 Favored 'General case' 0 CA--C 1.484 -1.572 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.939 -179.177 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.676 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.8 p -73.08 -30.16 30.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -175.428 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.522 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.4 tm? -61.21 -50.16 74.22 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.493 178.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.59 -24.5 62.77 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.835 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.658 HG21 ' O ' ' X' ' 32' ' ' ASP . 98.8 t -70.57 -51.34 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.98 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.118 177.084 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 44.7 mt -69.29 -43.13 74.46 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.87 -170.336 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.48 ' O ' HG11 ' X' ' 42' ' ' VAL . 25.7 mt -60.98 -43.51 98.72 Favored 'General case' 0 N--CA 1.419 -2.019 0 O-C-N 124.283 0.989 . . . . 0.0 111.226 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.82 -44.05 67.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.987 0.423 . . . . 0.0 111.128 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.545 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 7.8 t60 -59.52 -45.21 92.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.63 -175.733 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.616 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 60.5 t80 -60.16 -51.79 68.09 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.94 178.037 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.48 HG11 ' O ' ' X' ' 38' ' ' LEU 0.258 9.5 p -67.51 -32.28 56.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.494 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.716 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -70.47 -37.49 74.27 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.99 -0.444 . . . . 0.0 112.073 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.526 HG12 ' O ' ' X' ' 40' ' ' HIS . 18.5 pt -78.75 -31.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.248 0.547 . . . . 0.0 110.776 -178.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.411 ' O ' ' HD2' ' X' ' 83' ' ' ARG . 53.7 p -84.36 -42.4 15.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.04 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.57 25.97 6.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.159 1.784 . . . . 0.0 110.446 -176.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 44.8 t-80 -80.35 135.66 53.63 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 114.286 -1.324 . . . . 0.0 107.797 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.434 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -69.45 -15.56 38.31 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 122.933 2.422 . . . . 0.0 112.737 -173.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 20.7 m-20 -127.17 32.85 5.0 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.616 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.09 -59.23 4.04 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.966 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.475 ' O ' ' HD2' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -73.26 -32.39 64.66 Favored 'General case' 0 C--N 1.246 -3.933 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.537 -171.036 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.75 -36.0 79.75 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.494 178.165 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -59.82 -45.55 92.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 176.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 85.2 mt -67.62 -40.73 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.431 179.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.475 ' HD2' ' O ' ' X' ' 51' ' ' THR . 17.0 m-85 -59.34 -46.65 88.03 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.078 177.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.6 pt-20 -67.68 -36.13 80.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.24 176.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.45 79.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 122.947 0.155 . . . . 0.0 110.757 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.83 -48.05 82.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.747 0.654 . . . . 0.0 110.269 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.96 -40.86 78.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -65.67 -33.04 74.96 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.517 0.727 . . . . 0.0 111.817 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.1 39.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.134 0.493 . . . . 0.0 110.694 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -46.78 56.05 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.43 78.03 1.81 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . 0.496 ' ND2' ' HA3' ' X' ' 69' ' ' GLY . 42.7 t-20 -66.45 116.04 30.05 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.684 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.73 -11.69 13.92 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.99 2.46 . . . . 0.0 114.469 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.74 -175.28 16.23 Favored Glycine 0 CA--C 1.489 -1.563 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.13 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.57 -80.47 1.83 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.9 -41.02 0.36 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . 0.496 ' HA3' ' ND2' ' X' ' 64' ' ' ASN . . . 107.48 -142.28 15.77 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.485 174.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.62 31.54 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.519 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 158.39 -177.24 35.14 Favored Glycine 0 N--CA 1.404 -3.498 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 -179.621 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.703 ' O ' HG11 ' X' ' 76' ' ' VAL . 9.2 Cg_endo -58.3 -43.15 49.16 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.771 2.981 . . . . 0.0 112.403 -176.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.456 ' C ' HG23 ' X' ' 76' ' ' VAL . 37.0 mt-10 -85.5 1.87 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 123.771 0.828 . . . . 0.0 110.796 -176.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -107.98 -29.72 4.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 119.264 -1.446 . . . . 0.0 112.886 173.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.519 HG12 ' O ' ' X' ' 71' ' ' GLY . 1.6 pt -69.64 -28.5 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 CA-C-N 117.576 0.688 . . . . 0.0 110.762 173.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.703 HG11 ' O ' ' X' ' 72' ' ' PRO . 31.4 m -59.89 -35.92 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 121.76 0.79 . . . . 0.0 110.787 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' X' ' 74' ' ' GLY . 40.4 tttp -62.38 -49.11 76.82 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.302 174.293 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.33 -41.2 84.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 23.5 mm -63.0 -45.85 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.067 177.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 61.5 pttt -71.87 -38.58 70.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.993 -176.287 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.1 mt-10 -69.4 -32.32 71.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.839 -178.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.434 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -65.99 -46.15 79.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.228 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.465 HH22 HG12 ' X' ' 7' ' ' ILE . 0.9 OUTLIER -66.26 -39.74 89.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.274 177.205 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.27 86.51 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.817 0.698 . . . . 0.0 111.717 -179.065 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.786 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.23 -40.03 15.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.15 28.71 3.49 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -175.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -93.55 156.46 39.71 Favored Pre-proline 0 N--CA 1.412 -2.328 0 C-N-CA 124.225 1.01 . . . . 0.0 108.779 179.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -63.71 129.57 25.29 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.574 2.183 . . . . 0.0 112.979 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.99 -132.57 7.78 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.945 178.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 42.4 m-85 -96.21 152.75 18.27 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.251 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -88.85 169.55 11.49 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.29 136.0 41.86 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.82 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.926 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -177.695 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . 0.443 ' HB3' ' HZ3' ' X' ' 4' ' ' LYS . 11.1 tp10 . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . 0.402 HD21 HD13 ' X' ' 18' ' ' LEU . 40.4 mt -92.19 126.8 37.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.455 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 35.3 mmtt -95.62 -161.06 0.83 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.177 -173.577 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -108.79 -33.51 6.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -130.69 166.61 20.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.624 -176.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.2 tp -67.65 -25.15 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.595 0.712 . . . . 0.0 109.785 178.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -77.67 -11.54 59.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.261 -173.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -99.28 1.13 44.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.04 121.43 40.97 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.855 -174.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 11' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 80.1 p -79.52 167.94 20.1 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 170.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.581 ' O ' HG11 ' X' ' 16' ' ' VAL . 6.0 pt-20 -59.96 -41.86 92.82 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.031 178.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.434 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.58 -38.5 74.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.47 177.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.72 -36.17 76.0 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.403 0.62 . . . . 0.0 109.973 174.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.715 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 18.8 t80 -70.92 -46.17 62.97 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.867 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.606 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 4.9 m -62.57 -29.97 48.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.523 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -60.76 -49.41 77.61 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.969 0.907 . . . . 0.0 109.697 174.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.645 ' O ' HG13 ' X' ' 22' ' ' ILE . 22.7 tp -57.72 -46.79 83.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.577 0.704 . . . . 0.0 109.677 175.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.1 mt -58.23 -38.71 77.38 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.055 -178.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 97.6 mttt -70.3 -39.21 74.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.957 0.408 . . . . 0.0 110.157 176.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.41 -37.47 87.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 178.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.645 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.5 mt -65.82 -46.74 87.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.98 -39.86 79.24 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.367 1.067 . . . . 0.0 113.053 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . 0.531 ' HG3' ' OE1' ' X' ' 25' ' ' GLU . 24.3 tptp -60.21 -48.67 80.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . 0.531 ' OE1' ' HG3' ' X' ' 24' ' ' LYS . 9.4 mm-40 -92.15 -1.83 56.93 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.484 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -70.84 -53.39 15.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.71 -28.31 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.962 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -23.36 33.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.959 0.409 . . . . 0.0 110.316 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.77 71.21 0.58 Allowed 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.57 1.548 . . . . 0.0 111.935 -176.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 68.9 p -91.25 -164.03 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.34 -38.71 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.716 177.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.492 ' O ' HG22 ' X' ' 36' ' ' VAL . 33.8 t70 -67.78 -55.09 14.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -172.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.661 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.86 -28.88 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 118.711 -1.195 . . . . 0.0 108.267 -177.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.07 -49.73 76.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.92 -176.203 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.52 -16.02 59.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.294 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.492 HG22 ' O ' ' X' ' 32' ' ' ASP . 57.3 t -71.69 -50.4 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 C-N-CA 118.599 -1.24 . . . . 0.0 107.815 172.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 82.3 mt -68.18 -42.44 79.94 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 113.457 -1.702 . . . . 0.0 112.059 -169.395 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.0 mt -59.12 -45.78 90.03 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.352 1.033 . . . . 0.0 110.524 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -70.55 -43.3 69.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.893 178.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.53 ' O ' HG12 ' X' ' 44' ' ' ILE . 19.6 t60 -59.89 -46.37 89.55 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.109 -176.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.616 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.7 t80 -62.45 -50.54 71.07 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.095 -179.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.481 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.5 p -67.08 -30.97 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.549 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.0 pttt -73.08 -35.41 66.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.364 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.53 HG12 ' O ' ' X' ' 40' ' ' HIS . 28.6 pt -81.21 -38.69 16.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.9 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 77.2 p -79.47 -36.15 39.19 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-O 121.227 0.537 . . . . 0.0 110.398 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 65.02 23.82 12.55 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -75.28 134.14 74.08 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . 0.476 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.7 Cg_exo -72.17 -3.09 12.66 Favored 'Trans proline' 0 CA--C 1.493 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.549 -174.428 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.431 ' CG ' ' HB2' ' X' ' 52' ' ' ALA . 24.0 t70 -138.51 32.48 2.29 Favored 'General case' 0 N--CA 1.389 -3.507 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -174.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.616 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.44 -59.72 4.56 Favored Glycine 1 CA--C 1.45 -4.01 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.353 -179.152 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.471 ' CG2' HD11 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.23 -32.4 70.25 Favored 'General case' 0 C--N 1.248 -3.81 0 CA-C-N 114.764 -0.718 . . . . 0.0 111.461 -173.149 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -75.08 -24.07 58.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.037 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.31 -40.48 94.36 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.435 173.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.438 HD13 HG22 ' X' ' 22' ' ' ILE . 11.7 mt -66.23 -46.11 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -57.45 -49.06 77.46 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.437 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.57 -36.11 70.79 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.148 177.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -39.26 76.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.159 0.436 . . . . 0.0 110.335 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.9 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.638 0.586 . . . . 0.0 110.465 175.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.22 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.424 0.631 . . . . 0.0 111.026 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -67.64 -32.71 73.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.869 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . 0.52 ' HB1' ' N ' ' X' ' 71' ' ' GLY . . . -76.9 -22.86 52.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.729 0.3 . . . . 0.0 111.024 177.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.23 77.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.955 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.48 -47.09 7.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 57.26 83.68 0.22 Allowed Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.602 1.561 . . . . 0.0 112.419 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.45 106.38 2.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.825 2.35 . . . . 0.0 111.58 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -49.43 4.23 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.904 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.08 -37.33 0.65 Allowed Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.275 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -100.89 172.66 6.9 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.932 0.396 . . . . 0.0 110.711 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.54 -68.72 0.25 Allowed Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.17 -178.24 28.93 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.52 ' N ' ' HB1' ' X' ' 61' ' ' ALA . . . 84.43 173.66 49.93 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.46 ' O ' HG13 ' X' ' 75' ' ' ILE . 11.6 Cg_endo -58.31 -44.4 38.61 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.899 -178.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.79 1.05 7.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.03 -22.78 6.72 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.739 176.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.486 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -65.63 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.703 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.497 HG13 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -58.27 -47.2 88.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.291 178.653 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . 0.449 ' H ' HG11 ' X' ' 76' ' ' VAL . 23.9 ttmm -58.26 -44.66 88.45 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.72 -29.73 64.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.285 0.564 . . . . 0.0 110.664 -178.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.486 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.3 mm -69.02 -45.92 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.028 175.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.2 pttp -63.07 -36.29 83.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.186 -174.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.21 -37.6 75.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.144 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . 0.476 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.4 t90 -68.42 -47.38 67.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.192 0.52 . . . . 0.0 110.239 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.473 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 12.3 tpt180 -60.48 -45.66 92.94 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.26 -175.127 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.32 87.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.804 0.335 . . . . 0.0 111.457 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.46 -30.44 64.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.6 34.77 4.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.843 177.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . 0.473 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 58.7 mttm -111.91 148.27 38.62 Favored Pre-proline 0 N--CA 1.403 -2.802 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.01 126.54 14.65 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.512 2.142 . . . . 0.0 110.344 175.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.79 -114.61 3.13 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.096 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . 0.472 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 18.0 m-85 -88.59 158.5 18.25 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 121.114 0.483 . . . . 0.0 110.273 -174.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.6 ptmt -98.45 166.43 11.36 Favored 'General case' 0 N--CA 1.381 -3.881 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.03 136.46 44.46 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 173.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.119 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.39 -177.166 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 67.8 mt -94.18 142.75 27.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 4' ' ' LYS . . . . . 0.473 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 36.3 mmtt -101.66 -159.84 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.98 -22.55 6.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.134 0.492 . . . . 0.0 110.446 175.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.1 p -140.0 165.95 25.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.559 179.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 7' ' ' ILE . . . . . 0.562 HG12 ' NH1' ' X' ' 83' ' ' ARG . 4.7 tp -70.38 -18.02 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.488 0.661 . . . . 0.0 110.317 -175.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -70.67 -18.89 62.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.851 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 9' ' ' ASP . . . . . 0.483 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.8 t0 -104.09 6.9 36.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.904 0.859 . . . . 0.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 15.4 m-85 -96.3 123.81 40.08 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.57 -176.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.3 p -86.29 172.73 10.24 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 171.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 12' ' ' GLU . . . . . 0.582 ' O ' HG12 ' X' ' 16' ' ' VAL . 4.1 mm-40 -56.05 -52.04 65.67 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.138 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 13' ' ' ALA . . . . . 0.406 ' O ' HG21 ' X' ' 16' ' ' VAL . . . -70.13 -38.55 75.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.82 -174.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' X' ' 17' ' ' GLN . 5.2 mm-40 -62.35 -33.47 74.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.899 175.562 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 15' ' ' PHE . . . . . 0.651 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 27.1 t80 -71.94 -44.96 62.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 16' ' ' VAL . . . . . 0.582 HG12 ' O ' ' X' ' 12' ' ' GLU . 3.6 m -62.51 -30.43 49.13 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.176 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' X' ' 17' ' ' GLN . 0.3 OUTLIER -59.22 -50.21 74.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.647 0.779 . . . . 0.0 109.023 174.788 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' X' X ' 18' ' ' LEU . . . . . 0.623 ' O ' HG13 ' X' ' 22' ' ' ILE . 26.0 tp -58.62 -45.91 88.2 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.042 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 22.3 mt -57.93 -40.96 81.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.937 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 99.4 mttt -65.22 -37.49 87.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.23 176.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 21' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' X' ' 24' ' ' LYS . 7.9 mm-40 -71.8 -37.37 70.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 22' ' ' ILE . . . . . 0.623 HG13 ' O ' ' X' ' 18' ' ' LEU . 18.5 mt -62.4 -39.61 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.738 178.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.73 -47.05 83.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.356 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' X' ' 21' ' ' GLU . 17.4 pttp -67.42 -36.26 80.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.497 -175.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -71.86 -31.64 66.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.269 0.557 . . . . 0.0 110.038 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -72.46 -50.79 23.59 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.473 177.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.8 m -68.82 -32.35 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -10.06 49.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 109.92 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.62 80.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.701 1.6 . . . . 0.0 113.495 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 30' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 61.7 p -105.16 -168.53 1.48 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -143.01 -29.13 0.55 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.555 177.465 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 32' ' ' ASP . . . . . 0.569 ' O ' HG21 ' X' ' 36' ' ' VAL . 11.0 m-20 -67.87 -57.8 5.65 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.043 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 33' ' ' VAL . . . . . 0.666 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 85.6 t -86.36 -29.02 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.472 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 34' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.01 -44.25 87.13 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 35' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 28.1 t70 -71.7 -35.2 70.15 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.287 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . 0.569 HG21 ' O ' ' X' ' 32' ' ' ASP . 80.9 t -57.76 -49.85 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.008 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 37' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 64.9 mt -68.12 -43.21 78.92 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.615 -172.179 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 38' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.5 mt -60.58 -49.09 78.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 124.154 0.909 . . . . 0.0 111.876 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 39' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.6 pt-20 -71.36 -36.39 71.47 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.8 178.549 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 40' ' ' HIS . . . . . 0.528 ' O ' HG12 ' X' ' 44' ' ' ILE . 13.6 t60 -62.72 -46.53 87.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 41' ' ' PHE . . . . . 0.627 ' O ' HG22 ' X' ' 45' ' ' THR . 54.8 t80 -58.02 -56.03 27.24 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 42' ' ' VAL . . . . . 0.456 HG12 ' O ' ' X' ' 38' ' ' LEU . 10.6 p -67.06 -32.87 59.83 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 43' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 9.2 pttp -70.3 -31.99 69.56 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.026 -179.068 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 44' ' ' ILE . . . . . 0.528 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.9 pt -83.24 -37.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.164 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 45' ' ' THR . . . . . 0.627 HG22 ' O ' ' X' ' 41' ' ' PHE . 7.3 t -84.78 -29.59 25.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.22 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 60.44 34.69 20.49 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.418 1.087 . . . . 0.0 111.549 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 47' ' ' HIS . . . . . 0.461 ' H ' HG21 ' X' ' 45' ' ' THR . 45.1 t-80 -85.3 134.26 40.94 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 114.542 -1.208 . . . . 0.0 107.742 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -69.63 -15.55 37.64 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.945 2.43 . . . . 0.0 113.146 -174.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 49' ' ' ASP . . . . . 0.408 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 10.8 m-20 -124.29 29.29 6.41 Favored 'General case' 0 N--CA 1.402 -2.827 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -173.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 50' ' ' GLY . . . . . 0.529 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -58.05 5.12 Favored Glycine 1 CA--C 1.447 -4.186 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.473 -176.73 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' X' X ' 51' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -75.66 -33.23 60.42 Favored 'General case' 1 C--N 1.242 -4.091 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.512 -171.876 . . . . . . . . 4 4 . 1 . 030 nuclear orig full ' X' X ' 52' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.11 -37.03 76.21 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.527 177.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 42.6 mt -57.82 -44.73 86.61 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.774 0.671 . . . . 0.0 112.007 177.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 54' ' ' ILE . . . . . 0.581 HD12 ' CD2' ' X' ' 41' ' ' PHE . 4.0 mp -67.38 -43.46 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.645 -179.651 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 55' ' ' TYR . . . . . 0.519 ' HD1' ' O ' ' X' ' 51' ' ' THR . 29.6 m-85 -55.03 -47.46 74.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.292 177.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 56' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.1 pt-20 -71.53 -36.74 71.1 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 176.079 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.03 83.49 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 118.184 0.447 . . . . 0.0 110.784 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.89 81.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.963 178.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.43 -43.52 85.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.188 0.518 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 60' ' ' ARG . . . . . 0.527 ' O ' ' HD3' ' X' ' 65' ' ' PRO . 63.3 mtm180 -66.53 -30.96 71.39 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.593 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.31 58.78 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.306 176.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.84 91.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.85 -48.29 59.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.87 85.72 0.15 Allowed Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 125.98 1.712 . . . . 0.0 112.441 178.209 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 65' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 47.9 Cg_endo -99.12 5.4 0.98 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.91 2.407 . . . . 0.0 111.937 177.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.82 -151.75 23.38 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -177.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -93.16 -15.96 49.27 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.289 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -67.73 92.73 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.82 0.93 86.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.103 176.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.64 71.87 1.51 Allowed Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.78 173.93 13.11 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.931 178.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.523 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.8 Cg_endo -62.87 -38.4 48.24 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.637 2.891 . . . . 0.0 111.845 -179.017 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.8 -0.2 12.69 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.16 -22.3 7.97 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.771 176.066 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 75' ' ' ILE . . . . . 0.523 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -67.19 -42.74 88.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.356 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' X' X ' 76' ' ' VAL . . . . . 0.509 HG13 HG13 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -58.76 -41.3 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.785 177.487 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -60.06 -48.61 80.99 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.809 177.159 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.42 -45.11 84.96 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.888 0.851 . . . . 0.0 110.053 176.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 79' ' ' ILE . . . . . 0.458 HG22 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -61.46 -40.81 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.881 176.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.67 -39.97 69.92 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.458 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.11 -41.97 85.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 57.8 t90 -64.08 -46.85 82.44 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.65 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 83' ' ' ARG . . . . . 0.562 ' NH1' HG12 ' X' ' 7' ' ' ILE . 0.8 OUTLIER -66.28 -39.72 89.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.783 176.874 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.69 96.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.555 0.534 . . . . 0.0 110.864 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.03 83.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.857 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.31 -49.2 15.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.43 0.633 . . . . 0.0 110.381 -176.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.52 27.99 3.92 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -99.04 155.52 36.48 Favored Pre-proline 0 N--CA 1.406 -2.625 0 C-N-CA 123.342 0.657 . . . . 0.0 109.903 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.58 110.89 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.698 2.265 . . . . 0.0 111.947 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 90' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -85.28 -111.22 0.71 Allowed Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.468 -177.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -109.87 164.21 12.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.357 -179.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 21.1 ptmt -91.45 168.04 11.83 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.014 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.47 139.44 30.71 Favored 'General case' 0 C--N 1.266 -3.053 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.393 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.744 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.553 HD22 HD13 ' X' ' 18' ' ' LEU . 29.6 mt . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 120.992 0.425 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 31.3 mmtt -95.93 -165.51 1.29 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -109.35 -33.9 6.7 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.112 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 69.6 p -127.17 166.62 17.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.304 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.451 HD11 ' CE1' ' X' ' 91' ' ' PHE . 9.7 tp -65.36 -18.03 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 110.47 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.5 m -83.6 -9.59 58.81 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.606 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 22.0 t70 -104.44 -1.0 27.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.52 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.29 120.0 31.06 Favored 'General case' 0 CA--C 1.47 -2.112 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.407 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 75.0 p -83.03 170.41 14.89 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 172.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.649 ' O ' HG13 ' X' ' 16' ' ' VAL . 5.8 pt-20 -58.33 -46.11 86.82 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.322 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.478 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.09 -38.24 75.62 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -64.78 -32.91 74.82 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 121.671 -0.643 . . . . 0.0 110.646 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 29.1 t80 -71.36 -43.64 66.54 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.725 HG12 HG11 ' X' ' 76' ' ' VAL . 3.5 m -62.79 -28.98 45.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.739 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -61.63 -45.9 92.07 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.573 ' O ' HG13 ' X' ' 22' ' ' ILE . 29.5 tp -61.76 -47.19 86.31 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 123.858 0.724 . . . . 0.0 109.629 175.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -58.23 -37.57 75.13 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.031 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.1 mttm -70.62 -35.67 73.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.42 -36.75 74.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.947 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.66 HG12 ' HB3' ' X' ' 37' ' ' LEU . 56.2 mt -63.01 -41.71 93.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -47.57 81.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.495 1.118 . . . . 0.0 108.618 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -61.39 -52.68 63.62 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.32 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -72.22 -25.64 61.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.34 -46.45 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.78 -25.36 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.717 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.31 -26.79 35.38 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.96 68.44 0.63 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.398 1.479 . . . . 0.0 111.682 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.8 p -99.47 -171.66 2.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -131.93 -44.82 0.95 Allowed 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 118.205 -1.398 . . . . 0.0 112.585 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.666 ' O ' HG23 ' X' ' 36' ' ' VAL . 21.7 t70 -64.78 -52.48 56.67 Favored 'General case' 0 CA--C 1.476 -1.894 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.775 -172.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -85.8 -30.41 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 O-C-N 123.714 0.634 . . . . 0.0 110.64 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -59.1 -47.35 85.57 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.59 -26.88 64.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.285 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.666 HG23 ' O ' ' X' ' 32' ' ' ASP . 92.9 t -67.11 -50.26 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 C-N-CA 118.622 -1.231 . . . . 0.0 108.79 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.66 ' HB3' HG12 ' X' ' 22' ' ' ILE . 67.2 mt -68.64 -39.48 80.72 Favored 'General case' 0 N--CA 1.41 -2.436 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.935 -170.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.9 mt -59.26 -49.18 78.82 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 124.253 0.971 . . . . 0.0 110.431 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.57 -39.97 73.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.693 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.495 ' O ' HG12 ' X' ' 44' ' ' ILE . 12.8 t60 -59.62 -46.22 89.64 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.412 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.545 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 56.3 t80 -60.32 -52.99 62.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.649 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.472 HG12 ' O ' ' X' ' 38' ' ' LEU . 7.4 p -66.65 -31.01 51.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -73.0 -33.57 65.87 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.75 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.495 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.1 pt -84.05 -35.74 11.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.238 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.424 HG22 HG21 ' X' ' 79' ' ' ILE . 75.8 p -81.72 -34.67 30.43 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 64.96 22.4 12.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.825 1.65 . . . . 0.0 110.338 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.474 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 34.1 t-80 -72.61 133.67 82.46 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.517 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 34.6 Cg_exo -67.46 -17.94 49.11 Favored 'Trans proline' 0 CA--C 1.499 -1.274 0 C-N-CA 123.119 2.546 . . . . 0.0 111.639 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 9.4 m-20 -124.13 33.68 5.23 Favored 'General case' 0 N--CA 1.383 -3.788 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.545 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -56.15 6.03 Favored Glycine 0 CA--C 1.457 -3.569 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.839 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.555 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.369 0.4 OUTLIER -85.85 -18.3 33.21 Favored 'General case' 0 C--N 1.25 -3.719 0 C-N-CA 117.116 -1.834 . . . . 0.0 114.26 -175.883 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.88 -31.6 72.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.8 mt -66.91 -38.42 86.2 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 123.691 0.619 . . . . 0.0 111.212 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.53 HD13 HG21 ' X' ' 75' ' ' ILE . 21.0 mm -66.57 -48.12 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.244 1.021 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.472 ' HD1' ' O ' ' X' ' 51' ' ' THR . 43.8 m-85 -64.39 -40.74 96.41 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 113.715 -1.584 . . . . 0.0 113.914 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.15 -36.92 72.22 Favored 'General case' 0 C--O 1.194 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.858 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 O-C-N 123.122 0.264 . . . . 0.0 110.553 179.697 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.403 -3.509 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.497 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.5 Cg_endo -57.87 -40.15 80.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.792 2.995 . . . . 0.0 112.887 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.45 0.66 9.67 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.74 -3.98 30.13 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.829 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.53 HG21 HD13 ' X' ' 54' ' ' ILE . 1.8 mt -78.13 -46.02 26.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.725 HG11 HG12 ' X' ' 16' ' ' VAL . 0.8 OUTLIER -56.47 -44.47 80.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.648 176.383 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.3 ttmm -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.309 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.51 -38.51 65.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.424 HG21 HG22 ' X' ' 45' ' ' THR . 44.6 mm -67.31 -39.45 82.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.003 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 21.2 ptmt -61.59 -38.28 87.0 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.65 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -72.33 -39.09 68.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.433 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 59.4 t90 -67.36 -47.14 71.29 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.049 0.452 . . . . 0.0 110.026 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.536 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 10.6 tpt180 -60.83 -45.08 95.88 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.457 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.77 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.363 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.92 95.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.048 0.452 . . . . 0.0 111.513 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -69.04 -28.97 67.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.51 9.12 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.536 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 53.7 mttm -104.8 147.9 35.21 Favored Pre-proline 0 N--CA 1.405 -2.68 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -68.01 122.56 9.67 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 121.856 1.704 . . . . 0.0 109.643 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -96.82 -129.0 6.02 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.243 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.451 ' CE1' HD11 ' X' ' 7' ' ' ILE . 29.7 m-85 -78.18 158.1 29.14 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.059 -0.57 . . . . 0.0 110.535 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' X' ' 11' ' ' THR . 39.7 pttt -101.89 175.23 5.61 Favored 'General case' 0 N--CA 1.38 -3.968 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -105.75 144.25 32.76 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.417 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 58.3 mt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 29.4 mmtt -103.2 168.0 9.46 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.68 -27.12 34.18 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.582 0.706 . . . . 0.0 110.479 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.4 p -134.18 163.12 30.31 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' X' ' 91' ' ' PHE . 6.0 tp -68.0 -18.1 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.155 0.982 . . . . 0.0 109.854 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.0 p -76.45 -16.23 59.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.646 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 4.0 t70 -104.07 2.66 32.35 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -97.36 120.86 38.5 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.907 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.431 HG22 ' HG3' ' X' ' 92' ' ' LYS . 74.7 p -79.31 163.16 25.12 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 167.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.64 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.6 pt-20 -59.03 -35.65 73.65 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.102 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.45 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.42 -39.37 74.46 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -58.81 -37.16 75.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.934 0.874 . . . . 0.0 109.282 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.639 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 38.1 t80 -74.82 -39.53 61.6 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.475 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.696 HG12 HG11 ' X' ' 76' ' ' VAL . 8.6 m -62.69 -29.87 47.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.257 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.04 -50.09 75.39 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.673 ' O ' HG13 ' X' ' 22' ' ' ILE . 46.6 tp -59.7 -46.47 89.0 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.799 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 34.4 mt -57.29 -43.28 83.05 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.232 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 98.5 mttt -61.49 -46.54 89.57 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.964 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.09 -39.32 89.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.796 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.673 HG13 ' O ' ' X' ' 18' ' ' LEU . 50.7 mt -60.77 -44.71 97.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 O-C-N 123.337 0.398 . . . . 0.0 110.59 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.454 ' O ' HG22 ' X' ' 27' ' ' VAL . 46.8 mt-10 -57.02 -46.06 82.64 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.398 0.618 . . . . 0.0 109.723 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.15 -46.85 88.29 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.387 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -85.83 -30.39 23.0 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.305 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.65 -44.64 85.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.092 0.157 . . . . 0.0 111.183 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 27' ' ' VAL . . . . . 0.454 HG22 ' O ' ' X' ' 23' ' ' GLU . 32.4 m -71.11 -22.53 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.57 -24.99 22.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.68 88.9 0.11 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.899 1.68 . . . . 0.0 110.867 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.614 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 44.7 p -96.89 -151.88 0.37 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.92 -66.82 0.37 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 112.726 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.601 ' O ' HG23 ' X' ' 36' ' ' VAL . 38.1 t70 -66.98 -46.26 75.14 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.23 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.8 p -81.66 -28.13 10.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.046 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.614 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.7 tm? -58.73 -52.54 65.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.321 1.049 . . . . 0.0 108.823 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.5 -19.71 62.91 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.601 HG23 ' O ' ' X' ' 32' ' ' ASP . 97.7 t -72.02 -52.11 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.027 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.875 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.621 ' HB3' HG12 ' X' ' 22' ' ' ILE . 41.4 mt -69.42 -43.7 72.87 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.552 -168.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.4 mt -59.72 -46.77 88.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 124.567 1.167 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -71.43 -40.56 70.34 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.556 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.3 t60 -59.71 -45.7 91.35 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.508 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.589 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.22 -52.79 63.81 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.467 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.456 HG12 ' O ' ' X' ' 38' ' ' LEU 0.267 11.8 p -67.67 -31.94 54.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.0 ptmm? -70.59 -33.2 70.81 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.711 -0.618 . . . . 0.0 112.151 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.486 HG12 ' O ' ' X' ' 40' ' ' HIS . 14.5 pt -84.81 -33.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.564 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.446 HG22 HG21 ' X' ' 79' ' ' ILE . 76.2 p -84.42 -35.77 22.85 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 120.965 0.412 . . . . 0.0 110.654 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.01 25.73 15.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.952 1.701 . . . . 0.0 110.163 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 26.3 t-80 -74.02 134.07 78.11 Favored Pre-proline 0 N--CA 1.429 -1.51 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.548 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -71.33 -9.71 25.8 Favored 'Trans proline' 0 CA--C 1.496 -1.423 0 C-N-CA 122.989 2.46 . . . . 0.0 112.058 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.429 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.0 m-20 -130.31 29.66 4.84 Favored 'General case' 0 N--CA 1.396 -3.145 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -170.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.589 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.59 -59.04 5.61 Favored Glycine 0 CA--C 1.461 -3.298 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.199 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.488 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -74.67 -28.89 61.03 Favored 'General case' 0 C--N 1.247 -3.891 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.547 -172.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.07 -35.74 81.73 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -61.74 -39.07 90.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.605 0.566 . . . . 0.0 111.522 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.583 HD13 HG21 ' X' ' 22' ' ' ILE . 36.8 mt -67.17 -47.05 82.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.412 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.6 m-85 -57.91 -45.7 86.08 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.432 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.0 pt-20 -70.4 -39.94 74.2 Favored 'General case' 0 C--O 1.201 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.737 0 CA-C-N 117.727 0.24 . . . . 0.0 110.883 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.221 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.557 ' O ' HG13 ' X' ' 75' ' ' ILE . 34.0 Cg_endo -71.95 -22.03 23.68 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 123.725 2.95 . . . . 0.0 113.325 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -72.55 0.44 10.47 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.2 -14.06 23.34 Favored Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.889 -1.624 . . . . 0.0 113.275 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.557 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.9 OUTLIER -70.2 -43.39 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.696 HG11 HG12 ' X' ' 16' ' ' VAL . 1.1 p -59.85 -47.07 92.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.686 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.86 -42.35 97.67 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.24 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.2 -40.6 86.25 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.446 HG21 HG22 ' X' ' 45' ' ' THR . 41.0 mm -67.21 -46.43 84.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.928 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -63.82 -35.68 81.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.759 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.57 -41.48 92.89 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.979 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.548 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 84.1 t90 -66.41 -47.99 71.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 11.9 tpt180 -61.27 -45.52 94.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.43 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.72 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.219 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.26 -26.5 66.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.978 0.418 . . . . 0.0 111.308 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -85.24 -12.25 52.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.78 37.71 44.23 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.991 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.0 mtpp -117.25 137.83 24.36 Favored Pre-proline 0 N--CA 1.392 -3.353 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.7 129.79 27.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.346 2.03 . . . . 0.0 110.42 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.0 -114.6 3.38 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.187 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' X' ' 7' ' ' ILE . 72.4 m-85 -83.67 152.22 24.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.095 -0.553 . . . . 0.0 110.958 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.8 ptmt -87.73 166.73 14.42 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -105.92 142.21 36.01 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 176.038 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.418 ' CD2' HD21 ' X' ' 18' ' ' LEU . 94.8 mt . . . . . 0 CA--C 1.493 -1.244 0 CA-C-O 120.693 0.282 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.545 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 28.6 mmtt -101.72 -159.45 0.73 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.04 -23.58 8.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -143.14 166.69 23.98 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tp -62.7 -18.67 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -77.52 -4.37 45.29 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.711 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.545 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 9.6 t70 -112.34 -3.8 14.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.476 ' CZ ' ' HG2' ' X' ' 4' ' ' LYS . 39.4 m-85 -93.99 116.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.706 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 70.8 p -75.77 173.48 11.06 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 170.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.65 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.9 pt-20 -56.09 -44.54 79.11 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.303 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.404 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.58 -38.57 74.09 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 32.1 mm-40 -58.89 -36.61 74.94 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.729 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -67.33 -50.09 61.43 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.706 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.773 HG12 HG11 ' X' ' 76' ' ' VAL . 2.7 m -61.56 -34.55 62.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 O-C-N 123.182 0.301 . . . . 0.0 111.328 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.62 77.18 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.196 0.998 . . . . 0.0 108.678 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.554 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -65.95 -41.2 91.57 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.153 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.3 mt -58.52 -37.59 75.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.226 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 76.7 mttt -66.52 -36.86 83.72 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.535 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.27 -33.11 61.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.688 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' X' ' 37' ' ' LEU . 48.1 mt -61.97 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.15 -35.02 79.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.57 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -70.21 -52.17 25.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.597 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -70.03 -18.18 63.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.464 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.68 -52.02 20.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.938 0.895 . . . . 0.0 110.26 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.6 -23.56 19.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.857 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.5 -4.23 57.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 0.0 109.616 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 49.36 62.41 2.64 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.693 1.597 . . . . 0.0 112.927 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.619 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 54.8 p -88.34 -177.84 5.75 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.77 -63.42 0.7 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.634 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.609 ' O ' HG23 ' X' ' 36' ' ' VAL . 30.8 m-20 -58.02 -48.59 79.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 12.0 p -84.56 -32.63 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.362 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.54 -44.71 93.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.82 -32.71 72.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.473 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.609 HG23 ' O ' ' X' ' 32' ' ' ASP . 71.6 t -59.27 -49.13 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-O 121.877 0.846 . . . . 0.0 109.121 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.724 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.3 mt -68.33 -40.58 81.55 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 113.415 -1.721 . . . . 0.0 110.889 -174.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -58.8 -49.29 78.25 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 124.316 1.01 . . . . 0.0 110.729 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -69.29 -42.09 75.94 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.287 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 43.2 t60 -61.38 -44.98 96.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.227 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.65 ' O ' HG22 ' X' ' 45' ' ' THR . 42.3 t80 -55.71 -53.08 60.94 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.693 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.408 HG12 ' O ' ' X' ' 38' ' ' LEU 0.293 8.1 p -66.77 -31.6 54.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -74.44 -33.13 62.85 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.055 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.541 HG12 ' O ' ' X' ' 40' ' ' HIS . 30.1 pt -79.9 -36.83 17.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.207 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.65 HG22 ' O ' ' X' ' 41' ' ' PHE . 10.0 t -85.41 -28.26 25.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 61.35 27.8 17.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.213 1.005 . . . . 0.0 110.839 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.517 ' H ' HG23 ' X' ' 45' ' ' THR . 76.6 t60 -82.51 137.58 44.83 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' X' ' 47' ' ' HIS . 13.3 Cg_exo -75.14 0.01 9.48 Favored 'Trans proline' 0 CA--C 1.486 -1.889 0 C-N-CA 123.235 2.624 . . . . 0.0 113.067 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 29.5 m-20 -139.0 34.01 2.15 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.82 -56.08 9.07 Favored Glycine 0 CA--C 1.461 -3.326 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.091 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.564 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.332 0.8 OUTLIER -84.01 -20.1 33.34 Favored 'General case' 0 C--N 1.259 -3.345 0 C-N-CA 116.886 -1.926 . . . . 0.0 114.316 -176.574 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.16 -36.62 82.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 30.3 mt -61.83 -42.82 99.51 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 123.813 0.695 . . . . 0.0 112.236 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.61 -45.96 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.353 1.073 . . . . 0.0 108.831 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.59 -42.7 98.26 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.479 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -69.03 -35.18 76.33 Favored 'General case' 0 C--O 1.206 -1.221 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.402 175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 CA--C 1.501 -0.931 0 C-N-CA 122.704 0.402 . . . . 0.0 111.182 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.729 0 CA-C-O 121.314 0.397 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.54 ' O ' HG12 ' X' ' 76' ' ' VAL . 25.0 Cg_endo -71.98 -56.12 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.497 2.798 . . . . 0.0 114.076 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.01 0.59 1.81 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.39 -31.17 3.1 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.607 -1.758 . . . . 0.0 114.137 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.665 HG13 HD13 ' X' ' 19' ' ' LEU . 9.9 pt -67.11 -34.12 67.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 117.487 0.643 . . . . 0.0 110.602 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.773 HG11 HG12 ' X' ' 16' ' ' VAL . 0.2 OUTLIER -59.08 -43.26 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-O 121.997 0.903 . . . . 0.0 110.913 175.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 88.2 tttt -62.16 -47.24 85.4 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.33 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.22 -40.44 90.17 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.48 HD12 ' OG1' ' X' ' 45' ' ' THR . 22.5 mm -61.92 -46.23 96.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.485 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.488 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 20.3 pttp -70.41 -35.76 73.63 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.676 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 40.0 mt-10 -68.19 -39.88 82.37 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.209 0.318 . . . . 0.0 111.424 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -67.38 -48.1 68.41 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.173 0.511 . . . . 0.0 110.297 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.557 ' NH1' ' HA ' ' X' ' 45' ' ' THR . 15.9 ttt180 -70.98 -38.31 72.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.73 0.3 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -31.66 69.51 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.327 0.584 . . . . 0.0 110.378 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.55 -30.71 63.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.201 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.07 26.7 25.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -106.88 132.75 20.66 Favored Pre-proline 0 N--CA 1.399 -3.014 0 C-N-CA 123.491 0.717 . . . . 0.0 109.243 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.25 119.19 3.33 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.995 3.13 . . . . 0.0 113.768 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' X' ' 83' ' ' ARG . . . -95.15 -126.52 4.87 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.944 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 11.6 m-85 -84.84 165.65 17.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' X' ' 93' ' ' GLN . 19.5 ptmt -86.47 179.33 6.87 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 93' ' ' GLN . . . . . 0.453 ' O ' ' HE2' ' X' ' 92' ' ' LYS . 24.9 mp0 -96.55 139.3 32.85 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.615 0.722 . . . . 0.0 110.607 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.402 -3.627 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 177.204 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.456 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 83.7 mt . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' X' ' 9' ' ' ASP . 28.9 mmtt -111.66 -179.15 3.62 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -91.61 -39.26 11.97 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.192 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 6' ' ' SER . . . . . 0.43 ' HA ' HG22 ' X' ' 44' ' ' ILE . 64.8 p -127.87 167.23 16.87 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.653 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.06 -14.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.63 0.772 . . . . 0.0 109.836 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -79.08 -17.93 54.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.34 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' X' ' 4' ' ' LYS . 5.3 t70 -98.36 1.34 46.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.67 119.8 33.13 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.473 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -78.0 159.75 28.59 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.647 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.1 pt-20 -65.64 -30.64 71.37 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.644 -1.622 . . . . 0.0 111.723 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.76 77.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.07 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -58.04 -40.06 79.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.79 0.805 . . . . 0.0 109.092 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.666 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.1 t80 -71.15 -44.92 64.59 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.905 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.737 HG12 HG11 ' X' ' 76' ' ' VAL . 4.0 m -62.43 -34.81 66.5 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.825 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.39 -45.43 88.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.718 0.807 . . . . 0.0 109.347 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.514 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -66.63 -43.79 83.75 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.228 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.3 mt -58.08 -46.05 86.12 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.773 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 63.6 mtpt -62.02 -35.83 79.73 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.766 0.826 . . . . 0.0 110.0 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -74.52 -35.37 63.16 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.715 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.514 HG13 ' O ' ' X' ' 18' ' ' LEU . 44.1 mt -59.69 -44.41 93.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.921 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.426 ' O ' HG22 ' X' ' 27' ' ' VAL . 42.8 mt-10 -56.93 -44.82 82.85 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.383 0.611 . . . . 0.0 110.475 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -60.31 -46.09 91.08 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.647 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.5 ' HB2' ' CG2' ' X' ' 30' ' ' THR . 3.1 pp20? -84.92 -30.32 24.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.749 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 26' ' ' ASN . . . . . 0.416 ' HA ' HD23 ' X' ' 34' ' ' LEU . 23.0 t-20 -63.02 -40.67 98.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.59 0.756 . . . . 0.0 111.698 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 27' ' ' VAL . . . . . 0.426 HG22 ' O ' ' X' ' 23' ' ' GLU . 34.7 m -80.5 -7.04 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.256 0.55 . . . . 0.0 111.313 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.03 -25.77 13.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.71 85.36 0.13 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.698 1.599 . . . . 0.0 110.297 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 72.7 p -92.07 -24.23 19.22 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 70.41 -50.81 0.66 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.37 1.868 . . . . 0.0 114.358 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.533 ' O ' HG23 ' X' ' 36' ' ' VAL . 14.3 t70 -70.25 -56.79 5.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 118.034 0.379 . . . . 0.0 110.23 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.5 p -80.87 -25.45 10.87 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.457 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.6 tm? -58.23 -48.31 80.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.779 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.71 -32.46 73.1 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.839 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.533 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.0 t -66.81 -50.69 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.549 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 35.4 mt -68.45 -43.81 76.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.02 -171.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.5 HD13 ' CG2' ' X' ' 51' ' ' THR . 46.4 mt -61.98 -45.67 92.61 Favored 'General case' 0 N--CA 1.419 -2.016 0 O-C-N 124.211 0.944 . . . . 0.0 111.707 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -70.3 -43.28 70.7 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.882 0.372 . . . . 0.0 111.757 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.478 ' O ' HG12 ' X' ' 44' ' ' ILE . 9.6 t60 -59.56 -45.14 92.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.328 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.599 ' O ' HG22 ' X' ' 45' ' ' THR . 27.5 t80 -59.68 -55.75 30.43 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.641 1.213 . . . . 0.0 110.824 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' X' ' 38' ' ' LEU 0.278 14.7 p -66.87 -31.64 54.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -69.84 -30.53 68.04 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.84 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.478 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.0 pt -85.27 -35.92 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.574 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.599 HG22 ' O ' ' X' ' 41' ' ' PHE . 4.7 t -84.47 -30.86 24.89 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.394 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.58 36.75 13.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 125.041 1.336 . . . . 0.0 110.34 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.464 ' H ' HG23 ' X' ' 45' ' ' THR . 26.2 t-80 -81.94 136.21 47.7 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.271 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 22.3 Cg_exo -70.96 -14.33 32.22 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.787 2.324 . . . . 0.0 111.941 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.427 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 22.3 m-20 -128.3 31.98 4.95 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -172.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.08 8.38 Favored Glycine 0 CA--C 1.457 -3.54 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.419 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.5 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.77 -33.94 58.03 Favored 'General case' 0 C--N 1.251 -3.697 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.055 -174.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.59 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.65 -31.88 69.94 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.191 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 mt -62.29 -48.51 79.55 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 123.574 0.546 . . . . 0.0 112.101 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.523 ' H ' HD12 ' X' ' 54' ' ' ILE . 4.4 mp -66.81 -40.43 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.742 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.45 ' HD1' ' O ' ' X' ' 51' ' ' THR . 27.1 m-85 -61.62 -43.29 99.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.78 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.9 pt-20 -71.97 -37.04 69.98 Favored 'General case' 0 C--O 1.203 -1.345 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.202 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 122.594 0.358 . . . . 0.0 110.978 178.853 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 114.429 0.531 . . . . 0.0 114.429 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' HG13 ' X' ' 75' ' ' ILE . 36.7 Cg_endo -60.05 -53.6 2.96 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 123.694 2.929 . . . . 0.0 114.701 -167.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.88 0.17 9.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 74' ' ' GLY . . . . . 0.596 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -105.58 -18.58 11.53 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.004 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.504 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.5 OUTLIER -67.26 -44.22 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.737 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -60.49 -39.75 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.656 176.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 22.5 ttpp -58.55 -47.67 83.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.856 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 78' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 7.2 mm-40 -58.01 -45.08 87.43 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.125 0.964 . . . . 0.0 109.196 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.489 HG12 ' O ' ' X' ' 75' ' ' ILE . 41.9 mm -61.62 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.447 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.1 ptpt -65.89 -38.31 88.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.983 -177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.65 -40.16 76.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.907 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 63.1 t90 -70.17 -46.77 63.96 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.787 0.327 . . . . 0.0 110.684 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.52 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 8.4 tpt180 -60.55 -45.58 93.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.38 88.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.947 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.33 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.974 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -69.4 -34.99 75.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.68 44.07 1.86 Allowed Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.484 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 54.9 mttm -119.5 146.42 41.17 Favored Pre-proline 0 N--CA 1.4 -2.941 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.78 124.68 15.47 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.634 2.223 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -88.39 -132.43 4.11 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.864 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 80.8 m-85 -89.54 166.18 13.82 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.32 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -99.28 166.99 10.94 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.21 144.5 25.76 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.673 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 CA--C 1.487 -1.476 0 CA-C-O 121.16 0.505 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.415 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 31.6 mmtt -105.3 -164.43 1.03 Allowed 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -114.25 -28.36 7.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.357 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -128.97 163.46 25.29 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -67.5 -16.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-O 121.471 0.653 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -79.1 -3.26 44.51 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.55 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.467 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.1 t0 -110.21 1.64 18.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.213 1.006 . . . . 0.0 108.92 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -93.75 121.01 34.74 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.521 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -82.37 176.14 9.67 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.572 ' O ' HG13 ' X' ' 16' ' ' VAL . 4.7 mm-40 -59.23 -51.97 67.7 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.799 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.84 -38.7 76.57 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.879 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.64 -40.97 80.48 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.172 0.51 . . . . 0.0 109.843 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.523 ' O ' HD13 ' X' ' 19' ' ' LEU . 30.2 t80 -75.06 -48.53 23.51 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.095 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.799 HG22 ' HA ' ' X' ' 13' ' ' ALA . 15.7 m -58.6 -38.58 71.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -66.8 -46.27 75.76 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 122.682 0.393 . . . . 0.0 111.027 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.562 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.4 tm? -62.95 -41.31 99.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.523 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.31 -36.86 76.4 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.148 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.704 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 61.4 mttm -63.58 -40.13 96.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.964 0.888 . . . . 0.0 108.816 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -65.13 -36.06 83.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.966 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.599 HG12 ' HB3' ' X' ' 37' ' ' LEU . 19.3 mt -63.74 -39.55 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.285 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -56.87 -46.07 82.07 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.602 0.564 . . . . 0.0 109.915 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -62.93 -43.89 97.56 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.081 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.08 -33.33 70.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.284 0.564 . . . . 0.0 109.885 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.37 -44.94 57.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.564 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.34 -29.86 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.744 0.307 . . . . 0.0 111.693 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -4.67 57.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.464 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 48.34 64.85 1.51 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.179 1.392 . . . . 0.0 112.256 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 72.7 p -83.22 -161.07 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -130.42 -71.16 0.6 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.393 -1.323 . . . . 0.0 114.398 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.611 ' O ' HG23 ' X' ' 36' ' ' VAL . 27.6 t70 -56.64 -52.43 64.9 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 68.9 t -86.83 -25.11 6.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.239 -174.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -58.79 -50.8 72.62 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.7 -19.81 61.33 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.611 HG23 ' O ' ' X' ' 32' ' ' ASP . 59.2 t -71.48 -49.76 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.074 0 C-N-CA 118.289 -1.365 . . . . 0.0 108.471 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' X' ' 22' ' ' ILE . 88.5 mt -68.5 -43.54 76.62 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.091 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.5 mt -60.54 -47.09 87.7 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 124.337 1.023 . . . . 0.0 110.457 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -71.03 -43.72 67.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.618 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 39.1 t60 -60.34 -45.58 92.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.223 0.535 . . . . 0.0 110.062 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.622 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 38.4 t80 -59.14 -53.0 63.25 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.191 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.506 HG12 ' O ' ' X' ' 38' ' ' LEU . 13.1 p -67.99 -32.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -67.0 -36.98 83.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 122.07 -0.394 . . . . 0.0 111.502 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.566 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -81.1 -34.1 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.855 0.36 . . . . 0.0 111.378 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 35.2 p -83.84 -42.46 16.4 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.96 74.97 0.42 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 125.173 1.389 . . . . 0.0 109.583 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.559 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -126.11 139.01 33.32 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.164 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.46 -7.89 22.18 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.794 2.329 . . . . 0.0 112.31 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 16.3 m-20 -135.21 31.9 3.18 Favored 'General case' 0 N--CA 1.391 -3.386 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.622 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.81 -58.2 8.77 Favored Glycine 0 CA--C 1.461 -3.316 0 O-C-N 123.679 0.612 . . . . 0.0 112.704 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.472 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.23 -28.65 63.3 Favored 'General case' 0 C--N 1.248 -3.82 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.148 -174.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.78 -34.34 77.94 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.323 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.57 -45.4 77.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.905 0.482 . . . . 0.0 110.052 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.595 HD13 HG21 ' X' ' 22' ' ' ILE . 23.4 mt -66.84 -44.37 89.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.608 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -59.49 -49.68 76.86 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.754 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.7 pt-20 -66.94 -35.76 80.7 Favored 'General case' 0 C--O 1.188 -2.158 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.634 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.89 0.376 . . . . 0.0 110.763 179.122 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.636 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.581 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.0 Cg_endo -59.12 -38.64 85.6 Favored 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.536 2.824 . . . . 0.0 113.48 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.438 ' C ' HG22 ' X' ' 76' ' ' VAL . 23.3 mt-10 -85.03 1.65 46.74 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 123.212 0.605 . . . . 0.0 109.918 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.05 -36.91 2.08 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.36 -1.4 . . . . 0.0 112.641 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' X' ' 72' ' ' PRO . 5.8 pt -60.71 -34.33 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 172.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.676 HG11 HG12 ' X' ' 16' ' ' VAL . 16.6 m -56.62 -39.36 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.559 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 23.4 ttmm -68.77 -39.41 80.23 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.041 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -67.08 -32.15 73.13 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.965 0.888 . . . . 0.0 109.155 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.491 ' HA ' HH21 ' X' ' 83' ' ' ARG . 83.0 mt -67.62 -46.35 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.873 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 14.4 ptmm? -67.71 -36.27 80.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 111.105 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.1 mt-10 -70.45 -36.79 74.15 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.899 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -66.8 -41.16 88.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.559 HH22 ' CD2' ' X' ' 47' ' ' HIS . 0.5 OUTLIER -61.87 -46.27 90.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.379 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.65 91.78 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.796 0.685 . . . . 0.0 111.517 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.937 0.398 . . . . 0.0 110.85 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -68.33 -48.54 64.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.486 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.52 4.77 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.91 151.6 37.54 Favored Pre-proline 0 N--CA 1.407 -2.58 0 C-N-CA 123.933 0.893 . . . . 0.0 108.828 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.97 140.96 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.978 1.785 . . . . 0.0 111.617 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.82 -131.3 6.61 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 10.7 m-85 -93.46 159.36 15.28 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 19.7 ptmt -93.94 172.8 8.01 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -96.25 135.69 37.73 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.712 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.203 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.163 178.406 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.406 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 87.3 mt . . . . . 0 N--CA 1.428 -1.554 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 26.1 mmtt -105.89 152.53 23.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -80.2 -11.7 59.71 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.138 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 67.5 p -141.88 162.3 35.81 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -69.4 -13.07 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 121.643 0.735 . . . . 0.0 110.676 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -77.98 -17.91 56.6 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 14.3 t70 -102.43 5.33 39.56 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.6 m-85 -94.03 114.32 26.47 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.938 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.421 HG22 ' HG3' ' X' ' 92' ' ' LYS . 53.2 p -77.32 157.11 30.87 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.431 ' O ' HG12 ' X' ' 16' ' ' VAL . 6.2 pt-20 -64.67 -26.39 68.36 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.734 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.74 69.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.677 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -57.32 -41.65 80.36 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.266 0.555 . . . . 0.0 109.537 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -64.98 -58.27 6.54 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.041 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.627 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 13.8 p -63.43 -29.55 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -60.21 -44.73 94.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.524 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.3 tm? -67.22 -40.92 86.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.547 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.2 mt -58.27 -36.63 73.56 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.34 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 54.5 mtpt -66.84 -35.74 80.74 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.327 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 21' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 12.0 pt-20 -75.5 -31.43 60.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.851 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' X' ' 18' ' ' LEU . 49.9 mt -60.3 -39.99 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 123.77 0.669 . . . . 0.0 109.843 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -58.35 -41.21 84.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.559 0.695 . . . . 0.0 109.635 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.44 -47.79 46.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.401 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.71 ' OE2' ' HA ' ' X' ' 34' ' ' LEU 0.274 0.0 OUTLIER -75.47 -19.5 59.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.446 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' X' X ' 26' ' ' ASN . . . . . 0.458 HD21 HD21 ' X' ' 38' ' ' LEU . 2.2 m-80 -76.77 -42.1 42.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.385 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 -34.51 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.314 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.24 48.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.66 0.267 . . . . 0.0 110.464 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.83 95.77 0.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.173 1.389 . . . . 0.0 111.977 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 38.8 p -107.66 -171.37 1.86 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -136.34 -20.19 1.42 Allowed 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.102 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.564 ' O ' HG23 ' X' ' 36' ' ' VAL . 10.9 m-20 -85.51 -61.85 1.67 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.154 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.593 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.6 p -76.55 -26.93 16.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.007 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.71 ' HA ' ' OE2' ' X' ' 25' ' ' GLU . 3.1 tm? -58.78 -44.66 90.74 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 124.333 1.021 . . . . 0.0 108.701 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.7 t70 -72.42 -36.77 68.69 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.363 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.564 HG23 ' O ' ' X' ' 32' ' ' ASP . 47.2 t -63.66 -49.79 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 O-C-N 124.324 1.015 . . . . 0.0 110.609 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 41.2 mt -68.14 -41.14 82.1 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.991 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 14.4 mt -59.45 -49.66 76.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 O-C-N 124.437 1.085 . . . . 0.0 111.815 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.3 pt-20 -70.98 -42.29 69.87 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.102 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.485 ' O ' HG12 ' X' ' 44' ' ' ILE . 69.9 t60 -60.26 -45.72 92.3 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.014 0.526 . . . . 0.0 110.373 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.653 ' O ' HG22 ' X' ' 45' ' ' THR . 39.4 t80 -57.95 -53.72 55.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 124.265 0.978 . . . . 0.0 110.834 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -66.34 -31.06 51.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -63.38 -47.46 81.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.494 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 4.9 pt -75.15 -36.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.653 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.67 -31.58 24.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.509 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 61.91 29.59 17.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.914 0.864 . . . . 0.0 111.319 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.541 ' H ' HG23 ' X' ' 45' ' ' THR . 50.5 t-80 -77.94 135.87 62.77 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 30.3 Cg_exo -66.11 -19.22 57.22 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 123.151 2.567 . . . . 0.0 112.316 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.98 36.22 4.35 Favored 'General case' 0 N--CA 1.393 -3.296 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.585 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.64 -55.91 7.76 Favored Glycine 0 CA--C 1.462 -3.226 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.136 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.448 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -77.0 -26.17 53.55 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.332 -171.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.58 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.14 -36.71 83.86 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.303 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.3 -38.93 85.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 123.504 0.503 . . . . 0.0 111.729 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -66.73 -47.26 83.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.704 0.764 . . . . 0.0 109.416 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -63.67 -46.87 83.59 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.86 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.9 pt-20 -68.53 -36.39 78.78 Favored 'General case' 0 C--O 1.196 -1.758 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.79 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 CA-C-N 118.246 0.475 . . . . 0.0 111.561 -179.485 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.385 -4.764 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.538 ' HA ' HD11 ' X' ' 75' ' ' ILE . 2.9 Cg_endo -64.42 -30.94 62.45 Favored 'Trans proline' 0 CA--C 1.497 -1.366 0 C-N-CA 122.854 2.369 . . . . 0.0 111.14 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.04 -4.18 56.21 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.891 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.84 -15.41 14.94 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.284 -1.912 . . . . 0.0 113.007 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.55 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -68.04 -49.2 70.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.036 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' X' ' 16' ' ' VAL . 1.2 p -55.49 -45.57 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.841 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 56.0 tttp -59.8 -47.3 86.27 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.399 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.55 HG12 ' O ' ' X' ' 75' ' ' ILE . 46.7 mm -66.03 -45.42 90.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.873 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.5 ptpt -61.98 -42.17 98.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.905 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.62 -38.75 70.76 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.54 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 85.1 t90 -66.17 -47.92 72.42 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 110.715 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.572 ' HG2' ' HB2' ' X' ' 88' ' ' LYS . 3.4 ttt-85 -68.9 -41.6 78.02 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.222 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.41 84.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.2 86.72 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.525 0.202 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.468 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.0 t-20 -63.29 -43.82 96.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.37 18.89 6.45 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.572 ' HB2' ' HG2' ' X' ' 83' ' ' ARG . 68.5 mttm -99.15 158.64 31.92 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 89' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' X' ' 83' ' ' ARG . 36.8 Cg_endo -71.5 130.0 16.58 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.434 1.423 . . . . 0.0 110.819 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -119.41 2.37 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.291 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.429 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.7 m-85 -96.74 154.52 17.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 120.524 0.202 . . . . 0.0 110.539 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.421 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.9 ptmt -89.86 176.28 6.88 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -94.23 137.51 33.32 Favored 'General case' 0 N--CA 1.398 -3.04 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.184 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.26 0 CA-C-O 118.074 -1.403 . . . . 0.0 110.304 177.857 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.493 -1.229 0 CA-C-O 121.18 0.514 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 40.1 mmtt -103.12 -170.3 1.77 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 171.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -112.41 -24.28 9.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.064 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.5 p -134.35 164.88 26.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.03 -12.52 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.617 0.722 . . . . 0.0 111.051 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -76.07 -18.43 59.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.527 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.426 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.2 t70 -102.74 2.74 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.239 1.019 . . . . 0.0 108.454 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -96.05 113.41 25.02 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.218 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 62.2 p -73.53 160.56 31.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.638 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.83 -32.19 71.58 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.566 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.61 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.4 -39.04 74.72 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.536 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 22.7 mm-40 -58.07 -42.35 85.31 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.552 1.168 . . . . 0.0 108.61 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.33 -47.48 60.87 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 113.137 -1.847 . . . . 0.0 110.492 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.711 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 22.8 m -58.49 -39.41 75.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.394 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.5 -50.57 73.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.251 0.62 . . . . 0.0 111.25 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.522 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.5 tm? -66.52 -40.36 89.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.723 0.773 . . . . 0.0 109.041 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' X' ' 75' ' ' ILE . 9.9 tp -59.66 -42.61 93.22 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.957 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.5 mttt -61.43 -34.84 76.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.201 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.32 -41.59 85.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.025 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' X' ' 37' ' ' LEU . 13.0 mt -57.52 -42.49 81.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.23 -44.83 88.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.493 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -67.57 -45.48 75.45 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.054 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.454 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -69.8 -19.04 63.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.418 177.324 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -86.06 -46.53 10.39 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.275 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.94 -32.36 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.26 -6.3 57.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.732 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.99 80.4 0.11 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.754 1.622 . . . . 0.0 113.323 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.645 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 64.2 p -91.68 -165.48 1.36 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.23 -73.09 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.089 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.618 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.2 t70 -60.35 -51.21 70.46 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 123.434 0.459 . . . . 0.0 111.449 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.68 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.0 p -73.03 -35.27 47.95 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.363 -175.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.645 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.4 tm? -58.95 -47.6 84.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.703 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.35 -41.5 98.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.319 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.618 HG23 ' O ' ' X' ' 32' ' ' ASP . 77.9 t -56.71 -49.56 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 O-C-N 123.77 0.669 . . . . 0.0 109.927 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 86.1 mt -68.41 -43.79 76.44 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.982 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 29.6 mt -61.21 -48.47 81.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 124.154 0.909 . . . . 0.0 110.637 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -70.72 -41.53 71.79 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.131 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.553 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.9 t60 -61.29 -45.91 92.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.238 0.542 . . . . 0.0 109.846 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.641 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.2 t80 -59.14 -52.6 64.99 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.334 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.432 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.1 p -67.62 -32.15 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 53.1 pttt -68.48 -39.61 81.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.53 HG12 ' O ' ' X' ' 40' ' ' HIS . 27.4 pt -77.67 -31.38 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.5 p -84.07 -39.99 18.88 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 46' ' ' GLU . . . . . 0.403 ' HB2' ' NH1' ' X' ' 83' ' ' ARG . 6.4 mm-40 67.07 20.19 10.38 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 123.915 0.886 . . . . 0.0 111.24 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.415 ' HA ' ' HD3' ' X' ' 48' ' ' PRO . 39.7 t-80 -80.73 133.25 55.8 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.431 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.2 Cg_exo -71.34 -2.26 10.94 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.488 2.792 . . . . 0.0 113.043 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 15.1 m-20 -130.05 27.65 5.11 Favored 'General case' 0 N--CA 1.394 -3.237 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.641 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -43.73 -60.28 3.41 Favored Glycine 0 CA--C 1.459 -3.407 0 O-C-N 124.388 1.055 . . . . 0.0 112.931 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.497 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.35 -29.33 63.7 Favored 'General case' 0 C--N 1.251 -3.711 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.716 -173.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.611 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.2 -30.47 70.94 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 53' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 97.9 mt -61.05 -41.52 96.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.153 0.502 . . . . 0.0 109.752 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.593 HD13 HG21 ' X' ' 22' ' ' ILE . 57.0 mt -67.21 -46.24 84.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.095 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -58.39 -49.52 76.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.645 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.5 pt-20 -68.0 -37.24 81.21 Favored 'General case' 0 C--O 1.207 -1.169 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.693 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.663 0.21 . . . . 0.0 110.81 178.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.372 -5.59 0 CA-C-O 120.795 0.108 . . . . 0.0 112.889 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.522 ' O ' HG13 ' X' ' 76' ' ' VAL . 11.6 Cg_endo -64.31 -48.29 4.88 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 124.645 3.563 . . . . 0.0 112.349 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.487 ' C ' HG22 ' X' ' 76' ' ' VAL . 42.0 mt-10 -77.78 1.92 18.65 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.0 -39.3 2.33 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 118.651 -1.738 . . . . 0.0 112.769 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.557 ' O ' HG13 ' X' ' 79' ' ' ILE . 3.1 pt -62.73 -28.25 44.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 CA-C-N 117.495 0.647 . . . . 0.0 110.94 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.595 HG11 HG12 ' X' ' 16' ' ' VAL . 21.6 m -60.27 -36.11 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.945 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 83.6 tttt -65.86 -41.93 91.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.653 174.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 78' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' X' ' 75' ' ' ILE . 7.8 tp10 -58.07 -44.13 87.35 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.557 HG13 ' O ' ' X' ' 75' ' ' ILE . 82.9 mt -67.42 -46.34 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.618 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.6 ptmt -64.3 -37.77 88.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.38 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.84 -38.38 73.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 62.8 t90 -65.49 -47.36 76.29 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.797 0.808 . . . . 0.0 109.626 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 16.9 tpt180 -61.15 -45.8 93.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.693 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.93 81.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.125 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -32.79 73.67 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.442 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 25.3 t-20 -78.77 -48.81 14.14 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.55 34.3 1.45 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.442 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 66.6 mttm -103.81 141.85 23.38 Favored Pre-proline 0 N--CA 1.392 -3.368 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.39 121.51 9.34 Favored 'Trans proline' 0 CA--C 1.517 -0.34 0 C-N-CA 122.135 1.89 . . . . 0.0 110.956 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -95.14 -135.6 8.17 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.341 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -78.65 146.9 33.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.1 ptmt -85.81 174.51 9.27 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.98 139.12 51.62 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.597 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 CA--C 1.495 -1.17 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 21.2 mmtt -112.47 151.81 29.48 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.95 -9.07 59.69 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.278 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -145.71 160.93 41.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -67.71 -19.05 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.259 0.624 . . . . 0.0 111.037 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -73.75 -12.63 60.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.584 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 20.1 t70 -105.22 -0.81 26.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.895 0.855 . . . . 0.0 108.877 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.05 119.03 33.82 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.738 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 30.4 p -77.8 169.01 19.01 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.617 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.639 177.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.54 -38.69 74.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.6 -40.67 79.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.851 0.75 . . . . 0.0 109.399 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.57 ' HD2' HG12 ' X' ' 76' ' ' VAL . 20.5 t80 -70.56 -48.07 57.19 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.874 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.723 HG12 HG11 ' X' ' 76' ' ' VAL . 6.3 m -59.29 -39.57 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.519 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.19 -48.23 82.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.125 0.97 . . . . 0.0 110.884 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.451 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -66.17 -38.92 89.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.446 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.7 mp -62.47 -36.8 83.62 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.932 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 47.1 mtmt -61.43 -35.12 76.67 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.87 -34.73 69.44 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.333 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' X' ' 37' ' ' LEU . 20.8 mt -64.18 -40.26 88.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.004 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -59.83 -46.22 89.92 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.877 0.846 . . . . 0.0 108.789 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -60.54 -52.34 65.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.556 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 -25.63 68.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.272 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -78.72 -47.67 16.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.997 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -71.66 -23.27 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.789 0.328 . . . . 0.0 111.875 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.9 -17.71 30.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.64 67.16 1.0 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.74 1.216 . . . . 0.0 111.026 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -81.86 -31.24 31.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.655 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 68.37 -61.65 0.39 Allowed 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.082 1.753 . . . . 0.0 113.56 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.476 ' O ' HG23 ' X' ' 36' ' ' VAL . 6.5 m-20 -57.07 -57.99 10.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.066 0.547 . . . . 0.0 111.579 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -81.1 -28.9 11.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.202 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.346 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -44.06 92.72 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.84 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.96 -38.45 91.12 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.191 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' X' ' 39' ' ' GLU . 72.2 t -57.64 -48.97 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 O-C-N 124.405 1.066 . . . . 0.0 109.349 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 76.5 mt -65.21 -43.05 92.79 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.53 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.2 mt -59.99 -49.83 76.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.566 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' X' ' 36' ' ' VAL . 0.0 OUTLIER -70.9 -35.07 72.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.332 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.532 ' O ' HG12 ' X' ' 44' ' ' ILE . 24.0 t60 -66.07 -46.17 78.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.585 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.666 ' CD2' HD11 ' X' ' 54' ' ' ILE . 43.4 t80 -58.15 -53.28 60.03 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.432 HG23 ' O ' ' X' ' 47' ' ' HIS . 7.2 p -66.95 -32.6 58.72 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.606 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 42.9 pttt -75.21 -27.73 59.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.532 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.5 pt -84.13 -39.6 14.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.573 HG22 ' O ' ' X' ' 41' ' ' PHE . 15.1 t -85.18 -27.35 26.21 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 61.36 38.35 16.29 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 122.142 0.972 . . . . 0.0 111.238 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.432 ' O ' HG23 ' X' ' 42' ' ' VAL . 44.6 t-80 -94.32 132.94 28.0 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.542 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.7 -16.39 33.62 Favored 'Trans proline' 0 CA--C 1.495 -1.455 0 C-N-CA 123.042 2.494 . . . . 0.0 113.184 -173.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -120.78 30.48 6.88 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.12 -56.54 6.85 Favored Glycine 1 CA--C 1.447 -4.178 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.083 -177.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.439 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -79.13 -26.9 42.82 Favored 'General case' 0 C--N 1.249 -3.796 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.512 -170.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -58.38 -46.49 86.26 Favored 'General case' 0 C--O 1.189 -2.109 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -52.58 -46.01 66.73 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.666 HD11 ' CD2' ' X' ' 41' ' ' PHE . 3.9 mp -68.33 -47.15 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.256 -1.378 . . . . 0.0 109.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.01 -45.39 90.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.534 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 12.8 mm-40 -65.49 -44.88 85.71 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 122.765 0.426 . . . . 0.0 111.688 -178.506 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.538 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.418 -2.526 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.483 ' O ' HG13 ' X' ' 76' ' ' VAL . 10.6 Cg_endo -55.52 -50.49 12.59 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 124.154 3.236 . . . . 0.0 113.63 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.23 1.17 19.33 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.14 -39.9 1.9 Allowed Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 118.998 -1.572 . . . . 0.0 112.571 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.538 HG12 ' O ' ' X' ' 71' ' ' GLY . 5.1 pt -61.8 -31.69 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-N 117.164 0.482 . . . . 0.0 110.923 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.723 HG11 HG12 ' X' ' 16' ' ' VAL . 15.6 m -61.06 -33.08 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 121.086 0.47 . . . . 0.0 112.182 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 60.3 tttm -67.8 -48.01 67.49 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -61.45 -36.59 80.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.646 0.736 . . . . 0.0 109.317 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mm -66.81 -46.62 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.076 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.414 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 21.0 pttp -71.05 -39.61 72.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.101 0.477 . . . . 0.0 111.857 -173.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.1 mt-10 -66.59 -32.37 73.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.287 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -66.05 -47.65 73.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.96 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -37.3 84.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.192 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.2 99.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 123.987 0.804 . . . . 0.0 110.718 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.06 -32.4 59.26 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.624 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -76.13 -39.84 54.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.753 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.15 32.45 3.75 Favored Glycine 0 C--N 1.318 -0.466 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -110.6 163.07 18.12 Favored Pre-proline 0 N--CA 1.418 -2.06 0 C-N-CA 124.336 1.055 . . . . 0.0 109.481 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.32 141.13 61.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.406 2.071 . . . . 0.0 112.384 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.5 -155.26 19.33 Favored Glycine 0 N--CA 1.42 -2.427 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.18 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 30.8 m-85 -78.18 151.77 33.05 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -81.7 160.39 23.69 Favored 'General case' 0 N--CA 1.382 -3.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.41 133.93 37.46 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.828 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' X' ' 40' ' ' HIS . 95.1 mt . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 29.7 mmtt -107.23 156.45 18.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -77.72 -22.24 50.71 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.581 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 58.0 p -143.21 164.58 29.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.151 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.07 -16.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 111.496 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -14.62 61.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.117 0.484 . . . . 0.0 111.61 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 18.0 t70 -103.51 3.3 34.64 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.446 ' CE2' HD12 ' X' ' 44' ' ' ILE . 2.5 m-85 -96.91 112.84 24.42 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.904 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 46.6 p -76.95 155.22 32.88 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -56.95 -39.84 75.32 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.6 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.2 73.7 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.75 -42.16 83.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.76 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.1 t80 -67.2 -54.01 25.05 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.372 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.828 HG12 HG11 ' X' ' 76' ' ' VAL . 10.5 m -60.09 -32.82 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -68.46 -42.95 78.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.667 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.8 tm? -63.24 -40.07 96.41 Favored 'General case' 0 C--O 1.205 -1.237 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 56.5 mt -64.8 -36.44 84.32 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.637 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.453 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 48.2 mttp -66.18 -37.58 85.94 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.59 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 21' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' X' ' 18' ' ' LEU . 13.2 pt-20 -72.17 -31.88 66.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.536 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.667 HG13 ' O ' ' X' ' 18' ' ' LEU . 29.9 mt -66.11 -45.54 90.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.04 -42.0 84.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.383 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.55 -47.16 87.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.596 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -79.65 -24.67 41.69 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.983 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -65.05 -43.77 91.2 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.716 0.293 . . . . 0.0 110.27 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.5 m -76.28 -34.72 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.534 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -29.63 67.67 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.762 0.791 . . . . 0.0 109.097 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 76.49 87.57 0.08 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 127.469 2.307 . . . . 0.0 113.855 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -109.22 175.59 5.4 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -136.31 -4.68 2.1 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.03 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.499 ' O ' HG23 ' X' ' 36' ' ' VAL . 17.7 p-10 -86.14 -62.81 1.43 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.0 p -81.54 -26.03 10.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.539 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.8 tm? -58.06 -46.27 85.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.626 175.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 37.3 t70 -61.24 -45.83 92.93 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.539 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.499 HG23 ' O ' ' X' ' 32' ' ' ASP . 42.9 t -62.01 -50.01 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 O-C-N 124.4 1.063 . . . . 0.0 110.92 -176.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 91.1 mt -67.9 -41.81 82.12 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.937 -172.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.2 mt -59.36 -50.13 75.16 Favored 'General case' 0 N--CA 1.417 -2.107 0 O-C-N 124.122 0.888 . . . . 0.0 111.72 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.1 pt-20 -71.82 -36.52 70.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.588 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 5.0 t60 -65.78 -38.28 88.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.603 ' O ' HG22 ' X' ' 45' ' ' THR . 31.7 t80 -62.7 -51.66 66.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.14 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.422 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 5.9 p -67.17 -32.57 58.28 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.848 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -68.65 -30.13 68.76 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.999 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.468 HG12 ' O ' ' X' ' 40' ' ' HIS . 9.5 pt -83.96 -42.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 122.146 -0.346 . . . . 0.0 111.635 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.603 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.0 t -84.16 -28.39 27.44 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.608 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 62.91 26.14 15.4 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.472 ' H ' HG23 ' X' ' 45' ' ' THR . 42.6 t-80 -75.09 134.26 74.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -69.93 -14.45 35.55 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.831 2.354 . . . . 0.0 112.082 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.4 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.18 29.68 6.03 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 -173.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.597 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.96 -57.88 8.3 Favored Glycine 0 CA--C 1.455 -3.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.107 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.428 ' CG2' HD13 ' X' ' 38' ' ' LEU . 1.4 m -73.34 -29.15 62.47 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.755 -172.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.6 97.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.658 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -57.73 -43.31 85.22 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 123.558 0.536 . . . . 0.0 112.251 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.548 HD13 HG21 ' X' ' 22' ' ' ILE . 64.2 mt -66.59 -42.2 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 121.684 0.754 . . . . 0.0 110.044 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.77 91.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.05 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.24 77.78 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.948 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.443 0 O-C-N 123.222 0.326 . . . . 0.0 110.809 178.234 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.073 0 CA-C-O 121.208 0.338 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.453 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 18.0 Cg_endo -60.57 -29.05 87.73 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 124.755 3.637 . . . . 0.0 113.9 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.472 ' C ' HG22 ' X' ' 76' ' ' VAL . 84.0 mt-10 -95.66 1.96 53.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.676 0.274 . . . . 0.0 110.326 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.78 -37.47 3.19 Favored Glycine 0 N--CA 1.426 -1.984 0 C-N-CA 118.587 -1.768 . . . . 0.0 111.803 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.551 ' CD1' HD13 ' X' ' 19' ' ' LEU . 9.0 pt -58.33 -32.11 44.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 120.68 0.276 . . . . 0.0 110.927 174.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.828 HG11 HG12 ' X' ' 16' ' ' VAL . 19.1 m -63.93 -36.65 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.7 ttmm -67.14 -38.12 84.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -68.67 -40.59 80.08 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.447 HG23 ' OG1' ' X' ' 45' ' ' THR . 22.0 mm -61.98 -46.57 96.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.771 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 19.9 pttp -66.95 -41.01 87.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.396 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.46 -31.96 73.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.575 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 91.3 t90 -72.24 -48.94 38.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.196 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' X' ' 88' ' ' LYS . 10.1 ttt85 -71.17 -37.02 72.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.623 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.18 87.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.741 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.23 -26.35 65.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.117 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.38 -22.02 57.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 120.943 0.402 . . . . 0.0 110.162 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 49.91 16.3 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 60.3 tttp -133.6 126.53 19.11 Favored Pre-proline 0 N--CA 1.414 -2.241 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.72 119.42 5.58 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.283 3.322 . . . . 0.0 113.887 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.63 -127.12 4.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.255 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.9 m-85 -79.3 151.55 31.01 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 120.555 0.217 . . . . 0.0 110.577 -174.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.422 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 20.4 ptmt -93.31 179.1 5.51 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -110.91 142.24 43.25 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 123.031 0.532 . . . . 0.0 109.738 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.119 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.427 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 76.5 mt . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 121.887 0.851 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 26.7 mmtt -104.85 -162.06 0.86 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -119.56 -31.64 4.53 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.201 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.2 p -126.07 166.95 16.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.568 HD13 HH12 ' X' ' 83' ' ' ARG . 7.9 tt -81.1 -0.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.975 0.893 . . . . 0.0 111.275 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.8 m -80.99 -10.13 59.75 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.28 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 18.9 t70 -106.85 1.27 24.58 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 7.9 m-85 -98.6 114.14 26.48 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.121 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.463 HG22 ' HG3' ' X' ' 92' ' ' LYS . 76.9 p -79.6 160.54 26.36 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.612 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.9 pt-20 -61.19 -36.94 81.22 Favored 'General case' 0 C--O 1.2 -1.552 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.828 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.35 -38.7 74.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.428 ' HB2' ' OG1' ' X' ' 11' ' ' THR . 1.0 OUTLIER -59.98 -42.18 93.64 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.111 0.958 . . . . 0.0 108.769 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -68.33 -49.02 63.25 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.534 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.722 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 18.7 m -57.78 -41.73 80.35 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 CA-C-N 117.98 0.355 . . . . 0.0 110.206 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -61.27 -49.4 77.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.698 0.799 . . . . 0.0 110.366 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.515 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -64.18 -41.96 96.89 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' X' ' 75' ' ' ILE . 13.9 tp -59.7 -44.27 93.76 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.913 1.285 . . . . 0.0 111.319 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.7 mttt -61.56 -35.21 77.15 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.904 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.12 -38.31 82.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.548 HG21 HD13 ' X' ' 54' ' ' ILE . 23.2 mt -61.07 -43.73 96.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -34.97 73.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.81 -50.95 37.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -25.22 68.0 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.461 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -66.94 -55.41 14.71 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.254 1.022 . . . . 0.0 110.132 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 m -73.22 -21.43 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.75 -12.44 51.03 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.5 57.81 6.18 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.754 1.222 . . . . 0.0 110.982 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -78.17 -24.93 47.06 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.474 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 66.89 -64.31 0.24 Allowed 'General case' 0 C--O 1.205 -1.254 0 C-N-CA 126.043 1.737 . . . . 0.0 114.948 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.503 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.7 t70 -57.29 -57.09 14.14 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.252 0.478 . . . . 0.0 111.573 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -80.26 -30.7 12.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.35 -175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.22 -45.47 91.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.611 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.81 -36.55 83.81 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.317 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.503 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -57.31 -49.11 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 87.3 mt -67.99 -43.26 79.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.109 -173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.0 mt -59.24 -43.73 92.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.938 0.774 . . . . 0.0 110.991 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.12 -45.17 70.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.629 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.7 t60 -60.86 -45.7 93.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.018 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.594 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 58.8 t80 -58.65 -51.67 68.94 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.676 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.59 -34.11 66.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -71.86 -30.46 65.46 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.697 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.629 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.8 pt -84.1 -36.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.689 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -76.2 -42.57 45.8 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.524 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 61.5 30.23 18.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.922 1.289 . . . . 0.0 109.864 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -89.12 133.38 35.32 Favored Pre-proline 0 N--CA 1.415 -2.222 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.04 16.67 0.53 Allowed 'Trans proline' 0 CA--C 1.497 -1.352 0 C-N-CA 122.908 2.405 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.502 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 3.2 m-20 -142.99 23.06 1.9 Allowed 'General case' 0 N--CA 1.394 -3.255 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.594 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.16 -66.49 1.04 Allowed Glycine 0 CA--C 1.462 -3.255 0 O-C-N 124.724 1.265 . . . . 0.0 113.821 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.461 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -71.54 -26.03 62.47 Favored 'General case' 0 C--N 1.258 -3.4 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.842 -173.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.44 -38.3 90.55 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.675 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 53' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 96.5 mt -57.83 -46.51 84.64 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 124.202 0.939 . . . . 0.0 111.258 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.548 HD13 HG21 ' X' ' 22' ' ' ILE . 65.2 mt -67.14 -46.67 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.843 0.83 . . . . 0.0 109.891 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.23 -38.99 93.34 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.167 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.2 pt-20 -71.82 -36.45 70.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.012 176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.18 177.361 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.414 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.397 -3.911 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.425 ' CG ' ' HG2' ' X' ' 20' ' ' LYS . 3.9 Cg_exo -46.53 -52.36 7.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 125.257 3.971 . . . . 0.0 114.101 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -76.84 1.54 17.13 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.7 -39.28 1.91 Allowed Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.062 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.574 ' O ' HG13 ' X' ' 79' ' ' ILE . 2.5 pt -60.87 -33.0 53.71 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-N 117.261 0.531 . . . . 0.0 111.097 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.616 HG11 HG12 ' X' ' 16' ' ' VAL . 9.7 m -59.16 -32.29 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.504 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 25.0 ttmm -67.9 -42.38 81.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.078 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.27 -43.25 99.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.574 HG13 ' O ' ' X' ' 75' ' ' ILE . 76.9 mt -64.74 -44.14 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.868 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 19.1 ptpt -66.85 -43.47 83.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.747 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 42.0 mt-10 -67.95 -32.01 72.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.86 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -66.9 -48.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.568 HH12 HD13 ' X' ' 7' ' ' ILE . 1.3 mpp_? -70.77 -37.36 73.37 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.8 92.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.788 0.68 . . . . 0.0 110.498 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.1 -26.33 56.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 111.513 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.437 ' OD1' ' HD3' ' X' ' 88' ' ' LYS . 12.1 t-20 -77.33 -31.37 54.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.807 0.337 . . . . 0.0 110.578 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.55 40.06 5.14 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.437 ' HD3' ' OD1' ' X' ' 86' ' ' ASN . 12.7 mtpp -130.74 155.55 81.16 Favored Pre-proline 0 N--CA 1.416 -2.159 0 C-N-CA 123.504 0.722 . . . . 0.0 109.749 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.06 125.86 20.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.262 2.642 . . . . 0.0 112.586 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -106.7 -95.65 2.42 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.663 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.74 148.83 52.6 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.0 ptmt -85.04 164.9 17.95 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -95.64 136.24 36.29 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.66 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.254 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.461 ' CD2' HD13 ' X' ' 18' ' ' LEU . 40.1 mt . . . . . 0 CA--C 1.499 -1.01 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -97.06 -159.44 0.74 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -116.88 -27.24 6.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.07 0.462 . . . . 0.0 110.487 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 6' ' ' SER . . . . . 0.41 ' HA ' HG22 ' X' ' 44' ' ' ILE . 92.7 p -136.56 166.98 22.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.455 ' HB ' ' HB ' ' X' ' 44' ' ' ILE . 14.3 tt -67.3 -11.92 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 121.52 0.676 . . . . 0.0 110.618 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -75.37 -27.07 58.98 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.35 -170.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.62 -4.72 40.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.525 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -80.53 115.25 19.95 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.415 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 71.0 p -76.3 159.72 30.3 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 169.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.646 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.26 -34.84 74.28 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.032 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.25 -37.94 75.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -58.55 -39.45 80.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.56 0.695 . . . . 0.0 109.416 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.515 ' HD2' HG12 ' X' ' 76' ' ' VAL . 42.5 t80 -71.8 -44.22 64.33 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.156 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.735 HG12 HG11 ' X' ' 76' ' ' VAL . 7.6 m -61.94 -37.16 77.58 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.442 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.405 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -49.16 78.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.848 0.859 . . . . 0.0 108.778 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.668 ' O ' HG13 ' X' ' 22' ' ' ILE . 16.9 tp -57.53 -48.04 80.38 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.055 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' X' ' 23' ' ' GLU . 8.1 mp -60.36 -40.25 90.1 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.707 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 80.9 mttt -63.41 -35.59 80.93 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.218 0.532 . . . . 0.0 110.034 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -69.43 -42.4 75.06 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.668 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.9 mt -61.23 -42.3 92.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.333 0 O-C-N 124.073 0.858 . . . . 0.0 109.645 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' X' ' 19' ' ' LEU . 51.7 mt-10 -57.33 -46.29 83.41 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.5 -51.8 67.9 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.681 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -79.38 -21.75 45.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.44 -46.05 64.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.35 -33.08 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 110.557 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.25 -6.44 59.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.389 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.44 83.65 0.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.135 1.774 . . . . 0.0 114.435 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 16.4 p -99.72 -172.67 2.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.15 -29.76 0.88 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.614 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.504 ' O ' HG23 ' X' ' 36' ' ' VAL . 28.1 m-20 -70.68 -62.31 1.44 Allowed 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.336 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.705 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.6 p -78.85 -27.34 13.67 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.941 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.3 tm? -58.44 -47.07 85.18 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.212 1.005 . . . . 0.0 109.527 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.3 -28.19 62.93 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.504 HG23 ' O ' ' X' ' 32' ' ' ASP . 64.8 t -67.72 -50.72 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.977 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.506 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 51.6 mt -69.66 -43.99 71.44 Favored 'General case' 0 N--CA 1.412 -2.332 0 O-C-N 124.513 1.133 . . . . 0.0 111.711 -170.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.53 HD22 HG22 ' X' ' 51' ' ' THR . 28.4 mt -60.93 -46.41 90.81 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 124.233 0.958 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -70.74 -39.47 73.3 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.039 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.569 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.6 t60 -63.43 -45.44 90.94 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.245 0.545 . . . . 0.0 109.716 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 37.9 t80 -59.05 -53.46 58.18 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.665 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.409 HG12 ' O ' ' X' ' 38' ' ' LEU 0.252 11.9 p -68.08 -32.29 55.45 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.969 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 50.9 pttt -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.192 -0.317 . . . . 0.0 111.595 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.498 HG12 ' O ' ' X' ' 40' ' ' HIS . 31.5 pt -88.27 -31.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.058 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 47.1 p -85.06 -35.25 21.98 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 120.93 0.395 . . . . 0.0 111.285 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.82 29.53 17.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 125.353 1.461 . . . . 0.0 110.778 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 32.1 t-80 -76.08 138.57 68.75 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 107.861 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.9 Cg_exo -74.26 -6.89 19.06 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 C-N-CA 123.146 2.564 . . . . 0.0 112.151 -176.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.9 m-20 -130.71 30.63 4.63 Favored 'General case' 0 N--CA 1.389 -3.477 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.581 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.51 -59.82 6.85 Favored Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.617 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.53 HG22 HD22 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.97 -28.28 55.09 Favored 'General case' 0 C--N 1.248 -3.828 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.847 -176.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.614 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.74 -42.97 98.41 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.227 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.36 -49.23 76.83 Favored 'General case' 0 C--O 1.208 -1.085 0 O-C-N 123.525 0.515 . . . . 0.0 112.119 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.422 HD13 HG21 ' X' ' 22' ' ' ILE . 79.2 mt -67.74 -42.16 85.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.819 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.502 ' HD2' ' O ' ' X' ' 51' ' ' THR . 15.3 m-85 -60.21 -47.0 87.83 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.585 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 10.4 pt-20 -71.12 -36.43 72.12 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.687 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.063 0 O-C-N 123.305 0.378 . . . . 0.0 110.438 178.883 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.497 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.41 -3.078 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.572 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 19.3 Cg_endo -61.96 -47.52 10.47 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.081 3.188 . . . . 0.0 112.825 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.518 ' HG2' HG11 ' X' ' 16' ' ' VAL . 43.2 mt-10 -77.37 1.24 19.53 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 -35.03 2.82 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 118.526 -1.797 . . . . 0.0 112.651 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.497 HG12 ' O ' ' X' ' 71' ' ' GLY . 3.6 pt -65.36 -29.38 47.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.761 173.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.735 HG11 HG12 ' X' ' 16' ' ' VAL . 19.6 m -63.38 -35.04 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.7 0 CA-C-O 121.407 0.622 . . . . 0.0 111.419 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.522 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 61.9 tttm -66.88 -39.26 87.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.151 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.13 -38.34 90.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.13 -46.56 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.256 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 18.0 ptpt -66.94 -39.98 87.45 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.816 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.61 -35.85 77.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.377 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.519 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.0 t90 -67.66 -48.05 67.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.629 0.728 . . . . 0.0 109.19 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.484 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 18.4 tpt180 -61.34 -45.75 93.1 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.219 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.65 83.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.66 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.96 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.26 0.35 . . . . 0.0 110.852 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.419 ' OD1' ' HE2' ' X' ' 88' ' ' LYS . 17.5 t-20 -69.08 -37.37 78.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.56 29.38 5.36 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.15 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.419 ' HE2' ' OD1' ' X' ' 86' ' ' ASN . 64.0 mttm -106.41 147.53 35.09 Favored Pre-proline 0 N--CA 1.401 -2.904 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.45 130.03 25.55 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.4 2.066 . . . . 0.0 110.751 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.88 -128.51 5.4 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.689 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -88.72 154.85 19.96 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.2 pttt -90.06 163.97 14.68 Favored 'General case' 0 N--CA 1.39 -3.464 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.49 141.18 29.27 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.276 -2.752 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 175.838 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.451 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 73.0 mt . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.492 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 35.0 mmtt -99.94 -178.77 3.95 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.376 0.607 . . . . 0.0 110.065 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -104.81 -13.67 15.78 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.47 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -142.73 160.04 41.07 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.1 tt -69.1 -22.89 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.378 0.608 . . . . 0.0 110.746 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -84.36 -2.91 57.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.384 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.492 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -98.67 -3.45 35.98 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.443 ' C ' ' HG2' ' X' ' 92' ' ' LYS . 5.9 m-85 -98.62 121.98 41.25 Favored 'General case' 0 CA--C 1.475 -1.941 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.949 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.626 ' O ' HG13 ' X' ' 16' ' ' VAL . 12.9 pt-20 -63.37 -33.79 76.31 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.829 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.436 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.77 -38.25 76.68 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.357 0.123 . . . . 0.0 110.998 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -59.1 -37.51 77.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.643 0.735 . . . . 0.0 109.477 173.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 33.6 t80 -74.27 -40.88 62.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.483 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.767 HG12 HG11 ' X' ' 76' ' ' VAL . 6.3 m -62.58 -32.08 54.17 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.214 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.16 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -65.05 -46.06 82.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.633 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -58.82 -44.33 90.84 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.799 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.8 mt -58.22 -40.24 81.13 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.197 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' X' ' 23' ' ' GLU . 95.7 mttt -70.22 -34.11 72.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.338 0.589 . . . . 0.0 110.224 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.82 -42.2 98.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.898 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.68 HG12 ' HB3' ' X' ' 37' ' ' LEU . 17.6 mt -65.13 -39.52 85.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.621 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 12.8 tt0 -57.24 -47.82 80.4 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 124.343 1.057 . . . . 0.0 108.459 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -47.92 81.49 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.146 -178.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.451 ' OE1' ' HB ' ' X' ' 33' ' ' VAL . 28.6 mm-40 -68.72 -31.7 70.95 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -79.2 -44.07 22.6 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.237 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.97 -25.86 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.51 -4.29 45.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 45.14 78.8 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.744 1.618 . . . . 0.0 112.987 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 81.8 p -99.58 -160.51 0.81 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.098 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.57 -63.51 0.67 Allowed 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.627 ' O ' HG23 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.64 -60.02 3.85 Favored 'General case' 0 CA--C 1.472 -2.053 0 O-C-N 123.718 0.637 . . . . 0.0 112.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -82.75 -25.9 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.186 -172.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -59.16 -46.94 87.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 31.0 t70 -66.72 -43.58 83.88 Favored 'General case' 0 CA--C 1.479 -1.766 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.001 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.627 HG23 ' O ' ' X' ' 32' ' ' ASP . 49.8 t -55.95 -50.23 70.46 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 O-C-N 124.114 0.884 . . . . 0.0 110.493 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.68 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.6 mt -69.23 -39.03 78.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 O-C-N 124.423 1.077 . . . . 0.0 112.123 -173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.3 mt -60.25 -50.18 74.66 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.0 0.813 . . . . 0.0 110.69 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 2.7 pt-20 -71.41 -33.79 69.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.529 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.519 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.9 t60 -61.37 -45.89 92.47 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.533 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 69.6 t80 -60.7 -54.11 49.24 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.841 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.485 HG12 ' O ' ' X' ' 38' ' ' LEU . 4.8 p -67.22 -32.87 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.9 ptmm? -68.12 -42.43 80.24 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.82 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.519 HG12 ' O ' ' X' ' 40' ' ' HIS . 12.2 pt -77.1 -34.49 21.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.721 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.402 ' HA ' HD12 ' X' ' 7' ' ' ILE . 77.1 p -84.32 -39.19 19.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.459 -178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 58.81 74.81 0.42 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.537 1.16 . . . . 0.0 110.382 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -123.82 132.49 24.29 Favored Pre-proline 0 N--CA 1.405 -2.679 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.3 -18.59 55.7 Favored 'Trans proline' 0 CA--C 1.498 -1.304 0 C-N-CA 122.99 2.46 . . . . 0.0 111.885 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 15.3 m-20 -126.99 33.89 4.85 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -170.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.533 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.85 -55.81 7.06 Favored Glycine 0 CA--C 1.461 -3.288 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.866 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.493 HG22 HD22 ' X' ' 38' ' ' LEU 0.313 1.9 p -85.25 -17.19 37.73 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 117.208 -1.797 . . . . 0.0 113.618 -176.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.88 -35.52 80.28 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.35 -40.71 96.41 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 123.604 0.565 . . . . 0.0 110.937 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.427 HD13 HG21 ' X' ' 75' ' ' ILE . 17.9 mm -66.57 -46.27 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.796 0.808 . . . . 0.0 109.773 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -63.02 -43.39 98.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.415 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -71.39 -37.32 71.57 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.791 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 C-N-CA 122.32 0.248 . . . . 0.0 111.347 179.688 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.093 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.553 ' O ' HG13 ' X' ' 75' ' ' ILE . 9.6 Cg_endo -54.04 -34.59 78.19 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 124.457 3.438 . . . . 0.0 112.131 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.67 0.63 5.2 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.64 -10.78 28.23 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 118.836 -1.649 . . . . 0.0 113.248 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.553 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -74.15 -44.86 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.767 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -55.56 -43.07 71.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.266 175.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 21.7 ttmm -60.48 -47.63 85.31 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.869 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.81 -37.87 86.02 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.122 0.963 . . . . 0.0 108.592 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.497 ' HA ' HH21 ' X' ' 83' ' ' ARG . 36.2 mm -65.58 -45.75 91.53 Favored 'Isoleucine or valine' 0 C--O 1.254 1.304 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.086 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.6 ptpt -63.17 -37.68 88.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.282 0.364 . . . . 0.0 110.86 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 35.7 mt-10 -71.28 -43.91 66.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.422 ' HB3' ' NH2' ' X' ' 83' ' ' ARG . 59.6 t90 -62.96 -41.02 99.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' X' ' 79' ' ' ILE . 0.5 OUTLIER -61.94 -45.33 94.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.504 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -39.58 93.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.678 0.611 . . . . 0.0 111.324 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.79 82.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.45 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 23.1 t-20 -67.57 -46.96 71.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.26 22.87 5.7 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.45 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 61.3 mttm -102.02 144.73 29.16 Favored Pre-proline 0 N--CA 1.403 -2.815 0 C-N-CA 124.396 1.079 . . . . 0.0 108.114 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.15 132.76 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.697 1.598 . . . . 0.0 111.485 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -92.04 -117.81 2.33 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.038 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.41 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 54.6 m-85 -99.61 166.19 11.25 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 21.9 ptmt -94.62 174.43 7.12 Favored 'General case' 0 N--CA 1.387 -3.605 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -120.67 136.12 54.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 CA-C-O 121.242 0.544 . . . . 0.0 110.659 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.737 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.47 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 78.3 mt . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.634 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 10.9 mptt -120.56 -178.4 3.7 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.793 -175.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.97 -46.44 12.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.446 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.3 p -140.42 167.91 21.03 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.549 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' X' ' 44' ' ' ILE . 14.5 tt -61.59 -19.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.822 0.82 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.1 m -82.26 -5.01 58.24 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.717 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.631 ' HB3' ' CG ' ' X' ' 4' ' ' LYS . 3.5 t70 -105.42 3.6 29.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 4.8 m-85 -105.37 118.11 35.72 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.314 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 18.2 p -79.22 163.76 24.73 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.661 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.1 pt-20 -56.58 -42.17 78.2 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.002 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.52 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.86 -38.37 76.41 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 53.4 mm-40 -60.89 -36.35 79.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.74 0.781 . . . . 0.0 109.213 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 41.7 t80 -75.26 -42.92 53.99 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.517 -177.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.792 HG12 HG11 ' X' ' 76' ' ' VAL . 10.2 m -58.43 -33.61 48.42 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 O-C-N 123.215 0.322 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.69 -49.37 77.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.675 1.19 . . . . 0.0 110.171 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.512 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.5 tm? -61.77 -42.91 99.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.117 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -61.3 -42.66 99.02 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.366 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.0 mttt -63.87 -35.93 82.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.318 0.58 . . . . 0.0 109.975 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -67.56 -34.92 78.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' X' ' 37' ' ' LEU . 25.5 mt -66.22 -42.25 90.69 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.402 ' OE2' ' HD3' ' X' ' 72' ' ' PRO . 51.1 mt-10 -57.17 -37.32 71.93 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.927 0.87 . . . . 0.0 110.666 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.1 -52.38 55.81 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.941 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 1.7 pp20? -97.61 -11.42 23.64 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 118.83 -1.148 . . . . 0.0 113.482 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.61 -38.06 83.48 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.074 0.464 . . . . 0.0 110.948 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.93 -20.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.302 0.572 . . . . 0.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -39.79 13.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.495 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.86 75.93 0.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.0 1.72 . . . . 0.0 109.768 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.425 HG23 ' HB2' ' X' ' 25' ' ' GLU . 49.2 p -78.75 -21.34 48.1 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.351 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 t70 72.99 -48.54 0.69 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.491 ' O ' HG23 ' X' ' 36' ' ' VAL . 21.1 t70 -63.07 -52.55 62.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.727 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 15.0 p -94.01 -25.26 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.857 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.653 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.4 tm? -58.02 -46.58 85.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.647 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 35.2 t70 -63.03 -42.5 99.79 Favored 'General case' 0 CA--C 1.473 -1.987 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.016 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.491 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.2 t -61.55 -49.54 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 O-C-N 124.65 1.219 . . . . 0.0 110.837 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.7 mt -65.97 -43.68 87.15 Favored 'General case' 0 N--CA 1.415 -2.223 0 O-C-N 124.13 0.894 . . . . 0.0 110.362 -173.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.561 ' O ' HG12 ' X' ' 42' ' ' VAL . 32.4 mt -63.14 -50.65 69.58 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.73 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 16.7 pt-20 -71.76 -37.37 70.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.31 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.499 ' O ' HG12 ' X' ' 44' ' ' ILE . 8.9 t60 -59.89 -44.85 93.98 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.492 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 28.8 t80 -62.09 -56.93 13.96 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.438 1.086 . . . . 0.0 111.65 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.561 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 8.9 p -67.36 -31.18 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -67.6 -30.37 69.95 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.663 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.499 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.1 pt -91.4 -32.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.567 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -81.62 -36.8 28.5 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.315 0.578 . . . . 0.0 110.107 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.61 26.98 16.55 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.497 1.519 . . . . 0.0 111.022 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.0 130.74 80.23 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -67.19 -14.57 43.64 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 123.226 2.617 . . . . 0.0 112.745 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 36.8 m-20 -126.04 32.46 5.24 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -173.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.15 -54.55 8.28 Favored Glycine 0 CA--C 1.457 -3.548 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.576 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.55 HG23 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -33.34 59.59 Favored 'General case' 0 C--N 1.257 -3.436 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.639 -172.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.35 -36.11 77.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.409 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 mt -58.02 -43.14 86.56 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.44 ' H ' HD12 ' X' ' 54' ' ' ILE . 5.0 mp -66.79 -41.42 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -63.18 -50.27 70.99 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.6 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.1 pt-20 -66.62 -36.61 83.02 Favored 'General case' 0 C--O 1.206 -1.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.199 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 57' ' ' ALA . . . . . 0.426 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.631 0 O-C-N 123.219 0.324 . . . . 0.0 110.63 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.801 0 CA-C-O 120.824 0.124 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.59 ' O ' HG13 ' X' ' 76' ' ' VAL . 32.5 Cg_endo -66.45 -41.0 12.77 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 124.617 3.544 . . . . 0.0 112.313 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.5 ' HG2' HG11 ' X' ' 16' ' ' VAL . 35.1 mt-10 -84.69 2.02 43.74 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.386 0.675 . . . . 0.0 110.182 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.79 -35.78 3.16 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.89 172.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.489 ' CD1' HD13 ' X' ' 19' ' ' LEU . 4.0 pt -64.78 -22.72 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-N 117.712 0.756 . . . . 0.0 111.582 173.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.792 HG11 HG12 ' X' ' 16' ' ' VAL . 30.7 m -63.06 -39.21 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-O 121.601 0.715 . . . . 0.0 110.534 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 52.2 tttp -64.12 -42.69 96.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.691 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 78' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 39.7 mm-40 -58.3 -45.34 88.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.85 0.833 . . . . 0.0 109.526 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -64.46 -46.79 91.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.009 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 13.5 ptmm? -67.87 -36.32 80.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.761 -174.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.0 -36.69 69.82 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.141 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.519 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.4 t90 -62.97 -48.1 80.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 18.0 tpt180 -65.89 -45.89 80.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.913 -174.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.75 -40.93 79.57 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 122.853 0.461 . . . . 0.0 112.064 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.13 82.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.084 0.469 . . . . 0.0 109.962 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.09 -21.74 56.36 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.3 42.78 9.06 Favored Glycine 0 CA--C 1.498 -0.993 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.012 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.9 mtpp -122.44 144.35 41.86 Favored Pre-proline 0 N--CA 1.393 -3.289 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.93 127.69 20.1 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 122.803 2.336 . . . . 0.0 111.543 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.62 -110.08 3.12 Favored Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.578 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.56 161.67 20.1 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.093 0.473 . . . . 0.0 110.687 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' X' ' 11' ' ' THR . 21.3 ptmt -108.26 171.69 7.26 Favored 'General case' 0 N--CA 1.393 -3.305 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -106.93 140.93 38.95 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.498 0 CA-C-O 118.083 -1.399 . . . . 0.0 110.149 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.462 HD22 HD13 ' X' ' 18' ' ' LEU . 48.8 mt . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 120.864 0.364 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 25.1 mmtt -99.62 -160.34 0.8 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -117.7 -19.68 9.22 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.042 -0.411 . . . . 0.0 110.852 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 83.4 p -135.8 160.87 37.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.06 -21.92 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.613 0.765 . . . . 0.0 110.279 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 8' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 23.7 m -85.64 -1.75 57.47 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.448 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 25.6 t0 -101.67 -0.11 35.18 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.74 123.63 46.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.216 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.526 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 70.6 p -78.18 172.11 14.05 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.569 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.0 pt-20 -56.33 -45.09 80.5 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.169 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.47 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.44 -37.85 74.44 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' X' ' 11' ' ' THR . 5.3 mm-40 -57.8 -35.94 71.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.385 0.612 . . . . 0.0 110.227 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.657 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 30.1 t80 -75.67 -40.51 55.86 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.9 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.698 HG12 HG11 ' X' ' 76' ' ' VAL . 4.3 m -62.92 -28.99 46.08 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.923 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.505 ' O ' ' HG2' ' X' ' 21' ' ' GLU . 0.9 OUTLIER -57.63 -48.79 78.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.613 ' O ' HG13 ' X' ' 22' ' ' ILE . 20.3 tp -61.81 -46.99 87.14 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 121.196 0.522 . . . . 0.0 110.655 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 37.2 mt -57.94 -36.88 73.13 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.924 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 95.9 mttt -70.78 -33.97 71.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.128 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' X' ' 17' ' ' GLN . 8.7 mm-40 -67.37 -43.27 81.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.614 HG12 ' HB3' ' X' ' 37' ' ' LEU . 35.5 mt -58.81 -42.2 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.095 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.22 -47.84 82.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.695 1.198 . . . . 0.0 110.165 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.92 -52.1 58.28 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.73 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -17.19 64.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.426 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.53 -38.45 14.92 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.121 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.25 -33.25 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.214 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.83 -26.26 37.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 77.27 0.31 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.326 1.451 . . . . 0.0 112.913 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.9 p -98.55 -177.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.2 -56.09 1.44 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.887 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.641 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.2 p-10 -57.68 -55.7 31.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 123.535 0.522 . . . . 0.0 111.921 -175.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -81.33 -32.52 12.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.375 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.27 -45.81 90.22 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.154 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.76 -24.61 60.97 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.207 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.641 HG23 ' O ' ' X' ' 32' ' ' ASP . 88.7 t -61.01 -49.1 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.187 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 65.4 mt -68.11 -43.05 79.28 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.962 -173.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.1 mt -58.87 -46.57 87.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.292 0.995 . . . . 0.0 110.597 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.85 -40.93 72.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.087 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 63.9 t60 -62.4 -45.56 92.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.393 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.8 t80 -58.27 -51.73 68.53 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.752 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.458 HG23 ' HA3' ' X' ' 50' ' ' GLY . 15.0 p -67.86 -32.85 58.23 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.9 ptmt -68.96 -33.44 73.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 122.046 -0.409 . . . . 0.0 111.897 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.505 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.1 pt -85.13 -32.49 7.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.734 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 73.9 p -84.97 -33.62 22.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 56.8 33.59 23.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.664 1.186 . . . . 0.0 110.274 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.415 ' CE1' HD11 ' X' ' 53' ' ' LEU . 41.3 t-80 -80.61 134.46 54.19 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.225 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.464 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -67.77 -12.18 34.59 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 123.18 2.587 . . . . 0.0 112.437 -175.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -130.24 28.56 4.98 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.581 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.68 -62.59 2.84 Favored Glycine 1 CA--C 1.449 -4.049 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.741 -175.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -77.64 -23.99 49.59 Favored 'General case' 0 C--N 1.249 -3.774 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.24 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.0 -34.95 78.66 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.03 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 53' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' X' ' 47' ' ' HIS . 34.8 mt -62.91 -37.67 87.91 Favored 'General case' 0 CA--C 1.486 -1.493 0 O-C-N 123.362 0.414 . . . . 0.0 110.711 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.2 mt -66.46 -44.03 90.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.86 -44.62 95.63 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.261 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.7 pt-20 -68.52 -46.43 69.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.364 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.015 0 O-C-N 123.224 0.328 . . . . 0.0 111.456 -178.544 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.397 -3.904 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.507 ' O ' HG13 ' X' ' 75' ' ' ILE . 10.2 Cg_endo -57.81 -40.92 74.87 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.449 2.766 . . . . 0.0 111.785 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -74.12 0.75 12.9 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.137 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.59 -17.67 10.3 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.807 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.507 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -68.04 -41.96 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.698 HG11 HG12 ' X' ' 16' ' ' VAL . 1.0 OUTLIER -56.43 -44.6 80.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.714 177.051 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 23.1 ttpp -57.98 -47.74 82.08 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.338 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.3 -36.24 73.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.456 0.646 . . . . 0.0 109.657 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.8 -45.81 71.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.369 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.2 pttp -64.32 -35.5 81.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.923 0.392 . . . . 0.0 110.48 -176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 49.5 mt-10 -69.22 -39.35 78.63 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.464 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -67.96 -47.29 69.02 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 17.7 tpt180 -60.9 -45.28 95.24 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.296 -174.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.6 83.27 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.011 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.31 -33.73 75.89 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.502 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.15 -46.77 48.99 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.42 41.93 1.31 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 62.1 mttm -117.62 144.79 34.95 Favored Pre-proline 0 N--CA 1.399 -3.017 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.06 124.74 13.47 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 121.991 1.794 . . . . 0.0 109.862 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.55 -121.43 3.48 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.179 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -83.03 161.38 21.72 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.544 -0.828 . . . . 0.0 109.974 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.0 ptmt -87.59 167.62 13.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.21 132.03 48.39 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.116 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 178.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.482 ' CD2' HD13 ' X' ' 18' ' ' LEU . 53.5 mt . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.7 mmtt -110.22 148.43 31.87 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -84.44 -1.21 55.27 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.021 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 53.0 p -147.08 158.46 43.94 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.8 tp -73.03 -12.41 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.241 0.543 . . . . 0.0 111.615 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.27 -14.27 60.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.421 0.629 . . . . 0.0 111.386 -173.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.2 t70 -105.28 5.26 31.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -100.18 121.51 41.55 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.737 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.514 HG22 ' HG3' ' X' ' 92' ' ' LYS . 29.8 p -83.57 165.33 19.15 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.622 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.3 pt-20 -56.07 -43.62 78.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.346 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.97 -37.31 75.73 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.451 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 17.4 mm-40 -56.83 -39.73 74.75 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.65 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 16.9 t80 -72.81 -43.21 62.99 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.639 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.767 HG12 HG11 ' X' ' 76' ' ' VAL . 4.3 m -62.74 -29.03 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.89 -44.91 88.09 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.583 ' O ' HG13 ' X' ' 22' ' ' ILE . 27.5 tp -61.42 -46.23 91.01 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.546 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 36.0 mt -57.24 -41.45 79.6 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.678 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.6 mttm -63.58 -35.84 81.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.664 175.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.08 -31.42 50.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.452 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' X' ' 37' ' ' LEU . 27.4 mt -62.27 -41.86 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -58.56 -40.62 83.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -60.4 -41.84 94.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.71 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -80.21 -32.19 38.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.292 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -61.16 -52.75 63.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.051 0.54 . . . . 0.0 111.646 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -65.91 -27.3 40.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.27 -20.96 26.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.73 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.69 61.57 2.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.737 1.215 . . . . 0.0 111.887 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.9 p -88.21 -164.8 1.17 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.359 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -134.2 -50.89 0.82 Allowed 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.998 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.551 ' O ' HG23 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.29 -63.06 1.27 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.642 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 90.5 t -85.93 -27.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.052 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.451 -173.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.8 tm? -58.85 -43.29 90.74 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.5 t70 -68.18 -42.06 80.52 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.118 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.551 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.1 t -57.54 -50.23 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 O-C-N 124.058 0.849 . . . . 0.0 110.27 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' X' ' 22' ' ' ILE . 75.8 mt -67.98 -40.31 83.15 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.091 -170.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 26.5 mt -64.08 -49.13 73.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 O-C-N 124.328 1.017 . . . . 0.0 111.498 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.21 -36.68 71.96 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.5 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.549 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 77.6 t60 -60.82 -45.93 92.53 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.579 ' CD2' HD11 ' X' ' 54' ' ' ILE . 56.5 t80 -57.51 -53.63 55.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.778 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.498 HG12 ' O ' ' X' ' 38' ' ' LEU 0.264 4.6 p -67.14 -31.79 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 17.5 ptmt -71.4 -30.03 65.62 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.851 -0.53 . . . . 0.0 112.369 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.524 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.0 pt -88.96 -35.94 8.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.098 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.461 ' HB ' HD12 ' X' ' 79' ' ' ILE . 77.1 p -82.64 -36.91 25.61 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 110.597 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 64.22 31.22 13.25 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.466 1.507 . . . . 0.0 111.404 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.433 ' O ' HG23 ' X' ' 42' ' ' VAL . 43.7 t-80 -80.88 139.17 49.9 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.465 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.8 Cg_exo -70.94 -18.94 31.07 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 122.859 2.372 . . . . 0.0 112.454 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.414 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.1 35.76 4.71 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.6 -52.74 23.6 Favored Glycine 1 CA--C 1.447 -4.208 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.857 -177.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.445 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.66 -32.06 57.72 Favored 'General case' 0 C--N 1.248 -3.839 0 C-N-CA 118.498 -1.281 . . . . 0.0 110.791 -172.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.59 -33.99 74.84 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.258 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.01 -43.23 91.53 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.579 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.8 mp -67.2 -42.43 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.708 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -62.61 -46.13 89.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.686 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.1 pt-20 -71.57 -38.49 70.94 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.46 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-N 117.832 0.287 . . . . 0.0 110.57 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.252 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.453 ' O ' HG13 ' X' ' 75' ' ' ILE . 26.1 Cg_endo -64.51 -39.53 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.591 2.861 . . . . 0.0 111.974 -174.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.33 0.86 20.69 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.77 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.03 -20.97 8.01 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 119.196 -1.478 . . . . 0.0 113.027 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.453 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -63.07 -46.34 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.767 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -56.49 -46.96 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.86 177.18 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 65.7 tttm -58.88 -48.2 82.25 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.632 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -58.46 -37.73 76.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' X' ' 45' ' ' THR . 38.6 mm -68.87 -46.83 78.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.765 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -66.81 -36.37 82.21 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.578 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 47.8 mt-10 -72.42 -34.55 67.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.866 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.465 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 89.7 t90 -69.14 -46.15 68.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.57 . . . . 0.0 110.09 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -67.84 -35.99 79.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.065 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.598 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.58 81.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.762 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' X' ' 88' ' ' LYS . 25.7 t-20 -67.0 -41.25 87.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 46.77 4.58 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 106.607 -2.597 . . . . 0.0 106.607 -169.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.481 ' HB2' ' OD1' ' X' ' 86' ' ' ASN . 22.9 ttmm -121.33 135.57 25.11 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.54 114.87 2.14 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.348 2.699 . . . . 0.0 112.347 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.52 -116.14 3.78 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.805 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -86.51 155.01 20.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.9 ptmt -91.42 -175.65 4.29 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -105.87 144.18 32.97 Favored 'General case' 0 N--CA 1.399 -2.994 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.153 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.048 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.433 HD22 HD13 ' X' ' 18' ' ' LEU . 35.3 mt . . . . . 0 N--CA 1.437 -1.121 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 30.8 mmtt -96.92 -176.2 3.49 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.514 0.673 . . . . 0.0 111.96 -173.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.7 -36.18 11.84 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 61.6 p -135.12 166.68 22.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.323 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.83 -16.52 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.446 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -69.98 -25.66 63.72 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.573 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 16.0 t0 -94.93 -15.65 23.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -75.64 119.17 19.31 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.464 ' HA ' ' CB ' ' X' ' 92' ' ' LYS . 51.8 p -78.31 167.28 21.59 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.601 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.7 pt-20 -57.75 -41.01 81.04 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.981 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.68 -37.63 76.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.16 -37.72 83.89 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.581 -0.699 . . . . 0.0 110.264 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.533 ' HD2' HG12 ' X' ' 76' ' ' VAL . 33.5 t80 -71.81 -44.51 63.81 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.557 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.723 HG12 HG11 ' X' ' 76' ' ' VAL . 9.9 m -60.5 -35.86 65.99 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -49.78 76.33 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.231 1.012 . . . . 0.0 110.142 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.654 ' O ' HG13 ' X' ' 22' ' ' ILE . 28.4 tp -58.03 -47.16 83.94 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.584 0.707 . . . . 0.0 110.118 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.529 HD13 ' O ' ' X' ' 15' ' ' PHE . 8.1 mp -60.95 -37.0 80.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.169 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 52.9 mtmt -66.5 -35.43 80.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -65.6 -45.07 84.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.825 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.654 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.4 mt -55.92 -39.58 57.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.436 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.26 -47.33 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.087 0.47 . . . . 0.0 110.761 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.25 -51.56 43.85 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.612 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -23.25 67.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.305 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -71.6 -55.95 6.8 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.12 -20.77 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.46 -19.73 22.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.63 0.252 . . . . 0.0 110.553 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.6 64.37 1.77 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.275 1.03 . . . . 0.0 111.071 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 51.4 p -77.21 -26.23 52.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.369 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.26 22.9 t70 74.36 -68.5 0.21 Allowed 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 125.806 1.643 . . . . 0.0 115.076 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.606 ' O ' HG23 ' X' ' 36' ' ' VAL . 30.2 t70 -57.19 -55.9 28.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.093 0.86 . . . . 0.0 112.284 -174.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.811 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -78.32 -32.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.507 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.869 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.02 -45.89 89.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.3 t70 -65.01 -40.48 94.98 Favored 'General case' 0 CA--C 1.479 -1.788 0 O-C-N 123.369 0.418 . . . . 0.0 110.668 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.606 HG23 ' O ' ' X' ' 32' ' ' ASP . 98.3 t -54.62 -49.57 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.921 0 O-C-N 124.412 1.07 . . . . 0.0 109.193 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.811 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 54.9 mt -67.48 -41.05 85.2 Favored 'General case' 0 N--CA 1.405 -2.694 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.259 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.8 mt -60.57 -50.82 71.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.22 0.95 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.65 -36.66 70.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.437 ' O ' HG12 ' X' ' 44' ' ' ILE . 6.5 t60 -59.99 -46.15 90.4 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.609 ' O ' HG22 ' X' ' 45' ' ' THR . 57.4 t80 -59.94 -56.71 18.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.573 1.171 . . . . 0.0 110.948 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.438 HG12 ' O ' ' X' ' 38' ' ' LEU 0.271 8.4 p -66.62 -31.88 55.52 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.771 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -70.25 -28.33 65.16 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.811 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.437 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.7 pt -87.51 -39.0 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.653 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.609 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.77 -32.78 23.23 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.093 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.01 22.6 13.55 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.414 . . . . 0.0 112.306 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.488 ' H ' HG23 ' X' ' 45' ' ' THR . 55.3 t-80 -70.21 135.22 86.97 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.594 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.3 Cg_exo -70.22 4.52 2.34 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 123.527 2.818 . . . . 0.0 112.864 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 27.9 m-20 -136.83 27.25 2.99 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.17 -58.05 5.26 Favored Glycine 0 CA--C 1.476 -2.387 0 O-C-N 124.511 1.132 . . . . 0.0 113.199 -175.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.51 HG21 HD13 ' X' ' 38' ' ' LEU 0.276 0.0 OUTLIER -79.34 -25.61 42.25 Favored 'General case' 0 C--N 1.257 -3.427 0 C-N-CA 118.059 -1.456 . . . . 0.0 113.65 -176.813 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.16 -37.31 87.0 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 53' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 65.2 mt -64.76 -37.86 89.02 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.676 0.61 . . . . 0.0 111.249 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.429 HD13 HG21 ' X' ' 22' ' ' ILE . 25.3 mt -66.78 -46.33 85.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.735 0.779 . . . . 0.0 109.461 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.455 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.8 m-85 -63.45 -46.74 84.88 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -64.24 -40.08 95.28 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.76 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 C--O 1.201 -1.493 0 O-C-N 123.116 0.26 . . . . 0.0 111.387 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.773 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.559 ' O ' HG13 ' X' ' 76' ' ' VAL . 7.9 Cg_endo -57.02 -42.01 68.84 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.632 2.888 . . . . 0.0 110.623 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.527 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.6 mt-10 -78.35 1.93 20.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.205 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.17 -34.86 2.84 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 119.021 -1.561 . . . . 0.0 112.948 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' X' ' 57' ' ' ALA . 1.1 pt -67.2 -26.18 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-N 117.503 0.652 . . . . 0.0 110.765 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.723 HG11 HG12 ' X' ' 16' ' ' VAL . 27.8 m -61.4 -34.44 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.141 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 60.6 tttm -61.79 -47.02 87.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.504 174.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.8 -43.71 90.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.567 0.699 . . . . 0.0 109.415 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.525 HG23 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -64.8 -46.54 91.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.22 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.519 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 17.4 pttp -67.44 -37.08 82.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.312 -174.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.92 -39.46 72.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.33 0.394 . . . . 0.0 111.35 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.594 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 70.4 t90 -64.79 -47.83 76.66 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.7 0.625 . . . . 0.0 109.443 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.616 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 16.2 tpt180 -61.45 -45.67 93.3 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.223 -176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.69 -38.73 84.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.232 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.9 78.5 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.903 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -69.02 -36.16 77.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.8 41.94 2.78 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.616 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 55.7 mttm -118.97 147.96 43.62 Favored Pre-proline 0 N--CA 1.396 -3.172 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.79 130.17 32.02 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.229 1.952 . . . . 0.0 111.071 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.444 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -100.09 -140.63 11.49 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.302 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.1 m-85 -78.29 150.45 33.33 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.047 0.451 . . . . 0.0 110.945 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.464 ' CB ' ' HA ' ' X' ' 11' ' ' THR . 0.7 OUTLIER -72.72 157.37 37.65 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.979 174.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -85.46 1.16 49.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.004 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.261 -3.62 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.212 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 33.0 mmtt -108.72 160.31 16.05 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -83.0 -17.38 43.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.679 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.7 p -139.7 163.84 31.53 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.112 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.6 tp -64.92 -22.61 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.047 0.939 . . . . 0.0 110.023 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -76.32 -11.61 59.93 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.789 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 26.6 t0 -105.31 -7.17 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.882 0.849 . . . . 0.0 108.914 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -83.59 115.33 22.08 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.947 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 16.3 p -76.77 169.02 19.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.86 -33.58 73.29 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 119.676 1.125 . . . . 0.0 112.173 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -44.07 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.381 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -57.22 -41.65 79.88 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.414 0.626 . . . . 0.0 109.949 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.3 t80 -65.75 -55.55 16.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HB2' ' X' ' 19' ' ' LEU . 14.7 p -63.63 -27.79 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -60.77 -47.38 86.57 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.473 HD21 HD22 ' X' ' 37' ' ' LEU . 2.3 tm? -62.61 -40.79 98.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.123 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 21.9 mt -57.78 -43.8 85.81 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.787 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -61.32 -38.74 87.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.45 -31.64 70.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.594 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.457 HG13 ' O ' ' X' ' 18' ' ' LEU . 35.1 mt -66.68 -46.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -57.72 -34.53 69.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.807 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.28 -40.69 96.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.42 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -88.57 -30.27 19.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.735 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -50.38 -47.61 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.81 1.244 . . . . 0.0 111.706 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -69.95 -17.14 20.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -105.52 -19.54 13.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.635 0.255 . . . . 0.0 110.565 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.52 87.64 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.436 1.495 . . . . 0.0 110.73 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.2 p -95.26 -164.62 1.18 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.48 -42.33 0.7 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.417 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.695 ' O ' HG23 ' X' ' 36' ' ' VAL . 13.8 t70 -71.1 -62.02 1.55 Allowed 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.527 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.673 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.3 p -75.8 -27.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.228 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.514 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.8 tm? -57.64 -52.84 63.77 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 124.258 1.023 . . . . 0.0 108.565 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.63 -25.51 60.34 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.294 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.695 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.3 t -68.5 -50.74 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.037 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.623 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.1 mt -68.87 -43.36 75.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 O-C-N 124.744 1.278 . . . . 0.0 111.36 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.6 mt -61.14 -44.83 96.72 Favored 'General case' 0 N--CA 1.415 -2.191 0 O-C-N 124.274 0.984 . . . . 0.0 112.054 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -71.05 -42.95 68.79 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.782 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.521 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 26.5 t60 -60.22 -45.92 91.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.47 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' X' ' 54' ' ' ILE . 34.2 t80 -62.77 -48.36 79.51 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.419 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.1 p -67.52 -31.23 51.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 52.2 pttt -73.11 -35.08 66.5 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.599 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 21.7 pt -79.03 -32.46 15.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -83.55 -33.9 25.35 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.843 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.9 28.27 17.24 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.091 0.948 . . . . 0.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.499 ' ND1' ' HB2' ' X' ' 49' ' ' ASP . 54.8 t-80 -85.89 145.82 42.01 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.516 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.572 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.5 Cg_exo -77.48 12.97 1.71 Allowed 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.342 2.694 . . . . 0.0 112.643 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.499 ' HB2' ' ND1' ' X' ' 47' ' ' HIS . 0.8 OUTLIER -123.86 -64.38 1.15 Allowed 'General case' 0 N--CA 1.404 -2.743 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.539 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . 58.42 -84.33 0.01 OUTLIER Glycine 1 CA--C 1.428 -5.361 0 O-C-N 125.337 1.648 . . . . 0.0 111.997 177.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.42 HG23 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.4 -37.27 74.45 Favored 'General case' 1 C--N 1.211 -5.44 0 CA-C-N 112.698 -1.751 . . . . 0.0 109.239 -172.138 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.07 -31.08 70.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.071 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.36 -42.19 96.32 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.423 0.452 . . . . 0.0 111.82 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' X' ' 41' ' ' PHE . 5.0 mp -67.27 -42.0 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.096 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -61.88 -41.86 98.38 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.81 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.8 pt-20 -71.74 -37.12 70.61 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.876 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.018 0 C-N-CA 122.943 0.497 . . . . 0.0 111.281 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.048 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.588 ' HA ' HD11 ' X' ' 75' ' ' ILE . 20.3 Cg_endo -63.93 -30.92 67.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.026 2.484 . . . . 0.0 112.379 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.89 -11.65 59.91 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 74' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -99.8 -29.08 7.08 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 118.2 -1.952 . . . . 0.0 113.063 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.0 OUTLIER -60.52 -44.02 95.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.474 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 1.7 p -63.13 -43.68 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.996 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 85.9 tttt -61.71 -44.78 96.27 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 78' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 13.5 mm-40 -59.35 -45.13 92.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.481 0.658 . . . . 0.0 110.504 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.568 HG12 ' O ' ' X' ' 75' ' ' ILE . 48.2 mm -61.86 -45.33 98.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.972 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.2 ptmt -63.06 -38.07 89.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.347 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -71.7 -43.81 65.29 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.479 0.487 . . . . 0.0 111.847 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.572 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.3 t90 -63.98 -48.15 77.58 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.457 0.646 . . . . 0.0 110.916 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' CA ' ' X' ' 90' ' ' GLY . 12.0 tpt180 -60.9 -45.14 95.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.696 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.33 -38.18 81.29 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.199 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.62 88.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.132 0.492 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.466 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.5 t-20 -74.51 -42.2 59.34 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.91 31.77 3.77 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.466 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 63.7 mttm -102.35 146.66 32.74 Favored Pre-proline 0 N--CA 1.405 -2.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.44 126.62 17.28 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.046 1.831 . . . . 0.0 109.701 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' X' ' 83' ' ' ARG . . . -110.88 -119.8 3.99 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.506 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.69 149.32 29.79 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.383 1.087 . . . . 0.0 113.422 -171.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' X' ' 11' ' ' THR . 28.3 ttpt -88.19 172.81 9.2 Favored 'General case' 1 N--CA 1.365 -4.716 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.148 174.498 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.06 27.67 1.04 Allowed 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 121.317 0.58 . . . . 0.0 112.198 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 94' ' ' GLY . . . . . 0.421 ' OXT' ' HE3' ' X' ' 92' ' ' LYS . . . . . . . . 0 C--N 1.277 -2.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.383 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' X' ' 18' ' ' LEU . 37.2 mt . . . . . 0 CA--C 1.501 -0.922 0 CA-C-O 121.632 0.729 . . . . 0.0 111.877 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 39.4 mmtt -100.59 -161.47 0.87 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.106 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -117.82 -28.63 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.963 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -136.09 167.03 22.0 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.96 -11.37 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.681 0.753 . . . . 0.0 110.316 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 8' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 8.2 m -70.1 -26.74 64.12 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.89 0.876 . . . . 0.0 111.294 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.516 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 10.2 t70 -105.01 5.74 32.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.652 0.739 . . . . 0.0 109.677 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 12.3 m-85 -95.87 124.98 40.11 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.646 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 45.4 p -89.4 171.67 9.57 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.626 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.5 -45.72 80.89 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.131 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.74 -38.46 73.52 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.84 -34.46 77.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.402 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.451 ' CD2' HG12 ' X' ' 76' ' ' VAL . 62.0 t80 -71.48 -43.06 67.27 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.723 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.67 HG12 HG11 ' X' ' 76' ' ' VAL . 5.9 m -62.64 -29.94 48.11 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.468 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -61.74 -45.98 91.61 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.285 0.634 . . . . 0.0 109.865 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.614 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.7 tp -61.95 -48.19 81.51 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.625 HD13 HD12 ' X' ' 22' ' ' ILE . 4.3 mm? -60.46 -36.31 77.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.329 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 64.4 mttm -68.49 -36.93 79.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.85 -35.55 78.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.358 0.599 . . . . 0.0 110.104 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' X' ' 37' ' ' LEU . 67.7 mt -63.06 -46.28 96.57 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.38 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.727 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -57.82 -45.5 86.06 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 109.802 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.28 -51.85 67.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.126 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.701 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 6.2 mm-40 -82.47 -14.67 54.67 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -69.85 -47.17 63.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 120.835 0.35 . . . . 0.0 110.191 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.4 -19.75 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.39 -18.67 25.05 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.969 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.37 72.76 0.38 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.146 1.378 . . . . 0.0 111.837 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 57.2 p -93.84 -168.4 1.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -134.84 -55.7 0.82 Allowed 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.894 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.542 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.0 p-10 -57.53 -48.08 80.25 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.8 p -87.92 -32.9 6.27 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.608 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.22 -44.56 92.29 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.713 0.805 . . . . 0.0 109.487 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.92 -32.38 69.29 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.924 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.542 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.4 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.142 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 66.2 mt -68.37 -43.03 78.26 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.707 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 15.9 mt -60.22 -45.08 94.45 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 124.265 0.978 . . . . 0.0 110.325 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -70.39 -38.75 74.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.985 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.6 t60 -64.41 -45.15 88.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.454 0.645 . . . . 0.0 109.627 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.588 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.7 t80 -59.04 -51.13 71.36 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -67.98 -33.03 58.84 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.869 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.1 ptmt -68.96 -36.12 77.53 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.039 0.447 . . . . 0.0 111.687 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.455 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.7 pt -79.17 -33.29 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.106 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -84.66 -39.69 18.3 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.317 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 63.8 31.77 13.92 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.694 1.198 . . . . 0.0 109.991 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -80.38 135.34 53.81 Favored Pre-proline 0 N--CA 1.424 -1.77 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.117 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.0 Cg_exo -76.62 9.68 2.51 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 C-N-CA 123.367 2.711 . . . . 0.0 111.904 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -140.8 19.14 2.33 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.588 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.88 -69.01 0.68 Allowed Glycine 0 CA--C 1.46 -3.4 0 O-C-N 124.38 1.05 . . . . 0.0 114.512 -173.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.445 HG21 HD13 ' X' ' 38' ' ' LEU . 0.6 OUTLIER -74.38 -18.84 60.61 Favored 'General case' 0 C--N 1.253 -3.593 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.026 -173.025 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -71.32 -34.19 70.35 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.58 -37.9 88.02 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.621 0.576 . . . . 0.0 110.645 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.435 HD13 HG21 ' X' ' 22' ' ' ILE . 49.2 mt -66.94 -47.07 83.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.863 0.839 . . . . 0.0 109.092 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.05 -47.96 80.74 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.07 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.0 pt-20 -65.71 -36.64 84.18 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.217 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.68 0 CA-C-N 118.181 0.446 . . . . 0.0 110.947 178.77 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.026 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.638 ' HA ' HD11 ' X' ' 75' ' ' ILE . 15.9 Cg_endo -57.02 -34.51 97.79 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 124.157 3.238 . . . . 0.0 113.664 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.488 ' C ' HG22 ' X' ' 76' ' ' VAL . 41.5 mt-10 -82.73 2.11 35.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.912 0.386 . . . . 0.0 112.024 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.59 -27.76 6.62 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.268 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.0 OUTLIER -66.23 -34.05 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.67 HG11 HG12 ' X' ' 16' ' ' VAL . 29.2 m -64.7 -34.79 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.254 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.951 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 41.7 ttmt -64.79 -43.6 92.68 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 78' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 7.6 mm-40 -57.79 -45.09 86.54 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.978 0.894 . . . . 0.0 109.084 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 22.6 mm -62.34 -46.62 95.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.787 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -67.17 -35.64 80.09 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.69 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -69.26 -32.04 70.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.553 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.9 t90 -70.08 -48.58 57.13 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.122 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.438 ' HE ' ' HB2' ' X' ' 83' ' ' ARG . 0.0 OUTLIER -65.95 -37.2 85.41 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.591 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.77 90.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.785 0.678 . . . . 0.0 111.652 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.76 -44.88 39.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.95 0.405 . . . . 0.0 110.695 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.5 -33.93 73.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.208 0.528 . . . . 0.0 110.665 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.65 30.86 6.3 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -103.48 163.35 17.61 Favored Pre-proline 0 N--CA 1.405 -2.689 0 C-N-CA 124.042 0.937 . . . . 0.0 109.651 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 89' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 36.3 Cg_exo -62.47 131.05 32.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.913 2.409 . . . . 0.0 113.07 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.86 -150.56 24.4 Favored Glycine 0 N--CA 1.429 -1.815 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.529 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -85.42 150.02 25.01 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' X' ' 8' ' ' SER . 20.0 ptmt -77.89 165.14 24.49 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.32 133.02 36.24 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.256 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.604 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.494 ' CD2' HD13 ' X' ' 18' ' ' LEU . 31.9 mt . . . . . 0 CA--C 1.5 -0.944 0 CA-C-O 121.073 0.464 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -96.37 -162.34 0.95 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.05 -24.49 8.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.358 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 6' ' ' SER . . . . . 0.429 ' HA ' HG22 ' X' ' 44' ' ' ILE . 84.7 p -134.61 166.81 22.05 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -65.33 -15.18 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.381 0.672 . . . . 0.0 110.725 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 8' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 16.6 t -76.53 -20.64 56.69 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.882 -170.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 6.87 37.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 118.297 -1.361 . . . . 0.0 109.673 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.21 122.63 34.0 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.105 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.0 p -82.87 167.73 17.77 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.632 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.42 -42.92 92.94 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.189 -1.404 . . . . 0.0 111.85 176.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.602 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -67.34 -38.76 85.37 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -59.13 -39.13 81.38 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.643 0.735 . . . . 0.0 110.1 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.681 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -74.78 -42.15 58.7 Favored 'General case' 0 N--CA 1.407 -2.581 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.017 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.779 HG12 HG11 ' X' ' 76' ' ' VAL . 8.9 m -62.62 -32.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.41 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -62.33 -43.98 97.56 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.64 ' O ' HG13 ' X' ' 22' ' ' ILE . 36.8 tp -61.71 -46.54 89.25 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-O 121.253 0.549 . . . . 0.0 109.974 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -57.32 -41.93 80.88 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.765 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.4 mttm -64.28 -41.97 96.65 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.22 0.534 . . . . 0.0 109.648 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.21 -38.1 87.16 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.042 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.64 HG13 ' O ' ' X' ' 18' ' ' LEU . 47.4 mt -60.15 -46.06 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.348 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.27 -43.58 88.03 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.365 0.602 . . . . 0.0 110.23 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 24' ' ' LYS . . . . . 0.509 ' HG3' ' OE2' ' X' ' 25' ' ' GLU . 26.1 tptp -59.5 -50.42 73.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.846 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.509 ' OE2' ' HG3' ' X' ' 24' ' ' LYS . 16.0 mm-40 -86.15 -5.61 59.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.339 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -79.23 -44.89 20.9 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.53 -32.39 52.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.256 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -19.67 42.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.752 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.83 80.87 0.19 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.343 1.457 . . . . 0.0 112.911 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 77.0 p -106.77 -169.49 1.56 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.47 -26.33 0.76 Allowed 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.098 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.509 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.6 m-20 -67.28 -57.9 5.81 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.621 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.53 -31.12 7.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.132 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.9 tm? -59.48 -46.03 89.97 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.974 -175.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -32.34 72.98 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.206 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.509 HG23 ' O ' ' X' ' 32' ' ' ASP . 38.3 t -66.33 -49.27 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.574 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 58.0 mt -66.73 -42.65 85.95 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.0 -170.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.3 mt -59.42 -47.84 83.93 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.541 1.151 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.42 -42.55 71.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.549 ' O ' HG12 ' X' ' 44' ' ' ILE . 22.8 t60 -59.46 -45.55 91.3 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.506 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.595 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.12 -55.12 37.84 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.879 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.502 HG12 ' O ' ' X' ' 38' ' ' LEU . 8.3 p -66.76 -31.81 55.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.3 pttp -71.27 -34.32 70.58 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.769 -0.582 . . . . 0.0 111.781 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.549 HG12 ' O ' ' X' ' 40' ' ' HIS . 23.7 pt -88.48 -29.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.511 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.528 ' HB ' HD12 ' X' ' 79' ' ' ILE . 70.1 p -84.46 -37.77 20.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.544 0.688 . . . . 0.0 109.494 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 69.04 21.56 7.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.249 1.82 . . . . 0.0 112.076 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.455 ' O ' HG23 ' X' ' 42' ' ' VAL . 48.7 t-80 -72.23 132.96 83.76 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 31.5 Cg_exo -66.74 -21.3 51.56 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.149 2.566 . . . . 0.0 112.146 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -122.44 35.69 4.82 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.595 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.12 -55.3 8.79 Favored Glycine 1 CA--C 1.448 -4.124 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.585 -178.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.496 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.24 -34.51 68.34 Favored 'General case' 0 C--N 1.255 -3.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.208 -173.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.56 -29.37 70.64 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.653 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 53' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 53' ' ' LEU . 26.4 mt -61.42 -42.68 99.13 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 175.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.582 HD13 HG21 ' X' ' 22' ' ' ILE . 10.5 mt -66.59 -42.54 90.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -63.02 -44.67 95.3 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.802 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.9 pt-20 -69.8 -39.3 76.63 Favored 'General case' 0 C--O 1.201 -1.48 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.635 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.391 0 C-N-CA 122.26 0.224 . . . . 0.0 111.279 -179.722 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.552 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.511 ' O ' HG13 ' X' ' 75' ' ' ILE . 29.1 Cg_endo -61.8 -37.5 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.254 2.636 . . . . 0.0 110.992 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.14 0.69 18.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.764 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.27 -8.87 26.59 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.008 174.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.511 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -73.82 -45.43 49.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.779 HG11 HG12 ' X' ' 16' ' ' VAL . 1.2 p -57.71 -42.16 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.966 175.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttp -58.52 -47.86 82.77 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.747 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.4 -39.12 89.58 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.528 HD12 ' HB ' ' X' ' 45' ' ' THR . 41.8 mm -67.86 -46.34 82.37 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.832 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.6 pttp -63.72 -36.29 83.39 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.384 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.85 -38.82 70.04 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.874 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.515 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 66.7 t90 -69.75 -47.79 61.69 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.016 0.436 . . . . 0.0 110.025 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.584 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 14.5 tpt180 -60.35 -45.52 93.2 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.0 89.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.704 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.28 92.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.163 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -64.67 -32.56 74.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.78 4.84 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.584 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 64.5 mttm -112.83 144.58 31.3 Favored Pre-proline 0 N--CA 1.388 -3.542 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -64.22 139.3 65.52 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.093 1.862 . . . . 0.0 109.31 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -109.38 -125.23 5.03 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.31 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.428 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 76.9 m-85 -82.86 152.53 25.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.665 -0.768 . . . . 0.0 111.2 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' X' ' 8' ' ' SER . 19.8 ptmt -83.59 -179.27 7.29 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.49 140.07 30.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.884 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.406 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 71.2 mt . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -97.83 -174.7 2.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.87 -9.17 14.07 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.237 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -144.47 164.89 29.52 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -70.79 -8.7 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.444 0.64 . . . . 0.0 110.688 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -76.81 -25.82 53.71 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.02 -11.94 21.04 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.406 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 8.7 m-85 -72.99 118.11 15.53 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.31 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.459 HG22 ' HG2' ' X' ' 92' ' ' LYS . 76.0 p -78.4 162.0 26.73 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 169.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.654 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.05 -45.28 79.27 Favored 'General case' 0 C--N 1.28 -2.42 0 O-C-N 123.571 0.544 . . . . 0.0 111.015 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.49 -38.23 77.58 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -57.44 -37.5 72.92 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 118.436 0.562 . . . . 0.0 110.107 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.736 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 5.7 t80 -80.0 -45.38 18.51 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.751 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.695 HG12 HG21 ' X' ' 76' ' ' VAL . 11.7 m -58.82 -31.78 45.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.043 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.86 -47.19 78.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.939 0.896 . . . . 0.0 109.79 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.495 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -62.75 -41.77 99.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.01 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -61.34 -37.77 84.5 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.519 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 56.6 mttp -64.47 -36.0 82.77 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.439 0.638 . . . . 0.0 109.578 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.74 -32.82 73.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.905 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.573 HG12 HD13 ' X' ' 37' ' ' LEU . 34.1 mt -64.92 -41.49 92.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -57.49 -46.14 84.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.786 0.803 . . . . 0.0 108.841 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -60.06 -45.36 93.13 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.929 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.594 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -85.24 -29.61 24.5 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.178 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.67 -34.88 79.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.781 0.324 . . . . 0.0 111.359 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.7 m -77.27 -12.59 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.07 -22.68 16.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.56 85.72 0.14 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.127 1.771 . . . . 0.0 112.043 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -106.1 172.26 6.9 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -135.91 8.67 3.27 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.642 170.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.467 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 m-20 -91.16 -70.66 0.67 Allowed 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.706 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.7 p -74.66 -30.69 25.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.978 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.594 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 3.0 tm? -58.3 -46.03 86.87 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.13 -32.8 74.18 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.282 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.467 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.9 t -64.8 -50.12 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 68.6 mt -68.66 -41.77 78.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.858 -171.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 7.0 mt -61.17 -46.64 89.66 Favored 'General case' 0 N--CA 1.418 -2.063 0 O-C-N 124.102 0.876 . . . . 0.0 110.915 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.18 -42.35 72.55 Favored 'General case' 0 N--CA 1.433 -1.283 0 O-C-N 123.418 0.449 . . . . 0.0 110.884 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.469 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 25.3 t60 -59.57 -45.34 92.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 123.68 0.792 . . . . 0.0 110.595 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.405 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 34.2 t80 -61.02 -55.32 34.23 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.156 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.46 HG23 ' HA3' ' X' ' 50' ' ' GLY . 12.3 p -67.3 -31.65 53.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 0.0 OUTLIER -69.68 -39.26 77.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 122.232 -0.293 . . . . 0.0 111.772 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.616 HD11 ' CE1' ' X' ' 15' ' ' PHE . 49.9 pt -80.97 -30.63 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.941 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -85.02 -35.09 22.16 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.76 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 61.76 28.15 17.28 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.409 ' HA ' ' HD3' ' X' ' 48' ' ' PRO . 37.4 t-80 -77.18 139.53 64.96 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.435 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 20.3 Cg_exo -70.41 -19.3 33.2 Favored 'Trans proline' 0 CA--C 1.495 -1.432 0 C-N-CA 123.087 2.525 . . . . 0.0 112.488 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 14.4 m-20 -127.23 40.98 3.61 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.46 ' HA3' HG23 ' X' ' 42' ' ' VAL . . . -51.22 -51.77 34.69 Favored Glycine 0 CA--C 1.466 -2.976 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.978 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 51' ' ' THR . . . . . . . . . . . . 0.35 0.6 OUTLIER -80.99 -25.06 37.54 Favored 'General case' 0 C--N 1.256 -3.497 0 C-N-CA 117.48 -1.688 . . . . 0.0 114.165 -174.512 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' X' ' 49' ' ' ASP . . . -61.2 -41.12 96.26 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.12 -46.52 88.12 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.292 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 31.1 mt -67.07 -47.54 81.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 CA-C-O 121.344 0.592 . . . . 0.0 110.736 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -59.8 -49.06 79.2 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.359 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.35 -40.7 96.38 Favored 'General case' 0 C--O 1.174 -2.917 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.769 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 57' ' ' ALA . . . . . 0.454 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 CA--C 1.501 -0.932 0 CA-C-N 118.412 0.551 . . . . 0.0 111.296 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.517 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.42 -24.63 56.87 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.196 3.264 . . . . 0.0 113.316 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.406 ' HA ' ' CG2' ' X' ' 76' ' ' VAL . 33.5 mt-10 -96.32 1.41 51.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.026 0.441 . . . . 0.0 109.937 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -103.34 -31.65 4.88 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.602 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.522 ' CD1' HD13 ' X' ' 19' ' ' LEU . 5.3 pt -65.43 -32.55 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 O-C-N 122.277 -0.543 . . . . 0.0 111.616 175.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.695 HG21 HG12 ' X' ' 16' ' ' VAL . 0.2 OUTLIER -65.56 -32.23 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.469 176.095 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 59.6 tttm -66.7 -45.67 78.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.84 -44.76 86.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.376 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.45 -46.81 88.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.079 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -69.39 -36.29 76.64 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.472 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.5 mt-10 -71.37 -37.21 71.65 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.481 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.8 t90 -66.55 -47.25 73.43 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.923 0.868 . . . . 0.0 109.719 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -61.28 -46.1 91.73 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.771 -176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.2 81.64 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.79 -45.62 93.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.954 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.403 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 23.5 t-20 -69.25 -39.0 78.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.2 37.68 2.63 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 67.7 mttm -109.18 147.16 35.39 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.55 131.36 37.67 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.527 2.151 . . . . 0.0 111.785 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.35 -144.14 15.37 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.182 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -78.17 145.82 35.4 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 111.33 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' X' ' 11' ' ' THR . 5.3 tttt -86.28 163.03 17.96 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 93' ' ' GLN . . . . . 0.439 ' N ' ' HG3' ' X' ' 92' ' ' LYS 0.251 83.1 mt-30 -88.87 131.01 35.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.633 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.925 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 174.809 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' X' ' 40' ' ' HIS . 66.5 mt . . . . . 0 N--CA 1.433 -1.276 0 CA-C-O 120.979 0.419 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 46.3 mmtt -102.08 -159.16 0.71 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -116.33 -28.49 6.49 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.703 0.763 . . . . 0.0 109.499 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 65.0 p -132.74 166.83 21.31 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.652 177.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.594 HD11 ' CE1' ' X' ' 91' ' ' PHE . 10.9 tp -70.81 -15.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.533 0.683 . . . . 0.0 110.68 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -77.74 -9.0 58.77 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.425 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -109.27 3.67 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.243 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 6.7 m-85 -94.8 115.51 27.59 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.646 -174.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 76.1 p -76.06 156.86 33.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 167.168 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.67 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.7 pt-20 -60.84 -30.61 70.21 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.88 73.78 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.113 0.415 . . . . 0.0 111.382 175.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.449 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 10.1 mm-40 -57.46 -39.02 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.624 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.4 t80 -71.54 -49.01 44.88 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.584 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.842 HG12 HG11 ' X' ' 76' ' ' VAL . 5.0 m -62.6 -30.04 48.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.731 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' X' ' 21' ' ' GLU . 6.6 tt0 -63.0 -49.01 76.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.585 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.1 tm? -58.75 -44.71 90.62 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.56 177.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.673 HD13 HG13 ' X' ' 75' ' ' ILE . 33.0 mt -58.12 -42.21 85.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.163 176.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.6 mttm -67.78 -35.04 77.96 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.172 176.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' X' ' 17' ' ' GLN . 45.3 mt-10 -67.24 -37.68 83.95 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.681 176.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.585 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.6 mt -62.13 -43.72 98.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 0.9 OUTLIER -58.06 -47.68 82.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.621 1.168 . . . . 0.0 109.883 176.989 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.61 -52.04 59.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.427 -176.406 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.03 -25.95 64.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -70.94 -50.35 35.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.51 177.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.45 -11.68 13.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.14 -19.12 21.08 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 76.42 0.28 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.878 1.271 . . . . 0.0 111.275 -176.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -95.79 -25.67 15.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.168 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 66.41 -64.46 0.22 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 126.19 1.796 . . . . 0.0 114.721 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.501 ' O ' HG23 ' X' ' 36' ' ' VAL . 8.1 p-10 -63.97 -48.57 75.95 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.761 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -83.13 -29.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.838 -177.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -41.84 90.14 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.692 175.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.61 -36.19 82.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.501 HG23 ' O ' ' X' ' 32' ' ' ASP . 99.3 t -57.57 -48.42 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.965 0 O-C-N 123.835 0.709 . . . . 0.0 109.218 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 43.9 mt -68.07 -43.12 79.3 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.447 -174.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.535 ' HB3' HG21 ' X' ' 51' ' ' THR . 17.8 mt -58.89 -49.5 77.55 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 124.11 0.881 . . . . 0.0 111.173 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -68.47 -39.06 81.55 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.231 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.59 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 46.3 t60 -65.98 -45.26 82.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.094 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.577 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.5 t80 -55.29 -52.1 64.53 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.886 177.456 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.9 -32.83 58.09 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 21.0 ptmt -71.33 -33.22 69.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.934 -0.479 . . . . 0.0 112.118 -178.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.582 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.3 pt -83.08 -34.58 11.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.283 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 66.7 p -84.32 -38.73 20.02 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 63.97 27.23 14.29 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 109.983 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' X' ' 49' ' ' ASP . 37.4 t-80 -70.75 136.36 85.56 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 113.762 -1.563 . . . . 0.0 106.82 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.423 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 8.8 Cg_exo -76.73 6.03 4.42 Favored 'Trans proline' 0 CA--C 1.482 -2.088 0 C-N-CA 122.89 2.394 . . . . 0.0 112.686 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.487 ' CG ' ' HB3' ' X' ' 52' ' ' ALA . 24.9 t70 -144.76 32.21 1.15 Allowed 'General case' 0 N--CA 1.39 -3.448 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 -173.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.577 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.48 -62.53 3.93 Favored Glycine 1 CA--C 1.449 -4.036 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.43 -176.922 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.535 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.437 1.6 p -82.72 -13.33 56.54 Favored 'General case' 0 N--CA 1.386 -3.664 0 C-N-CA 116.46 -2.096 . . . . 0.0 115.267 -177.649 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.651 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -72.09 -29.87 64.54 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 117.863 -1.535 . . . . 0.0 108.814 174.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -60.55 -43.52 97.12 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.599 0.562 . . . . 0.0 110.961 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.48 -47.18 81.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.139 0.971 . . . . 0.0 109.672 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -63.57 -44.33 94.41 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.897 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -67.82 -35.77 79.21 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.38 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.973 0 O-C-N 123.059 0.224 . . . . 0.0 111.093 -179.017 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.946 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.404 ' O ' HG12 ' X' ' 75' ' ' ILE . 14.8 Cg_endo -58.98 -48.43 14.36 Favored 'Trans proline' 0 C--O 1.207 -1.052 0 C-N-CA 124.071 3.181 . . . . 0.0 113.57 -176.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.93 0.57 17.91 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.985 -0.447 . . . . 0.0 112.183 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 74' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.56 -23.9 5.51 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.776 175.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.673 HG13 HD13 ' X' ' 19' ' ' LEU . 4.1 pt -69.92 -31.91 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 122.09 -0.653 . . . . 0.0 110.313 176.519 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.842 HG11 HG12 ' X' ' 16' ' ' VAL . 0.5 OUTLIER -61.7 -41.81 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-O 122.257 1.027 . . . . 0.0 110.737 173.852 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' X' ' 74' ' ' GLY . 53.1 tttm -58.4 -42.29 86.83 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.228 176.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.07 -33.54 76.28 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.629 0.728 . . . . 0.0 109.566 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.421 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.9 mm -70.69 -45.94 71.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.144 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -62.5 -36.44 82.55 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.032 -177.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.56 -44.2 78.8 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.354 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 90.4 t90 -66.8 -48.86 67.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -176.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -71.44 -39.62 70.89 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.558 -174.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.16 -43.37 78.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.862 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -69.45 -30.38 68.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.97 29.53 7.19 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -117.08 141.08 27.87 Favored Pre-proline 0 N--CA 1.393 -3.296 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.53 118.77 5.25 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.476 2.784 . . . . 0.0 112.022 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.16 -124.63 4.33 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.6 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.594 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.0 m-85 -85.88 159.02 19.8 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.081 -178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -89.71 172.95 8.56 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -120.82 134.28 55.29 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.248 0.547 . . . . 0.0 111.862 -175.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.317 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 177.879 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.434 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 26.6 mt . . . . . 0 N--CA 1.444 -0.727 0 CA-C-O 121.063 0.459 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.424 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 36.7 mmtt -98.3 -159.57 0.75 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -113.03 -30.88 6.85 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.722 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.1 p -126.2 166.19 17.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' X' ' 91' ' ' PHE . 7.0 tp -69.21 -18.72 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.781 0.801 . . . . 0.0 109.763 -177.094 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -75.09 -17.75 60.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.364 -172.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.424 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 36.3 t0 -102.73 5.21 38.76 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 122.255 1.026 . . . . 0.0 108.919 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.434 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 9.3 m-85 -96.46 125.11 40.72 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.632 -176.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 67.9 p -88.08 172.53 9.46 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.657 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -62.02 -41.4 98.04 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.669 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.75 -37.86 76.59 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.445 ' HB2' ' H ' ' X' ' 11' ' ' THR . 43.5 mm-40 -60.85 -40.19 91.96 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.287 0.565 . . . . 0.0 109.69 174.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 26.7 t80 -71.74 -45.4 61.86 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.208 -178.482 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.669 HG22 ' HA ' ' X' ' 13' ' ' ALA . 13.6 m -61.88 -28.86 45.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.61 -46.78 86.71 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.623 ' O ' HG13 ' X' ' 22' ' ' ILE . 35.1 tp -60.86 -45.68 93.57 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.587 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 42.1 mt -57.67 -39.54 77.34 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 82.6 mttt -71.68 -38.7 70.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.101 176.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 21' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 73.7 mm-40 -60.72 -44.74 96.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.625 176.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.623 HG13 ' O ' ' X' ' 18' ' ' LEU . 48.1 mt -57.83 -46.1 87.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 O-C-N 123.967 0.792 . . . . 0.0 111.328 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.479 ' O ' HG22 ' X' ' 27' ' ' VAL . 44.5 mt-10 -57.61 -47.88 80.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.387 0.613 . . . . 0.0 110.894 -176.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -60.61 -43.03 97.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.766 -174.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.432 ' HB2' ' CG2' ' X' ' 30' ' ' THR . 3.0 pp20? -89.02 -34.04 16.95 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.566 -177.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 26' ' ' ASN . . . . . 0.517 ' HA ' HD23 ' X' ' 34' ' ' LEU . 39.2 t30 -60.04 -46.7 88.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.747 0.419 . . . . 0.0 111.798 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 27' ' ' VAL . . . . . 0.479 HG22 ' O ' ' X' ' 23' ' ' GLU . 31.2 m -79.55 0.6 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.164 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.37 0.19 12.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.239 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 44.95 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.067 1.747 . . . . 0.0 113.537 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 74.1 p -98.41 -24.38 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.493 . . . . 0.0 111.659 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 68.01 -59.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.245 1.418 . . . . 0.0 113.985 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.628 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 t70 -58.88 -61.39 2.66 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -82.24 -25.03 9.1 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' X' ' 26' ' ' ASN . 2.9 tm? -58.64 -50.09 75.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.352 176.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.47 -33.8 76.51 Favored 'General case' 0 CA--C 1.483 -1.61 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.784 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.628 HG23 ' O ' ' X' ' 32' ' ' ASP . 40.2 t -65.75 -50.23 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.623 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 40.7 mt -69.04 -43.66 74.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 O-C-N 124.442 1.089 . . . . 0.0 111.379 -172.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.475 ' O ' HG12 ' X' ' 42' ' ' VAL . 34.1 mt -61.54 -45.29 94.78 Favored 'General case' 0 N--CA 1.421 -1.878 0 O-C-N 124.163 0.914 . . . . 0.0 111.571 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.49 -41.57 72.49 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.253 177.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.518 ' O ' HG12 ' X' ' 44' ' ' ILE . 16.0 t60 -62.3 -45.9 91.16 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.466 0.478 . . . . 0.0 109.92 -175.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.496 ' CD2' HD11 ' X' ' 54' ' ' ILE . 43.7 t80 -58.25 -53.18 61.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.295 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' X' ' 38' ' ' LEU 0.285 14.5 p -67.86 -31.62 52.94 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.891 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.8 pttp -69.14 -32.27 71.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.745 -0.597 . . . . 0.0 111.991 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.518 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.7 pt -85.17 -35.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.869 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 61.1 p -84.22 -35.43 23.47 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 58.25 30.73 19.91 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.195 1.398 . . . . 0.0 111.325 -176.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 36.4 t-80 -77.14 134.66 67.29 Favored Pre-proline 0 N--CA 1.423 -1.788 0 CA-C-N 114.024 -1.444 . . . . 0.0 107.862 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.1 Cg_exo -71.0 -2.27 10.8 Favored 'Trans proline' 0 CA--C 1.493 -1.541 0 C-N-CA 123.362 2.708 . . . . 0.0 112.805 -175.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 11.8 m-20 -138.21 29.84 2.47 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -173.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.485 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.99 -61.05 3.64 Favored Glycine 1 CA--C 1.45 -4.017 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.946 -176.48 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.46 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -28.44 57.65 Favored 'General case' 0 C--N 1.248 -3.837 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.252 -172.5 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.587 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.76 -40.47 95.25 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.026 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.3 mt -56.32 -44.5 80.01 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.731 0.644 . . . . 0.0 112.087 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.496 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -66.63 -45.24 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.276 -177.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.423 ' HD2' ' O ' ' X' ' 51' ' ' THR . 29.7 m-85 -61.01 -49.31 77.93 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.74 -178.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.5 pt-20 -70.29 -36.28 74.25 Favored 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.638 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.518 0 CA-C-N 117.652 0.206 . . . . 0.0 111.319 179.383 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.406 -3.307 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.489 ' O ' HG12 ' X' ' 76' ' ' VAL . 25.7 Cg_endo -65.0 -50.98 1.81 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 123.085 2.524 . . . . 0.0 110.956 -176.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.85 1.68 6.66 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 74' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.55 -29.16 3.48 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.065 174.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.614 HG13 HD13 ' X' ' 19' ' ' LEU . 5.2 pt -66.3 -32.98 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.248 1.024 . . . . 0.0 111.045 175.477 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.668 HG11 HG12 ' X' ' 16' ' ' VAL . 0.5 OUTLIER -59.6 -43.64 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-O 121.998 0.904 . . . . 0.0 110.327 173.177 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 54.4 tttp -58.42 -46.13 87.08 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.551 175.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -67.21 -30.71 70.72 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.463 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.4 mm -68.21 -45.99 81.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 175.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -64.02 -36.11 82.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.726 0.298 . . . . 0.0 110.699 -176.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.31 -32.31 70.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.837 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.497 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 76.2 t90 -72.16 -44.1 63.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.77 -43.08 98.49 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.775 -176.649 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.44 84.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.821 178.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.22 99.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.359 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -73.46 -34.1 65.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.59 47.73 2.91 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -118.77 147.94 43.35 Favored Pre-proline 0 N--CA 1.4 -2.942 0 C-N-CA 123.234 0.614 . . . . 0.0 109.863 -178.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.1 130.83 28.44 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.309 2.006 . . . . 0.0 110.477 175.158 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.27 -126.59 5.58 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.465 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' X' ' 7' ' ' ILE . 36.8 m-85 -81.27 156.7 25.45 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.108 -174.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' X' ' 11' ' ' THR . 53.0 pttt -94.57 174.28 7.2 Favored 'General case' 0 N--CA 1.389 -3.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.4 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.08 141.73 35.71 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.775 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.236 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.552 HD22 HD13 ' X' ' 18' ' ' LEU . 22.6 mt . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.149 0.499 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.544 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 37.7 mmtt -102.8 -179.96 4.11 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.203 -175.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.0 -24.79 16.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.325 0.583 . . . . 0.0 109.741 178.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.4 p -142.02 162.93 34.23 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.079 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -67.3 -17.92 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.24 1.016 . . . . 0.0 111.341 -176.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 75.8 m -86.6 -3.09 58.98 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.544 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 25.6 t0 -103.56 4.44 35.78 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.247 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 9.7 m-85 -99.0 121.06 40.46 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.6 -177.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.444 HG22 ' HG3' ' X' ' 92' ' ' LYS . 73.7 p -79.18 167.08 21.48 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 169.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.631 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.4 pt-20 -56.52 -42.65 78.78 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.629 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -38.31 75.6 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.124 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' X' ' 11' ' ' THR . 22.3 mm-40 -59.0 -37.65 77.36 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.363 0.601 . . . . 0.0 110.12 174.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.701 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -73.42 -42.8 61.61 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.743 HG12 HG11 ' X' ' 76' ' ' VAL . 3.9 m -62.99 -29.05 46.28 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.447 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.978 178.177 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -61.01 -46.75 89.47 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.625 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.1 tp -61.34 -47.23 86.82 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 175.332 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.1 mt -58.21 -38.54 76.99 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.158 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 68.3 mttm -71.55 -34.83 70.34 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.659 176.078 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.85 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.67 HG12 ' HB3' ' X' ' 37' ' ' LEU . 60.9 mt -62.92 -42.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.431 ' O ' HG22 ' X' ' 27' ' ' VAL . 1.6 tt0 -58.14 -44.45 87.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.242 174.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -59.11 -48.69 80.68 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.384 1.074 . . . . 0.0 109.567 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.8 -26.75 49.85 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.357 -178.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -80.01 -41.41 25.87 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 122.157 -0.34 . . . . 0.0 111.81 -179.01 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 27' ' ' VAL . . . . . 0.431 HG22 ' O ' ' X' ' 23' ' ' GLU . 33.0 m -70.52 -20.84 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.845 -179.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.93 -16.85 18.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.39 76.13 0.31 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.161 1.384 . . . . 0.0 111.969 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.8 p -96.37 -168.81 1.8 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.87 -43.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.943 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.516 ' O ' HG23 ' X' ' 36' ' ' VAL . 23.6 t70 -64.89 -53.02 53.19 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 79.4 t -87.15 -27.12 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.604 -178.106 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.04 -46.53 87.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.05 -20.6 61.65 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.516 HG23 ' O ' ' X' ' 32' ' ' ASP . 54.7 t -70.86 -49.77 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 C-N-CA 118.563 -1.255 . . . . 0.0 108.286 175.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 63.3 mt -68.29 -41.68 80.59 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 113.756 -1.565 . . . . 0.0 112.345 -170.253 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.5 mt -59.28 -44.57 92.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 124.151 0.907 . . . . 0.0 110.517 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.53 -45.0 63.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.71 177.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.58 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 20.2 t60 -59.33 -45.48 91.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.2 -175.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.586 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 39.6 t80 -60.49 -50.83 72.02 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.877 178.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.87 -32.19 55.38 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.538 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -179.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -69.53 -33.77 73.27 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.998 -0.439 . . . . 0.0 111.925 -178.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.469 HG12 ' O ' ' X' ' 40' ' ' HIS . 11.7 pt -85.07 -31.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 -178.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 53.2 p -84.77 -32.26 23.51 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.255 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 58.45 31.89 21.49 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.652 1.181 . . . . 0.0 109.949 -177.348 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 33.8 t-80 -82.52 135.14 46.86 Favored Pre-proline 0 N--CA 1.424 -1.774 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.441 -178.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.51 -12.33 31.29 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 123.068 2.512 . . . . 0.0 112.681 -176.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 9.0 m-20 -130.51 30.28 4.72 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.586 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.38 -58.69 5.69 Favored Glycine 0 CA--C 1.453 -3.805 0 CA-C-N 114.491 -1.231 . . . . 0.0 113.277 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.484 HG21 HD13 ' X' ' 38' ' ' LEU . 1.5 m -79.09 -23.3 44.23 Favored 'General case' 0 C--N 1.251 -3.707 0 C-N-CA 117.944 -1.502 . . . . 0.0 110.759 -172.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.53 67.15 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 175.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 28.3 mt -66.67 -37.28 84.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.627 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mt -66.37 -42.79 91.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.891 0.853 . . . . 0.0 108.827 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -62.72 -43.35 99.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.083 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.89 -40.09 75.88 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.048 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.078 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' X' ' 72' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.786 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.545 ' O ' HG13 ' X' ' 75' ' ' ILE . 12.8 Cg_endo -54.1 -45.44 41.0 Favored 'Trans proline' 0 C--O 1.212 -0.804 0 C-N-CA 123.959 3.106 . . . . 0.0 114.077 -171.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -74.15 1.35 11.41 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.64 -6.25 25.19 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 119.901 -1.142 . . . . 0.0 112.769 174.222 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.545 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.0 OUTLIER -77.04 -43.68 31.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.242 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.743 HG11 HG12 ' X' ' 16' ' ' VAL . 1.2 p -58.22 -43.18 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.989 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 87.8 tttt -58.58 -48.15 81.89 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.393 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.35 -39.46 90.68 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.791 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.408 HG12 ' O ' ' X' ' 75' ' ' ILE . 47.6 mm -66.5 -45.31 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.278 178.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.9 pttp -62.34 -36.24 81.6 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -70.78 -36.23 72.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.134 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -70.2 -47.86 59.66 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.768 0.794 . . . . 0.0 108.877 178.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 13.6 tpt180 -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.783 -175.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.25 -43.08 78.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.175 0.59 . . . . 0.0 111.723 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -30.85 71.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -78.06 -37.4 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.08 33.63 5.68 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.345 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 20.2 mtpp -113.95 143.34 29.43 Favored Pre-proline 0 N--CA 1.4 -2.957 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -176.274 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 128.12 22.59 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.972 2.448 . . . . 0.0 111.884 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.36 -112.0 3.64 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.45 -178.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.98 166.18 14.68 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.406 -173.495 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.444 ' HG3' HG22 ' X' ' 11' ' ' THR . 22.2 ptmt -99.76 170.72 8.35 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -97.27 141.14 30.74 Favored 'General case' 0 N--CA 1.391 -3.409 0 CA-C-O 121.678 0.751 . . . . 0.0 109.571 178.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.109 0 N-CA-C 107.374 -2.29 . . . . 0.0 107.374 178.987 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 85.0 mt . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.1 mmtt -104.14 142.33 34.68 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -75.12 -16.01 60.57 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.113 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.5 p -132.2 162.73 30.2 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.959 175.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.454 HD11 ' CE1' ' X' ' 91' ' ' PHE . 8.5 tp -69.27 -17.84 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.717 0.807 . . . . 0.0 109.679 -177.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -19.61 59.18 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.359 -172.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 17.6 t70 -101.82 5.0 40.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.974 0.892 . . . . 0.0 109.095 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.2 m-85 -95.01 114.95 26.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.085 -174.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.523 HG22 ' HG3' ' X' ' 92' ' ' LYS . 70.8 p -80.42 162.36 24.49 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.592 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.5 pt-20 -56.56 -44.77 81.27 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.579 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -39.05 75.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -58.61 -38.46 78.04 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.277 0.49 . . . . 0.0 110.023 175.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -73.49 -43.12 60.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.338 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.817 HG12 HG11 ' X' ' 76' ' ' VAL . 11.0 m -62.58 -36.39 74.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.082 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.513 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -61.52 -49.46 76.63 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 109.649 177.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.508 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -61.19 -43.32 99.07 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.546 HD23 HG13 ' X' ' 75' ' ' ILE . 3.0 mp -58.41 -36.94 74.35 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.553 -1.203 . . . . 0.0 114.046 176.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 91.4 mttt -66.26 -40.0 89.87 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.188 0.518 . . . . 0.0 109.643 176.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.78 -37.36 87.34 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.595 178.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' X' ' 37' ' ' LEU . 26.3 mt -61.0 -45.18 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.413 ' CD ' ' HD3' ' X' ' 72' ' ' PRO . 52.6 mt-10 -58.54 -46.22 87.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.551 0.691 . . . . 0.0 110.639 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.01 -49.83 76.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.069 -175.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -71.82 -27.63 63.04 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -70.59 -53.92 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.462 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.62 -20.65 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.38 -13.98 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.543 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.87 70.25 0.6 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.297 1.039 . . . . 0.0 111.071 -176.033 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p -88.9 -17.56 29.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 110.951 -176.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.394 1.7 m-20 65.3 -59.55 0.27 Allowed 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 178.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.671 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.6 t70 -63.55 -57.01 11.51 Favored 'General case' 0 CA--C 1.478 -1.816 0 CA-C-N 119.817 1.19 . . . . 0.0 111.733 -176.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.73 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 44.0 t -76.42 -32.25 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.067 -177.139 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.628 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 1.8 tm? -58.35 -47.28 84.28 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.243 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 32.8 t70 -65.02 -41.84 94.93 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.671 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.6 t -56.53 -50.03 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 O-C-N 124.224 0.953 . . . . 0.0 110.079 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.2 mt -67.65 -39.92 84.58 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.603 -172.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 43.8 mt -63.21 -49.95 72.21 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 7.3 pt-20 -71.2 -34.45 70.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.889 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.564 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 59.3 t60 -60.21 -45.49 92.98 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.309 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.416 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 63.7 t80 -60.63 -52.98 62.83 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.781 178.271 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.526 HG12 ' O ' ' X' ' 38' ' ' LEU 0.291 2.7 p -67.49 -32.91 59.2 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.915 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.0 ptmm? -67.17 -33.39 75.3 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.924 -0.485 . . . . 0.0 111.876 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.487 HG12 ' O ' ' X' ' 40' ' ' HIS . 17.6 pt -86.23 -36.05 9.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.833 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -84.18 -33.45 24.18 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 120.891 0.377 . . . . 0.0 111.117 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 64.05 19.34 11.71 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.266 1.427 . . . . 0.0 111.392 -176.298 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.418 ' O ' HG23 ' X' ' 42' ' ' VAL . 47.8 t-80 -73.0 132.22 82.98 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.533 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -70.19 -17.05 35.88 Favored 'Trans proline' 0 CA--C 1.492 -1.613 0 C-N-CA 122.833 2.355 . . . . 0.0 112.662 -172.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 5.4 m-20 -127.14 36.19 4.46 Favored 'General case' 0 N--CA 1.389 -3.508 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -173.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.416 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.48 -53.52 16.15 Favored Glycine 0 CA--C 1.454 -3.731 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.422 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.482 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.43 -31.56 57.96 Favored 'General case' 0 C--N 1.247 -3.874 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.731 -173.615 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.88 -38.08 84.38 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.058 177.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.8 -48.45 75.35 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.477 0.486 . . . . 0.0 112.136 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.454 HG12 HG21 ' X' ' 22' ' ' ILE . 5.1 mp -67.88 -42.17 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 118.272 -1.371 . . . . 0.0 110.079 -178.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.413 ' HD2' ' O ' ' X' ' 51' ' ' THR . 27.0 m-85 -62.55 -45.51 92.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.158 -178.479 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.8 pt-20 -68.66 -35.92 77.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.283 176.056 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.136 0 C-N-CA 122.482 0.313 . . . . 0.0 110.982 178.22 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.464 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.407 -3.246 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.562 ' O ' HG12 ' X' ' 76' ' ' VAL . 12.8 Cg_endo -61.09 -43.77 27.92 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.541 2.828 . . . . 0.0 112.564 -175.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.89 0.82 16.93 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.2 -40.31 1.41 Allowed Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.381 177.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.546 HG13 HD23 ' X' ' 19' ' ' LEU . 3.6 pt -60.52 -29.72 45.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.169 0.485 . . . . 0.0 111.771 176.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.817 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -65.51 -45.59 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 122.327 1.061 . . . . 0.0 111.088 175.12 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 40.7 ttmt -63.07 -37.72 88.31 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.584 -1.643 . . . . 0.0 109.761 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.91 -43.74 98.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.319 0.581 . . . . 0.0 111.124 174.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.469 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.5 mm -61.24 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.912 176.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 22.3 ptmt -63.59 -36.3 83.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.963 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.6 mt-10 -64.55 -41.64 96.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.415 0.447 . . . . 0.0 110.752 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.533 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.3 t90 -68.12 -45.33 73.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.524 0.678 . . . . 0.0 109.769 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -60.91 -45.28 95.27 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.454 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.11 85.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.59 92.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.951 0.405 . . . . 0.0 110.738 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.469 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 21.7 t-20 -69.63 -41.34 75.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.726 0.774 . . . . 0.0 109.444 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.79 28.75 5.23 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 67.7 mttm -100.31 150.85 37.28 Favored Pre-proline 0 N--CA 1.402 -2.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.67 128.56 28.63 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.281 2.654 . . . . 0.0 112.152 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.21 -149.47 25.5 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.941 -177.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' X' ' 7' ' ' ILE . 42.2 m-85 -79.28 159.66 27.15 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -176.011 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.3 ptmt -98.73 176.31 5.67 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-O 121.723 0.773 . . . . 0.0 110.126 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -112.34 141.84 45.58 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.554 174.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.569 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 -179.794 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.239 0.503 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -111.68 -169.84 1.54 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -107.75 -29.18 9.25 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.628 0.727 . . . . 0.0 110.236 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -131.82 163.52 28.08 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.352 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -69.68 -13.4 17.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 CA-C-O 121.549 0.69 . . . . 0.0 110.668 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 10.8 m -72.82 -22.13 60.85 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.636 -174.39 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 21.9 t70 -100.57 3.4 42.67 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.165 0.983 . . . . 0.0 108.883 177.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -92.49 115.12 27.81 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.473 -176.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 65.2 p -76.53 159.18 30.58 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 171.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.636 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.7 pt-20 -61.13 -35.27 76.61 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.951 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.44 -38.45 74.53 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.802 177.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.2 -40.99 83.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.12 0.962 . . . . 0.0 109.243 173.053 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.562 ' HD2' HG12 ' X' ' 76' ' ' VAL . 41.4 t80 -69.27 -45.02 70.68 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.057 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.786 HG12 HG11 ' X' ' 76' ' ' VAL . 8.4 m -61.86 -38.75 81.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.46 -36.48 79.06 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 121.487 0.661 . . . . 0.0 111.544 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.487 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -66.92 -46.18 75.61 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.702 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' X' ' 41' ' ' PHE . 7.3 mp -60.13 -36.97 78.66 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.081 177.28 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.649 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 62.5 mttm -63.11 -35.64 80.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.477 0.656 . . . . 0.0 109.964 176.481 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -69.38 -33.5 73.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.632 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' X' ' 37' ' ' LEU . 9.5 mt -67.46 -40.84 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.72 -46.75 84.0 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.55 -42.81 97.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.907 -176.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -77.16 -29.05 54.31 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.164 -0.335 . . . . 0.0 111.493 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -75.42 -46.37 33.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.131 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.44 -35.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.909 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.33 -10.07 56.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 177.743 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.07 74.51 0.29 Allowed 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.543 1.537 . . . . 0.0 113.431 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 56.6 p -99.24 -166.27 1.33 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.34 -61.84 1.01 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.59 ' O ' HG23 ' X' ' 36' ' ' VAL . 18.5 m-20 -56.96 -50.93 71.14 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.668 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 62.0 t -88.59 -29.16 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.52 -45.65 88.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.64 -30.4 67.02 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.267 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.59 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -63.29 -49.73 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.493 176.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.669 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.0 mt -68.47 -43.78 76.25 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.486 -170.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 36.2 mt -61.14 -46.22 91.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 124.099 0.874 . . . . 0.0 110.428 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.44 -43.77 69.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.989 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.485 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.2 t60 -60.12 -45.71 92.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.607 -176.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.636 ' CD2' HD11 ' X' ' 54' ' ' ILE . 39.5 t80 -61.43 -51.49 68.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.224 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.432 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.9 p -67.7 -32.59 57.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.8 pttt -72.63 -26.59 61.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.46 HG12 ' O ' ' X' ' 40' ' ' HIS . 26.6 pt -87.26 -34.87 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.779 179.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -84.3 -31.97 24.59 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 58.06 31.71 21.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.633 1.173 . . . . 0.0 109.877 -176.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 40.9 t-80 -82.43 138.52 44.74 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 113.514 -1.675 . . . . 0.0 108.117 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' X' ' 47' ' ' HIS . 15.6 Cg_exo -73.5 -6.42 18.73 Favored 'Trans proline' 0 CA--C 1.492 -1.593 0 C-N-CA 123.1 2.533 . . . . 0.0 112.599 -175.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.433 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 38.0 m-20 -135.63 32.19 3.04 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.583 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.73 -59.99 5.13 Favored Glycine 1 CA--C 1.445 -4.34 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.872 -176.842 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.469 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -75.18 -30.13 60.6 Favored 'General case' 1 C--N 1.242 -4.092 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.019 -172.641 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.15 -28.13 69.85 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 53' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' X' ' 56' ' ' GLU . 28.1 mt -65.13 -43.1 93.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 175.21 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.636 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -67.2 -41.66 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.789 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -58.27 -47.28 84.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.685 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.6 pt-20 -67.67 -36.72 81.23 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.325 175.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 118.125 0.421 . . . . 0.0 111.824 -178.452 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.492 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.407 -3.262 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.623 ' O ' HG13 ' X' ' 76' ' ' VAL . 12.7 Cg_endo -74.46 -46.24 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.353 2.702 . . . . 0.0 112.353 -172.184 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.483 ' C ' HG22 ' X' ' 76' ' ' VAL . 31.5 mt-10 -73.5 0.86 11.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -177.116 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.31 -34.3 2.95 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.518 172.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.52 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.8 pt -66.89 -27.11 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 117.647 0.723 . . . . 0.0 110.633 172.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.786 HG11 HG12 ' X' ' 16' ' ' VAL . 27.6 m -62.16 -37.99 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.889 0 CA-C-O 121.689 0.757 . . . . 0.0 110.992 176.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 39.8 ttmt -65.74 -45.01 84.22 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.788 176.023 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -58.1 -38.05 75.71 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.57 -46.89 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.412 177.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 17.9 ptpt -66.82 -38.5 86.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.726 -175.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 46.2 mt-10 -69.69 -32.22 70.7 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.252 -178.419 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.403 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 81.2 t90 -72.19 -48.28 44.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.559 0.695 . . . . 0.0 109.354 177.341 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 14.9 tpt180 -61.39 -45.45 94.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.415 -174.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.42 84.3 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.04 84.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.862 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.58 -45.74 57.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.645 0.736 . . . . 0.0 109.061 177.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.35 37.5 1.94 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 93.0 mttt -112.51 143.47 29.0 Favored Pre-proline 0 N--CA 1.391 -3.387 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.51 131.23 27.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.43 2.086 . . . . 0.0 110.314 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -114.59 -115.71 3.12 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.818 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -79.18 145.93 33.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -174.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' X' ' 11' ' ' THR . 45.8 pttt -97.38 172.4 7.79 Favored 'General case' 0 N--CA 1.384 -3.771 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.97 148.64 22.11 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 177.86 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' X' ' 18' ' ' LEU . 35.0 mt . . . . . 0 N--CA 1.427 -1.588 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 35.1 mmtt -93.09 -166.73 1.58 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.357 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -118.16 -0.08 11.65 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 174.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -153.44 158.89 42.08 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.212 176.325 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' X' ' 10' ' ' TYR . 11.3 tt -67.4 -24.43 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.488 0.661 . . . . 0.0 110.571 -178.422 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -85.44 0.09 53.31 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.951 -174.124 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.6 t70 -104.11 -1.28 27.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.332 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' X' ' 7' ' ' ILE . 8.0 m-85 -97.53 124.61 41.83 Favored 'General case' 0 CA--C 1.472 -2.025 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.804 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 47.9 p -78.75 159.4 27.94 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.014 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.63 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.21 -41.11 75.1 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 123.321 0.388 . . . . 0.0 110.383 -179.41 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.719 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.4 76.26 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.48 -38.9 82.05 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.737 0.779 . . . . 0.0 109.682 173.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.599 ' CD2' HG12 ' X' ' 76' ' ' VAL . 22.0 t80 -75.3 -41.73 56.28 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.73 -177.222 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.719 HG22 ' HA ' ' X' ' 13' ' ' ALA . 15.1 m -62.87 -32.79 57.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 176.436 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -64.24 -47.33 80.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 122.912 0.485 . . . . 0.0 109.966 178.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.679 ' O ' HG13 ' X' ' 22' ' ' ILE . 19.9 tp -57.23 -47.59 80.94 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 123.873 0.733 . . . . 0.0 109.292 177.699 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.94 -36.82 77.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.345 177.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.623 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 97.4 mttt -61.23 -46.47 90.29 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.518 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 21' ' ' GLU . . . . . 0.499 ' HA ' ' HE3' ' X' ' 24' ' ' LYS . 54.8 mt-10 -64.14 -37.81 88.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.627 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.701 HG12 ' HB3' ' X' ' 37' ' ' LEU . 27.4 mt -63.17 -44.61 99.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' X' ' 20' ' ' LYS . 4.8 pt-20 -65.68 -35.07 79.71 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.143 0.973 . . . . 0.0 109.423 -178.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 24' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' X' ' 21' ' ' GLU . 27.8 ttpp -72.29 -52.03 18.11 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.474 -174.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -17.33 64.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.947 0.403 . . . . 0.0 111.305 176.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -81.08 -51.38 8.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.524 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 m -73.09 -26.39 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.24 -22.01 33.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.31 78.82 0.27 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.171 1.388 . . . . 0.0 112.011 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -92.31 -28.04 17.2 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 67.79 -55.15 0.49 Allowed 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.297 1.839 . . . . 0.0 115.374 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.44 ' O ' HG23 ' X' ' 36' ' ' VAL . 9.5 p-10 -68.36 -47.4 67.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.445 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -85.95 -29.88 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.13 -41.27 87.84 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 177.309 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 27.0 t70 -62.0 -41.69 98.33 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 123.386 0.429 . . . . 0.0 110.02 178.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' X' ' 33' ' ' VAL . 58.2 t -59.29 -48.74 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 O-C-N 124.622 1.201 . . . . 0.0 109.47 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.2 mt -64.64 -43.22 94.37 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.662 -173.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -60.11 -50.69 72.68 Favored 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 124.119 0.887 . . . . 0.0 111.051 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 1.5 pt-20 -70.69 -37.5 73.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.697 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.5 t60 -59.75 -46.26 89.71 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.268 0.627 . . . . 0.0 109.644 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.556 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.9 t80 -61.8 -53.52 54.77 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.259 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.452 HG12 ' O ' ' X' ' 38' ' ' LEU . 8.2 p -67.09 -31.7 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 54.1 pttt -69.63 -38.88 77.35 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 122.089 -0.382 . . . . 0.0 111.948 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.48 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.1 pt -79.63 -31.79 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.795 0.331 . . . . 0.0 110.747 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 54.7 p -84.04 -34.99 24.13 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.81 22.95 13.25 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.65 1.18 . . . . 0.0 109.929 -176.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -79.3 133.31 60.58 Favored Pre-proline 0 N--CA 1.433 -1.305 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.278 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.445 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -71.69 -19.48 27.7 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.282 -173.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -118.5 30.37 7.24 Favored 'General case' 0 N--CA 1.4 -2.957 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -171.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.556 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.0 -57.33 6.25 Favored Glycine 0 CA--C 1.461 -3.34 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.9 -178.428 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.525 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -82.26 -22.78 35.61 Favored 'General case' 0 C--N 1.247 -3.867 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.959 -172.206 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.84 -36.69 84.06 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.754 174.48 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.09 -40.44 97.66 Favored 'General case' 0 C--O 1.207 -1.142 0 O-C-N 123.609 0.568 . . . . 0.0 110.643 175.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.497 HD13 HG21 ' X' ' 22' ' ' ILE . 51.1 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.392 0.615 . . . . 0.0 109.864 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -62.17 -44.49 96.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.69 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.6 pt-20 -71.17 -38.38 72.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.924 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.818 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.396 -3.979 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.755 ' HA ' HD11 ' X' ' 75' ' ' ILE . 24.1 Cg_endo -66.11 -24.64 51.74 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.472 . . . . 0.0 112.805 -175.501 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.479 ' HG2' HG11 ' X' ' 16' ' ' VAL . 35.7 mt-10 -85.68 1.96 47.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.964 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 74' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -105.44 -32.82 3.82 Favored Glycine 0 N--CA 1.419 -2.441 0 C-N-CA 118.377 -1.868 . . . . 0.0 114.322 176.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.755 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -69.95 -28.21 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-N 118.68 1.24 . . . . 0.0 110.204 175.128 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.599 HG12 ' CD2' ' X' ' 15' ' ' PHE . 27.5 m -63.61 -38.06 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-O 121.347 0.594 . . . . 0.0 110.489 177.225 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttm -61.28 -48.46 81.29 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.445 173.318 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.16 -37.45 82.95 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.741 -178.382 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.422 HG12 ' O ' ' X' ' 75' ' ' ILE . 31.4 mm -68.46 -46.36 80.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.571 177.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -65.09 -38.06 89.51 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.666 -174.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.23 -38.78 75.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.272 -178.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.445 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 71.2 t90 -66.69 -47.88 71.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 109.131 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 19.7 tpt180 -61.19 -46.33 90.92 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.071 -175.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.58 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.868 -178.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.05 75.02 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.923 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -72.82 -42.63 63.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.64 34.99 1.62 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.918 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 65.9 mttm -115.43 140.13 25.48 Favored Pre-proline 0 N--CA 1.385 -3.685 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -177.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -61.5 136.31 62.49 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.422 2.082 . . . . 0.0 110.899 176.295 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.0 -120.33 4.68 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.233 -174.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -86.87 166.42 15.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 124.202 0.59 . . . . 0.0 109.441 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' X' ' 11' ' ' THR . 18.0 ptmt -105.18 162.14 13.65 Favored 'General case' 1 N--CA 1.374 -4.265 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.176 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.83 134.44 49.98 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.489 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.265 -3.379 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.806 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.849 0.833 . . . . 0.0 112.623 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 32.2 mmtt -101.76 -157.52 0.61 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -120.5 -20.37 7.19 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.222 171.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.4 p -141.01 165.7 26.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.464 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.09 -23.11 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.649 1.18 . . . . 0.0 110.393 -179.3 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.9 m -73.68 -16.33 61.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.798 -173.242 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 19.2 t70 -102.97 3.27 36.13 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.508 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.463 ' OH ' HD22 ' X' ' 18' ' ' LEU . 8.6 m-85 -97.04 118.4 33.35 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.39 -175.235 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 23.8 p -80.15 164.62 23.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.624 ' O ' HG13 ' X' ' 16' ' ' VAL . 5.8 pt-20 -59.08 -40.44 85.26 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.403 178.552 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.636 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.63 76.32 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.939 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.42 -38.0 79.48 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.707 0.765 . . . . 0.0 110.261 174.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.575 ' HD2' HG12 ' X' ' 76' ' ' VAL . 36.3 t80 -72.87 -46.02 55.12 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.617 -179.054 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.741 HG12 HG11 ' X' ' 76' ' ' VAL . 10.4 m -62.34 -34.42 64.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.848 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.09 -49.69 76.3 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.657 ' O ' HG13 ' X' ' 22' ' ' ILE . 55.3 tp -60.0 -46.78 88.35 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.524 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.423 HD21 ' CD1' ' X' ' 41' ' ' PHE . 4.4 mm? -58.51 -36.86 74.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.619 178.224 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.5 mttt -63.83 -37.23 86.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 110.568 175.584 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.31 -35.61 66.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.657 HG13 ' O ' ' X' ' 18' ' ' LEU . 17.3 mt -67.64 -42.09 86.2 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.176 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.405 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -42.8 84.75 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.917 1.287 . . . . 0.0 109.604 177.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.74 -47.62 74.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.619 -177.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.676 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 7.1 mm-40 -76.97 -15.4 59.66 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.319 178.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -70.53 -45.93 64.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.51 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.16 -26.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.383 179.408 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.42 50.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.061 176.405 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.8 77.27 0.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.166 1.386 . . . . 0.0 111.267 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 27.2 p -101.46 -168.73 1.59 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.73 -35.35 0.58 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.126 176.338 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.481 ' O ' HG23 ' X' ' 36' ' ' VAL . 37.7 m-20 -65.11 -53.02 51.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.823 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.742 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 4.8 p -88.52 -31.12 5.49 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.943 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.181 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.25 -45.02 92.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.322 -175.195 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.76 -29.71 63.54 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.887 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.481 HG23 ' O ' ' X' ' 32' ' ' ASP . 92.4 t -64.46 -48.78 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.063 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.457 176.676 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 85.9 mt -67.58 -43.57 80.26 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.121 -172.556 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 44.5 mt -61.81 -45.06 95.5 Favored 'General case' 0 N--CA 1.422 -1.837 0 O-C-N 124.194 0.934 . . . . 0.0 110.786 -179.575 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.24 -47.28 62.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.504 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.3 t60 -59.71 -44.2 93.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.584 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.593 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 30.9 t80 -59.95 -52.97 63.13 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.884 177.582 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.518 HG12 ' O ' ' X' ' 38' ' ' LEU . 13.8 p -67.71 -32.55 57.2 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.773 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.0 pttp -70.17 -28.59 65.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.454 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -84.38 -40.77 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.369 -177.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.573 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.4 t -83.64 -32.11 25.85 Favored 'General case' 0 C--O 1.252 1.224 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.653 178.122 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.56 30.55 12.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 125.908 1.683 . . . . 0.0 111.342 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.514 ' H ' HG23 ' X' ' 45' ' ' THR . 48.0 t-80 -76.65 137.0 67.01 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.85 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 18.6 Cg_exo -70.99 -13.07 31.35 Favored 'Trans proline' 0 CA--C 1.502 -1.115 0 C-N-CA 123.099 2.533 . . . . 0.0 112.645 -174.099 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.55 31.45 4.78 Favored 'General case' 0 N--CA 1.398 -3.051 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -173.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.15 -56.88 7.49 Favored Glycine 0 CA--C 1.457 -3.584 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.921 -178.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.459 HG23 HD22 ' X' ' 38' ' ' LEU . 1.3 m -72.08 -32.55 67.14 Favored 'General case' 0 C--N 1.256 -3.479 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.271 -173.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.32 -37.21 86.39 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.996 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 53' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' X' ' 75' ' ' ILE . 27.6 mt -58.47 -39.02 78.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.766 0.666 . . . . 0.0 112.22 178.155 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.628 HD13 HG21 ' X' ' 22' ' ' ILE . 67.8 mt -65.89 -44.43 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.638 . . . . 0.0 109.304 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.56 -49.74 74.09 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.274 178.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.8 pt-20 -69.65 -42.43 74.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.187 -179.603 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.109 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.512 ' HA ' HD11 ' X' ' 75' ' ' ILE . 18.7 Cg_endo -55.98 -37.71 95.71 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 123.884 3.056 . . . . 0.0 114.126 -176.331 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.444 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.7 mt-10 -86.37 2.39 47.68 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.76 -28.03 5.5 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 118.684 -1.722 . . . . 0.0 112.481 173.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.3 OUTLIER -61.12 -39.69 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 122.326 1.06 . . . . 0.0 108.277 176.349 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.741 HG11 HG12 ' X' ' 16' ' ' VAL . 29.2 m -59.46 -33.76 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 CA-C-N 113.314 -1.766 . . . . 0.0 112.686 -176.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -60.06 -51.64 68.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.773 172.014 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -59.32 -42.29 91.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.488 HD12 HG21 ' X' ' 45' ' ' THR . 29.0 mm -62.75 -46.29 96.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.014 177.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.49 -43.36 73.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.621 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -72.16 -32.21 66.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.156 -175.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.609 ' CZ3' ' HE3' ' X' ' 88' ' ' LYS . 62.0 t90 -66.11 -45.85 79.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.597 1.189 . . . . 0.0 109.133 175.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.438 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 9.2 tpt180 -66.24 -46.92 75.48 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.169 -177.087 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -38.35 81.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.489 0.716 . . . . 0.0 112.094 -176.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.24 70.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 86' ' ' ASN . . . . . 0.597 ' HB3' ' NZ ' ' X' ' 88' ' ' LYS . 56.4 t30 -101.4 6.16 42.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.075 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.43 42.32 49.19 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.004 175.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.609 ' HE3' ' CZ3' ' X' ' 82' ' ' TRP . 36.6 mtmm -105.19 139.44 20.13 Favored Pre-proline 1 N--CA 1.378 -4.042 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.849 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.08 114.7 2.12 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 111.788 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.0 -125.11 4.09 Favored Glycine 0 CA--C 1.489 -1.587 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.659 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.71 152.84 28.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.975 0.417 . . . . 0.0 110.285 -175.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.07 177.71 6.85 Favored 'General case' 0 N--CA 1.391 -3.375 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -117.59 143.37 46.18 Favored 'General case' 1 N--CA 1.377 -4.09 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 -178.682 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 177.065 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.511 ' CD2' HD13 ' X' ' 18' ' ' LEU . 33.9 mt . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 34.3 mmtt -102.06 -162.45 0.93 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -118.52 -19.61 8.73 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.447 -0.783 . . . . 0.0 111.34 173.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 60.7 p -135.86 163.61 29.83 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.545 HG12 HH12 ' X' ' 83' ' ' ARG . 3.6 tp -69.81 -14.88 18.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.667 -177.175 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.5 m -71.87 -17.55 62.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.184 -174.036 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 17.2 t70 -106.83 5.06 28.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.791 0.805 . . . . 0.0 108.932 178.409 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.82 121.58 38.84 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.216 -176.512 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 43.6 p -88.61 179.51 6.25 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.144 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.665 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.3 mm-40 -59.16 -52.36 66.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.507 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.22 -38.74 78.7 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.741 -171.244 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.56 -36.27 80.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 110.279 175.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.681 ' HD2' HG12 ' X' ' 76' ' ' VAL . 44.7 t80 -75.94 -44.66 39.02 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.354 -177.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.78 HG12 HG11 ' X' ' 76' ' ' VAL . 6.2 m -62.44 -33.25 58.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 116.939 -0.119 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -65.4 -47.84 74.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 123.024 0.53 . . . . 0.0 110.077 178.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.651 ' O ' HG13 ' X' ' 22' ' ' ILE . 17.9 tp -57.64 -47.44 82.22 Favored 'General case' 0 C--O 1.208 -1.09 0 CA-C-O 121.222 0.534 . . . . 0.0 109.789 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.515 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.48 -39.2 82.95 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.234 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 50.6 mttp -63.73 -38.5 91.33 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.174 0.511 . . . . 0.0 109.997 176.153 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' X' ' 24' ' ' LYS . 42.9 mt-10 -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.198 177.269 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.651 HG13 ' O ' ' X' ' 18' ' ' LEU . 31.0 mt -67.3 -40.89 85.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.351 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 23' ' ' GLU . . . . . 0.448 ' O ' HG22 ' X' ' 27' ' ' VAL . 52.3 mt-10 -57.89 -42.74 85.27 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.903 0.858 . . . . 0.0 109.728 177.749 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 24' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' X' ' 21' ' ' GLU . 80.1 tttt -60.23 -52.15 66.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.389 -176.605 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' X' ' 21' ' ' GLU . 1.2 pp20? -83.71 -32.93 25.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -58.3 -45.6 87.66 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.324 0.249 . . . . 0.0 111.503 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 27' ' ' VAL . . . . . 0.448 HG22 ' O ' ' X' ' 23' ' ' GLU . 31.7 m -76.22 -24.24 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.22 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -21.23 46.33 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.962 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.85 80.92 0.17 Allowed 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.878 1.671 . . . . 0.0 111.796 -178.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 0.7 OUTLIER -98.34 -175.2 3.04 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.139 174.433 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.71 -55.93 0.62 Allowed 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.724 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.67 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.9 t70 -63.12 -57.42 10.65 Favored 'General case' 0 CA--C 1.484 -1.572 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.939 -179.177 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.687 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.8 p -73.08 -30.16 30.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -175.428 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.537 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.4 tm? -61.21 -50.16 74.22 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.493 178.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.59 -24.5 62.77 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.835 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.67 HG23 ' O ' ' X' ' 32' ' ' ASP . 98.8 t -70.57 -51.34 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.98 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.118 177.084 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 44.7 mt -69.29 -43.13 74.46 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.87 -170.336 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.476 ' O ' HG12 ' X' ' 42' ' ' VAL . 25.7 mt -60.98 -43.51 98.72 Favored 'General case' 0 N--CA 1.419 -2.019 0 O-C-N 124.283 0.989 . . . . 0.0 111.226 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.82 -44.05 67.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.987 0.423 . . . . 0.0 111.128 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.516 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 7.8 t60 -59.52 -45.21 92.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.63 -175.733 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.617 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 60.5 t80 -60.16 -51.79 68.09 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.94 178.037 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.476 HG12 ' O ' ' X' ' 38' ' ' LEU 0.258 9.5 p -67.51 -32.28 56.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.494 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.716 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -70.47 -37.49 74.27 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.99 -0.444 . . . . 0.0 112.073 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.511 HG12 ' O ' ' X' ' 40' ' ' HIS . 18.5 pt -78.75 -31.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.248 0.547 . . . . 0.0 110.776 -178.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.433 ' O ' ' HD2' ' X' ' 83' ' ' ARG . 53.7 p -84.36 -42.4 15.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.04 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.57 25.97 6.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.159 1.784 . . . . 0.0 110.446 -176.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -80.35 135.66 53.63 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 114.286 -1.324 . . . . 0.0 107.797 178.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -69.45 -15.56 38.31 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 122.933 2.422 . . . . 0.0 112.737 -173.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -127.17 32.85 5.0 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.51 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.617 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.09 -59.23 4.04 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.966 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.474 ' O ' ' HD2' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -73.26 -32.39 64.66 Favored 'General case' 0 C--N 1.246 -3.933 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.537 -171.036 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.75 -36.0 79.75 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.494 178.165 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -59.82 -45.55 92.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 176.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.469 HD13 HG21 ' X' ' 22' ' ' ILE . 85.2 mt -67.62 -40.73 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.431 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.474 ' HD2' ' O ' ' X' ' 51' ' ' THR . 17.0 m-85 -59.34 -46.65 88.03 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.078 177.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.6 pt-20 -67.68 -36.13 80.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.24 176.835 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.515 0 O-C-N 122.947 0.155 . . . . 0.0 110.757 179.674 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.54 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.404 -3.498 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.623 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.2 Cg_endo -58.3 -43.15 49.16 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.771 2.981 . . . . 0.0 112.403 -176.787 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.462 ' C ' HG22 ' X' ' 76' ' ' VAL . 37.0 mt-10 -85.5 1.87 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 123.771 0.828 . . . . 0.0 110.796 -176.748 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 74' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -107.98 -29.72 4.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 119.264 -1.446 . . . . 0.0 112.886 173.628 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.54 HG12 ' O ' ' X' ' 71' ' ' GLY . 1.6 pt -69.64 -28.5 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 CA-C-N 117.576 0.688 . . . . 0.0 110.762 173.743 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.78 HG11 HG12 ' X' ' 16' ' ' VAL . 31.4 m -59.89 -35.92 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 121.76 0.79 . . . . 0.0 110.787 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.549 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 40.4 tttp -62.38 -49.11 76.82 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.302 174.293 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.33 -41.2 84.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 23.5 mm -63.0 -45.85 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.067 177.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 61.5 pttt -71.87 -38.58 70.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.993 -176.287 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 81' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.1 mt-10 -69.4 -32.32 71.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.839 -178.589 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.442 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -65.99 -46.15 79.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.228 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.545 HH12 HG12 ' X' ' 7' ' ' ILE . 0.9 OUTLIER -66.26 -39.74 89.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.274 177.205 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.27 86.51 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.817 0.698 . . . . 0.0 111.717 -179.065 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.786 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.23 -40.03 15.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.15 28.71 3.49 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -175.02 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -93.55 156.46 39.71 Favored Pre-proline 0 N--CA 1.412 -2.328 0 C-N-CA 124.225 1.01 . . . . 0.0 108.779 179.27 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -63.71 129.57 25.29 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.574 2.183 . . . . 0.0 112.979 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.99 -132.57 7.78 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.945 178.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 42.4 m-85 -96.21 152.75 18.27 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.251 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -88.85 169.55 11.49 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.29 136.0 41.86 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.82 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.926 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -177.695 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.545 HD22 HD13 ' X' ' 18' ' ' LEU . 40.4 mt . . . . . 0 N--CA 1.435 -1.22 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.457 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 35.3 mmtt -95.62 -161.06 0.83 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.177 -173.577 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -108.79 -33.51 6.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -130.69 166.61 20.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.624 -176.202 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.2 tp -67.65 -25.15 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.595 0.712 . . . . 0.0 109.785 178.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -77.67 -11.54 59.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.261 -173.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 37.0 t0 -99.28 1.13 44.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.04 121.43 40.97 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.855 -174.493 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 11' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 80.1 p -79.52 167.94 20.1 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 170.798 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.0 pt-20 -59.96 -41.86 92.82 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.031 178.627 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.58 -38.5 74.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.47 177.284 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' X' ' 11' ' ' THR . 9.6 mm-40 -59.72 -36.17 76.0 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.403 0.62 . . . . 0.0 109.973 174.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.728 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 18.8 t80 -70.92 -46.17 62.97 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.867 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.74 HG12 HG11 ' X' ' 76' ' ' VAL . 4.9 m -62.57 -29.97 48.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.523 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -60.76 -49.41 77.61 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.969 0.907 . . . . 0.0 109.697 174.478 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.653 ' O ' HG13 ' X' ' 22' ' ' ILE . 22.7 tp -57.72 -46.79 83.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.577 0.704 . . . . 0.0 109.677 175.537 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.1 mt -58.23 -38.71 77.38 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.055 -178.761 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 97.6 mttt -70.3 -39.21 74.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.957 0.408 . . . . 0.0 110.157 176.11 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.41 -37.47 87.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 178.418 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.653 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.5 mt -65.82 -46.74 87.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.232 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.98 -39.86 79.24 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.367 1.067 . . . . 0.0 113.053 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 24' ' ' LYS . . . . . 0.543 ' HG3' ' OE1' ' X' ' 25' ' ' GLU . 24.3 tptp -60.21 -48.67 80.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 25' ' ' GLU . . . . . 0.543 ' OE1' ' HG3' ' X' ' 24' ' ' LYS . 9.4 mm-40 -92.15 -1.83 56.93 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.484 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -70.84 -53.39 15.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.71 -28.31 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.962 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -23.36 33.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.959 0.409 . . . . 0.0 110.316 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.77 71.21 0.58 Allowed 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.57 1.548 . . . . 0.0 111.935 -176.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 68.9 p -91.25 -164.03 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.34 -38.71 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.716 177.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.525 ' O ' HG23 ' X' ' 36' ' ' VAL . 33.8 t70 -67.78 -55.09 14.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -172.468 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.675 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.86 -28.88 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 118.711 -1.195 . . . . 0.0 108.267 -177.765 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.07 -49.73 76.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.92 -176.203 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.52 -16.02 59.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.294 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.525 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.3 t -71.69 -50.4 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 C-N-CA 118.599 -1.24 . . . . 0.0 107.815 172.254 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 82.3 mt -68.18 -42.44 79.94 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 113.457 -1.702 . . . . 0.0 112.059 -169.395 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.0 mt -59.12 -45.78 90.03 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.352 1.033 . . . . 0.0 110.524 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -70.55 -43.3 69.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.893 178.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.524 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.6 t60 -59.89 -46.37 89.55 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.109 -176.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.611 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.7 t80 -62.45 -50.54 71.07 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.095 -179.54 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.461 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.5 p -67.08 -30.97 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.549 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.0 pttt -73.08 -35.41 66.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.364 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.517 HG12 ' O ' ' X' ' 40' ' ' HIS . 28.6 pt -81.21 -38.69 16.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.9 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 77.2 p -79.47 -36.15 39.19 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-O 121.227 0.537 . . . . 0.0 110.398 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 65.02 23.82 12.55 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -75.28 134.14 74.08 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.483 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.7 Cg_exo -72.17 -3.09 12.66 Favored 'Trans proline' 0 CA--C 1.493 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.549 -174.428 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' X' ' 52' ' ' ALA . 24.0 t70 -138.51 32.48 2.29 Favored 'General case' 0 N--CA 1.389 -3.507 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -174.21 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.611 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.44 -59.72 4.56 Favored Glycine 1 CA--C 1.45 -4.01 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.353 -179.152 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.452 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.23 -32.4 70.25 Favored 'General case' 0 C--N 1.248 -3.81 0 CA-C-N 114.764 -0.718 . . . . 0.0 111.461 -173.149 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -75.08 -24.07 58.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.037 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.31 -40.48 94.36 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.435 173.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.58 HD13 HG21 ' X' ' 22' ' ' ILE . 11.7 mt -66.23 -46.11 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -57.45 -49.06 77.46 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.437 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.57 -36.11 70.79 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.148 177.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 118.159 0.436 . . . . 0.0 110.335 178.851 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.409 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.481 ' O ' HG13 ' X' ' 75' ' ' ILE . 11.6 Cg_endo -58.31 -44.4 38.61 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.899 -178.531 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.79 1.05 7.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.03 -22.78 6.72 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.739 176.464 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.505 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -65.63 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.703 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.74 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -58.27 -47.2 88.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.291 178.653 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 23.9 ttmm -58.26 -44.66 88.45 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.72 -29.73 64.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.285 0.564 . . . . 0.0 110.664 -178.365 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.505 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.3 mm -69.02 -45.92 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.028 175.281 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.2 pttp -63.07 -36.29 83.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.186 -174.771 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.21 -37.6 75.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.144 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.483 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.4 t90 -68.42 -47.38 67.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.192 0.52 . . . . 0.0 110.239 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.485 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 12.3 tpt180 -60.48 -45.66 92.94 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.26 -175.127 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.32 87.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.804 0.335 . . . . 0.0 111.457 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.46 -30.44 64.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.6 34.77 4.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.843 177.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 88' ' ' LYS . . . . . 0.485 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 58.7 mttm -111.91 148.27 38.62 Favored Pre-proline 0 N--CA 1.403 -2.802 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.03 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.01 126.54 14.65 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.512 2.142 . . . . 0.0 110.344 175.656 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.79 -114.61 3.13 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.096 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 91' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 18.0 m-85 -88.59 158.5 18.25 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 121.114 0.483 . . . . 0.0 110.273 -174.685 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.6 ptmt -98.45 166.43 11.36 Favored 'General case' 0 N--CA 1.381 -3.881 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.03 136.46 44.46 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 173.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.119 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.39 -177.166 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' X' X ' 3' ' ' LEU . . . . . 0.49 HD22 HD13 ' X' ' 18' ' ' LEU . 67.8 mt . . . . . 0 C--O 1.242 0.658 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 4' ' ' LYS . . . . . 0.472 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 36.3 mmtt -101.66 -159.84 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.98 -22.55 6.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.134 0.492 . . . . 0.0 110.446 175.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 6' ' ' SER . . . . . 0.489 ' HA ' HG22 ' X' ' 44' ' ' ILE . 23.1 p -140.0 165.95 25.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.559 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 7' ' ' ILE . . . . . 0.724 HG12 HH12 ' X' ' 83' ' ' ARG . 4.7 tp -70.38 -18.02 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.488 0.661 . . . . 0.0 110.317 -175.85 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -70.67 -18.89 62.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.851 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 9' ' ' ASP . . . . . 0.519 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.8 t0 -104.09 6.9 36.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.904 0.859 . . . . 0.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 15.4 m-85 -96.3 123.81 40.08 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.57 -176.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.3 p -86.29 172.73 10.24 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 171.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 12' ' ' GLU . . . . . 0.612 ' O ' HG13 ' X' ' 16' ' ' VAL . 4.1 mm-40 -56.05 -52.04 65.67 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.138 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 13' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.13 -38.55 75.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.82 -174.816 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' X' ' 17' ' ' GLN . 5.2 mm-40 -62.35 -33.47 74.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.899 175.562 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 15' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 27.1 t80 -71.94 -44.96 62.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 16' ' ' VAL . . . . . 0.779 HG12 HG11 ' X' ' 76' ' ' VAL . 3.6 m -62.51 -30.43 49.13 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.176 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' X' ' 14' ' ' GLU . 6.7 tt0 -59.22 -50.21 74.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.647 0.779 . . . . 0.0 109.023 174.788 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 18' ' ' LEU . . . . . 0.637 ' O ' HG13 ' X' ' 22' ' ' ILE . 26.0 tp -58.62 -45.91 88.2 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.042 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 22.3 mt -57.93 -40.96 81.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.937 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 99.4 mttt -65.22 -37.49 87.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.23 176.774 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' X' ' 24' ' ' LYS . 7.9 mm-40 -71.8 -37.37 70.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 22' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' X' ' 37' ' ' LEU . 18.5 mt -62.4 -39.61 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.738 178.599 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.73 -47.05 83.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.356 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 24' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' X' ' 21' ' ' GLU . 17.4 pttp -67.42 -36.26 80.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.497 -175.111 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -71.86 -31.64 66.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.269 0.557 . . . . 0.0 110.038 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -72.46 -50.79 23.59 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.473 177.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 27' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' X' ' 24' ' ' LYS . 32.8 m -68.82 -32.35 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -10.06 49.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 109.92 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.62 80.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.701 1.6 . . . . 0.0 113.495 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 30' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 61.7 p -105.16 -168.53 1.48 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.85 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -143.01 -29.13 0.55 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.555 177.465 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 32' ' ' ASP . . . . . 0.583 ' O ' HG23 ' X' ' 36' ' ' VAL . 11.0 m-20 -67.87 -57.8 5.65 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.043 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 33' ' ' VAL . . . . . 0.677 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 85.6 t -86.36 -29.02 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.472 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 34' ' ' LEU . . . . . 0.636 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.01 -44.25 87.13 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.62 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 35' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 28.1 t70 -71.7 -35.2 70.15 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.287 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 36' ' ' VAL . . . . . 0.583 HG23 ' O ' ' X' ' 32' ' ' ASP . 80.9 t -57.76 -49.85 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.008 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 37' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 64.9 mt -68.12 -43.21 78.92 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.615 -172.179 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 38' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.5 mt -60.58 -49.09 78.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 124.154 0.909 . . . . 0.0 111.876 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 39' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.6 pt-20 -71.36 -36.39 71.47 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.8 178.549 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 40' ' ' HIS . . . . . 0.513 ' O ' HG12 ' X' ' 44' ' ' ILE . 13.6 t60 -62.72 -46.53 87.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 41' ' ' PHE . . . . . 0.644 ' O ' HG22 ' X' ' 45' ' ' THR . 54.8 t80 -58.02 -56.03 27.24 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 42' ' ' VAL . . . . . 0.435 HG12 ' O ' ' X' ' 38' ' ' LEU . 10.6 p -67.06 -32.87 59.83 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 43' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 9.2 pttp -70.3 -31.99 69.56 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.026 -179.068 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 44' ' ' ILE . . . . . 0.513 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.9 pt -83.24 -37.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.164 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 45' ' ' THR . . . . . 0.644 HG22 ' O ' ' X' ' 41' ' ' PHE . 7.3 t -84.78 -29.59 25.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.22 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 60.44 34.69 20.49 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.418 1.087 . . . . 0.0 111.549 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 47' ' ' HIS . . . . . 0.55 ' H ' HG23 ' X' ' 45' ' ' THR . 45.1 t-80 -85.3 134.26 40.94 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 114.542 -1.208 . . . . 0.0 107.742 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 21.7 Cg_exo -69.63 -15.55 37.64 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.945 2.43 . . . . 0.0 113.146 -174.68 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 10.8 m-20 -124.29 29.29 6.41 Favored 'General case' 0 N--CA 1.402 -2.827 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -173.433 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 50' ' ' GLY . . . . . 0.525 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -58.05 5.12 Favored Glycine 1 CA--C 1.447 -4.186 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.473 -176.73 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' X' X ' 51' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -75.66 -33.23 60.42 Favored 'General case' 1 C--N 1.242 -4.091 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.512 -171.876 . . . . . . . . 4 4 . 1 . 030 nuclear build core ' X' X ' 52' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.11 -37.03 76.21 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.527 177.234 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 42.6 mt -57.82 -44.73 86.61 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.774 0.671 . . . . 0.0 112.007 177.311 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 54' ' ' ILE . . . . . 0.603 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.0 mp -67.38 -43.46 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.645 -179.651 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 55' ' ' TYR . . . . . 0.519 ' HD1' ' O ' ' X' ' 51' ' ' THR . 29.6 m-85 -55.03 -47.46 74.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.292 177.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 56' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.1 pt-20 -71.53 -36.74 71.1 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 176.079 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 CA-C-N 118.184 0.447 . . . . 0.0 110.784 178.985 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.204 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.8 Cg_endo -62.87 -38.4 48.24 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.637 2.891 . . . . 0.0 111.845 -179.017 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.8 -0.2 12.69 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.16 -22.3 7.97 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.771 176.066 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 75' ' ' ILE . . . . . 0.521 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -67.19 -42.74 88.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.356 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' X' X ' 76' ' ' VAL . . . . . 0.779 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -58.76 -41.3 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.785 177.487 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' X' X ' 77' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' X' ' 80' ' ' LYS . 26.1 ttpp -60.06 -48.61 80.99 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.809 177.159 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.42 -45.11 84.96 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.888 0.851 . . . . 0.0 110.053 176.695 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 79' ' ' ILE . . . . . 0.469 HG23 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -61.46 -40.81 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.881 176.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 80' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' X' ' 77' ' ' LYS . 0.4 OUTLIER -71.67 -39.97 69.92 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.458 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.11 -41.97 85.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 82' ' ' TRP . . . . . 0.401 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 57.8 t90 -64.08 -46.85 82.44 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.65 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 83' ' ' ARG . . . . . 0.724 HH12 HG12 ' X' ' 7' ' ' ILE . 0.8 OUTLIER -66.28 -39.72 89.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.783 176.874 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.69 96.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.555 0.534 . . . . 0.0 110.864 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.03 83.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.857 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.31 -49.2 15.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.43 0.633 . . . . 0.0 110.381 -176.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.52 27.99 3.92 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -99.04 155.52 36.48 Favored Pre-proline 0 N--CA 1.406 -2.625 0 C-N-CA 123.342 0.657 . . . . 0.0 109.903 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.58 110.89 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.698 2.265 . . . . 0.0 111.947 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 90' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -85.28 -111.22 0.71 Allowed Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.468 -177.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -109.87 164.21 12.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.357 -179.028 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 92' ' ' LYS . . . . . 0.519 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 21.1 ptmt -91.45 168.04 11.83 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.014 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -93.47 139.44 30.71 Favored 'General case' 0 C--N 1.266 -3.053 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.393 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.744 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.512 -0.497 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.553 HD22 HD13 ' X' ' 18' ' ' LEU . 29.6 mt -91.77 129.73 37.68 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.239 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 31.3 mmtt -95.93 -165.51 1.29 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -109.35 -33.9 6.7 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.112 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 69.6 p -127.17 166.62 17.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.304 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.451 HD11 ' CE1' ' X' ' 91' ' ' PHE . 9.7 tp -65.36 -18.03 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 110.47 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.5 m -83.6 -9.59 58.81 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.606 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 22.0 t70 -104.44 -1.0 27.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.52 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.29 120.0 31.06 Favored 'General case' 0 CA--C 1.47 -2.112 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.407 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 75.0 p -83.03 170.41 14.89 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 172.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.649 ' O ' HG13 ' X' ' 16' ' ' VAL . 5.8 pt-20 -58.33 -46.11 86.82 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.322 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.478 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.09 -38.24 75.62 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -64.78 -32.91 74.82 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 121.671 -0.643 . . . . 0.0 110.646 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 29.1 t80 -71.36 -43.64 66.54 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.725 HG12 HG11 ' X' ' 76' ' ' VAL . 3.5 m -62.79 -28.98 45.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.739 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -61.63 -45.9 92.07 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.573 ' O ' HG13 ' X' ' 22' ' ' ILE . 29.5 tp -61.76 -47.19 86.31 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 123.858 0.724 . . . . 0.0 109.629 175.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -58.23 -37.57 75.13 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.031 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.1 mttm -70.62 -35.67 73.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.42 -36.75 74.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.947 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.66 HG12 ' HB3' ' X' ' 37' ' ' LEU . 56.2 mt -63.01 -41.71 93.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -47.57 81.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.495 1.118 . . . . 0.0 108.618 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -61.39 -52.68 63.62 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.32 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -72.22 -25.64 61.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.34 -46.45 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.78 -25.36 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.717 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.31 -26.79 35.38 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.96 68.44 0.63 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.398 1.479 . . . . 0.0 111.682 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.8 p -99.47 -171.66 2.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -131.93 -44.82 0.95 Allowed 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 118.205 -1.398 . . . . 0.0 112.585 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.666 ' O ' HG23 ' X' ' 36' ' ' VAL . 21.7 t70 -64.78 -52.48 56.67 Favored 'General case' 0 CA--C 1.476 -1.894 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.775 -172.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -85.8 -30.41 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 O-C-N 123.714 0.634 . . . . 0.0 110.64 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -59.1 -47.35 85.57 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.59 -26.88 64.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.285 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.666 HG23 ' O ' ' X' ' 32' ' ' ASP . 92.9 t -67.11 -50.26 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 C-N-CA 118.622 -1.231 . . . . 0.0 108.79 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.66 ' HB3' HG12 ' X' ' 22' ' ' ILE . 67.2 mt -68.64 -39.48 80.72 Favored 'General case' 0 N--CA 1.41 -2.436 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.935 -170.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.9 mt -59.26 -49.18 78.82 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 124.253 0.971 . . . . 0.0 110.431 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.57 -39.97 73.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.693 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.495 ' O ' HG12 ' X' ' 44' ' ' ILE . 12.8 t60 -59.62 -46.22 89.64 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.412 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.545 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 56.3 t80 -60.32 -52.99 62.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.649 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.472 HG12 ' O ' ' X' ' 38' ' ' LEU . 7.4 p -66.65 -31.01 51.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -73.0 -33.57 65.87 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.75 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.495 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.1 pt -84.05 -35.74 11.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.238 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.424 HG22 HG21 ' X' ' 79' ' ' ILE . 75.8 p -81.72 -34.67 30.43 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 64.96 22.4 12.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.825 1.65 . . . . 0.0 110.338 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.474 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 34.1 t-80 -72.61 133.67 82.46 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.517 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 34.6 Cg_exo -67.46 -17.94 49.11 Favored 'Trans proline' 0 CA--C 1.499 -1.274 0 C-N-CA 123.119 2.546 . . . . 0.0 111.639 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 9.4 m-20 -124.13 33.68 5.23 Favored 'General case' 0 N--CA 1.383 -3.788 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.545 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -56.15 6.03 Favored Glycine 0 CA--C 1.457 -3.569 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.839 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.555 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.369 0.4 OUTLIER -85.85 -18.3 33.21 Favored 'General case' 0 C--N 1.25 -3.719 0 C-N-CA 117.116 -1.834 . . . . 0.0 114.26 -175.883 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.88 -31.6 72.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.8 mt -66.91 -38.42 86.2 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 123.691 0.619 . . . . 0.0 111.212 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.53 HD13 HG21 ' X' ' 75' ' ' ILE . 21.0 mm -66.57 -48.12 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.244 1.021 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.472 ' HD1' ' O ' ' X' ' 51' ' ' THR . 43.8 m-85 -64.39 -40.74 96.41 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 113.715 -1.584 . . . . 0.0 113.914 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.15 -36.92 72.22 Favored 'General case' 0 C--O 1.194 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.858 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.32 77.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.122 0.264 . . . . 0.0 110.553 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.07 -47.91 78.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.523 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.48 91.19 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.706 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.518 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 75.4 mtp180 -64.48 -30.77 71.8 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.315 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.69 54.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.815 0.341 . . . . 0.0 110.49 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.03 91.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.043 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.39 -48.16 17.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.919 0.39 . . . . 0.0 110.082 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 54.86 88.3 0.13 Allowed Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.002 1.721 . . . . 0.0 112.857 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.88 -66.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.285 1.99 . . . . 0.0 111.823 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.69 37.18 2.15 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.184 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 -63.05 2.95 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 68' ' ' ASP . . . . . 0.463 ' OD1' ' HE3' ' X' ' 77' ' ' LYS . 23.3 m-20 -56.22 125.91 23.86 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 69' ' ' GLY . . . . . 0.518 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 92.64 -16.62 59.71 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.615 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 69.38 1.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.48 170.12 17.28 Favored Glycine 0 N--CA 1.403 -3.509 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.497 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.5 Cg_endo -57.87 -40.15 80.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.792 2.995 . . . . 0.0 112.887 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.45 0.66 9.67 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.74 -3.98 30.13 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.829 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.53 HG21 HD13 ' X' ' 54' ' ' ILE . 1.8 mt -78.13 -46.02 26.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.725 HG11 HG12 ' X' ' 16' ' ' VAL . 0.8 OUTLIER -56.47 -44.47 80.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.648 176.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.3 ttmm -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.309 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.51 -38.51 65.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.424 HG21 HG22 ' X' ' 45' ' ' THR . 44.6 mm -67.31 -39.45 82.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.003 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 21.2 ptmt -61.59 -38.28 87.0 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.65 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -72.33 -39.09 68.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.433 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 59.4 t90 -67.36 -47.14 71.29 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.049 0.452 . . . . 0.0 110.026 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.536 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 10.6 tpt180 -60.83 -45.08 95.88 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.457 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.77 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.363 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.92 95.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.048 0.452 . . . . 0.0 111.513 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -69.04 -28.97 67.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.51 9.12 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.536 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 53.7 mttm -104.8 147.9 35.21 Favored Pre-proline 0 N--CA 1.405 -2.68 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -68.01 122.56 9.67 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 121.856 1.704 . . . . 0.0 109.643 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -96.82 -129.0 6.02 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.243 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.451 ' CE1' HD11 ' X' ' 7' ' ' ILE . 29.7 m-85 -78.18 158.1 29.14 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.059 -0.57 . . . . 0.0 110.535 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' X' ' 11' ' ' THR . 39.7 pttt -101.89 175.23 5.61 Favored 'General case' 0 N--CA 1.38 -3.968 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -105.75 144.25 32.76 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.417 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.506 -0.745 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 58.3 mt -92.17 128.74 38.12 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 29.4 mmtt -103.2 168.0 9.46 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.68 -27.12 34.18 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.582 0.706 . . . . 0.0 110.479 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.4 p -134.18 163.12 30.31 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' X' ' 91' ' ' PHE . 6.0 tp -68.0 -18.1 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.155 0.982 . . . . 0.0 109.854 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.0 p -76.45 -16.23 59.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.646 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 4.0 t70 -104.07 2.66 32.35 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -97.36 120.86 38.5 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.907 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.431 HG22 ' HG3' ' X' ' 92' ' ' LYS . 74.7 p -79.31 163.16 25.12 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 167.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.64 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.6 pt-20 -59.03 -35.65 73.65 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.102 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.45 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.42 -39.37 74.46 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -58.81 -37.16 75.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.934 0.874 . . . . 0.0 109.282 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.639 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 38.1 t80 -74.82 -39.53 61.6 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.475 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.696 HG12 HG11 ' X' ' 76' ' ' VAL . 8.6 m -62.69 -29.87 47.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.257 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.04 -50.09 75.39 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.673 ' O ' HG13 ' X' ' 22' ' ' ILE . 46.6 tp -59.7 -46.47 89.0 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.799 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 34.4 mt -57.29 -43.28 83.05 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.232 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 98.5 mttt -61.49 -46.54 89.57 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.964 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.09 -39.32 89.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.796 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.673 HG13 ' O ' ' X' ' 18' ' ' LEU . 50.7 mt -60.77 -44.71 97.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 O-C-N 123.337 0.398 . . . . 0.0 110.59 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.454 ' O ' HG22 ' X' ' 27' ' ' VAL . 46.8 mt-10 -57.02 -46.06 82.64 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.398 0.618 . . . . 0.0 109.723 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.15 -46.85 88.29 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.387 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -85.83 -30.39 23.0 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.305 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.65 -44.64 85.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.092 0.157 . . . . 0.0 111.183 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 27' ' ' VAL . . . . . 0.454 HG22 ' O ' ' X' ' 23' ' ' GLU . 32.4 m -71.11 -22.53 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.57 -24.99 22.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.68 88.9 0.11 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.899 1.68 . . . . 0.0 110.867 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.614 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 44.7 p -96.89 -151.88 0.37 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.92 -66.82 0.37 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 112.726 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.601 ' O ' HG23 ' X' ' 36' ' ' VAL . 38.1 t70 -66.98 -46.26 75.14 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.23 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.8 p -81.66 -28.13 10.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.046 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.614 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.7 tm? -58.73 -52.54 65.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.321 1.049 . . . . 0.0 108.823 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.5 -19.71 62.91 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.601 HG23 ' O ' ' X' ' 32' ' ' ASP . 97.7 t -72.02 -52.11 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.027 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.875 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.621 ' HB3' HG12 ' X' ' 22' ' ' ILE . 41.4 mt -69.42 -43.7 72.87 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.552 -168.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.4 mt -59.72 -46.77 88.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 124.567 1.167 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -71.43 -40.56 70.34 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.556 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.3 t60 -59.71 -45.7 91.35 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.508 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.589 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.22 -52.79 63.81 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.467 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.456 HG12 ' O ' ' X' ' 38' ' ' LEU 0.267 11.8 p -67.67 -31.94 54.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.0 ptmm? -70.59 -33.2 70.81 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.711 -0.618 . . . . 0.0 112.151 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.486 HG12 ' O ' ' X' ' 40' ' ' HIS . 14.5 pt -84.81 -33.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.564 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.446 HG22 HG21 ' X' ' 79' ' ' ILE . 76.2 p -84.42 -35.77 22.85 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 120.965 0.412 . . . . 0.0 110.654 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.01 25.73 15.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.952 1.701 . . . . 0.0 110.163 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 26.3 t-80 -74.02 134.07 78.11 Favored Pre-proline 0 N--CA 1.429 -1.51 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.548 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -71.33 -9.71 25.8 Favored 'Trans proline' 0 CA--C 1.496 -1.423 0 C-N-CA 122.989 2.46 . . . . 0.0 112.058 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.429 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.0 m-20 -130.31 29.66 4.84 Favored 'General case' 0 N--CA 1.396 -3.145 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -170.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.589 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.59 -59.04 5.61 Favored Glycine 0 CA--C 1.461 -3.298 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.199 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.488 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -74.67 -28.89 61.03 Favored 'General case' 0 C--N 1.247 -3.891 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.547 -172.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.07 -35.74 81.73 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -61.74 -39.07 90.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.605 0.566 . . . . 0.0 111.522 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.583 HD13 HG21 ' X' ' 22' ' ' ILE . 36.8 mt -67.17 -47.05 82.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.412 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.6 m-85 -57.91 -45.7 86.08 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.432 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.0 pt-20 -70.4 -39.94 74.2 Favored 'General case' 0 C--O 1.201 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.77 -39.52 85.12 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 117.727 0.24 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.31 -42.12 86.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.537 0.523 . . . . 0.0 110.153 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.29 65.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.172 0.51 . . . . 0.0 110.224 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -61.05 -37.53 82.94 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.811 0.844 . . . . 0.0 110.578 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.33 -30.11 42.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.697 0.285 . . . . 0.0 111.018 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.4 82.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 -44.65 20.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 63.7 92.04 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 124.868 1.267 . . . . 0.0 112.049 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.12 -12.51 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.666 1.578 . . . . 0.0 110.271 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.23 -156.36 15.62 Favored Glycine 0 N--CA 1.422 -2.242 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.9 -118.88 15.96 Favored Glycine 0 N--CA 1.433 -1.563 0 O-C-N 124.494 0.761 . . . . 0.0 113.445 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 68' ' ' ASP . . . . . 0.571 ' OD2' ' HD3' ' X' ' 77' ' ' LYS . 4.6 p-10 -123.3 -27.85 4.06 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 123.447 0.699 . . . . 0.0 110.125 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.23 -7.49 72.14 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.889 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.37 31.95 5.48 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.75 -175.4 44.04 Favored Glycine 0 N--CA 1.408 -3.221 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.557 ' O ' HG13 ' X' ' 75' ' ' ILE . 34.0 Cg_endo -71.95 -22.03 23.68 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 123.725 2.95 . . . . 0.0 113.325 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -72.55 0.44 10.47 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.2 -14.06 23.34 Favored Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.889 -1.624 . . . . 0.0 113.275 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.557 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.9 OUTLIER -70.2 -43.39 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.696 HG11 HG12 ' X' ' 16' ' ' VAL . 1.1 p -59.85 -47.07 92.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.686 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.571 ' HD3' ' OD2' ' X' ' 68' ' ' ASP . 83.5 tttt -60.86 -42.35 97.67 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.24 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.2 -40.6 86.25 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.446 HG21 HG22 ' X' ' 45' ' ' THR . 41.0 mm -67.21 -46.43 84.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.928 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -63.82 -35.68 81.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.759 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.57 -41.48 92.89 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.979 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.548 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 84.1 t90 -66.41 -47.99 71.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 11.9 tpt180 -61.27 -45.52 94.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.43 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.72 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.219 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.26 -26.5 66.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.978 0.418 . . . . 0.0 111.308 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -85.24 -12.25 52.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.78 37.71 44.23 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.991 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.0 mtpp -117.25 137.83 24.36 Favored Pre-proline 0 N--CA 1.392 -3.353 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.7 129.79 27.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.346 2.03 . . . . 0.0 110.42 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.0 -114.6 3.38 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.187 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' X' ' 7' ' ' ILE . 72.4 m-85 -83.67 152.22 24.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.095 -0.553 . . . . 0.0 110.958 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.8 ptmt -87.73 166.73 14.42 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -105.92 142.21 36.01 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 176.038 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' X' X ' 2' ' ' GLU . . . . . 0.776 ' N ' HE22 ' X' ' 17' ' ' GLN . 43.6 mt-10 . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.418 ' CD2' HD21 ' X' ' 18' ' ' LEU . 94.8 mt -112.47 143.07 44.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 O-C-N 123.501 0.501 . . . . 0.0 110.438 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.545 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 28.6 mmtt -101.72 -159.45 0.73 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.04 -23.58 8.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -143.14 166.69 23.98 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tp -62.7 -18.67 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -77.52 -4.37 45.29 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.711 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.545 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 9.6 t70 -112.34 -3.8 14.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.476 ' CZ ' ' HG2' ' X' ' 4' ' ' LYS . 39.4 m-85 -93.99 116.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.706 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 70.8 p -75.77 173.48 11.06 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 170.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.65 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.9 pt-20 -56.09 -44.54 79.11 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.303 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.404 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.58 -38.57 74.09 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 32.1 mm-40 -58.89 -36.61 74.94 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.729 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -67.33 -50.09 61.43 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.706 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.773 HG12 HG11 ' X' ' 76' ' ' VAL . 2.7 m -61.56 -34.55 62.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 O-C-N 123.182 0.301 . . . . 0.0 111.328 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.776 HE22 ' N ' ' X' ' 2' ' ' GLU . 0.7 OUTLIER -58.98 -49.62 77.18 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.196 0.998 . . . . 0.0 108.678 176.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.554 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -65.95 -41.2 91.57 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.153 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.3 mt -58.52 -37.59 75.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.226 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 76.7 mttt -66.52 -36.86 83.72 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.535 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.27 -33.11 61.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.688 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' X' ' 37' ' ' LEU . 48.1 mt -61.97 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.15 -35.02 79.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.57 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -70.21 -52.17 25.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.597 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -70.03 -18.18 63.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.464 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.68 -52.02 20.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.938 0.895 . . . . 0.0 110.26 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.6 -23.56 19.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.857 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.5 -4.23 57.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 0.0 109.616 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 49.36 62.41 2.64 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.693 1.597 . . . . 0.0 112.927 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.619 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 54.8 p -88.34 -177.84 5.75 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.77 -63.42 0.7 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.634 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.609 ' O ' HG23 ' X' ' 36' ' ' VAL . 30.8 m-20 -58.02 -48.59 79.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 12.0 p -84.56 -32.63 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.362 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.54 -44.71 93.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.82 -32.71 72.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.473 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.609 HG23 ' O ' ' X' ' 32' ' ' ASP . 71.6 t -59.27 -49.13 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-O 121.877 0.846 . . . . 0.0 109.121 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.724 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.3 mt -68.33 -40.58 81.55 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 113.415 -1.721 . . . . 0.0 110.889 -174.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -58.8 -49.29 78.25 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 124.316 1.01 . . . . 0.0 110.729 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -69.29 -42.09 75.94 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.287 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 43.2 t60 -61.38 -44.98 96.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.227 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.65 ' O ' HG22 ' X' ' 45' ' ' THR . 42.3 t80 -55.71 -53.08 60.94 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.693 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.408 HG12 ' O ' ' X' ' 38' ' ' LEU 0.293 8.1 p -66.77 -31.6 54.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -74.44 -33.13 62.85 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.055 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.541 HG12 ' O ' ' X' ' 40' ' ' HIS . 30.1 pt -79.9 -36.83 17.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.207 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.65 HG22 ' O ' ' X' ' 41' ' ' PHE . 10.0 t -85.41 -28.26 25.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 61.35 27.8 17.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.213 1.005 . . . . 0.0 110.839 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.517 ' H ' HG23 ' X' ' 45' ' ' THR . 76.6 t60 -82.51 137.58 44.83 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' X' ' 47' ' ' HIS . 13.3 Cg_exo -75.14 0.01 9.48 Favored 'Trans proline' 0 CA--C 1.486 -1.889 0 C-N-CA 123.235 2.624 . . . . 0.0 113.067 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 29.5 m-20 -139.0 34.01 2.15 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.82 -56.08 9.07 Favored Glycine 0 CA--C 1.461 -3.326 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.091 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.564 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.332 0.8 OUTLIER -84.01 -20.1 33.34 Favored 'General case' 0 C--N 1.259 -3.345 0 C-N-CA 116.886 -1.926 . . . . 0.0 114.316 -176.574 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.16 -36.62 82.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 30.3 mt -61.83 -42.82 99.51 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 123.813 0.695 . . . . 0.0 112.236 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.61 -45.96 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.353 1.073 . . . . 0.0 108.831 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.59 -42.7 98.26 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.479 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -69.03 -35.18 76.33 Favored 'General case' 0 C--O 1.206 -1.221 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.402 175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . -56.72 -40.11 75.12 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 122.704 0.402 . . . . 0.0 111.182 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.32 80.91 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.881 0.738 . . . . 0.0 110.235 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.07 96.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.584 0.707 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.63 -30.78 70.44 Favored 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.529 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.77 -41.18 27.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.48 81.81 2.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' X' ' 65' ' ' PRO . 23.0 p30 -78.53 131.65 67.63 Favored Pre-proline 0 CA--C 1.49 -1.333 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.469 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 65' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' X' ' 64' ' ' ASN . 62.8 Cg_endo -92.16 0.05 4.16 Favored 'Trans proline' 0 N--CA 1.43 -2.242 0 C-N-CA 122.262 1.975 . . . . 0.0 112.207 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.55 -166.28 12.23 Favored Glycine 0 CA--C 1.485 -1.787 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.75 -115.11 6.98 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 124.207 0.592 . . . . 0.0 112.504 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.54 -12.98 28.33 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.79 -107.79 2.15 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.937 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -159.13 -144.87 4.08 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.02 -156.3 52.08 Favored Glycine 0 N--CA 1.415 -2.729 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.076 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.54 ' O ' HG12 ' X' ' 76' ' ' VAL . 25.0 Cg_endo -71.98 -56.12 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.497 2.798 . . . . 0.0 114.076 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.01 0.59 1.81 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.39 -31.17 3.1 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.607 -1.758 . . . . 0.0 114.137 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.665 HG13 HD13 ' X' ' 19' ' ' LEU . 9.9 pt -67.11 -34.12 67.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 117.487 0.643 . . . . 0.0 110.602 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.773 HG11 HG12 ' X' ' 16' ' ' VAL . 0.2 OUTLIER -59.08 -43.26 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-O 121.997 0.903 . . . . 0.0 110.913 175.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 88.2 tttt -62.16 -47.24 85.4 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.33 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.22 -40.44 90.17 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.48 HD12 ' OG1' ' X' ' 45' ' ' THR . 22.5 mm -61.92 -46.23 96.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.485 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.488 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 20.3 pttp -70.41 -35.76 73.63 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.676 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 40.0 mt-10 -68.19 -39.88 82.37 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.209 0.318 . . . . 0.0 111.424 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -67.38 -48.1 68.41 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.173 0.511 . . . . 0.0 110.297 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.557 ' NH1' ' HA ' ' X' ' 45' ' ' THR . 15.9 ttt180 -70.98 -38.31 72.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.73 0.3 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -31.66 69.51 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.327 0.584 . . . . 0.0 110.378 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.55 -30.71 63.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.201 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.07 26.7 25.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -106.88 132.75 20.66 Favored Pre-proline 0 N--CA 1.399 -3.014 0 C-N-CA 123.491 0.717 . . . . 0.0 109.243 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.25 119.19 3.33 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.995 3.13 . . . . 0.0 113.768 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' X' ' 83' ' ' ARG . . . -95.15 -126.52 4.87 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.944 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 11.6 m-85 -84.84 165.65 17.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' X' ' 93' ' ' GLN . 19.5 ptmt -86.47 179.33 6.87 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 93' ' ' GLN . . . . . 0.453 ' O ' ' HE2' ' X' ' 92' ' ' LYS . 24.9 mp0 -96.55 139.3 32.85 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.615 0.722 . . . . 0.0 110.607 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.402 -3.627 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 177.204 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.008 0.433 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.456 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 83.7 mt -92.68 140.92 29.04 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.052 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' X' ' 9' ' ' ASP . 28.9 mmtt -111.66 -179.15 3.62 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -91.61 -39.26 11.97 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.192 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 6' ' ' SER . . . . . 0.43 ' HA ' HG22 ' X' ' 44' ' ' ILE . 64.8 p -127.87 167.23 16.87 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.653 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.06 -14.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.63 0.772 . . . . 0.0 109.836 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -79.08 -17.93 54.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.34 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' X' ' 4' ' ' LYS . 5.3 t70 -98.36 1.34 46.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.67 119.8 33.13 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.473 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -78.0 159.75 28.59 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.647 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.1 pt-20 -65.64 -30.64 71.37 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.644 -1.622 . . . . 0.0 111.723 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.76 77.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.07 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -58.04 -40.06 79.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.79 0.805 . . . . 0.0 109.092 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.666 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.1 t80 -71.15 -44.92 64.59 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.905 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.737 HG12 HG11 ' X' ' 76' ' ' VAL . 4.0 m -62.43 -34.81 66.5 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.825 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.39 -45.43 88.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.718 0.807 . . . . 0.0 109.347 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.514 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -66.63 -43.79 83.75 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.228 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.3 mt -58.08 -46.05 86.12 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.773 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 63.6 mtpt -62.02 -35.83 79.73 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.766 0.826 . . . . 0.0 110.0 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -74.52 -35.37 63.16 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.715 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.514 HG13 ' O ' ' X' ' 18' ' ' LEU . 44.1 mt -59.69 -44.41 93.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.921 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.426 ' O ' HG22 ' X' ' 27' ' ' VAL . 42.8 mt-10 -56.93 -44.82 82.85 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.383 0.611 . . . . 0.0 110.475 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -60.31 -46.09 91.08 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.647 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.5 ' HB2' ' CG2' ' X' ' 30' ' ' THR . 3.1 pp20? -84.92 -30.32 24.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.749 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 26' ' ' ASN . . . . . 0.416 ' HA ' HD23 ' X' ' 34' ' ' LEU . 23.0 t-20 -63.02 -40.67 98.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.59 0.756 . . . . 0.0 111.698 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 27' ' ' VAL . . . . . 0.426 HG22 ' O ' ' X' ' 23' ' ' GLU . 34.7 m -80.5 -7.04 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.256 0.55 . . . . 0.0 111.313 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.03 -25.77 13.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.71 85.36 0.13 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.698 1.599 . . . . 0.0 110.297 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 72.7 p -92.07 -24.23 19.22 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 70.41 -50.81 0.66 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.37 1.868 . . . . 0.0 114.358 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.533 ' O ' HG23 ' X' ' 36' ' ' VAL . 14.3 t70 -70.25 -56.79 5.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 118.034 0.379 . . . . 0.0 110.23 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.5 p -80.87 -25.45 10.87 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.457 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.6 tm? -58.23 -48.31 80.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.779 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.71 -32.46 73.1 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.839 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.533 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.0 t -66.81 -50.69 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.549 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 35.4 mt -68.45 -43.81 76.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.02 -171.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.5 HD13 ' CG2' ' X' ' 51' ' ' THR . 46.4 mt -61.98 -45.67 92.61 Favored 'General case' 0 N--CA 1.419 -2.016 0 O-C-N 124.211 0.944 . . . . 0.0 111.707 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -70.3 -43.28 70.7 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.882 0.372 . . . . 0.0 111.757 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.478 ' O ' HG12 ' X' ' 44' ' ' ILE . 9.6 t60 -59.56 -45.14 92.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.328 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.599 ' O ' HG22 ' X' ' 45' ' ' THR . 27.5 t80 -59.68 -55.75 30.43 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.641 1.213 . . . . 0.0 110.824 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' X' ' 38' ' ' LEU 0.278 14.7 p -66.87 -31.64 54.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -69.84 -30.53 68.04 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.84 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.478 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.0 pt -85.27 -35.92 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.574 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.599 HG22 ' O ' ' X' ' 41' ' ' PHE . 4.7 t -84.47 -30.86 24.89 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.394 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.58 36.75 13.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 125.041 1.336 . . . . 0.0 110.34 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.464 ' H ' HG23 ' X' ' 45' ' ' THR . 26.2 t-80 -81.94 136.21 47.7 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.271 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 22.3 Cg_exo -70.96 -14.33 32.22 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.787 2.324 . . . . 0.0 111.941 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.427 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 22.3 m-20 -128.3 31.98 4.95 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -172.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.08 8.38 Favored Glycine 0 CA--C 1.457 -3.54 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.419 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.5 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.77 -33.94 58.03 Favored 'General case' 0 C--N 1.251 -3.697 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.055 -174.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.59 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.65 -31.88 69.94 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.191 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 mt -62.29 -48.51 79.55 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 123.574 0.546 . . . . 0.0 112.101 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.523 ' H ' HD12 ' X' ' 54' ' ' ILE . 4.4 mp -66.81 -40.43 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.742 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.45 ' HD1' ' O ' ' X' ' 51' ' ' THR . 27.1 m-85 -61.62 -43.29 99.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.78 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.9 pt-20 -71.97 -37.04 69.98 Favored 'General case' 0 C--O 1.203 -1.345 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.202 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.51 82.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.594 0.358 . . . . 0.0 110.978 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.39 90.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.991 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.6 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.756 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 29.9 mtp180 -63.47 -39.27 94.01 Favored 'General case' 0 C--O 1.199 -1.564 0 C-N-CA 124.488 1.115 . . . . 0.0 112.155 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.87 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.793 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.38 71.68 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.607 0.718 . . . . 0.0 109.227 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.32 89.57 2.74 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 44.1 m-80 -60.86 125.96 84.43 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.043 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.67 6.96 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.707 2.271 . . . . 0.0 110.738 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.43 -126.76 1.91 Allowed Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.66 14.6 1.39 Allowed Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.271 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.0 -41.76 95.09 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.813 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.53 93.26 0.09 OUTLIER Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.66 -70.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.224 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.95 -114.74 2.38 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.317 -0.944 . . . . 0.0 114.429 -173.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' HG13 ' X' ' 75' ' ' ILE . 36.7 Cg_endo -60.05 -53.6 2.96 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 123.694 2.929 . . . . 0.0 114.701 -167.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.88 0.17 9.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 74' ' ' GLY . . . . . 0.596 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -105.58 -18.58 11.53 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.004 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.504 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.5 OUTLIER -67.26 -44.22 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.737 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -60.49 -39.75 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.656 176.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 22.5 ttpp -58.55 -47.67 83.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.856 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 78' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 7.2 mm-40 -58.01 -45.08 87.43 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.125 0.964 . . . . 0.0 109.196 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.489 HG12 ' O ' ' X' ' 75' ' ' ILE . 41.9 mm -61.62 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.447 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.1 ptpt -65.89 -38.31 88.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.983 -177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.65 -40.16 76.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.907 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 63.1 t90 -70.17 -46.77 63.96 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.787 0.327 . . . . 0.0 110.684 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.52 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 8.4 tpt180 -60.55 -45.58 93.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.38 88.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.947 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.33 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.974 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -69.4 -34.99 75.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.68 44.07 1.86 Allowed Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.484 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 54.9 mttm -119.5 146.42 41.17 Favored Pre-proline 0 N--CA 1.4 -2.941 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.78 124.68 15.47 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.634 2.223 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -88.39 -132.43 4.11 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.864 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 80.8 m-85 -89.54 166.18 13.82 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.32 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -99.28 166.99 10.94 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.21 144.5 25.76 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.673 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.75 132.98 36.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.16 0.505 . . . . 0.0 110.598 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.415 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 31.6 mmtt -105.3 -164.43 1.03 Allowed 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -114.25 -28.36 7.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.357 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -128.97 163.46 25.29 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -67.5 -16.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-O 121.471 0.653 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -79.1 -3.26 44.51 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.55 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.467 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.1 t0 -110.21 1.64 18.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.213 1.006 . . . . 0.0 108.92 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -93.75 121.01 34.74 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.521 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -82.37 176.14 9.67 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.572 ' O ' HG13 ' X' ' 16' ' ' VAL . 4.7 mm-40 -59.23 -51.97 67.7 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.799 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.84 -38.7 76.57 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.879 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.64 -40.97 80.48 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.172 0.51 . . . . 0.0 109.843 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.523 ' O ' HD13 ' X' ' 19' ' ' LEU . 30.2 t80 -75.06 -48.53 23.51 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.095 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.799 HG22 ' HA ' ' X' ' 13' ' ' ALA . 15.7 m -58.6 -38.58 71.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -66.8 -46.27 75.76 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 122.682 0.393 . . . . 0.0 111.027 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.562 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.4 tm? -62.95 -41.31 99.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.523 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.31 -36.86 76.4 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.148 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.704 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 61.4 mttm -63.58 -40.13 96.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.964 0.888 . . . . 0.0 108.816 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -65.13 -36.06 83.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.966 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.599 HG12 ' HB3' ' X' ' 37' ' ' LEU . 19.3 mt -63.74 -39.55 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.285 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -56.87 -46.07 82.07 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.602 0.564 . . . . 0.0 109.915 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -62.93 -43.89 97.56 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.081 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.08 -33.33 70.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.284 0.564 . . . . 0.0 109.885 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.37 -44.94 57.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.564 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.34 -29.86 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.744 0.307 . . . . 0.0 111.693 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -4.67 57.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.464 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 48.34 64.85 1.51 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.179 1.392 . . . . 0.0 112.256 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 72.7 p -83.22 -161.07 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -130.42 -71.16 0.6 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.393 -1.323 . . . . 0.0 114.398 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.611 ' O ' HG23 ' X' ' 36' ' ' VAL . 27.6 t70 -56.64 -52.43 64.9 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 68.9 t -86.83 -25.11 6.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.239 -174.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -58.79 -50.8 72.62 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.7 -19.81 61.33 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.611 HG23 ' O ' ' X' ' 32' ' ' ASP . 59.2 t -71.48 -49.76 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.074 0 C-N-CA 118.289 -1.365 . . . . 0.0 108.471 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' X' ' 22' ' ' ILE . 88.5 mt -68.5 -43.54 76.62 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.091 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.5 mt -60.54 -47.09 87.7 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 124.337 1.023 . . . . 0.0 110.457 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -71.03 -43.72 67.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.618 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 39.1 t60 -60.34 -45.58 92.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.223 0.535 . . . . 0.0 110.062 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.622 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 38.4 t80 -59.14 -53.0 63.25 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.191 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.506 HG12 ' O ' ' X' ' 38' ' ' LEU . 13.1 p -67.99 -32.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -67.0 -36.98 83.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 122.07 -0.394 . . . . 0.0 111.502 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.566 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -81.1 -34.1 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.855 0.36 . . . . 0.0 111.378 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 35.2 p -83.84 -42.46 16.4 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.96 74.97 0.42 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 125.173 1.389 . . . . 0.0 109.583 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.559 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -126.11 139.01 33.32 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.164 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.46 -7.89 22.18 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.794 2.329 . . . . 0.0 112.31 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 16.3 m-20 -135.21 31.9 3.18 Favored 'General case' 0 N--CA 1.391 -3.386 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.622 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.81 -58.2 8.77 Favored Glycine 0 CA--C 1.461 -3.316 0 O-C-N 123.679 0.612 . . . . 0.0 112.704 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.472 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.23 -28.65 63.3 Favored 'General case' 0 C--N 1.248 -3.82 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.148 -174.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.78 -34.34 77.94 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.323 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.57 -45.4 77.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.905 0.482 . . . . 0.0 110.052 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.595 HD13 HG21 ' X' ' 22' ' ' ILE . 23.4 mt -66.84 -44.37 89.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.608 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -59.49 -49.68 76.86 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.754 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.7 pt-20 -66.94 -35.76 80.7 Favored 'General case' 0 C--O 1.188 -2.158 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.634 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.27 73.22 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.89 0.376 . . . . 0.0 110.763 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.89 92.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.3 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.03 64.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.892 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' X' ' 56' ' ' GLU . 44.8 mtp180 -61.8 -40.38 95.03 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 123.76 0.824 . . . . 0.0 111.115 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.87 -30.05 58.73 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.998 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.57 47.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -44.58 19.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.912 0.387 . . . . 0.0 110.3 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 54.54 82.93 0.23 Allowed Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.258 1.423 . . . . 0.0 112.755 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.88 -42.57 3.16 Favored 'Trans proline' 0 C--O 1.241 0.668 0 C-N-CA 122.104 1.869 . . . . 0.0 110.372 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.84 126.87 2.7 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.22 -150.23 21.79 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -109.73 0.77 19.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.718 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.34 79.91 0.33 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.216 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.5 -90.59 1.49 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.96 -132.86 6.2 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.181 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.581 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.0 Cg_endo -59.12 -38.64 85.6 Favored 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.536 2.824 . . . . 0.0 113.48 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.438 ' C ' HG22 ' X' ' 76' ' ' VAL . 23.3 mt-10 -85.03 1.65 46.74 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 123.212 0.605 . . . . 0.0 109.918 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.05 -36.91 2.08 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.36 -1.4 . . . . 0.0 112.641 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' X' ' 72' ' ' PRO . 5.8 pt -60.71 -34.33 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 172.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.676 HG11 HG12 ' X' ' 16' ' ' VAL . 16.6 m -56.62 -39.36 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.559 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 23.4 ttmm -68.77 -39.41 80.23 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.041 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -67.08 -32.15 73.13 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.965 0.888 . . . . 0.0 109.155 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.491 ' HA ' HH21 ' X' ' 83' ' ' ARG . 83.0 mt -67.62 -46.35 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.873 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 14.4 ptmm? -67.71 -36.27 80.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 111.105 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.1 mt-10 -70.45 -36.79 74.15 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.899 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -66.8 -41.16 88.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.559 HH22 ' CD2' ' X' ' 47' ' ' HIS . 0.5 OUTLIER -61.87 -46.27 90.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.379 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.65 91.78 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.796 0.685 . . . . 0.0 111.517 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.937 0.398 . . . . 0.0 110.85 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -68.33 -48.54 64.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.486 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.52 4.77 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.91 151.6 37.54 Favored Pre-proline 0 N--CA 1.407 -2.58 0 C-N-CA 123.933 0.893 . . . . 0.0 108.828 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.97 140.96 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.978 1.785 . . . . 0.0 111.617 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.82 -131.3 6.61 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 10.7 m-85 -93.46 159.36 15.28 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 19.7 ptmt -93.94 172.8 8.01 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -96.25 135.69 37.73 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.712 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.203 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.163 178.406 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.406 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 87.3 mt -103.82 127.66 51.3 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 26.1 mmtt -105.89 152.53 23.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -80.2 -11.7 59.71 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.138 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 67.5 p -141.88 162.3 35.81 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -69.4 -13.07 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 121.643 0.735 . . . . 0.0 110.676 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -77.98 -17.91 56.6 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 14.3 t70 -102.43 5.33 39.56 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.6 m-85 -94.03 114.32 26.47 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.938 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.421 HG22 ' HG3' ' X' ' 92' ' ' LYS . 53.2 p -77.32 157.11 30.87 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.431 ' O ' HG12 ' X' ' 16' ' ' VAL . 6.2 pt-20 -64.67 -26.39 68.36 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.734 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.74 69.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.677 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -57.32 -41.65 80.36 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.266 0.555 . . . . 0.0 109.537 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -64.98 -58.27 6.54 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.041 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.627 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 13.8 p -63.43 -29.55 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -60.21 -44.73 94.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.524 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.3 tm? -67.22 -40.92 86.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.547 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.2 mt -58.27 -36.63 73.56 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.34 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 54.5 mtpt -66.84 -35.74 80.74 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.327 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 21' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 12.0 pt-20 -75.5 -31.43 60.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.851 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' X' ' 18' ' ' LEU . 49.9 mt -60.3 -39.99 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 123.77 0.669 . . . . 0.0 109.843 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -58.35 -41.21 84.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.559 0.695 . . . . 0.0 109.635 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.44 -47.79 46.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.401 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.71 ' OE2' ' HA ' ' X' ' 34' ' ' LEU 0.274 0.0 OUTLIER -75.47 -19.5 59.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.446 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' X' X ' 26' ' ' ASN . . . . . 0.458 HD21 HD21 ' X' ' 38' ' ' LEU . 2.2 m-80 -76.77 -42.1 42.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.385 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 -34.51 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.314 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.24 48.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.66 0.267 . . . . 0.0 110.464 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.83 95.77 0.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.173 1.389 . . . . 0.0 111.977 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 38.8 p -107.66 -171.37 1.86 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -136.34 -20.19 1.42 Allowed 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.102 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.564 ' O ' HG23 ' X' ' 36' ' ' VAL . 10.9 m-20 -85.51 -61.85 1.67 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.154 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.593 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.6 p -76.55 -26.93 16.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.007 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.71 ' HA ' ' OE2' ' X' ' 25' ' ' GLU . 3.1 tm? -58.78 -44.66 90.74 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 124.333 1.021 . . . . 0.0 108.701 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.7 t70 -72.42 -36.77 68.69 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.363 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.564 HG23 ' O ' ' X' ' 32' ' ' ASP . 47.2 t -63.66 -49.79 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 O-C-N 124.324 1.015 . . . . 0.0 110.609 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 41.2 mt -68.14 -41.14 82.1 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.991 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 14.4 mt -59.45 -49.66 76.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 O-C-N 124.437 1.085 . . . . 0.0 111.815 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.3 pt-20 -70.98 -42.29 69.87 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.102 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.485 ' O ' HG12 ' X' ' 44' ' ' ILE . 69.9 t60 -60.26 -45.72 92.3 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.014 0.526 . . . . 0.0 110.373 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.653 ' O ' HG22 ' X' ' 45' ' ' THR . 39.4 t80 -57.95 -53.72 55.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 124.265 0.978 . . . . 0.0 110.834 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -66.34 -31.06 51.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -63.38 -47.46 81.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.494 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 4.9 pt -75.15 -36.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.653 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.67 -31.58 24.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.509 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 61.91 29.59 17.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.914 0.864 . . . . 0.0 111.319 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.541 ' H ' HG23 ' X' ' 45' ' ' THR . 50.5 t-80 -77.94 135.87 62.77 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 30.3 Cg_exo -66.11 -19.22 57.22 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 123.151 2.567 . . . . 0.0 112.316 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.98 36.22 4.35 Favored 'General case' 0 N--CA 1.393 -3.296 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.585 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.64 -55.91 7.76 Favored Glycine 0 CA--C 1.462 -3.226 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.136 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.448 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -77.0 -26.17 53.55 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.332 -171.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.58 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.14 -36.71 83.86 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.303 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.3 -38.93 85.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 123.504 0.503 . . . . 0.0 111.729 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -66.73 -47.26 83.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.704 0.764 . . . . 0.0 109.416 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -63.67 -46.87 83.59 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.86 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.9 pt-20 -68.53 -36.39 78.78 Favored 'General case' 0 C--O 1.196 -1.758 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.79 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.2 76.44 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.246 0.475 . . . . 0.0 111.561 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.021 0.438 . . . . 0.0 110.468 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.74 65.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.722 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 83.6 mtp180 -61.59 -28.35 69.29 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 124.685 1.194 . . . . 0.0 112.546 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.422 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -73.91 -39.04 64.12 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.456 174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.17 -47.28 52.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.723 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.75 76.37 0.97 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.722 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 6.0 t-20 -69.83 120.42 77.54 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.659 -172.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.62 -37.35 97.77 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.227 2.618 . . . . 0.0 111.722 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.72 73.46 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.595 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.12 -53.52 2.52 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.72 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.32 151.93 42.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.786 0.327 . . . . 0.0 110.464 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.53 36.15 87.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.483 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.61 66.13 3.97 Favored Glycine 0 CA--C 1.478 -2.225 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.62 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.422 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 65.45 -128.85 33.44 Favored Glycine 1 N--CA 1.385 -4.764 0 CA-C-N 114.416 -0.892 . . . . 0.0 112.513 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.538 ' HA ' HD11 ' X' ' 75' ' ' ILE . 2.9 Cg_endo -64.42 -30.94 62.45 Favored 'Trans proline' 0 CA--C 1.497 -1.366 0 C-N-CA 122.854 2.369 . . . . 0.0 111.14 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.04 -4.18 56.21 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.891 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.84 -15.41 14.94 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.284 -1.912 . . . . 0.0 113.007 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.55 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -68.04 -49.2 70.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.036 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' X' ' 16' ' ' VAL . 1.2 p -55.49 -45.57 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.841 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 56.0 tttp -59.8 -47.3 86.27 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.399 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.55 HG12 ' O ' ' X' ' 75' ' ' ILE . 46.7 mm -66.03 -45.42 90.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.873 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.5 ptpt -61.98 -42.17 98.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.905 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.62 -38.75 70.76 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.54 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 85.1 t90 -66.17 -47.92 72.42 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 110.715 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.572 ' HG2' ' HB2' ' X' ' 88' ' ' LYS . 3.4 ttt-85 -68.9 -41.6 78.02 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.222 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.41 84.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.2 86.72 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.525 0.202 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.468 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.0 t-20 -63.29 -43.82 96.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.37 18.89 6.45 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.572 ' HB2' ' HG2' ' X' ' 83' ' ' ARG . 68.5 mttm -99.15 158.64 31.92 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 89' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' X' ' 83' ' ' ARG . 36.8 Cg_endo -71.5 130.0 16.58 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.434 1.423 . . . . 0.0 110.819 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -119.41 2.37 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.291 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.429 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.7 m-85 -96.74 154.52 17.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 120.524 0.202 . . . . 0.0 110.539 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.421 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.9 ptmt -89.86 176.28 6.88 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -94.23 137.51 33.32 Favored 'General case' 0 N--CA 1.398 -3.04 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.184 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.26 0 CA-C-O 118.074 -1.403 . . . . 0.0 110.304 177.857 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 76.3 mt -108.64 140.49 41.95 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.554 0.534 . . . . 0.0 111.666 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 40.1 mmtt -103.12 -170.3 1.77 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 171.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -112.41 -24.28 9.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.064 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.5 p -134.35 164.88 26.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.03 -12.52 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.617 0.722 . . . . 0.0 111.051 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -76.07 -18.43 59.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.527 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.426 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.2 t70 -102.74 2.74 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.239 1.019 . . . . 0.0 108.454 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -96.05 113.41 25.02 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.218 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 62.2 p -73.53 160.56 31.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.638 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.83 -32.19 71.58 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.566 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.61 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.4 -39.04 74.72 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.536 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 22.7 mm-40 -58.07 -42.35 85.31 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.552 1.168 . . . . 0.0 108.61 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.33 -47.48 60.87 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 113.137 -1.847 . . . . 0.0 110.492 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.711 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 22.8 m -58.49 -39.41 75.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.394 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.5 -50.57 73.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.251 0.62 . . . . 0.0 111.25 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.522 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.5 tm? -66.52 -40.36 89.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.723 0.773 . . . . 0.0 109.041 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' X' ' 75' ' ' ILE . 9.9 tp -59.66 -42.61 93.22 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.957 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.5 mttt -61.43 -34.84 76.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.201 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.32 -41.59 85.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.025 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' X' ' 37' ' ' LEU . 13.0 mt -57.52 -42.49 81.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.23 -44.83 88.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.493 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -67.57 -45.48 75.45 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.054 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.454 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -69.8 -19.04 63.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.418 177.324 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -86.06 -46.53 10.39 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.275 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.94 -32.36 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.26 -6.3 57.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.732 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.99 80.4 0.11 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.754 1.622 . . . . 0.0 113.323 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.645 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 64.2 p -91.68 -165.48 1.36 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.23 -73.09 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.089 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.618 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.2 t70 -60.35 -51.21 70.46 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 123.434 0.459 . . . . 0.0 111.449 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.68 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.0 p -73.03 -35.27 47.95 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.363 -175.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.645 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.4 tm? -58.95 -47.6 84.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.703 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.35 -41.5 98.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.319 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.618 HG23 ' O ' ' X' ' 32' ' ' ASP . 77.9 t -56.71 -49.56 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 O-C-N 123.77 0.669 . . . . 0.0 109.927 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 86.1 mt -68.41 -43.79 76.44 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.982 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 29.6 mt -61.21 -48.47 81.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 124.154 0.909 . . . . 0.0 110.637 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -70.72 -41.53 71.79 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.131 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.553 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.9 t60 -61.29 -45.91 92.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.238 0.542 . . . . 0.0 109.846 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.641 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.2 t80 -59.14 -52.6 64.99 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.334 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.432 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.1 p -67.62 -32.15 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 53.1 pttt -68.48 -39.61 81.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.53 HG12 ' O ' ' X' ' 40' ' ' HIS . 27.4 pt -77.67 -31.38 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.5 p -84.07 -39.99 18.88 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 46' ' ' GLU . . . . . 0.403 ' HB2' ' NH1' ' X' ' 83' ' ' ARG . 6.4 mm-40 67.07 20.19 10.38 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 123.915 0.886 . . . . 0.0 111.24 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.415 ' HA ' ' HD3' ' X' ' 48' ' ' PRO . 39.7 t-80 -80.73 133.25 55.8 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.431 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.2 Cg_exo -71.34 -2.26 10.94 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.488 2.792 . . . . 0.0 113.043 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 15.1 m-20 -130.05 27.65 5.11 Favored 'General case' 0 N--CA 1.394 -3.237 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.641 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -43.73 -60.28 3.41 Favored Glycine 0 CA--C 1.459 -3.407 0 O-C-N 124.388 1.055 . . . . 0.0 112.931 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.497 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.35 -29.33 63.7 Favored 'General case' 0 C--N 1.251 -3.711 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.716 -173.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.611 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.2 -30.47 70.94 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 53' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 97.9 mt -61.05 -41.52 96.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.153 0.502 . . . . 0.0 109.752 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.593 HD13 HG21 ' X' ' 22' ' ' ILE . 57.0 mt -67.21 -46.24 84.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.095 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -58.39 -49.52 76.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.645 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.5 pt-20 -68.0 -37.24 81.21 Favored 'General case' 0 C--O 1.207 -1.169 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.693 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.55 77.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.663 0.21 . . . . 0.0 110.81 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.5 94.59 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.672 0.608 . . . . 0.0 111.496 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.63 62.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.531 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.527 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 74.3 mtp180 -67.91 -44.33 77.15 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.51 64.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.822 0.344 . . . . 0.0 111.411 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.47 96.43 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.221 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -33.24 15.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.563 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.73 87.57 0.12 Allowed Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 125.433 1.493 . . . . 0.0 112.783 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 65' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 4.8 Cg_endo -91.04 109.41 0.32 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.827 2.351 . . . . 0.0 109.26 173.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.44 112.56 3.1 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.188 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.94 -115.31 0.65 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -128.44 153.25 47.31 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 69' ' ' GLY . . . . . 0.527 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 88.86 27.55 23.66 Favored Glycine 0 C--N 1.305 -1.184 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.174 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.06 4.95 Favored Glycine 0 CA--C 1.483 -1.937 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.605 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.64 -142.82 16.13 Favored Glycine 1 N--CA 1.372 -5.59 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.889 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.522 ' O ' HG13 ' X' ' 76' ' ' VAL . 11.6 Cg_endo -64.31 -48.29 4.88 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 124.645 3.563 . . . . 0.0 112.349 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.487 ' C ' HG22 ' X' ' 76' ' ' VAL . 42.0 mt-10 -77.78 1.92 18.65 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.0 -39.3 2.33 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 118.651 -1.738 . . . . 0.0 112.769 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.557 ' O ' HG13 ' X' ' 79' ' ' ILE . 3.1 pt -62.73 -28.25 44.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 CA-C-N 117.495 0.647 . . . . 0.0 110.94 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.595 HG11 HG12 ' X' ' 16' ' ' VAL . 21.6 m -60.27 -36.11 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.945 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 83.6 tttt -65.86 -41.93 91.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.653 174.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 78' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' X' ' 75' ' ' ILE . 7.8 tp10 -58.07 -44.13 87.35 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.557 HG13 ' O ' ' X' ' 75' ' ' ILE . 82.9 mt -67.42 -46.34 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.618 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.6 ptmt -64.3 -37.77 88.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.38 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.84 -38.38 73.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 62.8 t90 -65.49 -47.36 76.29 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.797 0.808 . . . . 0.0 109.626 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 16.9 tpt180 -61.15 -45.8 93.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.693 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.93 81.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.125 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -32.79 73.67 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.442 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 25.3 t-20 -78.77 -48.81 14.14 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.55 34.3 1.45 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.442 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 66.6 mttm -103.81 141.85 23.38 Favored Pre-proline 0 N--CA 1.392 -3.368 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.39 121.51 9.34 Favored 'Trans proline' 0 CA--C 1.517 -0.34 0 C-N-CA 122.135 1.89 . . . . 0.0 110.956 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -95.14 -135.6 8.17 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.341 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -78.65 146.9 33.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.1 ptmt -85.81 174.51 9.27 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.98 139.12 51.62 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.597 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 CA--C 1.505 -0.76 0 CA-C-O 120.631 0.253 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.69 129.95 37.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.611 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 21.2 mmtt -112.47 151.81 29.48 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.95 -9.07 59.69 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.278 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -145.71 160.93 41.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -67.71 -19.05 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.259 0.624 . . . . 0.0 111.037 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -73.75 -12.63 60.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.584 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 20.1 t70 -105.22 -0.81 26.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.895 0.855 . . . . 0.0 108.877 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.05 119.03 33.82 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.738 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 30.4 p -77.8 169.01 19.01 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.617 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.639 177.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.54 -38.69 74.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.6 -40.67 79.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.851 0.75 . . . . 0.0 109.399 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.57 ' HD2' HG12 ' X' ' 76' ' ' VAL . 20.5 t80 -70.56 -48.07 57.19 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.874 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.723 HG12 HG11 ' X' ' 76' ' ' VAL . 6.3 m -59.29 -39.57 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.519 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.19 -48.23 82.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.125 0.97 . . . . 0.0 110.884 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.451 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -66.17 -38.92 89.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.446 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.7 mp -62.47 -36.8 83.62 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.932 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 47.1 mtmt -61.43 -35.12 76.67 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.87 -34.73 69.44 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.333 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' X' ' 37' ' ' LEU . 20.8 mt -64.18 -40.26 88.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.004 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -59.83 -46.22 89.92 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.877 0.846 . . . . 0.0 108.789 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -60.54 -52.34 65.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.556 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 -25.63 68.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.272 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -78.72 -47.67 16.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.997 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -71.66 -23.27 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.789 0.328 . . . . 0.0 111.875 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.9 -17.71 30.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.64 67.16 1.0 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.74 1.216 . . . . 0.0 111.026 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -81.86 -31.24 31.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.655 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 68.37 -61.65 0.39 Allowed 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.082 1.753 . . . . 0.0 113.56 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.476 ' O ' HG23 ' X' ' 36' ' ' VAL . 6.5 m-20 -57.07 -57.99 10.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.066 0.547 . . . . 0.0 111.579 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -81.1 -28.9 11.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.202 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.346 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -44.06 92.72 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.84 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.96 -38.45 91.12 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.191 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' X' ' 39' ' ' GLU . 72.2 t -57.64 -48.97 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 O-C-N 124.405 1.066 . . . . 0.0 109.349 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 76.5 mt -65.21 -43.05 92.79 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.53 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.2 mt -59.99 -49.83 76.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.566 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' X' ' 36' ' ' VAL . 0.0 OUTLIER -70.9 -35.07 72.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.332 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.532 ' O ' HG12 ' X' ' 44' ' ' ILE . 24.0 t60 -66.07 -46.17 78.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.585 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.666 ' CD2' HD11 ' X' ' 54' ' ' ILE . 43.4 t80 -58.15 -53.28 60.03 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.432 HG23 ' O ' ' X' ' 47' ' ' HIS . 7.2 p -66.95 -32.6 58.72 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.606 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 42.9 pttt -75.21 -27.73 59.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.532 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.5 pt -84.13 -39.6 14.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.573 HG22 ' O ' ' X' ' 41' ' ' PHE . 15.1 t -85.18 -27.35 26.21 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 61.36 38.35 16.29 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 122.142 0.972 . . . . 0.0 111.238 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.432 ' O ' HG23 ' X' ' 42' ' ' VAL . 44.6 t-80 -94.32 132.94 28.0 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.542 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.7 -16.39 33.62 Favored 'Trans proline' 0 CA--C 1.495 -1.455 0 C-N-CA 123.042 2.494 . . . . 0.0 113.184 -173.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -120.78 30.48 6.88 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.12 -56.54 6.85 Favored Glycine 1 CA--C 1.447 -4.178 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.083 -177.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.439 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -79.13 -26.9 42.82 Favored 'General case' 0 C--N 1.249 -3.796 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.512 -170.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -58.38 -46.49 86.26 Favored 'General case' 0 C--O 1.189 -2.109 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -52.58 -46.01 66.73 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.666 HD11 ' CD2' ' X' ' 41' ' ' PHE . 3.9 mp -68.33 -47.15 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.256 -1.378 . . . . 0.0 109.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.01 -45.39 90.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.534 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 12.8 mm-40 -65.49 -44.88 85.71 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.62 -41.48 81.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.765 0.426 . . . . 0.0 111.688 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.37 -46.71 79.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.783 0.325 . . . . 0.0 110.441 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -43.69 60.72 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -62.44 -38.18 88.78 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.948 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.46 -29.47 41.76 Favored 'General case' 0 C--O 1.245 0.868 0 O-C-N 123.071 0.232 . . . . 0.0 111.564 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.56 99.07 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.14 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.26 -70.96 0.61 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t30 44.4 86.81 0.13 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 126.141 1.777 . . . . 0.0 114.076 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.83 -54.28 4.35 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.651 2.234 . . . . 0.0 111.163 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.06 61.22 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.355 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.22 -122.41 2.17 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.64 152.88 46.1 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.344 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 55.76 4.71 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.87 -86.33 0.86 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.538 ' O ' HG12 ' X' ' 75' ' ' ILE . . . -123.17 -136.03 4.71 Favored Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.012 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.483 ' O ' HG13 ' X' ' 76' ' ' VAL . 10.6 Cg_endo -55.52 -50.49 12.59 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 124.154 3.236 . . . . 0.0 113.63 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.23 1.17 19.33 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.14 -39.9 1.9 Allowed Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 118.998 -1.572 . . . . 0.0 112.571 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.538 HG12 ' O ' ' X' ' 71' ' ' GLY . 5.1 pt -61.8 -31.69 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-N 117.164 0.482 . . . . 0.0 110.923 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.723 HG11 HG12 ' X' ' 16' ' ' VAL . 15.6 m -61.06 -33.08 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 121.086 0.47 . . . . 0.0 112.182 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 60.3 tttm -67.8 -48.01 67.49 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -61.45 -36.59 80.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.646 0.736 . . . . 0.0 109.317 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mm -66.81 -46.62 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.076 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.414 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 21.0 pttp -71.05 -39.61 72.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.101 0.477 . . . . 0.0 111.857 -173.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.1 mt-10 -66.59 -32.37 73.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.287 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -66.05 -47.65 73.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.96 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -37.3 84.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.192 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.2 99.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 123.987 0.804 . . . . 0.0 110.718 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.06 -32.4 59.26 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.624 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -76.13 -39.84 54.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.753 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.15 32.45 3.75 Favored Glycine 0 C--N 1.318 -0.466 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -110.6 163.07 18.12 Favored Pre-proline 0 N--CA 1.418 -2.06 0 C-N-CA 124.336 1.055 . . . . 0.0 109.481 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.32 141.13 61.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.406 2.071 . . . . 0.0 112.384 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.5 -155.26 19.33 Favored Glycine 0 N--CA 1.42 -2.427 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.18 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 30.8 m-85 -78.18 151.77 33.05 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -81.7 160.39 23.69 Favored 'General case' 0 N--CA 1.382 -3.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.41 133.93 37.46 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.828 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' X' ' 40' ' ' HIS . 95.1 mt -94.52 128.45 41.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 29.7 mmtt -107.23 156.45 18.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -77.72 -22.24 50.71 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.581 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 58.0 p -143.21 164.58 29.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.151 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.07 -16.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 111.496 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -14.62 61.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.117 0.484 . . . . 0.0 111.61 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 18.0 t70 -103.51 3.3 34.64 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.446 ' CE2' HD12 ' X' ' 44' ' ' ILE . 2.5 m-85 -96.91 112.84 24.42 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.904 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 46.6 p -76.95 155.22 32.88 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -56.95 -39.84 75.32 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.6 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.2 73.7 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.75 -42.16 83.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.76 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.1 t80 -67.2 -54.01 25.05 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.372 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.828 HG12 HG11 ' X' ' 76' ' ' VAL . 10.5 m -60.09 -32.82 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -68.46 -42.95 78.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.667 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.8 tm? -63.24 -40.07 96.41 Favored 'General case' 0 C--O 1.205 -1.237 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 56.5 mt -64.8 -36.44 84.32 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.637 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.453 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 48.2 mttp -66.18 -37.58 85.94 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.59 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 21' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' X' ' 18' ' ' LEU . 13.2 pt-20 -72.17 -31.88 66.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.536 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.667 HG13 ' O ' ' X' ' 18' ' ' LEU . 29.9 mt -66.11 -45.54 90.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.04 -42.0 84.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.383 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.55 -47.16 87.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.596 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -79.65 -24.67 41.69 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.983 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -65.05 -43.77 91.2 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.716 0.293 . . . . 0.0 110.27 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.5 m -76.28 -34.72 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.534 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -29.63 67.67 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.762 0.791 . . . . 0.0 109.097 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 76.49 87.57 0.08 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 127.469 2.307 . . . . 0.0 113.855 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -109.22 175.59 5.4 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -136.31 -4.68 2.1 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.03 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.499 ' O ' HG23 ' X' ' 36' ' ' VAL . 17.7 p-10 -86.14 -62.81 1.43 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.0 p -81.54 -26.03 10.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.539 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.8 tm? -58.06 -46.27 85.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.626 175.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 37.3 t70 -61.24 -45.83 92.93 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.539 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.499 HG23 ' O ' ' X' ' 32' ' ' ASP . 42.9 t -62.01 -50.01 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 O-C-N 124.4 1.063 . . . . 0.0 110.92 -176.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 91.1 mt -67.9 -41.81 82.12 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.937 -172.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.2 mt -59.36 -50.13 75.16 Favored 'General case' 0 N--CA 1.417 -2.107 0 O-C-N 124.122 0.888 . . . . 0.0 111.72 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.1 pt-20 -71.82 -36.52 70.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.588 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 5.0 t60 -65.78 -38.28 88.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.603 ' O ' HG22 ' X' ' 45' ' ' THR . 31.7 t80 -62.7 -51.66 66.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.14 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.422 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 5.9 p -67.17 -32.57 58.28 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.848 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -68.65 -30.13 68.76 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.999 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.468 HG12 ' O ' ' X' ' 40' ' ' HIS . 9.5 pt -83.96 -42.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 122.146 -0.346 . . . . 0.0 111.635 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.603 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.0 t -84.16 -28.39 27.44 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.608 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 62.91 26.14 15.4 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.472 ' H ' HG23 ' X' ' 45' ' ' THR . 42.6 t-80 -75.09 134.26 74.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -69.93 -14.45 35.55 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.831 2.354 . . . . 0.0 112.082 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.4 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.18 29.68 6.03 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 -173.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.597 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.96 -57.88 8.3 Favored Glycine 0 CA--C 1.455 -3.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.107 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.428 ' CG2' HD13 ' X' ' 38' ' ' LEU . 1.4 m -73.34 -29.15 62.47 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.755 -172.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.6 97.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.658 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -57.73 -43.31 85.22 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 123.558 0.536 . . . . 0.0 112.251 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.548 HD13 HG21 ' X' ' 22' ' ' ILE . 64.2 mt -66.59 -42.2 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 121.684 0.754 . . . . 0.0 110.044 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.77 91.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.05 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.24 77.78 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.948 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.5 -46.86 83.28 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.222 0.326 . . . . 0.0 110.809 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.1 92.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.67 75.13 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.976 0.417 . . . . 0.0 111.364 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -68.29 -31.24 70.54 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.409 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.45 -34.72 65.54 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 121.154 -0.219 . . . . 0.0 110.861 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.51 -42.64 88.16 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.581 0.551 . . . . 0.0 110.613 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.43 72.97 1.49 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.73 122.61 87.41 Favored Pre-proline 0 CA--C 1.478 -1.799 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -81.33 -33.96 0.64 Allowed 'Trans proline' 0 N--CA 1.423 -2.662 0 C-N-CA 121.331 1.354 . . . . 0.0 110.851 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.74 -86.9 1.52 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.99 -31.05 0.9 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.49 -36.1 80.44 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.635 0.731 . . . . 0.0 109.692 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.33 150.51 19.21 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.17 66.59 0.95 Allowed Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.4 162.29 21.37 Favored Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 119.105 -1.522 . . . . 0.0 113.834 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.453 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 18.0 Cg_endo -60.57 -29.05 87.73 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 124.755 3.637 . . . . 0.0 113.9 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.472 ' C ' HG22 ' X' ' 76' ' ' VAL . 84.0 mt-10 -95.66 1.96 53.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.676 0.274 . . . . 0.0 110.326 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.78 -37.47 3.19 Favored Glycine 0 N--CA 1.426 -1.984 0 C-N-CA 118.587 -1.768 . . . . 0.0 111.803 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.551 ' CD1' HD13 ' X' ' 19' ' ' LEU . 9.0 pt -58.33 -32.11 44.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 120.68 0.276 . . . . 0.0 110.927 174.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.828 HG11 HG12 ' X' ' 16' ' ' VAL . 19.1 m -63.93 -36.65 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.7 ttmm -67.14 -38.12 84.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -68.67 -40.59 80.08 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.447 HG23 ' OG1' ' X' ' 45' ' ' THR . 22.0 mm -61.98 -46.57 96.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.771 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 19.9 pttp -66.95 -41.01 87.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.396 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.46 -31.96 73.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.575 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 91.3 t90 -72.24 -48.94 38.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.196 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' X' ' 88' ' ' LYS . 10.1 ttt85 -71.17 -37.02 72.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.623 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.18 87.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.741 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.23 -26.35 65.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.117 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.38 -22.02 57.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 120.943 0.402 . . . . 0.0 110.162 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 49.91 16.3 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 60.3 tttp -133.6 126.53 19.11 Favored Pre-proline 0 N--CA 1.414 -2.241 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.72 119.42 5.58 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.283 3.322 . . . . 0.0 113.887 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.63 -127.12 4.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.255 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.9 m-85 -79.3 151.55 31.01 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 120.555 0.217 . . . . 0.0 110.577 -174.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.422 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 20.4 ptmt -93.31 179.1 5.51 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -110.91 142.24 43.25 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 123.031 0.532 . . . . 0.0 109.738 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.119 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 . . . . . 0 CA--C 1.488 -1.411 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.427 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 76.5 mt -91.5 129.58 37.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.887 0.851 . . . . 0.0 112.17 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 26.7 mmtt -104.85 -162.06 0.86 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -119.56 -31.64 4.53 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.201 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.2 p -126.07 166.95 16.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.568 HD13 HH12 ' X' ' 83' ' ' ARG . 7.9 tt -81.1 -0.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.975 0.893 . . . . 0.0 111.275 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.8 m -80.99 -10.13 59.75 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.28 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 18.9 t70 -106.85 1.27 24.58 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 7.9 m-85 -98.6 114.14 26.48 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.121 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.463 HG22 ' HG3' ' X' ' 92' ' ' LYS . 76.9 p -79.6 160.54 26.36 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.612 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.9 pt-20 -61.19 -36.94 81.22 Favored 'General case' 0 C--O 1.2 -1.552 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.828 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.35 -38.7 74.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.428 ' HB2' ' OG1' ' X' ' 11' ' ' THR . 1.0 OUTLIER -59.98 -42.18 93.64 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.111 0.958 . . . . 0.0 108.769 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -68.33 -49.02 63.25 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.534 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.722 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 18.7 m -57.78 -41.73 80.35 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 CA-C-N 117.98 0.355 . . . . 0.0 110.206 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -61.27 -49.4 77.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.698 0.799 . . . . 0.0 110.366 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.515 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -64.18 -41.96 96.89 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' X' ' 75' ' ' ILE . 13.9 tp -59.7 -44.27 93.76 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.913 1.285 . . . . 0.0 111.319 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.7 mttt -61.56 -35.21 77.15 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.904 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.12 -38.31 82.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.548 HG21 HD13 ' X' ' 54' ' ' ILE . 23.2 mt -61.07 -43.73 96.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -34.97 73.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.81 -50.95 37.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -25.22 68.0 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.461 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -66.94 -55.41 14.71 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.254 1.022 . . . . 0.0 110.132 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 m -73.22 -21.43 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.75 -12.44 51.03 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.5 57.81 6.18 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.754 1.222 . . . . 0.0 110.982 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -78.17 -24.93 47.06 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.474 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 66.89 -64.31 0.24 Allowed 'General case' 0 C--O 1.205 -1.254 0 C-N-CA 126.043 1.737 . . . . 0.0 114.948 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.503 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.7 t70 -57.29 -57.09 14.14 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.252 0.478 . . . . 0.0 111.573 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -80.26 -30.7 12.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.35 -175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.22 -45.47 91.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.611 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.81 -36.55 83.81 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.317 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.503 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -57.31 -49.11 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 87.3 mt -67.99 -43.26 79.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.109 -173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.0 mt -59.24 -43.73 92.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.938 0.774 . . . . 0.0 110.991 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.12 -45.17 70.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.629 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.7 t60 -60.86 -45.7 93.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.018 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.594 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 58.8 t80 -58.65 -51.67 68.94 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.676 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.59 -34.11 66.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -71.86 -30.46 65.46 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.697 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.629 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.8 pt -84.1 -36.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.689 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -76.2 -42.57 45.8 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.524 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 61.5 30.23 18.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.922 1.289 . . . . 0.0 109.864 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -89.12 133.38 35.32 Favored Pre-proline 0 N--CA 1.415 -2.222 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.04 16.67 0.53 Allowed 'Trans proline' 0 CA--C 1.497 -1.352 0 C-N-CA 122.908 2.405 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.502 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 3.2 m-20 -142.99 23.06 1.9 Allowed 'General case' 0 N--CA 1.394 -3.255 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.594 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.16 -66.49 1.04 Allowed Glycine 0 CA--C 1.462 -3.255 0 O-C-N 124.724 1.265 . . . . 0.0 113.821 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.461 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -71.54 -26.03 62.47 Favored 'General case' 0 C--N 1.258 -3.4 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.842 -173.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.44 -38.3 90.55 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.675 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 53' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 96.5 mt -57.83 -46.51 84.64 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 124.202 0.939 . . . . 0.0 111.258 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.548 HD13 HG21 ' X' ' 22' ' ' ILE . 65.2 mt -67.14 -46.67 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.843 0.83 . . . . 0.0 109.891 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.23 -38.99 93.34 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.167 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.2 pt-20 -71.82 -36.45 70.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.012 176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.56 79.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.18 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.05 81.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.475 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.24 -43.58 77.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.824 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 77.6 mtp85 -67.53 -30.01 69.56 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.783 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' X' ' 70' ' ' GLY . . . -79.74 -31.09 41.01 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.647 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.92 86.42 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.582 0.706 . . . . 0.0 109.804 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.54 95.37 2.81 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 87.5 m-20 -57.79 119.97 37.97 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 123.912 0.757 . . . . 0.0 111.33 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -0.5 10.21 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.641 2.227 . . . . 0.0 111.694 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.54 -128.85 1.15 Allowed Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.56 48.6 0.36 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.876 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -97.57 -31.38 12.34 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.07 86.67 0.21 Allowed Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.049 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 70' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' X' ' 61' ' ' ALA . . . -95.57 104.32 3.1 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.414 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 146.91 -176.86 25.57 Favored Glycine 0 N--CA 1.397 -3.911 0 C-N-CA 120.486 -0.864 . . . . 0.0 110.964 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.425 ' CG ' ' HG2' ' X' ' 20' ' ' LYS . 3.9 Cg_exo -46.53 -52.36 7.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 125.257 3.971 . . . . 0.0 114.101 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -76.84 1.54 17.13 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.7 -39.28 1.91 Allowed Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.062 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.574 ' O ' HG13 ' X' ' 79' ' ' ILE . 2.5 pt -60.87 -33.0 53.71 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-N 117.261 0.531 . . . . 0.0 111.097 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.616 HG11 HG12 ' X' ' 16' ' ' VAL . 9.7 m -59.16 -32.29 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.504 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 25.0 ttmm -67.9 -42.38 81.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.078 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.27 -43.25 99.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.574 HG13 ' O ' ' X' ' 75' ' ' ILE . 76.9 mt -64.74 -44.14 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.868 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 19.1 ptpt -66.85 -43.47 83.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.747 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 42.0 mt-10 -67.95 -32.01 72.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.86 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -66.9 -48.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.568 HH12 HD13 ' X' ' 7' ' ' ILE . 1.3 mpp_? -70.77 -37.36 73.37 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.8 92.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.788 0.68 . . . . 0.0 110.498 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.1 -26.33 56.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 111.513 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.437 ' OD1' ' HD3' ' X' ' 88' ' ' LYS . 12.1 t-20 -77.33 -31.37 54.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.807 0.337 . . . . 0.0 110.578 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.55 40.06 5.14 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.437 ' HD3' ' OD1' ' X' ' 86' ' ' ASN . 12.7 mtpp -130.74 155.55 81.16 Favored Pre-proline 0 N--CA 1.416 -2.159 0 C-N-CA 123.504 0.722 . . . . 0.0 109.749 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.06 125.86 20.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.262 2.642 . . . . 0.0 112.586 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -106.7 -95.65 2.42 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.663 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.74 148.83 52.6 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.0 ptmt -85.04 164.9 17.95 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -95.64 136.24 36.29 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.66 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.254 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.461 ' CD2' HD13 ' X' ' 18' ' ' LEU . 40.1 mt -91.71 137.79 32.08 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -97.06 -159.44 0.74 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -116.88 -27.24 6.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.07 0.462 . . . . 0.0 110.487 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 6' ' ' SER . . . . . 0.41 ' HA ' HG22 ' X' ' 44' ' ' ILE . 92.7 p -136.56 166.98 22.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.455 ' HB ' ' HB ' ' X' ' 44' ' ' ILE . 14.3 tt -67.3 -11.92 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 121.52 0.676 . . . . 0.0 110.618 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -75.37 -27.07 58.98 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.35 -170.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.62 -4.72 40.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.525 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -80.53 115.25 19.95 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.415 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 71.0 p -76.3 159.72 30.3 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 169.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.646 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.26 -34.84 74.28 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.032 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.25 -37.94 75.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -58.55 -39.45 80.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.56 0.695 . . . . 0.0 109.416 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.515 ' HD2' HG12 ' X' ' 76' ' ' VAL . 42.5 t80 -71.8 -44.22 64.33 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.156 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.735 HG12 HG11 ' X' ' 76' ' ' VAL . 7.6 m -61.94 -37.16 77.58 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.442 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.405 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -49.16 78.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.848 0.859 . . . . 0.0 108.778 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.668 ' O ' HG13 ' X' ' 22' ' ' ILE . 16.9 tp -57.53 -48.04 80.38 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.055 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' X' ' 23' ' ' GLU . 8.1 mp -60.36 -40.25 90.1 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.707 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 80.9 mttt -63.41 -35.59 80.93 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.218 0.532 . . . . 0.0 110.034 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -69.43 -42.4 75.06 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.668 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.9 mt -61.23 -42.3 92.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.333 0 O-C-N 124.073 0.858 . . . . 0.0 109.645 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' X' ' 19' ' ' LEU . 51.7 mt-10 -57.33 -46.29 83.41 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.5 -51.8 67.9 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.681 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -79.38 -21.75 45.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.44 -46.05 64.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.35 -33.08 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 110.557 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.25 -6.44 59.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.389 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.44 83.65 0.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.135 1.774 . . . . 0.0 114.435 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 16.4 p -99.72 -172.67 2.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.15 -29.76 0.88 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.614 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.504 ' O ' HG23 ' X' ' 36' ' ' VAL . 28.1 m-20 -70.68 -62.31 1.44 Allowed 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.336 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.705 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.6 p -78.85 -27.34 13.67 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.941 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.3 tm? -58.44 -47.07 85.18 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.212 1.005 . . . . 0.0 109.527 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.3 -28.19 62.93 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.504 HG23 ' O ' ' X' ' 32' ' ' ASP . 64.8 t -67.72 -50.72 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.977 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.506 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 51.6 mt -69.66 -43.99 71.44 Favored 'General case' 0 N--CA 1.412 -2.332 0 O-C-N 124.513 1.133 . . . . 0.0 111.711 -170.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.53 HD22 HG22 ' X' ' 51' ' ' THR . 28.4 mt -60.93 -46.41 90.81 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 124.233 0.958 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -70.74 -39.47 73.3 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.039 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.569 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.6 t60 -63.43 -45.44 90.94 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.245 0.545 . . . . 0.0 109.716 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 37.9 t80 -59.05 -53.46 58.18 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.665 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.409 HG12 ' O ' ' X' ' 38' ' ' LEU 0.252 11.9 p -68.08 -32.29 55.45 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.969 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 50.9 pttt -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.192 -0.317 . . . . 0.0 111.595 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.498 HG12 ' O ' ' X' ' 40' ' ' HIS . 31.5 pt -88.27 -31.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.058 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 47.1 p -85.06 -35.25 21.98 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 120.93 0.395 . . . . 0.0 111.285 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.82 29.53 17.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 125.353 1.461 . . . . 0.0 110.778 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 32.1 t-80 -76.08 138.57 68.75 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 107.861 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.9 Cg_exo -74.26 -6.89 19.06 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 C-N-CA 123.146 2.564 . . . . 0.0 112.151 -176.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.9 m-20 -130.71 30.63 4.63 Favored 'General case' 0 N--CA 1.389 -3.477 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.581 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.51 -59.82 6.85 Favored Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.617 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.53 HG22 HD22 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.97 -28.28 55.09 Favored 'General case' 0 C--N 1.248 -3.828 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.847 -176.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.614 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.74 -42.97 98.41 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.227 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.36 -49.23 76.83 Favored 'General case' 0 C--O 1.208 -1.085 0 O-C-N 123.525 0.515 . . . . 0.0 112.119 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.422 HD13 HG21 ' X' ' 22' ' ' ILE . 79.2 mt -67.74 -42.16 85.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.819 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.502 ' HD2' ' O ' ' X' ' 51' ' ' THR . 15.3 m-85 -60.21 -47.0 87.83 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.585 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 10.4 pt-20 -71.12 -36.43 72.12 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.687 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.42 85.1 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 123.305 0.378 . . . . 0.0 110.438 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.93 87.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.156 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.13 76.4 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.058 0.456 . . . . 0.0 111.314 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -68.18 -31.12 70.43 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.332 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.34 44.23 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.484 -0.135 . . . . 0.0 111.33 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.75 87.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.234 0.54 . . . . 0.0 109.624 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.6 84.01 2.21 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -88.34 120.17 70.4 Favored Pre-proline 0 CA--C 1.489 -1.38 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.847 -173.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.15 -16.73 9.61 Favored 'Trans proline' 0 N--CA 1.432 -2.13 0 C-N-CA 121.664 1.576 . . . . 0.0 112.786 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.47 117.61 3.0 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.882 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.7 -140.98 10.26 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -124.5 150.76 45.42 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.87 -48.77 0.94 Allowed Glycine 0 CA--C 1.469 -2.784 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.58 72.13 2.78 Favored Glycine 0 N--CA 1.416 -2.684 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.497 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 157.05 163.11 12.09 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.572 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 19.3 Cg_endo -61.96 -47.52 10.47 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.081 3.188 . . . . 0.0 112.825 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.518 ' HG2' HG11 ' X' ' 16' ' ' VAL . 43.2 mt-10 -77.37 1.24 19.53 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 -35.03 2.82 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 118.526 -1.797 . . . . 0.0 112.651 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.497 HG12 ' O ' ' X' ' 71' ' ' GLY . 3.6 pt -65.36 -29.38 47.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.761 173.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.735 HG11 HG12 ' X' ' 16' ' ' VAL . 19.6 m -63.38 -35.04 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.7 0 CA-C-O 121.407 0.622 . . . . 0.0 111.419 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.522 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 61.9 tttm -66.88 -39.26 87.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.151 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.13 -38.34 90.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.13 -46.56 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.256 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 18.0 ptpt -66.94 -39.98 87.45 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.816 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.61 -35.85 77.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.377 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.519 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.0 t90 -67.66 -48.05 67.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.629 0.728 . . . . 0.0 109.19 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.484 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 18.4 tpt180 -61.34 -45.75 93.1 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.219 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.65 83.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.66 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.96 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.26 0.35 . . . . 0.0 110.852 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.419 ' OD1' ' HE2' ' X' ' 88' ' ' LYS . 17.5 t-20 -69.08 -37.37 78.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.56 29.38 5.36 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.15 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.419 ' HE2' ' OD1' ' X' ' 86' ' ' ASN . 64.0 mttm -106.41 147.53 35.09 Favored Pre-proline 0 N--CA 1.401 -2.904 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.45 130.03 25.55 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.4 2.066 . . . . 0.0 110.751 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.88 -128.51 5.4 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.689 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -88.72 154.85 19.96 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.2 pttt -90.06 163.97 14.68 Favored 'General case' 0 N--CA 1.39 -3.464 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.49 141.18 29.27 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.276 -2.752 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 175.838 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.451 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 73.0 mt -94.14 128.61 40.66 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.492 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 35.0 mmtt -99.94 -178.77 3.95 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.376 0.607 . . . . 0.0 110.065 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -104.81 -13.67 15.78 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.47 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -142.73 160.04 41.07 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.1 tt -69.1 -22.89 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.378 0.608 . . . . 0.0 110.746 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -84.36 -2.91 57.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.384 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.492 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -98.67 -3.45 35.98 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.443 ' C ' ' HG2' ' X' ' 92' ' ' LYS . 5.9 m-85 -98.62 121.98 41.25 Favored 'General case' 0 CA--C 1.475 -1.941 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.949 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.626 ' O ' HG13 ' X' ' 16' ' ' VAL . 12.9 pt-20 -63.37 -33.79 76.31 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.829 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.436 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.77 -38.25 76.68 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.357 0.123 . . . . 0.0 110.998 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -59.1 -37.51 77.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.643 0.735 . . . . 0.0 109.477 173.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 33.6 t80 -74.27 -40.88 62.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.483 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.767 HG12 HG11 ' X' ' 76' ' ' VAL . 6.3 m -62.58 -32.08 54.17 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.214 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.16 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -65.05 -46.06 82.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.633 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -58.82 -44.33 90.84 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.799 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.8 mt -58.22 -40.24 81.13 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.197 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' X' ' 23' ' ' GLU . 95.7 mttt -70.22 -34.11 72.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.338 0.589 . . . . 0.0 110.224 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.82 -42.2 98.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.898 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.68 HG12 ' HB3' ' X' ' 37' ' ' LEU . 17.6 mt -65.13 -39.52 85.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.621 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 12.8 tt0 -57.24 -47.82 80.4 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 124.343 1.057 . . . . 0.0 108.459 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -47.92 81.49 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.146 -178.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.451 ' OE1' ' HB ' ' X' ' 33' ' ' VAL . 28.6 mm-40 -68.72 -31.7 70.95 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.2 -44.07 22.6 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.237 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.97 -25.86 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.51 -4.29 45.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 45.14 78.8 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.744 1.618 . . . . 0.0 112.987 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 81.8 p -99.58 -160.51 0.81 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.098 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.57 -63.51 0.67 Allowed 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.627 ' O ' HG23 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.64 -60.02 3.85 Favored 'General case' 0 CA--C 1.472 -2.053 0 O-C-N 123.718 0.637 . . . . 0.0 112.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -82.75 -25.9 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.186 -172.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -59.16 -46.94 87.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 31.0 t70 -66.72 -43.58 83.88 Favored 'General case' 0 CA--C 1.479 -1.766 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.001 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.627 HG23 ' O ' ' X' ' 32' ' ' ASP . 49.8 t -55.95 -50.23 70.46 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 O-C-N 124.114 0.884 . . . . 0.0 110.493 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.68 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.6 mt -69.23 -39.03 78.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 O-C-N 124.423 1.077 . . . . 0.0 112.123 -173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.3 mt -60.25 -50.18 74.66 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.0 0.813 . . . . 0.0 110.69 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 2.7 pt-20 -71.41 -33.79 69.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.529 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.519 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.9 t60 -61.37 -45.89 92.47 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.533 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 69.6 t80 -60.7 -54.11 49.24 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.841 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.485 HG12 ' O ' ' X' ' 38' ' ' LEU . 4.8 p -67.22 -32.87 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.9 ptmm? -68.12 -42.43 80.24 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.82 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.519 HG12 ' O ' ' X' ' 40' ' ' HIS . 12.2 pt -77.1 -34.49 21.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.721 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.402 ' HA ' HD12 ' X' ' 7' ' ' ILE . 77.1 p -84.32 -39.19 19.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.459 -178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 58.81 74.81 0.42 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.537 1.16 . . . . 0.0 110.382 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -123.82 132.49 24.29 Favored Pre-proline 0 N--CA 1.405 -2.679 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.3 -18.59 55.7 Favored 'Trans proline' 0 CA--C 1.498 -1.304 0 C-N-CA 122.99 2.46 . . . . 0.0 111.885 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 15.3 m-20 -126.99 33.89 4.85 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -170.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.533 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.85 -55.81 7.06 Favored Glycine 0 CA--C 1.461 -3.288 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.866 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.493 HG22 HD22 ' X' ' 38' ' ' LEU 0.313 1.9 p -85.25 -17.19 37.73 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 117.208 -1.797 . . . . 0.0 113.618 -176.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.88 -35.52 80.28 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.35 -40.71 96.41 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 123.604 0.565 . . . . 0.0 110.937 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.427 HD13 HG21 ' X' ' 75' ' ' ILE . 17.9 mm -66.57 -46.27 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.796 0.808 . . . . 0.0 109.773 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -63.02 -43.39 98.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.415 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -71.39 -37.32 71.57 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.791 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.25 80.44 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 122.32 0.248 . . . . 0.0 111.347 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.25 -46.34 83.13 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.461 0.476 . . . . 0.0 110.49 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.25 -43.53 67.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.383 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' X' ' 65' ' ' PRO . 74.2 mtp180 -60.99 -34.18 74.38 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.133 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.78 -36.49 37.03 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.574 0.226 . . . . 0.0 111.488 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.6 84.42 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 109.976 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.36 -50.53 8.26 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.68 87.57 0.13 Allowed Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.404 1.482 . . . . 0.0 109.561 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 65' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 22.8 Cg_exo -64.27 -65.53 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.903 2.402 . . . . 0.0 113.096 -173.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 47.01 1.03 Allowed Glycine 0 CA--C 1.475 -2.424 0 C-N-CA 119.991 -1.099 . . . . 0.0 112.03 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.43 -82.85 1.14 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.246 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.7 120.83 22.41 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 122.92 0.488 . . . . 0.0 109.935 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.28 23.42 9.65 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.07 52.68 0.78 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.91 173.89 42.87 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.553 ' O ' HG13 ' X' ' 75' ' ' ILE . 9.6 Cg_endo -54.04 -34.59 78.19 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 124.457 3.438 . . . . 0.0 112.131 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.67 0.63 5.2 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.64 -10.78 28.23 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 118.836 -1.649 . . . . 0.0 113.248 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.553 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -74.15 -44.86 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.767 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -55.56 -43.07 71.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.266 175.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 21.7 ttmm -60.48 -47.63 85.31 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.869 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.81 -37.87 86.02 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.122 0.963 . . . . 0.0 108.592 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.497 ' HA ' HH21 ' X' ' 83' ' ' ARG . 36.2 mm -65.58 -45.75 91.53 Favored 'Isoleucine or valine' 0 C--O 1.254 1.304 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.086 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.6 ptpt -63.17 -37.68 88.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.282 0.364 . . . . 0.0 110.86 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 35.7 mt-10 -71.28 -43.91 66.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.422 ' HB3' ' NH2' ' X' ' 83' ' ' ARG . 59.6 t90 -62.96 -41.02 99.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' X' ' 79' ' ' ILE . 0.5 OUTLIER -61.94 -45.33 94.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.504 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -39.58 93.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.678 0.611 . . . . 0.0 111.324 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.79 82.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.45 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 23.1 t-20 -67.57 -46.96 71.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.26 22.87 5.7 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.45 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 61.3 mttm -102.02 144.73 29.16 Favored Pre-proline 0 N--CA 1.403 -2.815 0 C-N-CA 124.396 1.079 . . . . 0.0 108.114 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.15 132.76 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.697 1.598 . . . . 0.0 111.485 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -92.04 -117.81 2.33 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.038 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.41 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 54.6 m-85 -99.61 166.19 11.25 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 21.9 ptmt -94.62 174.43 7.12 Favored 'General case' 0 N--CA 1.387 -3.605 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -120.67 136.12 54.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 CA-C-O 121.242 0.544 . . . . 0.0 110.659 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.737 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' X' X ' 2' ' ' GLU . . . . . 0.715 ' N ' HE22 ' X' ' 17' ' ' GLN . 6.0 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 121.606 0.717 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.47 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 78.3 mt -91.84 153.5 19.51 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.932 -176.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.634 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 10.9 mptt -120.56 -178.4 3.7 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.793 -175.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.97 -46.44 12.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.446 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.3 p -140.42 167.91 21.03 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.549 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' X' ' 44' ' ' ILE . 14.5 tt -61.59 -19.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.822 0.82 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.1 m -82.26 -5.01 58.24 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.717 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.631 ' HB3' ' CG ' ' X' ' 4' ' ' LYS . 3.5 t70 -105.42 3.6 29.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 4.8 m-85 -105.37 118.11 35.72 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.314 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 18.2 p -79.22 163.76 24.73 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.661 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.1 pt-20 -56.58 -42.17 78.2 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.002 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.52 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.86 -38.37 76.41 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 53.4 mm-40 -60.89 -36.35 79.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.74 0.781 . . . . 0.0 109.213 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 41.7 t80 -75.26 -42.92 53.99 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.517 -177.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.792 HG12 HG11 ' X' ' 76' ' ' VAL . 10.2 m -58.43 -33.61 48.42 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 O-C-N 123.215 0.322 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.715 HE22 ' N ' ' X' ' 2' ' ' GLU . 0.6 OUTLIER -58.69 -49.37 77.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.675 1.19 . . . . 0.0 110.171 178.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.512 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.5 tm? -61.77 -42.91 99.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.117 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -61.3 -42.66 99.02 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.366 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.0 mttt -63.87 -35.93 82.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.318 0.58 . . . . 0.0 109.975 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -67.56 -34.92 78.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' X' ' 37' ' ' LEU . 25.5 mt -66.22 -42.25 90.69 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.402 ' OE2' ' HD3' ' X' ' 72' ' ' PRO . 51.1 mt-10 -57.17 -37.32 71.93 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.927 0.87 . . . . 0.0 110.666 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.1 -52.38 55.81 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.941 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 1.7 pp20? -97.61 -11.42 23.64 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 118.83 -1.148 . . . . 0.0 113.482 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.61 -38.06 83.48 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.074 0.464 . . . . 0.0 110.948 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.93 -20.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.302 0.572 . . . . 0.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -39.79 13.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.495 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.86 75.93 0.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.0 1.72 . . . . 0.0 109.768 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.425 HG23 ' HB2' ' X' ' 25' ' ' GLU . 49.2 p -78.75 -21.34 48.1 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.351 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 t70 72.99 -48.54 0.69 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.491 ' O ' HG23 ' X' ' 36' ' ' VAL . 21.1 t70 -63.07 -52.55 62.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.727 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 15.0 p -94.01 -25.26 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.857 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.653 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.4 tm? -58.02 -46.58 85.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.647 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 35.2 t70 -63.03 -42.5 99.79 Favored 'General case' 0 CA--C 1.473 -1.987 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.016 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.491 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.2 t -61.55 -49.54 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 O-C-N 124.65 1.219 . . . . 0.0 110.837 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.7 mt -65.97 -43.68 87.15 Favored 'General case' 0 N--CA 1.415 -2.223 0 O-C-N 124.13 0.894 . . . . 0.0 110.362 -173.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.561 ' O ' HG12 ' X' ' 42' ' ' VAL . 32.4 mt -63.14 -50.65 69.58 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.73 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 16.7 pt-20 -71.76 -37.37 70.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.31 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.499 ' O ' HG12 ' X' ' 44' ' ' ILE . 8.9 t60 -59.89 -44.85 93.98 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.492 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 28.8 t80 -62.09 -56.93 13.96 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.438 1.086 . . . . 0.0 111.65 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.561 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 8.9 p -67.36 -31.18 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -67.6 -30.37 69.95 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.663 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.499 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.1 pt -91.4 -32.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.567 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -81.62 -36.8 28.5 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.315 0.578 . . . . 0.0 110.107 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.61 26.98 16.55 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.497 1.519 . . . . 0.0 111.022 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.0 130.74 80.23 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -67.19 -14.57 43.64 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 123.226 2.617 . . . . 0.0 112.745 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 36.8 m-20 -126.04 32.46 5.24 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -173.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.15 -54.55 8.28 Favored Glycine 0 CA--C 1.457 -3.548 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.576 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.55 HG23 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -33.34 59.59 Favored 'General case' 0 C--N 1.257 -3.436 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.639 -172.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.35 -36.11 77.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.409 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 mt -58.02 -43.14 86.56 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.44 ' H ' HD12 ' X' ' 54' ' ' ILE . 5.0 mp -66.79 -41.42 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -63.18 -50.27 70.99 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.6 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.1 pt-20 -66.62 -36.61 83.02 Favored 'General case' 0 C--O 1.206 -1.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.199 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 57' ' ' ALA . . . . . 0.426 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . -57.78 -39.83 78.4 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 123.219 0.324 . . . . 0.0 110.63 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.87 91.74 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.491 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.41 -42.6 74.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.222 0.534 . . . . 0.0 110.221 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.632 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 72.5 mtp180 -61.22 -35.79 78.15 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.225 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.29 -39.57 28.53 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.57 64.97 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.45 -13.35 23.18 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.513 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 87.6 m-20 41.3 75.14 0.64 Allowed Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.98 -27.35 25.5 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 169.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.41 150.09 20.96 Favored Glycine 0 N--CA 1.399 -3.812 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.36 -20.14 75.41 Favored Glycine 0 C--N 1.304 -1.225 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.77 112.17 3.11 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 124.099 0.96 . . . . 0.0 109.726 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 69' ' ' GLY . . . . . 0.632 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 84.7 5.54 86.46 Favored Glycine 0 CA--C 1.498 -0.98 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.32 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.16 70.14 3.05 Favored Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.54 -178.73 20.81 Favored Glycine 0 N--CA 1.399 -3.801 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.792 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.59 ' O ' HG13 ' X' ' 76' ' ' VAL . 32.5 Cg_endo -66.45 -41.0 12.77 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 124.617 3.544 . . . . 0.0 112.313 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.5 ' HG2' HG11 ' X' ' 16' ' ' VAL . 35.1 mt-10 -84.69 2.02 43.74 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.386 0.675 . . . . 0.0 110.182 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.79 -35.78 3.16 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.89 172.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.489 ' CD1' HD13 ' X' ' 19' ' ' LEU . 4.0 pt -64.78 -22.72 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-N 117.712 0.756 . . . . 0.0 111.582 173.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.792 HG11 HG12 ' X' ' 16' ' ' VAL . 30.7 m -63.06 -39.21 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-O 121.601 0.715 . . . . 0.0 110.534 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 52.2 tttp -64.12 -42.69 96.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.691 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 78' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 39.7 mm-40 -58.3 -45.34 88.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.85 0.833 . . . . 0.0 109.526 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -64.46 -46.79 91.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.009 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 13.5 ptmm? -67.87 -36.32 80.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.761 -174.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.0 -36.69 69.82 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.141 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.519 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.4 t90 -62.97 -48.1 80.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 18.0 tpt180 -65.89 -45.89 80.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.913 -174.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.75 -40.93 79.57 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 122.853 0.461 . . . . 0.0 112.064 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.13 82.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.084 0.469 . . . . 0.0 109.962 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.09 -21.74 56.36 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.3 42.78 9.06 Favored Glycine 0 CA--C 1.498 -0.993 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.012 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.9 mtpp -122.44 144.35 41.86 Favored Pre-proline 0 N--CA 1.393 -3.289 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.93 127.69 20.1 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 122.803 2.336 . . . . 0.0 111.543 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.62 -110.08 3.12 Favored Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.578 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.56 161.67 20.1 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.093 0.473 . . . . 0.0 110.687 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' X' ' 11' ' ' THR . 21.3 ptmt -108.26 171.69 7.26 Favored 'General case' 0 N--CA 1.393 -3.305 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -106.93 140.93 38.95 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.498 0 CA-C-O 118.083 -1.399 . . . . 0.0 110.149 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.462 HD22 HD13 ' X' ' 18' ' ' LEU . 48.8 mt -90.79 148.38 22.57 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.483 -174.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 25.1 mmtt -99.62 -160.34 0.8 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -117.7 -19.68 9.22 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.042 -0.411 . . . . 0.0 110.852 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 83.4 p -135.8 160.87 37.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.06 -21.92 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.613 0.765 . . . . 0.0 110.279 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 8' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 23.7 m -85.64 -1.75 57.47 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.448 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 25.6 t0 -101.67 -0.11 35.18 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.74 123.63 46.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.216 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.526 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 70.6 p -78.18 172.11 14.05 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.569 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.0 pt-20 -56.33 -45.09 80.5 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.169 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.47 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.44 -37.85 74.44 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' X' ' 11' ' ' THR . 5.3 mm-40 -57.8 -35.94 71.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.385 0.612 . . . . 0.0 110.227 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.657 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 30.1 t80 -75.67 -40.51 55.86 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.9 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.698 HG12 HG11 ' X' ' 76' ' ' VAL . 4.3 m -62.92 -28.99 46.08 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.923 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.505 ' O ' ' HG2' ' X' ' 21' ' ' GLU . 0.9 OUTLIER -57.63 -48.79 78.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.613 ' O ' HG13 ' X' ' 22' ' ' ILE . 20.3 tp -61.81 -46.99 87.14 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 121.196 0.522 . . . . 0.0 110.655 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 37.2 mt -57.94 -36.88 73.13 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.924 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 95.9 mttt -70.78 -33.97 71.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.128 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' X' ' 17' ' ' GLN . 8.7 mm-40 -67.37 -43.27 81.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.614 HG12 ' HB3' ' X' ' 37' ' ' LEU . 35.5 mt -58.81 -42.2 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.095 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.22 -47.84 82.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.695 1.198 . . . . 0.0 110.165 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.92 -52.1 58.28 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.73 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -17.19 64.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.426 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.53 -38.45 14.92 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.121 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.25 -33.25 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.214 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.83 -26.26 37.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 77.27 0.31 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.326 1.451 . . . . 0.0 112.913 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.9 p -98.55 -177.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.2 -56.09 1.44 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.887 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.641 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.2 p-10 -57.68 -55.7 31.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 123.535 0.522 . . . . 0.0 111.921 -175.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -81.33 -32.52 12.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.375 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.27 -45.81 90.22 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.154 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.76 -24.61 60.97 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.207 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.641 HG23 ' O ' ' X' ' 32' ' ' ASP . 88.7 t -61.01 -49.1 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.187 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 65.4 mt -68.11 -43.05 79.28 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.962 -173.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.1 mt -58.87 -46.57 87.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.292 0.995 . . . . 0.0 110.597 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.85 -40.93 72.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.087 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 63.9 t60 -62.4 -45.56 92.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.393 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.8 t80 -58.27 -51.73 68.53 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.752 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.458 HG23 ' HA3' ' X' ' 50' ' ' GLY . 15.0 p -67.86 -32.85 58.23 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.9 ptmt -68.96 -33.44 73.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 122.046 -0.409 . . . . 0.0 111.897 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.505 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.1 pt -85.13 -32.49 7.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.734 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 73.9 p -84.97 -33.62 22.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 56.8 33.59 23.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.664 1.186 . . . . 0.0 110.274 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.415 ' CE1' HD11 ' X' ' 53' ' ' LEU . 41.3 t-80 -80.61 134.46 54.19 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.225 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.464 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -67.77 -12.18 34.59 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 123.18 2.587 . . . . 0.0 112.437 -175.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -130.24 28.56 4.98 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.581 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.68 -62.59 2.84 Favored Glycine 1 CA--C 1.449 -4.049 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.741 -175.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -77.64 -23.99 49.59 Favored 'General case' 0 C--N 1.249 -3.774 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.24 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.0 -34.95 78.66 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.03 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 53' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' X' ' 47' ' ' HIS . 34.8 mt -62.91 -37.67 87.91 Favored 'General case' 0 CA--C 1.486 -1.493 0 O-C-N 123.362 0.414 . . . . 0.0 110.711 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.2 mt -66.46 -44.03 90.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.86 -44.62 95.63 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.261 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.7 pt-20 -68.52 -46.43 69.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.364 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.16 94.19 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.224 0.328 . . . . 0.0 111.456 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.32 94.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.218 0.323 . . . . 0.0 111.551 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.46 84.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.74 0.781 . . . . 0.0 110.016 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 96.8 mtt180 -67.37 -29.23 68.7 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.414 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.451 ' HB2' ' HA2' ' X' ' 71' ' ' GLY . . . -79.32 -37.5 37.48 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 176.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.92 83.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 110.035 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 63' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' X' ' 65' ' ' PRO . . . -117.64 85.94 2.43 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 28.4 t-20 -78.66 114.66 45.42 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 65' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' X' ' 63' ' ' ALA . 30.0 Cg_endo -104.11 27.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.941 2.427 . . . . 0.0 109.889 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.08 -84.57 0.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -169.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.71 -177.09 52.1 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.047 -0.576 . . . . 0.0 114.314 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.35 -53.3 2.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.72 75.95 0.3 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 108.184 -1.967 . . . . 0.0 108.184 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.4 42.76 1.86 Allowed Glycine 0 CA--C 1.49 -1.494 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.403 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' X' ' 61' ' ' ALA . . . 168.09 169.67 31.86 Favored Glycine 0 N--CA 1.397 -3.904 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.507 ' O ' HG13 ' X' ' 75' ' ' ILE . 10.2 Cg_endo -57.81 -40.92 74.87 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.449 2.766 . . . . 0.0 111.785 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -74.12 0.75 12.9 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.137 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.59 -17.67 10.3 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.807 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.507 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -68.04 -41.96 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.698 HG11 HG12 ' X' ' 16' ' ' VAL . 1.0 OUTLIER -56.43 -44.6 80.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.714 177.051 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 23.1 ttpp -57.98 -47.74 82.08 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.338 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.3 -36.24 73.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.456 0.646 . . . . 0.0 109.657 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.8 -45.81 71.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.369 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.2 pttp -64.32 -35.5 81.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.923 0.392 . . . . 0.0 110.48 -176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 49.5 mt-10 -69.22 -39.35 78.63 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.464 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -67.96 -47.29 69.02 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 17.7 tpt180 -60.9 -45.28 95.24 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.296 -174.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.6 83.27 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.011 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.31 -33.73 75.89 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.502 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.15 -46.77 48.99 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.42 41.93 1.31 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 62.1 mttm -117.62 144.79 34.95 Favored Pre-proline 0 N--CA 1.399 -3.017 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.06 124.74 13.47 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 121.991 1.794 . . . . 0.0 109.862 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.55 -121.43 3.48 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.179 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -83.03 161.38 21.72 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.544 -0.828 . . . . 0.0 109.974 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.0 ptmt -87.59 167.62 13.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.21 132.03 48.39 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.116 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 178.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.482 ' CD2' HD13 ' X' ' 18' ' ' LEU . 53.5 mt -90.49 146.34 24.19 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.7 mmtt -110.22 148.43 31.87 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -84.44 -1.21 55.27 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.021 -176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 53.0 p -147.08 158.46 43.94 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.8 tp -73.03 -12.41 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.241 0.543 . . . . 0.0 111.615 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.27 -14.27 60.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.421 0.629 . . . . 0.0 111.386 -173.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.2 t70 -105.28 5.26 31.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -100.18 121.51 41.55 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.737 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.514 HG22 ' HG3' ' X' ' 92' ' ' LYS . 29.8 p -83.57 165.33 19.15 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.622 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.3 pt-20 -56.07 -43.62 78.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.346 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.97 -37.31 75.73 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.451 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 17.4 mm-40 -56.83 -39.73 74.75 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.65 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 16.9 t80 -72.81 -43.21 62.99 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.639 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.767 HG12 HG11 ' X' ' 76' ' ' VAL . 4.3 m -62.74 -29.03 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.89 -44.91 88.09 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.583 ' O ' HG13 ' X' ' 22' ' ' ILE . 27.5 tp -61.42 -46.23 91.01 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.546 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 36.0 mt -57.24 -41.45 79.6 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.678 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.6 mttm -63.58 -35.84 81.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.664 175.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.08 -31.42 50.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.452 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' X' ' 37' ' ' LEU . 27.4 mt -62.27 -41.86 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -58.56 -40.62 83.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -60.4 -41.84 94.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.71 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -80.21 -32.19 38.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.292 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -61.16 -52.75 63.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.051 0.54 . . . . 0.0 111.646 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -65.91 -27.3 40.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.27 -20.96 26.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.73 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.69 61.57 2.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.737 1.215 . . . . 0.0 111.887 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.9 p -88.21 -164.8 1.17 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.359 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -134.2 -50.89 0.82 Allowed 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.998 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.551 ' O ' HG23 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.29 -63.06 1.27 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.642 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 90.5 t -85.93 -27.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.052 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.451 -173.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.8 tm? -58.85 -43.29 90.74 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.5 t70 -68.18 -42.06 80.52 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.118 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.551 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.1 t -57.54 -50.23 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 O-C-N 124.058 0.849 . . . . 0.0 110.27 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' X' ' 22' ' ' ILE . 75.8 mt -67.98 -40.31 83.15 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.091 -170.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 26.5 mt -64.08 -49.13 73.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 O-C-N 124.328 1.017 . . . . 0.0 111.498 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.21 -36.68 71.96 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.5 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.549 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 77.6 t60 -60.82 -45.93 92.53 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.579 ' CD2' HD11 ' X' ' 54' ' ' ILE . 56.5 t80 -57.51 -53.63 55.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.778 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.498 HG12 ' O ' ' X' ' 38' ' ' LEU 0.264 4.6 p -67.14 -31.79 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 17.5 ptmt -71.4 -30.03 65.62 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.851 -0.53 . . . . 0.0 112.369 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.524 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.0 pt -88.96 -35.94 8.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.098 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.461 ' HB ' HD12 ' X' ' 79' ' ' ILE . 77.1 p -82.64 -36.91 25.61 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 110.597 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 64.22 31.22 13.25 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.466 1.507 . . . . 0.0 111.404 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.433 ' O ' HG23 ' X' ' 42' ' ' VAL . 43.7 t-80 -80.88 139.17 49.9 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.465 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.8 Cg_exo -70.94 -18.94 31.07 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 122.859 2.372 . . . . 0.0 112.454 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.414 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.1 35.76 4.71 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.6 -52.74 23.6 Favored Glycine 1 CA--C 1.447 -4.208 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.857 -177.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.445 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.66 -32.06 57.72 Favored 'General case' 0 C--N 1.248 -3.839 0 C-N-CA 118.498 -1.281 . . . . 0.0 110.791 -172.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.59 -33.99 74.84 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.258 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.01 -43.23 91.53 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.579 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.8 mp -67.2 -42.43 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.708 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -62.61 -46.13 89.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.686 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.1 pt-20 -71.57 -38.49 70.94 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.46 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.74 76.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.832 0.287 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.78 84.19 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.687 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.77 -40.07 76.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.08 0.466 . . . . 0.0 110.358 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.503 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 67.8 mtp180 -62.86 -30.33 71.42 Favored 'General case' 0 C--O 1.207 -1.182 0 C-N-CA 123.691 0.796 . . . . 0.0 110.846 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.548 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -80.64 -46.18 16.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.18 -43.49 78.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.155 0.582 . . . . 0.0 110.63 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.43 86.86 2.43 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.07 121.72 77.34 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.239 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 7.71 3.53 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.385 2.723 . . . . 0.0 113.245 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.42 57.04 1.7 Allowed Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.24 174.77 37.03 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.522 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.27 168.21 13.4 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 69' ' ' GLY . . . . . 0.503 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 92.28 10.21 61.09 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.04 113.25 4.38 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.548 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 102.18 -179.81 27.26 Favored Glycine 0 N--CA 1.407 -3.252 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.213 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.453 ' O ' HG13 ' X' ' 75' ' ' ILE . 26.1 Cg_endo -64.51 -39.53 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.591 2.861 . . . . 0.0 111.974 -174.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.33 0.86 20.69 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.77 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.03 -20.97 8.01 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 119.196 -1.478 . . . . 0.0 113.027 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.453 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -63.07 -46.34 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.767 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -56.49 -46.96 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.86 177.18 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' X' ' 81' ' ' GLU . 65.7 tttm -58.88 -48.2 82.25 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.632 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -58.46 -37.73 76.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' X' ' 45' ' ' THR . 38.6 mm -68.87 -46.83 78.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.765 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -66.81 -36.37 82.21 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.578 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' X' ' 77' ' ' LYS . 47.8 mt-10 -72.42 -34.55 67.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.866 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.465 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 89.7 t90 -69.14 -46.15 68.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.57 . . . . 0.0 110.09 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -67.84 -35.99 79.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.065 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.598 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.58 81.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.762 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' X' ' 88' ' ' LYS . 25.7 t-20 -67.0 -41.25 87.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 46.77 4.58 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 106.607 -2.597 . . . . 0.0 106.607 -169.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.481 ' HB2' ' OD1' ' X' ' 86' ' ' ASN . 22.9 ttmm -121.33 135.57 25.11 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.54 114.87 2.14 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.348 2.699 . . . . 0.0 112.347 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.52 -116.14 3.78 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.805 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -86.51 155.01 20.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.9 ptmt -91.42 -175.65 4.29 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -105.87 144.18 32.97 Favored 'General case' 0 N--CA 1.399 -2.994 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.153 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.048 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.51 -0.573 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.433 HD22 HD13 ' X' ' 18' ' ' LEU . 35.3 mt -91.74 128.61 37.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 30.8 mmtt -96.92 -176.2 3.49 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.514 0.673 . . . . 0.0 111.96 -173.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.7 -36.18 11.84 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 61.6 p -135.12 166.68 22.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.323 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.83 -16.52 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.446 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -69.98 -25.66 63.72 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.573 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 16.0 t0 -94.93 -15.65 23.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -75.64 119.17 19.31 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.464 ' HA ' ' CB ' ' X' ' 92' ' ' LYS . 51.8 p -78.31 167.28 21.59 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.601 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.7 pt-20 -57.75 -41.01 81.04 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.981 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.68 -37.63 76.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.16 -37.72 83.89 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.581 -0.699 . . . . 0.0 110.264 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.533 ' HD2' HG12 ' X' ' 76' ' ' VAL . 33.5 t80 -71.81 -44.51 63.81 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.557 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.723 HG12 HG11 ' X' ' 76' ' ' VAL . 9.9 m -60.5 -35.86 65.99 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -49.78 76.33 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.231 1.012 . . . . 0.0 110.142 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.654 ' O ' HG13 ' X' ' 22' ' ' ILE . 28.4 tp -58.03 -47.16 83.94 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.584 0.707 . . . . 0.0 110.118 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.529 HD13 ' O ' ' X' ' 15' ' ' PHE . 8.1 mp -60.95 -37.0 80.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.169 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 52.9 mtmt -66.5 -35.43 80.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -65.6 -45.07 84.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.825 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.654 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.4 mt -55.92 -39.58 57.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.436 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.26 -47.33 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.087 0.47 . . . . 0.0 110.761 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.25 -51.56 43.85 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.612 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -23.25 67.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.305 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -71.6 -55.95 6.8 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.12 -20.77 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.46 -19.73 22.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.63 0.252 . . . . 0.0 110.553 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.6 64.37 1.77 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.275 1.03 . . . . 0.0 111.071 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 51.4 p -77.21 -26.23 52.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.369 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.26 22.9 t70 74.36 -68.5 0.21 Allowed 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 125.806 1.643 . . . . 0.0 115.076 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.606 ' O ' HG23 ' X' ' 36' ' ' VAL . 30.2 t70 -57.19 -55.9 28.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.093 0.86 . . . . 0.0 112.284 -174.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.811 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -78.32 -32.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.507 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.869 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.02 -45.89 89.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.3 t70 -65.01 -40.48 94.98 Favored 'General case' 0 CA--C 1.479 -1.788 0 O-C-N 123.369 0.418 . . . . 0.0 110.668 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.606 HG23 ' O ' ' X' ' 32' ' ' ASP . 98.3 t -54.62 -49.57 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.921 0 O-C-N 124.412 1.07 . . . . 0.0 109.193 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.811 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 54.9 mt -67.48 -41.05 85.2 Favored 'General case' 0 N--CA 1.405 -2.694 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.259 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.8 mt -60.57 -50.82 71.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.22 0.95 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.65 -36.66 70.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.437 ' O ' HG12 ' X' ' 44' ' ' ILE . 6.5 t60 -59.99 -46.15 90.4 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.609 ' O ' HG22 ' X' ' 45' ' ' THR . 57.4 t80 -59.94 -56.71 18.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.573 1.171 . . . . 0.0 110.948 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.438 HG12 ' O ' ' X' ' 38' ' ' LEU 0.271 8.4 p -66.62 -31.88 55.52 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.771 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -70.25 -28.33 65.16 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.811 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.437 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.7 pt -87.51 -39.0 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.653 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.609 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.77 -32.78 23.23 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.093 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.01 22.6 13.55 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.414 . . . . 0.0 112.306 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.488 ' H ' HG23 ' X' ' 45' ' ' THR . 55.3 t-80 -70.21 135.22 86.97 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.594 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.3 Cg_exo -70.22 4.52 2.34 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 123.527 2.818 . . . . 0.0 112.864 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 27.9 m-20 -136.83 27.25 2.99 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.17 -58.05 5.26 Favored Glycine 0 CA--C 1.476 -2.387 0 O-C-N 124.511 1.132 . . . . 0.0 113.199 -175.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.51 HG21 HD13 ' X' ' 38' ' ' LEU 0.276 0.0 OUTLIER -79.34 -25.61 42.25 Favored 'General case' 0 C--N 1.257 -3.427 0 C-N-CA 118.059 -1.456 . . . . 0.0 113.65 -176.813 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.16 -37.31 87.0 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 53' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 65.2 mt -64.76 -37.86 89.02 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.676 0.61 . . . . 0.0 111.249 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.429 HD13 HG21 ' X' ' 22' ' ' ILE . 25.3 mt -66.78 -46.33 85.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.735 0.779 . . . . 0.0 109.461 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.455 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.8 m-85 -63.45 -46.74 84.88 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -64.24 -40.08 95.28 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.76 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . -58.79 -51.04 71.69 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 123.116 0.26 . . . . 0.0 111.387 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.37 80.28 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.733 0.646 . . . . 0.0 111.405 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -44.04 65.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.59 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.31 -38.13 81.28 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.74 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HA2' ' X' ' 71' ' ' GLY . . . -72.08 -25.95 61.97 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 122.974 0.509 . . . . 0.0 111.808 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.02 -22.86 66.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.111 0.481 . . . . 0.0 110.878 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.21 -39.15 6.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 63.94 87.98 0.12 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.885 1.674 . . . . 0.0 113.135 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.48 -18.1 6.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.655 2.237 . . . . 0.0 111.261 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.32 169.54 41.77 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.09 83.93 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.01 138.76 42.43 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -58.51 2.72 Favored Glycine 0 C--O 1.242 0.616 0 CA-C-N 116.205 -0.452 . . . . 0.0 113.837 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.2 62.03 4.56 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' X' ' 61' ' ' ALA . . . 164.0 161.65 13.53 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.559 ' O ' HG13 ' X' ' 76' ' ' VAL . 7.9 Cg_endo -57.02 -42.01 68.84 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.632 2.888 . . . . 0.0 110.623 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.527 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.6 mt-10 -78.35 1.93 20.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.205 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.17 -34.86 2.84 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 119.021 -1.561 . . . . 0.0 112.948 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' X' ' 57' ' ' ALA . 1.1 pt -67.2 -26.18 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-N 117.503 0.652 . . . . 0.0 110.765 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.723 HG11 HG12 ' X' ' 16' ' ' VAL . 27.8 m -61.4 -34.44 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.141 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 60.6 tttm -61.79 -47.02 87.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.504 174.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.8 -43.71 90.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.567 0.699 . . . . 0.0 109.415 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.525 HG23 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -64.8 -46.54 91.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.22 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.519 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 17.4 pttp -67.44 -37.08 82.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.312 -174.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.92 -39.46 72.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.33 0.394 . . . . 0.0 111.35 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.594 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 70.4 t90 -64.79 -47.83 76.66 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.7 0.625 . . . . 0.0 109.443 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.616 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 16.2 tpt180 -61.45 -45.67 93.3 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.223 -176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.69 -38.73 84.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.232 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.9 78.5 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.903 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -69.02 -36.16 77.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.8 41.94 2.78 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.616 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 55.7 mttm -118.97 147.96 43.62 Favored Pre-proline 0 N--CA 1.396 -3.172 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.79 130.17 32.02 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.229 1.952 . . . . 0.0 111.071 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.444 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -100.09 -140.63 11.49 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.302 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.1 m-85 -78.29 150.45 33.33 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.047 0.451 . . . . 0.0 110.945 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.464 ' CB ' ' HA ' ' X' ' 11' ' ' THR . 0.7 OUTLIER -72.72 157.37 37.65 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.979 174.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -85.46 1.16 49.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.004 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.261 -3.62 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.212 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 CA--C 1.506 -0.736 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt -123.12 148.29 45.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 33.0 mmtt -108.72 160.31 16.05 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -83.0 -17.38 43.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.679 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.7 p -139.7 163.84 31.53 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.112 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.6 tp -64.92 -22.61 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.047 0.939 . . . . 0.0 110.023 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -76.32 -11.61 59.93 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.789 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 26.6 t0 -105.31 -7.17 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.882 0.849 . . . . 0.0 108.914 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -83.59 115.33 22.08 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.947 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 16.3 p -76.77 169.02 19.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.86 -33.58 73.29 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 119.676 1.125 . . . . 0.0 112.173 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -44.07 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.381 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -57.22 -41.65 79.88 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.414 0.626 . . . . 0.0 109.949 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.3 t80 -65.75 -55.55 16.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HB2' ' X' ' 19' ' ' LEU . 14.7 p -63.63 -27.79 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -60.77 -47.38 86.57 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.473 HD21 HD22 ' X' ' 37' ' ' LEU . 2.3 tm? -62.61 -40.79 98.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.123 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 21.9 mt -57.78 -43.8 85.81 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.787 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -61.32 -38.74 87.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.45 -31.64 70.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.594 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.457 HG13 ' O ' ' X' ' 18' ' ' LEU . 35.1 mt -66.68 -46.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -57.72 -34.53 69.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.807 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.28 -40.69 96.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.42 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -88.57 -30.27 19.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.735 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -50.38 -47.61 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.81 1.244 . . . . 0.0 111.706 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -69.95 -17.14 20.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -105.52 -19.54 13.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.635 0.255 . . . . 0.0 110.565 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.52 87.64 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.436 1.495 . . . . 0.0 110.73 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.2 p -95.26 -164.62 1.18 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.48 -42.33 0.7 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.417 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.695 ' O ' HG23 ' X' ' 36' ' ' VAL . 13.8 t70 -71.1 -62.02 1.55 Allowed 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.527 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.673 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.3 p -75.8 -27.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.228 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.514 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.8 tm? -57.64 -52.84 63.77 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 124.258 1.023 . . . . 0.0 108.565 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.63 -25.51 60.34 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.294 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.695 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.3 t -68.5 -50.74 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.037 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.623 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.1 mt -68.87 -43.36 75.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 O-C-N 124.744 1.278 . . . . 0.0 111.36 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.6 mt -61.14 -44.83 96.72 Favored 'General case' 0 N--CA 1.415 -2.191 0 O-C-N 124.274 0.984 . . . . 0.0 112.054 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -71.05 -42.95 68.79 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.782 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.521 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 26.5 t60 -60.22 -45.92 91.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.47 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' X' ' 54' ' ' ILE . 34.2 t80 -62.77 -48.36 79.51 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.419 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.1 p -67.52 -31.23 51.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 52.2 pttt -73.11 -35.08 66.5 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.599 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 21.7 pt -79.03 -32.46 15.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -83.55 -33.9 25.35 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.843 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.9 28.27 17.24 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.091 0.948 . . . . 0.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.499 ' ND1' ' HB2' ' X' ' 49' ' ' ASP . 54.8 t-80 -85.89 145.82 42.01 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.516 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.572 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.5 Cg_exo -77.48 12.97 1.71 Allowed 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.342 2.694 . . . . 0.0 112.643 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.499 ' HB2' ' ND1' ' X' ' 47' ' ' HIS . 0.8 OUTLIER -123.86 -64.38 1.15 Allowed 'General case' 0 N--CA 1.404 -2.743 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.539 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . 58.42 -84.33 0.01 OUTLIER Glycine 1 CA--C 1.428 -5.361 0 O-C-N 125.337 1.648 . . . . 0.0 111.997 177.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.42 HG23 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.4 -37.27 74.45 Favored 'General case' 1 C--N 1.211 -5.44 0 CA-C-N 112.698 -1.751 . . . . 0.0 109.239 -172.138 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.07 -31.08 70.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.071 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.36 -42.19 96.32 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.423 0.452 . . . . 0.0 111.82 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' X' ' 41' ' ' PHE . 5.0 mp -67.27 -42.0 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.096 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -61.88 -41.86 98.38 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.81 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.8 pt-20 -71.74 -37.12 70.61 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.876 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.23 77.62 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 122.943 0.497 . . . . 0.0 111.281 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 58' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' X' ' 61' ' ' ALA . . . -62.16 -37.81 86.64 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.332 0.395 . . . . 0.0 111.333 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.19 62.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.797 0.808 . . . . 0.0 109.641 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -61.0 -27.96 68.69 Favored 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.853 1.261 . . . . 0.0 110.404 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' X' ' 58' ' ' ALA . . . -66.25 -48.12 71.52 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.308 0.643 . . . . 0.0 110.74 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.13 -50.09 62.61 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.673 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.05 71.35 1.12 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' X' ' 65' ' ' PRO . 7.6 p30 -83.42 121.35 76.63 Favored Pre-proline 0 CA--C 1.486 -1.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.979 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 65' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' X' ' 64' ' ' ASN . 4.6 Cg_exo -78.61 -66.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.724 0 C-N-CA 120.911 1.074 . . . . 0.0 111.179 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.45 -138.89 3.76 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.46 60.44 4.29 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -148.19 -31.11 0.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 124.357 1.063 . . . . 0.0 108.64 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.41 -129.82 6.79 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.0 -26.28 7.84 Favored Glycine 0 C--N 1.306 -1.135 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.257 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.2 -102.36 1.06 Allowed Glycine 0 N--CA 1.41 -3.048 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.588 ' HA ' HD11 ' X' ' 75' ' ' ILE . 20.3 Cg_endo -63.93 -30.92 67.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.026 2.484 . . . . 0.0 112.379 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.89 -11.65 59.91 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 74' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -99.8 -29.08 7.08 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 118.2 -1.952 . . . . 0.0 113.063 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.0 OUTLIER -60.52 -44.02 95.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.474 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 1.7 p -63.13 -43.68 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.996 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 85.9 tttt -61.71 -44.78 96.27 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 78' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 13.5 mm-40 -59.35 -45.13 92.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.481 0.658 . . . . 0.0 110.504 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.568 HG12 ' O ' ' X' ' 75' ' ' ILE . 48.2 mm -61.86 -45.33 98.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.972 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.2 ptmt -63.06 -38.07 89.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.347 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -71.7 -43.81 65.29 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.479 0.487 . . . . 0.0 111.847 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.572 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.3 t90 -63.98 -48.15 77.58 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.457 0.646 . . . . 0.0 110.916 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' CA ' ' X' ' 90' ' ' GLY . 12.0 tpt180 -60.9 -45.14 95.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.696 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.33 -38.18 81.29 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.199 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.62 88.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.132 0.492 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.466 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.5 t-20 -74.51 -42.2 59.34 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.91 31.77 3.77 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.466 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 63.7 mttm -102.35 146.66 32.74 Favored Pre-proline 0 N--CA 1.405 -2.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.44 126.62 17.28 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.046 1.831 . . . . 0.0 109.701 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' X' ' 83' ' ' ARG . . . -110.88 -119.8 3.99 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.506 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.69 149.32 29.79 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.383 1.087 . . . . 0.0 113.422 -171.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' X' ' 11' ' ' THR . 28.3 ttpt -88.19 172.81 9.2 Favored 'General case' 1 N--CA 1.365 -4.716 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.148 174.498 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.06 27.67 1.04 Allowed 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 121.317 0.58 . . . . 0.0 112.198 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 94' ' ' GLY . . . . . 0.421 ' OXT' ' HE3' ' X' ' 92' ' ' LYS . . . . . . . . 0 C--N 1.277 -2.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.383 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' X' ' 18' ' ' LEU . 37.2 mt -91.87 132.19 36.65 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.632 0.729 . . . . 0.0 111.877 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 39.4 mmtt -100.59 -161.47 0.87 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.106 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -117.82 -28.63 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.963 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -136.09 167.03 22.0 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.96 -11.37 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.681 0.753 . . . . 0.0 110.316 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 8' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 8.2 m -70.1 -26.74 64.12 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.89 0.876 . . . . 0.0 111.294 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.516 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 10.2 t70 -105.01 5.74 32.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.652 0.739 . . . . 0.0 109.677 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 12.3 m-85 -95.87 124.98 40.11 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.646 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 45.4 p -89.4 171.67 9.57 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.626 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.5 -45.72 80.89 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.131 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.74 -38.46 73.52 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.84 -34.46 77.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.402 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.451 ' CD2' HG12 ' X' ' 76' ' ' VAL . 62.0 t80 -71.48 -43.06 67.27 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.723 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.67 HG12 HG11 ' X' ' 76' ' ' VAL . 5.9 m -62.64 -29.94 48.11 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.468 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -61.74 -45.98 91.61 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.285 0.634 . . . . 0.0 109.865 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.614 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.7 tp -61.95 -48.19 81.51 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.625 HD13 HD12 ' X' ' 22' ' ' ILE . 4.3 mm? -60.46 -36.31 77.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.329 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 64.4 mttm -68.49 -36.93 79.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.85 -35.55 78.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.358 0.599 . . . . 0.0 110.104 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' X' ' 37' ' ' LEU . 67.7 mt -63.06 -46.28 96.57 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.38 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.727 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -57.82 -45.5 86.06 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 109.802 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.28 -51.85 67.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.126 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.701 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 6.2 mm-40 -82.47 -14.67 54.67 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -69.85 -47.17 63.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 120.835 0.35 . . . . 0.0 110.191 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.4 -19.75 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.39 -18.67 25.05 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.969 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.37 72.76 0.38 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.146 1.378 . . . . 0.0 111.837 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 57.2 p -93.84 -168.4 1.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -134.84 -55.7 0.82 Allowed 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.894 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.542 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.0 p-10 -57.53 -48.08 80.25 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.8 p -87.92 -32.9 6.27 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.608 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.22 -44.56 92.29 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.713 0.805 . . . . 0.0 109.487 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.92 -32.38 69.29 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.924 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.542 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.4 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.142 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 66.2 mt -68.37 -43.03 78.26 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.707 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 15.9 mt -60.22 -45.08 94.45 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 124.265 0.978 . . . . 0.0 110.325 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -70.39 -38.75 74.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.985 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.6 t60 -64.41 -45.15 88.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.454 0.645 . . . . 0.0 109.627 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.588 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.7 t80 -59.04 -51.13 71.36 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -67.98 -33.03 58.84 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.869 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.1 ptmt -68.96 -36.12 77.53 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.039 0.447 . . . . 0.0 111.687 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.455 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.7 pt -79.17 -33.29 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.106 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -84.66 -39.69 18.3 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.317 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 63.8 31.77 13.92 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.694 1.198 . . . . 0.0 109.991 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -80.38 135.34 53.81 Favored Pre-proline 0 N--CA 1.424 -1.77 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.117 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.0 Cg_exo -76.62 9.68 2.51 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 C-N-CA 123.367 2.711 . . . . 0.0 111.904 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -140.8 19.14 2.33 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.588 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.88 -69.01 0.68 Allowed Glycine 0 CA--C 1.46 -3.4 0 O-C-N 124.38 1.05 . . . . 0.0 114.512 -173.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.445 HG21 HD13 ' X' ' 38' ' ' LEU . 0.6 OUTLIER -74.38 -18.84 60.61 Favored 'General case' 0 C--N 1.253 -3.593 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.026 -173.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -71.32 -34.19 70.35 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.58 -37.9 88.02 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.621 0.576 . . . . 0.0 110.645 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.435 HD13 HG21 ' X' ' 22' ' ' ILE . 49.2 mt -66.94 -47.07 83.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.863 0.839 . . . . 0.0 109.092 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.05 -47.96 80.74 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.07 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.0 pt-20 -65.71 -36.64 84.18 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.217 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.08 83.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.181 0.446 . . . . 0.0 110.947 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.89 99.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 110.877 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.58 -43.71 63.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.36 -40.56 96.81 Favored 'General case' 0 C--O 1.2 -1.529 0 C-N-CA 123.224 0.61 . . . . 0.0 110.477 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.19 69.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -37.9 85.52 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.11 11.29 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.111 0.481 . . . . 0.0 109.934 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 60.58 89.41 0.11 Allowed Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 126.547 1.939 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.51 97.61 0.45 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.773 2.315 . . . . 0.0 111.249 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.5 -93.26 0.36 Allowed Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -157.9 20.5 0.37 Allowed Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -120.58 131.67 54.76 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.212 0.529 . . . . 0.0 110.801 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 6.52 89.28 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.497 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.57 62.16 0.38 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.38 166.47 12.16 Favored Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.724 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.638 ' HA ' HD11 ' X' ' 75' ' ' ILE . 15.9 Cg_endo -57.02 -34.51 97.79 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 124.157 3.238 . . . . 0.0 113.664 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.488 ' C ' HG22 ' X' ' 76' ' ' VAL . 41.5 mt-10 -82.73 2.11 35.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.912 0.386 . . . . 0.0 112.024 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.59 -27.76 6.62 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.268 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.0 OUTLIER -66.23 -34.05 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.67 HG11 HG12 ' X' ' 16' ' ' VAL . 29.2 m -64.7 -34.79 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.254 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.951 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 41.7 ttmt -64.79 -43.6 92.68 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 78' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 7.6 mm-40 -57.79 -45.09 86.54 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.978 0.894 . . . . 0.0 109.084 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 22.6 mm -62.34 -46.62 95.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.787 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -67.17 -35.64 80.09 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.69 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -69.26 -32.04 70.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.553 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.9 t90 -70.08 -48.58 57.13 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.122 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.438 ' HE ' ' HB2' ' X' ' 83' ' ' ARG . 0.0 OUTLIER -65.95 -37.2 85.41 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.591 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.77 90.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.785 0.678 . . . . 0.0 111.652 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.76 -44.88 39.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.95 0.405 . . . . 0.0 110.695 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.5 -33.93 73.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.208 0.528 . . . . 0.0 110.665 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.65 30.86 6.3 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -103.48 163.35 17.61 Favored Pre-proline 0 N--CA 1.405 -2.689 0 C-N-CA 124.042 0.937 . . . . 0.0 109.651 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 89' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 36.3 Cg_exo -62.47 131.05 32.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.913 2.409 . . . . 0.0 113.07 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.86 -150.56 24.4 Favored Glycine 0 N--CA 1.429 -1.815 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.529 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -85.42 150.02 25.01 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' X' ' 8' ' ' SER . 20.0 ptmt -77.89 165.14 24.49 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.32 133.02 36.24 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.256 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.604 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 CA--C 1.506 -0.726 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.494 ' CD2' HD13 ' X' ' 18' ' ' LEU . 31.9 mt -91.99 129.81 37.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.073 0.464 . . . . 0.0 110.443 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -96.37 -162.34 0.95 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.05 -24.49 8.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.358 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 6' ' ' SER . . . . . 0.429 ' HA ' HG22 ' X' ' 44' ' ' ILE . 84.7 p -134.61 166.81 22.05 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -65.33 -15.18 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.381 0.672 . . . . 0.0 110.725 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 8' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 16.6 t -76.53 -20.64 56.69 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.882 -170.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 6.87 37.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 118.297 -1.361 . . . . 0.0 109.673 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.21 122.63 34.0 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.105 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.0 p -82.87 167.73 17.77 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.632 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.42 -42.92 92.94 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.189 -1.404 . . . . 0.0 111.85 176.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.602 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -67.34 -38.76 85.37 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -59.13 -39.13 81.38 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.643 0.735 . . . . 0.0 110.1 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.681 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -74.78 -42.15 58.7 Favored 'General case' 0 N--CA 1.407 -2.581 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.017 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.779 HG12 HG11 ' X' ' 76' ' ' VAL . 8.9 m -62.62 -32.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.41 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -62.33 -43.98 97.56 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.64 ' O ' HG13 ' X' ' 22' ' ' ILE . 36.8 tp -61.71 -46.54 89.25 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-O 121.253 0.549 . . . . 0.0 109.974 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -57.32 -41.93 80.88 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.765 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.4 mttm -64.28 -41.97 96.65 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.22 0.534 . . . . 0.0 109.648 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.21 -38.1 87.16 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.042 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.64 HG13 ' O ' ' X' ' 18' ' ' LEU . 47.4 mt -60.15 -46.06 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.348 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.27 -43.58 88.03 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.365 0.602 . . . . 0.0 110.23 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 24' ' ' LYS . . . . . 0.509 ' HG3' ' OE2' ' X' ' 25' ' ' GLU . 26.1 tptp -59.5 -50.42 73.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.846 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.509 ' OE2' ' HG3' ' X' ' 24' ' ' LYS . 16.0 mm-40 -86.15 -5.61 59.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.339 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -79.23 -44.89 20.9 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.53 -32.39 52.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.256 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -19.67 42.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.752 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.83 80.87 0.19 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.343 1.457 . . . . 0.0 112.911 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 77.0 p -106.77 -169.49 1.56 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.47 -26.33 0.76 Allowed 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.098 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.509 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.6 m-20 -67.28 -57.9 5.81 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.621 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.53 -31.12 7.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.132 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.9 tm? -59.48 -46.03 89.97 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.974 -175.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -32.34 72.98 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.206 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.509 HG23 ' O ' ' X' ' 32' ' ' ASP . 38.3 t -66.33 -49.27 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.574 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 58.0 mt -66.73 -42.65 85.95 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.0 -170.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.3 mt -59.42 -47.84 83.93 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.541 1.151 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.42 -42.55 71.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.549 ' O ' HG12 ' X' ' 44' ' ' ILE . 22.8 t60 -59.46 -45.55 91.3 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.506 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.595 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.12 -55.12 37.84 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.879 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.502 HG12 ' O ' ' X' ' 38' ' ' LEU . 8.3 p -66.76 -31.81 55.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.3 pttp -71.27 -34.32 70.58 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.769 -0.582 . . . . 0.0 111.781 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.549 HG12 ' O ' ' X' ' 40' ' ' HIS . 23.7 pt -88.48 -29.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.511 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.528 ' HB ' HD12 ' X' ' 79' ' ' ILE . 70.1 p -84.46 -37.77 20.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.544 0.688 . . . . 0.0 109.494 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 69.04 21.56 7.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.249 1.82 . . . . 0.0 112.076 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.455 ' O ' HG23 ' X' ' 42' ' ' VAL . 48.7 t-80 -72.23 132.96 83.76 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 31.5 Cg_exo -66.74 -21.3 51.56 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.149 2.566 . . . . 0.0 112.146 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -122.44 35.69 4.82 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.595 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.12 -55.3 8.79 Favored Glycine 1 CA--C 1.448 -4.124 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.585 -178.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.496 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.24 -34.51 68.34 Favored 'General case' 0 C--N 1.255 -3.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.208 -173.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.56 -29.37 70.64 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.653 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 53' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 53' ' ' LEU . 26.4 mt -61.42 -42.68 99.13 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 175.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.582 HD13 HG21 ' X' ' 22' ' ' ILE . 10.5 mt -66.59 -42.54 90.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -63.02 -44.67 95.3 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.802 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.9 pt-20 -69.8 -39.3 76.63 Favored 'General case' 0 C--O 1.201 -1.48 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.635 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.51 83.8 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 122.26 0.224 . . . . 0.0 111.279 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.28 -48.05 81.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.756 0.66 . . . . 0.0 110.428 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.95 87.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.293 0.568 . . . . 0.0 110.453 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -63.6 -33.24 75.18 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.143 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.497 ' HB2' ' H ' ' X' ' 71' ' ' GLY . . . -79.39 -30.15 42.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.732 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.06 -39.51 82.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.387 0.613 . . . . 0.0 109.8 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.11 3.46 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 58.26 86.74 0.15 Allowed Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 126.213 1.805 . . . . 0.0 113.055 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.29 -37.97 28.9 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 122.265 1.977 . . . . 0.0 110.118 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.68 175.65 14.2 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.83 -95.99 0.93 Allowed Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.015 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -129.26 16.98 6.06 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 80.37 1.14 Allowed Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 114.807 -1.088 . . . . 0.0 114.079 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.72 -172.61 18.51 Favored Glycine 0 N--CA 1.428 -1.897 0 O-C-N 124.015 0.48 . . . . 0.0 112.391 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.497 ' H ' ' HB2' ' X' ' 61' ' ' ALA . . . 90.25 160.64 36.72 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 124.257 0.622 . . . . 0.0 112.637 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.511 ' O ' HG13 ' X' ' 75' ' ' ILE . 29.1 Cg_endo -61.8 -37.5 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.254 2.636 . . . . 0.0 110.992 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.14 0.69 18.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.764 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.27 -8.87 26.59 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.008 174.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.511 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -73.82 -45.43 49.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.779 HG11 HG12 ' X' ' 16' ' ' VAL . 1.2 p -57.71 -42.16 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.966 175.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttp -58.52 -47.86 82.77 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.747 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.4 -39.12 89.58 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.528 HD12 ' HB ' ' X' ' 45' ' ' THR . 41.8 mm -67.86 -46.34 82.37 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.832 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.6 pttp -63.72 -36.29 83.39 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.384 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.85 -38.82 70.04 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.874 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.515 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 66.7 t90 -69.75 -47.79 61.69 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.016 0.436 . . . . 0.0 110.025 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.584 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 14.5 tpt180 -60.35 -45.52 93.2 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.0 89.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.704 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.28 92.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.163 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -64.67 -32.56 74.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.78 4.84 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.584 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 64.5 mttm -112.83 144.58 31.3 Favored Pre-proline 0 N--CA 1.388 -3.542 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -64.22 139.3 65.52 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.093 1.862 . . . . 0.0 109.31 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -109.38 -125.23 5.03 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.31 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.428 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 76.9 m-85 -82.86 152.53 25.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.665 -0.768 . . . . 0.0 111.2 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' X' ' 8' ' ' SER . 19.8 ptmt -83.59 -179.27 7.29 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.49 140.07 30.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.884 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.406 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 71.2 mt -91.32 128.29 37.08 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -97.83 -174.7 2.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.87 -9.17 14.07 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.237 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -144.47 164.89 29.52 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -70.79 -8.7 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.444 0.64 . . . . 0.0 110.688 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -76.81 -25.82 53.71 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.02 -11.94 21.04 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.406 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 8.7 m-85 -72.99 118.11 15.53 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.31 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.459 HG22 ' HG2' ' X' ' 92' ' ' LYS . 76.0 p -78.4 162.0 26.73 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 169.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.654 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.05 -45.28 79.27 Favored 'General case' 0 C--N 1.28 -2.42 0 O-C-N 123.571 0.544 . . . . 0.0 111.015 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.49 -38.23 77.58 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -57.44 -37.5 72.92 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 118.436 0.562 . . . . 0.0 110.107 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.736 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 5.7 t80 -80.0 -45.38 18.51 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.751 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.695 HG12 HG21 ' X' ' 76' ' ' VAL . 11.7 m -58.82 -31.78 45.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.043 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.86 -47.19 78.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.939 0.896 . . . . 0.0 109.79 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.495 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -62.75 -41.77 99.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.01 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -61.34 -37.77 84.5 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.519 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 56.6 mttp -64.47 -36.0 82.77 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.439 0.638 . . . . 0.0 109.578 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.74 -32.82 73.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.905 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.573 HG12 HD13 ' X' ' 37' ' ' LEU . 34.1 mt -64.92 -41.49 92.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -57.49 -46.14 84.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.786 0.803 . . . . 0.0 108.841 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -60.06 -45.36 93.13 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.929 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.594 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -85.24 -29.61 24.5 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.178 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.67 -34.88 79.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.781 0.324 . . . . 0.0 111.359 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.7 m -77.27 -12.59 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.07 -22.68 16.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.56 85.72 0.14 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.127 1.771 . . . . 0.0 112.043 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -106.1 172.26 6.9 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -135.91 8.67 3.27 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.642 170.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.467 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 m-20 -91.16 -70.66 0.67 Allowed 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.706 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.7 p -74.66 -30.69 25.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.978 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.594 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 3.0 tm? -58.3 -46.03 86.87 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.13 -32.8 74.18 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.282 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.467 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.9 t -64.8 -50.12 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 68.6 mt -68.66 -41.77 78.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.858 -171.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 7.0 mt -61.17 -46.64 89.66 Favored 'General case' 0 N--CA 1.418 -2.063 0 O-C-N 124.102 0.876 . . . . 0.0 110.915 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.18 -42.35 72.55 Favored 'General case' 0 N--CA 1.433 -1.283 0 O-C-N 123.418 0.449 . . . . 0.0 110.884 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.469 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 25.3 t60 -59.57 -45.34 92.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 123.68 0.792 . . . . 0.0 110.595 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.405 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 34.2 t80 -61.02 -55.32 34.23 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.156 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.46 HG23 ' HA3' ' X' ' 50' ' ' GLY . 12.3 p -67.3 -31.65 53.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 0.0 OUTLIER -69.68 -39.26 77.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 122.232 -0.293 . . . . 0.0 111.772 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.616 HD11 ' CE1' ' X' ' 15' ' ' PHE . 49.9 pt -80.97 -30.63 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.941 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -85.02 -35.09 22.16 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.76 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 61.76 28.15 17.28 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.409 ' HA ' ' HD3' ' X' ' 48' ' ' PRO . 37.4 t-80 -77.18 139.53 64.96 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.435 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 20.3 Cg_exo -70.41 -19.3 33.2 Favored 'Trans proline' 0 CA--C 1.495 -1.432 0 C-N-CA 123.087 2.525 . . . . 0.0 112.488 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 14.4 m-20 -127.23 40.98 3.61 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.46 ' HA3' HG23 ' X' ' 42' ' ' VAL . . . -51.22 -51.77 34.69 Favored Glycine 0 CA--C 1.466 -2.976 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.978 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 51' ' ' THR . . . . . . . . . . . . 0.35 0.6 OUTLIER -80.99 -25.06 37.54 Favored 'General case' 0 C--N 1.256 -3.497 0 C-N-CA 117.48 -1.688 . . . . 0.0 114.165 -174.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' X' ' 49' ' ' ASP . . . -61.2 -41.12 96.26 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.12 -46.52 88.12 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.292 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 31.1 mt -67.07 -47.54 81.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 CA-C-O 121.344 0.592 . . . . 0.0 110.736 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -59.8 -49.06 79.2 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.359 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.35 -40.7 96.38 Favored 'General case' 0 C--O 1.174 -2.917 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.769 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 57' ' ' ALA . . . . . 0.454 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . -57.54 -47.96 80.62 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 118.412 0.551 . . . . 0.0 111.296 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.6 85.44 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.651 0.594 . . . . 0.0 110.823 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.7 -43.54 62.91 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.997 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 97.5 mtt180 -66.01 -31.77 72.85 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.099 0.959 . . . . 0.0 111.454 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.46 27.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.098 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.3 27.49 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.243 0.544 . . . . 0.0 110.909 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 63' ' ' ALA . . . . . 0.461 ' O ' ' HD3' ' X' ' 65' ' ' PRO . . . -109.75 79.57 1.23 Allowed 'General case' 0 CA--C 1.477 -1.863 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 173.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 27.2 t-20 -81.37 112.93 37.66 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.364 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 65' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' X' ' 63' ' ' ALA . 66.5 Cg_endo -96.04 10.83 1.42 Allowed 'Trans proline' 0 N--CA 1.437 -1.825 0 C-N-CA 122.35 2.033 . . . . 0.0 110.165 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 143.28 14.62 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.07 -176.44 48.02 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 118.489 -1.815 . . . . 0.0 114.032 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -110.7 -33.94 6.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.045 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -122.9 57.92 0.63 Allowed Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.64 67.72 0.22 Allowed Glycine 0 N--CA 1.415 -2.731 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.44 16.52 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.42 -24.63 56.87 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.196 3.264 . . . . 0.0 113.316 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.406 ' HA ' ' CG2' ' X' ' 76' ' ' VAL . 33.5 mt-10 -96.32 1.41 51.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.026 0.441 . . . . 0.0 109.937 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -103.34 -31.65 4.88 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.602 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.522 ' CD1' HD13 ' X' ' 19' ' ' LEU . 5.3 pt -65.43 -32.55 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 O-C-N 122.277 -0.543 . . . . 0.0 111.616 175.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.695 HG21 HG12 ' X' ' 16' ' ' VAL . 0.2 OUTLIER -65.56 -32.23 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.469 176.095 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 59.6 tttm -66.7 -45.67 78.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.84 -44.76 86.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.376 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.45 -46.81 88.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.079 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -69.39 -36.29 76.64 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.472 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.5 mt-10 -71.37 -37.21 71.65 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.481 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.8 t90 -66.55 -47.25 73.43 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.923 0.868 . . . . 0.0 109.719 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -61.28 -46.1 91.73 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.771 -176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.2 81.64 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.79 -45.62 93.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.954 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.403 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 23.5 t-20 -69.25 -39.0 78.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.2 37.68 2.63 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 67.7 mttm -109.18 147.16 35.39 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.55 131.36 37.67 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.527 2.151 . . . . 0.0 111.785 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.35 -144.14 15.37 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.182 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -78.17 145.82 35.4 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 111.33 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' X' ' 11' ' ' THR . 5.3 tttt -86.28 163.03 17.96 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 93' ' ' GLN . . . . . 0.439 ' N ' ' HG3' ' X' ' 92' ' ' LYS 0.251 83.1 mt-30 -88.87 131.01 35.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.633 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.925 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 174.809 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' X' ' 40' ' ' HIS . 66.5 mt -100.27 138.78 36.87 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.979 0.419 . . . . 0.0 110.906 -178.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 46.3 mmtt -102.08 -159.16 0.71 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -116.33 -28.49 6.49 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.703 0.763 . . . . 0.0 109.499 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 65.0 p -132.74 166.83 21.31 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.652 177.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.594 HD11 ' CE1' ' X' ' 91' ' ' PHE . 10.9 tp -70.81 -15.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.533 0.683 . . . . 0.0 110.68 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -77.74 -9.0 58.77 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.425 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -109.27 3.67 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.243 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 6.7 m-85 -94.8 115.51 27.59 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.646 -174.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 76.1 p -76.06 156.86 33.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 167.168 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.67 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.7 pt-20 -60.84 -30.61 70.21 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.88 73.78 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.113 0.415 . . . . 0.0 111.382 175.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.449 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 10.1 mm-40 -57.46 -39.02 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.624 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.4 t80 -71.54 -49.01 44.88 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.584 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.842 HG12 HG11 ' X' ' 76' ' ' VAL . 5.0 m -62.6 -30.04 48.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.731 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' X' ' 21' ' ' GLU . 6.6 tt0 -63.0 -49.01 76.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.585 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.1 tm? -58.75 -44.71 90.62 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.56 177.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.673 HD13 HG13 ' X' ' 75' ' ' ILE . 33.0 mt -58.12 -42.21 85.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.163 176.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.6 mttm -67.78 -35.04 77.96 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.172 176.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' X' ' 17' ' ' GLN . 45.3 mt-10 -67.24 -37.68 83.95 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.681 176.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.585 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.6 mt -62.13 -43.72 98.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 0.9 OUTLIER -58.06 -47.68 82.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.621 1.168 . . . . 0.0 109.883 176.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.61 -52.04 59.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.427 -176.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.03 -25.95 64.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -70.94 -50.35 35.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.51 177.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.45 -11.68 13.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.14 -19.12 21.08 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 76.42 0.28 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.878 1.271 . . . . 0.0 111.275 -176.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -95.79 -25.67 15.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.168 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 66.41 -64.46 0.22 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 126.19 1.796 . . . . 0.0 114.721 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.501 ' O ' HG23 ' X' ' 36' ' ' VAL . 8.1 p-10 -63.97 -48.57 75.95 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.761 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -83.13 -29.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.838 -177.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -41.84 90.14 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.692 175.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.61 -36.19 82.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.501 HG23 ' O ' ' X' ' 32' ' ' ASP . 99.3 t -57.57 -48.42 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.965 0 O-C-N 123.835 0.709 . . . . 0.0 109.218 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 43.9 mt -68.07 -43.12 79.3 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.447 -174.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.535 ' HB3' HG21 ' X' ' 51' ' ' THR . 17.8 mt -58.89 -49.5 77.55 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 124.11 0.881 . . . . 0.0 111.173 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -68.47 -39.06 81.55 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.231 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.59 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 46.3 t60 -65.98 -45.26 82.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.094 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.577 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.5 t80 -55.29 -52.1 64.53 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.886 177.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.9 -32.83 58.09 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 21.0 ptmt -71.33 -33.22 69.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.934 -0.479 . . . . 0.0 112.118 -178.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.582 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.3 pt -83.08 -34.58 11.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.283 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 66.7 p -84.32 -38.73 20.02 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 63.97 27.23 14.29 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 109.983 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' X' ' 49' ' ' ASP . 37.4 t-80 -70.75 136.36 85.56 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 113.762 -1.563 . . . . 0.0 106.82 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.423 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 8.8 Cg_exo -76.73 6.03 4.42 Favored 'Trans proline' 0 CA--C 1.482 -2.088 0 C-N-CA 122.89 2.394 . . . . 0.0 112.686 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.487 ' CG ' ' HB3' ' X' ' 52' ' ' ALA . 24.9 t70 -144.76 32.21 1.15 Allowed 'General case' 0 N--CA 1.39 -3.448 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 -173.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.577 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.48 -62.53 3.93 Favored Glycine 1 CA--C 1.449 -4.036 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.43 -176.922 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.535 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.437 1.6 p -82.72 -13.33 56.54 Favored 'General case' 0 N--CA 1.386 -3.664 0 C-N-CA 116.46 -2.096 . . . . 0.0 115.267 -177.649 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.651 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -72.09 -29.87 64.54 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 117.863 -1.535 . . . . 0.0 108.814 174.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -60.55 -43.52 97.12 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.599 0.562 . . . . 0.0 110.961 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.48 -47.18 81.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.139 0.971 . . . . 0.0 109.672 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -63.57 -44.33 94.41 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.897 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -67.82 -35.77 79.21 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.38 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.27 -42.34 81.46 Favored 'General case' 0 CA--C 1.5 -0.973 0 O-C-N 123.059 0.224 . . . . 0.0 111.093 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.49 93.93 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.74 0.65 . . . . 0.0 110.667 178.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.8 75.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.553 0.692 . . . . 0.0 110.802 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -64.27 -37.3 87.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.948 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.04 61.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.937 0.495 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.31 77.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.157 0.503 . . . . 0.0 109.934 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.78 8.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.233 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 63.65 92.46 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 113.05 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.75 177.59 8.23 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.653 2.235 . . . . 0.0 110.385 173.034 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.67 175.45 52.1 Favored Glycine 0 CA--C 1.497 -1.047 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.756 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.26 -131.09 19.64 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.22 85.26 6.89 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.43 176.19 48.1 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.474 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.59 136.45 39.01 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.44 171.53 29.8 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.404 ' O ' HG12 ' X' ' 75' ' ' ILE . 14.8 Cg_endo -58.98 -48.43 14.36 Favored 'Trans proline' 0 C--O 1.207 -1.052 0 C-N-CA 124.071 3.181 . . . . 0.0 113.57 -176.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.93 0.57 17.91 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.985 -0.447 . . . . 0.0 112.183 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 74' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.56 -23.9 5.51 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.776 175.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.673 HG13 HD13 ' X' ' 19' ' ' LEU . 4.1 pt -69.92 -31.91 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 122.09 -0.653 . . . . 0.0 110.313 176.519 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.842 HG11 HG12 ' X' ' 16' ' ' VAL . 0.5 OUTLIER -61.7 -41.81 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-O 122.257 1.027 . . . . 0.0 110.737 173.852 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' X' ' 74' ' ' GLY . 53.1 tttm -58.4 -42.29 86.83 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.228 176.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.07 -33.54 76.28 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.629 0.728 . . . . 0.0 109.566 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.421 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.9 mm -70.69 -45.94 71.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.144 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -62.5 -36.44 82.55 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.032 -177.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.56 -44.2 78.8 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.354 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 90.4 t90 -66.8 -48.86 67.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -176.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -71.44 -39.62 70.89 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.558 -174.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.16 -43.37 78.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.862 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -69.45 -30.38 68.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.97 29.53 7.19 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -117.08 141.08 27.87 Favored Pre-proline 0 N--CA 1.393 -3.296 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.53 118.77 5.25 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.476 2.784 . . . . 0.0 112.022 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.16 -124.63 4.33 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.6 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.594 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.0 m-85 -85.88 159.02 19.8 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.081 -178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -89.71 172.95 8.56 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -120.82 134.28 55.29 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.248 0.547 . . . . 0.0 111.862 -175.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.317 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 177.879 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.434 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 26.6 mt -92.28 128.67 38.21 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.063 0.459 . . . . 0.0 111.029 -175.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.424 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 36.7 mmtt -98.3 -159.57 0.75 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -113.03 -30.88 6.85 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.722 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.1 p -126.2 166.19 17.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' X' ' 91' ' ' PHE . 7.0 tp -69.21 -18.72 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.781 0.801 . . . . 0.0 109.763 -177.094 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -75.09 -17.75 60.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.364 -172.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.424 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 36.3 t0 -102.73 5.21 38.76 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 122.255 1.026 . . . . 0.0 108.919 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.434 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 9.3 m-85 -96.46 125.11 40.72 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.632 -176.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 67.9 p -88.08 172.53 9.46 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.657 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -62.02 -41.4 98.04 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.669 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.75 -37.86 76.59 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.445 ' HB2' ' H ' ' X' ' 11' ' ' THR . 43.5 mm-40 -60.85 -40.19 91.96 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.287 0.565 . . . . 0.0 109.69 174.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 26.7 t80 -71.74 -45.4 61.86 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.208 -178.482 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.669 HG22 ' HA ' ' X' ' 13' ' ' ALA . 13.6 m -61.88 -28.86 45.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.61 -46.78 86.71 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.623 ' O ' HG13 ' X' ' 22' ' ' ILE . 35.1 tp -60.86 -45.68 93.57 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.587 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 42.1 mt -57.67 -39.54 77.34 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 82.6 mttt -71.68 -38.7 70.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.101 176.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 21' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 73.7 mm-40 -60.72 -44.74 96.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.625 176.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.623 HG13 ' O ' ' X' ' 18' ' ' LEU . 48.1 mt -57.83 -46.1 87.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 O-C-N 123.967 0.792 . . . . 0.0 111.328 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.479 ' O ' HG22 ' X' ' 27' ' ' VAL . 44.5 mt-10 -57.61 -47.88 80.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.387 0.613 . . . . 0.0 110.894 -176.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -60.61 -43.03 97.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.766 -174.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.432 ' HB2' ' CG2' ' X' ' 30' ' ' THR . 3.0 pp20? -89.02 -34.04 16.95 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.566 -177.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 26' ' ' ASN . . . . . 0.517 ' HA ' HD23 ' X' ' 34' ' ' LEU . 39.2 t30 -60.04 -46.7 88.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.747 0.419 . . . . 0.0 111.798 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 27' ' ' VAL . . . . . 0.479 HG22 ' O ' ' X' ' 23' ' ' GLU . 31.2 m -79.55 0.6 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.164 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.37 0.19 12.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.239 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 44.95 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.067 1.747 . . . . 0.0 113.537 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 74.1 p -98.41 -24.38 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.493 . . . . 0.0 111.659 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 68.01 -59.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.245 1.418 . . . . 0.0 113.985 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.628 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 t70 -58.88 -61.39 2.66 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -82.24 -25.03 9.1 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' X' ' 26' ' ' ASN . 2.9 tm? -58.64 -50.09 75.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.352 176.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.47 -33.8 76.51 Favored 'General case' 0 CA--C 1.483 -1.61 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.784 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.628 HG23 ' O ' ' X' ' 32' ' ' ASP . 40.2 t -65.75 -50.23 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.623 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 40.7 mt -69.04 -43.66 74.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 O-C-N 124.442 1.089 . . . . 0.0 111.379 -172.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.475 ' O ' HG12 ' X' ' 42' ' ' VAL . 34.1 mt -61.54 -45.29 94.78 Favored 'General case' 0 N--CA 1.421 -1.878 0 O-C-N 124.163 0.914 . . . . 0.0 111.571 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.49 -41.57 72.49 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.253 177.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.518 ' O ' HG12 ' X' ' 44' ' ' ILE . 16.0 t60 -62.3 -45.9 91.16 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.466 0.478 . . . . 0.0 109.92 -175.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.496 ' CD2' HD11 ' X' ' 54' ' ' ILE . 43.7 t80 -58.25 -53.18 61.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.295 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' X' ' 38' ' ' LEU 0.285 14.5 p -67.86 -31.62 52.94 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.891 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.8 pttp -69.14 -32.27 71.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.745 -0.597 . . . . 0.0 111.991 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.518 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.7 pt -85.17 -35.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.869 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 61.1 p -84.22 -35.43 23.47 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 58.25 30.73 19.91 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.195 1.398 . . . . 0.0 111.325 -176.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 36.4 t-80 -77.14 134.66 67.29 Favored Pre-proline 0 N--CA 1.423 -1.788 0 CA-C-N 114.024 -1.444 . . . . 0.0 107.862 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.1 Cg_exo -71.0 -2.27 10.8 Favored 'Trans proline' 0 CA--C 1.493 -1.541 0 C-N-CA 123.362 2.708 . . . . 0.0 112.805 -175.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 11.8 m-20 -138.21 29.84 2.47 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -173.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.485 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.99 -61.05 3.64 Favored Glycine 1 CA--C 1.45 -4.017 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.946 -176.48 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.46 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -28.44 57.65 Favored 'General case' 0 C--N 1.248 -3.837 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.252 -172.5 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.587 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.76 -40.47 95.25 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.026 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.3 mt -56.32 -44.5 80.01 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.731 0.644 . . . . 0.0 112.087 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.496 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -66.63 -45.24 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.276 -177.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.423 ' HD2' ' O ' ' X' ' 51' ' ' THR . 29.7 m-85 -61.01 -49.31 77.93 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.74 -178.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.5 pt-20 -70.29 -36.28 74.25 Favored 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.638 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.652 0.206 . . . . 0.0 111.319 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.25 92.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 178.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -43.52 62.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.88 178.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 63.7 mtp180 -61.0 -30.92 70.58 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.684 1.193 . . . . 0.0 111.363 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.91 -45.78 17.97 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.2 176.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.91 81.55 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.173 -177.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.37 75.24 0.95 Allowed 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 174.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 16.0 t-20 -72.94 118.67 70.3 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.257 -177.024 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -92.56 27.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.122 2.548 . . . . 0.0 111.759 -178.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 45.1 7.65 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -174.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.09 172.66 20.98 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -176.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -128.91 157.78 40.63 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.94 -3.24 31.77 Favored Glycine 0 CA--C 1.494 -1.249 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.613 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.74 83.82 1.61 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.59 170.06 22.0 Favored Glycine 0 N--CA 1.406 -3.307 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.489 ' O ' HG12 ' X' ' 76' ' ' VAL . 25.7 Cg_endo -65.0 -50.98 1.81 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 123.085 2.524 . . . . 0.0 110.956 -176.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.85 1.68 6.66 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 74' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.55 -29.16 3.48 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.065 174.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.614 HG13 HD13 ' X' ' 19' ' ' LEU . 5.2 pt -66.3 -32.98 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.248 1.024 . . . . 0.0 111.045 175.477 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.668 HG11 HG12 ' X' ' 16' ' ' VAL . 0.5 OUTLIER -59.6 -43.64 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-O 121.998 0.904 . . . . 0.0 110.327 173.177 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 54.4 tttp -58.42 -46.13 87.08 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.551 175.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -67.21 -30.71 70.72 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.463 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.4 mm -68.21 -45.99 81.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 175.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -64.02 -36.11 82.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.726 0.298 . . . . 0.0 110.699 -176.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.31 -32.31 70.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.837 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.497 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 76.2 t90 -72.16 -44.1 63.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.77 -43.08 98.49 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.775 -176.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.44 84.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.821 178.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.22 99.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.359 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -73.46 -34.1 65.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.59 47.73 2.91 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -118.77 147.94 43.35 Favored Pre-proline 0 N--CA 1.4 -2.942 0 C-N-CA 123.234 0.614 . . . . 0.0 109.863 -178.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.1 130.83 28.44 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.309 2.006 . . . . 0.0 110.477 175.158 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.27 -126.59 5.58 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.465 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' X' ' 7' ' ' ILE . 36.8 m-85 -81.27 156.7 25.45 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.108 -174.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' X' ' 11' ' ' THR . 53.0 pttt -94.57 174.28 7.2 Favored 'General case' 0 N--CA 1.389 -3.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.4 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.08 141.73 35.71 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.775 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.236 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.552 HD22 HD13 ' X' ' 18' ' ' LEU . 22.6 mt -91.8 127.82 37.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.149 0.499 . . . . 0.0 110.6 -177.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.544 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 37.7 mmtt -102.8 -179.96 4.11 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.203 -175.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.0 -24.79 16.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.325 0.583 . . . . 0.0 109.741 178.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.4 p -142.02 162.93 34.23 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.079 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -67.3 -17.92 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.24 1.016 . . . . 0.0 111.341 -176.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 75.8 m -86.6 -3.09 58.98 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.544 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 25.6 t0 -103.56 4.44 35.78 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 9.7 m-85 -99.0 121.06 40.46 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.6 -177.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.444 HG22 ' HG3' ' X' ' 92' ' ' LYS . 73.7 p -79.18 167.08 21.48 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 169.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.631 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.4 pt-20 -56.52 -42.65 78.78 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.629 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -38.31 75.6 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' X' ' 11' ' ' THR . 22.3 mm-40 -59.0 -37.65 77.36 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.363 0.601 . . . . 0.0 110.12 174.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.701 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -73.42 -42.8 61.61 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.743 HG12 HG11 ' X' ' 76' ' ' VAL . 3.9 m -62.99 -29.05 46.28 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.447 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.978 178.177 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -61.01 -46.75 89.47 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.625 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.1 tp -61.34 -47.23 86.82 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 175.332 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.1 mt -58.21 -38.54 76.99 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.158 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 68.3 mttm -71.55 -34.83 70.34 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.659 176.078 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.85 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.67 HG12 ' HB3' ' X' ' 37' ' ' LEU . 60.9 mt -62.92 -42.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.431 ' O ' HG22 ' X' ' 27' ' ' VAL . 1.6 tt0 -58.14 -44.45 87.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.242 174.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -59.11 -48.69 80.68 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.384 1.074 . . . . 0.0 109.567 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.8 -26.75 49.85 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.357 -178.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -80.01 -41.41 25.87 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 122.157 -0.34 . . . . 0.0 111.81 -179.01 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 27' ' ' VAL . . . . . 0.431 HG22 ' O ' ' X' ' 23' ' ' GLU . 33.0 m -70.52 -20.84 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.845 -179.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.93 -16.85 18.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.39 76.13 0.31 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.161 1.384 . . . . 0.0 111.969 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.8 p -96.37 -168.81 1.8 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.87 -43.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.943 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.516 ' O ' HG23 ' X' ' 36' ' ' VAL . 23.6 t70 -64.89 -53.02 53.19 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 79.4 t -87.15 -27.12 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.604 -178.106 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.04 -46.53 87.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.05 -20.6 61.65 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.516 HG23 ' O ' ' X' ' 32' ' ' ASP . 54.7 t -70.86 -49.77 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 C-N-CA 118.563 -1.255 . . . . 0.0 108.286 175.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 63.3 mt -68.29 -41.68 80.59 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 113.756 -1.565 . . . . 0.0 112.345 -170.253 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.5 mt -59.28 -44.57 92.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 124.151 0.907 . . . . 0.0 110.517 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.53 -45.0 63.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.71 177.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.58 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 20.2 t60 -59.33 -45.48 91.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.2 -175.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.586 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 39.6 t80 -60.49 -50.83 72.02 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.877 178.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.87 -32.19 55.38 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.538 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -179.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -69.53 -33.77 73.27 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.998 -0.439 . . . . 0.0 111.925 -178.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.469 HG12 ' O ' ' X' ' 40' ' ' HIS . 11.7 pt -85.07 -31.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 -178.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 53.2 p -84.77 -32.26 23.51 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.255 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 58.45 31.89 21.49 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.652 1.181 . . . . 0.0 109.949 -177.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 33.8 t-80 -82.52 135.14 46.86 Favored Pre-proline 0 N--CA 1.424 -1.774 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.441 -178.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.51 -12.33 31.29 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 123.068 2.512 . . . . 0.0 112.681 -176.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 9.0 m-20 -130.51 30.28 4.72 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.586 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.38 -58.69 5.69 Favored Glycine 0 CA--C 1.453 -3.805 0 CA-C-N 114.491 -1.231 . . . . 0.0 113.277 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.484 HG21 HD13 ' X' ' 38' ' ' LEU . 1.5 m -79.09 -23.3 44.23 Favored 'General case' 0 C--N 1.251 -3.707 0 C-N-CA 117.944 -1.502 . . . . 0.0 110.759 -172.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.53 67.15 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 175.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 28.3 mt -66.67 -37.28 84.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.627 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mt -66.37 -42.79 91.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.891 0.853 . . . . 0.0 108.827 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -62.72 -43.35 99.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.083 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.89 -40.09 75.88 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.048 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.67 81.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.97 99.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.595 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.02 68.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.408 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -60.75 -40.19 91.53 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.623 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.481 ' HB2' ' CA ' ' X' ' 71' ' ' GLY . . . -75.82 -32.18 59.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.637 0.256 . . . . 0.0 111.188 177.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.23 88.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.1 179.032 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.13 14.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 61.81 89.1 0.11 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 111.082 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.96 176.16 10.26 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 122.603 2.202 . . . . 0.0 112.048 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.01 72.15 2.65 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.76 172.17 13.24 Favored Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 t70 73.64 -53.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.951 1.3 . . . . 0.0 111.909 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.97 -46.16 1.21 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.443 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.72 -46.85 2.09 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.481 ' CA ' ' HB2' ' X' ' 61' ' ' ALA . . . -82.09 -134.93 1.99 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 -172.078 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.545 ' O ' HG13 ' X' ' 75' ' ' ILE . 12.8 Cg_endo -54.1 -45.44 41.0 Favored 'Trans proline' 0 C--O 1.212 -0.804 0 C-N-CA 123.959 3.106 . . . . 0.0 114.077 -171.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -74.15 1.35 11.41 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.64 -6.25 25.19 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 119.901 -1.142 . . . . 0.0 112.769 174.222 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.545 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.0 OUTLIER -77.04 -43.68 31.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.242 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.743 HG11 HG12 ' X' ' 16' ' ' VAL . 1.2 p -58.22 -43.18 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.989 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 87.8 tttt -58.58 -48.15 81.89 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.393 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.35 -39.46 90.68 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.791 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.408 HG12 ' O ' ' X' ' 75' ' ' ILE . 47.6 mm -66.5 -45.31 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.278 178.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.9 pttp -62.34 -36.24 81.6 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -70.78 -36.23 72.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.134 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -70.2 -47.86 59.66 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.768 0.794 . . . . 0.0 108.877 178.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 13.6 tpt180 -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.783 -175.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.25 -43.08 78.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.175 0.59 . . . . 0.0 111.723 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -30.85 71.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -78.06 -37.4 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.08 33.63 5.68 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.345 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 20.2 mtpp -113.95 143.34 29.43 Favored Pre-proline 0 N--CA 1.4 -2.957 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -176.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 128.12 22.59 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.972 2.448 . . . . 0.0 111.884 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.36 -112.0 3.64 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.45 -178.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.98 166.18 14.68 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.406 -173.495 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.444 ' HG3' HG22 ' X' ' 11' ' ' THR . 22.2 ptmt -99.76 170.72 8.35 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -97.27 141.14 30.74 Favored 'General case' 0 N--CA 1.391 -3.409 0 CA-C-O 121.678 0.751 . . . . 0.0 109.571 178.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.109 0 N-CA-C 107.374 -2.29 . . . . 0.0 107.374 178.987 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 85.0 mt -95.75 127.4 41.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 176.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.1 mmtt -104.14 142.33 34.68 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -75.12 -16.01 60.57 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.113 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.5 p -132.2 162.73 30.2 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.959 175.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.454 HD11 ' CE1' ' X' ' 91' ' ' PHE . 8.5 tp -69.27 -17.84 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.717 0.807 . . . . 0.0 109.679 -177.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -19.61 59.18 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.359 -172.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 17.6 t70 -101.82 5.0 40.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.974 0.892 . . . . 0.0 109.095 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.2 m-85 -95.01 114.95 26.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.085 -174.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.523 HG22 ' HG3' ' X' ' 92' ' ' LYS . 70.8 p -80.42 162.36 24.49 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.592 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.5 pt-20 -56.56 -44.77 81.27 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.579 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -39.05 75.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -58.61 -38.46 78.04 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.277 0.49 . . . . 0.0 110.023 175.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -73.49 -43.12 60.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.338 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.817 HG12 HG11 ' X' ' 76' ' ' VAL . 11.0 m -62.58 -36.39 74.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.082 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.513 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -61.52 -49.46 76.63 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 109.649 177.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.508 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -61.19 -43.32 99.07 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.546 HD23 HG13 ' X' ' 75' ' ' ILE . 3.0 mp -58.41 -36.94 74.35 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.553 -1.203 . . . . 0.0 114.046 176.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 91.4 mttt -66.26 -40.0 89.87 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.188 0.518 . . . . 0.0 109.643 176.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.78 -37.36 87.34 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.595 178.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' X' ' 37' ' ' LEU . 26.3 mt -61.0 -45.18 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.413 ' CD ' ' HD3' ' X' ' 72' ' ' PRO . 52.6 mt-10 -58.54 -46.22 87.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.551 0.691 . . . . 0.0 110.639 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.01 -49.83 76.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.069 -175.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -71.82 -27.63 63.04 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -70.59 -53.92 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.462 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.62 -20.65 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.38 -13.98 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.543 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.87 70.25 0.6 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.297 1.039 . . . . 0.0 111.071 -176.033 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p -88.9 -17.56 29.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 110.951 -176.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.394 1.7 m-20 65.3 -59.55 0.27 Allowed 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 178.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.671 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.6 t70 -63.55 -57.01 11.51 Favored 'General case' 0 CA--C 1.478 -1.816 0 CA-C-N 119.817 1.19 . . . . 0.0 111.733 -176.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.73 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 44.0 t -76.42 -32.25 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.067 -177.139 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.628 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 1.8 tm? -58.35 -47.28 84.28 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 32.8 t70 -65.02 -41.84 94.93 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.671 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.6 t -56.53 -50.03 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 O-C-N 124.224 0.953 . . . . 0.0 110.079 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.2 mt -67.65 -39.92 84.58 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.603 -172.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 43.8 mt -63.21 -49.95 72.21 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 7.3 pt-20 -71.2 -34.45 70.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.889 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.564 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 59.3 t60 -60.21 -45.49 92.98 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.309 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.416 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 63.7 t80 -60.63 -52.98 62.83 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.781 178.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.526 HG12 ' O ' ' X' ' 38' ' ' LEU 0.291 2.7 p -67.49 -32.91 59.2 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.915 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.0 ptmm? -67.17 -33.39 75.3 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.924 -0.485 . . . . 0.0 111.876 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.487 HG12 ' O ' ' X' ' 40' ' ' HIS . 17.6 pt -86.23 -36.05 9.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.833 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -84.18 -33.45 24.18 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 120.891 0.377 . . . . 0.0 111.117 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 64.05 19.34 11.71 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.266 1.427 . . . . 0.0 111.392 -176.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.418 ' O ' HG23 ' X' ' 42' ' ' VAL . 47.8 t-80 -73.0 132.22 82.98 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.533 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -70.19 -17.05 35.88 Favored 'Trans proline' 0 CA--C 1.492 -1.613 0 C-N-CA 122.833 2.355 . . . . 0.0 112.662 -172.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 5.4 m-20 -127.14 36.19 4.46 Favored 'General case' 0 N--CA 1.389 -3.508 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -173.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.416 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.48 -53.52 16.15 Favored Glycine 0 CA--C 1.454 -3.731 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.422 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.482 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.43 -31.56 57.96 Favored 'General case' 0 C--N 1.247 -3.874 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.731 -173.615 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.88 -38.08 84.38 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.058 177.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.8 -48.45 75.35 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.477 0.486 . . . . 0.0 112.136 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.454 HG12 HG21 ' X' ' 22' ' ' ILE . 5.1 mp -67.88 -42.17 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 118.272 -1.371 . . . . 0.0 110.079 -178.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.413 ' HD2' ' O ' ' X' ' 51' ' ' THR . 27.0 m-85 -62.55 -45.51 92.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.158 -178.479 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.8 pt-20 -68.66 -35.92 77.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.283 176.056 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 57' ' ' ALA . . . . . 0.434 ' O ' ' HA3' ' X' ' 70' ' ' GLY . . . -57.48 -39.28 76.05 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 122.482 0.313 . . . . 0.0 110.982 178.22 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.74 87.42 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.41 78.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.834 0.826 . . . . 0.0 110.113 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -64.92 -30.34 71.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.058 178.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.45 58.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.112 0.482 . . . . 0.0 109.746 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.09 94.06 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.94 72.45 0.78 Allowed 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.456 0.646 . . . . 0.0 109.39 174.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -72.02 117.86 61.9 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.498 -177.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -85.74 -14.48 5.37 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.13 1.887 . . . . 0.0 112.181 177.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.89 177.46 14.9 Favored Glycine 0 CA--C 1.485 -1.805 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -177.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.85 -133.52 17.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.52 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -80.05 -50.45 10.34 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 175.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.17 -134.65 20.1 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 70' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' X' ' 57' ' ' ALA . . . -103.83 128.08 9.37 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 176.479 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.464 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 168.96 165.77 26.91 Favored Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.69 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.562 ' O ' HG12 ' X' ' 76' ' ' VAL . 12.8 Cg_endo -61.09 -43.77 27.92 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.541 2.828 . . . . 0.0 112.564 -175.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.89 0.82 16.93 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.2 -40.31 1.41 Allowed Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.381 177.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.546 HG13 HD23 ' X' ' 19' ' ' LEU . 3.6 pt -60.52 -29.72 45.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.169 0.485 . . . . 0.0 111.771 176.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.817 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -65.51 -45.59 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 122.327 1.061 . . . . 0.0 111.088 175.12 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 40.7 ttmt -63.07 -37.72 88.31 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.584 -1.643 . . . . 0.0 109.761 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.91 -43.74 98.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.319 0.581 . . . . 0.0 111.124 174.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.469 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.5 mm -61.24 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.912 176.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 22.3 ptmt -63.59 -36.3 83.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.963 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.6 mt-10 -64.55 -41.64 96.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.415 0.447 . . . . 0.0 110.752 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.533 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.3 t90 -68.12 -45.33 73.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.524 0.678 . . . . 0.0 109.769 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -60.91 -45.28 95.27 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.454 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.11 85.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.59 92.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.951 0.405 . . . . 0.0 110.738 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.469 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 21.7 t-20 -69.63 -41.34 75.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.726 0.774 . . . . 0.0 109.444 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.79 28.75 5.23 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 67.7 mttm -100.31 150.85 37.28 Favored Pre-proline 0 N--CA 1.402 -2.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.67 128.56 28.63 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.281 2.654 . . . . 0.0 112.152 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.21 -149.47 25.5 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.941 -177.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' X' ' 7' ' ' ILE . 42.2 m-85 -79.28 159.66 27.15 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -176.011 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.3 ptmt -98.73 176.31 5.67 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-O 121.723 0.773 . . . . 0.0 110.126 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -112.34 141.84 45.58 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.554 174.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.569 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 -179.794 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 CA--C 1.517 -0.303 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -116.94 136.37 53.0 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.503 0.502 . . . . 0.0 110.121 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -111.68 -169.84 1.54 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -107.75 -29.18 9.25 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.628 0.727 . . . . 0.0 110.236 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -131.82 163.52 28.08 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.352 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -69.68 -13.4 17.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 CA-C-O 121.549 0.69 . . . . 0.0 110.668 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 10.8 m -72.82 -22.13 60.85 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.636 -174.39 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 21.9 t70 -100.57 3.4 42.67 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.165 0.983 . . . . 0.0 108.883 177.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -92.49 115.12 27.81 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.473 -176.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 65.2 p -76.53 159.18 30.58 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 171.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.636 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.7 pt-20 -61.13 -35.27 76.61 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.951 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.44 -38.45 74.53 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.802 177.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.2 -40.99 83.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.12 0.962 . . . . 0.0 109.243 173.053 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.562 ' HD2' HG12 ' X' ' 76' ' ' VAL . 41.4 t80 -69.27 -45.02 70.68 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.057 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.786 HG12 HG11 ' X' ' 76' ' ' VAL . 8.4 m -61.86 -38.75 81.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.46 -36.48 79.06 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 121.487 0.661 . . . . 0.0 111.544 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.487 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -66.92 -46.18 75.61 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.702 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' X' ' 41' ' ' PHE . 7.3 mp -60.13 -36.97 78.66 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.081 177.28 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.649 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 62.5 mttm -63.11 -35.64 80.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.477 0.656 . . . . 0.0 109.964 176.481 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -69.38 -33.5 73.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.632 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' X' ' 37' ' ' LEU . 9.5 mt -67.46 -40.84 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.72 -46.75 84.0 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.55 -42.81 97.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.907 -176.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -77.16 -29.05 54.31 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.164 -0.335 . . . . 0.0 111.493 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -75.42 -46.37 33.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.131 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.44 -35.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.909 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.33 -10.07 56.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 177.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.07 74.51 0.29 Allowed 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.543 1.537 . . . . 0.0 113.431 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 56.6 p -99.24 -166.27 1.33 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.34 -61.84 1.01 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.59 ' O ' HG23 ' X' ' 36' ' ' VAL . 18.5 m-20 -56.96 -50.93 71.14 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.668 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 62.0 t -88.59 -29.16 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.52 -45.65 88.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.64 -30.4 67.02 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.267 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.59 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -63.29 -49.73 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.493 176.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.669 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.0 mt -68.47 -43.78 76.25 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.486 -170.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 36.2 mt -61.14 -46.22 91.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 124.099 0.874 . . . . 0.0 110.428 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.44 -43.77 69.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.989 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.485 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.2 t60 -60.12 -45.71 92.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.607 -176.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.636 ' CD2' HD11 ' X' ' 54' ' ' ILE . 39.5 t80 -61.43 -51.49 68.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.224 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.432 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.9 p -67.7 -32.59 57.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.8 pttt -72.63 -26.59 61.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.46 HG12 ' O ' ' X' ' 40' ' ' HIS . 26.6 pt -87.26 -34.87 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.779 179.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -84.3 -31.97 24.59 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 58.06 31.71 21.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.633 1.173 . . . . 0.0 109.877 -176.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 40.9 t-80 -82.43 138.52 44.74 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 113.514 -1.675 . . . . 0.0 108.117 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' X' ' 47' ' ' HIS . 15.6 Cg_exo -73.5 -6.42 18.73 Favored 'Trans proline' 0 CA--C 1.492 -1.593 0 C-N-CA 123.1 2.533 . . . . 0.0 112.599 -175.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.433 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 38.0 m-20 -135.63 32.19 3.04 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.583 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.73 -59.99 5.13 Favored Glycine 1 CA--C 1.445 -4.34 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.872 -176.842 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.469 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -75.18 -30.13 60.6 Favored 'General case' 1 C--N 1.242 -4.092 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.019 -172.641 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.15 -28.13 69.85 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 53' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' X' ' 56' ' ' GLU . 28.1 mt -65.13 -43.1 93.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 175.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.636 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -67.2 -41.66 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.789 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -58.27 -47.28 84.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.685 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.6 pt-20 -67.67 -36.72 81.23 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.325 175.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.53 -45.14 85.38 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.125 0.421 . . . . 0.0 111.824 -178.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.9 97.84 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.91 70.56 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.923 179.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 52.0 mtp180 -64.85 -30.71 71.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.064 0.946 . . . . 0.0 111.517 177.579 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.18 16.21 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.174 175.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.34 88.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.233 0.54 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 80.23 1.52 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 5.1 t-20 -72.11 112.47 14.65 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.911 -176.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.98 -50.46 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.956 1.77 . . . . 0.0 110.518 178.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.16 172.54 31.42 Favored Glycine 0 CA--C 1.473 -2.575 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.27 52.58 4.54 Favored Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 115.384 -0.408 . . . . 0.0 112.909 -176.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -93.46 -8.81 40.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.153 0.501 . . . . 0.0 109.864 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.99 81.21 0.94 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -177.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.6 88.79 1.47 Allowed Glycine 0 N--CA 1.418 -2.508 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 177.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.492 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 147.09 -143.94 11.96 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 178.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.623 ' O ' HG13 ' X' ' 76' ' ' VAL . 12.7 Cg_endo -74.46 -46.24 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.353 2.702 . . . . 0.0 112.353 -172.184 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.483 ' C ' HG22 ' X' ' 76' ' ' VAL . 31.5 mt-10 -73.5 0.86 11.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -177.116 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.31 -34.3 2.95 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.518 172.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.52 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.8 pt -66.89 -27.11 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 117.647 0.723 . . . . 0.0 110.633 172.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.786 HG11 HG12 ' X' ' 16' ' ' VAL . 27.6 m -62.16 -37.99 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.889 0 CA-C-O 121.689 0.757 . . . . 0.0 110.992 176.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 39.8 ttmt -65.74 -45.01 84.22 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.788 176.023 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -58.1 -38.05 75.71 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.57 -46.89 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.412 177.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 17.9 ptpt -66.82 -38.5 86.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.726 -175.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 46.2 mt-10 -69.69 -32.22 70.7 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.252 -178.419 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.403 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 81.2 t90 -72.19 -48.28 44.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.559 0.695 . . . . 0.0 109.354 177.341 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 14.9 tpt180 -61.39 -45.45 94.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.415 -174.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.42 84.3 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.04 84.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.862 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.58 -45.74 57.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.645 0.736 . . . . 0.0 109.061 177.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.35 37.5 1.94 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 93.0 mttt -112.51 143.47 29.0 Favored Pre-proline 0 N--CA 1.391 -3.387 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.51 131.23 27.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.43 2.086 . . . . 0.0 110.314 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -114.59 -115.71 3.12 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.818 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -79.18 145.93 33.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -174.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' X' ' 11' ' ' THR . 45.8 pttt -97.38 172.4 7.79 Favored 'General case' 0 N--CA 1.384 -3.771 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.97 148.64 22.11 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 177.86 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 CA--C 1.487 -1.467 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' X' ' 18' ' ' LEU . 35.0 mt -91.65 131.89 36.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 35.1 mmtt -93.09 -166.73 1.58 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.357 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -118.16 -0.08 11.65 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 174.763 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -153.44 158.89 42.08 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.212 176.325 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' X' ' 10' ' ' TYR . 11.3 tt -67.4 -24.43 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.488 0.661 . . . . 0.0 110.571 -178.422 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -85.44 0.09 53.31 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.951 -174.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.6 t70 -104.11 -1.28 27.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.332 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' X' ' 7' ' ' ILE . 8.0 m-85 -97.53 124.61 41.83 Favored 'General case' 0 CA--C 1.472 -2.025 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.804 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 47.9 p -78.75 159.4 27.94 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.014 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.63 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.21 -41.11 75.1 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 123.321 0.388 . . . . 0.0 110.383 -179.41 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.719 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.4 76.26 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.48 -38.9 82.05 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.737 0.779 . . . . 0.0 109.682 173.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.599 ' CD2' HG12 ' X' ' 76' ' ' VAL . 22.0 t80 -75.3 -41.73 56.28 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.73 -177.222 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.719 HG22 ' HA ' ' X' ' 13' ' ' ALA . 15.1 m -62.87 -32.79 57.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 176.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -64.24 -47.33 80.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 122.912 0.485 . . . . 0.0 109.966 178.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.679 ' O ' HG13 ' X' ' 22' ' ' ILE . 19.9 tp -57.23 -47.59 80.94 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 123.873 0.733 . . . . 0.0 109.292 177.699 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.94 -36.82 77.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.345 177.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.623 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 97.4 mttt -61.23 -46.47 90.29 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.518 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 21' ' ' GLU . . . . . 0.499 ' HA ' ' HE3' ' X' ' 24' ' ' LYS . 54.8 mt-10 -64.14 -37.81 88.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.627 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.701 HG12 ' HB3' ' X' ' 37' ' ' LEU . 27.4 mt -63.17 -44.61 99.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' X' ' 20' ' ' LYS . 4.8 pt-20 -65.68 -35.07 79.71 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.143 0.973 . . . . 0.0 109.423 -178.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 24' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' X' ' 21' ' ' GLU . 27.8 ttpp -72.29 -52.03 18.11 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.474 -174.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -17.33 64.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.947 0.403 . . . . 0.0 111.305 176.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -81.08 -51.38 8.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.524 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 m -73.09 -26.39 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.24 -22.01 33.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.31 78.82 0.27 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.171 1.388 . . . . 0.0 112.011 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -92.31 -28.04 17.2 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 67.79 -55.15 0.49 Allowed 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.297 1.839 . . . . 0.0 115.374 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.44 ' O ' HG23 ' X' ' 36' ' ' VAL . 9.5 p-10 -68.36 -47.4 67.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.445 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -85.95 -29.88 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.13 -41.27 87.84 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 177.309 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 27.0 t70 -62.0 -41.69 98.33 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 123.386 0.429 . . . . 0.0 110.02 178.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' X' ' 33' ' ' VAL . 58.2 t -59.29 -48.74 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 O-C-N 124.622 1.201 . . . . 0.0 109.47 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.2 mt -64.64 -43.22 94.37 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.662 -173.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -60.11 -50.69 72.68 Favored 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 124.119 0.887 . . . . 0.0 111.051 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 1.5 pt-20 -70.69 -37.5 73.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.697 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.5 t60 -59.75 -46.26 89.71 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.268 0.627 . . . . 0.0 109.644 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.556 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.9 t80 -61.8 -53.52 54.77 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.259 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.452 HG12 ' O ' ' X' ' 38' ' ' LEU . 8.2 p -67.09 -31.7 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 54.1 pttt -69.63 -38.88 77.35 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 122.089 -0.382 . . . . 0.0 111.948 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.48 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.1 pt -79.63 -31.79 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.795 0.331 . . . . 0.0 110.747 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 54.7 p -84.04 -34.99 24.13 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.81 22.95 13.25 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.65 1.18 . . . . 0.0 109.929 -176.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -79.3 133.31 60.58 Favored Pre-proline 0 N--CA 1.433 -1.305 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.278 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.445 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -71.69 -19.48 27.7 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.282 -173.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -118.5 30.37 7.24 Favored 'General case' 0 N--CA 1.4 -2.957 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -171.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.556 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.0 -57.33 6.25 Favored Glycine 0 CA--C 1.461 -3.34 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.9 -178.428 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.525 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -82.26 -22.78 35.61 Favored 'General case' 0 C--N 1.247 -3.867 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.959 -172.206 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.84 -36.69 84.06 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.754 174.48 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.09 -40.44 97.66 Favored 'General case' 0 C--O 1.207 -1.142 0 O-C-N 123.609 0.568 . . . . 0.0 110.643 175.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.497 HD13 HG21 ' X' ' 22' ' ' ILE . 51.1 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.392 0.615 . . . . 0.0 109.864 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -62.17 -44.49 96.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.69 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.6 pt-20 -71.17 -38.38 72.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.924 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.13 96.46 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.16 80.9 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.328 0.392 . . . . 0.0 110.595 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.17 -44.48 59.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.481 178.32 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -67.91 -31.31 70.99 Favored 'General case' 0 C--O 1.194 -1.845 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.036 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.72 -23.44 42.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.974 -0.454 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.02 69.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.866 178.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.52 85.61 2.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -87.74 112.07 46.36 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.21 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.19 -2.22 11.89 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.247 2.631 . . . . 0.0 113.513 -177.36 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.72 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.32 -168.06 38.53 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.083 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 64.78 25.42 12.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.743 1.217 . . . . 0.0 111.722 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.18 -30.22 0.1 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.86 61.3 4.54 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.81 170.14 23.05 Favored Glycine 0 N--CA 1.396 -3.979 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.755 ' HA ' HD11 ' X' ' 75' ' ' ILE . 24.1 Cg_endo -66.11 -24.64 51.74 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.472 . . . . 0.0 112.805 -175.501 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.479 ' HG2' HG11 ' X' ' 16' ' ' VAL . 35.7 mt-10 -85.68 1.96 47.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.964 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 74' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -105.44 -32.82 3.82 Favored Glycine 0 N--CA 1.419 -2.441 0 C-N-CA 118.377 -1.868 . . . . 0.0 114.322 176.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.755 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -69.95 -28.21 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-N 118.68 1.24 . . . . 0.0 110.204 175.128 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.599 HG12 ' CD2' ' X' ' 15' ' ' PHE . 27.5 m -63.61 -38.06 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-O 121.347 0.594 . . . . 0.0 110.489 177.225 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttm -61.28 -48.46 81.29 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.445 173.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.16 -37.45 82.95 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.741 -178.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.422 HG12 ' O ' ' X' ' 75' ' ' ILE . 31.4 mm -68.46 -46.36 80.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.571 177.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -65.09 -38.06 89.51 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.666 -174.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.23 -38.78 75.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.272 -178.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.445 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 71.2 t90 -66.69 -47.88 71.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 109.131 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 19.7 tpt180 -61.19 -46.33 90.92 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.071 -175.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.58 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.868 -178.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.05 75.02 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.923 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -72.82 -42.63 63.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.64 34.99 1.62 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.918 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 65.9 mttm -115.43 140.13 25.48 Favored Pre-proline 0 N--CA 1.385 -3.685 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -177.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -61.5 136.31 62.49 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.422 2.082 . . . . 0.0 110.899 176.295 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.0 -120.33 4.68 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.233 -174.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -86.87 166.42 15.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 124.202 0.59 . . . . 0.0 109.441 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' X' ' 11' ' ' THR . 18.0 ptmt -105.18 162.14 13.65 Favored 'General case' 1 N--CA 1.374 -4.265 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.176 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.83 134.44 49.98 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.489 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.265 -3.379 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.806 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 . . . . . 0 CA--C 1.509 -0.609 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.07 130.4 44.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.849 0.833 . . . . 0.0 112.623 -178.595 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 32.2 mmtt -101.76 -157.52 0.61 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -120.5 -20.37 7.19 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.222 171.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.4 p -141.01 165.7 26.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.464 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.09 -23.11 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.649 1.18 . . . . 0.0 110.393 -179.3 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.9 m -73.68 -16.33 61.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.798 -173.242 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 19.2 t70 -102.97 3.27 36.13 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.508 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.463 ' OH ' HD22 ' X' ' 18' ' ' LEU . 8.6 m-85 -97.04 118.4 33.35 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.39 -175.235 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 23.8 p -80.15 164.62 23.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.624 ' O ' HG13 ' X' ' 16' ' ' VAL . 5.8 pt-20 -59.08 -40.44 85.26 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.403 178.552 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.636 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.63 76.32 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.939 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.42 -38.0 79.48 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.707 0.765 . . . . 0.0 110.261 174.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.575 ' HD2' HG12 ' X' ' 76' ' ' VAL . 36.3 t80 -72.87 -46.02 55.12 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.617 -179.054 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.741 HG12 HG11 ' X' ' 76' ' ' VAL . 10.4 m -62.34 -34.42 64.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.848 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.09 -49.69 76.3 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.657 ' O ' HG13 ' X' ' 22' ' ' ILE . 55.3 tp -60.0 -46.78 88.35 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.524 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.423 HD21 ' CD1' ' X' ' 41' ' ' PHE . 4.4 mm? -58.51 -36.86 74.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.619 178.224 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.5 mttt -63.83 -37.23 86.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 110.568 175.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.31 -35.61 66.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.657 HG13 ' O ' ' X' ' 18' ' ' LEU . 17.3 mt -67.64 -42.09 86.2 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.176 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.405 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -42.8 84.75 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.917 1.287 . . . . 0.0 109.604 177.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.74 -47.62 74.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.619 -177.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.676 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 7.1 mm-40 -76.97 -15.4 59.66 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.319 178.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -70.53 -45.93 64.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.51 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.16 -26.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.383 179.408 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.42 50.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.061 176.405 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.8 77.27 0.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.166 1.386 . . . . 0.0 111.267 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 27.2 p -101.46 -168.73 1.59 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.73 -35.35 0.58 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.126 176.338 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.481 ' O ' HG23 ' X' ' 36' ' ' VAL . 37.7 m-20 -65.11 -53.02 51.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.742 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 4.8 p -88.52 -31.12 5.49 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.943 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.181 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.25 -45.02 92.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.322 -175.195 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.76 -29.71 63.54 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.887 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.481 HG23 ' O ' ' X' ' 32' ' ' ASP . 92.4 t -64.46 -48.78 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.063 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.457 176.676 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 85.9 mt -67.58 -43.57 80.26 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.121 -172.556 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 44.5 mt -61.81 -45.06 95.5 Favored 'General case' 0 N--CA 1.422 -1.837 0 O-C-N 124.194 0.934 . . . . 0.0 110.786 -179.575 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.24 -47.28 62.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.504 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.3 t60 -59.71 -44.2 93.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.593 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 30.9 t80 -59.95 -52.97 63.13 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.884 177.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.518 HG12 ' O ' ' X' ' 38' ' ' LEU . 13.8 p -67.71 -32.55 57.2 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.773 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.0 pttp -70.17 -28.59 65.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.454 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -84.38 -40.77 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.369 -177.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.573 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.4 t -83.64 -32.11 25.85 Favored 'General case' 0 C--O 1.252 1.224 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.653 178.122 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.56 30.55 12.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 125.908 1.683 . . . . 0.0 111.342 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.514 ' H ' HG23 ' X' ' 45' ' ' THR . 48.0 t-80 -76.65 137.0 67.01 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.85 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 18.6 Cg_exo -70.99 -13.07 31.35 Favored 'Trans proline' 0 CA--C 1.502 -1.115 0 C-N-CA 123.099 2.533 . . . . 0.0 112.645 -174.099 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.55 31.45 4.78 Favored 'General case' 0 N--CA 1.398 -3.051 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -173.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.15 -56.88 7.49 Favored Glycine 0 CA--C 1.457 -3.584 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.921 -178.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.459 HG23 HD22 ' X' ' 38' ' ' LEU . 1.3 m -72.08 -32.55 67.14 Favored 'General case' 0 C--N 1.256 -3.479 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.271 -173.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.32 -37.21 86.39 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.996 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 53' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' X' ' 75' ' ' ILE . 27.6 mt -58.47 -39.02 78.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.766 0.666 . . . . 0.0 112.22 178.155 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.628 HD13 HG21 ' X' ' 22' ' ' ILE . 67.8 mt -65.89 -44.43 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.638 . . . . 0.0 109.304 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.56 -49.74 74.09 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.274 178.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.8 pt-20 -69.65 -42.43 74.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.22 92.73 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.187 -179.603 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.26 73.52 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.033 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.93 75.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.701 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.37 -31.07 71.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.521 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -74.71 -35.75 62.71 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.063 178.792 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.97 97.91 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.995 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.53 -48.53 13.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.909 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 60.91 90.9 0.08 OUTLIER Pre-proline 0 C--O 1.241 0.612 0 C-N-CA 125.441 1.497 . . . . 0.0 113.158 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.28 2.99 4.44 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.771 2.314 . . . . 0.0 112.511 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.46 161.11 15.38 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.83 177.42 49.32 Favored Glycine 0 C--O 1.247 0.957 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -178.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -102.85 -169.57 1.67 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.75 -33.11 6.66 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -177.457 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.71 143.92 21.83 Favored Glycine 0 N--CA 1.414 -2.811 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 176.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.521 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 89.56 164.78 40.41 Favored Glycine 0 N--CA 1.424 -2.109 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.947 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.512 ' HA ' HD11 ' X' ' 75' ' ' ILE . 18.7 Cg_endo -55.98 -37.71 95.71 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 123.884 3.056 . . . . 0.0 114.126 -176.331 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.444 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.7 mt-10 -86.37 2.39 47.68 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.76 -28.03 5.5 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 118.684 -1.722 . . . . 0.0 112.481 173.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.3 OUTLIER -61.12 -39.69 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 122.326 1.06 . . . . 0.0 108.277 176.349 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.741 HG11 HG12 ' X' ' 16' ' ' VAL . 29.2 m -59.46 -33.76 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 CA-C-N 113.314 -1.766 . . . . 0.0 112.686 -176.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -60.06 -51.64 68.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.773 172.014 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -59.32 -42.29 91.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.488 HD12 HG21 ' X' ' 45' ' ' THR . 29.0 mm -62.75 -46.29 96.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.014 177.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.49 -43.36 73.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.621 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -72.16 -32.21 66.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.156 -175.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.609 ' CZ3' ' HE3' ' X' ' 88' ' ' LYS . 62.0 t90 -66.11 -45.85 79.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.597 1.189 . . . . 0.0 109.133 175.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.438 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 9.2 tpt180 -66.24 -46.92 75.48 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.169 -177.087 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -38.35 81.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.489 0.716 . . . . 0.0 112.094 -176.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.24 70.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 86' ' ' ASN . . . . . 0.597 ' HB3' ' NZ ' ' X' ' 88' ' ' LYS . 56.4 t30 -101.4 6.16 42.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.075 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.43 42.32 49.19 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.004 175.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.609 ' HE3' ' CZ3' ' X' ' 82' ' ' TRP . 36.6 mtmm -105.19 139.44 20.13 Favored Pre-proline 1 N--CA 1.378 -4.042 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.849 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.08 114.7 2.12 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 111.788 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.0 -125.11 4.09 Favored Glycine 0 CA--C 1.489 -1.587 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.659 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.71 152.84 28.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.975 0.417 . . . . 0.0 110.285 -175.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.07 177.71 6.85 Favored 'General case' 0 N--CA 1.391 -3.375 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -117.59 143.37 46.18 Favored 'General case' 1 N--CA 1.377 -4.09 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 -178.682 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 177.065 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.511 ' CD2' HD13 ' X' ' 18' ' ' LEU . 33.9 mt -103.01 134.32 46.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 34.3 mmtt -102.06 -162.45 0.93 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -118.52 -19.61 8.73 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.447 -0.783 . . . . 0.0 111.34 173.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 60.7 p -135.86 163.61 29.83 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.545 HG12 HH12 ' X' ' 83' ' ' ARG . 3.6 tp -69.81 -14.88 18.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.667 -177.175 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.5 m -71.87 -17.55 62.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.184 -174.036 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 17.2 t70 -106.83 5.06 28.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.791 0.805 . . . . 0.0 108.932 178.409 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.82 121.58 38.84 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.216 -176.512 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 43.6 p -88.61 179.51 6.25 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.665 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.3 mm-40 -59.16 -52.36 66.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.507 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.22 -38.74 78.7 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.741 -171.244 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.56 -36.27 80.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 110.279 175.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.681 ' HD2' HG12 ' X' ' 76' ' ' VAL . 44.7 t80 -75.94 -44.66 39.02 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.354 -177.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.78 HG12 HG11 ' X' ' 76' ' ' VAL . 6.2 m -62.44 -33.25 58.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 116.939 -0.119 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -65.4 -47.84 74.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 123.024 0.53 . . . . 0.0 110.077 178.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.651 ' O ' HG13 ' X' ' 22' ' ' ILE . 17.9 tp -57.64 -47.44 82.22 Favored 'General case' 0 C--O 1.208 -1.09 0 CA-C-O 121.222 0.534 . . . . 0.0 109.789 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.515 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.48 -39.2 82.95 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.234 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 50.6 mttp -63.73 -38.5 91.33 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.174 0.511 . . . . 0.0 109.997 176.153 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' X' ' 24' ' ' LYS . 42.9 mt-10 -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.198 177.269 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.651 HG13 ' O ' ' X' ' 18' ' ' LEU . 31.0 mt -67.3 -40.89 85.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.351 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 23' ' ' GLU . . . . . 0.448 ' O ' HG22 ' X' ' 27' ' ' VAL . 52.3 mt-10 -57.89 -42.74 85.27 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.903 0.858 . . . . 0.0 109.728 177.749 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 24' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' X' ' 21' ' ' GLU . 80.1 tttt -60.23 -52.15 66.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.389 -176.605 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' X' ' 21' ' ' GLU . 1.2 pp20? -83.71 -32.93 25.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -58.3 -45.6 87.66 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.324 0.249 . . . . 0.0 111.503 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 27' ' ' VAL . . . . . 0.448 HG22 ' O ' ' X' ' 23' ' ' GLU . 31.7 m -76.22 -24.24 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.22 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -21.23 46.33 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.962 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.85 80.92 0.17 Allowed 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.878 1.671 . . . . 0.0 111.796 -178.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 0.7 OUTLIER -98.34 -175.2 3.04 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.139 174.433 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.71 -55.93 0.62 Allowed 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.724 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.67 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.9 t70 -63.12 -57.42 10.65 Favored 'General case' 0 CA--C 1.484 -1.572 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.939 -179.177 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.687 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.8 p -73.08 -30.16 30.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -175.428 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.537 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.4 tm? -61.21 -50.16 74.22 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.493 178.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.59 -24.5 62.77 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.835 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.67 HG23 ' O ' ' X' ' 32' ' ' ASP . 98.8 t -70.57 -51.34 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.98 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.118 177.084 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 44.7 mt -69.29 -43.13 74.46 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.87 -170.336 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.476 ' O ' HG12 ' X' ' 42' ' ' VAL . 25.7 mt -60.98 -43.51 98.72 Favored 'General case' 0 N--CA 1.419 -2.019 0 O-C-N 124.283 0.989 . . . . 0.0 111.226 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.82 -44.05 67.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.987 0.423 . . . . 0.0 111.128 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.516 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 7.8 t60 -59.52 -45.21 92.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.63 -175.733 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.617 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 60.5 t80 -60.16 -51.79 68.09 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.94 178.037 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.476 HG12 ' O ' ' X' ' 38' ' ' LEU 0.258 9.5 p -67.51 -32.28 56.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.494 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.716 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -70.47 -37.49 74.27 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.99 -0.444 . . . . 0.0 112.073 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.511 HG12 ' O ' ' X' ' 40' ' ' HIS . 18.5 pt -78.75 -31.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.248 0.547 . . . . 0.0 110.776 -178.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.433 ' O ' ' HD2' ' X' ' 83' ' ' ARG . 53.7 p -84.36 -42.4 15.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.04 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.57 25.97 6.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.159 1.784 . . . . 0.0 110.446 -176.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -80.35 135.66 53.63 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 114.286 -1.324 . . . . 0.0 107.797 178.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -69.45 -15.56 38.31 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 122.933 2.422 . . . . 0.0 112.737 -173.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -127.17 32.85 5.0 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.617 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.09 -59.23 4.04 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.966 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.474 ' O ' ' HD2' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -73.26 -32.39 64.66 Favored 'General case' 0 C--N 1.246 -3.933 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.537 -171.036 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.75 -36.0 79.75 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.494 178.165 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -59.82 -45.55 92.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 176.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.469 HD13 HG21 ' X' ' 22' ' ' ILE . 85.2 mt -67.62 -40.73 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.431 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.474 ' HD2' ' O ' ' X' ' 51' ' ' THR . 17.0 m-85 -59.34 -46.65 88.03 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.078 177.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.6 pt-20 -67.68 -36.13 80.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.24 176.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.45 79.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 122.947 0.155 . . . . 0.0 110.757 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.83 -48.05 82.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.747 0.654 . . . . 0.0 110.269 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.96 -40.86 78.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -65.67 -33.04 74.96 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.517 0.727 . . . . 0.0 111.817 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.1 39.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.134 0.493 . . . . 0.0 110.694 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -46.78 56.05 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.43 78.03 1.81 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 64' ' ' ASN . . . . . 0.516 ' ND2' ' HA3' ' X' ' 69' ' ' GLY . 42.7 t-20 -66.45 116.04 30.05 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.684 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.73 -11.69 13.92 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.99 2.46 . . . . 0.0 114.469 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.74 -175.28 16.23 Favored Glycine 0 CA--C 1.489 -1.563 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.13 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.57 -80.47 1.83 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.9 -41.02 0.36 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.058 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 69' ' ' GLY . . . . . 0.516 ' HA3' ' ND2' ' X' ' 64' ' ' ASN . . . 107.48 -142.28 15.77 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.485 174.544 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.62 31.54 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.54 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 158.39 -177.24 35.14 Favored Glycine 0 N--CA 1.404 -3.498 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 -179.621 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.623 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.2 Cg_endo -58.3 -43.15 49.16 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.771 2.981 . . . . 0.0 112.403 -176.787 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.462 ' C ' HG22 ' X' ' 76' ' ' VAL . 37.0 mt-10 -85.5 1.87 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 123.771 0.828 . . . . 0.0 110.796 -176.748 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 74' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -107.98 -29.72 4.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 119.264 -1.446 . . . . 0.0 112.886 173.628 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.54 HG12 ' O ' ' X' ' 71' ' ' GLY . 1.6 pt -69.64 -28.5 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 CA-C-N 117.576 0.688 . . . . 0.0 110.762 173.743 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.78 HG11 HG12 ' X' ' 16' ' ' VAL . 31.4 m -59.89 -35.92 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 121.76 0.79 . . . . 0.0 110.787 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.549 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 40.4 tttp -62.38 -49.11 76.82 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.302 174.293 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.33 -41.2 84.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 23.5 mm -63.0 -45.85 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.067 177.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 61.5 pttt -71.87 -38.58 70.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.993 -176.287 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 81' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.1 mt-10 -69.4 -32.32 71.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.839 -178.589 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.442 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -65.99 -46.15 79.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.228 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.545 HH12 HG12 ' X' ' 7' ' ' ILE . 0.9 OUTLIER -66.26 -39.74 89.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.274 177.205 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.27 86.51 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.817 0.698 . . . . 0.0 111.717 -179.065 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.786 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.23 -40.03 15.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.15 28.71 3.49 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -175.02 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -93.55 156.46 39.71 Favored Pre-proline 0 N--CA 1.412 -2.328 0 C-N-CA 124.225 1.01 . . . . 0.0 108.779 179.27 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -63.71 129.57 25.29 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.574 2.183 . . . . 0.0 112.979 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.99 -132.57 7.78 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.945 178.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 42.4 m-85 -96.21 152.75 18.27 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.251 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -88.85 169.55 11.49 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.29 136.0 41.86 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.82 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.926 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -177.695 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.545 HD22 HD13 ' X' ' 18' ' ' LEU . 40.4 mt -92.19 126.8 37.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.457 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 35.3 mmtt -95.62 -161.06 0.83 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.177 -173.577 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -108.79 -33.51 6.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -130.69 166.61 20.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.624 -176.202 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.2 tp -67.65 -25.15 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.595 0.712 . . . . 0.0 109.785 178.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -77.67 -11.54 59.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.261 -173.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 37.0 t0 -99.28 1.13 44.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.04 121.43 40.97 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.855 -174.493 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 11' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 80.1 p -79.52 167.94 20.1 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 170.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.0 pt-20 -59.96 -41.86 92.82 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.031 178.627 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.58 -38.5 74.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.47 177.284 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' X' ' 11' ' ' THR . 9.6 mm-40 -59.72 -36.17 76.0 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.403 0.62 . . . . 0.0 109.973 174.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.728 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 18.8 t80 -70.92 -46.17 62.97 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.867 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.74 HG12 HG11 ' X' ' 76' ' ' VAL . 4.9 m -62.57 -29.97 48.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.523 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -60.76 -49.41 77.61 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.969 0.907 . . . . 0.0 109.697 174.478 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.653 ' O ' HG13 ' X' ' 22' ' ' ILE . 22.7 tp -57.72 -46.79 83.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.577 0.704 . . . . 0.0 109.677 175.537 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.1 mt -58.23 -38.71 77.38 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.055 -178.761 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 97.6 mttt -70.3 -39.21 74.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.957 0.408 . . . . 0.0 110.157 176.11 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.41 -37.47 87.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 178.418 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.653 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.5 mt -65.82 -46.74 87.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.232 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.98 -39.86 79.24 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.367 1.067 . . . . 0.0 113.053 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 24' ' ' LYS . . . . . 0.543 ' HG3' ' OE1' ' X' ' 25' ' ' GLU . 24.3 tptp -60.21 -48.67 80.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 25' ' ' GLU . . . . . 0.543 ' OE1' ' HG3' ' X' ' 24' ' ' LYS . 9.4 mm-40 -92.15 -1.83 56.93 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.484 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -70.84 -53.39 15.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.71 -28.31 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.962 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -23.36 33.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.959 0.409 . . . . 0.0 110.316 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.77 71.21 0.58 Allowed 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.57 1.548 . . . . 0.0 111.935 -176.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 68.9 p -91.25 -164.03 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.34 -38.71 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.716 177.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.525 ' O ' HG23 ' X' ' 36' ' ' VAL . 33.8 t70 -67.78 -55.09 14.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -172.468 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.675 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.86 -28.88 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 118.711 -1.195 . . . . 0.0 108.267 -177.765 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.07 -49.73 76.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.92 -176.203 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.52 -16.02 59.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.294 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.525 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.3 t -71.69 -50.4 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 C-N-CA 118.599 -1.24 . . . . 0.0 107.815 172.254 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 82.3 mt -68.18 -42.44 79.94 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 113.457 -1.702 . . . . 0.0 112.059 -169.395 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.0 mt -59.12 -45.78 90.03 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.352 1.033 . . . . 0.0 110.524 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -70.55 -43.3 69.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.893 178.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.524 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.6 t60 -59.89 -46.37 89.55 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.109 -176.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.611 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.7 t80 -62.45 -50.54 71.07 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.095 -179.54 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.461 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.5 p -67.08 -30.97 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.549 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.0 pttt -73.08 -35.41 66.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.364 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.517 HG12 ' O ' ' X' ' 40' ' ' HIS . 28.6 pt -81.21 -38.69 16.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.9 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 77.2 p -79.47 -36.15 39.19 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-O 121.227 0.537 . . . . 0.0 110.398 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 65.02 23.82 12.55 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -75.28 134.14 74.08 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.483 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.7 Cg_exo -72.17 -3.09 12.66 Favored 'Trans proline' 0 CA--C 1.493 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.549 -174.428 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' X' ' 52' ' ' ALA . 24.0 t70 -138.51 32.48 2.29 Favored 'General case' 0 N--CA 1.389 -3.507 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -174.21 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.611 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.44 -59.72 4.56 Favored Glycine 1 CA--C 1.45 -4.01 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.353 -179.152 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.452 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.23 -32.4 70.25 Favored 'General case' 0 C--N 1.248 -3.81 0 CA-C-N 114.764 -0.718 . . . . 0.0 111.461 -173.149 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -75.08 -24.07 58.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.037 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.31 -40.48 94.36 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.435 173.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.58 HD13 HG21 ' X' ' 22' ' ' ILE . 11.7 mt -66.23 -46.11 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -57.45 -49.06 77.46 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.437 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.57 -36.11 70.79 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.148 177.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -39.26 76.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.159 0.436 . . . . 0.0 110.335 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.9 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.638 0.586 . . . . 0.0 110.465 175.799 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.22 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.424 0.631 . . . . 0.0 111.026 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -67.64 -32.71 73.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.869 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 61' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -76.9 -22.86 52.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.729 0.3 . . . . 0.0 111.024 177.28 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.23 77.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.955 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.48 -47.09 7.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 57.26 83.68 0.22 Allowed Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.602 1.561 . . . . 0.0 112.419 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.45 106.38 2.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.825 2.35 . . . . 0.0 111.58 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -49.43 4.23 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.904 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.08 -37.33 0.65 Allowed Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.275 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -100.89 172.66 6.9 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.932 0.396 . . . . 0.0 110.711 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.54 -68.72 0.25 Allowed Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.17 -178.24 28.93 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.529 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 84.43 173.66 49.93 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.617 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.481 ' O ' HG13 ' X' ' 75' ' ' ILE . 11.6 Cg_endo -58.31 -44.4 38.61 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.899 -178.531 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.79 1.05 7.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.03 -22.78 6.72 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.739 176.464 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.505 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -65.63 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.703 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.74 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -58.27 -47.2 88.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.291 178.653 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 23.9 ttmm -58.26 -44.66 88.45 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.72 -29.73 64.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.285 0.564 . . . . 0.0 110.664 -178.365 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.505 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.3 mm -69.02 -45.92 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.028 175.281 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.2 pttp -63.07 -36.29 83.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.186 -174.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.21 -37.6 75.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.144 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.483 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.4 t90 -68.42 -47.38 67.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.192 0.52 . . . . 0.0 110.239 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.485 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 12.3 tpt180 -60.48 -45.66 92.94 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.26 -175.127 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.32 87.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.804 0.335 . . . . 0.0 111.457 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.46 -30.44 64.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.6 34.77 4.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.843 177.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 88' ' ' LYS . . . . . 0.485 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 58.7 mttm -111.91 148.27 38.62 Favored Pre-proline 0 N--CA 1.403 -2.802 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.03 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.01 126.54 14.65 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.512 2.142 . . . . 0.0 110.344 175.656 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.79 -114.61 3.13 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.096 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 91' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 18.0 m-85 -88.59 158.5 18.25 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 121.114 0.483 . . . . 0.0 110.273 -174.685 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.6 ptmt -98.45 166.43 11.36 Favored 'General case' 0 N--CA 1.381 -3.881 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.03 136.46 44.46 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 173.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.119 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.39 -177.166 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' X' X ' 2' ' ' GLU . . . . . 0.724 ' N ' HE22 ' X' ' 17' ' ' GLN . 39.1 mt-10 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 3' ' ' LEU . . . . . 0.49 HD22 HD13 ' X' ' 18' ' ' LEU . 67.8 mt -94.18 142.75 27.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.707 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 4' ' ' LYS . . . . . 0.472 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 36.3 mmtt -101.66 -159.84 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.98 -22.55 6.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.134 0.492 . . . . 0.0 110.446 175.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 6' ' ' SER . . . . . 0.489 ' HA ' HG22 ' X' ' 44' ' ' ILE . 23.1 p -140.0 165.95 25.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.559 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 7' ' ' ILE . . . . . 0.724 HG12 HH12 ' X' ' 83' ' ' ARG . 4.7 tp -70.38 -18.02 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.488 0.661 . . . . 0.0 110.317 -175.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -70.67 -18.89 62.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.851 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 9' ' ' ASP . . . . . 0.519 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.8 t0 -104.09 6.9 36.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.904 0.859 . . . . 0.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 15.4 m-85 -96.3 123.81 40.08 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.57 -176.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.3 p -86.29 172.73 10.24 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 171.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 12' ' ' GLU . . . . . 0.612 ' O ' HG13 ' X' ' 16' ' ' VAL . 4.1 mm-40 -56.05 -52.04 65.67 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.138 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 13' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.13 -38.55 75.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.82 -174.816 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' X' ' 17' ' ' GLN . 5.2 mm-40 -62.35 -33.47 74.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.899 175.562 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 15' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 27.1 t80 -71.94 -44.96 62.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 16' ' ' VAL . . . . . 0.779 HG12 HG11 ' X' ' 76' ' ' VAL . 3.6 m -62.51 -30.43 49.13 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.176 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.724 HE22 ' N ' ' X' ' 2' ' ' GLU . 6.7 tt0 -59.22 -50.21 74.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.647 0.779 . . . . 0.0 109.023 174.788 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 18' ' ' LEU . . . . . 0.637 ' O ' HG13 ' X' ' 22' ' ' ILE . 26.0 tp -58.62 -45.91 88.2 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.042 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 22.3 mt -57.93 -40.96 81.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.937 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 99.4 mttt -65.22 -37.49 87.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.23 176.774 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' X' ' 24' ' ' LYS . 7.9 mm-40 -71.8 -37.37 70.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 22' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' X' ' 37' ' ' LEU . 18.5 mt -62.4 -39.61 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.738 178.599 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.73 -47.05 83.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.356 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 24' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' X' ' 21' ' ' GLU . 17.4 pttp -67.42 -36.26 80.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.497 -175.111 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -71.86 -31.64 66.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.269 0.557 . . . . 0.0 110.038 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -72.46 -50.79 23.59 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.473 177.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 27' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' X' ' 24' ' ' LYS . 32.8 m -68.82 -32.35 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -10.06 49.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 109.92 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.62 80.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.701 1.6 . . . . 0.0 113.495 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 30' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 61.7 p -105.16 -168.53 1.48 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -143.01 -29.13 0.55 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.555 177.465 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 32' ' ' ASP . . . . . 0.583 ' O ' HG23 ' X' ' 36' ' ' VAL . 11.0 m-20 -67.87 -57.8 5.65 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.043 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 33' ' ' VAL . . . . . 0.677 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 85.6 t -86.36 -29.02 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.472 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 34' ' ' LEU . . . . . 0.636 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.01 -44.25 87.13 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.62 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 35' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 28.1 t70 -71.7 -35.2 70.15 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.287 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 36' ' ' VAL . . . . . 0.583 HG23 ' O ' ' X' ' 32' ' ' ASP . 80.9 t -57.76 -49.85 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.008 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 37' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 64.9 mt -68.12 -43.21 78.92 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.615 -172.179 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 38' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.5 mt -60.58 -49.09 78.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 124.154 0.909 . . . . 0.0 111.876 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 39' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.6 pt-20 -71.36 -36.39 71.47 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.8 178.549 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 40' ' ' HIS . . . . . 0.513 ' O ' HG12 ' X' ' 44' ' ' ILE . 13.6 t60 -62.72 -46.53 87.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 41' ' ' PHE . . . . . 0.644 ' O ' HG22 ' X' ' 45' ' ' THR . 54.8 t80 -58.02 -56.03 27.24 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 42' ' ' VAL . . . . . 0.435 HG12 ' O ' ' X' ' 38' ' ' LEU . 10.6 p -67.06 -32.87 59.83 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 43' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 9.2 pttp -70.3 -31.99 69.56 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.026 -179.068 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 44' ' ' ILE . . . . . 0.513 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.9 pt -83.24 -37.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.164 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 45' ' ' THR . . . . . 0.644 HG22 ' O ' ' X' ' 41' ' ' PHE . 7.3 t -84.78 -29.59 25.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.22 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 60.44 34.69 20.49 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.418 1.087 . . . . 0.0 111.549 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 47' ' ' HIS . . . . . 0.55 ' H ' HG23 ' X' ' 45' ' ' THR . 45.1 t-80 -85.3 134.26 40.94 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 114.542 -1.208 . . . . 0.0 107.742 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 21.7 Cg_exo -69.63 -15.55 37.64 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.945 2.43 . . . . 0.0 113.146 -174.68 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 10.8 m-20 -124.29 29.29 6.41 Favored 'General case' 0 N--CA 1.402 -2.827 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -173.433 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 50' ' ' GLY . . . . . 0.525 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -58.05 5.12 Favored Glycine 1 CA--C 1.447 -4.186 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.473 -176.73 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' X' X ' 51' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -75.66 -33.23 60.42 Favored 'General case' 1 C--N 1.242 -4.091 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.512 -171.876 . . . . . . . . 4 4 . 1 . 030 nuclear build full ' X' X ' 52' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.11 -37.03 76.21 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.527 177.234 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 42.6 mt -57.82 -44.73 86.61 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.774 0.671 . . . . 0.0 112.007 177.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 54' ' ' ILE . . . . . 0.603 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.0 mp -67.38 -43.46 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.645 -179.651 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 55' ' ' TYR . . . . . 0.519 ' HD1' ' O ' ' X' ' 51' ' ' THR . 29.6 m-85 -55.03 -47.46 74.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.292 177.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 56' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.1 pt-20 -71.53 -36.74 71.1 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 176.079 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.03 83.49 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 118.184 0.447 . . . . 0.0 110.784 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.89 81.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.963 178.089 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.43 -43.52 85.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.188 0.518 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 60' ' ' ARG . . . . . 0.55 ' O ' ' HD3' ' X' ' 65' ' ' PRO . 63.3 mtm180 -66.53 -30.96 71.39 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.593 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.31 58.78 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.306 176.55 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.84 91.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.85 -48.29 59.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.87 85.72 0.15 Allowed Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 125.98 1.712 . . . . 0.0 112.441 178.209 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 65' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 47.9 Cg_endo -99.12 5.4 0.98 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.91 2.407 . . . . 0.0 111.937 177.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.82 -151.75 23.38 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -177.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -93.16 -15.96 49.27 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.289 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -67.73 92.73 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.82 0.93 86.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.103 176.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.64 71.87 1.51 Allowed Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.78 173.93 13.11 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.931 178.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.8 Cg_endo -62.87 -38.4 48.24 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.637 2.891 . . . . 0.0 111.845 -179.017 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.8 -0.2 12.69 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.16 -22.3 7.97 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.771 176.066 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 75' ' ' ILE . . . . . 0.521 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -67.19 -42.74 88.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.356 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' X' X ' 76' ' ' VAL . . . . . 0.779 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -58.76 -41.3 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.785 177.487 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' X' X ' 77' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' X' ' 80' ' ' LYS . 26.1 ttpp -60.06 -48.61 80.99 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.809 177.159 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.42 -45.11 84.96 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.888 0.851 . . . . 0.0 110.053 176.695 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 79' ' ' ILE . . . . . 0.469 HG23 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -61.46 -40.81 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.881 176.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 80' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' X' ' 77' ' ' LYS . 0.4 OUTLIER -71.67 -39.97 69.92 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.458 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.11 -41.97 85.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 82' ' ' TRP . . . . . 0.401 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 57.8 t90 -64.08 -46.85 82.44 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.65 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 83' ' ' ARG . . . . . 0.724 HH12 HG12 ' X' ' 7' ' ' ILE . 0.8 OUTLIER -66.28 -39.72 89.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.783 176.874 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.69 96.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.555 0.534 . . . . 0.0 110.864 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.03 83.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.857 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.31 -49.2 15.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.43 0.633 . . . . 0.0 110.381 -176.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.52 27.99 3.92 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -99.04 155.52 36.48 Favored Pre-proline 0 N--CA 1.406 -2.625 0 C-N-CA 123.342 0.657 . . . . 0.0 109.903 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.58 110.89 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.698 2.265 . . . . 0.0 111.947 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 90' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -85.28 -111.22 0.71 Allowed Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.468 -177.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -109.87 164.21 12.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.357 -179.028 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.519 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 21.1 ptmt -91.45 168.04 11.83 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.014 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -93.47 139.44 30.71 Favored 'General case' 0 C--N 1.266 -3.053 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.393 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.744 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.553 HD22 HD13 ' X' ' 18' ' ' LEU . 29.6 mt . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 120.992 0.425 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 31.3 mmtt -95.93 -165.51 1.29 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -109.35 -33.9 6.7 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.112 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 69.6 p -127.17 166.62 17.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.304 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.451 HD11 ' CE1' ' X' ' 91' ' ' PHE . 9.7 tp -65.36 -18.03 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 110.47 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.5 m -83.6 -9.59 58.81 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.606 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 22.0 t70 -104.44 -1.0 27.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.52 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.29 120.0 31.06 Favored 'General case' 0 CA--C 1.47 -2.112 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.407 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 75.0 p -83.03 170.41 14.89 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 172.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.649 ' O ' HG13 ' X' ' 16' ' ' VAL . 5.8 pt-20 -58.33 -46.11 86.82 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.322 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.478 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.09 -38.24 75.62 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -64.78 -32.91 74.82 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 121.671 -0.643 . . . . 0.0 110.646 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 29.1 t80 -71.36 -43.64 66.54 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.725 HG12 HG11 ' X' ' 76' ' ' VAL . 3.5 m -62.79 -28.98 45.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.739 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -61.63 -45.9 92.07 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.573 ' O ' HG13 ' X' ' 22' ' ' ILE . 29.5 tp -61.76 -47.19 86.31 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 123.858 0.724 . . . . 0.0 109.629 175.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -58.23 -37.57 75.13 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.031 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.1 mttm -70.62 -35.67 73.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.42 -36.75 74.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.947 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.66 HG12 ' HB3' ' X' ' 37' ' ' LEU . 56.2 mt -63.01 -41.71 93.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -47.57 81.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.495 1.118 . . . . 0.0 108.618 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -61.39 -52.68 63.62 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.32 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -72.22 -25.64 61.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.34 -46.45 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.78 -25.36 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.717 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.31 -26.79 35.38 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.96 68.44 0.63 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.398 1.479 . . . . 0.0 111.682 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.8 p -99.47 -171.66 2.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -131.93 -44.82 0.95 Allowed 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 118.205 -1.398 . . . . 0.0 112.585 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.666 ' O ' HG23 ' X' ' 36' ' ' VAL . 21.7 t70 -64.78 -52.48 56.67 Favored 'General case' 0 CA--C 1.476 -1.894 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.775 -172.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -85.8 -30.41 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 O-C-N 123.714 0.634 . . . . 0.0 110.64 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -59.1 -47.35 85.57 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.59 -26.88 64.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.285 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.666 HG23 ' O ' ' X' ' 32' ' ' ASP . 92.9 t -67.11 -50.26 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 C-N-CA 118.622 -1.231 . . . . 0.0 108.79 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.66 ' HB3' HG12 ' X' ' 22' ' ' ILE . 67.2 mt -68.64 -39.48 80.72 Favored 'General case' 0 N--CA 1.41 -2.436 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.935 -170.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.9 mt -59.26 -49.18 78.82 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 124.253 0.971 . . . . 0.0 110.431 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.57 -39.97 73.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.693 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.495 ' O ' HG12 ' X' ' 44' ' ' ILE . 12.8 t60 -59.62 -46.22 89.64 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.412 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.545 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 56.3 t80 -60.32 -52.99 62.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.649 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.472 HG12 ' O ' ' X' ' 38' ' ' LEU . 7.4 p -66.65 -31.01 51.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -73.0 -33.57 65.87 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.75 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.495 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.1 pt -84.05 -35.74 11.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.238 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.424 HG22 HG21 ' X' ' 79' ' ' ILE . 75.8 p -81.72 -34.67 30.43 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 64.96 22.4 12.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.825 1.65 . . . . 0.0 110.338 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.474 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 34.1 t-80 -72.61 133.67 82.46 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.517 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 34.6 Cg_exo -67.46 -17.94 49.11 Favored 'Trans proline' 0 CA--C 1.499 -1.274 0 C-N-CA 123.119 2.546 . . . . 0.0 111.639 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 9.4 m-20 -124.13 33.68 5.23 Favored 'General case' 0 N--CA 1.383 -3.788 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.545 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -56.15 6.03 Favored Glycine 0 CA--C 1.457 -3.569 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.839 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.555 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.369 0.4 OUTLIER -85.85 -18.3 33.21 Favored 'General case' 0 C--N 1.25 -3.719 0 C-N-CA 117.116 -1.834 . . . . 0.0 114.26 -175.883 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.88 -31.6 72.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.8 mt -66.91 -38.42 86.2 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 123.691 0.619 . . . . 0.0 111.212 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.53 HD13 HG21 ' X' ' 75' ' ' ILE . 21.0 mm -66.57 -48.12 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.244 1.021 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.472 ' HD1' ' O ' ' X' ' 51' ' ' THR . 43.8 m-85 -64.39 -40.74 96.41 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 113.715 -1.584 . . . . 0.0 113.914 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.15 -36.92 72.22 Favored 'General case' 0 C--O 1.194 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.858 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 O-C-N 123.122 0.264 . . . . 0.0 110.553 179.697 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.403 -3.509 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.497 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.5 Cg_endo -57.87 -40.15 80.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.792 2.995 . . . . 0.0 112.887 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.45 0.66 9.67 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.74 -3.98 30.13 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.829 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.53 HG21 HD13 ' X' ' 54' ' ' ILE . 1.8 mt -78.13 -46.02 26.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.725 HG11 HG12 ' X' ' 16' ' ' VAL . 0.8 OUTLIER -56.47 -44.47 80.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.648 176.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.3 ttmm -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.309 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.51 -38.51 65.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.424 HG21 HG22 ' X' ' 45' ' ' THR . 44.6 mm -67.31 -39.45 82.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.003 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 21.2 ptmt -61.59 -38.28 87.0 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.65 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -72.33 -39.09 68.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.433 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 59.4 t90 -67.36 -47.14 71.29 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.049 0.452 . . . . 0.0 110.026 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.536 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 10.6 tpt180 -60.83 -45.08 95.88 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.457 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.77 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.363 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.92 95.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.048 0.452 . . . . 0.0 111.513 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -69.04 -28.97 67.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.51 9.12 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.536 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 53.7 mttm -104.8 147.9 35.21 Favored Pre-proline 0 N--CA 1.405 -2.68 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -68.01 122.56 9.67 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 121.856 1.704 . . . . 0.0 109.643 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -96.82 -129.0 6.02 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.243 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.451 ' CE1' HD11 ' X' ' 7' ' ' ILE . 29.7 m-85 -78.18 158.1 29.14 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.059 -0.57 . . . . 0.0 110.535 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' X' ' 11' ' ' THR . 39.7 pttt -101.89 175.23 5.61 Favored 'General case' 0 N--CA 1.38 -3.968 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -105.75 144.25 32.76 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.417 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 58.3 mt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 29.4 mmtt -103.2 168.0 9.46 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.68 -27.12 34.18 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.582 0.706 . . . . 0.0 110.479 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.4 p -134.18 163.12 30.31 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' X' ' 91' ' ' PHE . 6.0 tp -68.0 -18.1 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.155 0.982 . . . . 0.0 109.854 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.0 p -76.45 -16.23 59.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.646 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 4.0 t70 -104.07 2.66 32.35 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -97.36 120.86 38.5 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.907 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.431 HG22 ' HG3' ' X' ' 92' ' ' LYS . 74.7 p -79.31 163.16 25.12 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 167.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.64 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.6 pt-20 -59.03 -35.65 73.65 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.102 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.45 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.42 -39.37 74.46 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -58.81 -37.16 75.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.934 0.874 . . . . 0.0 109.282 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.639 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 38.1 t80 -74.82 -39.53 61.6 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.475 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.696 HG12 HG11 ' X' ' 76' ' ' VAL . 8.6 m -62.69 -29.87 47.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.257 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.04 -50.09 75.39 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.673 ' O ' HG13 ' X' ' 22' ' ' ILE . 46.6 tp -59.7 -46.47 89.0 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.799 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 34.4 mt -57.29 -43.28 83.05 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.232 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 98.5 mttt -61.49 -46.54 89.57 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.964 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.09 -39.32 89.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.796 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.673 HG13 ' O ' ' X' ' 18' ' ' LEU . 50.7 mt -60.77 -44.71 97.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 O-C-N 123.337 0.398 . . . . 0.0 110.59 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.454 ' O ' HG22 ' X' ' 27' ' ' VAL . 46.8 mt-10 -57.02 -46.06 82.64 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.398 0.618 . . . . 0.0 109.723 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.15 -46.85 88.29 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.387 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -85.83 -30.39 23.0 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.305 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.65 -44.64 85.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.092 0.157 . . . . 0.0 111.183 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . 0.454 HG22 ' O ' ' X' ' 23' ' ' GLU . 32.4 m -71.11 -22.53 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.57 -24.99 22.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.68 88.9 0.11 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.899 1.68 . . . . 0.0 110.867 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.614 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 44.7 p -96.89 -151.88 0.37 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.92 -66.82 0.37 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 112.726 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.601 ' O ' HG23 ' X' ' 36' ' ' VAL . 38.1 t70 -66.98 -46.26 75.14 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.23 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.8 p -81.66 -28.13 10.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.046 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.614 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.7 tm? -58.73 -52.54 65.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.321 1.049 . . . . 0.0 108.823 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.5 -19.71 62.91 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.601 HG23 ' O ' ' X' ' 32' ' ' ASP . 97.7 t -72.02 -52.11 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.027 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.875 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.621 ' HB3' HG12 ' X' ' 22' ' ' ILE . 41.4 mt -69.42 -43.7 72.87 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.552 -168.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.4 mt -59.72 -46.77 88.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 124.567 1.167 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -71.43 -40.56 70.34 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.556 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.3 t60 -59.71 -45.7 91.35 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.508 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.589 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.22 -52.79 63.81 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.467 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.456 HG12 ' O ' ' X' ' 38' ' ' LEU 0.267 11.8 p -67.67 -31.94 54.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.0 ptmm? -70.59 -33.2 70.81 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.711 -0.618 . . . . 0.0 112.151 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.486 HG12 ' O ' ' X' ' 40' ' ' HIS . 14.5 pt -84.81 -33.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.564 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.446 HG22 HG21 ' X' ' 79' ' ' ILE . 76.2 p -84.42 -35.77 22.85 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 120.965 0.412 . . . . 0.0 110.654 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.01 25.73 15.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.952 1.701 . . . . 0.0 110.163 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 26.3 t-80 -74.02 134.07 78.11 Favored Pre-proline 0 N--CA 1.429 -1.51 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.548 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -71.33 -9.71 25.8 Favored 'Trans proline' 0 CA--C 1.496 -1.423 0 C-N-CA 122.989 2.46 . . . . 0.0 112.058 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.429 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.0 m-20 -130.31 29.66 4.84 Favored 'General case' 0 N--CA 1.396 -3.145 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -170.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.589 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.59 -59.04 5.61 Favored Glycine 0 CA--C 1.461 -3.298 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.199 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.488 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -74.67 -28.89 61.03 Favored 'General case' 0 C--N 1.247 -3.891 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.547 -172.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.07 -35.74 81.73 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -61.74 -39.07 90.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.605 0.566 . . . . 0.0 111.522 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.583 HD13 HG21 ' X' ' 22' ' ' ILE . 36.8 mt -67.17 -47.05 82.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.412 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.6 m-85 -57.91 -45.7 86.08 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.432 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.0 pt-20 -70.4 -39.94 74.2 Favored 'General case' 0 C--O 1.201 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.737 0 CA-C-N 117.727 0.24 . . . . 0.0 110.883 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.221 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.557 ' O ' HG13 ' X' ' 75' ' ' ILE . 34.0 Cg_endo -71.95 -22.03 23.68 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 123.725 2.95 . . . . 0.0 113.325 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -72.55 0.44 10.47 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.2 -14.06 23.34 Favored Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.889 -1.624 . . . . 0.0 113.275 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.557 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.9 OUTLIER -70.2 -43.39 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.696 HG11 HG12 ' X' ' 16' ' ' VAL . 1.1 p -59.85 -47.07 92.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.686 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.86 -42.35 97.67 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.24 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.2 -40.6 86.25 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.446 HG21 HG22 ' X' ' 45' ' ' THR . 41.0 mm -67.21 -46.43 84.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.928 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -63.82 -35.68 81.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.759 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.57 -41.48 92.89 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.979 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.548 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 84.1 t90 -66.41 -47.99 71.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 11.9 tpt180 -61.27 -45.52 94.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.43 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.72 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.219 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.26 -26.5 66.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.978 0.418 . . . . 0.0 111.308 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -85.24 -12.25 52.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.78 37.71 44.23 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.991 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.0 mtpp -117.25 137.83 24.36 Favored Pre-proline 0 N--CA 1.392 -3.353 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.7 129.79 27.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.346 2.03 . . . . 0.0 110.42 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.0 -114.6 3.38 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.187 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' X' ' 7' ' ' ILE . 72.4 m-85 -83.67 152.22 24.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.095 -0.553 . . . . 0.0 110.958 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.8 ptmt -87.73 166.73 14.42 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -105.92 142.21 36.01 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 176.038 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.418 ' CD2' HD21 ' X' ' 18' ' ' LEU . 94.8 mt . . . . . 0 CA--C 1.493 -1.244 0 CA-C-O 120.693 0.282 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.545 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 28.6 mmtt -101.72 -159.45 0.73 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.04 -23.58 8.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -143.14 166.69 23.98 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tp -62.7 -18.67 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -77.52 -4.37 45.29 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.711 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.545 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 9.6 t70 -112.34 -3.8 14.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.476 ' CZ ' ' HG2' ' X' ' 4' ' ' LYS . 39.4 m-85 -93.99 116.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.706 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 70.8 p -75.77 173.48 11.06 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 170.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.65 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.9 pt-20 -56.09 -44.54 79.11 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.303 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.404 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.58 -38.57 74.09 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 32.1 mm-40 -58.89 -36.61 74.94 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.729 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -67.33 -50.09 61.43 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.706 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.773 HG12 HG11 ' X' ' 76' ' ' VAL . 2.7 m -61.56 -34.55 62.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 O-C-N 123.182 0.301 . . . . 0.0 111.328 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.62 77.18 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.196 0.998 . . . . 0.0 108.678 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.554 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -65.95 -41.2 91.57 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.153 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.3 mt -58.52 -37.59 75.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.226 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 76.7 mttt -66.52 -36.86 83.72 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.535 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.27 -33.11 61.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.688 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' X' ' 37' ' ' LEU . 48.1 mt -61.97 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.15 -35.02 79.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.57 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -70.21 -52.17 25.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.597 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -70.03 -18.18 63.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.464 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.68 -52.02 20.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.938 0.895 . . . . 0.0 110.26 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.6 -23.56 19.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.857 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.5 -4.23 57.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 0.0 109.616 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 49.36 62.41 2.64 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.693 1.597 . . . . 0.0 112.927 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.619 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 54.8 p -88.34 -177.84 5.75 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.77 -63.42 0.7 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.634 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.609 ' O ' HG23 ' X' ' 36' ' ' VAL . 30.8 m-20 -58.02 -48.59 79.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 12.0 p -84.56 -32.63 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.362 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.54 -44.71 93.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.82 -32.71 72.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.473 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.609 HG23 ' O ' ' X' ' 32' ' ' ASP . 71.6 t -59.27 -49.13 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-O 121.877 0.846 . . . . 0.0 109.121 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.724 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.3 mt -68.33 -40.58 81.55 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 113.415 -1.721 . . . . 0.0 110.889 -174.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -58.8 -49.29 78.25 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 124.316 1.01 . . . . 0.0 110.729 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -69.29 -42.09 75.94 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.287 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 43.2 t60 -61.38 -44.98 96.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.227 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.65 ' O ' HG22 ' X' ' 45' ' ' THR . 42.3 t80 -55.71 -53.08 60.94 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.693 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.408 HG12 ' O ' ' X' ' 38' ' ' LEU 0.293 8.1 p -66.77 -31.6 54.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -74.44 -33.13 62.85 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.055 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.541 HG12 ' O ' ' X' ' 40' ' ' HIS . 30.1 pt -79.9 -36.83 17.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.207 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.65 HG22 ' O ' ' X' ' 41' ' ' PHE . 10.0 t -85.41 -28.26 25.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 61.35 27.8 17.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.213 1.005 . . . . 0.0 110.839 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.517 ' H ' HG23 ' X' ' 45' ' ' THR . 47.3 t-80 -82.51 137.58 44.83 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' X' ' 47' ' ' HIS . 13.3 Cg_exo -75.14 0.01 9.48 Favored 'Trans proline' 0 CA--C 1.486 -1.889 0 C-N-CA 123.235 2.624 . . . . 0.0 113.067 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.487 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.5 m-20 -139.0 34.01 2.15 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.82 -56.08 9.07 Favored Glycine 0 CA--C 1.461 -3.326 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.091 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.564 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.332 0.8 OUTLIER -84.01 -20.1 33.34 Favored 'General case' 0 C--N 1.259 -3.345 0 C-N-CA 116.886 -1.926 . . . . 0.0 114.316 -176.574 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.16 -36.62 82.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 30.3 mt -61.83 -42.82 99.51 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 123.813 0.695 . . . . 0.0 112.236 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.61 -45.96 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.353 1.073 . . . . 0.0 108.831 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.59 -42.7 98.26 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.479 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -69.03 -35.18 76.33 Favored 'General case' 0 C--O 1.206 -1.221 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.402 175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 CA--C 1.501 -0.931 0 C-N-CA 122.704 0.402 . . . . 0.0 111.182 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.729 0 CA-C-O 121.314 0.397 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.54 ' O ' HG12 ' X' ' 76' ' ' VAL . 25.0 Cg_endo -71.98 -56.12 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.497 2.798 . . . . 0.0 114.076 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.01 0.59 1.81 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.39 -31.17 3.1 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.607 -1.758 . . . . 0.0 114.137 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.665 HG13 HD13 ' X' ' 19' ' ' LEU . 9.9 pt -67.11 -34.12 67.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 117.487 0.643 . . . . 0.0 110.602 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.773 HG11 HG12 ' X' ' 16' ' ' VAL . 0.2 OUTLIER -59.08 -43.26 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-O 121.997 0.903 . . . . 0.0 110.913 175.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 88.2 tttt -62.16 -47.24 85.4 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.33 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.22 -40.44 90.17 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.48 HD12 ' OG1' ' X' ' 45' ' ' THR . 22.5 mm -61.92 -46.23 96.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.485 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.488 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 20.3 pttp -70.41 -35.76 73.63 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.676 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 40.0 mt-10 -68.19 -39.88 82.37 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.209 0.318 . . . . 0.0 111.424 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -67.38 -48.1 68.41 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.173 0.511 . . . . 0.0 110.297 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.557 ' NH1' ' HA ' ' X' ' 45' ' ' THR . 15.9 ttt180 -70.98 -38.31 72.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.73 0.3 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -31.66 69.51 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.327 0.584 . . . . 0.0 110.378 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.517 ' ND2' ' HD3' ' X' ' 88' ' ' LYS . 39.9 t-20 -73.55 -30.71 63.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.201 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.07 26.7 25.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.517 ' HD3' ' ND2' ' X' ' 86' ' ' ASN . 21.7 mtpp -106.88 132.75 20.66 Favored Pre-proline 0 N--CA 1.399 -3.014 0 C-N-CA 123.491 0.717 . . . . 0.0 109.243 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.25 119.19 3.33 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.995 3.13 . . . . 0.0 113.768 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' X' ' 83' ' ' ARG . . . -95.15 -126.52 4.87 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.944 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 11.6 m-85 -84.84 165.65 17.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' X' ' 93' ' ' GLN . 19.5 ptmt -86.47 179.33 6.87 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . 0.453 ' O ' ' HE2' ' X' ' 92' ' ' LYS . 2.3 mp0 -96.55 139.3 32.85 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.615 0.722 . . . . 0.0 110.607 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.402 -3.627 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 177.204 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.456 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 83.7 mt . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' X' ' 9' ' ' ASP . 28.9 mmtt -111.66 -179.15 3.62 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -91.61 -39.26 11.97 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.192 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . 0.43 ' HA ' HG22 ' X' ' 44' ' ' ILE . 64.8 p -127.87 167.23 16.87 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.653 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.06 -14.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.63 0.772 . . . . 0.0 109.836 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -79.08 -17.93 54.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.34 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' X' ' 4' ' ' LYS . 5.3 t70 -98.36 1.34 46.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.67 119.8 33.13 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.473 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -78.0 159.75 28.59 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.647 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.1 pt-20 -65.64 -30.64 71.37 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.644 -1.622 . . . . 0.0 111.723 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.76 77.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.07 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -58.04 -40.06 79.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.79 0.805 . . . . 0.0 109.092 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.666 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.1 t80 -71.15 -44.92 64.59 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.905 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.737 HG12 HG11 ' X' ' 76' ' ' VAL . 4.0 m -62.43 -34.81 66.5 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.825 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.39 -45.43 88.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.718 0.807 . . . . 0.0 109.347 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.514 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -66.63 -43.79 83.75 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.228 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.3 mt -58.08 -46.05 86.12 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.773 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 63.6 mtpt -62.02 -35.83 79.73 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.766 0.826 . . . . 0.0 110.0 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -74.52 -35.37 63.16 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.715 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.514 HG13 ' O ' ' X' ' 18' ' ' LEU . 44.1 mt -59.69 -44.41 93.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.921 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.426 ' O ' HG22 ' X' ' 27' ' ' VAL . 42.8 mt-10 -56.93 -44.82 82.85 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.383 0.611 . . . . 0.0 110.475 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -60.31 -46.09 91.08 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.647 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.5 ' HB2' ' CG2' ' X' ' 30' ' ' THR . 3.1 pp20? -84.92 -30.32 24.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.749 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . 0.416 ' HA ' HD23 ' X' ' 34' ' ' LEU . 23.0 t-20 -63.02 -40.67 98.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.59 0.756 . . . . 0.0 111.698 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . 0.426 HG22 ' O ' ' X' ' 23' ' ' GLU . 34.7 m -80.5 -7.04 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.256 0.55 . . . . 0.0 111.313 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.03 -25.77 13.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.71 85.36 0.13 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.698 1.599 . . . . 0.0 110.297 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 72.7 p -92.07 -24.23 19.22 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 70.41 -50.81 0.66 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.37 1.868 . . . . 0.0 114.358 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.533 ' O ' HG23 ' X' ' 36' ' ' VAL . 14.3 t70 -70.25 -56.79 5.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 118.034 0.379 . . . . 0.0 110.23 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.5 p -80.87 -25.45 10.87 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.457 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.6 tm? -58.23 -48.31 80.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.779 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.71 -32.46 73.1 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.839 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.533 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.0 t -66.81 -50.69 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.549 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 35.4 mt -68.45 -43.81 76.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.02 -171.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.5 HD13 ' CG2' ' X' ' 51' ' ' THR . 46.4 mt -61.98 -45.67 92.61 Favored 'General case' 0 N--CA 1.419 -2.016 0 O-C-N 124.211 0.944 . . . . 0.0 111.707 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -70.3 -43.28 70.7 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.882 0.372 . . . . 0.0 111.757 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.478 ' O ' HG12 ' X' ' 44' ' ' ILE . 9.6 t60 -59.56 -45.14 92.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.328 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.599 ' O ' HG22 ' X' ' 45' ' ' THR . 27.5 t80 -59.68 -55.75 30.43 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.641 1.213 . . . . 0.0 110.824 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' X' ' 38' ' ' LEU 0.278 14.7 p -66.87 -31.64 54.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -69.84 -30.53 68.04 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.84 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.478 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.0 pt -85.27 -35.92 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.574 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.599 HG22 ' O ' ' X' ' 41' ' ' PHE . 4.7 t -84.47 -30.86 24.89 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.394 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.58 36.75 13.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 125.041 1.336 . . . . 0.0 110.34 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.464 ' H ' HG23 ' X' ' 45' ' ' THR . 26.2 t-80 -81.94 136.21 47.7 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.271 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 22.3 Cg_exo -70.96 -14.33 32.22 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.787 2.324 . . . . 0.0 111.941 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.427 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 22.3 m-20 -128.3 31.98 4.95 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -172.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.08 8.38 Favored Glycine 0 CA--C 1.457 -3.54 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.419 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.5 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.77 -33.94 58.03 Favored 'General case' 0 C--N 1.251 -3.697 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.055 -174.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.59 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.65 -31.88 69.94 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.191 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 mt -62.29 -48.51 79.55 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 123.574 0.546 . . . . 0.0 112.101 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.523 ' H ' HD12 ' X' ' 54' ' ' ILE . 4.4 mp -66.81 -40.43 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.742 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.45 ' HD1' ' O ' ' X' ' 51' ' ' THR . 27.1 m-85 -61.62 -43.29 99.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.78 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.9 pt-20 -71.97 -37.04 69.98 Favored 'General case' 0 C--O 1.203 -1.345 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.202 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 122.594 0.358 . . . . 0.0 110.978 178.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 114.429 0.531 . . . . 0.0 114.429 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' HG13 ' X' ' 75' ' ' ILE . 36.7 Cg_endo -60.05 -53.6 2.96 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 123.694 2.929 . . . . 0.0 114.701 -167.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.88 0.17 9.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . 0.596 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -105.58 -18.58 11.53 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.004 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.504 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.5 OUTLIER -67.26 -44.22 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.737 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -60.49 -39.75 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.656 176.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 22.5 ttpp -58.55 -47.67 83.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.856 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 7.2 mm-40 -58.01 -45.08 87.43 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.125 0.964 . . . . 0.0 109.196 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.489 HG12 ' O ' ' X' ' 75' ' ' ILE . 41.9 mm -61.62 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.447 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.1 ptpt -65.89 -38.31 88.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.983 -177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.65 -40.16 76.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.907 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 63.1 t90 -70.17 -46.77 63.96 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.787 0.327 . . . . 0.0 110.684 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.52 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 8.4 tpt180 -60.55 -45.58 93.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.38 88.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.947 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.33 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.974 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -69.4 -34.99 75.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.68 44.07 1.86 Allowed Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.484 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 54.9 mttm -119.5 146.42 41.17 Favored Pre-proline 0 N--CA 1.4 -2.941 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.78 124.68 15.47 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.634 2.223 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -88.39 -132.43 4.11 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.864 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 80.8 m-85 -89.54 166.18 13.82 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.32 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -99.28 166.99 10.94 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.21 144.5 25.76 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.673 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 CA--C 1.487 -1.476 0 CA-C-O 121.16 0.505 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.415 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 31.6 mmtt -105.3 -164.43 1.03 Allowed 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' X' ' 5' ' ' ASN . 11.6 m120 -114.25 -28.36 7.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.357 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -128.97 163.46 25.29 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -67.5 -16.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-O 121.471 0.653 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -79.1 -3.26 44.51 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.55 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.467 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.1 t0 -110.21 1.64 18.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.213 1.006 . . . . 0.0 108.92 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -93.75 121.01 34.74 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.521 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -82.37 176.14 9.67 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.572 ' O ' HG13 ' X' ' 16' ' ' VAL . 4.7 mm-40 -59.23 -51.97 67.7 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.799 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.84 -38.7 76.57 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.879 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.64 -40.97 80.48 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.172 0.51 . . . . 0.0 109.843 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.523 ' O ' HD13 ' X' ' 19' ' ' LEU . 30.2 t80 -75.06 -48.53 23.51 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.095 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.799 HG22 ' HA ' ' X' ' 13' ' ' ALA . 15.7 m -58.6 -38.58 71.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -66.8 -46.27 75.76 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 122.682 0.393 . . . . 0.0 111.027 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.562 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.4 tm? -62.95 -41.31 99.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.523 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.31 -36.86 76.4 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.148 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.704 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 61.4 mttm -63.58 -40.13 96.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.964 0.888 . . . . 0.0 108.816 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -65.13 -36.06 83.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.966 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.599 HG12 ' HB3' ' X' ' 37' ' ' LEU . 19.3 mt -63.74 -39.55 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.285 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -56.87 -46.07 82.07 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.602 0.564 . . . . 0.0 109.915 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -62.93 -43.89 97.56 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.081 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.08 -33.33 70.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.284 0.564 . . . . 0.0 109.885 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.37 -44.94 57.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.564 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.34 -29.86 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.744 0.307 . . . . 0.0 111.693 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -4.67 57.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.464 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 48.34 64.85 1.51 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.179 1.392 . . . . 0.0 112.256 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 72.7 p -83.22 -161.07 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -130.42 -71.16 0.6 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.393 -1.323 . . . . 0.0 114.398 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.611 ' O ' HG23 ' X' ' 36' ' ' VAL . 27.6 t70 -56.64 -52.43 64.9 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 68.9 t -86.83 -25.11 6.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.239 -174.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -58.79 -50.8 72.62 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.7 -19.81 61.33 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.611 HG23 ' O ' ' X' ' 32' ' ' ASP . 59.2 t -71.48 -49.76 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.074 0 C-N-CA 118.289 -1.365 . . . . 0.0 108.471 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' X' ' 22' ' ' ILE . 88.5 mt -68.5 -43.54 76.62 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.091 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.5 mt -60.54 -47.09 87.7 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 124.337 1.023 . . . . 0.0 110.457 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -71.03 -43.72 67.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.618 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 39.1 t60 -60.34 -45.58 92.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.223 0.535 . . . . 0.0 110.062 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.622 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 38.4 t80 -59.14 -53.0 63.25 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.191 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.506 HG12 ' O ' ' X' ' 38' ' ' LEU . 13.1 p -67.99 -32.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -67.0 -36.98 83.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 122.07 -0.394 . . . . 0.0 111.502 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.566 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -81.1 -34.1 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.855 0.36 . . . . 0.0 111.378 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 35.2 p -83.84 -42.46 16.4 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.96 74.97 0.42 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 125.173 1.389 . . . . 0.0 109.583 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.559 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -126.11 139.01 33.32 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.164 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.46 -7.89 22.18 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.794 2.329 . . . . 0.0 112.31 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 16.3 m-20 -135.21 31.9 3.18 Favored 'General case' 0 N--CA 1.391 -3.386 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.622 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.81 -58.2 8.77 Favored Glycine 0 CA--C 1.461 -3.316 0 O-C-N 123.679 0.612 . . . . 0.0 112.704 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.472 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.23 -28.65 63.3 Favored 'General case' 0 C--N 1.248 -3.82 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.148 -174.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.78 -34.34 77.94 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.323 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.57 -45.4 77.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.905 0.482 . . . . 0.0 110.052 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.595 HD13 HG21 ' X' ' 22' ' ' ILE . 23.4 mt -66.84 -44.37 89.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.608 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -59.49 -49.68 76.86 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.754 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.7 pt-20 -66.94 -35.76 80.7 Favored 'General case' 0 C--O 1.188 -2.158 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.634 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.89 0.376 . . . . 0.0 110.763 179.122 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.636 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.581 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.0 Cg_endo -59.12 -38.64 85.6 Favored 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.536 2.824 . . . . 0.0 113.48 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.438 ' C ' HG22 ' X' ' 76' ' ' VAL . 23.3 mt-10 -85.03 1.65 46.74 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 123.212 0.605 . . . . 0.0 109.918 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.05 -36.91 2.08 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.36 -1.4 . . . . 0.0 112.641 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' X' ' 72' ' ' PRO . 5.8 pt -60.71 -34.33 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 172.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.676 HG11 HG12 ' X' ' 16' ' ' VAL . 16.6 m -56.62 -39.36 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.559 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 23.4 ttmm -68.77 -39.41 80.23 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.041 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -67.08 -32.15 73.13 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.965 0.888 . . . . 0.0 109.155 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.491 ' HA ' HH21 ' X' ' 83' ' ' ARG . 83.0 mt -67.62 -46.35 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.873 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 14.4 ptmm? -67.71 -36.27 80.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 111.105 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.1 mt-10 -70.45 -36.79 74.15 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.899 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -66.8 -41.16 88.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.559 HH22 ' CD2' ' X' ' 47' ' ' HIS . 0.5 OUTLIER -61.87 -46.27 90.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.379 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.65 91.78 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.796 0.685 . . . . 0.0 111.517 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.937 0.398 . . . . 0.0 110.85 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -68.33 -48.54 64.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.486 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.52 4.77 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.91 151.6 37.54 Favored Pre-proline 0 N--CA 1.407 -2.58 0 C-N-CA 123.933 0.893 . . . . 0.0 108.828 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.97 140.96 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.978 1.785 . . . . 0.0 111.617 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.82 -131.3 6.61 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 10.7 m-85 -93.46 159.36 15.28 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 19.7 ptmt -93.94 172.8 8.01 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -96.25 135.69 37.73 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.712 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.203 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.163 178.406 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.406 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 87.3 mt . . . . . 0 N--CA 1.428 -1.554 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 26.1 mmtt -105.89 152.53 23.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -80.2 -11.7 59.71 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.138 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 67.5 p -141.88 162.3 35.81 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -69.4 -13.07 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 121.643 0.735 . . . . 0.0 110.676 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -77.98 -17.91 56.6 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 14.3 t70 -102.43 5.33 39.56 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.6 m-85 -94.03 114.32 26.47 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.938 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.421 HG22 ' HG3' ' X' ' 92' ' ' LYS . 53.2 p -77.32 157.11 30.87 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.431 ' O ' HG12 ' X' ' 16' ' ' VAL . 6.2 pt-20 -64.67 -26.39 68.36 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.734 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.74 69.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.677 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -57.32 -41.65 80.36 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.266 0.555 . . . . 0.0 109.537 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -64.98 -58.27 6.54 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.041 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.627 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 13.8 p -63.43 -29.55 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -60.21 -44.73 94.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.524 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.3 tm? -67.22 -40.92 86.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.547 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.2 mt -58.27 -36.63 73.56 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.34 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 54.5 mtpt -66.84 -35.74 80.74 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.327 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 12.0 pt-20 -75.5 -31.43 60.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.851 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' X' ' 18' ' ' LEU . 49.9 mt -60.3 -39.99 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 123.77 0.669 . . . . 0.0 109.843 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -58.35 -41.21 84.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.559 0.695 . . . . 0.0 109.635 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.44 -47.79 46.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.401 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.71 ' OE2' ' HA ' ' X' ' 34' ' ' LEU 0.274 0.0 OUTLIER -75.47 -19.5 59.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.446 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . 0.458 HD21 HD21 ' X' ' 38' ' ' LEU . 2.2 m-80 -76.77 -42.1 42.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.385 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 -34.51 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.314 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.24 48.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.66 0.267 . . . . 0.0 110.464 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.83 95.77 0.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.173 1.389 . . . . 0.0 111.977 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 38.8 p -107.66 -171.37 1.86 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -136.34 -20.19 1.42 Allowed 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.102 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.564 ' O ' HG23 ' X' ' 36' ' ' VAL . 10.9 m-20 -85.51 -61.85 1.67 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.154 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.593 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.6 p -76.55 -26.93 16.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.007 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.71 ' HA ' ' OE2' ' X' ' 25' ' ' GLU . 3.1 tm? -58.78 -44.66 90.74 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 124.333 1.021 . . . . 0.0 108.701 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.7 t70 -72.42 -36.77 68.69 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.363 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.564 HG23 ' O ' ' X' ' 32' ' ' ASP . 47.2 t -63.66 -49.79 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 O-C-N 124.324 1.015 . . . . 0.0 110.609 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 41.2 mt -68.14 -41.14 82.1 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.991 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 14.4 mt -59.45 -49.66 76.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 O-C-N 124.437 1.085 . . . . 0.0 111.815 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.3 pt-20 -70.98 -42.29 69.87 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.102 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.485 ' O ' HG12 ' X' ' 44' ' ' ILE . 69.9 t60 -60.26 -45.72 92.3 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.014 0.526 . . . . 0.0 110.373 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.653 ' O ' HG22 ' X' ' 45' ' ' THR . 39.4 t80 -57.95 -53.72 55.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 124.265 0.978 . . . . 0.0 110.834 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -66.34 -31.06 51.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -63.38 -47.46 81.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.494 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 4.9 pt -75.15 -36.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.653 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.67 -31.58 24.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.509 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 61.91 29.59 17.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.914 0.864 . . . . 0.0 111.319 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.541 ' H ' HG23 ' X' ' 45' ' ' THR . 50.5 t-80 -77.94 135.87 62.77 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 30.3 Cg_exo -66.11 -19.22 57.22 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 123.151 2.567 . . . . 0.0 112.316 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.98 36.22 4.35 Favored 'General case' 0 N--CA 1.393 -3.296 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.585 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.64 -55.91 7.76 Favored Glycine 0 CA--C 1.462 -3.226 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.136 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.448 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -77.0 -26.17 53.55 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.332 -171.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.58 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.14 -36.71 83.86 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.303 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.3 -38.93 85.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 123.504 0.503 . . . . 0.0 111.729 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -66.73 -47.26 83.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.704 0.764 . . . . 0.0 109.416 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -63.67 -46.87 83.59 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.86 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.9 pt-20 -68.53 -36.39 78.78 Favored 'General case' 0 C--O 1.196 -1.758 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.79 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 CA-C-N 118.246 0.475 . . . . 0.0 111.561 -179.485 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.385 -4.764 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.538 ' HA ' HD11 ' X' ' 75' ' ' ILE . 2.9 Cg_endo -64.42 -30.94 62.45 Favored 'Trans proline' 0 CA--C 1.497 -1.366 0 C-N-CA 122.854 2.369 . . . . 0.0 111.14 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.04 -4.18 56.21 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.891 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.84 -15.41 14.94 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.284 -1.912 . . . . 0.0 113.007 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.55 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -68.04 -49.2 70.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' X' ' 16' ' ' VAL . 1.2 p -55.49 -45.57 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.841 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 56.0 tttp -59.8 -47.3 86.27 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.399 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.55 HG12 ' O ' ' X' ' 75' ' ' ILE . 46.7 mm -66.03 -45.42 90.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.873 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.5 ptpt -61.98 -42.17 98.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.905 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.62 -38.75 70.76 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.54 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 85.1 t90 -66.17 -47.92 72.42 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 110.715 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.572 ' HG2' ' HB2' ' X' ' 88' ' ' LYS . 3.4 ttt-85 -68.9 -41.6 78.02 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.222 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.41 84.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.2 86.72 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.525 0.202 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.468 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.0 t-20 -63.29 -43.82 96.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.37 18.89 6.45 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.572 ' HB2' ' HG2' ' X' ' 83' ' ' ARG . 68.5 mttm -99.15 158.64 31.92 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' X' ' 83' ' ' ARG . 36.8 Cg_endo -71.5 130.0 16.58 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.434 1.423 . . . . 0.0 110.819 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -119.41 2.37 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.291 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.429 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.7 m-85 -96.74 154.52 17.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 120.524 0.202 . . . . 0.0 110.539 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.421 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.9 ptmt -89.86 176.28 6.88 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.23 137.51 33.32 Favored 'General case' 0 N--CA 1.398 -3.04 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.184 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.26 0 CA-C-O 118.074 -1.403 . . . . 0.0 110.304 177.857 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.493 -1.229 0 CA-C-O 121.18 0.514 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 40.1 mmtt -103.12 -170.3 1.77 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 171.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -112.41 -24.28 9.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.064 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.5 p -134.35 164.88 26.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.03 -12.52 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.617 0.722 . . . . 0.0 111.051 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -76.07 -18.43 59.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.527 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.426 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.2 t70 -102.74 2.74 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.239 1.019 . . . . 0.0 108.454 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -96.05 113.41 25.02 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.218 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 62.2 p -73.53 160.56 31.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.638 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.83 -32.19 71.58 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.566 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.61 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.4 -39.04 74.72 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.536 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 22.7 mm-40 -58.07 -42.35 85.31 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.552 1.168 . . . . 0.0 108.61 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.33 -47.48 60.87 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 113.137 -1.847 . . . . 0.0 110.492 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.711 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 22.8 m -58.49 -39.41 75.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.394 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.5 -50.57 73.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.251 0.62 . . . . 0.0 111.25 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.522 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.5 tm? -66.52 -40.36 89.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.723 0.773 . . . . 0.0 109.041 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' X' ' 75' ' ' ILE . 9.9 tp -59.66 -42.61 93.22 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.957 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.5 mttt -61.43 -34.84 76.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.201 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.32 -41.59 85.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.025 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' X' ' 37' ' ' LEU . 13.0 mt -57.52 -42.49 81.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.23 -44.83 88.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.493 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -67.57 -45.48 75.45 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.054 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.454 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -69.8 -19.04 63.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.418 177.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.06 -46.53 10.39 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.275 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.94 -32.36 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.26 -6.3 57.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.732 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.99 80.4 0.11 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.754 1.622 . . . . 0.0 113.323 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.645 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 64.2 p -91.68 -165.48 1.36 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.23 -73.09 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.089 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.618 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.2 t70 -60.35 -51.21 70.46 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 123.434 0.459 . . . . 0.0 111.449 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.68 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.0 p -73.03 -35.27 47.95 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.363 -175.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.645 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.4 tm? -58.95 -47.6 84.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.703 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.35 -41.5 98.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.319 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.618 HG23 ' O ' ' X' ' 32' ' ' ASP . 77.9 t -56.71 -49.56 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 O-C-N 123.77 0.669 . . . . 0.0 109.927 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 86.1 mt -68.41 -43.79 76.44 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.982 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 29.6 mt -61.21 -48.47 81.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 124.154 0.909 . . . . 0.0 110.637 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -70.72 -41.53 71.79 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.131 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.553 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.9 t60 -61.29 -45.91 92.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.238 0.542 . . . . 0.0 109.846 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.641 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.2 t80 -59.14 -52.6 64.99 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.334 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.432 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.1 p -67.62 -32.15 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 53.1 pttt -68.48 -39.61 81.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.53 HG12 ' O ' ' X' ' 40' ' ' HIS . 27.4 pt -77.67 -31.38 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.5 p -84.07 -39.99 18.88 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . 0.403 ' HB2' ' NH1' ' X' ' 83' ' ' ARG . 6.4 mm-40 67.07 20.19 10.38 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 123.915 0.886 . . . . 0.0 111.24 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.415 ' HA ' ' HD3' ' X' ' 48' ' ' PRO . 39.7 t-80 -80.73 133.25 55.8 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.431 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.2 Cg_exo -71.34 -2.26 10.94 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.488 2.792 . . . . 0.0 113.043 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 15.1 m-20 -130.05 27.65 5.11 Favored 'General case' 0 N--CA 1.394 -3.237 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.641 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -43.73 -60.28 3.41 Favored Glycine 0 CA--C 1.459 -3.407 0 O-C-N 124.388 1.055 . . . . 0.0 112.931 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.497 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.35 -29.33 63.7 Favored 'General case' 0 C--N 1.251 -3.711 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.716 -173.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.611 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.2 -30.47 70.94 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 97.9 mt -61.05 -41.52 96.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.153 0.502 . . . . 0.0 109.752 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.593 HD13 HG21 ' X' ' 22' ' ' ILE . 57.0 mt -67.21 -46.24 84.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.095 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -58.39 -49.52 76.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.645 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.5 pt-20 -68.0 -37.24 81.21 Favored 'General case' 0 C--O 1.207 -1.169 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.693 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.663 0.21 . . . . 0.0 110.81 178.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.372 -5.59 0 CA-C-O 120.795 0.108 . . . . 0.0 112.889 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.522 ' O ' HG13 ' X' ' 76' ' ' VAL . 11.6 Cg_endo -64.31 -48.29 4.88 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 124.645 3.563 . . . . 0.0 112.349 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.487 ' C ' HG22 ' X' ' 76' ' ' VAL . 42.0 mt-10 -77.78 1.92 18.65 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.0 -39.3 2.33 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 118.651 -1.738 . . . . 0.0 112.769 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.557 ' O ' HG13 ' X' ' 79' ' ' ILE . 3.1 pt -62.73 -28.25 44.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 CA-C-N 117.495 0.647 . . . . 0.0 110.94 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.595 HG11 HG12 ' X' ' 16' ' ' VAL . 21.6 m -60.27 -36.11 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.945 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 83.6 tttt -65.86 -41.93 91.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.653 174.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' X' ' 75' ' ' ILE . 7.8 tp10 -58.07 -44.13 87.35 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.557 HG13 ' O ' ' X' ' 75' ' ' ILE . 82.9 mt -67.42 -46.34 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.618 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.6 ptmt -64.3 -37.77 88.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.38 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.84 -38.38 73.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 62.8 t90 -65.49 -47.36 76.29 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.797 0.808 . . . . 0.0 109.626 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 16.9 tpt180 -61.15 -45.8 93.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.693 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.93 81.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.125 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -32.79 73.67 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.442 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 25.3 t-20 -78.77 -48.81 14.14 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.55 34.3 1.45 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.442 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 66.6 mttm -103.81 141.85 23.38 Favored Pre-proline 0 N--CA 1.392 -3.368 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.39 121.51 9.34 Favored 'Trans proline' 0 CA--C 1.517 -0.34 0 C-N-CA 122.135 1.89 . . . . 0.0 110.956 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -95.14 -135.6 8.17 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.341 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -78.65 146.9 33.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.1 ptmt -85.81 174.51 9.27 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.98 139.12 51.62 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.597 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 CA--C 1.495 -1.17 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 21.2 mmtt -112.47 151.81 29.48 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.95 -9.07 59.69 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.278 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -145.71 160.93 41.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -67.71 -19.05 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.259 0.624 . . . . 0.0 111.037 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -73.75 -12.63 60.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.584 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 20.1 t70 -105.22 -0.81 26.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.895 0.855 . . . . 0.0 108.877 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.05 119.03 33.82 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.738 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 30.4 p -77.8 169.01 19.01 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.617 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.639 177.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.54 -38.69 74.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.6 -40.67 79.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.851 0.75 . . . . 0.0 109.399 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.57 ' HD2' HG12 ' X' ' 76' ' ' VAL . 20.5 t80 -70.56 -48.07 57.19 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.874 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.723 HG12 HG11 ' X' ' 76' ' ' VAL . 6.3 m -59.29 -39.57 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.519 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.19 -48.23 82.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.125 0.97 . . . . 0.0 110.884 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.451 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -66.17 -38.92 89.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.446 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.7 mp -62.47 -36.8 83.62 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.932 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 47.1 mtmt -61.43 -35.12 76.67 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.87 -34.73 69.44 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.333 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' X' ' 37' ' ' LEU . 20.8 mt -64.18 -40.26 88.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.004 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -59.83 -46.22 89.92 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.877 0.846 . . . . 0.0 108.789 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -60.54 -52.34 65.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.556 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 -25.63 68.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.272 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -78.72 -47.67 16.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.997 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -71.66 -23.27 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.789 0.328 . . . . 0.0 111.875 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.9 -17.71 30.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.64 67.16 1.0 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.74 1.216 . . . . 0.0 111.026 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -81.86 -31.24 31.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.655 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 68.37 -61.65 0.39 Allowed 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.082 1.753 . . . . 0.0 113.56 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.476 ' O ' HG23 ' X' ' 36' ' ' VAL . 6.5 m-20 -57.07 -57.99 10.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.066 0.547 . . . . 0.0 111.579 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -81.1 -28.9 11.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.202 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.346 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -44.06 92.72 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.84 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.96 -38.45 91.12 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.191 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' X' ' 39' ' ' GLU . 72.2 t -57.64 -48.97 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 O-C-N 124.405 1.066 . . . . 0.0 109.349 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 76.5 mt -65.21 -43.05 92.79 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.53 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.2 mt -59.99 -49.83 76.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.566 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' X' ' 36' ' ' VAL . 0.0 OUTLIER -70.9 -35.07 72.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.332 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.532 ' O ' HG12 ' X' ' 44' ' ' ILE . 24.0 t60 -66.07 -46.17 78.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.585 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.666 ' CD2' HD11 ' X' ' 54' ' ' ILE . 43.4 t80 -58.15 -53.28 60.03 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.432 HG23 ' O ' ' X' ' 47' ' ' HIS . 7.2 p -66.95 -32.6 58.72 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.606 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 42.9 pttt -75.21 -27.73 59.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.532 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.5 pt -84.13 -39.6 14.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.573 HG22 ' O ' ' X' ' 41' ' ' PHE . 15.1 t -85.18 -27.35 26.21 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 61.36 38.35 16.29 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 122.142 0.972 . . . . 0.0 111.238 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.432 ' O ' HG23 ' X' ' 42' ' ' VAL . 44.6 t-80 -94.32 132.94 28.0 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.542 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.7 -16.39 33.62 Favored 'Trans proline' 0 CA--C 1.495 -1.455 0 C-N-CA 123.042 2.494 . . . . 0.0 113.184 -173.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -120.78 30.48 6.88 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.12 -56.54 6.85 Favored Glycine 1 CA--C 1.447 -4.178 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.083 -177.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.439 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -79.13 -26.9 42.82 Favored 'General case' 0 C--N 1.249 -3.796 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.512 -170.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -58.38 -46.49 86.26 Favored 'General case' 0 C--O 1.189 -2.109 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -52.58 -46.01 66.73 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.666 HD11 ' CD2' ' X' ' 41' ' ' PHE . 3.9 mp -68.33 -47.15 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.256 -1.378 . . . . 0.0 109.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.01 -45.39 90.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.534 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 12.8 mm-40 -65.49 -44.88 85.71 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 122.765 0.426 . . . . 0.0 111.688 -178.506 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.538 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.418 -2.526 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.483 ' O ' HG13 ' X' ' 76' ' ' VAL . 10.6 Cg_endo -55.52 -50.49 12.59 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 124.154 3.236 . . . . 0.0 113.63 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.23 1.17 19.33 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.14 -39.9 1.9 Allowed Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 118.998 -1.572 . . . . 0.0 112.571 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.538 HG12 ' O ' ' X' ' 71' ' ' GLY . 5.1 pt -61.8 -31.69 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-N 117.164 0.482 . . . . 0.0 110.923 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.723 HG11 HG12 ' X' ' 16' ' ' VAL . 15.6 m -61.06 -33.08 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 121.086 0.47 . . . . 0.0 112.182 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 60.3 tttm -67.8 -48.01 67.49 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -61.45 -36.59 80.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.646 0.736 . . . . 0.0 109.317 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mm -66.81 -46.62 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.076 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.414 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 21.0 pttp -71.05 -39.61 72.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.101 0.477 . . . . 0.0 111.857 -173.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.1 mt-10 -66.59 -32.37 73.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.287 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -66.05 -47.65 73.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.96 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -37.3 84.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.192 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.2 99.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 123.987 0.804 . . . . 0.0 110.718 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.06 -32.4 59.26 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.624 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.429 HD22 ' HG3' ' X' ' 88' ' ' LYS . 4.2 t30 -76.13 -39.84 54.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.753 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.15 32.45 3.75 Favored Glycine 0 C--N 1.318 -0.466 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.429 ' HG3' HD22 ' X' ' 86' ' ' ASN . 58.1 mttm -110.6 163.07 18.12 Favored Pre-proline 0 N--CA 1.418 -2.06 0 C-N-CA 124.336 1.055 . . . . 0.0 109.481 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.32 141.13 61.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.406 2.071 . . . . 0.0 112.384 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.5 -155.26 19.33 Favored Glycine 0 N--CA 1.42 -2.427 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.18 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 30.8 m-85 -78.18 151.77 33.05 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -81.7 160.39 23.69 Favored 'General case' 0 N--CA 1.382 -3.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.41 133.93 37.46 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.828 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' X' ' 40' ' ' HIS . 95.1 mt . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 29.7 mmtt -107.23 156.45 18.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -77.72 -22.24 50.71 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.581 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 58.0 p -143.21 164.58 29.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.151 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.07 -16.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 111.496 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -14.62 61.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.117 0.484 . . . . 0.0 111.61 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 18.0 t70 -103.51 3.3 34.64 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.446 ' CE2' HD12 ' X' ' 44' ' ' ILE . 2.5 m-85 -96.91 112.84 24.42 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.904 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 46.6 p -76.95 155.22 32.88 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -56.95 -39.84 75.32 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.6 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.2 73.7 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.75 -42.16 83.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.76 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.1 t80 -67.2 -54.01 25.05 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.372 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.828 HG12 HG11 ' X' ' 76' ' ' VAL . 10.5 m -60.09 -32.82 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.46 -42.95 78.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.667 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.8 tm? -63.24 -40.07 96.41 Favored 'General case' 0 C--O 1.205 -1.237 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 56.5 mt -64.8 -36.44 84.32 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.637 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.453 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 48.2 mttp -66.18 -37.58 85.94 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.59 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' X' ' 18' ' ' LEU . 13.2 pt-20 -72.17 -31.88 66.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.536 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.667 HG13 ' O ' ' X' ' 18' ' ' LEU . 29.9 mt -66.11 -45.54 90.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.04 -42.0 84.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.383 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.55 -47.16 87.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.596 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -79.65 -24.67 41.69 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.983 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -65.05 -43.77 91.2 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.716 0.293 . . . . 0.0 110.27 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.5 m -76.28 -34.72 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.534 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -29.63 67.67 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.762 0.791 . . . . 0.0 109.097 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 76.49 87.57 0.08 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 127.469 2.307 . . . . 0.0 113.855 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -109.22 175.59 5.4 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -136.31 -4.68 2.1 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.03 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.499 ' O ' HG23 ' X' ' 36' ' ' VAL . 17.7 p-10 -86.14 -62.81 1.43 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.0 p -81.54 -26.03 10.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.539 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.8 tm? -58.06 -46.27 85.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.626 175.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 37.3 t70 -61.24 -45.83 92.93 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.539 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.499 HG23 ' O ' ' X' ' 32' ' ' ASP . 42.9 t -62.01 -50.01 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 O-C-N 124.4 1.063 . . . . 0.0 110.92 -176.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 91.1 mt -67.9 -41.81 82.12 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.937 -172.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.2 mt -59.36 -50.13 75.16 Favored 'General case' 0 N--CA 1.417 -2.107 0 O-C-N 124.122 0.888 . . . . 0.0 111.72 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.1 pt-20 -71.82 -36.52 70.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.588 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 5.0 t60 -65.78 -38.28 88.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.603 ' O ' HG22 ' X' ' 45' ' ' THR . 31.7 t80 -62.7 -51.66 66.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.14 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.422 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 5.9 p -67.17 -32.57 58.28 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.848 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -68.65 -30.13 68.76 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.999 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.468 HG12 ' O ' ' X' ' 40' ' ' HIS . 9.5 pt -83.96 -42.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 122.146 -0.346 . . . . 0.0 111.635 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.603 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.0 t -84.16 -28.39 27.44 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.608 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 62.91 26.14 15.4 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.472 ' H ' HG23 ' X' ' 45' ' ' THR . 42.6 t-80 -75.09 134.26 74.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -69.93 -14.45 35.55 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.831 2.354 . . . . 0.0 112.082 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.4 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.18 29.68 6.03 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 -173.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.597 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.96 -57.88 8.3 Favored Glycine 0 CA--C 1.455 -3.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.107 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.428 ' CG2' HD13 ' X' ' 38' ' ' LEU . 1.4 m -73.34 -29.15 62.47 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.755 -172.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.6 97.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.658 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -57.73 -43.31 85.22 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 123.558 0.536 . . . . 0.0 112.251 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.548 HD13 HG21 ' X' ' 22' ' ' ILE . 64.2 mt -66.59 -42.2 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 121.684 0.754 . . . . 0.0 110.044 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.77 91.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.05 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.24 77.78 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.948 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.443 0 O-C-N 123.222 0.326 . . . . 0.0 110.809 178.234 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.073 0 CA-C-O 121.208 0.338 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.453 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 18.0 Cg_endo -60.57 -29.05 87.73 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 124.755 3.637 . . . . 0.0 113.9 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.472 ' C ' HG22 ' X' ' 76' ' ' VAL . 84.0 mt-10 -95.66 1.96 53.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.676 0.274 . . . . 0.0 110.326 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.78 -37.47 3.19 Favored Glycine 0 N--CA 1.426 -1.984 0 C-N-CA 118.587 -1.768 . . . . 0.0 111.803 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.551 ' CD1' HD13 ' X' ' 19' ' ' LEU . 9.0 pt -58.33 -32.11 44.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 120.68 0.276 . . . . 0.0 110.927 174.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.828 HG11 HG12 ' X' ' 16' ' ' VAL . 19.1 m -63.93 -36.65 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.7 ttmm -67.14 -38.12 84.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -68.67 -40.59 80.08 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.447 HG23 ' OG1' ' X' ' 45' ' ' THR . 22.0 mm -61.98 -46.57 96.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.771 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 19.9 pttp -66.95 -41.01 87.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.396 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.46 -31.96 73.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.575 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 91.3 t90 -72.24 -48.94 38.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.196 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' X' ' 88' ' ' LYS . 10.1 ttt85 -71.17 -37.02 72.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.623 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.18 87.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.741 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.23 -26.35 65.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.117 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.38 -22.02 57.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 120.943 0.402 . . . . 0.0 110.162 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 49.91 16.3 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 60.3 tttp -133.6 126.53 19.11 Favored Pre-proline 0 N--CA 1.414 -2.241 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.72 119.42 5.58 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.283 3.322 . . . . 0.0 113.887 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.63 -127.12 4.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.255 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.9 m-85 -79.3 151.55 31.01 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 120.555 0.217 . . . . 0.0 110.577 -174.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.422 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 20.4 ptmt -93.31 179.1 5.51 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -110.91 142.24 43.25 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 123.031 0.532 . . . . 0.0 109.738 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.119 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.427 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 76.5 mt . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 121.887 0.851 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 26.7 mmtt -104.85 -162.06 0.86 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -119.56 -31.64 4.53 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.201 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.2 p -126.07 166.95 16.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.568 HD13 HH12 ' X' ' 83' ' ' ARG . 7.9 tt -81.1 -0.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.975 0.893 . . . . 0.0 111.275 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.8 m -80.99 -10.13 59.75 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.28 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 18.9 t70 -106.85 1.27 24.58 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 7.9 m-85 -98.6 114.14 26.48 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.121 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.463 HG22 ' HG3' ' X' ' 92' ' ' LYS . 76.9 p -79.6 160.54 26.36 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.612 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.9 pt-20 -61.19 -36.94 81.22 Favored 'General case' 0 C--O 1.2 -1.552 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.828 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.35 -38.7 74.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.428 ' HB2' ' OG1' ' X' ' 11' ' ' THR . 1.0 OUTLIER -59.98 -42.18 93.64 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.111 0.958 . . . . 0.0 108.769 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -68.33 -49.02 63.25 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.534 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.722 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 18.7 m -57.78 -41.73 80.35 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 CA-C-N 117.98 0.355 . . . . 0.0 110.206 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -61.27 -49.4 77.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.698 0.799 . . . . 0.0 110.366 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.515 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -64.18 -41.96 96.89 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' X' ' 75' ' ' ILE . 13.9 tp -59.7 -44.27 93.76 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.913 1.285 . . . . 0.0 111.319 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.7 mttt -61.56 -35.21 77.15 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.904 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.12 -38.31 82.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.548 HG21 HD13 ' X' ' 54' ' ' ILE . 23.2 mt -61.07 -43.73 96.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -34.97 73.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.81 -50.95 37.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -25.22 68.0 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.461 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -66.94 -55.41 14.71 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.254 1.022 . . . . 0.0 110.132 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 m -73.22 -21.43 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.75 -12.44 51.03 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.5 57.81 6.18 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.754 1.222 . . . . 0.0 110.982 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -78.17 -24.93 47.06 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.474 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 66.89 -64.31 0.24 Allowed 'General case' 0 C--O 1.205 -1.254 0 C-N-CA 126.043 1.737 . . . . 0.0 114.948 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.503 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.7 t70 -57.29 -57.09 14.14 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.252 0.478 . . . . 0.0 111.573 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -80.26 -30.7 12.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.35 -175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.22 -45.47 91.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.611 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.81 -36.55 83.81 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.317 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.503 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -57.31 -49.11 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 87.3 mt -67.99 -43.26 79.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.109 -173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.0 mt -59.24 -43.73 92.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.938 0.774 . . . . 0.0 110.991 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.12 -45.17 70.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.629 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.7 t60 -60.86 -45.7 93.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.018 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.594 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 58.8 t80 -58.65 -51.67 68.94 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.676 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.59 -34.11 66.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -71.86 -30.46 65.46 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.697 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.629 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.8 pt -84.1 -36.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.689 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -76.2 -42.57 45.8 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.524 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 61.5 30.23 18.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.922 1.289 . . . . 0.0 109.864 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -89.12 133.38 35.32 Favored Pre-proline 0 N--CA 1.415 -2.222 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.04 16.67 0.53 Allowed 'Trans proline' 0 CA--C 1.497 -1.352 0 C-N-CA 122.908 2.405 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.502 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 3.2 m-20 -142.99 23.06 1.9 Allowed 'General case' 0 N--CA 1.394 -3.255 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.594 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.16 -66.49 1.04 Allowed Glycine 0 CA--C 1.462 -3.255 0 O-C-N 124.724 1.265 . . . . 0.0 113.821 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.461 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -71.54 -26.03 62.47 Favored 'General case' 0 C--N 1.258 -3.4 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.842 -173.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.44 -38.3 90.55 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.675 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 96.5 mt -57.83 -46.51 84.64 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 124.202 0.939 . . . . 0.0 111.258 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.548 HD13 HG21 ' X' ' 22' ' ' ILE . 65.2 mt -67.14 -46.67 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.843 0.83 . . . . 0.0 109.891 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.23 -38.99 93.34 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.167 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.2 pt-20 -71.82 -36.45 70.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.012 176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.18 177.361 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.414 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.397 -3.911 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.425 ' CG ' ' HG2' ' X' ' 20' ' ' LYS . 3.9 Cg_exo -46.53 -52.36 7.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 125.257 3.971 . . . . 0.0 114.101 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -76.84 1.54 17.13 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.7 -39.28 1.91 Allowed Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.062 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.574 ' O ' HG13 ' X' ' 79' ' ' ILE . 2.5 pt -60.87 -33.0 53.71 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-N 117.261 0.531 . . . . 0.0 111.097 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.616 HG11 HG12 ' X' ' 16' ' ' VAL . 9.7 m -59.16 -32.29 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.504 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 25.0 ttmm -67.9 -42.38 81.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.078 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.27 -43.25 99.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.574 HG13 ' O ' ' X' ' 75' ' ' ILE . 76.9 mt -64.74 -44.14 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.868 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 19.1 ptpt -66.85 -43.47 83.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.747 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 42.0 mt-10 -67.95 -32.01 72.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.86 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -66.9 -48.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.568 HH12 HD13 ' X' ' 7' ' ' ILE . 1.3 mpp_? -70.77 -37.36 73.37 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.8 92.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.788 0.68 . . . . 0.0 110.498 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.1 -26.33 56.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 111.513 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.573 ' ND2' ' HD3' ' X' ' 88' ' ' LYS . 4.5 t30 -77.33 -31.37 54.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.807 0.337 . . . . 0.0 110.578 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.55 40.06 5.14 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.573 ' HD3' ' ND2' ' X' ' 86' ' ' ASN . 12.7 mtpp -130.74 155.55 81.16 Favored Pre-proline 0 N--CA 1.416 -2.159 0 C-N-CA 123.504 0.722 . . . . 0.0 109.749 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.06 125.86 20.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.262 2.642 . . . . 0.0 112.586 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -106.7 -95.65 2.42 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.663 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.74 148.83 52.6 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.0 ptmt -85.04 164.9 17.95 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.64 136.24 36.29 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.66 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.254 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.461 ' CD2' HD13 ' X' ' 18' ' ' LEU . 40.1 mt . . . . . 0 CA--C 1.499 -1.01 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -97.06 -159.44 0.74 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -116.88 -27.24 6.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.07 0.462 . . . . 0.0 110.487 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . 0.41 ' HA ' HG22 ' X' ' 44' ' ' ILE . 92.7 p -136.56 166.98 22.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.455 ' HB ' ' HB ' ' X' ' 44' ' ' ILE . 14.3 tt -67.3 -11.92 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 121.52 0.676 . . . . 0.0 110.618 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -75.37 -27.07 58.98 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.35 -170.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.62 -4.72 40.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.525 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -80.53 115.25 19.95 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.415 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 71.0 p -76.3 159.72 30.3 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 169.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.646 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.26 -34.84 74.28 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.032 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.25 -37.94 75.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -58.55 -39.45 80.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.56 0.695 . . . . 0.0 109.416 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.515 ' HD2' HG12 ' X' ' 76' ' ' VAL . 42.5 t80 -71.8 -44.22 64.33 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.156 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.735 HG12 HG11 ' X' ' 76' ' ' VAL . 7.6 m -61.94 -37.16 77.58 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.442 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.405 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -49.16 78.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.848 0.859 . . . . 0.0 108.778 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.668 ' O ' HG13 ' X' ' 22' ' ' ILE . 16.9 tp -57.53 -48.04 80.38 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.055 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' X' ' 23' ' ' GLU . 8.1 mp -60.36 -40.25 90.1 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.707 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 80.9 mttt -63.41 -35.59 80.93 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.218 0.532 . . . . 0.0 110.034 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -69.43 -42.4 75.06 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.668 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.9 mt -61.23 -42.3 92.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.333 0 O-C-N 124.073 0.858 . . . . 0.0 109.645 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' X' ' 19' ' ' LEU . 51.7 mt-10 -57.33 -46.29 83.41 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.5 -51.8 67.9 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.681 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -79.38 -21.75 45.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.44 -46.05 64.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.35 -33.08 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 110.557 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.25 -6.44 59.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.389 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.44 83.65 0.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.135 1.774 . . . . 0.0 114.435 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 16.4 p -99.72 -172.67 2.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.15 -29.76 0.88 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.614 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.504 ' O ' HG23 ' X' ' 36' ' ' VAL . 28.1 m-20 -70.68 -62.31 1.44 Allowed 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.336 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.705 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.6 p -78.85 -27.34 13.67 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.941 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.3 tm? -58.44 -47.07 85.18 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.212 1.005 . . . . 0.0 109.527 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.3 -28.19 62.93 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.504 HG23 ' O ' ' X' ' 32' ' ' ASP . 64.8 t -67.72 -50.72 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.977 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.506 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 51.6 mt -69.66 -43.99 71.44 Favored 'General case' 0 N--CA 1.412 -2.332 0 O-C-N 124.513 1.133 . . . . 0.0 111.711 -170.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.53 HD22 HG22 ' X' ' 51' ' ' THR . 28.4 mt -60.93 -46.41 90.81 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 124.233 0.958 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -70.74 -39.47 73.3 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.039 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.569 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.6 t60 -63.43 -45.44 90.94 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.245 0.545 . . . . 0.0 109.716 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 37.9 t80 -59.05 -53.46 58.18 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.665 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.409 HG12 ' O ' ' X' ' 38' ' ' LEU 0.252 11.9 p -68.08 -32.29 55.45 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.969 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 50.9 pttt -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.192 -0.317 . . . . 0.0 111.595 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.498 HG12 ' O ' ' X' ' 40' ' ' HIS . 31.5 pt -88.27 -31.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.058 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 47.1 p -85.06 -35.25 21.98 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 120.93 0.395 . . . . 0.0 111.285 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.82 29.53 17.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 125.353 1.461 . . . . 0.0 110.778 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 32.1 t-80 -76.08 138.57 68.75 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 107.861 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.9 Cg_exo -74.26 -6.89 19.06 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 C-N-CA 123.146 2.564 . . . . 0.0 112.151 -176.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.9 m-20 -130.71 30.63 4.63 Favored 'General case' 0 N--CA 1.389 -3.477 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.581 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.51 -59.82 6.85 Favored Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.617 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.53 HG22 HD22 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.97 -28.28 55.09 Favored 'General case' 0 C--N 1.248 -3.828 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.847 -176.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.614 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.74 -42.97 98.41 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.227 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.36 -49.23 76.83 Favored 'General case' 0 C--O 1.208 -1.085 0 O-C-N 123.525 0.515 . . . . 0.0 112.119 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.422 HD13 HG21 ' X' ' 22' ' ' ILE . 79.2 mt -67.74 -42.16 85.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.819 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.502 ' HD2' ' O ' ' X' ' 51' ' ' THR . 15.3 m-85 -60.21 -47.0 87.83 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.585 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 10.4 pt-20 -71.12 -36.43 72.12 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.687 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.063 0 O-C-N 123.305 0.378 . . . . 0.0 110.438 178.883 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.497 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.41 -3.078 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.572 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 19.3 Cg_endo -61.96 -47.52 10.47 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.081 3.188 . . . . 0.0 112.825 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.518 ' HG2' HG11 ' X' ' 16' ' ' VAL . 43.2 mt-10 -77.37 1.24 19.53 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 -35.03 2.82 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 118.526 -1.797 . . . . 0.0 112.651 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.497 HG12 ' O ' ' X' ' 71' ' ' GLY . 3.6 pt -65.36 -29.38 47.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.761 173.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.735 HG11 HG12 ' X' ' 16' ' ' VAL . 19.6 m -63.38 -35.04 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.7 0 CA-C-O 121.407 0.622 . . . . 0.0 111.419 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.522 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 61.9 tttm -66.88 -39.26 87.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.151 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.13 -38.34 90.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.13 -46.56 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.256 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 18.0 ptpt -66.94 -39.98 87.45 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.816 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.61 -35.85 77.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.377 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.519 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.0 t90 -67.66 -48.05 67.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.629 0.728 . . . . 0.0 109.19 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.484 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 18.4 tpt180 -61.34 -45.75 93.1 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.219 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.65 83.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.66 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.96 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.26 0.35 . . . . 0.0 110.852 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.419 ' OD1' ' HE2' ' X' ' 88' ' ' LYS . 17.5 t-20 -69.08 -37.37 78.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.56 29.38 5.36 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.15 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.419 ' HE2' ' OD1' ' X' ' 86' ' ' ASN . 64.0 mttm -106.41 147.53 35.09 Favored Pre-proline 0 N--CA 1.401 -2.904 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.45 130.03 25.55 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.4 2.066 . . . . 0.0 110.751 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.88 -128.51 5.4 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.689 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -88.72 154.85 19.96 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.2 pttt -90.06 163.97 14.68 Favored 'General case' 0 N--CA 1.39 -3.464 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.49 141.18 29.27 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.276 -2.752 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 175.838 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.451 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 73.0 mt . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.492 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 35.0 mmtt -99.94 -178.77 3.95 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.376 0.607 . . . . 0.0 110.065 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -104.81 -13.67 15.78 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.47 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -142.73 160.04 41.07 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.1 tt -69.1 -22.89 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.378 0.608 . . . . 0.0 110.746 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -84.36 -2.91 57.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.384 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.492 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -98.67 -3.45 35.98 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.443 ' C ' ' HG2' ' X' ' 92' ' ' LYS . 5.9 m-85 -98.62 121.98 41.25 Favored 'General case' 0 CA--C 1.475 -1.941 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.949 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.626 ' O ' HG13 ' X' ' 16' ' ' VAL . 12.9 pt-20 -63.37 -33.79 76.31 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.829 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.436 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.77 -38.25 76.68 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.357 0.123 . . . . 0.0 110.998 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -59.1 -37.51 77.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.643 0.735 . . . . 0.0 109.477 173.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 33.6 t80 -74.27 -40.88 62.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.483 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.767 HG12 HG11 ' X' ' 76' ' ' VAL . 6.3 m -62.58 -32.08 54.17 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.214 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.16 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.05 -46.06 82.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.633 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -58.82 -44.33 90.84 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.799 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.8 mt -58.22 -40.24 81.13 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.197 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' X' ' 23' ' ' GLU . 95.7 mttt -70.22 -34.11 72.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.338 0.589 . . . . 0.0 110.224 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.82 -42.2 98.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.898 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.68 HG12 ' HB3' ' X' ' 37' ' ' LEU . 17.6 mt -65.13 -39.52 85.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.621 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 12.8 tt0 -57.24 -47.82 80.4 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 124.343 1.057 . . . . 0.0 108.459 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -47.92 81.49 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.146 -178.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.451 ' OE1' ' HB ' ' X' ' 33' ' ' VAL . 28.6 mm-40 -68.72 -31.7 70.95 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.2 -44.07 22.6 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.237 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.97 -25.86 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.51 -4.29 45.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 45.14 78.8 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.744 1.618 . . . . 0.0 112.987 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 81.8 p -99.58 -160.51 0.81 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.098 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.57 -63.51 0.67 Allowed 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.627 ' O ' HG23 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.64 -60.02 3.85 Favored 'General case' 0 CA--C 1.472 -2.053 0 O-C-N 123.718 0.637 . . . . 0.0 112.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -82.75 -25.9 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.186 -172.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -59.16 -46.94 87.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 31.0 t70 -66.72 -43.58 83.88 Favored 'General case' 0 CA--C 1.479 -1.766 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.001 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.627 HG23 ' O ' ' X' ' 32' ' ' ASP . 49.8 t -55.95 -50.23 70.46 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 O-C-N 124.114 0.884 . . . . 0.0 110.493 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.68 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.6 mt -69.23 -39.03 78.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 O-C-N 124.423 1.077 . . . . 0.0 112.123 -173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.3 mt -60.25 -50.18 74.66 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.0 0.813 . . . . 0.0 110.69 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 2.7 pt-20 -71.41 -33.79 69.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.529 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.519 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.9 t60 -61.37 -45.89 92.47 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.533 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 69.6 t80 -60.7 -54.11 49.24 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.841 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.485 HG12 ' O ' ' X' ' 38' ' ' LEU . 4.8 p -67.22 -32.87 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.9 ptmm? -68.12 -42.43 80.24 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.82 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.519 HG12 ' O ' ' X' ' 40' ' ' HIS . 12.2 pt -77.1 -34.49 21.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.721 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.402 ' HA ' HD12 ' X' ' 7' ' ' ILE . 77.1 p -84.32 -39.19 19.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.459 -178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 58.81 74.81 0.42 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.537 1.16 . . . . 0.0 110.382 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -123.82 132.49 24.29 Favored Pre-proline 0 N--CA 1.405 -2.679 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.3 -18.59 55.7 Favored 'Trans proline' 0 CA--C 1.498 -1.304 0 C-N-CA 122.99 2.46 . . . . 0.0 111.885 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 15.3 m-20 -126.99 33.89 4.85 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -170.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.533 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.85 -55.81 7.06 Favored Glycine 0 CA--C 1.461 -3.288 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.866 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.493 HG22 HD22 ' X' ' 38' ' ' LEU 0.313 1.9 p -85.25 -17.19 37.73 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 117.208 -1.797 . . . . 0.0 113.618 -176.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.88 -35.52 80.28 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.35 -40.71 96.41 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 123.604 0.565 . . . . 0.0 110.937 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.427 HD13 HG21 ' X' ' 75' ' ' ILE . 17.9 mm -66.57 -46.27 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.796 0.808 . . . . 0.0 109.773 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -63.02 -43.39 98.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.415 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -71.39 -37.32 71.57 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.791 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 C-N-CA 122.32 0.248 . . . . 0.0 111.347 179.688 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.093 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.553 ' O ' HG13 ' X' ' 75' ' ' ILE . 9.6 Cg_endo -54.04 -34.59 78.19 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 124.457 3.438 . . . . 0.0 112.131 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.67 0.63 5.2 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.64 -10.78 28.23 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 118.836 -1.649 . . . . 0.0 113.248 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.553 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -74.15 -44.86 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.767 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -55.56 -43.07 71.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.266 175.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 21.7 ttmm -60.48 -47.63 85.31 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.869 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.81 -37.87 86.02 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.122 0.963 . . . . 0.0 108.592 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.497 ' HA ' HH21 ' X' ' 83' ' ' ARG . 36.2 mm -65.58 -45.75 91.53 Favored 'Isoleucine or valine' 0 C--O 1.254 1.304 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.086 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.6 ptpt -63.17 -37.68 88.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.282 0.364 . . . . 0.0 110.86 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 35.7 mt-10 -71.28 -43.91 66.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.422 ' HB3' ' NH2' ' X' ' 83' ' ' ARG . 59.6 t90 -62.96 -41.02 99.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' X' ' 79' ' ' ILE . 0.5 OUTLIER -61.94 -45.33 94.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.504 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -39.58 93.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.678 0.611 . . . . 0.0 111.324 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.79 82.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.45 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 23.1 t-20 -67.57 -46.96 71.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.26 22.87 5.7 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.45 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 61.3 mttm -102.02 144.73 29.16 Favored Pre-proline 0 N--CA 1.403 -2.815 0 C-N-CA 124.396 1.079 . . . . 0.0 108.114 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.15 132.76 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.697 1.598 . . . . 0.0 111.485 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -92.04 -117.81 2.33 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.038 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.41 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 54.6 m-85 -99.61 166.19 11.25 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 21.9 ptmt -94.62 174.43 7.12 Favored 'General case' 0 N--CA 1.387 -3.605 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -120.67 136.12 54.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 CA-C-O 121.242 0.544 . . . . 0.0 110.659 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.737 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.47 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 78.3 mt . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.634 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 10.9 mptt -120.56 -178.4 3.7 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.793 -175.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.97 -46.44 12.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.446 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.3 p -140.42 167.91 21.03 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.549 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' X' ' 44' ' ' ILE . 14.5 tt -61.59 -19.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.822 0.82 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.1 m -82.26 -5.01 58.24 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.717 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.631 ' HB3' ' CG ' ' X' ' 4' ' ' LYS . 3.5 t70 -105.42 3.6 29.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 4.8 m-85 -105.37 118.11 35.72 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.314 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 18.2 p -79.22 163.76 24.73 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.661 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.1 pt-20 -56.58 -42.17 78.2 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.002 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.52 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.86 -38.37 76.41 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 53.4 mm-40 -60.89 -36.35 79.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.74 0.781 . . . . 0.0 109.213 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 41.7 t80 -75.26 -42.92 53.99 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.517 -177.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.792 HG12 HG11 ' X' ' 76' ' ' VAL . 10.2 m -58.43 -33.61 48.42 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 O-C-N 123.215 0.322 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.69 -49.37 77.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.675 1.19 . . . . 0.0 110.171 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.512 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.5 tm? -61.77 -42.91 99.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.117 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -61.3 -42.66 99.02 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.366 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.0 mttt -63.87 -35.93 82.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.318 0.58 . . . . 0.0 109.975 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -67.56 -34.92 78.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' X' ' 37' ' ' LEU . 25.5 mt -66.22 -42.25 90.69 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.402 ' OE2' ' HD3' ' X' ' 72' ' ' PRO . 51.1 mt-10 -57.17 -37.32 71.93 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.927 0.87 . . . . 0.0 110.666 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.1 -52.38 55.81 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.941 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 1.7 pp20? -97.61 -11.42 23.64 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 118.83 -1.148 . . . . 0.0 113.482 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.61 -38.06 83.48 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.074 0.464 . . . . 0.0 110.948 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.93 -20.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.302 0.572 . . . . 0.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -39.79 13.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.495 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.86 75.93 0.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.0 1.72 . . . . 0.0 109.768 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.425 HG23 ' HB2' ' X' ' 25' ' ' GLU . 49.2 p -78.75 -21.34 48.1 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.351 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 t70 72.99 -48.54 0.69 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.491 ' O ' HG23 ' X' ' 36' ' ' VAL . 21.1 t70 -63.07 -52.55 62.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.727 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 15.0 p -94.01 -25.26 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.857 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.653 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.4 tm? -58.02 -46.58 85.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.647 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 35.2 t70 -63.03 -42.5 99.79 Favored 'General case' 0 CA--C 1.473 -1.987 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.016 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.491 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.2 t -61.55 -49.54 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 O-C-N 124.65 1.219 . . . . 0.0 110.837 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.7 mt -65.97 -43.68 87.15 Favored 'General case' 0 N--CA 1.415 -2.223 0 O-C-N 124.13 0.894 . . . . 0.0 110.362 -173.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.561 ' O ' HG12 ' X' ' 42' ' ' VAL . 32.4 mt -63.14 -50.65 69.58 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.73 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 16.7 pt-20 -71.76 -37.37 70.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.31 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.499 ' O ' HG12 ' X' ' 44' ' ' ILE . 8.9 t60 -59.89 -44.85 93.98 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.492 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 28.8 t80 -62.09 -56.93 13.96 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.438 1.086 . . . . 0.0 111.65 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.561 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 8.9 p -67.36 -31.18 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -67.6 -30.37 69.95 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.663 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.499 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.1 pt -91.4 -32.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.567 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -81.62 -36.8 28.5 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.315 0.578 . . . . 0.0 110.107 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.61 26.98 16.55 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.497 1.519 . . . . 0.0 111.022 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.0 130.74 80.23 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -67.19 -14.57 43.64 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 123.226 2.617 . . . . 0.0 112.745 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 36.8 m-20 -126.04 32.46 5.24 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -173.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.15 -54.55 8.28 Favored Glycine 0 CA--C 1.457 -3.548 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.576 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.55 HG23 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -33.34 59.59 Favored 'General case' 0 C--N 1.257 -3.436 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.639 -172.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.35 -36.11 77.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.409 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 mt -58.02 -43.14 86.56 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.44 ' H ' HD12 ' X' ' 54' ' ' ILE . 5.0 mp -66.79 -41.42 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -63.18 -50.27 70.99 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.6 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.1 pt-20 -66.62 -36.61 83.02 Favored 'General case' 0 C--O 1.206 -1.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.199 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . 0.426 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.631 0 O-C-N 123.219 0.324 . . . . 0.0 110.63 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.801 0 CA-C-O 120.824 0.124 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.59 ' O ' HG13 ' X' ' 76' ' ' VAL . 32.5 Cg_endo -66.45 -41.0 12.77 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 124.617 3.544 . . . . 0.0 112.313 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.5 ' HG2' HG11 ' X' ' 16' ' ' VAL . 35.1 mt-10 -84.69 2.02 43.74 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.386 0.675 . . . . 0.0 110.182 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.79 -35.78 3.16 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.89 172.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.489 ' CD1' HD13 ' X' ' 19' ' ' LEU . 4.0 pt -64.78 -22.72 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-N 117.712 0.756 . . . . 0.0 111.582 173.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.792 HG11 HG12 ' X' ' 16' ' ' VAL . 30.7 m -63.06 -39.21 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-O 121.601 0.715 . . . . 0.0 110.534 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 52.2 tttp -64.12 -42.69 96.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.691 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 39.7 mm-40 -58.3 -45.34 88.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.85 0.833 . . . . 0.0 109.526 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -64.46 -46.79 91.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.009 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 13.5 ptmm? -67.87 -36.32 80.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.761 -174.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.0 -36.69 69.82 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.141 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.519 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.4 t90 -62.97 -48.1 80.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 18.0 tpt180 -65.89 -45.89 80.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.913 -174.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.75 -40.93 79.57 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 122.853 0.461 . . . . 0.0 112.064 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.13 82.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.084 0.469 . . . . 0.0 109.962 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.09 -21.74 56.36 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.3 42.78 9.06 Favored Glycine 0 CA--C 1.498 -0.993 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.012 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.9 mtpp -122.44 144.35 41.86 Favored Pre-proline 0 N--CA 1.393 -3.289 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.93 127.69 20.1 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 122.803 2.336 . . . . 0.0 111.543 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.62 -110.08 3.12 Favored Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.578 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.56 161.67 20.1 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.093 0.473 . . . . 0.0 110.687 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' X' ' 11' ' ' THR . 21.3 ptmt -108.26 171.69 7.26 Favored 'General case' 0 N--CA 1.393 -3.305 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -106.93 140.93 38.95 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.498 0 CA-C-O 118.083 -1.399 . . . . 0.0 110.149 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.462 HD22 HD13 ' X' ' 18' ' ' LEU . 48.8 mt . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 120.864 0.364 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 25.1 mmtt -99.62 -160.34 0.8 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -117.7 -19.68 9.22 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.042 -0.411 . . . . 0.0 110.852 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 83.4 p -135.8 160.87 37.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.06 -21.92 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.613 0.765 . . . . 0.0 110.279 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 23.7 m -85.64 -1.75 57.47 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.448 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 25.6 t0 -101.67 -0.11 35.18 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.74 123.63 46.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.216 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.526 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 70.6 p -78.18 172.11 14.05 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.569 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.0 pt-20 -56.33 -45.09 80.5 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.169 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.47 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.44 -37.85 74.44 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' X' ' 11' ' ' THR . 5.3 mm-40 -57.8 -35.94 71.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.385 0.612 . . . . 0.0 110.227 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.657 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 30.1 t80 -75.67 -40.51 55.86 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.9 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.698 HG12 HG11 ' X' ' 76' ' ' VAL . 4.3 m -62.92 -28.99 46.08 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.923 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.505 ' O ' ' HG2' ' X' ' 21' ' ' GLU . 0.9 OUTLIER -57.63 -48.79 78.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.613 ' O ' HG13 ' X' ' 22' ' ' ILE . 20.3 tp -61.81 -46.99 87.14 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 121.196 0.522 . . . . 0.0 110.655 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 37.2 mt -57.94 -36.88 73.13 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.924 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 95.9 mttt -70.78 -33.97 71.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.128 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' X' ' 17' ' ' GLN . 8.7 mm-40 -67.37 -43.27 81.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.614 HG12 ' HB3' ' X' ' 37' ' ' LEU . 35.5 mt -58.81 -42.2 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.095 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.22 -47.84 82.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.695 1.198 . . . . 0.0 110.165 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.92 -52.1 58.28 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.73 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -17.19 64.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.426 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.53 -38.45 14.92 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.121 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.25 -33.25 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.214 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.83 -26.26 37.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 77.27 0.31 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.326 1.451 . . . . 0.0 112.913 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.9 p -98.55 -177.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.2 -56.09 1.44 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.887 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.641 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.2 p-10 -57.68 -55.7 31.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 123.535 0.522 . . . . 0.0 111.921 -175.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -81.33 -32.52 12.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.375 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.27 -45.81 90.22 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.154 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.76 -24.61 60.97 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.207 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.641 HG23 ' O ' ' X' ' 32' ' ' ASP . 88.7 t -61.01 -49.1 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.187 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 65.4 mt -68.11 -43.05 79.28 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.962 -173.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.1 mt -58.87 -46.57 87.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.292 0.995 . . . . 0.0 110.597 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.85 -40.93 72.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.087 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 63.9 t60 -62.4 -45.56 92.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.393 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.8 t80 -58.27 -51.73 68.53 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.752 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.458 HG23 ' HA3' ' X' ' 50' ' ' GLY . 15.0 p -67.86 -32.85 58.23 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.9 ptmt -68.96 -33.44 73.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 122.046 -0.409 . . . . 0.0 111.897 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.505 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.1 pt -85.13 -32.49 7.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.734 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 73.9 p -84.97 -33.62 22.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 56.8 33.59 23.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.664 1.186 . . . . 0.0 110.274 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.415 ' CE1' HD11 ' X' ' 53' ' ' LEU . 41.3 t-80 -80.61 134.46 54.19 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.225 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.464 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -67.77 -12.18 34.59 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 123.18 2.587 . . . . 0.0 112.437 -175.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -130.24 28.56 4.98 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.581 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.68 -62.59 2.84 Favored Glycine 1 CA--C 1.449 -4.049 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.741 -175.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -77.64 -23.99 49.59 Favored 'General case' 0 C--N 1.249 -3.774 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.24 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.0 -34.95 78.66 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.03 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' X' ' 47' ' ' HIS . 34.8 mt -62.91 -37.67 87.91 Favored 'General case' 0 CA--C 1.486 -1.493 0 O-C-N 123.362 0.414 . . . . 0.0 110.711 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.2 mt -66.46 -44.03 90.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.86 -44.62 95.63 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.261 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.7 pt-20 -68.52 -46.43 69.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.364 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.015 0 O-C-N 123.224 0.328 . . . . 0.0 111.456 -178.544 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.397 -3.904 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.507 ' O ' HG13 ' X' ' 75' ' ' ILE . 10.2 Cg_endo -57.81 -40.92 74.87 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.449 2.766 . . . . 0.0 111.785 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -74.12 0.75 12.9 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.137 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.59 -17.67 10.3 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.807 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.507 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -68.04 -41.96 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.698 HG11 HG12 ' X' ' 16' ' ' VAL . 1.0 OUTLIER -56.43 -44.6 80.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.714 177.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 23.1 ttpp -57.98 -47.74 82.08 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.338 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.3 -36.24 73.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.456 0.646 . . . . 0.0 109.657 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.8 -45.81 71.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.369 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.2 pttp -64.32 -35.5 81.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.923 0.392 . . . . 0.0 110.48 -176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 49.5 mt-10 -69.22 -39.35 78.63 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.464 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -67.96 -47.29 69.02 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 17.7 tpt180 -60.9 -45.28 95.24 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.296 -174.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.6 83.27 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.011 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.31 -33.73 75.89 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.502 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.15 -46.77 48.99 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.42 41.93 1.31 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 62.1 mttm -117.62 144.79 34.95 Favored Pre-proline 0 N--CA 1.399 -3.017 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.06 124.74 13.47 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 121.991 1.794 . . . . 0.0 109.862 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.55 -121.43 3.48 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.179 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -83.03 161.38 21.72 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.544 -0.828 . . . . 0.0 109.974 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.0 ptmt -87.59 167.62 13.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.21 132.03 48.39 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.116 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 178.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.482 ' CD2' HD13 ' X' ' 18' ' ' LEU . 53.5 mt . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.7 mmtt -110.22 148.43 31.87 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' X' ' 5' ' ' ASN . 0.9 OUTLIER -84.44 -1.21 55.27 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.021 -176.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 53.0 p -147.08 158.46 43.94 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.8 tp -73.03 -12.41 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.241 0.543 . . . . 0.0 111.615 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.27 -14.27 60.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.421 0.629 . . . . 0.0 111.386 -173.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.2 t70 -105.28 5.26 31.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -100.18 121.51 41.55 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.737 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.514 HG22 ' HG3' ' X' ' 92' ' ' LYS . 29.8 p -83.57 165.33 19.15 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.622 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.3 pt-20 -56.07 -43.62 78.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.346 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.97 -37.31 75.73 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.451 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 17.4 mm-40 -56.83 -39.73 74.75 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.65 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 16.9 t80 -72.81 -43.21 62.99 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.639 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.767 HG12 HG11 ' X' ' 76' ' ' VAL . 4.3 m -62.74 -29.03 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.89 -44.91 88.09 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.583 ' O ' HG13 ' X' ' 22' ' ' ILE . 27.5 tp -61.42 -46.23 91.01 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.546 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 36.0 mt -57.24 -41.45 79.6 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.678 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.6 mttm -63.58 -35.84 81.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.664 175.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.08 -31.42 50.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.452 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' X' ' 37' ' ' LEU . 27.4 mt -62.27 -41.86 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -58.56 -40.62 83.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -60.4 -41.84 94.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.71 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -80.21 -32.19 38.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.292 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -61.16 -52.75 63.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.051 0.54 . . . . 0.0 111.646 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -65.91 -27.3 40.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.27 -20.96 26.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.73 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.69 61.57 2.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.737 1.215 . . . . 0.0 111.887 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.9 p -88.21 -164.8 1.17 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.359 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -134.2 -50.89 0.82 Allowed 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.998 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.551 ' O ' HG23 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.29 -63.06 1.27 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.642 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 90.5 t -85.93 -27.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.052 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.451 -173.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.8 tm? -58.85 -43.29 90.74 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.5 t70 -68.18 -42.06 80.52 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.118 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.551 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.1 t -57.54 -50.23 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 O-C-N 124.058 0.849 . . . . 0.0 110.27 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' X' ' 22' ' ' ILE . 75.8 mt -67.98 -40.31 83.15 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.091 -170.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 26.5 mt -64.08 -49.13 73.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 O-C-N 124.328 1.017 . . . . 0.0 111.498 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.21 -36.68 71.96 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.5 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.549 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 77.6 t60 -60.82 -45.93 92.53 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.579 ' CD2' HD11 ' X' ' 54' ' ' ILE . 56.5 t80 -57.51 -53.63 55.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.778 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.498 HG12 ' O ' ' X' ' 38' ' ' LEU 0.264 4.6 p -67.14 -31.79 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 17.5 ptmt -71.4 -30.03 65.62 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.851 -0.53 . . . . 0.0 112.369 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.524 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.0 pt -88.96 -35.94 8.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.098 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.461 ' HB ' HD12 ' X' ' 79' ' ' ILE . 77.1 p -82.64 -36.91 25.61 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 110.597 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 64.22 31.22 13.25 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.466 1.507 . . . . 0.0 111.404 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.433 ' O ' HG23 ' X' ' 42' ' ' VAL . 43.7 t-80 -80.88 139.17 49.9 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.465 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.8 Cg_exo -70.94 -18.94 31.07 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 122.859 2.372 . . . . 0.0 112.454 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.414 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.1 35.76 4.71 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.6 -52.74 23.6 Favored Glycine 1 CA--C 1.447 -4.208 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.857 -177.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.445 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.66 -32.06 57.72 Favored 'General case' 0 C--N 1.248 -3.839 0 C-N-CA 118.498 -1.281 . . . . 0.0 110.791 -172.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.59 -33.99 74.84 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.258 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.01 -43.23 91.53 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.579 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.8 mp -67.2 -42.43 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.708 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -62.61 -46.13 89.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.686 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.1 pt-20 -71.57 -38.49 70.94 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.46 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-N 117.832 0.287 . . . . 0.0 110.57 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.252 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.453 ' O ' HG13 ' X' ' 75' ' ' ILE . 26.1 Cg_endo -64.51 -39.53 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.591 2.861 . . . . 0.0 111.974 -174.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.33 0.86 20.69 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.77 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.03 -20.97 8.01 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 119.196 -1.478 . . . . 0.0 113.027 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.453 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -63.07 -46.34 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.767 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -56.49 -46.96 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.86 177.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 65.7 tttm -58.88 -48.2 82.25 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.632 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -58.46 -37.73 76.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' X' ' 45' ' ' THR . 38.6 mm -68.87 -46.83 78.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.765 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -66.81 -36.37 82.21 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.578 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 47.8 mt-10 -72.42 -34.55 67.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.866 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.465 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 89.7 t90 -69.14 -46.15 68.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.57 . . . . 0.0 110.09 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -67.84 -35.99 79.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.065 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.598 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.58 81.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.762 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' X' ' 88' ' ' LYS . 25.7 t-20 -67.0 -41.25 87.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 46.77 4.58 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 106.607 -2.597 . . . . 0.0 106.607 -169.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.481 ' HB2' ' OD1' ' X' ' 86' ' ' ASN . 22.9 ttmm -121.33 135.57 25.11 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.54 114.87 2.14 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.348 2.699 . . . . 0.0 112.347 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.52 -116.14 3.78 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.805 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -86.51 155.01 20.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.9 ptmt -91.42 -175.65 4.29 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.87 144.18 32.97 Favored 'General case' 0 N--CA 1.399 -2.994 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.153 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.048 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.433 HD22 HD13 ' X' ' 18' ' ' LEU . 35.3 mt . . . . . 0 N--CA 1.437 -1.121 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 30.8 mmtt -96.92 -176.2 3.49 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.514 0.673 . . . . 0.0 111.96 -173.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.7 -36.18 11.84 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 61.6 p -135.12 166.68 22.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.323 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.83 -16.52 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.446 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -69.98 -25.66 63.72 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.573 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 16.0 t0 -94.93 -15.65 23.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -75.64 119.17 19.31 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.464 ' HA ' ' CB ' ' X' ' 92' ' ' LYS . 51.8 p -78.31 167.28 21.59 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.601 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.7 pt-20 -57.75 -41.01 81.04 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.981 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.68 -37.63 76.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.16 -37.72 83.89 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.581 -0.699 . . . . 0.0 110.264 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.533 ' HD2' HG12 ' X' ' 76' ' ' VAL . 33.5 t80 -71.81 -44.51 63.81 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.557 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.723 HG12 HG11 ' X' ' 76' ' ' VAL . 9.9 m -60.5 -35.86 65.99 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -49.78 76.33 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.231 1.012 . . . . 0.0 110.142 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.654 ' O ' HG13 ' X' ' 22' ' ' ILE . 28.4 tp -58.03 -47.16 83.94 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.584 0.707 . . . . 0.0 110.118 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.529 HD13 ' O ' ' X' ' 15' ' ' PHE . 8.1 mp -60.95 -37.0 80.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.169 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 52.9 mtmt -66.5 -35.43 80.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -65.6 -45.07 84.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.825 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.654 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.4 mt -55.92 -39.58 57.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.436 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.26 -47.33 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.087 0.47 . . . . 0.0 110.761 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.25 -51.56 43.85 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.612 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -23.25 67.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.305 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -71.6 -55.95 6.8 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.12 -20.77 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.46 -19.73 22.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.63 0.252 . . . . 0.0 110.553 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.6 64.37 1.77 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.275 1.03 . . . . 0.0 111.071 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 51.4 p -77.21 -26.23 52.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.369 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.26 22.9 t70 74.36 -68.5 0.21 Allowed 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 125.806 1.643 . . . . 0.0 115.076 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.606 ' O ' HG23 ' X' ' 36' ' ' VAL . 30.2 t70 -57.19 -55.9 28.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.093 0.86 . . . . 0.0 112.284 -174.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.811 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -78.32 -32.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.507 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.869 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.02 -45.89 89.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.3 t70 -65.01 -40.48 94.98 Favored 'General case' 0 CA--C 1.479 -1.788 0 O-C-N 123.369 0.418 . . . . 0.0 110.668 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.606 HG23 ' O ' ' X' ' 32' ' ' ASP . 98.3 t -54.62 -49.57 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.921 0 O-C-N 124.412 1.07 . . . . 0.0 109.193 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.811 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 54.9 mt -67.48 -41.05 85.2 Favored 'General case' 0 N--CA 1.405 -2.694 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.259 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.8 mt -60.57 -50.82 71.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.22 0.95 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.65 -36.66 70.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.437 ' O ' HG12 ' X' ' 44' ' ' ILE . 6.5 t60 -59.99 -46.15 90.4 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.609 ' O ' HG22 ' X' ' 45' ' ' THR . 57.4 t80 -59.94 -56.71 18.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.573 1.171 . . . . 0.0 110.948 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.438 HG12 ' O ' ' X' ' 38' ' ' LEU 0.271 8.4 p -66.62 -31.88 55.52 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.771 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -70.25 -28.33 65.16 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.811 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.437 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.7 pt -87.51 -39.0 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.653 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.609 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.77 -32.78 23.23 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.093 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.01 22.6 13.55 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.414 . . . . 0.0 112.306 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.488 ' H ' HG23 ' X' ' 45' ' ' THR . 55.3 t-80 -70.21 135.22 86.97 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.594 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.3 Cg_exo -70.22 4.52 2.34 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 123.527 2.818 . . . . 0.0 112.864 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 27.9 m-20 -136.83 27.25 2.99 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.17 -58.05 5.26 Favored Glycine 0 CA--C 1.476 -2.387 0 O-C-N 124.511 1.132 . . . . 0.0 113.199 -175.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.51 HG21 HD13 ' X' ' 38' ' ' LEU 0.276 0.0 OUTLIER -79.34 -25.61 42.25 Favored 'General case' 0 C--N 1.257 -3.427 0 C-N-CA 118.059 -1.456 . . . . 0.0 113.65 -176.813 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.16 -37.31 87.0 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 65.2 mt -64.76 -37.86 89.02 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.676 0.61 . . . . 0.0 111.249 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.429 HD13 HG21 ' X' ' 22' ' ' ILE . 25.3 mt -66.78 -46.33 85.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.735 0.779 . . . . 0.0 109.461 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.455 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.8 m-85 -63.45 -46.74 84.88 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -64.24 -40.08 95.28 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.76 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 C--O 1.201 -1.493 0 O-C-N 123.116 0.26 . . . . 0.0 111.387 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.773 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.559 ' O ' HG13 ' X' ' 76' ' ' VAL . 7.9 Cg_endo -57.02 -42.01 68.84 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.632 2.888 . . . . 0.0 110.623 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.527 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.6 mt-10 -78.35 1.93 20.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.205 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.17 -34.86 2.84 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 119.021 -1.561 . . . . 0.0 112.948 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' X' ' 57' ' ' ALA . 1.1 pt -67.2 -26.18 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-N 117.503 0.652 . . . . 0.0 110.765 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.723 HG11 HG12 ' X' ' 16' ' ' VAL . 27.8 m -61.4 -34.44 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.141 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 60.6 tttm -61.79 -47.02 87.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.504 174.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.8 -43.71 90.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.567 0.699 . . . . 0.0 109.415 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.525 HG23 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -64.8 -46.54 91.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.22 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.519 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 17.4 pttp -67.44 -37.08 82.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.312 -174.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.92 -39.46 72.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.33 0.394 . . . . 0.0 111.35 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.594 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 70.4 t90 -64.79 -47.83 76.66 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.7 0.625 . . . . 0.0 109.443 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.616 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 16.2 tpt180 -61.45 -45.67 93.3 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.223 -176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.69 -38.73 84.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.232 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.9 78.5 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.903 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -69.02 -36.16 77.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.8 41.94 2.78 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.616 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 55.7 mttm -118.97 147.96 43.62 Favored Pre-proline 0 N--CA 1.396 -3.172 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.79 130.17 32.02 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.229 1.952 . . . . 0.0 111.071 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.444 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -100.09 -140.63 11.49 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.302 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.1 m-85 -78.29 150.45 33.33 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.047 0.451 . . . . 0.0 110.945 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.464 ' CB ' ' HA ' ' X' ' 11' ' ' THR . 0.7 OUTLIER -72.72 157.37 37.65 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.979 174.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -85.46 1.16 49.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.004 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.261 -3.62 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.212 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 33.0 mmtt -108.72 160.31 16.05 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.0 -17.38 43.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.679 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.7 p -139.7 163.84 31.53 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.112 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.6 tp -64.92 -22.61 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.047 0.939 . . . . 0.0 110.023 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -76.32 -11.61 59.93 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.789 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 26.6 t0 -105.31 -7.17 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.882 0.849 . . . . 0.0 108.914 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -83.59 115.33 22.08 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.947 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 16.3 p -76.77 169.02 19.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.86 -33.58 73.29 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 119.676 1.125 . . . . 0.0 112.173 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -44.07 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.381 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -57.22 -41.65 79.88 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.414 0.626 . . . . 0.0 109.949 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.3 t80 -65.75 -55.55 16.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HB2' ' X' ' 19' ' ' LEU . 14.7 p -63.63 -27.79 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -60.77 -47.38 86.57 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.473 HD21 HD22 ' X' ' 37' ' ' LEU . 2.3 tm? -62.61 -40.79 98.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.123 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 21.9 mt -57.78 -43.8 85.81 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.787 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -61.32 -38.74 87.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.45 -31.64 70.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.594 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.457 HG13 ' O ' ' X' ' 18' ' ' LEU . 35.1 mt -66.68 -46.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -57.72 -34.53 69.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.807 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.28 -40.69 96.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.42 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -88.57 -30.27 19.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.735 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -50.38 -47.61 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.81 1.244 . . . . 0.0 111.706 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -69.95 -17.14 20.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -105.52 -19.54 13.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.635 0.255 . . . . 0.0 110.565 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.52 87.64 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.436 1.495 . . . . 0.0 110.73 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.2 p -95.26 -164.62 1.18 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.48 -42.33 0.7 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.417 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.695 ' O ' HG23 ' X' ' 36' ' ' VAL . 13.8 t70 -71.1 -62.02 1.55 Allowed 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.527 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.673 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.3 p -75.8 -27.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.228 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.514 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.8 tm? -57.64 -52.84 63.77 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 124.258 1.023 . . . . 0.0 108.565 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.63 -25.51 60.34 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.294 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.695 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.3 t -68.5 -50.74 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.037 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.623 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.1 mt -68.87 -43.36 75.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 O-C-N 124.744 1.278 . . . . 0.0 111.36 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.6 mt -61.14 -44.83 96.72 Favored 'General case' 0 N--CA 1.415 -2.191 0 O-C-N 124.274 0.984 . . . . 0.0 112.054 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -71.05 -42.95 68.79 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.782 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.521 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 26.5 t60 -60.22 -45.92 91.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.47 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' X' ' 54' ' ' ILE . 34.2 t80 -62.77 -48.36 79.51 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.419 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.1 p -67.52 -31.23 51.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 52.2 pttt -73.11 -35.08 66.5 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.599 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 21.7 pt -79.03 -32.46 15.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -83.55 -33.9 25.35 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.843 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.9 28.27 17.24 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.091 0.948 . . . . 0.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.499 ' ND1' ' HB2' ' X' ' 49' ' ' ASP . 54.8 t-80 -85.89 145.82 42.01 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.516 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.572 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.5 Cg_exo -77.48 12.97 1.71 Allowed 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.342 2.694 . . . . 0.0 112.643 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.499 ' HB2' ' ND1' ' X' ' 47' ' ' HIS . 0.8 OUTLIER -123.86 -64.38 1.15 Allowed 'General case' 0 N--CA 1.404 -2.743 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.539 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . 58.42 -84.33 0.01 OUTLIER Glycine 1 CA--C 1.428 -5.361 0 O-C-N 125.337 1.648 . . . . 0.0 111.997 177.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.42 HG23 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.4 -37.27 74.45 Favored 'General case' 1 C--N 1.211 -5.44 0 CA-C-N 112.698 -1.751 . . . . 0.0 109.239 -172.138 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.07 -31.08 70.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.071 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.36 -42.19 96.32 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.423 0.452 . . . . 0.0 111.82 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' X' ' 41' ' ' PHE . 5.0 mp -67.27 -42.0 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.096 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -61.88 -41.86 98.38 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.81 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.8 pt-20 -71.74 -37.12 70.61 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.876 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.018 0 C-N-CA 122.943 0.497 . . . . 0.0 111.281 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.048 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.588 ' HA ' HD11 ' X' ' 75' ' ' ILE . 20.3 Cg_endo -63.93 -30.92 67.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.026 2.484 . . . . 0.0 112.379 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.89 -11.65 59.91 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -99.8 -29.08 7.08 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 118.2 -1.952 . . . . 0.0 113.063 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.0 OUTLIER -60.52 -44.02 95.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.474 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 1.7 p -63.13 -43.68 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.996 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 85.9 tttt -61.71 -44.78 96.27 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 13.5 mm-40 -59.35 -45.13 92.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.481 0.658 . . . . 0.0 110.504 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.568 HG12 ' O ' ' X' ' 75' ' ' ILE . 48.2 mm -61.86 -45.33 98.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.972 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.2 ptmt -63.06 -38.07 89.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.347 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -71.7 -43.81 65.29 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.479 0.487 . . . . 0.0 111.847 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.572 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.3 t90 -63.98 -48.15 77.58 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.457 0.646 . . . . 0.0 110.916 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' CA ' ' X' ' 90' ' ' GLY . 12.0 tpt180 -60.9 -45.14 95.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.696 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.33 -38.18 81.29 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.199 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.62 88.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.132 0.492 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.466 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.5 t-20 -74.51 -42.2 59.34 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.91 31.77 3.77 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.466 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 63.7 mttm -102.35 146.66 32.74 Favored Pre-proline 0 N--CA 1.405 -2.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.44 126.62 17.28 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.046 1.831 . . . . 0.0 109.701 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' X' ' 83' ' ' ARG . . . -110.88 -119.8 3.99 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.506 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.69 149.32 29.79 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.383 1.087 . . . . 0.0 113.422 -171.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' X' ' 11' ' ' THR . 28.3 ttpt -88.19 172.81 9.2 Favored 'General case' 1 N--CA 1.365 -4.716 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.148 174.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.06 27.67 1.04 Allowed 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 121.317 0.58 . . . . 0.0 112.198 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . 0.421 ' OXT' ' HE3' ' X' ' 92' ' ' LYS . . . . . . . . 0 C--N 1.277 -2.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.383 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' X' ' 18' ' ' LEU . 37.2 mt . . . . . 0 CA--C 1.501 -0.922 0 CA-C-O 121.632 0.729 . . . . 0.0 111.877 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 39.4 mmtt -100.59 -161.47 0.87 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.106 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -117.82 -28.63 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.963 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -136.09 167.03 22.0 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.96 -11.37 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.681 0.753 . . . . 0.0 110.316 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 8.2 m -70.1 -26.74 64.12 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.89 0.876 . . . . 0.0 111.294 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.516 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 10.2 t70 -105.01 5.74 32.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.652 0.739 . . . . 0.0 109.677 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 12.3 m-85 -95.87 124.98 40.11 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.646 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 45.4 p -89.4 171.67 9.57 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.626 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.5 -45.72 80.89 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.131 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.74 -38.46 73.52 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.84 -34.46 77.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.402 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.451 ' CD2' HG12 ' X' ' 76' ' ' VAL . 62.0 t80 -71.48 -43.06 67.27 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.723 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.67 HG12 HG11 ' X' ' 76' ' ' VAL . 5.9 m -62.64 -29.94 48.11 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.468 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -61.74 -45.98 91.61 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.285 0.634 . . . . 0.0 109.865 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.614 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.7 tp -61.95 -48.19 81.51 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.625 HD13 HD12 ' X' ' 22' ' ' ILE . 4.3 mm? -60.46 -36.31 77.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.329 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 64.4 mttm -68.49 -36.93 79.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.85 -35.55 78.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.358 0.599 . . . . 0.0 110.104 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' X' ' 37' ' ' LEU . 67.7 mt -63.06 -46.28 96.57 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.38 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.727 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -57.82 -45.5 86.06 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 109.802 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.28 -51.85 67.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.126 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.701 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 6.2 mm-40 -82.47 -14.67 54.67 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -69.85 -47.17 63.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 120.835 0.35 . . . . 0.0 110.191 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.4 -19.75 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.39 -18.67 25.05 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.969 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.37 72.76 0.38 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.146 1.378 . . . . 0.0 111.837 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 57.2 p -93.84 -168.4 1.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -134.84 -55.7 0.82 Allowed 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.894 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.542 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.0 p-10 -57.53 -48.08 80.25 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.8 p -87.92 -32.9 6.27 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.608 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.22 -44.56 92.29 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.713 0.805 . . . . 0.0 109.487 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.92 -32.38 69.29 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.924 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.542 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.4 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.142 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 66.2 mt -68.37 -43.03 78.26 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.707 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 15.9 mt -60.22 -45.08 94.45 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 124.265 0.978 . . . . 0.0 110.325 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -70.39 -38.75 74.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.985 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.6 t60 -64.41 -45.15 88.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.454 0.645 . . . . 0.0 109.627 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.588 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.7 t80 -59.04 -51.13 71.36 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -67.98 -33.03 58.84 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.869 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.1 ptmt -68.96 -36.12 77.53 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.039 0.447 . . . . 0.0 111.687 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.455 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.7 pt -79.17 -33.29 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.106 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -84.66 -39.69 18.3 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.317 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 63.8 31.77 13.92 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.694 1.198 . . . . 0.0 109.991 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -80.38 135.34 53.81 Favored Pre-proline 0 N--CA 1.424 -1.77 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.117 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.0 Cg_exo -76.62 9.68 2.51 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 C-N-CA 123.367 2.711 . . . . 0.0 111.904 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -140.8 19.14 2.33 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.588 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.88 -69.01 0.68 Allowed Glycine 0 CA--C 1.46 -3.4 0 O-C-N 124.38 1.05 . . . . 0.0 114.512 -173.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.445 HG21 HD13 ' X' ' 38' ' ' LEU . 0.6 OUTLIER -74.38 -18.84 60.61 Favored 'General case' 0 C--N 1.253 -3.593 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.026 -173.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -71.32 -34.19 70.35 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.58 -37.9 88.02 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.621 0.576 . . . . 0.0 110.645 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.435 HD13 HG21 ' X' ' 22' ' ' ILE . 49.2 mt -66.94 -47.07 83.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.863 0.839 . . . . 0.0 109.092 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.05 -47.96 80.74 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.07 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.0 pt-20 -65.71 -36.64 84.18 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.217 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.68 0 CA-C-N 118.181 0.446 . . . . 0.0 110.947 178.77 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.026 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.638 ' HA ' HD11 ' X' ' 75' ' ' ILE . 15.9 Cg_endo -57.02 -34.51 97.79 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 124.157 3.238 . . . . 0.0 113.664 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.488 ' C ' HG22 ' X' ' 76' ' ' VAL . 41.5 mt-10 -82.73 2.11 35.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.912 0.386 . . . . 0.0 112.024 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.59 -27.76 6.62 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.268 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.0 OUTLIER -66.23 -34.05 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.67 HG11 HG12 ' X' ' 16' ' ' VAL . 29.2 m -64.7 -34.79 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.254 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.951 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 41.7 ttmt -64.79 -43.6 92.68 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 7.6 mm-40 -57.79 -45.09 86.54 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.978 0.894 . . . . 0.0 109.084 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 22.6 mm -62.34 -46.62 95.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.787 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -67.17 -35.64 80.09 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.69 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -69.26 -32.04 70.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.553 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.9 t90 -70.08 -48.58 57.13 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.122 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.438 ' HE ' ' HB2' ' X' ' 83' ' ' ARG . 0.0 OUTLIER -65.95 -37.2 85.41 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.591 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.77 90.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.785 0.678 . . . . 0.0 111.652 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.76 -44.88 39.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.95 0.405 . . . . 0.0 110.695 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.5 -33.93 73.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.208 0.528 . . . . 0.0 110.665 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.65 30.86 6.3 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -103.48 163.35 17.61 Favored Pre-proline 0 N--CA 1.405 -2.689 0 C-N-CA 124.042 0.937 . . . . 0.0 109.651 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 36.3 Cg_exo -62.47 131.05 32.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.913 2.409 . . . . 0.0 113.07 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.86 -150.56 24.4 Favored Glycine 0 N--CA 1.429 -1.815 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.529 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -85.42 150.02 25.01 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' X' ' 8' ' ' SER . 20.0 ptmt -77.89 165.14 24.49 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.32 133.02 36.24 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.256 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.604 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.494 ' CD2' HD13 ' X' ' 18' ' ' LEU . 31.9 mt . . . . . 0 CA--C 1.5 -0.944 0 CA-C-O 121.073 0.464 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -96.37 -162.34 0.95 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -115.05 -24.49 8.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.358 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . 0.429 ' HA ' HG22 ' X' ' 44' ' ' ILE . 84.7 p -134.61 166.81 22.05 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -65.33 -15.18 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.381 0.672 . . . . 0.0 110.725 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 16.6 t -76.53 -20.64 56.69 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.882 -170.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 6.87 37.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 118.297 -1.361 . . . . 0.0 109.673 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.21 122.63 34.0 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.105 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.0 p -82.87 167.73 17.77 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.632 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.42 -42.92 92.94 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.189 -1.404 . . . . 0.0 111.85 176.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.602 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -67.34 -38.76 85.37 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -59.13 -39.13 81.38 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.643 0.735 . . . . 0.0 110.1 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.681 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -74.78 -42.15 58.7 Favored 'General case' 0 N--CA 1.407 -2.581 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.017 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.779 HG12 HG11 ' X' ' 76' ' ' VAL . 8.9 m -62.62 -32.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.41 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -62.33 -43.98 97.56 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.64 ' O ' HG13 ' X' ' 22' ' ' ILE . 36.8 tp -61.71 -46.54 89.25 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-O 121.253 0.549 . . . . 0.0 109.974 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -57.32 -41.93 80.88 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.765 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.4 mttm -64.28 -41.97 96.65 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.22 0.534 . . . . 0.0 109.648 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.21 -38.1 87.16 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.042 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.64 HG13 ' O ' ' X' ' 18' ' ' LEU . 47.4 mt -60.15 -46.06 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.348 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.27 -43.58 88.03 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.365 0.602 . . . . 0.0 110.23 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . 0.509 ' HG3' ' OE2' ' X' ' 25' ' ' GLU . 26.1 tptp -59.5 -50.42 73.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.846 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.509 ' OE2' ' HG3' ' X' ' 24' ' ' LYS . 16.0 mm-40 -86.15 -5.61 59.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.339 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -79.23 -44.89 20.9 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.53 -32.39 52.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.256 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -19.67 42.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.752 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.83 80.87 0.19 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.343 1.457 . . . . 0.0 112.911 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 77.0 p -106.77 -169.49 1.56 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.47 -26.33 0.76 Allowed 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.098 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.509 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.6 m-20 -67.28 -57.9 5.81 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.621 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.53 -31.12 7.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.132 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.9 tm? -59.48 -46.03 89.97 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.974 -175.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -32.34 72.98 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.206 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.509 HG23 ' O ' ' X' ' 32' ' ' ASP . 38.3 t -66.33 -49.27 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.574 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 58.0 mt -66.73 -42.65 85.95 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.0 -170.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.3 mt -59.42 -47.84 83.93 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.541 1.151 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.42 -42.55 71.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.549 ' O ' HG12 ' X' ' 44' ' ' ILE . 22.8 t60 -59.46 -45.55 91.3 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.506 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.595 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.12 -55.12 37.84 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.879 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.502 HG12 ' O ' ' X' ' 38' ' ' LEU . 8.3 p -66.76 -31.81 55.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.3 pttp -71.27 -34.32 70.58 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.769 -0.582 . . . . 0.0 111.781 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.549 HG12 ' O ' ' X' ' 40' ' ' HIS . 23.7 pt -88.48 -29.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.511 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.528 ' HB ' HD12 ' X' ' 79' ' ' ILE . 70.1 p -84.46 -37.77 20.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.544 0.688 . . . . 0.0 109.494 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 69.04 21.56 7.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.249 1.82 . . . . 0.0 112.076 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.455 ' O ' HG23 ' X' ' 42' ' ' VAL . 48.7 t-80 -72.23 132.96 83.76 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 31.5 Cg_exo -66.74 -21.3 51.56 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.149 2.566 . . . . 0.0 112.146 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -122.44 35.69 4.82 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.595 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.12 -55.3 8.79 Favored Glycine 1 CA--C 1.448 -4.124 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.585 -178.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.496 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.24 -34.51 68.34 Favored 'General case' 0 C--N 1.255 -3.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.208 -173.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.56 -29.37 70.64 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.653 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 53' ' ' LEU . 26.4 mt -61.42 -42.68 99.13 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 175.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.582 HD13 HG21 ' X' ' 22' ' ' ILE . 10.5 mt -66.59 -42.54 90.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -63.02 -44.67 95.3 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.802 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.9 pt-20 -69.8 -39.3 76.63 Favored 'General case' 0 C--O 1.201 -1.48 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.635 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.391 0 C-N-CA 122.26 0.224 . . . . 0.0 111.279 -179.722 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.552 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.511 ' O ' HG13 ' X' ' 75' ' ' ILE . 29.1 Cg_endo -61.8 -37.5 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.254 2.636 . . . . 0.0 110.992 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.14 0.69 18.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.764 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.27 -8.87 26.59 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.008 174.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.511 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -73.82 -45.43 49.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.779 HG11 HG12 ' X' ' 16' ' ' VAL . 1.2 p -57.71 -42.16 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.966 175.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttp -58.52 -47.86 82.77 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.747 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.4 -39.12 89.58 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.528 HD12 ' HB ' ' X' ' 45' ' ' THR . 41.8 mm -67.86 -46.34 82.37 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.832 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.6 pttp -63.72 -36.29 83.39 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.384 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.85 -38.82 70.04 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.874 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.515 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 66.7 t90 -69.75 -47.79 61.69 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.016 0.436 . . . . 0.0 110.025 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.584 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 14.5 tpt180 -60.35 -45.52 93.2 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.0 89.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.704 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.28 92.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.163 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -64.67 -32.56 74.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.78 4.84 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.584 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 64.5 mttm -112.83 144.58 31.3 Favored Pre-proline 0 N--CA 1.388 -3.542 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -64.22 139.3 65.52 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.093 1.862 . . . . 0.0 109.31 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -109.38 -125.23 5.03 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.31 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.428 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 76.9 m-85 -82.86 152.53 25.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.665 -0.768 . . . . 0.0 111.2 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' X' ' 8' ' ' SER . 19.8 ptmt -83.59 -179.27 7.29 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.49 140.07 30.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.884 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.406 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 71.2 mt . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -97.83 -174.7 2.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.87 -9.17 14.07 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.237 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -144.47 164.89 29.52 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -70.79 -8.7 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.444 0.64 . . . . 0.0 110.688 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -76.81 -25.82 53.71 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.02 -11.94 21.04 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.406 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 8.7 m-85 -72.99 118.11 15.53 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.31 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.459 HG22 ' HG2' ' X' ' 92' ' ' LYS . 76.0 p -78.4 162.0 26.73 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 169.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.654 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.05 -45.28 79.27 Favored 'General case' 0 C--N 1.28 -2.42 0 O-C-N 123.571 0.544 . . . . 0.0 111.015 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.49 -38.23 77.58 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -57.44 -37.5 72.92 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 118.436 0.562 . . . . 0.0 110.107 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.736 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 5.7 t80 -80.0 -45.38 18.51 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.751 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.695 HG12 HG21 ' X' ' 76' ' ' VAL . 11.7 m -58.82 -31.78 45.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.043 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.86 -47.19 78.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.939 0.896 . . . . 0.0 109.79 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.495 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -62.75 -41.77 99.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.01 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -61.34 -37.77 84.5 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.519 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 56.6 mttp -64.47 -36.0 82.77 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.439 0.638 . . . . 0.0 109.578 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.74 -32.82 73.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.905 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.573 HG12 HD13 ' X' ' 37' ' ' LEU . 34.1 mt -64.92 -41.49 92.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -57.49 -46.14 84.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.786 0.803 . . . . 0.0 108.841 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -60.06 -45.36 93.13 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.929 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.594 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -85.24 -29.61 24.5 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.178 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.67 -34.88 79.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.781 0.324 . . . . 0.0 111.359 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.7 m -77.27 -12.59 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.07 -22.68 16.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.56 85.72 0.14 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.127 1.771 . . . . 0.0 112.043 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -106.1 172.26 6.9 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -135.91 8.67 3.27 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.642 170.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.467 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 m-20 -91.16 -70.66 0.67 Allowed 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.706 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.7 p -74.66 -30.69 25.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.978 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.594 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 3.0 tm? -58.3 -46.03 86.87 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.13 -32.8 74.18 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.282 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.467 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.9 t -64.8 -50.12 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 68.6 mt -68.66 -41.77 78.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.858 -171.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 7.0 mt -61.17 -46.64 89.66 Favored 'General case' 0 N--CA 1.418 -2.063 0 O-C-N 124.102 0.876 . . . . 0.0 110.915 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.18 -42.35 72.55 Favored 'General case' 0 N--CA 1.433 -1.283 0 O-C-N 123.418 0.449 . . . . 0.0 110.884 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.469 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 25.3 t60 -59.57 -45.34 92.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 123.68 0.792 . . . . 0.0 110.595 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.405 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 34.2 t80 -61.02 -55.32 34.23 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.156 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.46 HG23 ' HA3' ' X' ' 50' ' ' GLY . 12.3 p -67.3 -31.65 53.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 0.0 OUTLIER -69.68 -39.26 77.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 122.232 -0.293 . . . . 0.0 111.772 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.616 HD11 ' CE1' ' X' ' 15' ' ' PHE . 49.9 pt -80.97 -30.63 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.941 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -85.02 -35.09 22.16 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.76 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 61.76 28.15 17.28 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.409 ' HA ' ' HD3' ' X' ' 48' ' ' PRO . 37.4 t-80 -77.18 139.53 64.96 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.435 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 20.3 Cg_exo -70.41 -19.3 33.2 Favored 'Trans proline' 0 CA--C 1.495 -1.432 0 C-N-CA 123.087 2.525 . . . . 0.0 112.488 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 14.4 m-20 -127.23 40.98 3.61 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.46 ' HA3' HG23 ' X' ' 42' ' ' VAL . . . -51.22 -51.77 34.69 Favored Glycine 0 CA--C 1.466 -2.976 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.978 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . . . . . . . . 0.35 0.6 OUTLIER -80.99 -25.06 37.54 Favored 'General case' 0 C--N 1.256 -3.497 0 C-N-CA 117.48 -1.688 . . . . 0.0 114.165 -174.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' X' ' 49' ' ' ASP . . . -61.2 -41.12 96.26 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.12 -46.52 88.12 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.292 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 31.1 mt -67.07 -47.54 81.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 CA-C-O 121.344 0.592 . . . . 0.0 110.736 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -59.8 -49.06 79.2 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.359 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.35 -40.7 96.38 Favored 'General case' 0 C--O 1.174 -2.917 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.769 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . 0.454 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . . . . . . 0 CA--C 1.501 -0.932 0 CA-C-N 118.412 0.551 . . . . 0.0 111.296 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.517 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.42 -24.63 56.87 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.196 3.264 . . . . 0.0 113.316 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.406 ' HA ' ' CG2' ' X' ' 76' ' ' VAL . 33.5 mt-10 -96.32 1.41 51.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.026 0.441 . . . . 0.0 109.937 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -103.34 -31.65 4.88 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.602 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.522 ' CD1' HD13 ' X' ' 19' ' ' LEU . 5.3 pt -65.43 -32.55 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 O-C-N 122.277 -0.543 . . . . 0.0 111.616 175.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.695 HG21 HG12 ' X' ' 16' ' ' VAL . 0.2 OUTLIER -65.56 -32.23 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.469 176.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 59.6 tttm -66.7 -45.67 78.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.84 -44.76 86.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.376 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.45 -46.81 88.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.079 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -69.39 -36.29 76.64 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.472 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.5 mt-10 -71.37 -37.21 71.65 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.481 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.8 t90 -66.55 -47.25 73.43 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.923 0.868 . . . . 0.0 109.719 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -61.28 -46.1 91.73 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.771 -176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.2 81.64 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.79 -45.62 93.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.954 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.403 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 23.5 t-20 -69.25 -39.0 78.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.2 37.68 2.63 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 67.7 mttm -109.18 147.16 35.39 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.55 131.36 37.67 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.527 2.151 . . . . 0.0 111.785 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.35 -144.14 15.37 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.182 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -78.17 145.82 35.4 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 111.33 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' X' ' 11' ' ' THR . 5.3 tttt -86.28 163.03 17.96 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . 0.439 ' N ' ' HG3' ' X' ' 92' ' ' LYS 0.251 13.6 mt-30 -88.87 131.01 35.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.633 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.925 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 174.809 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' X' ' 40' ' ' HIS . 66.5 mt . . . . . 0 N--CA 1.433 -1.276 0 CA-C-O 120.979 0.419 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 46.3 mmtt -102.08 -159.16 0.71 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -116.33 -28.49 6.49 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.703 0.763 . . . . 0.0 109.499 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 65.0 p -132.74 166.83 21.31 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.652 177.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.594 HD11 ' CE1' ' X' ' 91' ' ' PHE . 10.9 tp -70.81 -15.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.533 0.683 . . . . 0.0 110.68 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -77.74 -9.0 58.77 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.425 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -109.27 3.67 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 6.7 m-85 -94.8 115.51 27.59 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.646 -174.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 76.1 p -76.06 156.86 33.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 167.168 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.67 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.7 pt-20 -60.84 -30.61 70.21 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.88 73.78 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.113 0.415 . . . . 0.0 111.382 175.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.449 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 10.1 mm-40 -57.46 -39.02 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.624 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.4 t80 -71.54 -49.01 44.88 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.584 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.842 HG12 HG11 ' X' ' 76' ' ' VAL . 5.0 m -62.6 -30.04 48.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.731 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' X' ' 21' ' ' GLU . 6.6 tt0 -63.0 -49.01 76.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.585 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.1 tm? -58.75 -44.71 90.62 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.56 177.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.673 HD13 HG13 ' X' ' 75' ' ' ILE . 33.0 mt -58.12 -42.21 85.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.163 176.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.6 mttm -67.78 -35.04 77.96 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.172 176.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' X' ' 17' ' ' GLN . 45.3 mt-10 -67.24 -37.68 83.95 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.681 176.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.585 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.6 mt -62.13 -43.72 98.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 0.9 OUTLIER -58.06 -47.68 82.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.621 1.168 . . . . 0.0 109.883 176.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.61 -52.04 59.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.427 -176.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.03 -25.95 64.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -70.94 -50.35 35.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.51 177.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.45 -11.68 13.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.14 -19.12 21.08 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 76.42 0.28 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.878 1.271 . . . . 0.0 111.275 -176.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -95.79 -25.67 15.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.168 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 66.41 -64.46 0.22 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 126.19 1.796 . . . . 0.0 114.721 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.501 ' O ' HG23 ' X' ' 36' ' ' VAL . 8.1 p-10 -63.97 -48.57 75.95 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.761 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -83.13 -29.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.838 -177.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -41.84 90.14 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.692 175.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.61 -36.19 82.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.501 HG23 ' O ' ' X' ' 32' ' ' ASP . 99.3 t -57.57 -48.42 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.965 0 O-C-N 123.835 0.709 . . . . 0.0 109.218 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 43.9 mt -68.07 -43.12 79.3 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.447 -174.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.535 ' HB3' HG21 ' X' ' 51' ' ' THR . 17.8 mt -58.89 -49.5 77.55 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 124.11 0.881 . . . . 0.0 111.173 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -68.47 -39.06 81.55 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.231 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.59 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 46.3 t60 -65.98 -45.26 82.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.094 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.577 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.5 t80 -55.29 -52.1 64.53 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.886 177.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.9 -32.83 58.09 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 21.0 ptmt -71.33 -33.22 69.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.934 -0.479 . . . . 0.0 112.118 -178.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.582 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.3 pt -83.08 -34.58 11.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.283 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 66.7 p -84.32 -38.73 20.02 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 63.97 27.23 14.29 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 109.983 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' X' ' 49' ' ' ASP . 37.4 t-80 -70.75 136.36 85.56 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 113.762 -1.563 . . . . 0.0 106.82 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.423 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 8.8 Cg_exo -76.73 6.03 4.42 Favored 'Trans proline' 0 CA--C 1.482 -2.088 0 C-N-CA 122.89 2.394 . . . . 0.0 112.686 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.487 ' CG ' ' HB3' ' X' ' 52' ' ' ALA . 24.9 t70 -144.76 32.21 1.15 Allowed 'General case' 0 N--CA 1.39 -3.448 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 -173.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.577 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.48 -62.53 3.93 Favored Glycine 1 CA--C 1.449 -4.036 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.43 -176.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.535 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.437 1.6 p -82.72 -13.33 56.54 Favored 'General case' 0 N--CA 1.386 -3.664 0 C-N-CA 116.46 -2.096 . . . . 0.0 115.267 -177.649 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.651 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -72.09 -29.87 64.54 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 117.863 -1.535 . . . . 0.0 108.814 174.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -60.55 -43.52 97.12 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.599 0.562 . . . . 0.0 110.961 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.48 -47.18 81.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.139 0.971 . . . . 0.0 109.672 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -63.57 -44.33 94.41 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.897 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -67.82 -35.77 79.21 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.38 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.973 0 O-C-N 123.059 0.224 . . . . 0.0 111.093 -179.017 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.946 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.404 ' O ' HG12 ' X' ' 75' ' ' ILE . 14.8 Cg_endo -58.98 -48.43 14.36 Favored 'Trans proline' 0 C--O 1.207 -1.052 0 C-N-CA 124.071 3.181 . . . . 0.0 113.57 -176.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.93 0.57 17.91 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.985 -0.447 . . . . 0.0 112.183 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.56 -23.9 5.51 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.776 175.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.673 HG13 HD13 ' X' ' 19' ' ' LEU . 4.1 pt -69.92 -31.91 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 122.09 -0.653 . . . . 0.0 110.313 176.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.842 HG11 HG12 ' X' ' 16' ' ' VAL . 0.5 OUTLIER -61.7 -41.81 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-O 122.257 1.027 . . . . 0.0 110.737 173.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' X' ' 74' ' ' GLY . 53.1 tttm -58.4 -42.29 86.83 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.228 176.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.07 -33.54 76.28 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.629 0.728 . . . . 0.0 109.566 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.421 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.9 mm -70.69 -45.94 71.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.144 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -62.5 -36.44 82.55 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.032 -177.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.56 -44.2 78.8 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.354 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 90.4 t90 -66.8 -48.86 67.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -176.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -71.44 -39.62 70.89 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.558 -174.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.16 -43.37 78.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.862 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -69.45 -30.38 68.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.97 29.53 7.19 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -117.08 141.08 27.87 Favored Pre-proline 0 N--CA 1.393 -3.296 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.53 118.77 5.25 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.476 2.784 . . . . 0.0 112.022 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.16 -124.63 4.33 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.6 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.594 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.0 m-85 -85.88 159.02 19.8 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.081 -178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -89.71 172.95 8.56 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -120.82 134.28 55.29 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.248 0.547 . . . . 0.0 111.862 -175.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.317 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 177.879 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.434 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 26.6 mt . . . . . 0 N--CA 1.444 -0.727 0 CA-C-O 121.063 0.459 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.424 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 36.7 mmtt -98.3 -159.57 0.75 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -113.03 -30.88 6.85 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.722 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.1 p -126.2 166.19 17.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' X' ' 91' ' ' PHE . 7.0 tp -69.21 -18.72 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.781 0.801 . . . . 0.0 109.763 -177.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -75.09 -17.75 60.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.364 -172.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.424 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 36.3 t0 -102.73 5.21 38.76 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 122.255 1.026 . . . . 0.0 108.919 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.434 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 9.3 m-85 -96.46 125.11 40.72 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.632 -176.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 67.9 p -88.08 172.53 9.46 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.657 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -62.02 -41.4 98.04 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.669 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.75 -37.86 76.59 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.445 ' HB2' ' H ' ' X' ' 11' ' ' THR . 43.5 mm-40 -60.85 -40.19 91.96 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.287 0.565 . . . . 0.0 109.69 174.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 26.7 t80 -71.74 -45.4 61.86 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.208 -178.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.669 HG22 ' HA ' ' X' ' 13' ' ' ALA . 13.6 m -61.88 -28.86 45.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.61 -46.78 86.71 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.623 ' O ' HG13 ' X' ' 22' ' ' ILE . 35.1 tp -60.86 -45.68 93.57 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.587 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 42.1 mt -57.67 -39.54 77.34 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 82.6 mttt -71.68 -38.7 70.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.101 176.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 73.7 mm-40 -60.72 -44.74 96.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.625 176.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.623 HG13 ' O ' ' X' ' 18' ' ' LEU . 48.1 mt -57.83 -46.1 87.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 O-C-N 123.967 0.792 . . . . 0.0 111.328 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.479 ' O ' HG22 ' X' ' 27' ' ' VAL . 44.5 mt-10 -57.61 -47.88 80.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.387 0.613 . . . . 0.0 110.894 -176.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -60.61 -43.03 97.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.766 -174.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.432 ' HB2' ' CG2' ' X' ' 30' ' ' THR . 3.0 pp20? -89.02 -34.04 16.95 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.566 -177.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . 0.517 ' HA ' HD23 ' X' ' 34' ' ' LEU . 39.2 t30 -60.04 -46.7 88.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.747 0.419 . . . . 0.0 111.798 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . 0.479 HG22 ' O ' ' X' ' 23' ' ' GLU . 31.2 m -79.55 0.6 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.164 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.37 0.19 12.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.239 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 44.95 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.067 1.747 . . . . 0.0 113.537 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 74.1 p -98.41 -24.38 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.493 . . . . 0.0 111.659 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 68.01 -59.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.245 1.418 . . . . 0.0 113.985 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.628 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 t70 -58.88 -61.39 2.66 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -82.24 -25.03 9.1 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' X' ' 26' ' ' ASN . 2.9 tm? -58.64 -50.09 75.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.352 176.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.47 -33.8 76.51 Favored 'General case' 0 CA--C 1.483 -1.61 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.784 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.628 HG23 ' O ' ' X' ' 32' ' ' ASP . 40.2 t -65.75 -50.23 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.623 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 40.7 mt -69.04 -43.66 74.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 O-C-N 124.442 1.089 . . . . 0.0 111.379 -172.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.475 ' O ' HG12 ' X' ' 42' ' ' VAL . 34.1 mt -61.54 -45.29 94.78 Favored 'General case' 0 N--CA 1.421 -1.878 0 O-C-N 124.163 0.914 . . . . 0.0 111.571 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.49 -41.57 72.49 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.253 177.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.518 ' O ' HG12 ' X' ' 44' ' ' ILE . 16.0 t60 -62.3 -45.9 91.16 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.466 0.478 . . . . 0.0 109.92 -175.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.496 ' CD2' HD11 ' X' ' 54' ' ' ILE . 43.7 t80 -58.25 -53.18 61.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.295 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' X' ' 38' ' ' LEU 0.285 14.5 p -67.86 -31.62 52.94 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.891 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.8 pttp -69.14 -32.27 71.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.745 -0.597 . . . . 0.0 111.991 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.518 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.7 pt -85.17 -35.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.869 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 61.1 p -84.22 -35.43 23.47 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 58.25 30.73 19.91 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.195 1.398 . . . . 0.0 111.325 -176.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 36.4 t-80 -77.14 134.66 67.29 Favored Pre-proline 0 N--CA 1.423 -1.788 0 CA-C-N 114.024 -1.444 . . . . 0.0 107.862 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.1 Cg_exo -71.0 -2.27 10.8 Favored 'Trans proline' 0 CA--C 1.493 -1.541 0 C-N-CA 123.362 2.708 . . . . 0.0 112.805 -175.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 11.8 m-20 -138.21 29.84 2.47 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -173.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.485 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.99 -61.05 3.64 Favored Glycine 1 CA--C 1.45 -4.017 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.946 -176.48 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.46 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -28.44 57.65 Favored 'General case' 0 C--N 1.248 -3.837 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.252 -172.5 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.587 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.76 -40.47 95.25 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.026 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.3 mt -56.32 -44.5 80.01 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.731 0.644 . . . . 0.0 112.087 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.496 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -66.63 -45.24 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.276 -177.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.423 ' HD2' ' O ' ' X' ' 51' ' ' THR . 29.7 m-85 -61.01 -49.31 77.93 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.74 -178.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.5 pt-20 -70.29 -36.28 74.25 Favored 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.638 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.518 0 CA-C-N 117.652 0.206 . . . . 0.0 111.319 179.383 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.406 -3.307 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.489 ' O ' HG12 ' X' ' 76' ' ' VAL . 25.7 Cg_endo -65.0 -50.98 1.81 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 123.085 2.524 . . . . 0.0 110.956 -176.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.85 1.68 6.66 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.55 -29.16 3.48 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.065 174.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.614 HG13 HD13 ' X' ' 19' ' ' LEU . 5.2 pt -66.3 -32.98 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.248 1.024 . . . . 0.0 111.045 175.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.668 HG11 HG12 ' X' ' 16' ' ' VAL . 0.5 OUTLIER -59.6 -43.64 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-O 121.998 0.904 . . . . 0.0 110.327 173.177 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 54.4 tttp -58.42 -46.13 87.08 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.551 175.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -67.21 -30.71 70.72 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.463 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.4 mm -68.21 -45.99 81.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 175.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -64.02 -36.11 82.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.726 0.298 . . . . 0.0 110.699 -176.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.31 -32.31 70.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.837 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.497 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 76.2 t90 -72.16 -44.1 63.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.77 -43.08 98.49 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.775 -176.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.44 84.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.821 178.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.22 99.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.359 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.472 ' ND2' ' HE2' ' X' ' 88' ' ' LYS . 3.5 t30 -73.46 -34.1 65.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.59 47.73 2.91 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.472 ' HE2' ' ND2' ' X' ' 86' ' ' ASN . 60.1 mttm -118.77 147.94 43.35 Favored Pre-proline 0 N--CA 1.4 -2.942 0 C-N-CA 123.234 0.614 . . . . 0.0 109.863 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.1 130.83 28.44 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.309 2.006 . . . . 0.0 110.477 175.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.27 -126.59 5.58 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.465 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' X' ' 7' ' ' ILE . 36.8 m-85 -81.27 156.7 25.45 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.108 -174.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' X' ' 11' ' ' THR . 53.0 pttt -94.57 174.28 7.2 Favored 'General case' 0 N--CA 1.389 -3.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.08 141.73 35.71 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.775 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.236 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.552 HD22 HD13 ' X' ' 18' ' ' LEU . 22.6 mt . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.149 0.499 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.544 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 37.7 mmtt -102.8 -179.96 4.11 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.203 -175.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.0 -24.79 16.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.325 0.583 . . . . 0.0 109.741 178.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.4 p -142.02 162.93 34.23 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.079 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -67.3 -17.92 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.24 1.016 . . . . 0.0 111.341 -176.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 75.8 m -86.6 -3.09 58.98 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.544 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 25.6 t0 -103.56 4.44 35.78 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 9.7 m-85 -99.0 121.06 40.46 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.6 -177.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.444 HG22 ' HG3' ' X' ' 92' ' ' LYS . 73.7 p -79.18 167.08 21.48 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 169.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.631 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.4 pt-20 -56.52 -42.65 78.78 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.629 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -38.31 75.6 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' X' ' 11' ' ' THR . 22.3 mm-40 -59.0 -37.65 77.36 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.363 0.601 . . . . 0.0 110.12 174.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.701 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -73.42 -42.8 61.61 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.743 HG12 HG11 ' X' ' 76' ' ' VAL . 3.9 m -62.99 -29.05 46.28 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.447 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.978 178.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -61.01 -46.75 89.47 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.625 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.1 tp -61.34 -47.23 86.82 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 175.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.1 mt -58.21 -38.54 76.99 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.158 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 68.3 mttm -71.55 -34.83 70.34 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.659 176.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.85 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.67 HG12 ' HB3' ' X' ' 37' ' ' LEU . 60.9 mt -62.92 -42.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.431 ' O ' HG22 ' X' ' 27' ' ' VAL . 1.6 tt0 -58.14 -44.45 87.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.242 174.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -59.11 -48.69 80.68 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.384 1.074 . . . . 0.0 109.567 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.8 -26.75 49.85 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.357 -178.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -80.01 -41.41 25.87 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 122.157 -0.34 . . . . 0.0 111.81 -179.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . 0.431 HG22 ' O ' ' X' ' 23' ' ' GLU . 33.0 m -70.52 -20.84 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.845 -179.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.93 -16.85 18.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.39 76.13 0.31 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.161 1.384 . . . . 0.0 111.969 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.8 p -96.37 -168.81 1.8 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.87 -43.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.943 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.516 ' O ' HG23 ' X' ' 36' ' ' VAL . 23.6 t70 -64.89 -53.02 53.19 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 79.4 t -87.15 -27.12 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.604 -178.106 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.04 -46.53 87.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.05 -20.6 61.65 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.516 HG23 ' O ' ' X' ' 32' ' ' ASP . 54.7 t -70.86 -49.77 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 C-N-CA 118.563 -1.255 . . . . 0.0 108.286 175.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 63.3 mt -68.29 -41.68 80.59 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 113.756 -1.565 . . . . 0.0 112.345 -170.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.5 mt -59.28 -44.57 92.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 124.151 0.907 . . . . 0.0 110.517 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.53 -45.0 63.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.71 177.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.58 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 20.2 t60 -59.33 -45.48 91.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.2 -175.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.586 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 39.6 t80 -60.49 -50.83 72.02 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.877 178.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.87 -32.19 55.38 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.538 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -179.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -69.53 -33.77 73.27 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.998 -0.439 . . . . 0.0 111.925 -178.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.469 HG12 ' O ' ' X' ' 40' ' ' HIS . 11.7 pt -85.07 -31.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 -178.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 53.2 p -84.77 -32.26 23.51 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.255 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 58.45 31.89 21.49 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.652 1.181 . . . . 0.0 109.949 -177.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 33.8 t-80 -82.52 135.14 46.86 Favored Pre-proline 0 N--CA 1.424 -1.774 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.441 -178.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.51 -12.33 31.29 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 123.068 2.512 . . . . 0.0 112.681 -176.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 9.0 m-20 -130.51 30.28 4.72 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.586 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.38 -58.69 5.69 Favored Glycine 0 CA--C 1.453 -3.805 0 CA-C-N 114.491 -1.231 . . . . 0.0 113.277 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.484 HG21 HD13 ' X' ' 38' ' ' LEU . 1.5 m -79.09 -23.3 44.23 Favored 'General case' 0 C--N 1.251 -3.707 0 C-N-CA 117.944 -1.502 . . . . 0.0 110.759 -172.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.53 67.15 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 175.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 28.3 mt -66.67 -37.28 84.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.627 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mt -66.37 -42.79 91.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.891 0.853 . . . . 0.0 108.827 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -62.72 -43.35 99.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.083 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.89 -40.09 75.88 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.048 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.078 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' X' ' 72' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.786 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.545 ' O ' HG13 ' X' ' 75' ' ' ILE . 12.8 Cg_endo -54.1 -45.44 41.0 Favored 'Trans proline' 0 C--O 1.212 -0.804 0 C-N-CA 123.959 3.106 . . . . 0.0 114.077 -171.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -74.15 1.35 11.41 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.64 -6.25 25.19 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 119.901 -1.142 . . . . 0.0 112.769 174.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.545 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.0 OUTLIER -77.04 -43.68 31.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.743 HG11 HG12 ' X' ' 16' ' ' VAL . 1.2 p -58.22 -43.18 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.989 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 87.8 tttt -58.58 -48.15 81.89 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.393 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.35 -39.46 90.68 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.791 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.408 HG12 ' O ' ' X' ' 75' ' ' ILE . 47.6 mm -66.5 -45.31 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.278 178.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.9 pttp -62.34 -36.24 81.6 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -70.78 -36.23 72.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.134 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -70.2 -47.86 59.66 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.768 0.794 . . . . 0.0 108.877 178.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 13.6 tpt180 -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.783 -175.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.25 -43.08 78.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.175 0.59 . . . . 0.0 111.723 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -30.85 71.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -78.06 -37.4 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.08 33.63 5.68 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.345 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 20.2 mtpp -113.95 143.34 29.43 Favored Pre-proline 0 N--CA 1.4 -2.957 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -176.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 128.12 22.59 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.972 2.448 . . . . 0.0 111.884 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.36 -112.0 3.64 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.45 -178.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.98 166.18 14.68 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.406 -173.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.444 ' HG3' HG22 ' X' ' 11' ' ' THR . 22.2 ptmt -99.76 170.72 8.35 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.27 141.14 30.74 Favored 'General case' 0 N--CA 1.391 -3.409 0 CA-C-O 121.678 0.751 . . . . 0.0 109.571 178.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.109 0 N-CA-C 107.374 -2.29 . . . . 0.0 107.374 178.987 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 85.0 mt . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.1 mmtt -104.14 142.33 34.68 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -75.12 -16.01 60.57 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.113 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.5 p -132.2 162.73 30.2 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.959 175.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.454 HD11 ' CE1' ' X' ' 91' ' ' PHE . 8.5 tp -69.27 -17.84 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.717 0.807 . . . . 0.0 109.679 -177.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -19.61 59.18 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.359 -172.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 17.6 t70 -101.82 5.0 40.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.974 0.892 . . . . 0.0 109.095 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.2 m-85 -95.01 114.95 26.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.085 -174.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.523 HG22 ' HG3' ' X' ' 92' ' ' LYS . 70.8 p -80.42 162.36 24.49 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.592 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.5 pt-20 -56.56 -44.77 81.27 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.579 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -39.05 75.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -58.61 -38.46 78.04 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.277 0.49 . . . . 0.0 110.023 175.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -73.49 -43.12 60.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.338 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.817 HG12 HG11 ' X' ' 76' ' ' VAL . 11.0 m -62.58 -36.39 74.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.082 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.513 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.418 ' HB3' HE21 ' X' ' 17' ' ' GLN . 6.0 tt0 -61.52 -49.46 76.63 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 109.649 177.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.508 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -61.19 -43.32 99.07 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.546 HD23 HG13 ' X' ' 75' ' ' ILE . 3.0 mp -58.41 -36.94 74.35 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.553 -1.203 . . . . 0.0 114.046 176.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 91.4 mttt -66.26 -40.0 89.87 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.188 0.518 . . . . 0.0 109.643 176.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.78 -37.36 87.34 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.595 178.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' X' ' 37' ' ' LEU . 26.3 mt -61.0 -45.18 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.413 ' CD ' ' HD3' ' X' ' 72' ' ' PRO . 52.6 mt-10 -58.54 -46.22 87.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.551 0.691 . . . . 0.0 110.639 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.01 -49.83 76.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.069 -175.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -71.82 -27.63 63.04 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -70.59 -53.92 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.462 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.62 -20.65 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.38 -13.98 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.543 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.87 70.25 0.6 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.297 1.039 . . . . 0.0 111.071 -176.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p -88.9 -17.56 29.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 110.951 -176.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.394 1.7 m-20 65.3 -59.55 0.27 Allowed 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 178.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.671 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.6 t70 -63.55 -57.01 11.51 Favored 'General case' 0 CA--C 1.478 -1.816 0 CA-C-N 119.817 1.19 . . . . 0.0 111.733 -176.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.73 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 44.0 t -76.42 -32.25 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.067 -177.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.628 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 1.8 tm? -58.35 -47.28 84.28 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 32.8 t70 -65.02 -41.84 94.93 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.671 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.6 t -56.53 -50.03 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 O-C-N 124.224 0.953 . . . . 0.0 110.079 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.2 mt -67.65 -39.92 84.58 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.603 -172.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 43.8 mt -63.21 -49.95 72.21 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 7.3 pt-20 -71.2 -34.45 70.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.889 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.564 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 59.3 t60 -60.21 -45.49 92.98 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.416 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 63.7 t80 -60.63 -52.98 62.83 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.781 178.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.526 HG12 ' O ' ' X' ' 38' ' ' LEU 0.291 2.7 p -67.49 -32.91 59.2 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.915 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.0 ptmm? -67.17 -33.39 75.3 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.924 -0.485 . . . . 0.0 111.876 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.487 HG12 ' O ' ' X' ' 40' ' ' HIS . 17.6 pt -86.23 -36.05 9.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.833 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -84.18 -33.45 24.18 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 120.891 0.377 . . . . 0.0 111.117 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 64.05 19.34 11.71 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.266 1.427 . . . . 0.0 111.392 -176.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.418 ' O ' HG23 ' X' ' 42' ' ' VAL . 47.8 t-80 -73.0 132.22 82.98 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.533 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -70.19 -17.05 35.88 Favored 'Trans proline' 0 CA--C 1.492 -1.613 0 C-N-CA 122.833 2.355 . . . . 0.0 112.662 -172.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 5.4 m-20 -127.14 36.19 4.46 Favored 'General case' 0 N--CA 1.389 -3.508 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -173.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.416 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.48 -53.52 16.15 Favored Glycine 0 CA--C 1.454 -3.731 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.422 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.482 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.43 -31.56 57.96 Favored 'General case' 0 C--N 1.247 -3.874 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.731 -173.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.88 -38.08 84.38 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.058 177.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.8 -48.45 75.35 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.477 0.486 . . . . 0.0 112.136 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.454 HG12 HG21 ' X' ' 22' ' ' ILE . 5.1 mp -67.88 -42.17 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 118.272 -1.371 . . . . 0.0 110.079 -178.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.413 ' HD2' ' O ' ' X' ' 51' ' ' THR . 27.0 m-85 -62.55 -45.51 92.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.158 -178.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.8 pt-20 -68.66 -35.92 77.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.283 176.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.136 0 C-N-CA 122.482 0.313 . . . . 0.0 110.982 178.22 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.464 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.407 -3.246 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.562 ' O ' HG12 ' X' ' 76' ' ' VAL . 12.8 Cg_endo -61.09 -43.77 27.92 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.541 2.828 . . . . 0.0 112.564 -175.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.89 0.82 16.93 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.2 -40.31 1.41 Allowed Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.381 177.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.546 HG13 HD23 ' X' ' 19' ' ' LEU . 3.6 pt -60.52 -29.72 45.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.169 0.485 . . . . 0.0 111.771 176.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.817 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -65.51 -45.59 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 122.327 1.061 . . . . 0.0 111.088 175.12 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 40.7 ttmt -63.07 -37.72 88.31 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.584 -1.643 . . . . 0.0 109.761 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.91 -43.74 98.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.319 0.581 . . . . 0.0 111.124 174.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.469 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.5 mm -61.24 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.912 176.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 22.3 ptmt -63.59 -36.3 83.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.963 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.6 mt-10 -64.55 -41.64 96.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.415 0.447 . . . . 0.0 110.752 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.533 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.3 t90 -68.12 -45.33 73.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.524 0.678 . . . . 0.0 109.769 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -60.91 -45.28 95.27 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.454 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.11 85.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.59 92.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.951 0.405 . . . . 0.0 110.738 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.469 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 21.7 t-20 -69.63 -41.34 75.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.726 0.774 . . . . 0.0 109.444 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.79 28.75 5.23 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 67.7 mttm -100.31 150.85 37.28 Favored Pre-proline 0 N--CA 1.402 -2.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.67 128.56 28.63 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.281 2.654 . . . . 0.0 112.152 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.21 -149.47 25.5 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.941 -177.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' X' ' 7' ' ' ILE . 42.2 m-85 -79.28 159.66 27.15 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -176.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.3 ptmt -98.73 176.31 5.67 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-O 121.723 0.773 . . . . 0.0 110.126 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -112.34 141.84 45.58 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.554 174.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.569 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 -179.794 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.239 0.503 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -111.68 -169.84 1.54 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -107.75 -29.18 9.25 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.628 0.727 . . . . 0.0 110.236 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -131.82 163.52 28.08 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.352 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -69.68 -13.4 17.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 CA-C-O 121.549 0.69 . . . . 0.0 110.668 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 10.8 m -72.82 -22.13 60.85 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.636 -174.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 21.9 t70 -100.57 3.4 42.67 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.165 0.983 . . . . 0.0 108.883 177.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -92.49 115.12 27.81 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.473 -176.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 65.2 p -76.53 159.18 30.58 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 171.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.636 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.7 pt-20 -61.13 -35.27 76.61 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.951 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.44 -38.45 74.53 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.802 177.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.2 -40.99 83.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.12 0.962 . . . . 0.0 109.243 173.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.562 ' HD2' HG12 ' X' ' 76' ' ' VAL . 41.4 t80 -69.27 -45.02 70.68 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.057 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.786 HG12 HG11 ' X' ' 76' ' ' VAL . 8.4 m -61.86 -38.75 81.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.46 -36.48 79.06 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 121.487 0.661 . . . . 0.0 111.544 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.487 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -66.92 -46.18 75.61 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.702 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' X' ' 41' ' ' PHE . 7.3 mp -60.13 -36.97 78.66 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.081 177.28 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.649 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 62.5 mttm -63.11 -35.64 80.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.477 0.656 . . . . 0.0 109.964 176.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -69.38 -33.5 73.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.632 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' X' ' 37' ' ' LEU . 9.5 mt -67.46 -40.84 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.72 -46.75 84.0 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.55 -42.81 97.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.907 -176.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -77.16 -29.05 54.31 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.164 -0.335 . . . . 0.0 111.493 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -75.42 -46.37 33.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.131 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.44 -35.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.909 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.33 -10.07 56.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 177.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.07 74.51 0.29 Allowed 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.543 1.537 . . . . 0.0 113.431 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 56.6 p -99.24 -166.27 1.33 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.34 -61.84 1.01 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.59 ' O ' HG23 ' X' ' 36' ' ' VAL . 18.5 m-20 -56.96 -50.93 71.14 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.668 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 62.0 t -88.59 -29.16 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.52 -45.65 88.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.64 -30.4 67.02 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.267 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.59 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -63.29 -49.73 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.493 176.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.669 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.0 mt -68.47 -43.78 76.25 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.486 -170.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 36.2 mt -61.14 -46.22 91.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 124.099 0.874 . . . . 0.0 110.428 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.44 -43.77 69.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.989 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.485 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.2 t60 -60.12 -45.71 92.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.607 -176.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.636 ' CD2' HD11 ' X' ' 54' ' ' ILE . 39.5 t80 -61.43 -51.49 68.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.224 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.432 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.9 p -67.7 -32.59 57.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.8 pttt -72.63 -26.59 61.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.46 HG12 ' O ' ' X' ' 40' ' ' HIS . 26.6 pt -87.26 -34.87 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.779 179.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -84.3 -31.97 24.59 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 58.06 31.71 21.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.633 1.173 . . . . 0.0 109.877 -176.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 40.9 t-80 -82.43 138.52 44.74 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 113.514 -1.675 . . . . 0.0 108.117 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' X' ' 47' ' ' HIS . 15.6 Cg_exo -73.5 -6.42 18.73 Favored 'Trans proline' 0 CA--C 1.492 -1.593 0 C-N-CA 123.1 2.533 . . . . 0.0 112.599 -175.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.433 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 38.0 m-20 -135.63 32.19 3.04 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.583 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.73 -59.99 5.13 Favored Glycine 1 CA--C 1.445 -4.34 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.872 -176.842 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.469 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -75.18 -30.13 60.6 Favored 'General case' 1 C--N 1.242 -4.092 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.019 -172.641 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.15 -28.13 69.85 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' X' ' 56' ' ' GLU . 28.1 mt -65.13 -43.1 93.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 175.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.636 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -67.2 -41.66 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.789 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -58.27 -47.28 84.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.685 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.6 pt-20 -67.67 -36.72 81.23 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.325 175.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 118.125 0.421 . . . . 0.0 111.824 -178.452 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.492 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.407 -3.262 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.623 ' O ' HG13 ' X' ' 76' ' ' VAL . 12.7 Cg_endo -74.46 -46.24 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.353 2.702 . . . . 0.0 112.353 -172.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.483 ' C ' HG22 ' X' ' 76' ' ' VAL . 31.5 mt-10 -73.5 0.86 11.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -177.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.31 -34.3 2.95 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.518 172.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.52 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.8 pt -66.89 -27.11 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 117.647 0.723 . . . . 0.0 110.633 172.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.786 HG11 HG12 ' X' ' 16' ' ' VAL . 27.6 m -62.16 -37.99 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.889 0 CA-C-O 121.689 0.757 . . . . 0.0 110.992 176.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 39.8 ttmt -65.74 -45.01 84.22 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.788 176.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -58.1 -38.05 75.71 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.57 -46.89 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.412 177.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 17.9 ptpt -66.82 -38.5 86.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.726 -175.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 46.2 mt-10 -69.69 -32.22 70.7 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.252 -178.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.403 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 81.2 t90 -72.19 -48.28 44.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.559 0.695 . . . . 0.0 109.354 177.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 14.9 tpt180 -61.39 -45.45 94.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.415 -174.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.42 84.3 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.04 84.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.862 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.58 -45.74 57.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.645 0.736 . . . . 0.0 109.061 177.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.35 37.5 1.94 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 93.0 mttt -112.51 143.47 29.0 Favored Pre-proline 0 N--CA 1.391 -3.387 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.51 131.23 27.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.43 2.086 . . . . 0.0 110.314 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -114.59 -115.71 3.12 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.818 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -79.18 145.93 33.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -174.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' X' ' 11' ' ' THR . 45.8 pttt -97.38 172.4 7.79 Favored 'General case' 0 N--CA 1.384 -3.771 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.97 148.64 22.11 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 177.86 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' X' ' 18' ' ' LEU . 35.0 mt . . . . . 0 N--CA 1.427 -1.588 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 35.1 mmtt -93.09 -166.73 1.58 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -118.16 -0.08 11.65 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 174.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -153.44 158.89 42.08 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.212 176.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' X' ' 10' ' ' TYR . 11.3 tt -67.4 -24.43 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.488 0.661 . . . . 0.0 110.571 -178.422 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -85.44 0.09 53.31 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.951 -174.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.6 t70 -104.11 -1.28 27.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' X' ' 7' ' ' ILE . 8.0 m-85 -97.53 124.61 41.83 Favored 'General case' 0 CA--C 1.472 -2.025 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.804 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 47.9 p -78.75 159.4 27.94 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.014 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.63 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.21 -41.11 75.1 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 123.321 0.388 . . . . 0.0 110.383 -179.41 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.719 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.4 76.26 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.48 -38.9 82.05 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.737 0.779 . . . . 0.0 109.682 173.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.599 ' CD2' HG12 ' X' ' 76' ' ' VAL . 22.0 t80 -75.3 -41.73 56.28 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.73 -177.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.719 HG22 ' HA ' ' X' ' 13' ' ' ALA . 15.1 m -62.87 -32.79 57.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 176.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -64.24 -47.33 80.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 122.912 0.485 . . . . 0.0 109.966 178.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.679 ' O ' HG13 ' X' ' 22' ' ' ILE . 19.9 tp -57.23 -47.59 80.94 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 123.873 0.733 . . . . 0.0 109.292 177.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.94 -36.82 77.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.345 177.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.623 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 97.4 mttt -61.23 -46.47 90.29 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.518 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . 0.499 ' HA ' ' HE3' ' X' ' 24' ' ' LYS . 54.8 mt-10 -64.14 -37.81 88.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.627 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.701 HG12 ' HB3' ' X' ' 37' ' ' LEU . 27.4 mt -63.17 -44.61 99.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' X' ' 20' ' ' LYS . 4.8 pt-20 -65.68 -35.07 79.71 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.143 0.973 . . . . 0.0 109.423 -178.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' X' ' 21' ' ' GLU . 27.8 ttpp -72.29 -52.03 18.11 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.474 -174.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -17.33 64.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.947 0.403 . . . . 0.0 111.305 176.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -81.08 -51.38 8.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.524 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 m -73.09 -26.39 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.24 -22.01 33.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.31 78.82 0.27 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.171 1.388 . . . . 0.0 112.011 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -92.31 -28.04 17.2 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 67.79 -55.15 0.49 Allowed 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.297 1.839 . . . . 0.0 115.374 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.44 ' O ' HG23 ' X' ' 36' ' ' VAL . 9.5 p-10 -68.36 -47.4 67.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -85.95 -29.88 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.13 -41.27 87.84 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 177.309 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 27.0 t70 -62.0 -41.69 98.33 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 123.386 0.429 . . . . 0.0 110.02 178.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.44 HG23 ' O ' ' X' ' 32' ' ' ASP . 58.2 t -59.29 -48.74 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 O-C-N 124.622 1.201 . . . . 0.0 109.47 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.2 mt -64.64 -43.22 94.37 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.662 -173.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -60.11 -50.69 72.68 Favored 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 124.119 0.887 . . . . 0.0 111.051 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 1.5 pt-20 -70.69 -37.5 73.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.697 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.5 t60 -59.75 -46.26 89.71 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.268 0.627 . . . . 0.0 109.644 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.556 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.9 t80 -61.8 -53.52 54.77 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.259 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.452 HG12 ' O ' ' X' ' 38' ' ' LEU . 8.2 p -67.09 -31.7 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 54.1 pttt -69.63 -38.88 77.35 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 122.089 -0.382 . . . . 0.0 111.948 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.48 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.1 pt -79.63 -31.79 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.795 0.331 . . . . 0.0 110.747 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 54.7 p -84.04 -34.99 24.13 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.81 22.95 13.25 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.65 1.18 . . . . 0.0 109.929 -176.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -79.3 133.31 60.58 Favored Pre-proline 0 N--CA 1.433 -1.305 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.278 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.445 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -71.69 -19.48 27.7 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.282 -173.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -118.5 30.37 7.24 Favored 'General case' 0 N--CA 1.4 -2.957 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -171.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.556 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.0 -57.33 6.25 Favored Glycine 0 CA--C 1.461 -3.34 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.9 -178.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.525 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -82.26 -22.78 35.61 Favored 'General case' 0 C--N 1.247 -3.867 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.959 -172.206 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.84 -36.69 84.06 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.754 174.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.09 -40.44 97.66 Favored 'General case' 0 C--O 1.207 -1.142 0 O-C-N 123.609 0.568 . . . . 0.0 110.643 175.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.497 HD13 HG21 ' X' ' 22' ' ' ILE . 51.1 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.392 0.615 . . . . 0.0 109.864 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -62.17 -44.49 96.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.69 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.6 pt-20 -71.17 -38.38 72.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.924 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.818 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.396 -3.979 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.755 ' HA ' HD11 ' X' ' 75' ' ' ILE . 24.1 Cg_endo -66.11 -24.64 51.74 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.472 . . . . 0.0 112.805 -175.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.479 ' HG2' HG11 ' X' ' 16' ' ' VAL . 35.7 mt-10 -85.68 1.96 47.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.964 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -105.44 -32.82 3.82 Favored Glycine 0 N--CA 1.419 -2.441 0 C-N-CA 118.377 -1.868 . . . . 0.0 114.322 176.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.755 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -69.95 -28.21 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-N 118.68 1.24 . . . . 0.0 110.204 175.128 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.599 HG12 ' CD2' ' X' ' 15' ' ' PHE . 27.5 m -63.61 -38.06 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-O 121.347 0.594 . . . . 0.0 110.489 177.225 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttm -61.28 -48.46 81.29 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.445 173.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.16 -37.45 82.95 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.741 -178.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.422 HG12 ' O ' ' X' ' 75' ' ' ILE . 31.4 mm -68.46 -46.36 80.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.571 177.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -65.09 -38.06 89.51 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.666 -174.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.23 -38.78 75.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.272 -178.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.445 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 71.2 t90 -66.69 -47.88 71.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 109.131 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 19.7 tpt180 -61.19 -46.33 90.92 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.071 -175.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.58 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.868 -178.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.05 75.02 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.923 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.419 ' ND2' ' HE2' ' X' ' 88' ' ' LYS . 3.1 t30 -72.82 -42.63 63.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.64 34.99 1.62 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.918 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 65.9 mttm -115.43 140.13 25.48 Favored Pre-proline 0 N--CA 1.385 -3.685 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -177.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -61.5 136.31 62.49 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.422 2.082 . . . . 0.0 110.899 176.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.0 -120.33 4.68 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.233 -174.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -86.87 166.42 15.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 124.202 0.59 . . . . 0.0 109.441 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' X' ' 11' ' ' THR . 18.0 ptmt -105.18 162.14 13.65 Favored 'General case' 1 N--CA 1.374 -4.265 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.176 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.83 134.44 49.98 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.489 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.265 -3.379 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.806 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.849 0.833 . . . . 0.0 112.623 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 32.2 mmtt -101.76 -157.52 0.61 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -120.5 -20.37 7.19 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.222 171.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.4 p -141.01 165.7 26.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.464 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.09 -23.11 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.649 1.18 . . . . 0.0 110.393 -179.3 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.9 m -73.68 -16.33 61.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.798 -173.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 19.2 t70 -102.97 3.27 36.13 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.508 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.463 ' OH ' HD22 ' X' ' 18' ' ' LEU . 8.6 m-85 -97.04 118.4 33.35 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.39 -175.235 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 23.8 p -80.15 164.62 23.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.624 ' O ' HG13 ' X' ' 16' ' ' VAL . 5.8 pt-20 -59.08 -40.44 85.26 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.403 178.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.636 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.63 76.32 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.42 -38.0 79.48 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.707 0.765 . . . . 0.0 110.261 174.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.575 ' HD2' HG12 ' X' ' 76' ' ' VAL . 36.3 t80 -72.87 -46.02 55.12 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.617 -179.054 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.741 HG12 HG11 ' X' ' 76' ' ' VAL . 10.4 m -62.34 -34.42 64.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.848 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.09 -49.69 76.3 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.657 ' O ' HG13 ' X' ' 22' ' ' ILE . 55.3 tp -60.0 -46.78 88.35 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.524 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.423 HD21 ' CD1' ' X' ' 41' ' ' PHE . 4.4 mm? -58.51 -36.86 74.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.619 178.224 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.5 mttt -63.83 -37.23 86.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 110.568 175.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.31 -35.61 66.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.657 HG13 ' O ' ' X' ' 18' ' ' LEU . 17.3 mt -67.64 -42.09 86.2 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.176 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.405 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -42.8 84.75 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.917 1.287 . . . . 0.0 109.604 177.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.74 -47.62 74.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.619 -177.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.676 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 7.1 mm-40 -76.97 -15.4 59.66 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.319 178.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.53 -45.93 64.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.16 -26.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.383 179.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.42 50.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.061 176.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.8 77.27 0.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.166 1.386 . . . . 0.0 111.267 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 27.2 p -101.46 -168.73 1.59 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.73 -35.35 0.58 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.126 176.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.481 ' O ' HG23 ' X' ' 36' ' ' VAL . 37.7 m-20 -65.11 -53.02 51.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.742 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 4.8 p -88.52 -31.12 5.49 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.943 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.181 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.25 -45.02 92.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.322 -175.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.76 -29.71 63.54 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.887 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.481 HG23 ' O ' ' X' ' 32' ' ' ASP . 92.4 t -64.46 -48.78 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.063 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.457 176.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 85.9 mt -67.58 -43.57 80.26 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.121 -172.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 44.5 mt -61.81 -45.06 95.5 Favored 'General case' 0 N--CA 1.422 -1.837 0 O-C-N 124.194 0.934 . . . . 0.0 110.786 -179.575 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.24 -47.28 62.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.504 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.3 t60 -59.71 -44.2 93.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.593 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 30.9 t80 -59.95 -52.97 63.13 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.884 177.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.518 HG12 ' O ' ' X' ' 38' ' ' LEU . 13.8 p -67.71 -32.55 57.2 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.773 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.0 pttp -70.17 -28.59 65.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.454 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -84.38 -40.77 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.369 -177.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.573 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.4 t -83.64 -32.11 25.85 Favored 'General case' 0 C--O 1.252 1.224 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.653 178.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.56 30.55 12.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 125.908 1.683 . . . . 0.0 111.342 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.514 ' H ' HG23 ' X' ' 45' ' ' THR . 48.0 t-80 -76.65 137.0 67.01 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.85 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 18.6 Cg_exo -70.99 -13.07 31.35 Favored 'Trans proline' 0 CA--C 1.502 -1.115 0 C-N-CA 123.099 2.533 . . . . 0.0 112.645 -174.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.55 31.45 4.78 Favored 'General case' 0 N--CA 1.398 -3.051 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -173.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.15 -56.88 7.49 Favored Glycine 0 CA--C 1.457 -3.584 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.921 -178.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.459 HG23 HD22 ' X' ' 38' ' ' LEU . 1.3 m -72.08 -32.55 67.14 Favored 'General case' 0 C--N 1.256 -3.479 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.271 -173.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.32 -37.21 86.39 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.996 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' X' ' 75' ' ' ILE . 27.6 mt -58.47 -39.02 78.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.766 0.666 . . . . 0.0 112.22 178.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.628 HD13 HG21 ' X' ' 22' ' ' ILE . 67.8 mt -65.89 -44.43 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.638 . . . . 0.0 109.304 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.56 -49.74 74.09 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.274 178.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.8 pt-20 -69.65 -42.43 74.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.187 -179.603 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.109 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.512 ' HA ' HD11 ' X' ' 75' ' ' ILE . 18.7 Cg_endo -55.98 -37.71 95.71 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 123.884 3.056 . . . . 0.0 114.126 -176.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.444 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.7 mt-10 -86.37 2.39 47.68 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.76 -28.03 5.5 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 118.684 -1.722 . . . . 0.0 112.481 173.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.3 OUTLIER -61.12 -39.69 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 122.326 1.06 . . . . 0.0 108.277 176.349 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.741 HG11 HG12 ' X' ' 16' ' ' VAL . 29.2 m -59.46 -33.76 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 CA-C-N 113.314 -1.766 . . . . 0.0 112.686 -176.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -60.06 -51.64 68.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.773 172.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -59.32 -42.29 91.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.488 HD12 HG21 ' X' ' 45' ' ' THR . 29.0 mm -62.75 -46.29 96.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.014 177.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.49 -43.36 73.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.621 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -72.16 -32.21 66.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.156 -175.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.609 ' CZ3' ' HE3' ' X' ' 88' ' ' LYS . 62.0 t90 -66.11 -45.85 79.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.597 1.189 . . . . 0.0 109.133 175.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.438 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 9.2 tpt180 -66.24 -46.92 75.48 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.169 -177.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -38.35 81.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.489 0.716 . . . . 0.0 112.094 -176.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.24 70.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . 0.597 ' HB3' ' NZ ' ' X' ' 88' ' ' LYS . 56.4 t30 -101.4 6.16 42.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.075 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.43 42.32 49.19 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.004 175.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.609 ' HE3' ' CZ3' ' X' ' 82' ' ' TRP . 36.6 mtmm -105.19 139.44 20.13 Favored Pre-proline 1 N--CA 1.378 -4.042 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.849 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.08 114.7 2.12 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 111.788 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.0 -125.11 4.09 Favored Glycine 0 CA--C 1.489 -1.587 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.659 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.71 152.84 28.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.975 0.417 . . . . 0.0 110.285 -175.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.07 177.71 6.85 Favored 'General case' 0 N--CA 1.391 -3.375 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . 0.425 ' HA ' ' NE2' ' X' ' 93' ' ' GLN . 11.1 mm100 -117.59 143.37 46.18 Favored 'General case' 1 N--CA 1.377 -4.09 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 177.065 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.511 ' CD2' HD13 ' X' ' 18' ' ' LEU . 33.9 mt . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 34.3 mmtt -102.06 -162.45 0.93 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.52 -19.61 8.73 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.447 -0.783 . . . . 0.0 111.34 173.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 60.7 p -135.86 163.61 29.83 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.545 HG12 HH12 ' X' ' 83' ' ' ARG . 3.6 tp -69.81 -14.88 18.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.667 -177.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.5 m -71.87 -17.55 62.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.184 -174.036 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 17.2 t70 -106.83 5.06 28.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.791 0.805 . . . . 0.0 108.932 178.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.82 121.58 38.84 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.216 -176.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 43.6 p -88.61 179.51 6.25 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.665 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.3 mm-40 -59.16 -52.36 66.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.22 -38.74 78.7 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.741 -171.244 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.56 -36.27 80.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 110.279 175.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.681 ' HD2' HG12 ' X' ' 76' ' ' VAL . 44.7 t80 -75.94 -44.66 39.02 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.354 -177.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.78 HG12 HG11 ' X' ' 76' ' ' VAL . 6.2 m -62.44 -33.25 58.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 116.939 -0.119 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -65.4 -47.84 74.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 123.024 0.53 . . . . 0.0 110.077 178.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.651 ' O ' HG13 ' X' ' 22' ' ' ILE . 17.9 tp -57.64 -47.44 82.22 Favored 'General case' 0 C--O 1.208 -1.09 0 CA-C-O 121.222 0.534 . . . . 0.0 109.789 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.515 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.48 -39.2 82.95 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.234 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 50.6 mttp -63.73 -38.5 91.33 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.174 0.511 . . . . 0.0 109.997 176.153 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' X' ' 24' ' ' LYS . 42.9 mt-10 -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.198 177.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.651 HG13 ' O ' ' X' ' 18' ' ' LEU . 31.0 mt -67.3 -40.89 85.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.351 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . 0.448 ' O ' HG22 ' X' ' 27' ' ' VAL . 52.3 mt-10 -57.89 -42.74 85.27 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.903 0.858 . . . . 0.0 109.728 177.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' X' ' 21' ' ' GLU . 80.1 tttt -60.23 -52.15 66.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.389 -176.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' X' ' 21' ' ' GLU . 1.2 pp20? -83.71 -32.93 25.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -58.3 -45.6 87.66 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.324 0.249 . . . . 0.0 111.503 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . 0.448 HG22 ' O ' ' X' ' 23' ' ' GLU . 31.7 m -76.22 -24.24 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.22 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -21.23 46.33 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.962 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.85 80.92 0.17 Allowed 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.878 1.671 . . . . 0.0 111.796 -178.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 0.7 OUTLIER -98.34 -175.2 3.04 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.139 174.433 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.71 -55.93 0.62 Allowed 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.724 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.67 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.9 t70 -63.12 -57.42 10.65 Favored 'General case' 0 CA--C 1.484 -1.572 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.939 -179.177 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.687 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.8 p -73.08 -30.16 30.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -175.428 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.537 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.4 tm? -61.21 -50.16 74.22 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.493 178.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.59 -24.5 62.77 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.835 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.67 HG23 ' O ' ' X' ' 32' ' ' ASP . 98.8 t -70.57 -51.34 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.98 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.118 177.084 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 44.7 mt -69.29 -43.13 74.46 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.87 -170.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.476 ' O ' HG12 ' X' ' 42' ' ' VAL . 25.7 mt -60.98 -43.51 98.72 Favored 'General case' 0 N--CA 1.419 -2.019 0 O-C-N 124.283 0.989 . . . . 0.0 111.226 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.82 -44.05 67.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.987 0.423 . . . . 0.0 111.128 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.516 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 7.8 t60 -59.52 -45.21 92.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.63 -175.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.617 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 60.5 t80 -60.16 -51.79 68.09 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.94 178.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.476 HG12 ' O ' ' X' ' 38' ' ' LEU 0.258 9.5 p -67.51 -32.28 56.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.494 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.716 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -70.47 -37.49 74.27 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.99 -0.444 . . . . 0.0 112.073 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.511 HG12 ' O ' ' X' ' 40' ' ' HIS . 18.5 pt -78.75 -31.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.248 0.547 . . . . 0.0 110.776 -178.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.433 ' O ' ' HD2' ' X' ' 83' ' ' ARG . 53.7 p -84.36 -42.4 15.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.04 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.57 25.97 6.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.159 1.784 . . . . 0.0 110.446 -176.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 44.8 t-80 -80.35 135.66 53.63 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 114.286 -1.324 . . . . 0.0 107.797 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -69.45 -15.56 38.31 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 122.933 2.422 . . . . 0.0 112.737 -173.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.427 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 20.7 m-20 -127.17 32.85 5.0 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.617 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.09 -59.23 4.04 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.966 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.474 ' O ' ' HD2' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -73.26 -32.39 64.66 Favored 'General case' 0 C--N 1.246 -3.933 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.537 -171.036 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.75 -36.0 79.75 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.494 178.165 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -59.82 -45.55 92.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 176.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.469 HD13 HG21 ' X' ' 22' ' ' ILE . 85.2 mt -67.62 -40.73 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.431 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.474 ' HD2' ' O ' ' X' ' 51' ' ' THR . 17.0 m-85 -59.34 -46.65 88.03 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.078 177.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.6 pt-20 -67.68 -36.13 80.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.24 176.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.515 0 O-C-N 122.947 0.155 . . . . 0.0 110.757 179.674 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.54 ' O ' HG12 ' X' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.404 -3.498 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.623 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.2 Cg_endo -58.3 -43.15 49.16 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.771 2.981 . . . . 0.0 112.403 -176.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.462 ' C ' HG22 ' X' ' 76' ' ' VAL . 37.0 mt-10 -85.5 1.87 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 123.771 0.828 . . . . 0.0 110.796 -176.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -107.98 -29.72 4.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 119.264 -1.446 . . . . 0.0 112.886 173.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.54 HG12 ' O ' ' X' ' 71' ' ' GLY . 1.6 pt -69.64 -28.5 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 CA-C-N 117.576 0.688 . . . . 0.0 110.762 173.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.78 HG11 HG12 ' X' ' 16' ' ' VAL . 31.4 m -59.89 -35.92 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 121.76 0.79 . . . . 0.0 110.787 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.549 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 40.4 tttp -62.38 -49.11 76.82 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.302 174.293 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.33 -41.2 84.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 23.5 mm -63.0 -45.85 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.067 177.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 61.5 pttt -71.87 -38.58 70.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.993 -176.287 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.1 mt-10 -69.4 -32.32 71.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.839 -178.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.442 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -65.99 -46.15 79.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.228 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.545 HH12 HG12 ' X' ' 7' ' ' ILE . 0.9 OUTLIER -66.26 -39.74 89.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.274 177.205 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.27 86.51 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.817 0.698 . . . . 0.0 111.717 -179.065 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.786 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.23 -40.03 15.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.15 28.71 3.49 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -175.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -93.55 156.46 39.71 Favored Pre-proline 0 N--CA 1.412 -2.328 0 C-N-CA 124.225 1.01 . . . . 0.0 108.779 179.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -63.71 129.57 25.29 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.574 2.183 . . . . 0.0 112.979 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.99 -132.57 7.78 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.945 178.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 42.4 m-85 -96.21 152.75 18.27 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -88.85 169.55 11.49 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.29 136.0 41.86 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.82 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.926 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -177.695 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.545 HD22 HD13 ' X' ' 18' ' ' LEU . 40.4 mt . . . . . 0 N--CA 1.435 -1.22 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.457 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 35.3 mmtt -95.62 -161.06 0.83 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.177 -173.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -108.79 -33.51 6.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -130.69 166.61 20.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.624 -176.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.2 tp -67.65 -25.15 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.595 0.712 . . . . 0.0 109.785 178.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -77.67 -11.54 59.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.261 -173.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 37.0 t0 -99.28 1.13 44.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.04 121.43 40.97 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.855 -174.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 80.1 p -79.52 167.94 20.1 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 170.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.0 pt-20 -59.96 -41.86 92.82 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.031 178.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.58 -38.5 74.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.47 177.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' X' ' 11' ' ' THR . 9.6 mm-40 -59.72 -36.17 76.0 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.403 0.62 . . . . 0.0 109.973 174.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.728 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 18.8 t80 -70.92 -46.17 62.97 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.867 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.74 HG12 HG11 ' X' ' 76' ' ' VAL . 4.9 m -62.57 -29.97 48.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.523 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -60.76 -49.41 77.61 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.969 0.907 . . . . 0.0 109.697 174.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.653 ' O ' HG13 ' X' ' 22' ' ' ILE . 22.7 tp -57.72 -46.79 83.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.577 0.704 . . . . 0.0 109.677 175.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.1 mt -58.23 -38.71 77.38 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.055 -178.761 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 97.6 mttt -70.3 -39.21 74.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.957 0.408 . . . . 0.0 110.157 176.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.41 -37.47 87.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 178.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.653 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.5 mt -65.82 -46.74 87.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.98 -39.86 79.24 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.367 1.067 . . . . 0.0 113.053 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . 0.543 ' HG3' ' OE1' ' X' ' 25' ' ' GLU . 24.3 tptp -60.21 -48.67 80.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . 0.543 ' OE1' ' HG3' ' X' ' 24' ' ' LYS . 9.4 mm-40 -92.15 -1.83 56.93 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.484 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -70.84 -53.39 15.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.71 -28.31 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.962 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -23.36 33.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.959 0.409 . . . . 0.0 110.316 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.77 71.21 0.58 Allowed 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.57 1.548 . . . . 0.0 111.935 -176.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 68.9 p -91.25 -164.03 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.34 -38.71 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.716 177.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.525 ' O ' HG23 ' X' ' 36' ' ' VAL . 33.8 t70 -67.78 -55.09 14.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -172.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.675 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.86 -28.88 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 118.711 -1.195 . . . . 0.0 108.267 -177.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.07 -49.73 76.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.92 -176.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.52 -16.02 59.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.294 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.525 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.3 t -71.69 -50.4 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 C-N-CA 118.599 -1.24 . . . . 0.0 107.815 172.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 82.3 mt -68.18 -42.44 79.94 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 113.457 -1.702 . . . . 0.0 112.059 -169.395 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.0 mt -59.12 -45.78 90.03 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.352 1.033 . . . . 0.0 110.524 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -70.55 -43.3 69.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.893 178.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.524 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.6 t60 -59.89 -46.37 89.55 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.109 -176.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.611 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.7 t80 -62.45 -50.54 71.07 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.095 -179.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.461 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.5 p -67.08 -30.97 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.549 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.0 pttt -73.08 -35.41 66.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.364 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.517 HG12 ' O ' ' X' ' 40' ' ' HIS . 28.6 pt -81.21 -38.69 16.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.9 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 77.2 p -79.47 -36.15 39.19 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-O 121.227 0.537 . . . . 0.0 110.398 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 65.02 23.82 12.55 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -75.28 134.14 74.08 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.483 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.7 Cg_exo -72.17 -3.09 12.66 Favored 'Trans proline' 0 CA--C 1.493 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.549 -174.428 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' X' ' 52' ' ' ALA . 24.0 t70 -138.51 32.48 2.29 Favored 'General case' 0 N--CA 1.389 -3.507 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -174.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.611 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.44 -59.72 4.56 Favored Glycine 1 CA--C 1.45 -4.01 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.353 -179.152 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.452 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.23 -32.4 70.25 Favored 'General case' 0 C--N 1.248 -3.81 0 CA-C-N 114.764 -0.718 . . . . 0.0 111.461 -173.149 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -75.08 -24.07 58.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.037 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.31 -40.48 94.36 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.435 173.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.58 HD13 HG21 ' X' ' 22' ' ' ILE . 11.7 mt -66.23 -46.11 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -57.45 -49.06 77.46 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.437 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.57 -36.11 70.79 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.148 177.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 118.159 0.436 . . . . 0.0 110.335 178.851 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.409 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.481 ' O ' HG13 ' X' ' 75' ' ' ILE . 11.6 Cg_endo -58.31 -44.4 38.61 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.899 -178.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.79 1.05 7.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.03 -22.78 6.72 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.739 176.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.505 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -65.63 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.703 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.74 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -58.27 -47.2 88.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.291 178.653 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 23.9 ttmm -58.26 -44.66 88.45 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.72 -29.73 64.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.285 0.564 . . . . 0.0 110.664 -178.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.505 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.3 mm -69.02 -45.92 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.028 175.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.2 pttp -63.07 -36.29 83.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.186 -174.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.21 -37.6 75.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.144 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.483 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.4 t90 -68.42 -47.38 67.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.192 0.52 . . . . 0.0 110.239 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.485 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 12.3 tpt180 -60.48 -45.66 92.94 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.26 -175.127 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.32 87.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.804 0.335 . . . . 0.0 111.457 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.46 -30.44 64.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.6 34.77 4.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.843 177.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . 0.485 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 58.7 mttm -111.91 148.27 38.62 Favored Pre-proline 0 N--CA 1.403 -2.802 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.01 126.54 14.65 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.512 2.142 . . . . 0.0 110.344 175.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.79 -114.61 3.13 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.096 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 18.0 m-85 -88.59 158.5 18.25 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 121.114 0.483 . . . . 0.0 110.273 -174.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.6 ptmt -98.45 166.43 11.36 Favored 'General case' 0 N--CA 1.381 -3.881 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.03 136.46 44.46 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 173.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.119 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.39 -177.166 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' X' X ' 3' ' ' LEU . . . . . 0.49 HD22 HD13 ' X' ' 18' ' ' LEU . 67.8 mt . . . . . 0 C--O 1.242 0.658 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 4' ' ' LYS . . . . . 0.472 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 36.3 mmtt -101.66 -159.84 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.98 -22.55 6.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.134 0.492 . . . . 0.0 110.446 175.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . 0.489 ' HA ' HG22 ' X' ' 44' ' ' ILE . 23.1 p -140.0 165.95 25.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.559 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 7' ' ' ILE . . . . . 0.724 HG12 HH12 ' X' ' 83' ' ' ARG . 4.7 tp -70.38 -18.02 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.488 0.661 . . . . 0.0 110.317 -175.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -70.67 -18.89 62.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.851 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 9' ' ' ASP . . . . . 0.519 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.8 t0 -104.09 6.9 36.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.904 0.859 . . . . 0.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 15.4 m-85 -96.3 123.81 40.08 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.57 -176.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.3 p -86.29 172.73 10.24 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 171.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 12' ' ' GLU . . . . . 0.612 ' O ' HG13 ' X' ' 16' ' ' VAL . 4.1 mm-40 -56.05 -52.04 65.67 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.138 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 13' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.13 -38.55 75.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.82 -174.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' X' ' 17' ' ' GLN . 5.2 mm-40 -62.35 -33.47 74.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.899 175.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 15' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 27.1 t80 -71.94 -44.96 62.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 16' ' ' VAL . . . . . 0.779 HG12 HG11 ' X' ' 76' ' ' VAL . 3.6 m -62.51 -30.43 49.13 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.176 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.452 HE21 ' HB3' ' X' ' 17' ' ' GLN . 0.3 OUTLIER -59.22 -50.21 74.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.647 0.779 . . . . 0.0 109.023 174.788 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' X' X ' 18' ' ' LEU . . . . . 0.637 ' O ' HG13 ' X' ' 22' ' ' ILE . 26.0 tp -58.62 -45.91 88.2 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.042 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 22.3 mt -57.93 -40.96 81.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.937 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 99.4 mttt -65.22 -37.49 87.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.23 176.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' X' ' 24' ' ' LYS . 7.9 mm-40 -71.8 -37.37 70.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 22' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' X' ' 37' ' ' LEU . 18.5 mt -62.4 -39.61 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.738 178.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.73 -47.05 83.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.356 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 24' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' X' ' 21' ' ' GLU . 17.4 pttp -67.42 -36.26 80.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.497 -175.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -71.86 -31.64 66.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.269 0.557 . . . . 0.0 110.038 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -72.46 -50.79 23.59 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.473 177.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 27' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' X' ' 24' ' ' LYS . 32.8 m -68.82 -32.35 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -10.06 49.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 109.92 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.62 80.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.701 1.6 . . . . 0.0 113.495 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 30' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 61.7 p -105.16 -168.53 1.48 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -143.01 -29.13 0.55 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.555 177.465 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 32' ' ' ASP . . . . . 0.583 ' O ' HG23 ' X' ' 36' ' ' VAL . 11.0 m-20 -67.87 -57.8 5.65 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.043 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 33' ' ' VAL . . . . . 0.677 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 85.6 t -86.36 -29.02 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.472 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 34' ' ' LEU . . . . . 0.636 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.01 -44.25 87.13 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 35' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 28.1 t70 -71.7 -35.2 70.15 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.287 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 36' ' ' VAL . . . . . 0.583 HG23 ' O ' ' X' ' 32' ' ' ASP . 80.9 t -57.76 -49.85 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.008 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 37' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 64.9 mt -68.12 -43.21 78.92 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.615 -172.179 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 38' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.5 mt -60.58 -49.09 78.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 124.154 0.909 . . . . 0.0 111.876 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 39' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.6 pt-20 -71.36 -36.39 71.47 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.8 178.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 40' ' ' HIS . . . . . 0.513 ' O ' HG12 ' X' ' 44' ' ' ILE . 13.6 t60 -62.72 -46.53 87.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 41' ' ' PHE . . . . . 0.644 ' O ' HG22 ' X' ' 45' ' ' THR . 54.8 t80 -58.02 -56.03 27.24 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 42' ' ' VAL . . . . . 0.435 HG12 ' O ' ' X' ' 38' ' ' LEU . 10.6 p -67.06 -32.87 59.83 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 43' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 9.2 pttp -70.3 -31.99 69.56 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.026 -179.068 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 44' ' ' ILE . . . . . 0.513 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.9 pt -83.24 -37.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.164 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 45' ' ' THR . . . . . 0.644 HG22 ' O ' ' X' ' 41' ' ' PHE . 7.3 t -84.78 -29.59 25.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.22 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 60.44 34.69 20.49 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.418 1.087 . . . . 0.0 111.549 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 47' ' ' HIS . . . . . 0.55 ' H ' HG23 ' X' ' 45' ' ' THR . 45.1 t-80 -85.3 134.26 40.94 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 114.542 -1.208 . . . . 0.0 107.742 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 21.7 Cg_exo -69.63 -15.55 37.64 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.945 2.43 . . . . 0.0 113.146 -174.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 10.8 m-20 -124.29 29.29 6.41 Favored 'General case' 0 N--CA 1.402 -2.827 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -173.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 50' ' ' GLY . . . . . 0.525 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -58.05 5.12 Favored Glycine 1 CA--C 1.447 -4.186 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.473 -176.73 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' X' X ' 51' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -75.66 -33.23 60.42 Favored 'General case' 1 C--N 1.242 -4.091 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.512 -171.876 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild core ' X' X ' 52' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.11 -37.03 76.21 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.527 177.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 42.6 mt -57.82 -44.73 86.61 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.774 0.671 . . . . 0.0 112.007 177.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 54' ' ' ILE . . . . . 0.603 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.0 mp -67.38 -43.46 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.645 -179.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 55' ' ' TYR . . . . . 0.519 ' HD1' ' O ' ' X' ' 51' ' ' THR . 29.6 m-85 -55.03 -47.46 74.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.292 177.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 56' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.1 pt-20 -71.53 -36.74 71.1 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 176.079 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 CA-C-N 118.184 0.447 . . . . 0.0 110.784 178.985 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.204 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.8 Cg_endo -62.87 -38.4 48.24 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.637 2.891 . . . . 0.0 111.845 -179.017 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.8 -0.2 12.69 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.16 -22.3 7.97 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.771 176.066 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 75' ' ' ILE . . . . . 0.521 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -67.19 -42.74 88.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.356 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' X' X ' 76' ' ' VAL . . . . . 0.779 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -58.76 -41.3 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.785 177.487 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' X' X ' 77' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' X' ' 80' ' ' LYS . 26.1 ttpp -60.06 -48.61 80.99 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.809 177.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.42 -45.11 84.96 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.888 0.851 . . . . 0.0 110.053 176.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 79' ' ' ILE . . . . . 0.469 HG23 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -61.46 -40.81 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.881 176.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 80' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' X' ' 77' ' ' LYS . 0.4 OUTLIER -71.67 -39.97 69.92 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.458 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.11 -41.97 85.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 82' ' ' TRP . . . . . 0.401 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 57.8 t90 -64.08 -46.85 82.44 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.65 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 83' ' ' ARG . . . . . 0.724 HH12 HG12 ' X' ' 7' ' ' ILE . 0.8 OUTLIER -66.28 -39.72 89.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.783 176.874 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.69 96.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.555 0.534 . . . . 0.0 110.864 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.03 83.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.857 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.31 -49.2 15.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.43 0.633 . . . . 0.0 110.381 -176.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.52 27.99 3.92 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -99.04 155.52 36.48 Favored Pre-proline 0 N--CA 1.406 -2.625 0 C-N-CA 123.342 0.657 . . . . 0.0 109.903 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.58 110.89 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.698 2.265 . . . . 0.0 111.947 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 90' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -85.28 -111.22 0.71 Allowed Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.468 -177.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -109.87 164.21 12.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.357 -179.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 92' ' ' LYS . . . . . 0.519 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 21.1 ptmt -91.45 168.04 11.83 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.014 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.47 139.44 30.71 Favored 'General case' 0 C--N 1.266 -3.053 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.393 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.744 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.512 -0.497 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.553 HD22 HD13 ' X' ' 18' ' ' LEU . 29.6 mt -91.77 129.73 37.68 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.239 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 31.3 mmtt -95.93 -165.51 1.29 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -109.35 -33.9 6.7 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.112 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 69.6 p -127.17 166.62 17.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.304 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.451 HD11 ' CE1' ' X' ' 91' ' ' PHE . 9.7 tp -65.36 -18.03 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 110.47 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.5 m -83.6 -9.59 58.81 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.606 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 22.0 t70 -104.44 -1.0 27.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.52 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.29 120.0 31.06 Favored 'General case' 0 CA--C 1.47 -2.112 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.407 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 75.0 p -83.03 170.41 14.89 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 172.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.649 ' O ' HG13 ' X' ' 16' ' ' VAL . 5.8 pt-20 -58.33 -46.11 86.82 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.322 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.478 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.09 -38.24 75.62 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -64.78 -32.91 74.82 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 121.671 -0.643 . . . . 0.0 110.646 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 29.1 t80 -71.36 -43.64 66.54 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.725 HG12 HG11 ' X' ' 76' ' ' VAL . 3.5 m -62.79 -28.98 45.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.739 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -61.63 -45.9 92.07 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.573 ' O ' HG13 ' X' ' 22' ' ' ILE . 29.5 tp -61.76 -47.19 86.31 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 123.858 0.724 . . . . 0.0 109.629 175.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -58.23 -37.57 75.13 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.031 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.1 mttm -70.62 -35.67 73.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.42 -36.75 74.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.947 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.66 HG12 ' HB3' ' X' ' 37' ' ' LEU . 56.2 mt -63.01 -41.71 93.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -47.57 81.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.495 1.118 . . . . 0.0 108.618 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -61.39 -52.68 63.62 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.32 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -72.22 -25.64 61.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.34 -46.45 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.78 -25.36 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.717 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.31 -26.79 35.38 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.96 68.44 0.63 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.398 1.479 . . . . 0.0 111.682 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.8 p -99.47 -171.66 2.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -131.93 -44.82 0.95 Allowed 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 118.205 -1.398 . . . . 0.0 112.585 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.666 ' O ' HG23 ' X' ' 36' ' ' VAL . 21.7 t70 -64.78 -52.48 56.67 Favored 'General case' 0 CA--C 1.476 -1.894 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.775 -172.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -85.8 -30.41 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 O-C-N 123.714 0.634 . . . . 0.0 110.64 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -59.1 -47.35 85.57 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.59 -26.88 64.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.285 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.666 HG23 ' O ' ' X' ' 32' ' ' ASP . 92.9 t -67.11 -50.26 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 C-N-CA 118.622 -1.231 . . . . 0.0 108.79 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.66 ' HB3' HG12 ' X' ' 22' ' ' ILE . 67.2 mt -68.64 -39.48 80.72 Favored 'General case' 0 N--CA 1.41 -2.436 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.935 -170.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.9 mt -59.26 -49.18 78.82 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 124.253 0.971 . . . . 0.0 110.431 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.57 -39.97 73.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.693 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.495 ' O ' HG12 ' X' ' 44' ' ' ILE . 12.8 t60 -59.62 -46.22 89.64 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.412 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.545 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 56.3 t80 -60.32 -52.99 62.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.649 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.472 HG12 ' O ' ' X' ' 38' ' ' LEU . 7.4 p -66.65 -31.01 51.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -73.0 -33.57 65.87 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.75 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.495 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.1 pt -84.05 -35.74 11.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.238 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.424 HG22 HG21 ' X' ' 79' ' ' ILE . 75.8 p -81.72 -34.67 30.43 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 64.96 22.4 12.45 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.825 1.65 . . . . 0.0 110.338 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.474 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 34.1 t-80 -72.61 133.67 82.46 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.517 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 34.6 Cg_exo -67.46 -17.94 49.11 Favored 'Trans proline' 0 CA--C 1.499 -1.274 0 C-N-CA 123.119 2.546 . . . . 0.0 111.639 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 9.4 m-20 -124.13 33.68 5.23 Favored 'General case' 0 N--CA 1.383 -3.788 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.545 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -56.15 6.03 Favored Glycine 0 CA--C 1.457 -3.569 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.839 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.555 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.369 0.4 OUTLIER -85.85 -18.3 33.21 Favored 'General case' 0 C--N 1.25 -3.719 0 C-N-CA 117.116 -1.834 . . . . 0.0 114.26 -175.883 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.88 -31.6 72.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.8 mt -66.91 -38.42 86.2 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 123.691 0.619 . . . . 0.0 111.212 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.53 HD13 HG21 ' X' ' 75' ' ' ILE . 21.0 mm -66.57 -48.12 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.244 1.021 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.472 ' HD1' ' O ' ' X' ' 51' ' ' THR . 43.8 m-85 -64.39 -40.74 96.41 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 113.715 -1.584 . . . . 0.0 113.914 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.15 -36.92 72.22 Favored 'General case' 0 C--O 1.194 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.858 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.32 77.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.122 0.264 . . . . 0.0 110.553 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.07 -47.91 78.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.523 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.48 91.19 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.706 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.518 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 75.4 mtp180 -64.48 -30.77 71.8 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.315 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.69 54.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.815 0.341 . . . . 0.0 110.49 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.03 91.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.043 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.39 -48.16 17.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.919 0.39 . . . . 0.0 110.082 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 54.86 88.3 0.13 Allowed Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.002 1.721 . . . . 0.0 112.857 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.88 -66.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.285 1.99 . . . . 0.0 111.823 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.69 37.18 2.15 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.184 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 -63.05 2.95 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . 0.463 ' OD1' ' HE3' ' X' ' 77' ' ' LYS . 23.3 m-20 -56.22 125.91 23.86 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . 0.518 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 92.64 -16.62 59.71 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.615 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 69.38 1.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.48 170.12 17.28 Favored Glycine 0 N--CA 1.403 -3.509 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.497 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.5 Cg_endo -57.87 -40.15 80.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.792 2.995 . . . . 0.0 112.887 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.45 0.66 9.67 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.74 -3.98 30.13 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 118.573 -1.775 . . . . 0.0 112.829 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.53 HG21 HD13 ' X' ' 54' ' ' ILE . 1.8 mt -78.13 -46.02 26.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.725 HG11 HG12 ' X' ' 16' ' ' VAL . 0.8 OUTLIER -56.47 -44.47 80.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.648 176.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.3 ttmm -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.309 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.51 -38.51 65.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.424 HG21 HG22 ' X' ' 45' ' ' THR . 44.6 mm -67.31 -39.45 82.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.003 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 21.2 ptmt -61.59 -38.28 87.0 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.65 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -72.33 -39.09 68.44 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.433 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 59.4 t90 -67.36 -47.14 71.29 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.049 0.452 . . . . 0.0 110.026 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.536 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 10.6 tpt180 -60.83 -45.08 95.88 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.457 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.77 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.363 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.92 95.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.048 0.452 . . . . 0.0 111.513 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -69.04 -28.97 67.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.51 9.12 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.536 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 53.7 mttm -104.8 147.9 35.21 Favored Pre-proline 0 N--CA 1.405 -2.68 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -68.01 122.56 9.67 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 121.856 1.704 . . . . 0.0 109.643 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -96.82 -129.0 6.02 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.243 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.451 ' CE1' HD11 ' X' ' 7' ' ' ILE . 29.7 m-85 -78.18 158.1 29.14 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.059 -0.57 . . . . 0.0 110.535 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' X' ' 11' ' ' THR . 39.7 pttt -101.89 175.23 5.61 Favored 'General case' 0 N--CA 1.38 -3.968 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -105.75 144.25 32.76 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.417 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.506 -0.745 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 58.3 mt -92.17 128.74 38.12 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 29.4 mmtt -103.2 168.0 9.46 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.68 -27.12 34.18 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.582 0.706 . . . . 0.0 110.479 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.4 p -134.18 163.12 30.31 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' X' ' 91' ' ' PHE . 6.0 tp -68.0 -18.1 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.155 0.982 . . . . 0.0 109.854 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.0 p -76.45 -16.23 59.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.646 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 4.0 t70 -104.07 2.66 32.35 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -97.36 120.86 38.5 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.907 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.431 HG22 ' HG3' ' X' ' 92' ' ' LYS . 74.7 p -79.31 163.16 25.12 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 167.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.64 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.6 pt-20 -59.03 -35.65 73.65 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.102 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.45 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.42 -39.37 74.46 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -58.81 -37.16 75.78 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.934 0.874 . . . . 0.0 109.282 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.639 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 38.1 t80 -74.82 -39.53 61.6 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.475 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.696 HG12 HG11 ' X' ' 76' ' ' VAL . 8.6 m -62.69 -29.87 47.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.257 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.04 -50.09 75.39 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.673 ' O ' HG13 ' X' ' 22' ' ' ILE . 46.6 tp -59.7 -46.47 89.0 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.799 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 34.4 mt -57.29 -43.28 83.05 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.232 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 98.5 mttt -61.49 -46.54 89.57 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.964 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.09 -39.32 89.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.796 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.673 HG13 ' O ' ' X' ' 18' ' ' LEU . 50.7 mt -60.77 -44.71 97.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 O-C-N 123.337 0.398 . . . . 0.0 110.59 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.454 ' O ' HG22 ' X' ' 27' ' ' VAL . 46.8 mt-10 -57.02 -46.06 82.64 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.398 0.618 . . . . 0.0 109.723 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.15 -46.85 88.29 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.387 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -85.83 -30.39 23.0 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.305 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.65 -44.64 85.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.092 0.157 . . . . 0.0 111.183 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . 0.454 HG22 ' O ' ' X' ' 23' ' ' GLU . 32.4 m -71.11 -22.53 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.57 -24.99 22.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.68 88.9 0.11 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.899 1.68 . . . . 0.0 110.867 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.614 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 44.7 p -96.89 -151.88 0.37 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.92 -66.82 0.37 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 112.726 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.601 ' O ' HG23 ' X' ' 36' ' ' VAL . 38.1 t70 -66.98 -46.26 75.14 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.23 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.8 p -81.66 -28.13 10.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.046 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.614 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.7 tm? -58.73 -52.54 65.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.321 1.049 . . . . 0.0 108.823 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.5 -19.71 62.91 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.601 HG23 ' O ' ' X' ' 32' ' ' ASP . 97.7 t -72.02 -52.11 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.027 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.875 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.621 ' HB3' HG12 ' X' ' 22' ' ' ILE . 41.4 mt -69.42 -43.7 72.87 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.552 -168.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.4 mt -59.72 -46.77 88.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 124.567 1.167 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -71.43 -40.56 70.34 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.556 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.3 t60 -59.71 -45.7 91.35 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.508 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.589 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.22 -52.79 63.81 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.467 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.456 HG12 ' O ' ' X' ' 38' ' ' LEU 0.267 11.8 p -67.67 -31.94 54.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.0 ptmm? -70.59 -33.2 70.81 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.711 -0.618 . . . . 0.0 112.151 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.486 HG12 ' O ' ' X' ' 40' ' ' HIS . 14.5 pt -84.81 -33.08 7.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.564 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.446 HG22 HG21 ' X' ' 79' ' ' ILE . 76.2 p -84.42 -35.77 22.85 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 120.965 0.412 . . . . 0.0 110.654 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.01 25.73 15.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.952 1.701 . . . . 0.0 110.163 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 26.3 t-80 -74.02 134.07 78.11 Favored Pre-proline 0 N--CA 1.429 -1.51 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.548 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -71.33 -9.71 25.8 Favored 'Trans proline' 0 CA--C 1.496 -1.423 0 C-N-CA 122.989 2.46 . . . . 0.0 112.058 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.429 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.0 m-20 -130.31 29.66 4.84 Favored 'General case' 0 N--CA 1.396 -3.145 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -170.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.589 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.59 -59.04 5.61 Favored Glycine 0 CA--C 1.461 -3.298 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.199 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.488 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -74.67 -28.89 61.03 Favored 'General case' 0 C--N 1.247 -3.891 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.547 -172.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.07 -35.74 81.73 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -61.74 -39.07 90.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.605 0.566 . . . . 0.0 111.522 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.583 HD13 HG21 ' X' ' 22' ' ' ILE . 36.8 mt -67.17 -47.05 82.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.412 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.6 m-85 -57.91 -45.7 86.08 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.432 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.0 pt-20 -70.4 -39.94 74.2 Favored 'General case' 0 C--O 1.201 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.77 -39.52 85.12 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 117.727 0.24 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.31 -42.12 86.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.537 0.523 . . . . 0.0 110.153 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.29 65.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.172 0.51 . . . . 0.0 110.224 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -61.05 -37.53 82.94 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.811 0.844 . . . . 0.0 110.578 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.33 -30.11 42.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.697 0.285 . . . . 0.0 111.018 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.4 82.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.46 -44.65 20.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 63.7 92.04 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 124.868 1.267 . . . . 0.0 112.049 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.12 -12.51 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.666 1.578 . . . . 0.0 110.271 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.23 -156.36 15.62 Favored Glycine 0 N--CA 1.422 -2.242 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.9 -118.88 15.96 Favored Glycine 0 N--CA 1.433 -1.563 0 O-C-N 124.494 0.761 . . . . 0.0 113.445 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . 0.571 ' OD2' ' HD3' ' X' ' 77' ' ' LYS . 4.6 p-10 -123.3 -27.85 4.06 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 123.447 0.699 . . . . 0.0 110.125 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.23 -7.49 72.14 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.889 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.37 31.95 5.48 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.75 -175.4 44.04 Favored Glycine 0 N--CA 1.408 -3.221 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.557 ' O ' HG13 ' X' ' 75' ' ' ILE . 34.0 Cg_endo -71.95 -22.03 23.68 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 123.725 2.95 . . . . 0.0 113.325 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -72.55 0.44 10.47 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.2 -14.06 23.34 Favored Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.889 -1.624 . . . . 0.0 113.275 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.557 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.9 OUTLIER -70.2 -43.39 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.696 HG11 HG12 ' X' ' 16' ' ' VAL . 1.1 p -59.85 -47.07 92.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.686 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.571 ' HD3' ' OD2' ' X' ' 68' ' ' ASP . 83.5 tttt -60.86 -42.35 97.67 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.24 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.2 -40.6 86.25 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.446 HG21 HG22 ' X' ' 45' ' ' THR . 41.0 mm -67.21 -46.43 84.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.928 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -63.82 -35.68 81.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.759 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.57 -41.48 92.89 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.979 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.548 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 84.1 t90 -66.41 -47.99 71.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 11.9 tpt180 -61.27 -45.52 94.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.43 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.72 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.219 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.26 -26.5 66.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.978 0.418 . . . . 0.0 111.308 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -85.24 -12.25 52.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.78 37.71 44.23 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.991 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.0 mtpp -117.25 137.83 24.36 Favored Pre-proline 0 N--CA 1.392 -3.353 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.7 129.79 27.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.346 2.03 . . . . 0.0 110.42 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.0 -114.6 3.38 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.187 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' X' ' 7' ' ' ILE . 72.4 m-85 -83.67 152.22 24.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.095 -0.553 . . . . 0.0 110.958 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.8 ptmt -87.73 166.73 14.42 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -105.92 142.21 36.01 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 176.038 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.418 ' CD2' HD21 ' X' ' 18' ' ' LEU . 94.8 mt -112.47 143.07 44.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 O-C-N 123.501 0.501 . . . . 0.0 110.438 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.545 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 28.6 mmtt -101.72 -159.45 0.73 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.04 -23.58 8.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -143.14 166.69 23.98 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tp -62.7 -18.67 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.0 110.611 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -77.52 -4.37 45.29 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.711 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.545 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 9.6 t70 -112.34 -3.8 14.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.476 ' CZ ' ' HG2' ' X' ' 4' ' ' LYS . 39.4 m-85 -93.99 116.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.706 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 70.8 p -75.77 173.48 11.06 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 170.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.65 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.9 pt-20 -56.09 -44.54 79.11 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.303 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.404 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.58 -38.57 74.09 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 32.1 mm-40 -58.89 -36.61 74.94 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.729 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -67.33 -50.09 61.43 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.706 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.773 HG12 HG11 ' X' ' 76' ' ' VAL . 2.7 m -61.56 -34.55 62.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 O-C-N 123.182 0.301 . . . . 0.0 111.328 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.62 77.18 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.196 0.998 . . . . 0.0 108.678 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.554 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -65.95 -41.2 91.57 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.153 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.3 mt -58.52 -37.59 75.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.226 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 76.7 mttt -66.52 -36.86 83.72 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.535 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.27 -33.11 61.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.688 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' X' ' 37' ' ' LEU . 48.1 mt -61.97 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.15 -35.02 79.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.57 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -70.21 -52.17 25.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.597 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -70.03 -18.18 63.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.464 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.68 -52.02 20.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.938 0.895 . . . . 0.0 110.26 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.6 -23.56 19.47 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.857 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.5 -4.23 57.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 0.0 109.616 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 49.36 62.41 2.64 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 125.693 1.597 . . . . 0.0 112.927 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.619 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 54.8 p -88.34 -177.84 5.75 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.77 -63.42 0.7 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.634 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.609 ' O ' HG23 ' X' ' 36' ' ' VAL . 30.8 m-20 -58.02 -48.59 79.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 12.0 p -84.56 -32.63 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.362 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.54 -44.71 93.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.82 -32.71 72.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.473 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.609 HG23 ' O ' ' X' ' 32' ' ' ASP . 71.6 t -59.27 -49.13 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-O 121.877 0.846 . . . . 0.0 109.121 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.724 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.3 mt -68.33 -40.58 81.55 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 113.415 -1.721 . . . . 0.0 110.889 -174.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -58.8 -49.29 78.25 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 124.316 1.01 . . . . 0.0 110.729 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -69.29 -42.09 75.94 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.287 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 43.2 t60 -61.38 -44.98 96.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.227 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.65 ' O ' HG22 ' X' ' 45' ' ' THR . 42.3 t80 -55.71 -53.08 60.94 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.693 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.408 HG12 ' O ' ' X' ' 38' ' ' LEU 0.293 8.1 p -66.77 -31.6 54.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -74.44 -33.13 62.85 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.055 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.541 HG12 ' O ' ' X' ' 40' ' ' HIS . 30.1 pt -79.9 -36.83 17.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.207 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.65 HG22 ' O ' ' X' ' 41' ' ' PHE . 10.0 t -85.41 -28.26 25.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 61.35 27.8 17.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.213 1.005 . . . . 0.0 110.839 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.517 ' H ' HG23 ' X' ' 45' ' ' THR . 47.3 t-80 -82.51 137.58 44.83 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' X' ' 47' ' ' HIS . 13.3 Cg_exo -75.14 0.01 9.48 Favored 'Trans proline' 0 CA--C 1.486 -1.889 0 C-N-CA 123.235 2.624 . . . . 0.0 113.067 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.487 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.5 m-20 -139.0 34.01 2.15 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.82 -56.08 9.07 Favored Glycine 0 CA--C 1.461 -3.326 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.091 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.564 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.332 0.8 OUTLIER -84.01 -20.1 33.34 Favored 'General case' 0 C--N 1.259 -3.345 0 C-N-CA 116.886 -1.926 . . . . 0.0 114.316 -176.574 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.16 -36.62 82.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 30.3 mt -61.83 -42.82 99.51 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 123.813 0.695 . . . . 0.0 112.236 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.61 -45.96 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.353 1.073 . . . . 0.0 108.831 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.59 -42.7 98.26 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.479 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -69.03 -35.18 76.33 Favored 'General case' 0 C--O 1.206 -1.221 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.402 175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . -56.72 -40.11 75.12 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 122.704 0.402 . . . . 0.0 111.182 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.32 80.91 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.881 0.738 . . . . 0.0 110.235 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.07 96.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.584 0.707 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.63 -30.78 70.44 Favored 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.529 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.77 -41.18 27.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.48 81.81 2.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' X' ' 65' ' ' PRO . 23.0 p30 -78.53 131.65 67.63 Favored Pre-proline 0 CA--C 1.49 -1.333 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.469 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' X' ' 64' ' ' ASN . 62.8 Cg_endo -92.16 0.05 4.16 Favored 'Trans proline' 0 N--CA 1.43 -2.242 0 C-N-CA 122.262 1.975 . . . . 0.0 112.207 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.55 -166.28 12.23 Favored Glycine 0 CA--C 1.485 -1.787 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.75 -115.11 6.98 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 124.207 0.592 . . . . 0.0 112.504 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.54 -12.98 28.33 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.79 -107.79 2.15 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.937 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -159.13 -144.87 4.08 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.02 -156.3 52.08 Favored Glycine 0 N--CA 1.415 -2.729 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.076 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.54 ' O ' HG12 ' X' ' 76' ' ' VAL . 25.0 Cg_endo -71.98 -56.12 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.497 2.798 . . . . 0.0 114.076 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.01 0.59 1.81 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.39 -31.17 3.1 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.607 -1.758 . . . . 0.0 114.137 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.665 HG13 HD13 ' X' ' 19' ' ' LEU . 9.9 pt -67.11 -34.12 67.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 117.487 0.643 . . . . 0.0 110.602 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.773 HG11 HG12 ' X' ' 16' ' ' VAL . 0.2 OUTLIER -59.08 -43.26 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-O 121.997 0.903 . . . . 0.0 110.913 175.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 88.2 tttt -62.16 -47.24 85.4 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.33 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.22 -40.44 90.17 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.48 HD12 ' OG1' ' X' ' 45' ' ' THR . 22.5 mm -61.92 -46.23 96.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.485 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.488 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 20.3 pttp -70.41 -35.76 73.63 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.676 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 40.0 mt-10 -68.19 -39.88 82.37 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.209 0.318 . . . . 0.0 111.424 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -67.38 -48.1 68.41 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.173 0.511 . . . . 0.0 110.297 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.557 ' NH1' ' HA ' ' X' ' 45' ' ' THR . 15.9 ttt180 -70.98 -38.31 72.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.73 0.3 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -31.66 69.51 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.327 0.584 . . . . 0.0 110.378 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.517 ' ND2' ' HD3' ' X' ' 88' ' ' LYS . 39.9 t-20 -73.55 -30.71 63.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.201 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.07 26.7 25.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.517 ' HD3' ' ND2' ' X' ' 86' ' ' ASN . 21.7 mtpp -106.88 132.75 20.66 Favored Pre-proline 0 N--CA 1.399 -3.014 0 C-N-CA 123.491 0.717 . . . . 0.0 109.243 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.25 119.19 3.33 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.995 3.13 . . . . 0.0 113.768 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' X' ' 83' ' ' ARG . . . -95.15 -126.52 4.87 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.944 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 11.6 m-85 -84.84 165.65 17.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' X' ' 93' ' ' GLN . 19.5 ptmt -86.47 179.33 6.87 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . 0.453 ' O ' ' HE2' ' X' ' 92' ' ' LYS . 2.3 mp0 -96.55 139.3 32.85 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.615 0.722 . . . . 0.0 110.607 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.402 -3.627 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 177.204 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.008 0.433 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.456 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 83.7 mt -92.68 140.92 29.04 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.052 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' X' ' 9' ' ' ASP . 28.9 mmtt -111.66 -179.15 3.62 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -91.61 -39.26 11.97 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.192 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . 0.43 ' HA ' HG22 ' X' ' 44' ' ' ILE . 64.8 p -127.87 167.23 16.87 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.653 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.06 -14.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.63 0.772 . . . . 0.0 109.836 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -79.08 -17.93 54.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.34 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' X' ' 4' ' ' LYS . 5.3 t70 -98.36 1.34 46.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.67 119.8 33.13 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.473 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -78.0 159.75 28.59 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.647 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.1 pt-20 -65.64 -30.64 71.37 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.644 -1.622 . . . . 0.0 111.723 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.76 77.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.07 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -58.04 -40.06 79.98 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.79 0.805 . . . . 0.0 109.092 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.666 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.1 t80 -71.15 -44.92 64.59 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.905 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.737 HG12 HG11 ' X' ' 76' ' ' VAL . 4.0 m -62.43 -34.81 66.5 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.825 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.871 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.39 -45.43 88.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.718 0.807 . . . . 0.0 109.347 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.514 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.0 tm? -66.63 -43.79 83.75 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.228 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.3 mt -58.08 -46.05 86.12 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.773 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 63.6 mtpt -62.02 -35.83 79.73 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.766 0.826 . . . . 0.0 110.0 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -74.52 -35.37 63.16 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.715 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.514 HG13 ' O ' ' X' ' 18' ' ' LEU . 44.1 mt -59.69 -44.41 93.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.921 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.426 ' O ' HG22 ' X' ' 27' ' ' VAL . 42.8 mt-10 -56.93 -44.82 82.85 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.383 0.611 . . . . 0.0 110.475 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -60.31 -46.09 91.08 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.647 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.5 ' HB2' ' CG2' ' X' ' 30' ' ' THR . 3.1 pp20? -84.92 -30.32 24.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.749 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . 0.416 ' HA ' HD23 ' X' ' 34' ' ' LEU . 23.0 t-20 -63.02 -40.67 98.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.59 0.756 . . . . 0.0 111.698 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . 0.426 HG22 ' O ' ' X' ' 23' ' ' GLU . 34.7 m -80.5 -7.04 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.256 0.55 . . . . 0.0 111.313 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.03 -25.77 13.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.71 85.36 0.13 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.698 1.599 . . . . 0.0 110.297 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 72.7 p -92.07 -24.23 19.22 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 70.41 -50.81 0.66 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.37 1.868 . . . . 0.0 114.358 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.533 ' O ' HG23 ' X' ' 36' ' ' VAL . 14.3 t70 -70.25 -56.79 5.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 118.034 0.379 . . . . 0.0 110.23 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.5 p -80.87 -25.45 10.87 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.457 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.6 tm? -58.23 -48.31 80.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.779 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.71 -32.46 73.1 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.839 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.533 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.0 t -66.81 -50.69 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.549 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 35.4 mt -68.45 -43.81 76.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.02 -171.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.5 HD13 ' CG2' ' X' ' 51' ' ' THR . 46.4 mt -61.98 -45.67 92.61 Favored 'General case' 0 N--CA 1.419 -2.016 0 O-C-N 124.211 0.944 . . . . 0.0 111.707 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -70.3 -43.28 70.7 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.882 0.372 . . . . 0.0 111.757 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.478 ' O ' HG12 ' X' ' 44' ' ' ILE . 9.6 t60 -59.56 -45.14 92.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.328 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.599 ' O ' HG22 ' X' ' 45' ' ' THR . 27.5 t80 -59.68 -55.75 30.43 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.641 1.213 . . . . 0.0 110.824 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' X' ' 38' ' ' LEU 0.278 14.7 p -66.87 -31.64 54.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -69.84 -30.53 68.04 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.84 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.478 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.0 pt -85.27 -35.92 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.574 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.599 HG22 ' O ' ' X' ' 41' ' ' PHE . 4.7 t -84.47 -30.86 24.89 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.394 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.58 36.75 13.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 125.041 1.336 . . . . 0.0 110.34 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.464 ' H ' HG23 ' X' ' 45' ' ' THR . 26.2 t-80 -81.94 136.21 47.7 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.271 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 22.3 Cg_exo -70.96 -14.33 32.22 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.787 2.324 . . . . 0.0 111.941 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.427 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 22.3 m-20 -128.3 31.98 4.95 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -172.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.08 8.38 Favored Glycine 0 CA--C 1.457 -3.54 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.419 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.5 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.77 -33.94 58.03 Favored 'General case' 0 C--N 1.251 -3.697 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.055 -174.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.59 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.65 -31.88 69.94 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.191 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 mt -62.29 -48.51 79.55 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 123.574 0.546 . . . . 0.0 112.101 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.523 ' H ' HD12 ' X' ' 54' ' ' ILE . 4.4 mp -66.81 -40.43 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.742 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.45 ' HD1' ' O ' ' X' ' 51' ' ' THR . 27.1 m-85 -61.62 -43.29 99.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.78 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.9 pt-20 -71.97 -37.04 69.98 Favored 'General case' 0 C--O 1.203 -1.345 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.202 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.51 82.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.594 0.358 . . . . 0.0 110.978 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.39 90.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.991 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.6 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.756 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 29.9 mtp180 -63.47 -39.27 94.01 Favored 'General case' 0 C--O 1.199 -1.564 0 C-N-CA 124.488 1.115 . . . . 0.0 112.155 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.87 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.793 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.38 71.68 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.607 0.718 . . . . 0.0 109.227 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.32 89.57 2.74 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 44.1 m-80 -60.86 125.96 84.43 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.043 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.67 6.96 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.707 2.271 . . . . 0.0 110.738 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.43 -126.76 1.91 Allowed Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.66 14.6 1.39 Allowed Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.271 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.0 -41.76 95.09 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.813 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.53 93.26 0.09 OUTLIER Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.66 -70.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.224 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.95 -114.74 2.38 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.317 -0.944 . . . . 0.0 114.429 -173.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.504 ' O ' HG13 ' X' ' 75' ' ' ILE . 36.7 Cg_endo -60.05 -53.6 2.96 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 123.694 2.929 . . . . 0.0 114.701 -167.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.88 0.17 9.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . 0.596 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -105.58 -18.58 11.53 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.004 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.504 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.5 OUTLIER -67.26 -44.22 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.737 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -60.49 -39.75 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.656 176.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 22.5 ttpp -58.55 -47.67 83.45 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.856 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 7.2 mm-40 -58.01 -45.08 87.43 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.125 0.964 . . . . 0.0 109.196 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.489 HG12 ' O ' ' X' ' 75' ' ' ILE . 41.9 mm -61.62 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.447 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.1 ptpt -65.89 -38.31 88.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.983 -177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.65 -40.16 76.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.907 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 63.1 t90 -70.17 -46.77 63.96 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.787 0.327 . . . . 0.0 110.684 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.52 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 8.4 tpt180 -60.55 -45.58 93.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.38 88.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.947 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.33 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.974 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -69.4 -34.99 75.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.68 44.07 1.86 Allowed Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.484 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 54.9 mttm -119.5 146.42 41.17 Favored Pre-proline 0 N--CA 1.4 -2.941 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.78 124.68 15.47 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.634 2.223 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -88.39 -132.43 4.11 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.864 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 80.8 m-85 -89.54 166.18 13.82 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.32 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -99.28 166.99 10.94 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.21 144.5 25.76 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.673 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.75 132.98 36.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.16 0.505 . . . . 0.0 110.598 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.415 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 31.6 mmtt -105.3 -164.43 1.03 Allowed 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' X' ' 5' ' ' ASN . 11.6 m120 -114.25 -28.36 7.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.357 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -128.97 163.46 25.29 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -67.5 -16.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-O 121.471 0.653 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -79.1 -3.26 44.51 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.55 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.467 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.1 t0 -110.21 1.64 18.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.213 1.006 . . . . 0.0 108.92 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -93.75 121.01 34.74 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.521 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -82.37 176.14 9.67 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.572 ' O ' HG13 ' X' ' 16' ' ' VAL . 4.7 mm-40 -59.23 -51.97 67.7 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.799 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.84 -38.7 76.57 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.879 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.64 -40.97 80.48 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.172 0.51 . . . . 0.0 109.843 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.523 ' O ' HD13 ' X' ' 19' ' ' LEU . 30.2 t80 -75.06 -48.53 23.51 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.095 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.799 HG22 ' HA ' ' X' ' 13' ' ' ALA . 15.7 m -58.6 -38.58 71.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -66.8 -46.27 75.76 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 122.682 0.393 . . . . 0.0 111.027 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.562 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.4 tm? -62.95 -41.31 99.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.523 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.31 -36.86 76.4 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.148 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.704 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 61.4 mttm -63.58 -40.13 96.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.964 0.888 . . . . 0.0 108.816 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -65.13 -36.06 83.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.966 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.599 HG12 ' HB3' ' X' ' 37' ' ' LEU . 19.3 mt -63.74 -39.55 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.285 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -56.87 -46.07 82.07 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.602 0.564 . . . . 0.0 109.915 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -62.93 -43.89 97.56 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.081 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.08 -33.33 70.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.284 0.564 . . . . 0.0 109.885 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.37 -44.94 57.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.564 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.34 -29.86 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.744 0.307 . . . . 0.0 111.693 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -4.67 57.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.464 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 48.34 64.85 1.51 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.179 1.392 . . . . 0.0 112.256 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 72.7 p -83.22 -161.07 0.46 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -130.42 -71.16 0.6 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.393 -1.323 . . . . 0.0 114.398 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.611 ' O ' HG23 ' X' ' 36' ' ' VAL . 27.6 t70 -56.64 -52.43 64.9 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 68.9 t -86.83 -25.11 6.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.239 -174.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -58.79 -50.8 72.62 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.7 -19.81 61.33 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.611 HG23 ' O ' ' X' ' 32' ' ' ASP . 59.2 t -71.48 -49.76 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.074 0 C-N-CA 118.289 -1.365 . . . . 0.0 108.471 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' X' ' 22' ' ' ILE . 88.5 mt -68.5 -43.54 76.62 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.091 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.5 mt -60.54 -47.09 87.7 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 124.337 1.023 . . . . 0.0 110.457 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -71.03 -43.72 67.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.618 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 39.1 t60 -60.34 -45.58 92.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.223 0.535 . . . . 0.0 110.062 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.622 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 38.4 t80 -59.14 -53.0 63.25 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.191 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.506 HG12 ' O ' ' X' ' 38' ' ' LEU . 13.1 p -67.99 -32.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -67.0 -36.98 83.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 122.07 -0.394 . . . . 0.0 111.502 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.566 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -81.1 -34.1 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.855 0.36 . . . . 0.0 111.378 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 35.2 p -83.84 -42.46 16.4 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.96 74.97 0.42 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 125.173 1.389 . . . . 0.0 109.583 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.559 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -126.11 139.01 33.32 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.164 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.46 -7.89 22.18 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.794 2.329 . . . . 0.0 112.31 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 16.3 m-20 -135.21 31.9 3.18 Favored 'General case' 0 N--CA 1.391 -3.386 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.622 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.81 -58.2 8.77 Favored Glycine 0 CA--C 1.461 -3.316 0 O-C-N 123.679 0.612 . . . . 0.0 112.704 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.472 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.23 -28.65 63.3 Favored 'General case' 0 C--N 1.248 -3.82 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.148 -174.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -65.78 -34.34 77.94 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.323 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.57 -45.4 77.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.905 0.482 . . . . 0.0 110.052 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.595 HD13 HG21 ' X' ' 22' ' ' ILE . 23.4 mt -66.84 -44.37 89.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.608 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -59.49 -49.68 76.86 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.754 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.7 pt-20 -66.94 -35.76 80.7 Favored 'General case' 0 C--O 1.188 -2.158 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.634 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.27 73.22 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.89 0.376 . . . . 0.0 110.763 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.89 92.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.3 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.03 64.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.892 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' X' ' 56' ' ' GLU . 44.8 mtp180 -61.8 -40.38 95.03 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 123.76 0.824 . . . . 0.0 111.115 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.87 -30.05 58.73 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.998 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.57 47.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -44.58 19.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.912 0.387 . . . . 0.0 110.3 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 54.54 82.93 0.23 Allowed Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.258 1.423 . . . . 0.0 112.755 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.88 -42.57 3.16 Favored 'Trans proline' 0 C--O 1.241 0.668 0 C-N-CA 122.104 1.869 . . . . 0.0 110.372 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.84 126.87 2.7 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.22 -150.23 21.79 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -109.73 0.77 19.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.718 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.34 79.91 0.33 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.216 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.5 -90.59 1.49 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.96 -132.86 6.2 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.181 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.581 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.0 Cg_endo -59.12 -38.64 85.6 Favored 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.536 2.824 . . . . 0.0 113.48 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.438 ' C ' HG22 ' X' ' 76' ' ' VAL . 23.3 mt-10 -85.03 1.65 46.74 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 123.212 0.605 . . . . 0.0 109.918 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.05 -36.91 2.08 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.36 -1.4 . . . . 0.0 112.641 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' X' ' 72' ' ' PRO . 5.8 pt -60.71 -34.33 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 172.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.676 HG11 HG12 ' X' ' 16' ' ' VAL . 16.6 m -56.62 -39.36 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.559 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 23.4 ttmm -68.77 -39.41 80.23 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.041 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -67.08 -32.15 73.13 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.965 0.888 . . . . 0.0 109.155 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.491 ' HA ' HH21 ' X' ' 83' ' ' ARG . 83.0 mt -67.62 -46.35 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.873 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 14.4 ptmm? -67.71 -36.27 80.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 111.105 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.1 mt-10 -70.45 -36.79 74.15 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.899 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -66.8 -41.16 88.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.559 HH22 ' CD2' ' X' ' 47' ' ' HIS . 0.5 OUTLIER -61.87 -46.27 90.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.379 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.65 91.78 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.796 0.685 . . . . 0.0 111.517 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.937 0.398 . . . . 0.0 110.85 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -68.33 -48.54 64.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.486 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.52 4.77 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.91 151.6 37.54 Favored Pre-proline 0 N--CA 1.407 -2.58 0 C-N-CA 123.933 0.893 . . . . 0.0 108.828 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.97 140.96 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.978 1.785 . . . . 0.0 111.617 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.82 -131.3 6.61 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 10.7 m-85 -93.46 159.36 15.28 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 19.7 ptmt -93.94 172.8 8.01 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -96.25 135.69 37.73 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.712 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.203 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.163 178.406 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.406 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 87.3 mt -103.82 127.66 51.3 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 26.1 mmtt -105.89 152.53 23.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -80.2 -11.7 59.71 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.138 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 67.5 p -141.88 162.3 35.81 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -69.4 -13.07 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 121.643 0.735 . . . . 0.0 110.676 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -77.98 -17.91 56.6 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 14.3 t70 -102.43 5.33 39.56 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.6 m-85 -94.03 114.32 26.47 Favored 'General case' 0 CA--C 1.466 -2.268 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.938 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.421 HG22 ' HG3' ' X' ' 92' ' ' LYS . 53.2 p -77.32 157.11 30.87 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 103.4 -2.815 . . . . 0.0 103.4 171.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.431 ' O ' HG12 ' X' ' 16' ' ' VAL . 6.2 pt-20 -64.67 -26.39 68.36 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.734 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.74 69.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.677 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -57.32 -41.65 80.36 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.266 0.555 . . . . 0.0 109.537 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 14.8 t80 -64.98 -58.27 6.54 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.041 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.627 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 13.8 p -63.43 -29.55 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -60.21 -44.73 94.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.524 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.3 tm? -67.22 -40.92 86.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.547 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 32.2 mt -58.27 -36.63 73.56 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.34 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 54.5 mtpt -66.84 -35.74 80.74 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.327 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 12.0 pt-20 -75.5 -31.43 60.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.851 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' X' ' 18' ' ' LEU . 49.9 mt -60.3 -39.99 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 123.77 0.669 . . . . 0.0 109.843 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -58.35 -41.21 84.16 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.559 0.695 . . . . 0.0 109.635 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.44 -47.79 46.17 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.401 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.71 ' OE2' ' HA ' ' X' ' 34' ' ' LEU 0.274 0.0 OUTLIER -75.47 -19.5 59.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.446 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . 0.458 HD21 HD21 ' X' ' 38' ' ' LEU . 2.2 m-80 -76.77 -42.1 42.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.385 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 -34.51 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.314 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.24 48.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.66 0.267 . . . . 0.0 110.464 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.83 95.77 0.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.173 1.389 . . . . 0.0 111.977 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 38.8 p -107.66 -171.37 1.86 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -136.34 -20.19 1.42 Allowed 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.102 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.564 ' O ' HG23 ' X' ' 36' ' ' VAL . 10.9 m-20 -85.51 -61.85 1.67 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.154 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.593 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.6 p -76.55 -26.93 16.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.007 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.71 ' HA ' ' OE2' ' X' ' 25' ' ' GLU . 3.1 tm? -58.78 -44.66 90.74 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 124.333 1.021 . . . . 0.0 108.701 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.7 t70 -72.42 -36.77 68.69 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.363 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.564 HG23 ' O ' ' X' ' 32' ' ' ASP . 47.2 t -63.66 -49.79 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 O-C-N 124.324 1.015 . . . . 0.0 110.609 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 41.2 mt -68.14 -41.14 82.1 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.991 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 14.4 mt -59.45 -49.66 76.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 O-C-N 124.437 1.085 . . . . 0.0 111.815 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.3 pt-20 -70.98 -42.29 69.87 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.102 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.485 ' O ' HG12 ' X' ' 44' ' ' ILE . 69.9 t60 -60.26 -45.72 92.3 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.014 0.526 . . . . 0.0 110.373 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.653 ' O ' HG22 ' X' ' 45' ' ' THR . 39.4 t80 -57.95 -53.72 55.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 124.265 0.978 . . . . 0.0 110.834 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 p -66.34 -31.06 51.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -63.38 -47.46 81.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.494 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 4.9 pt -75.15 -36.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.653 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.67 -31.58 24.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.509 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 61.91 29.59 17.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.914 0.864 . . . . 0.0 111.319 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.541 ' H ' HG23 ' X' ' 45' ' ' THR . 50.5 t-80 -77.94 135.87 62.77 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 30.3 Cg_exo -66.11 -19.22 57.22 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 123.151 2.567 . . . . 0.0 112.316 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.98 36.22 4.35 Favored 'General case' 0 N--CA 1.393 -3.296 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.585 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.64 -55.91 7.76 Favored Glycine 0 CA--C 1.462 -3.226 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.136 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.448 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -77.0 -26.17 53.55 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.332 -171.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.58 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.14 -36.71 83.86 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.303 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.3 -38.93 85.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 123.504 0.503 . . . . 0.0 111.729 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -66.73 -47.26 83.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.704 0.764 . . . . 0.0 109.416 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -63.67 -46.87 83.59 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.86 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.9 pt-20 -68.53 -36.39 78.78 Favored 'General case' 0 C--O 1.196 -1.758 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.79 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.2 76.44 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.246 0.475 . . . . 0.0 111.561 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.021 0.438 . . . . 0.0 110.468 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.74 65.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.722 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 83.6 mtp180 -61.59 -28.35 69.29 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 124.685 1.194 . . . . 0.0 112.546 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.422 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -73.91 -39.04 64.12 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.456 174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.17 -47.28 52.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.723 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.75 76.37 0.97 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.722 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 6.0 t-20 -69.83 120.42 77.54 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.659 -172.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.62 -37.35 97.77 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.227 2.618 . . . . 0.0 111.722 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.72 73.46 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.595 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.12 -53.52 2.52 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.72 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.32 151.93 42.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.786 0.327 . . . . 0.0 110.464 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.53 36.15 87.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.483 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.61 66.13 3.97 Favored Glycine 0 CA--C 1.478 -2.225 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.62 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.422 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 65.45 -128.85 33.44 Favored Glycine 1 N--CA 1.385 -4.764 0 CA-C-N 114.416 -0.892 . . . . 0.0 112.513 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.538 ' HA ' HD11 ' X' ' 75' ' ' ILE . 2.9 Cg_endo -64.42 -30.94 62.45 Favored 'Trans proline' 0 CA--C 1.497 -1.366 0 C-N-CA 122.854 2.369 . . . . 0.0 111.14 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.04 -4.18 56.21 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.891 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.84 -15.41 14.94 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.284 -1.912 . . . . 0.0 113.007 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.55 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -68.04 -49.2 70.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' X' ' 16' ' ' VAL . 1.2 p -55.49 -45.57 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.841 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 56.0 tttp -59.8 -47.3 86.27 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.399 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.55 HG12 ' O ' ' X' ' 75' ' ' ILE . 46.7 mm -66.03 -45.42 90.77 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.873 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.5 ptpt -61.98 -42.17 98.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.905 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.62 -38.75 70.76 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.54 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 85.1 t90 -66.17 -47.92 72.42 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 110.715 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.572 ' HG2' ' HB2' ' X' ' 88' ' ' LYS . 3.4 ttt-85 -68.9 -41.6 78.02 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.222 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.41 84.4 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.2 86.72 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.525 0.202 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.468 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.0 t-20 -63.29 -43.82 96.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.37 18.89 6.45 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.572 ' HB2' ' HG2' ' X' ' 83' ' ' ARG . 68.5 mttm -99.15 158.64 31.92 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' X' ' 83' ' ' ARG . 36.8 Cg_endo -71.5 130.0 16.58 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.434 1.423 . . . . 0.0 110.819 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -119.41 2.37 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.291 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.429 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.7 m-85 -96.74 154.52 17.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 120.524 0.202 . . . . 0.0 110.539 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.421 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.9 ptmt -89.86 176.28 6.88 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.23 137.51 33.32 Favored 'General case' 0 N--CA 1.398 -3.04 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.184 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.26 0 CA-C-O 118.074 -1.403 . . . . 0.0 110.304 177.857 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 76.3 mt -108.64 140.49 41.95 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.554 0.534 . . . . 0.0 111.666 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 40.1 mmtt -103.12 -170.3 1.77 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 171.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -112.41 -24.28 9.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.064 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.5 p -134.35 164.88 26.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.03 -12.52 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.617 0.722 . . . . 0.0 111.051 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -76.07 -18.43 59.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.527 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.426 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.2 t70 -102.74 2.74 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.239 1.019 . . . . 0.0 108.454 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -96.05 113.41 25.02 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.218 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 62.2 p -73.53 160.56 31.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.638 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.83 -32.19 71.58 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.566 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.61 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.4 -39.04 74.72 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.536 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 22.7 mm-40 -58.07 -42.35 85.31 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.552 1.168 . . . . 0.0 108.61 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.33 -47.48 60.87 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 113.137 -1.847 . . . . 0.0 110.492 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.711 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 22.8 m -58.49 -39.41 75.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.394 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.5 -50.57 73.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.251 0.62 . . . . 0.0 111.25 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.522 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.5 tm? -66.52 -40.36 89.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.723 0.773 . . . . 0.0 109.041 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' X' ' 75' ' ' ILE . 9.9 tp -59.66 -42.61 93.22 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.957 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.5 mttt -61.43 -34.84 76.08 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.201 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.32 -41.59 85.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.025 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' X' ' 37' ' ' LEU . 13.0 mt -57.52 -42.49 81.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.23 -44.83 88.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.493 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -67.57 -45.48 75.45 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.054 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.454 ' HB3' ' OG1' ' X' ' 30' ' ' THR . 0.4 OUTLIER -69.8 -19.04 63.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.418 177.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.06 -46.53 10.39 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.275 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.94 -32.36 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.26 -6.3 57.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.732 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.99 80.4 0.11 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.754 1.622 . . . . 0.0 113.323 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.645 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 64.2 p -91.68 -165.48 1.36 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.23 -73.09 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.089 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.618 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.2 t70 -60.35 -51.21 70.46 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 123.434 0.459 . . . . 0.0 111.449 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.68 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.0 p -73.03 -35.27 47.95 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.363 -175.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.645 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.4 tm? -58.95 -47.6 84.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.703 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.35 -41.5 98.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.319 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.618 HG23 ' O ' ' X' ' 32' ' ' ASP . 77.9 t -56.71 -49.56 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 O-C-N 123.77 0.669 . . . . 0.0 109.927 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 86.1 mt -68.41 -43.79 76.44 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.982 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 29.6 mt -61.21 -48.47 81.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 124.154 0.909 . . . . 0.0 110.637 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -70.72 -41.53 71.79 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.131 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.553 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.9 t60 -61.29 -45.91 92.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.238 0.542 . . . . 0.0 109.846 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.641 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.2 t80 -59.14 -52.6 64.99 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.334 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.432 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.1 p -67.62 -32.15 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 53.1 pttt -68.48 -39.61 81.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.53 HG12 ' O ' ' X' ' 40' ' ' HIS . 27.4 pt -77.67 -31.38 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.5 p -84.07 -39.99 18.88 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . 0.403 ' HB2' ' NH1' ' X' ' 83' ' ' ARG . 6.4 mm-40 67.07 20.19 10.38 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 123.915 0.886 . . . . 0.0 111.24 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.415 ' HA ' ' HD3' ' X' ' 48' ' ' PRO . 39.7 t-80 -80.73 133.25 55.8 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.431 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.2 Cg_exo -71.34 -2.26 10.94 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.488 2.792 . . . . 0.0 113.043 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 15.1 m-20 -130.05 27.65 5.11 Favored 'General case' 0 N--CA 1.394 -3.237 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.641 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -43.73 -60.28 3.41 Favored Glycine 0 CA--C 1.459 -3.407 0 O-C-N 124.388 1.055 . . . . 0.0 112.931 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.497 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.35 -29.33 63.7 Favored 'General case' 0 C--N 1.251 -3.711 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.716 -173.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.611 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -66.2 -30.47 70.94 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 97.9 mt -61.05 -41.52 96.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.153 0.502 . . . . 0.0 109.752 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.593 HD13 HG21 ' X' ' 22' ' ' ILE . 57.0 mt -67.21 -46.24 84.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.095 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -58.39 -49.52 76.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.645 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.5 pt-20 -68.0 -37.24 81.21 Favored 'General case' 0 C--O 1.207 -1.169 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.693 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.55 77.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.663 0.21 . . . . 0.0 110.81 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.5 94.59 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.672 0.608 . . . . 0.0 111.496 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.63 62.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.531 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.527 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 74.3 mtp180 -67.91 -44.33 77.15 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.51 64.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.822 0.344 . . . . 0.0 111.411 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.47 96.43 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.221 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -33.24 15.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.563 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.73 87.57 0.12 Allowed Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 125.433 1.493 . . . . 0.0 112.783 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 4.8 Cg_endo -91.04 109.41 0.32 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.827 2.351 . . . . 0.0 109.26 173.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.44 112.56 3.1 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.188 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.94 -115.31 0.65 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -128.44 153.25 47.31 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . 0.527 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 88.86 27.55 23.66 Favored Glycine 0 C--N 1.305 -1.184 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.174 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.06 4.95 Favored Glycine 0 CA--C 1.483 -1.937 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.605 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.64 -142.82 16.13 Favored Glycine 1 N--CA 1.372 -5.59 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.889 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.522 ' O ' HG13 ' X' ' 76' ' ' VAL . 11.6 Cg_endo -64.31 -48.29 4.88 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 124.645 3.563 . . . . 0.0 112.349 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.487 ' C ' HG22 ' X' ' 76' ' ' VAL . 42.0 mt-10 -77.78 1.92 18.65 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.0 -39.3 2.33 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 118.651 -1.738 . . . . 0.0 112.769 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.557 ' O ' HG13 ' X' ' 79' ' ' ILE . 3.1 pt -62.73 -28.25 44.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 CA-C-N 117.495 0.647 . . . . 0.0 110.94 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.595 HG11 HG12 ' X' ' 16' ' ' VAL . 21.6 m -60.27 -36.11 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.945 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 83.6 tttt -65.86 -41.93 91.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.653 174.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' X' ' 75' ' ' ILE . 7.8 tp10 -58.07 -44.13 87.35 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.557 HG13 ' O ' ' X' ' 75' ' ' ILE . 82.9 mt -67.42 -46.34 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.618 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.6 ptmt -64.3 -37.77 88.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.38 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.84 -38.38 73.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 62.8 t90 -65.49 -47.36 76.29 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.797 0.808 . . . . 0.0 109.626 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 16.9 tpt180 -61.15 -45.8 93.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.693 -177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.93 81.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.125 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -32.79 73.67 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.442 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 25.3 t-20 -78.77 -48.81 14.14 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.55 34.3 1.45 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.442 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 66.6 mttm -103.81 141.85 23.38 Favored Pre-proline 0 N--CA 1.392 -3.368 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.39 121.51 9.34 Favored 'Trans proline' 0 CA--C 1.517 -0.34 0 C-N-CA 122.135 1.89 . . . . 0.0 110.956 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -95.14 -135.6 8.17 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.341 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -78.65 146.9 33.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.1 ptmt -85.81 174.51 9.27 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.98 139.12 51.62 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.597 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 CA--C 1.505 -0.76 0 CA-C-O 120.631 0.253 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.69 129.95 37.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.611 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 21.2 mmtt -112.47 151.81 29.48 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.95 -9.07 59.69 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.278 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -145.71 160.93 41.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.6 tp -67.71 -19.05 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.259 0.624 . . . . 0.0 111.037 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -73.75 -12.63 60.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.584 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 20.1 t70 -105.22 -0.81 26.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.895 0.855 . . . . 0.0 108.877 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.05 119.03 33.82 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.738 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 30.4 p -77.8 169.01 19.01 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.617 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.639 177.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.54 -38.69 74.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.6 -40.67 79.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.851 0.75 . . . . 0.0 109.399 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.57 ' HD2' HG12 ' X' ' 76' ' ' VAL . 20.5 t80 -70.56 -48.07 57.19 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.874 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.723 HG12 HG11 ' X' ' 76' ' ' VAL . 6.3 m -59.29 -39.57 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.519 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.19 -48.23 82.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.125 0.97 . . . . 0.0 110.884 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.451 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -66.17 -38.92 89.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.446 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.7 mp -62.47 -36.8 83.62 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.932 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 47.1 mtmt -61.43 -35.12 76.67 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.87 -34.73 69.44 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.333 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' X' ' 37' ' ' LEU . 20.8 mt -64.18 -40.26 88.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.004 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -59.83 -46.22 89.92 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.877 0.846 . . . . 0.0 108.789 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -60.54 -52.34 65.61 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.556 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 -25.63 68.39 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.272 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -78.72 -47.67 16.43 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.997 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -71.66 -23.27 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.789 0.328 . . . . 0.0 111.875 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.9 -17.71 30.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.64 67.16 1.0 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.74 1.216 . . . . 0.0 111.026 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -81.86 -31.24 31.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.655 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 68.37 -61.65 0.39 Allowed 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.082 1.753 . . . . 0.0 113.56 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.476 ' O ' HG23 ' X' ' 36' ' ' VAL . 6.5 m-20 -57.07 -57.99 10.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.066 0.547 . . . . 0.0 111.579 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -81.1 -28.9 11.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.202 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.346 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -44.06 92.72 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.84 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.96 -38.45 91.12 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.191 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' X' ' 39' ' ' GLU . 72.2 t -57.64 -48.97 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 O-C-N 124.405 1.066 . . . . 0.0 109.349 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 76.5 mt -65.21 -43.05 92.79 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.53 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.2 mt -59.99 -49.83 76.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.566 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' X' ' 36' ' ' VAL . 0.0 OUTLIER -70.9 -35.07 72.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.332 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.532 ' O ' HG12 ' X' ' 44' ' ' ILE . 24.0 t60 -66.07 -46.17 78.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.585 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.666 ' CD2' HD11 ' X' ' 54' ' ' ILE . 43.4 t80 -58.15 -53.28 60.03 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.432 HG23 ' O ' ' X' ' 47' ' ' HIS . 7.2 p -66.95 -32.6 58.72 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.606 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 42.9 pttt -75.21 -27.73 59.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.532 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.5 pt -84.13 -39.6 14.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.573 HG22 ' O ' ' X' ' 41' ' ' PHE . 15.1 t -85.18 -27.35 26.21 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 61.36 38.35 16.29 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 122.142 0.972 . . . . 0.0 111.238 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.432 ' O ' HG23 ' X' ' 42' ' ' VAL . 44.6 t-80 -94.32 132.94 28.0 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.542 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.7 -16.39 33.62 Favored 'Trans proline' 0 CA--C 1.495 -1.455 0 C-N-CA 123.042 2.494 . . . . 0.0 113.184 -173.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -120.78 30.48 6.88 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.532 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.12 -56.54 6.85 Favored Glycine 1 CA--C 1.447 -4.178 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.083 -177.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.439 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -79.13 -26.9 42.82 Favored 'General case' 0 C--N 1.249 -3.796 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.512 -170.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -58.38 -46.49 86.26 Favored 'General case' 0 C--O 1.189 -2.109 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -52.58 -46.01 66.73 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.666 HD11 ' CD2' ' X' ' 41' ' ' PHE . 3.9 mp -68.33 -47.15 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.256 -1.378 . . . . 0.0 109.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.01 -45.39 90.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.534 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 12.8 mm-40 -65.49 -44.88 85.71 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.62 -41.48 81.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.765 0.426 . . . . 0.0 111.688 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.37 -46.71 79.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.783 0.325 . . . . 0.0 110.441 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -43.69 60.72 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.447 0.642 . . . . 0.0 111.013 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -62.44 -38.18 88.78 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.948 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.46 -29.47 41.76 Favored 'General case' 0 C--O 1.245 0.868 0 O-C-N 123.071 0.232 . . . . 0.0 111.564 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.56 99.07 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.14 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.26 -70.96 0.61 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t30 44.4 86.81 0.13 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 126.141 1.777 . . . . 0.0 114.076 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.83 -54.28 4.35 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.651 2.234 . . . . 0.0 111.163 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.06 61.22 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.355 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.22 -122.41 2.17 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.64 152.88 46.1 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.344 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 55.76 4.71 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.87 -86.33 0.86 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.538 ' O ' HG12 ' X' ' 75' ' ' ILE . . . -123.17 -136.03 4.71 Favored Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.012 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.483 ' O ' HG13 ' X' ' 76' ' ' VAL . 10.6 Cg_endo -55.52 -50.49 12.59 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 124.154 3.236 . . . . 0.0 113.63 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.23 1.17 19.33 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.14 -39.9 1.9 Allowed Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 118.998 -1.572 . . . . 0.0 112.571 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.538 HG12 ' O ' ' X' ' 71' ' ' GLY . 5.1 pt -61.8 -31.69 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-N 117.164 0.482 . . . . 0.0 110.923 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.723 HG11 HG12 ' X' ' 16' ' ' VAL . 15.6 m -61.06 -33.08 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 121.086 0.47 . . . . 0.0 112.182 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 60.3 tttm -67.8 -48.01 67.49 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -61.45 -36.59 80.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.646 0.736 . . . . 0.0 109.317 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mm -66.81 -46.62 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.076 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.414 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 21.0 pttp -71.05 -39.61 72.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.101 0.477 . . . . 0.0 111.857 -173.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.1 mt-10 -66.59 -32.37 73.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.287 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -66.05 -47.65 73.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.96 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -37.3 84.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.192 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.2 99.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 123.987 0.804 . . . . 0.0 110.718 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.06 -32.4 59.26 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.624 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.429 HD22 ' HG3' ' X' ' 88' ' ' LYS . 4.2 t30 -76.13 -39.84 54.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.753 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.15 32.45 3.75 Favored Glycine 0 C--N 1.318 -0.466 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.429 ' HG3' HD22 ' X' ' 86' ' ' ASN . 58.1 mttm -110.6 163.07 18.12 Favored Pre-proline 0 N--CA 1.418 -2.06 0 C-N-CA 124.336 1.055 . . . . 0.0 109.481 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.32 141.13 61.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.406 2.071 . . . . 0.0 112.384 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.5 -155.26 19.33 Favored Glycine 0 N--CA 1.42 -2.427 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.18 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 30.8 m-85 -78.18 151.77 33.05 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -81.7 160.39 23.69 Favored 'General case' 0 N--CA 1.382 -3.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.41 133.93 37.46 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.828 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' X' ' 40' ' ' HIS . 95.1 mt -94.52 128.45 41.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 29.7 mmtt -107.23 156.45 18.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -77.72 -22.24 50.71 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.581 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 58.0 p -143.21 164.58 29.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.151 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.07 -16.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 111.496 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -14.62 61.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.117 0.484 . . . . 0.0 111.61 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 18.0 t70 -103.51 3.3 34.64 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.446 ' CE2' HD12 ' X' ' 44' ' ' ILE . 2.5 m-85 -96.91 112.84 24.42 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.904 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 46.6 p -76.95 155.22 32.88 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -56.95 -39.84 75.32 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.6 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.2 73.7 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.75 -42.16 83.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.76 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.1 t80 -67.2 -54.01 25.05 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.372 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.828 HG12 HG11 ' X' ' 76' ' ' VAL . 10.5 m -60.09 -32.82 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.46 -42.95 78.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.667 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.8 tm? -63.24 -40.07 96.41 Favored 'General case' 0 C--O 1.205 -1.237 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 56.5 mt -64.8 -36.44 84.32 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.637 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.453 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 48.2 mttp -66.18 -37.58 85.94 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.59 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' X' ' 18' ' ' LEU . 13.2 pt-20 -72.17 -31.88 66.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.536 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.667 HG13 ' O ' ' X' ' 18' ' ' LEU . 29.9 mt -66.11 -45.54 90.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.04 -42.0 84.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.383 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.55 -47.16 87.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.596 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -79.65 -24.67 41.69 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.983 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -65.05 -43.77 91.2 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.716 0.293 . . . . 0.0 110.27 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.5 m -76.28 -34.72 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.534 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -29.63 67.67 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.762 0.791 . . . . 0.0 109.097 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 76.49 87.57 0.08 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 127.469 2.307 . . . . 0.0 113.855 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -109.22 175.59 5.4 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -136.31 -4.68 2.1 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.03 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.499 ' O ' HG23 ' X' ' 36' ' ' VAL . 17.7 p-10 -86.14 -62.81 1.43 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.0 p -81.54 -26.03 10.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.539 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.8 tm? -58.06 -46.27 85.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.626 175.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 37.3 t70 -61.24 -45.83 92.93 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.539 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.499 HG23 ' O ' ' X' ' 32' ' ' ASP . 42.9 t -62.01 -50.01 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 O-C-N 124.4 1.063 . . . . 0.0 110.92 -176.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 91.1 mt -67.9 -41.81 82.12 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.937 -172.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.2 mt -59.36 -50.13 75.16 Favored 'General case' 0 N--CA 1.417 -2.107 0 O-C-N 124.122 0.888 . . . . 0.0 111.72 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.1 pt-20 -71.82 -36.52 70.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.588 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 5.0 t60 -65.78 -38.28 88.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.603 ' O ' HG22 ' X' ' 45' ' ' THR . 31.7 t80 -62.7 -51.66 66.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.14 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.422 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 5.9 p -67.17 -32.57 58.28 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.848 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -68.65 -30.13 68.76 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.999 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.468 HG12 ' O ' ' X' ' 40' ' ' HIS . 9.5 pt -83.96 -42.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 122.146 -0.346 . . . . 0.0 111.635 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.603 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.0 t -84.16 -28.39 27.44 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.608 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 62.91 26.14 15.4 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.592 1.557 . . . . 0.0 111.961 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.472 ' H ' HG23 ' X' ' 45' ' ' THR . 42.6 t-80 -75.09 134.26 74.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -69.93 -14.45 35.55 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.831 2.354 . . . . 0.0 112.082 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.4 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.18 29.68 6.03 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 -173.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.597 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.96 -57.88 8.3 Favored Glycine 0 CA--C 1.455 -3.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.107 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.428 ' CG2' HD13 ' X' ' 38' ' ' LEU . 1.4 m -73.34 -29.15 62.47 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.755 -172.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.6 97.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.658 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -57.73 -43.31 85.22 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 123.558 0.536 . . . . 0.0 112.251 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.548 HD13 HG21 ' X' ' 22' ' ' ILE . 64.2 mt -66.59 -42.2 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 121.684 0.754 . . . . 0.0 110.044 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.77 91.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.05 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -36.24 77.78 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.948 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.5 -46.86 83.28 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.222 0.326 . . . . 0.0 110.809 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.1 92.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.67 75.13 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.976 0.417 . . . . 0.0 111.364 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -68.29 -31.24 70.54 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.409 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.45 -34.72 65.54 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 121.154 -0.219 . . . . 0.0 110.861 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.51 -42.64 88.16 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 123.581 0.551 . . . . 0.0 110.613 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.43 72.97 1.49 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.73 122.61 87.41 Favored Pre-proline 0 CA--C 1.478 -1.799 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -81.33 -33.96 0.64 Allowed 'Trans proline' 0 N--CA 1.423 -2.662 0 C-N-CA 121.331 1.354 . . . . 0.0 110.851 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.74 -86.9 1.52 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.99 -31.05 0.9 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.49 -36.1 80.44 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.635 0.731 . . . . 0.0 109.692 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.33 150.51 19.21 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.17 66.59 0.95 Allowed Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.4 162.29 21.37 Favored Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 119.105 -1.522 . . . . 0.0 113.834 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.453 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 18.0 Cg_endo -60.57 -29.05 87.73 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 124.755 3.637 . . . . 0.0 113.9 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.472 ' C ' HG22 ' X' ' 76' ' ' VAL . 84.0 mt-10 -95.66 1.96 53.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.676 0.274 . . . . 0.0 110.326 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.78 -37.47 3.19 Favored Glycine 0 N--CA 1.426 -1.984 0 C-N-CA 118.587 -1.768 . . . . 0.0 111.803 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.551 ' CD1' HD13 ' X' ' 19' ' ' LEU . 9.0 pt -58.33 -32.11 44.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 120.68 0.276 . . . . 0.0 110.927 174.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.828 HG11 HG12 ' X' ' 16' ' ' VAL . 19.1 m -63.93 -36.65 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 24.7 ttmm -67.14 -38.12 84.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -68.67 -40.59 80.08 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.447 HG23 ' OG1' ' X' ' 45' ' ' THR . 22.0 mm -61.98 -46.57 96.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.771 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 19.9 pttp -66.95 -41.01 87.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.396 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.46 -31.96 73.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.575 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 91.3 t90 -72.24 -48.94 38.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.196 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' X' ' 88' ' ' LYS . 10.1 ttt85 -71.17 -37.02 72.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.623 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.18 87.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.741 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.23 -26.35 65.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.117 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.38 -22.02 57.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 120.943 0.402 . . . . 0.0 110.162 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 49.91 16.3 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 60.3 tttp -133.6 126.53 19.11 Favored Pre-proline 0 N--CA 1.414 -2.241 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.72 119.42 5.58 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.283 3.322 . . . . 0.0 113.887 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.63 -127.12 4.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.255 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.9 m-85 -79.3 151.55 31.01 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 120.555 0.217 . . . . 0.0 110.577 -174.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.422 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 20.4 ptmt -93.31 179.1 5.51 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -110.91 142.24 43.25 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 123.031 0.532 . . . . 0.0 109.738 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.119 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 . . . . . 0 CA--C 1.488 -1.411 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.427 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 76.5 mt -91.5 129.58 37.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.887 0.851 . . . . 0.0 112.17 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 26.7 mmtt -104.85 -162.06 0.86 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -119.56 -31.64 4.53 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.201 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.2 p -126.07 166.95 16.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.568 HD13 HH12 ' X' ' 83' ' ' ARG . 7.9 tt -81.1 -0.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.975 0.893 . . . . 0.0 111.275 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 28.8 m -80.99 -10.13 59.75 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.28 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 18.9 t70 -106.85 1.27 24.58 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 7.9 m-85 -98.6 114.14 26.48 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.121 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.463 HG22 ' HG3' ' X' ' 92' ' ' LYS . 76.9 p -79.6 160.54 26.36 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.612 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.9 pt-20 -61.19 -36.94 81.22 Favored 'General case' 0 C--O 1.2 -1.552 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.828 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.35 -38.7 74.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.428 ' HB2' ' OG1' ' X' ' 11' ' ' THR . 1.0 OUTLIER -59.98 -42.18 93.64 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.111 0.958 . . . . 0.0 108.769 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -68.33 -49.02 63.25 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.534 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.722 ' O ' ' HG3' ' X' ' 20' ' ' LYS . 18.7 m -57.78 -41.73 80.35 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 CA-C-N 117.98 0.355 . . . . 0.0 110.206 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -61.27 -49.4 77.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.698 0.799 . . . . 0.0 110.366 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.515 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.2 tm? -64.18 -41.96 96.89 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' X' ' 75' ' ' ILE . 13.9 tp -59.7 -44.27 93.76 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.913 1.285 . . . . 0.0 111.319 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 96.7 mttt -61.56 -35.21 77.15 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.904 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.12 -38.31 82.08 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.548 HG21 HD13 ' X' ' 54' ' ' ILE . 23.2 mt -61.07 -43.73 96.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -34.97 73.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.81 -50.95 37.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -25.22 68.0 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.461 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -66.94 -55.41 14.71 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.254 1.022 . . . . 0.0 110.132 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 m -73.22 -21.43 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.75 -12.44 51.03 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.5 57.81 6.18 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.754 1.222 . . . . 0.0 110.982 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -78.17 -24.93 47.06 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.474 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 66.89 -64.31 0.24 Allowed 'General case' 0 C--O 1.205 -1.254 0 C-N-CA 126.043 1.737 . . . . 0.0 114.948 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.503 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.7 t70 -57.29 -57.09 14.14 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.252 0.478 . . . . 0.0 111.573 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -80.26 -30.7 12.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.35 -175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.22 -45.47 91.04 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.611 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.81 -36.55 83.81 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.317 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.503 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -57.31 -49.11 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 87.3 mt -67.99 -43.26 79.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.109 -173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 40.0 mt -59.24 -43.73 92.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 123.938 0.774 . . . . 0.0 110.991 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.12 -45.17 70.83 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.629 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.7 t60 -60.86 -45.7 93.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.018 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.594 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 58.8 t80 -58.65 -51.67 68.94 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.676 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.59 -34.11 66.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.3 ptmm? -71.86 -30.46 65.46 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.697 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.629 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.8 pt -84.1 -36.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.689 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -76.2 -42.57 45.8 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.524 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 61.5 30.23 18.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.922 1.289 . . . . 0.0 109.864 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -89.12 133.38 35.32 Favored Pre-proline 0 N--CA 1.415 -2.222 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.04 16.67 0.53 Allowed 'Trans proline' 0 CA--C 1.497 -1.352 0 C-N-CA 122.908 2.405 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.502 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 3.2 m-20 -142.99 23.06 1.9 Allowed 'General case' 0 N--CA 1.394 -3.255 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.594 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.16 -66.49 1.04 Allowed Glycine 0 CA--C 1.462 -3.255 0 O-C-N 124.724 1.265 . . . . 0.0 113.821 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.461 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -71.54 -26.03 62.47 Favored 'General case' 0 C--N 1.258 -3.4 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.842 -173.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.44 -38.3 90.55 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.675 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 96.5 mt -57.83 -46.51 84.64 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 124.202 0.939 . . . . 0.0 111.258 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.548 HD13 HG21 ' X' ' 22' ' ' ILE . 65.2 mt -67.14 -46.67 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.843 0.83 . . . . 0.0 109.891 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.23 -38.99 93.34 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.167 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.2 pt-20 -71.82 -36.45 70.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.012 176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.56 79.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.18 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.05 81.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.475 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.24 -43.58 77.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.824 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 77.6 mtp85 -67.53 -30.01 69.56 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.783 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.488 ' HA ' ' ND2' ' X' ' 64' ' ' ASN . . . -79.74 -31.09 41.01 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.647 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.92 86.42 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.582 0.706 . . . . 0.0 109.804 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.54 95.37 2.81 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' X' ' 61' ' ' ALA . 12.8 m120 -57.79 119.97 37.97 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 123.912 0.757 . . . . 0.0 111.33 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -0.5 10.21 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.641 2.227 . . . . 0.0 111.694 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.54 -128.85 1.15 Allowed Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.56 48.6 0.36 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.876 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -97.57 -31.38 12.34 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.07 86.67 0.21 Allowed Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.049 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' X' ' 61' ' ' ALA . . . -95.57 104.32 3.1 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.414 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 146.91 -176.86 25.57 Favored Glycine 0 N--CA 1.397 -3.911 0 C-N-CA 120.486 -0.864 . . . . 0.0 110.964 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.425 ' CG ' ' HG2' ' X' ' 20' ' ' LYS . 3.9 Cg_exo -46.53 -52.36 7.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 125.257 3.971 . . . . 0.0 114.101 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -76.84 1.54 17.13 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.7 -39.28 1.91 Allowed Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.062 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.574 ' O ' HG13 ' X' ' 79' ' ' ILE . 2.5 pt -60.87 -33.0 53.71 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-N 117.261 0.531 . . . . 0.0 111.097 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.616 HG11 HG12 ' X' ' 16' ' ' VAL . 9.7 m -59.16 -32.29 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.504 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 25.0 ttmm -67.9 -42.38 81.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.078 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.27 -43.25 99.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.574 HG13 ' O ' ' X' ' 75' ' ' ILE . 76.9 mt -64.74 -44.14 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.868 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 19.1 ptpt -66.85 -43.47 83.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.747 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 42.0 mt-10 -67.95 -32.01 72.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.86 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -66.9 -48.31 69.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.568 HH12 HD13 ' X' ' 7' ' ' ILE . 1.3 mpp_? -70.77 -37.36 73.37 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.8 92.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.788 0.68 . . . . 0.0 110.498 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.1 -26.33 56.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 111.513 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.573 ' ND2' ' HD3' ' X' ' 88' ' ' LYS . 4.5 t30 -77.33 -31.37 54.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.807 0.337 . . . . 0.0 110.578 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.55 40.06 5.14 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.573 ' HD3' ' ND2' ' X' ' 86' ' ' ASN . 12.7 mtpp -130.74 155.55 81.16 Favored Pre-proline 0 N--CA 1.416 -2.159 0 C-N-CA 123.504 0.722 . . . . 0.0 109.749 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.06 125.86 20.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.262 2.642 . . . . 0.0 112.586 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -106.7 -95.65 2.42 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.663 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.74 148.83 52.6 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.0 ptmt -85.04 164.9 17.95 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.64 136.24 36.29 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.66 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.254 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.461 ' CD2' HD13 ' X' ' 18' ' ' LEU . 40.1 mt -91.71 137.79 32.08 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -97.06 -159.44 0.74 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -116.88 -27.24 6.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.07 0.462 . . . . 0.0 110.487 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . 0.41 ' HA ' HG22 ' X' ' 44' ' ' ILE . 92.7 p -136.56 166.98 22.25 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.455 ' HB ' ' HB ' ' X' ' 44' ' ' ILE . 14.3 tt -67.3 -11.92 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 121.52 0.676 . . . . 0.0 110.618 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -75.37 -27.07 58.98 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.35 -170.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.62 -4.72 40.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.525 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -80.53 115.25 19.95 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.415 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 71.0 p -76.3 159.72 30.3 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 169.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.646 ' O ' HG13 ' X' ' 16' ' ' VAL . 9.7 pt-20 -60.26 -34.84 74.28 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.032 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.25 -37.94 75.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -58.55 -39.45 80.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.56 0.695 . . . . 0.0 109.416 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.515 ' HD2' HG12 ' X' ' 76' ' ' VAL . 42.5 t80 -71.8 -44.22 64.33 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.156 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.735 HG12 HG11 ' X' ' 76' ' ' VAL . 7.6 m -61.94 -37.16 77.58 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.442 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.405 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -49.16 78.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.848 0.859 . . . . 0.0 108.778 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.668 ' O ' HG13 ' X' ' 22' ' ' ILE . 16.9 tp -57.53 -48.04 80.38 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.055 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' X' ' 23' ' ' GLU . 8.1 mp -60.36 -40.25 90.1 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.707 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 80.9 mttt -63.41 -35.59 80.93 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.218 0.532 . . . . 0.0 110.034 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -69.43 -42.4 75.06 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.668 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.9 mt -61.23 -42.3 92.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.333 0 O-C-N 124.073 0.858 . . . . 0.0 109.645 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' X' ' 19' ' ' LEU . 51.7 mt-10 -57.33 -46.29 83.41 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.5 -51.8 67.9 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.681 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -79.38 -21.75 45.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.44 -46.05 64.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 97.8 t -69.35 -33.08 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 110.557 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.25 -6.44 59.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.389 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.44 83.65 0.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.135 1.774 . . . . 0.0 114.435 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 16.4 p -99.72 -172.67 2.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.15 -29.76 0.88 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.614 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.504 ' O ' HG23 ' X' ' 36' ' ' VAL . 28.1 m-20 -70.68 -62.31 1.44 Allowed 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.336 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.705 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.6 p -78.85 -27.34 13.67 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.941 -174.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.3 tm? -58.44 -47.07 85.18 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.212 1.005 . . . . 0.0 109.527 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.3 -28.19 62.93 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.504 HG23 ' O ' ' X' ' 32' ' ' ASP . 64.8 t -67.72 -50.72 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.977 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.506 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 51.6 mt -69.66 -43.99 71.44 Favored 'General case' 0 N--CA 1.412 -2.332 0 O-C-N 124.513 1.133 . . . . 0.0 111.711 -170.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.53 HD22 HG22 ' X' ' 51' ' ' THR . 28.4 mt -60.93 -46.41 90.81 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 124.233 0.958 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -70.74 -39.47 73.3 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.039 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.569 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.6 t60 -63.43 -45.44 90.94 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.245 0.545 . . . . 0.0 109.716 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 37.9 t80 -59.05 -53.46 58.18 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.665 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.409 HG12 ' O ' ' X' ' 38' ' ' LEU 0.252 11.9 p -68.08 -32.29 55.45 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.969 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 50.9 pttt -66.74 -32.83 74.38 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.192 -0.317 . . . . 0.0 111.595 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.498 HG12 ' O ' ' X' ' 40' ' ' HIS . 31.5 pt -88.27 -31.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.058 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 47.1 p -85.06 -35.25 21.98 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 120.93 0.395 . . . . 0.0 111.285 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.82 29.53 17.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 125.353 1.461 . . . . 0.0 110.778 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 32.1 t-80 -76.08 138.57 68.75 Favored Pre-proline 0 N--CA 1.429 -1.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 107.861 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.9 Cg_exo -74.26 -6.89 19.06 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 C-N-CA 123.146 2.564 . . . . 0.0 112.151 -176.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 29.9 m-20 -130.71 30.63 4.63 Favored 'General case' 0 N--CA 1.389 -3.477 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.581 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.51 -59.82 6.85 Favored Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.617 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.53 HG22 HD22 ' X' ' 38' ' ' LEU . 0.0 OUTLIER -76.97 -28.28 55.09 Favored 'General case' 0 C--N 1.248 -3.828 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.847 -176.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.614 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.74 -42.97 98.41 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.227 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.36 -49.23 76.83 Favored 'General case' 0 C--O 1.208 -1.085 0 O-C-N 123.525 0.515 . . . . 0.0 112.119 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.422 HD13 HG21 ' X' ' 22' ' ' ILE . 79.2 mt -67.74 -42.16 85.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.819 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.502 ' HD2' ' O ' ' X' ' 51' ' ' THR . 15.3 m-85 -60.21 -47.0 87.83 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.585 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 10.4 pt-20 -71.12 -36.43 72.12 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.687 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.42 85.1 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 123.305 0.378 . . . . 0.0 110.438 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.93 87.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.156 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.13 76.4 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.058 0.456 . . . . 0.0 111.314 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -68.18 -31.12 70.43 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.332 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.34 44.23 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.484 -0.135 . . . . 0.0 111.33 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.75 87.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.234 0.54 . . . . 0.0 109.624 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.6 84.01 2.21 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -88.34 120.17 70.4 Favored Pre-proline 0 CA--C 1.489 -1.38 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.847 -173.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.15 -16.73 9.61 Favored 'Trans proline' 0 N--CA 1.432 -2.13 0 C-N-CA 121.664 1.576 . . . . 0.0 112.786 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.47 117.61 3.0 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.882 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.7 -140.98 10.26 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -124.5 150.76 45.42 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.87 -48.77 0.94 Allowed Glycine 0 CA--C 1.469 -2.784 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.58 72.13 2.78 Favored Glycine 0 N--CA 1.416 -2.684 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.497 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 157.05 163.11 12.09 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.572 ' HG3' ' HG2' ' X' ' 20' ' ' LYS . 19.3 Cg_endo -61.96 -47.52 10.47 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.081 3.188 . . . . 0.0 112.825 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.518 ' HG2' HG11 ' X' ' 16' ' ' VAL . 43.2 mt-10 -77.37 1.24 19.53 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 -35.03 2.82 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 118.526 -1.797 . . . . 0.0 112.651 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.497 HG12 ' O ' ' X' ' 71' ' ' GLY . 3.6 pt -65.36 -29.38 47.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.761 173.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.735 HG11 HG12 ' X' ' 16' ' ' VAL . 19.6 m -63.38 -35.04 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.7 0 CA-C-O 121.407 0.622 . . . . 0.0 111.419 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.522 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 61.9 tttm -66.88 -39.26 87.45 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.151 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.13 -38.34 90.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.13 -46.56 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.256 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 18.0 ptpt -66.94 -39.98 87.45 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.816 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.61 -35.85 77.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.377 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.519 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.0 t90 -67.66 -48.05 67.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.629 0.728 . . . . 0.0 109.19 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.484 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 18.4 tpt180 -61.34 -45.75 93.1 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.219 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.65 83.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.66 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.96 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.26 0.35 . . . . 0.0 110.852 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.419 ' OD1' ' HE2' ' X' ' 88' ' ' LYS . 17.5 t-20 -69.08 -37.37 78.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.56 29.38 5.36 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.15 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.419 ' HE2' ' OD1' ' X' ' 86' ' ' ASN . 64.0 mttm -106.41 147.53 35.09 Favored Pre-proline 0 N--CA 1.401 -2.904 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.45 130.03 25.55 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.4 2.066 . . . . 0.0 110.751 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.88 -128.51 5.4 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.689 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -88.72 154.85 19.96 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.2 pttt -90.06 163.97 14.68 Favored 'General case' 0 N--CA 1.39 -3.464 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.49 141.18 29.27 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.276 -2.752 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 175.838 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.451 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 73.0 mt -94.14 128.61 40.66 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.492 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 35.0 mmtt -99.94 -178.77 3.95 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.376 0.607 . . . . 0.0 110.065 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -104.81 -13.67 15.78 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.47 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -142.73 160.04 41.07 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.1 tt -69.1 -22.89 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.378 0.608 . . . . 0.0 110.746 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 26.8 t -84.36 -2.91 57.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.384 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.492 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -98.67 -3.45 35.98 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.443 ' C ' ' HG2' ' X' ' 92' ' ' LYS . 5.9 m-85 -98.62 121.98 41.25 Favored 'General case' 0 CA--C 1.475 -1.941 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.949 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.626 ' O ' HG13 ' X' ' 16' ' ' VAL . 12.9 pt-20 -63.37 -33.79 76.31 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.829 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.436 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.77 -38.25 76.68 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.357 0.123 . . . . 0.0 110.998 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -59.1 -37.51 77.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.643 0.735 . . . . 0.0 109.477 173.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 33.6 t80 -74.27 -40.88 62.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.483 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.767 HG12 HG11 ' X' ' 76' ' ' VAL . 6.3 m -62.58 -32.08 54.17 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.214 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.16 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.05 -46.06 82.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.633 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -58.82 -44.33 90.84 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.799 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.8 mt -58.22 -40.24 81.13 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.197 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' X' ' 23' ' ' GLU . 95.7 mttt -70.22 -34.11 72.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.338 0.589 . . . . 0.0 110.224 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.82 -42.2 98.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.898 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.68 HG12 ' HB3' ' X' ' 37' ' ' LEU . 17.6 mt -65.13 -39.52 85.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.621 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 12.8 tt0 -57.24 -47.82 80.4 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 124.343 1.057 . . . . 0.0 108.459 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -47.92 81.49 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.146 -178.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.451 ' OE1' ' HB ' ' X' ' 33' ' ' VAL . 28.6 mm-40 -68.72 -31.7 70.95 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.2 -44.07 22.6 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.237 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.97 -25.86 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.51 -4.29 45.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 45.14 78.8 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.744 1.618 . . . . 0.0 112.987 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 81.8 p -99.58 -160.51 0.81 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.098 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.57 -63.51 0.67 Allowed 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.627 ' O ' HG23 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.64 -60.02 3.85 Favored 'General case' 0 CA--C 1.472 -2.053 0 O-C-N 123.718 0.637 . . . . 0.0 112.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 69.2 t -82.75 -25.9 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.186 -172.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.7 tm? -59.16 -46.94 87.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 31.0 t70 -66.72 -43.58 83.88 Favored 'General case' 0 CA--C 1.479 -1.766 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.001 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.627 HG23 ' O ' ' X' ' 32' ' ' ASP . 49.8 t -55.95 -50.23 70.46 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 O-C-N 124.114 0.884 . . . . 0.0 110.493 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.68 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.6 mt -69.23 -39.03 78.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 O-C-N 124.423 1.077 . . . . 0.0 112.123 -173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 10.3 mt -60.25 -50.18 74.66 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.0 0.813 . . . . 0.0 110.69 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 2.7 pt-20 -71.41 -33.79 69.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.529 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.519 ' O ' HG12 ' X' ' 44' ' ' ILE . 34.9 t60 -61.37 -45.89 92.47 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.533 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 69.6 t80 -60.7 -54.11 49.24 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.841 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.485 HG12 ' O ' ' X' ' 38' ' ' LEU . 4.8 p -67.22 -32.87 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.9 ptmm? -68.12 -42.43 80.24 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.82 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.519 HG12 ' O ' ' X' ' 40' ' ' HIS . 12.2 pt -77.1 -34.49 21.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.721 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.402 ' HA ' HD12 ' X' ' 7' ' ' ILE . 77.1 p -84.32 -39.19 19.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.459 -178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 58.81 74.81 0.42 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.537 1.16 . . . . 0.0 110.382 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CD2' HH22 ' X' ' 83' ' ' ARG . 33.7 t-80 -123.82 132.49 24.29 Favored Pre-proline 0 N--CA 1.405 -2.679 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.3 -18.59 55.7 Favored 'Trans proline' 0 CA--C 1.498 -1.304 0 C-N-CA 122.99 2.46 . . . . 0.0 111.885 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 15.3 m-20 -126.99 33.89 4.85 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -170.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.533 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.85 -55.81 7.06 Favored Glycine 0 CA--C 1.461 -3.288 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.866 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.493 HG22 HD22 ' X' ' 38' ' ' LEU 0.313 1.9 p -85.25 -17.19 37.73 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 117.208 -1.797 . . . . 0.0 113.618 -176.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.88 -35.52 80.28 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.35 -40.71 96.41 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 123.604 0.565 . . . . 0.0 110.937 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.427 HD13 HG21 ' X' ' 75' ' ' ILE . 17.9 mm -66.57 -46.27 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.796 0.808 . . . . 0.0 109.773 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -63.02 -43.39 98.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.415 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -71.39 -37.32 71.57 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.791 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.25 80.44 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 122.32 0.248 . . . . 0.0 111.347 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.25 -46.34 83.13 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.461 0.476 . . . . 0.0 110.49 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.25 -43.53 67.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.383 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' X' ' 65' ' ' PRO . 74.2 mtp180 -60.99 -34.18 74.38 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.133 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.78 -36.49 37.03 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.574 0.226 . . . . 0.0 111.488 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.6 84.42 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 109.976 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.36 -50.53 8.26 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.68 87.57 0.13 Allowed Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.404 1.482 . . . . 0.0 109.561 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 22.8 Cg_exo -64.27 -65.53 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.903 2.402 . . . . 0.0 113.096 -173.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 47.01 1.03 Allowed Glycine 0 CA--C 1.475 -2.424 0 C-N-CA 119.991 -1.099 . . . . 0.0 112.03 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.43 -82.85 1.14 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.246 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.7 120.83 22.41 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 122.92 0.488 . . . . 0.0 109.935 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.28 23.42 9.65 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.07 52.68 0.78 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.91 173.89 42.87 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.553 ' O ' HG13 ' X' ' 75' ' ' ILE . 9.6 Cg_endo -54.04 -34.59 78.19 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 124.457 3.438 . . . . 0.0 112.131 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.67 0.63 5.2 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.64 -10.78 28.23 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 118.836 -1.649 . . . . 0.0 113.248 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.553 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -74.15 -44.86 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.767 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -55.56 -43.07 71.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.266 175.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 21.7 ttmm -60.48 -47.63 85.31 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.869 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.81 -37.87 86.02 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.122 0.963 . . . . 0.0 108.592 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.497 ' HA ' HH21 ' X' ' 83' ' ' ARG . 36.2 mm -65.58 -45.75 91.53 Favored 'Isoleucine or valine' 0 C--O 1.254 1.304 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.086 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.6 ptpt -63.17 -37.68 88.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.282 0.364 . . . . 0.0 110.86 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 35.7 mt-10 -71.28 -43.91 66.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.422 ' HB3' ' NH2' ' X' ' 83' ' ' ARG . 59.6 t90 -62.96 -41.02 99.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' X' ' 79' ' ' ILE . 0.5 OUTLIER -61.94 -45.33 94.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.504 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -39.58 93.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.678 0.611 . . . . 0.0 111.324 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.79 82.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.45 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 23.1 t-20 -67.57 -46.96 71.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.721 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.26 22.87 5.7 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.45 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 61.3 mttm -102.02 144.73 29.16 Favored Pre-proline 0 N--CA 1.403 -2.815 0 C-N-CA 124.396 1.079 . . . . 0.0 108.114 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.15 132.76 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.697 1.598 . . . . 0.0 111.485 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -92.04 -117.81 2.33 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.038 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.41 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 54.6 m-85 -99.61 166.19 11.25 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' X' ' 10' ' ' TYR . 21.9 ptmt -94.62 174.43 7.12 Favored 'General case' 0 N--CA 1.387 -3.605 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -120.67 136.12 54.93 Favored 'General case' 0 N--CA 1.398 -3.043 0 CA-C-O 121.242 0.544 . . . . 0.0 110.659 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.737 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 121.606 0.717 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.47 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 78.3 mt -91.84 153.5 19.51 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.932 -176.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.634 ' HB2' ' CE2' ' X' ' 10' ' ' TYR . 10.9 mptt -120.56 -178.4 3.7 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.793 -175.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.97 -46.44 12.06 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.446 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 20.3 p -140.42 167.91 21.03 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.549 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' X' ' 44' ' ' ILE . 14.5 tt -61.59 -19.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.822 0.82 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.1 m -82.26 -5.01 58.24 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.717 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.631 ' HB3' ' CG ' ' X' ' 4' ' ' LYS . 3.5 t70 -105.42 3.6 29.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 4.8 m-85 -105.37 118.11 35.72 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.314 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 18.2 p -79.22 163.76 24.73 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.661 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.1 pt-20 -56.58 -42.17 78.2 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.002 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.52 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -69.86 -38.37 76.41 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 53.4 mm-40 -60.89 -36.35 79.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.74 0.781 . . . . 0.0 109.213 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 41.7 t80 -75.26 -42.92 53.99 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.517 -177.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.792 HG12 HG11 ' X' ' 76' ' ' VAL . 10.2 m -58.43 -33.61 48.42 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 O-C-N 123.215 0.322 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.69 -49.37 77.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.675 1.19 . . . . 0.0 110.171 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.512 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.5 tm? -61.77 -42.91 99.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.117 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -61.3 -42.66 99.02 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.366 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.0 mttt -63.87 -35.93 82.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.318 0.58 . . . . 0.0 109.975 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -67.56 -34.92 78.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' X' ' 37' ' ' LEU . 25.5 mt -66.22 -42.25 90.69 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.402 ' OE2' ' HD3' ' X' ' 72' ' ' PRO . 51.1 mt-10 -57.17 -37.32 71.93 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.927 0.87 . . . . 0.0 110.666 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.1 -52.38 55.81 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.941 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 1.7 pp20? -97.61 -11.42 23.64 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 118.83 -1.148 . . . . 0.0 113.482 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.61 -38.06 83.48 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.074 0.464 . . . . 0.0 110.948 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.93 -20.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.302 0.572 . . . . 0.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -39.79 13.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.495 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.86 75.93 0.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.0 1.72 . . . . 0.0 109.768 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.425 HG23 ' HB2' ' X' ' 25' ' ' GLU . 49.2 p -78.75 -21.34 48.1 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.351 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 t70 72.99 -48.54 0.69 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.475 1.51 . . . . 0.0 112.297 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.491 ' O ' HG23 ' X' ' 36' ' ' VAL . 21.1 t70 -63.07 -52.55 62.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.727 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 15.0 p -94.01 -25.26 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.857 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.653 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 2.4 tm? -58.02 -46.58 85.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.647 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 35.2 t70 -63.03 -42.5 99.79 Favored 'General case' 0 CA--C 1.473 -1.987 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.016 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.491 HG23 ' O ' ' X' ' 32' ' ' ASP . 39.2 t -61.55 -49.54 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 O-C-N 124.65 1.219 . . . . 0.0 110.837 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.7 mt -65.97 -43.68 87.15 Favored 'General case' 0 N--CA 1.415 -2.223 0 O-C-N 124.13 0.894 . . . . 0.0 110.362 -173.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.561 ' O ' HG12 ' X' ' 42' ' ' VAL . 32.4 mt -63.14 -50.65 69.58 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.73 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 16.7 pt-20 -71.76 -37.37 70.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.31 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.499 ' O ' HG12 ' X' ' 44' ' ' ILE . 8.9 t60 -59.89 -44.85 93.98 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.492 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 28.8 t80 -62.09 -56.93 13.96 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.438 1.086 . . . . 0.0 111.65 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.561 HG12 ' O ' ' X' ' 38' ' ' LEU 0.266 8.9 p -67.36 -31.18 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -67.6 -30.37 69.95 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.663 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.499 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.1 pt -91.4 -32.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.567 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -81.62 -36.8 28.5 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.315 0.578 . . . . 0.0 110.107 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.61 26.98 16.55 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.497 1.519 . . . . 0.0 111.022 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.0 130.74 80.23 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -67.19 -14.57 43.64 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 123.226 2.617 . . . . 0.0 112.745 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 36.8 m-20 -126.04 32.46 5.24 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -173.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.15 -54.55 8.28 Favored Glycine 0 CA--C 1.457 -3.548 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.576 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.55 HG23 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -33.34 59.59 Favored 'General case' 0 C--N 1.257 -3.436 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.639 -172.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.35 -36.11 77.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.409 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 mt -58.02 -43.14 86.56 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.44 ' H ' HD12 ' X' ' 54' ' ' ILE . 5.0 mp -66.79 -41.42 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -63.18 -50.27 70.99 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.6 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.1 pt-20 -66.62 -36.61 83.02 Favored 'General case' 0 C--O 1.206 -1.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.199 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . 0.426 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . -57.78 -39.83 78.4 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 123.219 0.324 . . . . 0.0 110.63 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.87 91.74 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.491 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.41 -42.6 74.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.222 0.534 . . . . 0.0 110.221 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.632 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 72.5 mtp180 -61.22 -35.79 78.15 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.225 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.29 -39.57 28.53 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.57 64.97 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.45 -13.35 23.18 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.513 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 11.0 m120 41.3 75.14 0.64 Allowed Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.98 -27.35 25.5 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 169.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.41 150.09 20.96 Favored Glycine 0 N--CA 1.399 -3.812 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.36 -20.14 75.41 Favored Glycine 0 C--N 1.304 -1.225 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.77 112.17 3.11 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 124.099 0.96 . . . . 0.0 109.726 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . 0.632 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 84.7 5.54 86.46 Favored Glycine 0 CA--C 1.498 -0.98 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.32 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.16 70.14 3.05 Favored Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.54 -178.73 20.81 Favored Glycine 0 N--CA 1.399 -3.801 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.792 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.59 ' O ' HG13 ' X' ' 76' ' ' VAL . 32.5 Cg_endo -66.45 -41.0 12.77 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 124.617 3.544 . . . . 0.0 112.313 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.5 ' HG2' HG11 ' X' ' 16' ' ' VAL . 35.1 mt-10 -84.69 2.02 43.74 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.386 0.675 . . . . 0.0 110.182 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -104.79 -35.78 3.16 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.89 172.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.489 ' CD1' HD13 ' X' ' 19' ' ' LEU . 4.0 pt -64.78 -22.72 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-N 117.712 0.756 . . . . 0.0 111.582 173.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.792 HG11 HG12 ' X' ' 16' ' ' VAL . 30.7 m -63.06 -39.21 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-O 121.601 0.715 . . . . 0.0 110.534 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 52.2 tttp -64.12 -42.69 96.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.691 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 39.7 mm-40 -58.3 -45.34 88.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.85 0.833 . . . . 0.0 109.526 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.2 mm -64.46 -46.79 91.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.009 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 13.5 ptmm? -67.87 -36.32 80.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.761 -174.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.0 -36.69 69.82 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.141 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.519 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.4 t90 -62.97 -48.1 80.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 18.0 tpt180 -65.89 -45.89 80.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.913 -174.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.75 -40.93 79.57 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 122.853 0.461 . . . . 0.0 112.064 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.13 82.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.084 0.469 . . . . 0.0 109.962 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.09 -21.74 56.36 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.3 42.78 9.06 Favored Glycine 0 CA--C 1.498 -0.993 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.012 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 23.9 mtpp -122.44 144.35 41.86 Favored Pre-proline 0 N--CA 1.393 -3.289 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.93 127.69 20.1 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 122.803 2.336 . . . . 0.0 111.543 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.62 -110.08 3.12 Favored Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.578 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.56 161.67 20.1 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.093 0.473 . . . . 0.0 110.687 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' X' ' 11' ' ' THR . 21.3 ptmt -108.26 171.69 7.26 Favored 'General case' 0 N--CA 1.393 -3.305 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -106.93 140.93 38.95 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.498 0 CA-C-O 118.083 -1.399 . . . . 0.0 110.149 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.462 HD22 HD13 ' X' ' 18' ' ' LEU . 48.8 mt -90.79 148.38 22.57 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.483 -174.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 25.1 mmtt -99.62 -160.34 0.8 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -117.7 -19.68 9.22 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.042 -0.411 . . . . 0.0 110.852 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 83.4 p -135.8 160.87 37.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.06 -21.92 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.613 0.765 . . . . 0.0 110.279 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 23.7 m -85.64 -1.75 57.47 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.448 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 25.6 t0 -101.67 -0.11 35.18 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.74 123.63 46.04 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.216 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.526 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 70.6 p -78.18 172.11 14.05 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.569 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.0 pt-20 -56.33 -45.09 80.5 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.169 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.47 ' O ' HG22 ' X' ' 16' ' ' VAL . . . -70.44 -37.85 74.44 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' X' ' 11' ' ' THR . 5.3 mm-40 -57.8 -35.94 71.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.385 0.612 . . . . 0.0 110.227 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.657 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 30.1 t80 -75.67 -40.51 55.86 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.9 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.698 HG12 HG11 ' X' ' 76' ' ' VAL . 4.3 m -62.92 -28.99 46.08 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.923 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.505 ' O ' ' HG2' ' X' ' 21' ' ' GLU . 0.9 OUTLIER -57.63 -48.79 78.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.613 ' O ' HG13 ' X' ' 22' ' ' ILE . 20.3 tp -61.81 -46.99 87.14 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 121.196 0.522 . . . . 0.0 110.655 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 37.2 mt -57.94 -36.88 73.13 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.924 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 95.9 mttt -70.78 -33.97 71.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.128 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' X' ' 17' ' ' GLN . 8.7 mm-40 -67.37 -43.27 81.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.614 HG12 ' HB3' ' X' ' 37' ' ' LEU . 35.5 mt -58.81 -42.2 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.095 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.22 -47.84 82.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.695 1.198 . . . . 0.0 110.165 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.92 -52.1 58.28 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.73 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -17.19 64.13 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.426 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.53 -38.45 14.92 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.121 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.25 -33.25 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.214 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.83 -26.26 37.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 77.27 0.31 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.326 1.451 . . . . 0.0 112.913 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.9 p -98.55 -177.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.2 -56.09 1.44 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.887 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.641 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.2 p-10 -57.68 -55.7 31.42 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 123.535 0.522 . . . . 0.0 111.921 -175.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -81.33 -32.52 12.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.375 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.27 -45.81 90.22 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.154 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.76 -24.61 60.97 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.207 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.641 HG23 ' O ' ' X' ' 32' ' ' ASP . 88.7 t -61.01 -49.1 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.187 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 65.4 mt -68.11 -43.05 79.28 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.962 -173.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.1 mt -58.87 -46.57 87.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.292 0.995 . . . . 0.0 110.597 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.85 -40.93 72.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.087 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 63.9 t60 -62.4 -45.56 92.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.393 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.8 t80 -58.27 -51.73 68.53 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.752 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.458 HG23 ' HA3' ' X' ' 50' ' ' GLY . 15.0 p -67.86 -32.85 58.23 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.9 ptmt -68.96 -33.44 73.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 122.046 -0.409 . . . . 0.0 111.897 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.505 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.1 pt -85.13 -32.49 7.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.734 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 73.9 p -84.97 -33.62 22.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 56.8 33.59 23.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.664 1.186 . . . . 0.0 110.274 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.415 ' CE1' HD11 ' X' ' 53' ' ' LEU . 41.3 t-80 -80.61 134.46 54.19 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.225 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.464 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.4 Cg_exo -67.77 -12.18 34.59 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 123.18 2.587 . . . . 0.0 112.437 -175.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -130.24 28.56 4.98 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.581 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.68 -62.59 2.84 Favored Glycine 1 CA--C 1.449 -4.049 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.741 -175.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -77.64 -23.99 49.59 Favored 'General case' 0 C--N 1.249 -3.774 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.24 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.0 -34.95 78.66 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.03 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' X' ' 47' ' ' HIS . 34.8 mt -62.91 -37.67 87.91 Favored 'General case' 0 CA--C 1.486 -1.493 0 O-C-N 123.362 0.414 . . . . 0.0 110.711 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.2 mt -66.46 -44.03 90.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.86 -44.62 95.63 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.261 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.7 pt-20 -68.52 -46.43 69.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.364 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.16 94.19 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.224 0.328 . . . . 0.0 111.456 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.32 94.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.218 0.323 . . . . 0.0 111.551 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.46 84.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.74 0.781 . . . . 0.0 110.016 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 96.8 mtt180 -67.37 -29.23 68.7 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.414 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.451 ' HB2' ' HA2' ' X' ' 71' ' ' GLY . . . -79.32 -37.5 37.48 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 176.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.92 83.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 110.035 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' X' ' 65' ' ' PRO . . . -117.64 85.94 2.43 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 28.4 t-20 -78.66 114.66 45.42 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' X' ' 63' ' ' ALA . 30.0 Cg_endo -104.11 27.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.941 2.427 . . . . 0.0 109.889 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.08 -84.57 0.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -169.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.71 -177.09 52.1 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.047 -0.576 . . . . 0.0 114.314 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.35 -53.3 2.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.72 75.95 0.3 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 108.184 -1.967 . . . . 0.0 108.184 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.4 42.76 1.86 Allowed Glycine 0 CA--C 1.49 -1.494 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.403 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' X' ' 61' ' ' ALA . . . 168.09 169.67 31.86 Favored Glycine 0 N--CA 1.397 -3.904 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.507 ' O ' HG13 ' X' ' 75' ' ' ILE . 10.2 Cg_endo -57.81 -40.92 74.87 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.449 2.766 . . . . 0.0 111.785 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -74.12 0.75 12.9 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.137 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.59 -17.67 10.3 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.807 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.507 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -68.04 -41.96 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.698 HG11 HG12 ' X' ' 16' ' ' VAL . 1.0 OUTLIER -56.43 -44.6 80.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.714 177.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 23.1 ttpp -57.98 -47.74 82.08 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.338 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.3 -36.24 73.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.456 0.646 . . . . 0.0 109.657 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.8 -45.81 71.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.369 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 19.2 pttp -64.32 -35.5 81.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.923 0.392 . . . . 0.0 110.48 -176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 49.5 mt-10 -69.22 -39.35 78.63 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.464 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -67.96 -47.29 69.02 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 17.7 tpt180 -60.9 -45.28 95.24 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.296 -174.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.6 83.27 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.011 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.31 -33.73 75.89 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.502 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.15 -46.77 48.99 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.42 41.93 1.31 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 62.1 mttm -117.62 144.79 34.95 Favored Pre-proline 0 N--CA 1.399 -3.017 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.06 124.74 13.47 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 121.991 1.794 . . . . 0.0 109.862 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.55 -121.43 3.48 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.179 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -83.03 161.38 21.72 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.544 -0.828 . . . . 0.0 109.974 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.0 ptmt -87.59 167.62 13.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.21 132.03 48.39 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.116 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 178.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.482 ' CD2' HD13 ' X' ' 18' ' ' LEU . 53.5 mt -90.49 146.34 24.19 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.7 mmtt -110.22 148.43 31.87 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' X' ' 5' ' ' ASN . 0.9 OUTLIER -84.44 -1.21 55.27 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.021 -176.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 53.0 p -147.08 158.46 43.94 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.8 tp -73.03 -12.41 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.241 0.543 . . . . 0.0 111.615 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.27 -14.27 60.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.421 0.629 . . . . 0.0 111.386 -173.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.2 t70 -105.28 5.26 31.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -100.18 121.51 41.55 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.737 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.514 HG22 ' HG3' ' X' ' 92' ' ' LYS . 29.8 p -83.57 165.33 19.15 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.622 ' O ' HG13 ' X' ' 16' ' ' VAL . 3.3 pt-20 -56.07 -43.62 78.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.346 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.97 -37.31 75.73 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.451 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 17.4 mm-40 -56.83 -39.73 74.75 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.65 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 16.9 t80 -72.81 -43.21 62.99 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.639 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.767 HG12 HG11 ' X' ' 76' ' ' VAL . 4.3 m -62.74 -29.03 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.89 -44.91 88.09 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.583 ' O ' HG13 ' X' ' 22' ' ' ILE . 27.5 tp -61.42 -46.23 91.01 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.546 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 36.0 mt -57.24 -41.45 79.6 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.678 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 65.6 mttm -63.58 -35.84 81.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.664 175.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.08 -31.42 50.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.452 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' X' ' 37' ' ' LEU . 27.4 mt -62.27 -41.86 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -58.56 -40.62 83.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -60.4 -41.84 94.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.71 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -80.21 -32.19 38.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.292 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -61.16 -52.75 63.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.051 0.54 . . . . 0.0 111.646 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -65.91 -27.3 40.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.27 -20.96 26.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.73 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.69 61.57 2.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.737 1.215 . . . . 0.0 111.887 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.9 p -88.21 -164.8 1.17 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.359 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -134.2 -50.89 0.82 Allowed 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.998 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.551 ' O ' HG23 ' X' ' 36' ' ' VAL . 4.4 m-20 -53.29 -63.06 1.27 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.642 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 90.5 t -85.93 -27.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.052 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.451 -173.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.8 tm? -58.85 -43.29 90.74 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.5 t70 -68.18 -42.06 80.52 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.118 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.551 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.1 t -57.54 -50.23 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.983 0 O-C-N 124.058 0.849 . . . . 0.0 110.27 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' X' ' 22' ' ' ILE . 75.8 mt -67.98 -40.31 83.15 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.091 -170.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 26.5 mt -64.08 -49.13 73.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 O-C-N 124.328 1.017 . . . . 0.0 111.498 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.21 -36.68 71.96 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.5 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.549 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 77.6 t60 -60.82 -45.93 92.53 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.579 ' CD2' HD11 ' X' ' 54' ' ' ILE . 56.5 t80 -57.51 -53.63 55.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.778 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.498 HG12 ' O ' ' X' ' 38' ' ' LEU 0.264 4.6 p -67.14 -31.79 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 17.5 ptmt -71.4 -30.03 65.62 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.851 -0.53 . . . . 0.0 112.369 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.524 HG12 ' O ' ' X' ' 40' ' ' HIS . 13.0 pt -88.96 -35.94 8.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.098 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.461 ' HB ' HD12 ' X' ' 79' ' ' ILE . 77.1 p -82.64 -36.91 25.61 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.133 0.492 . . . . 0.0 110.597 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 64.22 31.22 13.25 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.466 1.507 . . . . 0.0 111.404 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.433 ' O ' HG23 ' X' ' 42' ' ' VAL . 43.7 t-80 -80.88 139.17 49.9 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.465 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.8 Cg_exo -70.94 -18.94 31.07 Favored 'Trans proline' 0 CA--C 1.491 -1.63 0 C-N-CA 122.859 2.372 . . . . 0.0 112.454 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.414 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 7.6 m-20 -125.1 35.76 4.71 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.492 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -49.6 -52.74 23.6 Favored Glycine 1 CA--C 1.447 -4.208 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.857 -177.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.445 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.66 -32.06 57.72 Favored 'General case' 0 C--N 1.248 -3.839 0 C-N-CA 118.498 -1.281 . . . . 0.0 110.791 -172.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.59 -33.99 74.84 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.258 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.01 -43.23 91.53 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.579 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.8 mp -67.2 -42.43 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.708 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -62.61 -46.13 89.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.686 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.1 pt-20 -71.57 -38.49 70.94 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.46 176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.74 76.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.832 0.287 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.78 84.19 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.687 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.77 -40.07 76.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.08 0.466 . . . . 0.0 110.358 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.503 ' NH2' ' HA3' ' X' ' 69' ' ' GLY . 67.8 mtp180 -62.86 -30.33 71.42 Favored 'General case' 0 C--O 1.207 -1.182 0 C-N-CA 123.691 0.796 . . . . 0.0 110.846 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.548 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -80.64 -46.18 16.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.18 -43.49 78.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.155 0.582 . . . . 0.0 110.63 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.43 86.86 2.43 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.07 121.72 77.34 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.239 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 7.71 3.53 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.385 2.723 . . . . 0.0 113.245 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.42 57.04 1.7 Allowed Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.24 174.77 37.03 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.522 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.27 168.21 13.4 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . 0.503 ' HA3' ' NH2' ' X' ' 60' ' ' ARG . . . 92.28 10.21 61.09 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.04 113.25 4.38 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.548 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 102.18 -179.81 27.26 Favored Glycine 0 N--CA 1.407 -3.252 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.213 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.453 ' O ' HG13 ' X' ' 75' ' ' ILE . 26.1 Cg_endo -64.51 -39.53 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.591 2.861 . . . . 0.0 111.974 -174.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.33 0.86 20.69 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.77 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.03 -20.97 8.01 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 119.196 -1.478 . . . . 0.0 113.027 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.453 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.7 OUTLIER -63.07 -46.34 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.767 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -56.49 -46.96 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.86 177.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' X' ' 81' ' ' GLU . 65.7 tttm -58.88 -48.2 82.25 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.632 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -58.46 -37.73 76.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' X' ' 45' ' ' THR . 38.6 mm -68.87 -46.83 78.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.765 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -66.81 -36.37 82.21 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.578 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' X' ' 77' ' ' LYS . 47.8 mt-10 -72.42 -34.55 67.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.866 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.465 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 89.7 t90 -69.14 -46.15 68.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.57 . . . . 0.0 110.09 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -67.84 -35.99 79.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.065 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.598 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.58 81.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.762 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' X' ' 88' ' ' LYS . 25.7 t-20 -67.0 -41.25 87.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 46.77 4.58 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 106.607 -2.597 . . . . 0.0 106.607 -169.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.481 ' HB2' ' OD1' ' X' ' 86' ' ' ASN . 22.9 ttmm -121.33 135.57 25.11 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.54 114.87 2.14 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.348 2.699 . . . . 0.0 112.347 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.52 -116.14 3.78 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.805 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -86.51 155.01 20.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' X' ' 11' ' ' THR . 20.9 ptmt -91.42 -175.65 4.29 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.87 144.18 32.97 Favored 'General case' 0 N--CA 1.399 -2.994 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.153 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.048 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.51 -0.573 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.433 HD22 HD13 ' X' ' 18' ' ' LEU . 35.3 mt -91.74 128.61 37.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 30.8 mmtt -96.92 -176.2 3.49 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.514 0.673 . . . . 0.0 111.96 -173.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.7 -36.18 11.84 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 61.6 p -135.12 166.68 22.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.323 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -68.83 -16.52 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.446 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -69.98 -25.66 63.72 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.573 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 16.0 t0 -94.93 -15.65 23.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -75.64 119.17 19.31 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.464 ' HA ' ' CB ' ' X' ' 92' ' ' LYS . 51.8 p -78.31 167.28 21.59 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.601 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.7 pt-20 -57.75 -41.01 81.04 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.981 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.68 -37.63 76.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.16 -37.72 83.89 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.581 -0.699 . . . . 0.0 110.264 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.533 ' HD2' HG12 ' X' ' 76' ' ' VAL . 33.5 t80 -71.81 -44.51 63.81 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.557 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.723 HG12 HG11 ' X' ' 76' ' ' VAL . 9.9 m -60.5 -35.86 65.99 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -49.78 76.33 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.231 1.012 . . . . 0.0 110.142 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.654 ' O ' HG13 ' X' ' 22' ' ' ILE . 28.4 tp -58.03 -47.16 83.94 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.584 0.707 . . . . 0.0 110.118 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.529 HD13 ' O ' ' X' ' 15' ' ' PHE . 8.1 mp -60.95 -37.0 80.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.169 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 52.9 mtmt -66.5 -35.43 80.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -65.6 -45.07 84.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.825 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.654 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.4 mt -55.92 -39.58 57.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.436 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -57.26 -47.33 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.087 0.47 . . . . 0.0 110.761 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.25 -51.56 43.85 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.612 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -23.25 67.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.305 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -71.6 -55.95 6.8 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.12 -20.77 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.46 -19.73 22.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.63 0.252 . . . . 0.0 110.553 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.6 64.37 1.77 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.275 1.03 . . . . 0.0 111.071 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 51.4 p -77.21 -26.23 52.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.369 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.26 22.9 t70 74.36 -68.5 0.21 Allowed 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 125.806 1.643 . . . . 0.0 115.076 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.606 ' O ' HG23 ' X' ' 36' ' ' VAL . 30.2 t70 -57.19 -55.9 28.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.093 0.86 . . . . 0.0 112.284 -174.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.811 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -78.32 -32.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.507 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.869 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.1 tm? -59.02 -45.89 89.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 33.3 t70 -65.01 -40.48 94.98 Favored 'General case' 0 CA--C 1.479 -1.788 0 O-C-N 123.369 0.418 . . . . 0.0 110.668 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.606 HG23 ' O ' ' X' ' 32' ' ' ASP . 98.3 t -54.62 -49.57 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.921 0 O-C-N 124.412 1.07 . . . . 0.0 109.193 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.811 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 54.9 mt -67.48 -41.05 85.2 Favored 'General case' 0 N--CA 1.405 -2.694 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.259 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.8 mt -60.57 -50.82 71.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.22 0.95 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 5.6 pt-20 -71.65 -36.66 70.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.437 ' O ' HG12 ' X' ' 44' ' ' ILE . 6.5 t60 -59.99 -46.15 90.4 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.609 ' O ' HG22 ' X' ' 45' ' ' THR . 57.4 t80 -59.94 -56.71 18.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.573 1.171 . . . . 0.0 110.948 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.438 HG12 ' O ' ' X' ' 38' ' ' LEU 0.271 8.4 p -66.62 -31.88 55.52 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.771 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -70.25 -28.33 65.16 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.811 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.437 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.7 pt -87.51 -39.0 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.653 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.609 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.2 t -84.77 -32.78 23.23 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.093 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.01 22.6 13.55 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.414 . . . . 0.0 112.306 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.488 ' H ' HG23 ' X' ' 45' ' ' THR . 55.3 t-80 -70.21 135.22 86.97 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.594 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.3 Cg_exo -70.22 4.52 2.34 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 123.527 2.818 . . . . 0.0 112.864 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' X' ' 53' ' ' LEU . 27.9 m-20 -136.83 27.25 2.99 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.489 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.17 -58.05 5.26 Favored Glycine 0 CA--C 1.476 -2.387 0 O-C-N 124.511 1.132 . . . . 0.0 113.199 -175.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.51 HG21 HD13 ' X' ' 38' ' ' LEU 0.276 0.0 OUTLIER -79.34 -25.61 42.25 Favored 'General case' 0 C--N 1.257 -3.427 0 C-N-CA 118.059 -1.456 . . . . 0.0 113.65 -176.813 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -64.16 -37.31 87.0 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' X' ' 49' ' ' ASP . 65.2 mt -64.76 -37.86 89.02 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.676 0.61 . . . . 0.0 111.249 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.429 HD13 HG21 ' X' ' 22' ' ' ILE . 25.3 mt -66.78 -46.33 85.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.735 0.779 . . . . 0.0 109.461 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.455 ' HD2' ' O ' ' X' ' 51' ' ' THR . 31.8 m-85 -63.45 -46.74 84.88 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -64.24 -40.08 95.28 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.76 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . -58.79 -51.04 71.69 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 123.116 0.26 . . . . 0.0 111.387 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.37 80.28 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.733 0.646 . . . . 0.0 111.405 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -44.04 65.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.59 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.31 -38.13 81.28 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.74 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HA2' ' X' ' 71' ' ' GLY . . . -72.08 -25.95 61.97 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 122.974 0.509 . . . . 0.0 111.808 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.02 -22.86 66.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.111 0.481 . . . . 0.0 110.878 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.21 -39.15 6.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 63.94 87.98 0.12 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.885 1.674 . . . . 0.0 113.135 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.48 -18.1 6.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.655 2.237 . . . . 0.0 111.261 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.32 169.54 41.77 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.09 83.93 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.01 138.76 42.43 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -58.51 2.72 Favored Glycine 0 C--O 1.242 0.616 0 CA-C-N 116.205 -0.452 . . . . 0.0 113.837 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.2 62.03 4.56 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' X' ' 61' ' ' ALA . . . 164.0 161.65 13.53 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.559 ' O ' HG13 ' X' ' 76' ' ' VAL . 7.9 Cg_endo -57.02 -42.01 68.84 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.632 2.888 . . . . 0.0 110.623 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.527 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.6 mt-10 -78.35 1.93 20.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.205 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.17 -34.86 2.84 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 119.021 -1.561 . . . . 0.0 112.948 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' X' ' 57' ' ' ALA . 1.1 pt -67.2 -26.18 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-N 117.503 0.652 . . . . 0.0 110.765 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.723 HG11 HG12 ' X' ' 16' ' ' VAL . 27.8 m -61.4 -34.44 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.141 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 60.6 tttm -61.79 -47.02 87.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.504 174.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.8 -43.71 90.6 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.567 0.699 . . . . 0.0 109.415 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.525 HG23 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -64.8 -46.54 91.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.22 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.519 ' HB3' ' CE2' ' X' ' 91' ' ' PHE . 17.4 pttp -67.44 -37.08 82.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.312 -174.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.92 -39.46 72.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.33 0.394 . . . . 0.0 111.35 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.594 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 70.4 t90 -64.79 -47.83 76.66 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.7 0.625 . . . . 0.0 109.443 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.616 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 16.2 tpt180 -61.45 -45.67 93.3 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.223 -176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.69 -38.73 84.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.232 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.9 78.5 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.903 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -69.02 -36.16 77.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.8 41.94 2.78 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.616 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 55.7 mttm -118.97 147.96 43.62 Favored Pre-proline 0 N--CA 1.396 -3.172 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.79 130.17 32.02 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.229 1.952 . . . . 0.0 111.071 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.444 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -100.09 -140.63 11.49 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.302 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 15.1 m-85 -78.29 150.45 33.33 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.047 0.451 . . . . 0.0 110.945 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.464 ' CB ' ' HA ' ' X' ' 11' ' ' THR . 0.7 OUTLIER -72.72 157.37 37.65 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.979 174.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -85.46 1.16 49.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.004 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.261 -3.62 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.212 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 CA--C 1.506 -0.736 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt -123.12 148.29 45.85 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 33.0 mmtt -108.72 160.31 16.05 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.0 -17.38 43.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.679 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 6.7 p -139.7 163.84 31.53 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.112 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 9.6 tp -64.92 -22.61 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.047 0.939 . . . . 0.0 110.023 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -76.32 -11.61 59.93 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.789 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 26.6 t0 -105.31 -7.17 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.882 0.849 . . . . 0.0 108.914 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -83.59 115.33 22.08 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.947 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 16.3 p -76.77 169.02 19.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.86 -33.58 73.29 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 119.676 1.125 . . . . 0.0 112.173 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -44.07 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.381 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -57.22 -41.65 79.88 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.414 0.626 . . . . 0.0 109.949 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 24.3 t80 -65.75 -55.55 16.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.53 ' HA ' ' HB2' ' X' ' 19' ' ' LEU . 14.7 p -63.63 -27.79 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -60.77 -47.38 86.57 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.473 HD21 HD22 ' X' ' 37' ' ' LEU . 2.3 tm? -62.61 -40.79 98.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.123 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 21.9 mt -57.78 -43.8 85.81 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.787 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -61.32 -38.74 87.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.531 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.45 -31.64 70.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.594 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.457 HG13 ' O ' ' X' ' 18' ' ' LEU . 35.1 mt -66.68 -46.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -57.72 -34.53 69.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.807 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.28 -40.69 96.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.42 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -88.57 -30.27 19.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.735 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -50.38 -47.61 56.15 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.81 1.244 . . . . 0.0 111.706 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -69.95 -17.14 20.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -105.52 -19.54 13.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.635 0.255 . . . . 0.0 110.565 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.52 87.64 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.436 1.495 . . . . 0.0 110.73 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 40.2 p -95.26 -164.62 1.18 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -135.48 -42.33 0.7 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.417 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.695 ' O ' HG23 ' X' ' 36' ' ' VAL . 13.8 t70 -71.1 -62.02 1.55 Allowed 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.527 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.673 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 8.3 p -75.8 -27.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.228 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.514 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 2.8 tm? -57.64 -52.84 63.77 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 124.258 1.023 . . . . 0.0 108.565 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.63 -25.51 60.34 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.294 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.695 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.3 t -68.5 -50.74 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.037 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.623 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.1 mt -68.87 -43.36 75.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 O-C-N 124.744 1.278 . . . . 0.0 111.36 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 34.6 mt -61.14 -44.83 96.72 Favored 'General case' 0 N--CA 1.415 -2.191 0 O-C-N 124.274 0.984 . . . . 0.0 112.054 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -71.05 -42.95 68.79 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.782 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.521 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 26.5 t60 -60.22 -45.92 91.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.47 -175.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' X' ' 54' ' ' ILE . 34.2 t80 -62.77 -48.36 79.51 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.419 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.1 p -67.52 -31.23 51.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 52.2 pttt -73.11 -35.08 66.5 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.599 ' O ' ' HB ' ' X' ' 7' ' ' ILE . 21.7 pt -79.03 -32.46 15.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -83.55 -33.9 25.35 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.843 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.9 28.27 17.24 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.091 0.948 . . . . 0.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.499 ' ND1' ' HB2' ' X' ' 49' ' ' ASP . 54.8 t-80 -85.89 145.82 42.01 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.516 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.572 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.5 Cg_exo -77.48 12.97 1.71 Allowed 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.342 2.694 . . . . 0.0 112.643 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.499 ' HB2' ' ND1' ' X' ' 47' ' ' HIS . 0.8 OUTLIER -123.86 -64.38 1.15 Allowed 'General case' 0 N--CA 1.404 -2.743 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.539 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . 58.42 -84.33 0.01 OUTLIER Glycine 1 CA--C 1.428 -5.361 0 O-C-N 125.337 1.648 . . . . 0.0 111.997 177.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.42 HG23 HD22 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.4 -37.27 74.45 Favored 'General case' 1 C--N 1.211 -5.44 0 CA-C-N 112.698 -1.751 . . . . 0.0 109.239 -172.138 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.07 -31.08 70.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.071 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.36 -42.19 96.32 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.423 0.452 . . . . 0.0 111.82 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' X' ' 41' ' ' PHE . 5.0 mp -67.27 -42.0 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.096 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -61.88 -41.86 98.38 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.81 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 4.8 pt-20 -71.74 -37.12 70.61 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.876 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.23 77.62 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 122.943 0.497 . . . . 0.0 111.281 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' X' ' 61' ' ' ALA . . . -62.16 -37.81 86.64 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.332 0.395 . . . . 0.0 111.333 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.19 62.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.797 0.808 . . . . 0.0 109.641 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -61.0 -27.96 68.69 Favored 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.853 1.261 . . . . 0.0 110.404 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' X' ' 58' ' ' ALA . . . -66.25 -48.12 71.52 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.308 0.643 . . . . 0.0 110.74 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.13 -50.09 62.61 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.673 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.05 71.35 1.12 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' X' ' 65' ' ' PRO . 7.6 p30 -83.42 121.35 76.63 Favored Pre-proline 0 CA--C 1.486 -1.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.979 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' X' ' 64' ' ' ASN . 4.6 Cg_exo -78.61 -66.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.724 0 C-N-CA 120.911 1.074 . . . . 0.0 111.179 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.45 -138.89 3.76 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.46 60.44 4.29 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -148.19 -31.11 0.28 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 124.357 1.063 . . . . 0.0 108.64 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.41 -129.82 6.79 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.0 -26.28 7.84 Favored Glycine 0 C--N 1.306 -1.135 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.257 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.2 -102.36 1.06 Allowed Glycine 0 N--CA 1.41 -3.048 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.588 ' HA ' HD11 ' X' ' 75' ' ' ILE . 20.3 Cg_endo -63.93 -30.92 67.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.026 2.484 . . . . 0.0 112.379 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.89 -11.65 59.91 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' X' ' 78' ' ' GLU . . . -99.8 -29.08 7.08 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 118.2 -1.952 . . . . 0.0 113.063 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.0 OUTLIER -60.52 -44.02 95.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.474 ' HB ' ' CD1' ' X' ' 19' ' ' LEU . 1.7 p -63.13 -43.68 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.996 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 85.9 tttt -61.71 -44.78 96.27 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' X' ' 74' ' ' GLY . 13.5 mm-40 -59.35 -45.13 92.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.481 0.658 . . . . 0.0 110.504 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.568 HG12 ' O ' ' X' ' 75' ' ' ILE . 48.2 mm -61.86 -45.33 98.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.972 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.2 ptmt -63.06 -38.07 89.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.347 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -71.7 -43.81 65.29 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.479 0.487 . . . . 0.0 111.847 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.572 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.3 t90 -63.98 -48.15 77.58 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.457 0.646 . . . . 0.0 110.916 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' CA ' ' X' ' 90' ' ' GLY . 12.0 tpt180 -60.9 -45.14 95.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.696 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.33 -38.18 81.29 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.199 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.62 88.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.132 0.492 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.466 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 24.5 t-20 -74.51 -42.2 59.34 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.91 31.77 3.77 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.466 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 63.7 mttm -102.35 146.66 32.74 Favored Pre-proline 0 N--CA 1.405 -2.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.44 126.62 17.28 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.046 1.831 . . . . 0.0 109.701 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' X' ' 83' ' ' ARG . . . -110.88 -119.8 3.99 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.506 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.69 149.32 29.79 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.383 1.087 . . . . 0.0 113.422 -171.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' X' ' 11' ' ' THR . 28.3 ttpt -88.19 172.81 9.2 Favored 'General case' 1 N--CA 1.365 -4.716 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.148 174.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.06 27.67 1.04 Allowed 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 121.317 0.58 . . . . 0.0 112.198 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . 0.421 ' OXT' ' HE3' ' X' ' 92' ' ' LYS . . . . . . . . 0 C--N 1.277 -2.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.383 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' X' ' 18' ' ' LEU . 37.2 mt -91.87 132.19 36.65 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.632 0.729 . . . . 0.0 111.877 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 39.4 mmtt -100.59 -161.47 0.87 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.106 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -117.82 -28.63 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.963 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -136.09 167.03 22.0 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.96 -11.37 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 121.681 0.753 . . . . 0.0 110.316 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 8.2 m -70.1 -26.74 64.12 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 123.89 0.876 . . . . 0.0 111.294 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.516 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 10.2 t70 -105.01 5.74 32.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.652 0.739 . . . . 0.0 109.677 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 12.3 m-85 -95.87 124.98 40.11 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.646 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 45.4 p -89.4 171.67 9.57 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.626 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.5 -45.72 80.89 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.131 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.74 -38.46 73.52 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.84 -34.46 77.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.402 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.451 ' CD2' HG12 ' X' ' 76' ' ' VAL . 62.0 t80 -71.48 -43.06 67.27 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.723 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.67 HG12 HG11 ' X' ' 76' ' ' VAL . 5.9 m -62.64 -29.94 48.11 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.468 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -61.74 -45.98 91.61 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.285 0.634 . . . . 0.0 109.865 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.614 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.7 tp -61.95 -48.19 81.51 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.625 HD13 HD12 ' X' ' 22' ' ' ILE . 4.3 mm? -60.46 -36.31 77.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.329 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 64.4 mttm -68.49 -36.93 79.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.85 -35.55 78.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.358 0.599 . . . . 0.0 110.104 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' X' ' 37' ' ' LEU . 67.7 mt -63.06 -46.28 96.57 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.38 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.727 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -57.82 -45.5 86.06 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 109.802 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.28 -51.85 67.18 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.126 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.701 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 6.2 mm-40 -82.47 -14.67 54.67 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -69.85 -47.17 63.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 120.835 0.35 . . . . 0.0 110.191 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.4 -19.75 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.39 -18.67 25.05 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.969 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.37 72.76 0.38 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.146 1.378 . . . . 0.0 111.837 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 57.2 p -93.84 -168.4 1.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -134.84 -55.7 0.82 Allowed 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.894 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.542 ' O ' HG23 ' X' ' 36' ' ' VAL . 5.0 p-10 -57.53 -48.08 80.25 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.8 p -87.92 -32.9 6.27 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.608 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.22 -44.56 92.29 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.713 0.805 . . . . 0.0 109.487 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.92 -32.38 69.29 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.924 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.542 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.4 t -62.51 -49.86 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.142 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 66.2 mt -68.37 -43.03 78.26 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.707 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 15.9 mt -60.22 -45.08 94.45 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 124.265 0.978 . . . . 0.0 110.325 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -70.39 -38.75 74.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.985 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 9.6 t60 -64.41 -45.15 88.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.454 0.645 . . . . 0.0 109.627 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.588 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 49.7 t80 -59.04 -51.13 71.36 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 10.9 p -67.98 -33.03 58.84 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.869 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.1 ptmt -68.96 -36.12 77.53 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.039 0.447 . . . . 0.0 111.687 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.455 HG12 ' O ' ' X' ' 40' ' ' HIS . 24.7 pt -79.17 -33.29 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.106 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -84.66 -39.69 18.3 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.317 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 63.8 31.77 13.92 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.694 1.198 . . . . 0.0 109.991 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -80.38 135.34 53.81 Favored Pre-proline 0 N--CA 1.424 -1.77 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.117 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 14.0 Cg_exo -76.62 9.68 2.51 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 C-N-CA 123.367 2.711 . . . . 0.0 111.904 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -140.8 19.14 2.33 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.588 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -42.88 -69.01 0.68 Allowed Glycine 0 CA--C 1.46 -3.4 0 O-C-N 124.38 1.05 . . . . 0.0 114.512 -173.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.445 HG21 HD13 ' X' ' 38' ' ' LEU . 0.6 OUTLIER -74.38 -18.84 60.61 Favored 'General case' 0 C--N 1.253 -3.593 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.026 -173.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -71.32 -34.19 70.35 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.58 -37.9 88.02 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.621 0.576 . . . . 0.0 110.645 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.435 HD13 HG21 ' X' ' 22' ' ' ILE . 49.2 mt -66.94 -47.07 83.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.863 0.839 . . . . 0.0 109.092 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.05 -47.96 80.74 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.07 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.0 pt-20 -65.71 -36.64 84.18 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.217 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.08 83.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.181 0.446 . . . . 0.0 110.947 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.89 99.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 110.877 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.58 -43.71 63.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.36 -40.56 96.81 Favored 'General case' 0 C--O 1.2 -1.529 0 C-N-CA 123.224 0.61 . . . . 0.0 110.477 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.19 69.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -37.9 85.52 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.11 11.29 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.111 0.481 . . . . 0.0 109.934 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 60.58 89.41 0.11 Allowed Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 126.547 1.939 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.51 97.61 0.45 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.773 2.315 . . . . 0.0 111.249 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.5 -93.26 0.36 Allowed Glycine 0 N--CA 1.437 -1.252 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -157.9 20.5 0.37 Allowed Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -120.58 131.67 54.76 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.212 0.529 . . . . 0.0 110.801 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 6.52 89.28 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.497 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.57 62.16 0.38 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.38 166.47 12.16 Favored Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.724 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.638 ' HA ' HD11 ' X' ' 75' ' ' ILE . 15.9 Cg_endo -57.02 -34.51 97.79 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 124.157 3.238 . . . . 0.0 113.664 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.488 ' C ' HG22 ' X' ' 76' ' ' VAL . 41.5 mt-10 -82.73 2.11 35.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.912 0.386 . . . . 0.0 112.024 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.59 -27.76 6.62 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.268 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.0 OUTLIER -66.23 -34.05 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.67 HG11 HG12 ' X' ' 16' ' ' VAL . 29.2 m -64.7 -34.79 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.254 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.951 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 41.7 ttmt -64.79 -43.6 92.68 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.85 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' X' ' 75' ' ' ILE . 7.6 mm-40 -57.79 -45.09 86.54 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.978 0.894 . . . . 0.0 109.084 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 22.6 mm -62.34 -46.62 95.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.787 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -67.17 -35.64 80.09 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.69 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -69.26 -32.04 70.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.553 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 83.9 t90 -70.08 -48.58 57.13 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.122 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.438 ' HE ' ' HB2' ' X' ' 83' ' ' ARG . 0.0 OUTLIER -65.95 -37.2 85.41 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.591 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.77 90.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.785 0.678 . . . . 0.0 111.652 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.76 -44.88 39.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.95 0.405 . . . . 0.0 110.695 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.5 -33.93 73.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.208 0.528 . . . . 0.0 110.665 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.65 30.86 6.3 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -103.48 163.35 17.61 Favored Pre-proline 0 N--CA 1.405 -2.689 0 C-N-CA 124.042 0.937 . . . . 0.0 109.651 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' X' ' 83' ' ' ARG . 36.3 Cg_exo -62.47 131.05 32.18 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.913 2.409 . . . . 0.0 113.07 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.86 -150.56 24.4 Favored Glycine 0 N--CA 1.429 -1.815 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.529 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -85.42 150.02 25.01 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' X' ' 8' ' ' SER . 20.0 ptmt -77.89 165.14 24.49 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.32 133.02 36.24 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.256 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.604 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 CA--C 1.506 -0.726 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.494 ' CD2' HD13 ' X' ' 18' ' ' LEU . 31.9 mt -91.99 129.81 37.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.073 0.464 . . . . 0.0 110.443 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -96.37 -162.34 0.95 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -115.05 -24.49 8.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.358 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . 0.429 ' HA ' HG22 ' X' ' 44' ' ' ILE . 84.7 p -134.61 166.81 22.05 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -65.33 -15.18 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.381 0.672 . . . . 0.0 110.725 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' X' ' 92' ' ' LYS . 16.6 t -76.53 -20.64 56.69 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.882 -170.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 6.87 37.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 118.297 -1.361 . . . . 0.0 109.673 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.21 122.63 34.0 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.105 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 81.0 p -82.87 167.73 17.77 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.632 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -59.42 -42.92 92.94 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.189 -1.404 . . . . 0.0 111.85 176.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.602 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -67.34 -38.76 85.37 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -59.13 -39.13 81.38 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.643 0.735 . . . . 0.0 110.1 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.681 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -74.78 -42.15 58.7 Favored 'General case' 0 N--CA 1.407 -2.581 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.017 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.779 HG12 HG11 ' X' ' 76' ' ' VAL . 8.9 m -62.62 -32.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.41 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -62.33 -43.98 97.56 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.64 ' O ' HG13 ' X' ' 22' ' ' ILE . 36.8 tp -61.71 -46.54 89.25 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-O 121.253 0.549 . . . . 0.0 109.974 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 39.6 mt -57.32 -41.93 80.88 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.765 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.4 mttm -64.28 -41.97 96.65 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.22 0.534 . . . . 0.0 109.648 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.21 -38.1 87.16 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.042 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.64 HG13 ' O ' ' X' ' 18' ' ' LEU . 47.4 mt -60.15 -46.06 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.348 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.27 -43.58 88.03 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.365 0.602 . . . . 0.0 110.23 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . 0.509 ' HG3' ' OE2' ' X' ' 25' ' ' GLU . 26.1 tptp -59.5 -50.42 73.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.846 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.509 ' OE2' ' HG3' ' X' ' 24' ' ' LYS . 16.0 mm-40 -86.15 -5.61 59.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.339 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -79.23 -44.89 20.9 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.53 -32.39 52.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.256 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -19.67 42.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.752 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.83 80.87 0.19 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.343 1.457 . . . . 0.0 112.911 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 77.0 p -106.77 -169.49 1.56 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -140.47 -26.33 0.76 Allowed 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.098 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.509 ' O ' HG23 ' X' ' 36' ' ' VAL . 16.6 m-20 -67.28 -57.9 5.81 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.621 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.53 -31.12 7.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.132 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.9 tm? -59.48 -46.03 89.97 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.974 -175.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -32.34 72.98 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.206 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.509 HG23 ' O ' ' X' ' 32' ' ' ASP . 38.3 t -66.33 -49.27 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.574 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 58.0 mt -66.73 -42.65 85.95 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.0 -170.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 18.3 mt -59.42 -47.84 83.93 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.541 1.151 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.42 -42.55 71.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.549 ' O ' HG12 ' X' ' 44' ' ' ILE . 22.8 t60 -59.46 -45.55 91.3 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.506 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.595 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 53.5 t80 -60.12 -55.12 37.84 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.879 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.502 HG12 ' O ' ' X' ' 38' ' ' LEU . 8.3 p -66.76 -31.81 55.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 14.3 pttp -71.27 -34.32 70.58 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.769 -0.582 . . . . 0.0 111.781 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.549 HG12 ' O ' ' X' ' 40' ' ' HIS . 23.7 pt -88.48 -29.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.511 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.528 ' HB ' HD12 ' X' ' 79' ' ' ILE . 70.1 p -84.46 -37.77 20.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.544 0.688 . . . . 0.0 109.494 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 69.04 21.56 7.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.249 1.82 . . . . 0.0 112.076 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.455 ' O ' HG23 ' X' ' 42' ' ' VAL . 48.7 t-80 -72.23 132.96 83.76 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 31.5 Cg_exo -66.74 -21.3 51.56 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.149 2.566 . . . . 0.0 112.146 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -122.44 35.69 4.82 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.595 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.12 -55.3 8.79 Favored Glycine 1 CA--C 1.448 -4.124 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.585 -178.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.496 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -72.24 -34.51 68.34 Favored 'General case' 0 C--N 1.255 -3.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.208 -173.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.56 -29.37 70.64 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.653 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 53' ' ' LEU . 26.4 mt -61.42 -42.68 99.13 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 175.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.582 HD13 HG21 ' X' ' 22' ' ' ILE . 10.5 mt -66.59 -42.54 90.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -63.02 -44.67 95.3 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.802 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.9 pt-20 -69.8 -39.3 76.63 Favored 'General case' 0 C--O 1.201 -1.48 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.635 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.51 83.8 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 122.26 0.224 . . . . 0.0 111.279 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.28 -48.05 81.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.756 0.66 . . . . 0.0 110.428 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.95 87.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.293 0.568 . . . . 0.0 110.453 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -63.6 -33.24 75.18 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.143 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.497 ' HB2' ' H ' ' X' ' 71' ' ' GLY . . . -79.39 -30.15 42.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.732 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.06 -39.51 82.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.387 0.613 . . . . 0.0 109.8 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.11 3.46 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 58.26 86.74 0.15 Allowed Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 126.213 1.805 . . . . 0.0 113.055 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.29 -37.97 28.9 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 122.265 1.977 . . . . 0.0 110.118 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.68 175.65 14.2 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.83 -95.99 0.93 Allowed Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.015 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -129.26 16.98 6.06 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 80.37 1.14 Allowed Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 114.807 -1.088 . . . . 0.0 114.079 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.72 -172.61 18.51 Favored Glycine 0 N--CA 1.428 -1.897 0 O-C-N 124.015 0.48 . . . . 0.0 112.391 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.497 ' H ' ' HB2' ' X' ' 61' ' ' ALA . . . 90.25 160.64 36.72 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 124.257 0.622 . . . . 0.0 112.637 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.511 ' O ' HG13 ' X' ' 75' ' ' ILE . 29.1 Cg_endo -61.8 -37.5 66.77 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.254 2.636 . . . . 0.0 110.992 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.14 0.69 18.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.764 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.27 -8.87 26.59 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.008 174.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.511 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.2 mt -73.82 -45.43 49.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.779 HG11 HG12 ' X' ' 16' ' ' VAL . 1.2 p -57.71 -42.16 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.966 175.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttp -58.52 -47.86 82.77 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.747 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.4 -39.12 89.58 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.528 HD12 ' HB ' ' X' ' 45' ' ' THR . 41.8 mm -67.86 -46.34 82.37 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.832 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 17.6 pttp -63.72 -36.29 83.39 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.384 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.85 -38.82 70.04 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.874 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.515 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 66.7 t90 -69.75 -47.79 61.69 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.016 0.436 . . . . 0.0 110.025 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.584 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 14.5 tpt180 -60.35 -45.52 93.2 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.0 89.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.704 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.28 92.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.163 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -64.67 -32.56 74.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.78 4.84 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.584 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 64.5 mttm -112.83 144.58 31.3 Favored Pre-proline 0 N--CA 1.388 -3.542 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -64.22 139.3 65.52 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.093 1.862 . . . . 0.0 109.31 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -109.38 -125.23 5.03 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.31 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.428 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 76.9 m-85 -82.86 152.53 25.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.665 -0.768 . . . . 0.0 111.2 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' X' ' 8' ' ' SER . 19.8 ptmt -83.59 -179.27 7.29 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.49 140.07 30.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.884 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.825 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.406 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 71.2 mt -91.32 128.29 37.08 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -97.83 -174.7 2.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.87 -9.17 14.07 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.237 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -144.47 164.89 29.52 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -70.79 -8.7 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.444 0.64 . . . . 0.0 110.688 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 41.3 p -76.81 -25.82 53.71 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.02 -11.94 21.04 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.406 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 8.7 m-85 -72.99 118.11 15.53 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.31 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.459 HG22 ' HG2' ' X' ' 92' ' ' LYS . 76.0 p -78.4 162.0 26.73 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 169.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.654 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.05 -45.28 79.27 Favored 'General case' 0 C--N 1.28 -2.42 0 O-C-N 123.571 0.544 . . . . 0.0 111.015 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.49 -38.23 77.58 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -57.44 -37.5 72.92 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 118.436 0.562 . . . . 0.0 110.107 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.736 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 5.7 t80 -80.0 -45.38 18.51 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.751 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.695 HG12 HG21 ' X' ' 76' ' ' VAL . 11.7 m -58.82 -31.78 45.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.043 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.86 -47.19 78.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.939 0.896 . . . . 0.0 109.79 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.495 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -62.75 -41.77 99.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.01 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 47.1 mt -61.34 -37.77 84.5 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.519 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 56.6 mttp -64.47 -36.0 82.77 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.439 0.638 . . . . 0.0 109.578 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.74 -32.82 73.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.905 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.573 HG12 HD13 ' X' ' 37' ' ' LEU . 34.1 mt -64.92 -41.49 92.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -57.49 -46.14 84.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.786 0.803 . . . . 0.0 108.841 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -60.06 -45.36 93.13 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.929 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.594 ' OE1' ' HB2' ' X' ' 34' ' ' LEU . 2.9 pp20? -85.24 -29.61 24.5 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.178 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.67 -34.88 79.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.781 0.324 . . . . 0.0 111.359 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 32.7 m -77.27 -12.59 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.07 -22.68 16.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.56 85.72 0.14 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.127 1.771 . . . . 0.0 112.043 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -106.1 172.26 6.9 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -135.91 8.67 3.27 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.642 170.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.467 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 m-20 -91.16 -70.66 0.67 Allowed 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.706 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 11.7 p -74.66 -30.69 25.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.978 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.594 ' HB2' ' OE1' ' X' ' 25' ' ' GLU . 3.0 tm? -58.3 -46.03 86.87 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.13 -32.8 74.18 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.282 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.467 HG23 ' O ' ' X' ' 32' ' ' ASP . 75.9 t -64.8 -50.12 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 68.6 mt -68.66 -41.77 78.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.858 -171.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 7.0 mt -61.17 -46.64 89.66 Favored 'General case' 0 N--CA 1.418 -2.063 0 O-C-N 124.102 0.876 . . . . 0.0 110.915 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.18 -42.35 72.55 Favored 'General case' 0 N--CA 1.433 -1.283 0 O-C-N 123.418 0.449 . . . . 0.0 110.884 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.469 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 25.3 t60 -59.57 -45.34 92.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 123.68 0.792 . . . . 0.0 110.595 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.405 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 34.2 t80 -61.02 -55.32 34.23 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.156 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.46 HG23 ' HA3' ' X' ' 50' ' ' GLY . 12.3 p -67.3 -31.65 53.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 0.0 OUTLIER -69.68 -39.26 77.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 122.232 -0.293 . . . . 0.0 111.772 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.616 HD11 ' CE1' ' X' ' 15' ' ' PHE . 49.9 pt -80.97 -30.63 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.941 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -85.02 -35.09 22.16 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.76 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 61.76 28.15 17.28 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.64 1.176 . . . . 0.0 110.995 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.409 ' HA ' ' HD3' ' X' ' 48' ' ' PRO . 37.4 t-80 -77.18 139.53 64.96 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.435 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 20.3 Cg_exo -70.41 -19.3 33.2 Favored 'Trans proline' 0 CA--C 1.495 -1.432 0 C-N-CA 123.087 2.525 . . . . 0.0 112.488 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 14.4 m-20 -127.23 40.98 3.61 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.46 ' HA3' HG23 ' X' ' 42' ' ' VAL . . . -51.22 -51.77 34.69 Favored Glycine 0 CA--C 1.466 -2.976 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.978 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . . . . . . . . 0.35 0.6 OUTLIER -80.99 -25.06 37.54 Favored 'General case' 0 C--N 1.256 -3.497 0 C-N-CA 117.48 -1.688 . . . . 0.0 114.165 -174.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' X' ' 49' ' ' ASP . . . -61.2 -41.12 96.26 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.12 -46.52 88.12 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.292 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 31.1 mt -67.07 -47.54 81.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 CA-C-O 121.344 0.592 . . . . 0.0 110.736 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -59.8 -49.06 79.2 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.359 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.35 -40.7 96.38 Favored 'General case' 0 C--O 1.174 -2.917 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.769 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . 0.454 ' HB2' ' CG2' ' X' ' 75' ' ' ILE . . . -57.54 -47.96 80.62 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 118.412 0.551 . . . . 0.0 111.296 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.6 85.44 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.651 0.594 . . . . 0.0 110.823 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.7 -43.54 62.91 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.997 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 97.5 mtt180 -66.01 -31.77 72.85 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.099 0.959 . . . . 0.0 111.454 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.46 27.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.098 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.3 27.49 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.243 0.544 . . . . 0.0 110.909 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . 0.461 ' O ' ' HD3' ' X' ' 65' ' ' PRO . . . -109.75 79.57 1.23 Allowed 'General case' 0 CA--C 1.477 -1.863 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 173.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 27.2 t-20 -81.37 112.93 37.66 Favored Pre-proline 0 N--CA 1.424 -1.752 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.364 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' X' ' 63' ' ' ALA . 66.5 Cg_endo -96.04 10.83 1.42 Allowed 'Trans proline' 0 N--CA 1.437 -1.825 0 C-N-CA 122.35 2.033 . . . . 0.0 110.165 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 143.28 14.62 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.07 -176.44 48.02 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 118.489 -1.815 . . . . 0.0 114.032 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -110.7 -33.94 6.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.045 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -122.9 57.92 0.63 Allowed Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.64 67.72 0.22 Allowed Glycine 0 N--CA 1.415 -2.731 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.44 16.52 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.42 -24.63 56.87 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.196 3.264 . . . . 0.0 113.316 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.406 ' HA ' ' CG2' ' X' ' 76' ' ' VAL . 33.5 mt-10 -96.32 1.41 51.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.026 0.441 . . . . 0.0 109.937 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -103.34 -31.65 4.88 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.602 174.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.522 ' CD1' HD13 ' X' ' 19' ' ' LEU . 5.3 pt -65.43 -32.55 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 O-C-N 122.277 -0.543 . . . . 0.0 111.616 175.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.695 HG21 HG12 ' X' ' 16' ' ' VAL . 0.2 OUTLIER -65.56 -32.23 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.469 176.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 59.6 tttm -66.7 -45.67 78.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.84 -44.76 86.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.376 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.45 -46.81 88.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.079 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -69.39 -36.29 76.64 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.472 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.5 mt-10 -71.37 -37.21 71.65 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.204 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.481 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.8 t90 -66.55 -47.25 73.43 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.923 0.868 . . . . 0.0 109.719 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -61.28 -46.1 91.73 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.771 -176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.2 81.64 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.79 -45.62 93.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.954 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.403 ' CG ' ' HE2' ' X' ' 88' ' ' LYS . 23.5 t-20 -69.25 -39.0 78.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.2 37.68 2.63 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' X' ' 86' ' ' ASN . 67.7 mttm -109.18 147.16 35.39 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.55 131.36 37.67 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.527 2.151 . . . . 0.0 111.785 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.35 -144.14 15.37 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.182 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -78.17 145.82 35.4 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 111.33 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' X' ' 11' ' ' THR . 5.3 tttt -86.28 163.03 17.96 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . 0.439 ' N ' ' HG3' ' X' ' 92' ' ' LYS 0.251 13.6 mt-30 -88.87 131.01 35.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.633 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.925 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 174.809 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' X' ' 40' ' ' HIS . 66.5 mt -100.27 138.78 36.87 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.979 0.419 . . . . 0.0 110.906 -178.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 46.3 mmtt -102.08 -159.16 0.71 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -116.33 -28.49 6.49 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.703 0.763 . . . . 0.0 109.499 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 65.0 p -132.74 166.83 21.31 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.652 177.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.594 HD11 ' CE1' ' X' ' 91' ' ' PHE . 10.9 tp -70.81 -15.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 121.533 0.683 . . . . 0.0 110.68 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -77.74 -9.0 58.77 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.425 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 5.0 t70 -109.27 3.67 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 6.7 m-85 -94.8 115.51 27.59 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.646 -174.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' X' ' 14' ' ' GLU . 76.1 p -76.06 156.86 33.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 167.168 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.67 ' O ' HG13 ' X' ' 16' ' ' VAL . 10.7 pt-20 -60.84 -30.61 70.21 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.68 -38.88 73.78 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.113 0.415 . . . . 0.0 111.382 175.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.449 ' HG2' ' OG1' ' X' ' 11' ' ' THR . 10.1 mm-40 -57.46 -39.02 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.624 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 21.4 t80 -71.54 -49.01 44.88 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.584 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.842 HG12 HG11 ' X' ' 76' ' ' VAL . 5.0 m -62.6 -30.04 48.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.731 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' X' ' 21' ' ' GLU . 6.6 tt0 -63.0 -49.01 76.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.585 ' O ' HG13 ' X' ' 22' ' ' ILE . 2.1 tm? -58.75 -44.71 90.62 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.56 177.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.673 HD13 HG13 ' X' ' 75' ' ' ILE . 33.0 mt -58.12 -42.21 85.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.163 176.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 67.6 mttm -67.78 -35.04 77.96 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.172 176.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' X' ' 17' ' ' GLN . 45.3 mt-10 -67.24 -37.68 83.95 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.681 176.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.585 HG13 ' O ' ' X' ' 18' ' ' LEU . 37.6 mt -62.13 -43.72 98.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' X' ' 20' ' ' LYS . 0.9 OUTLIER -58.06 -47.68 82.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.621 1.168 . . . . 0.0 109.883 176.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.61 -52.04 59.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.427 -176.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.03 -25.95 64.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -70.94 -50.35 35.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.51 177.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.45 -11.68 13.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.14 -19.12 21.08 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 76.42 0.28 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.878 1.271 . . . . 0.0 111.275 -176.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -95.79 -25.67 15.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.168 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 66.41 -64.46 0.22 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 126.19 1.796 . . . . 0.0 114.721 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.501 ' O ' HG23 ' X' ' 36' ' ' VAL . 8.1 p-10 -63.97 -48.57 75.95 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.761 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.5 p -83.13 -29.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.838 -177.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.35 -41.84 90.14 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.692 175.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.61 -36.19 82.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.501 HG23 ' O ' ' X' ' 32' ' ' ASP . 99.3 t -57.57 -48.42 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.965 0 O-C-N 123.835 0.709 . . . . 0.0 109.218 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 43.9 mt -68.07 -43.12 79.3 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.447 -174.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.535 ' HB3' HG21 ' X' ' 51' ' ' THR . 17.8 mt -58.89 -49.5 77.55 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 124.11 0.881 . . . . 0.0 111.173 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -68.47 -39.06 81.55 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.231 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.59 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 46.3 t60 -65.98 -45.26 82.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.094 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.577 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.5 t80 -55.29 -52.1 64.53 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.886 177.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.9 -32.83 58.09 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 21.0 ptmt -71.33 -33.22 69.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.934 -0.479 . . . . 0.0 112.118 -178.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.582 HG12 ' O ' ' X' ' 40' ' ' HIS . 15.3 pt -83.08 -34.58 11.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.283 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 66.7 p -84.32 -38.73 20.02 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 63.97 27.23 14.29 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 109.983 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' X' ' 49' ' ' ASP . 37.4 t-80 -70.75 136.36 85.56 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 113.762 -1.563 . . . . 0.0 106.82 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.423 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 8.8 Cg_exo -76.73 6.03 4.42 Favored 'Trans proline' 0 CA--C 1.482 -2.088 0 C-N-CA 122.89 2.394 . . . . 0.0 112.686 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.487 ' CG ' ' HB3' ' X' ' 52' ' ' ALA . 24.9 t70 -144.76 32.21 1.15 Allowed 'General case' 0 N--CA 1.39 -3.448 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 -173.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.577 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.48 -62.53 3.93 Favored Glycine 1 CA--C 1.449 -4.036 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.43 -176.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.535 HG21 ' HB3' ' X' ' 38' ' ' LEU 0.437 1.6 p -82.72 -13.33 56.54 Favored 'General case' 0 N--CA 1.386 -3.664 0 C-N-CA 116.46 -2.096 . . . . 0.0 115.267 -177.649 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.651 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -72.09 -29.87 64.54 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 117.863 -1.535 . . . . 0.0 108.814 174.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 36.3 mt -60.55 -43.52 97.12 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.599 0.562 . . . . 0.0 110.961 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.48 -47.18 81.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.139 0.971 . . . . 0.0 109.672 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -63.57 -44.33 94.41 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.897 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.2 pt-20 -67.82 -35.77 79.21 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.38 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.27 -42.34 81.46 Favored 'General case' 0 CA--C 1.5 -0.973 0 O-C-N 123.059 0.224 . . . . 0.0 111.093 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.49 93.93 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.74 0.65 . . . . 0.0 110.667 178.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.8 75.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.553 0.692 . . . . 0.0 110.802 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -64.27 -37.3 87.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.948 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.04 61.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.937 0.495 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.31 77.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.157 0.503 . . . . 0.0 109.934 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.78 8.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.233 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 63.65 92.46 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 113.05 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.75 177.59 8.23 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.653 2.235 . . . . 0.0 110.385 173.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.67 175.45 52.1 Favored Glycine 0 CA--C 1.497 -1.047 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.756 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.26 -131.09 19.64 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.22 85.26 6.89 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.43 176.19 48.1 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.474 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.59 136.45 39.01 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.44 171.53 29.8 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.404 ' O ' HG12 ' X' ' 75' ' ' ILE . 14.8 Cg_endo -58.98 -48.43 14.36 Favored 'Trans proline' 0 C--O 1.207 -1.052 0 C-N-CA 124.071 3.181 . . . . 0.0 113.57 -176.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.93 0.57 17.91 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.985 -0.447 . . . . 0.0 112.183 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.56 -23.9 5.51 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.776 175.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.673 HG13 HD13 ' X' ' 19' ' ' LEU . 4.1 pt -69.92 -31.91 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 122.09 -0.653 . . . . 0.0 110.313 176.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.842 HG11 HG12 ' X' ' 16' ' ' VAL . 0.5 OUTLIER -61.7 -41.81 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-O 122.257 1.027 . . . . 0.0 110.737 173.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' X' ' 74' ' ' GLY . 53.1 tttm -58.4 -42.29 86.83 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.228 176.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.07 -33.54 76.28 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.629 0.728 . . . . 0.0 109.566 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.421 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.9 mm -70.69 -45.94 71.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.144 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -62.5 -36.44 82.55 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.032 -177.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.56 -44.2 78.8 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.354 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 90.4 t90 -66.8 -48.86 67.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -176.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -71.44 -39.62 70.89 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.558 -174.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.16 -43.37 78.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.862 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -69.45 -30.38 68.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.97 29.53 7.19 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -117.08 141.08 27.87 Favored Pre-proline 0 N--CA 1.393 -3.296 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.53 118.77 5.25 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.476 2.784 . . . . 0.0 112.022 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.16 -124.63 4.33 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.6 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.594 ' CE1' HD11 ' X' ' 7' ' ' ILE . 76.0 m-85 -85.88 159.02 19.8 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.081 -178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -89.71 172.95 8.56 Favored 'General case' 0 N--CA 1.383 -3.805 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -120.82 134.28 55.29 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.248 0.547 . . . . 0.0 111.862 -175.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.317 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 177.879 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.434 ' HA ' ' OH ' ' X' ' 10' ' ' TYR . 26.6 mt -92.28 128.67 38.21 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.063 0.459 . . . . 0.0 111.029 -175.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.424 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 36.7 mmtt -98.3 -159.57 0.75 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -113.03 -30.88 6.85 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.722 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 37.1 p -126.2 166.19 17.54 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' X' ' 91' ' ' PHE . 7.0 tp -69.21 -18.72 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.781 0.801 . . . . 0.0 109.763 -177.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -75.09 -17.75 60.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.364 -172.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.424 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 36.3 t0 -102.73 5.21 38.76 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 122.255 1.026 . . . . 0.0 108.919 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.434 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 9.3 m-85 -96.46 125.11 40.72 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.632 -176.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' X' ' 14' ' ' GLU . 67.9 p -88.08 172.53 9.46 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.657 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.4 pt-20 -62.02 -41.4 98.04 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.669 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.75 -37.86 76.59 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.445 ' HB2' ' H ' ' X' ' 11' ' ' THR . 43.5 mm-40 -60.85 -40.19 91.96 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.287 0.565 . . . . 0.0 109.69 174.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 26.7 t80 -71.74 -45.4 61.86 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.208 -178.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.669 HG22 ' HA ' ' X' ' 13' ' ' ALA . 13.6 m -61.88 -28.86 45.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.61 -46.78 86.71 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.623 ' O ' HG13 ' X' ' 22' ' ' ILE . 35.1 tp -60.86 -45.68 93.57 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.587 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 42.1 mt -57.67 -39.54 77.34 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 82.6 mttt -71.68 -38.7 70.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.101 176.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' X' ' 25' ' ' GLU . 73.7 mm-40 -60.72 -44.74 96.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.625 176.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.623 HG13 ' O ' ' X' ' 18' ' ' LEU . 48.1 mt -57.83 -46.1 87.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 O-C-N 123.967 0.792 . . . . 0.0 111.328 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.479 ' O ' HG22 ' X' ' 27' ' ' VAL . 44.5 mt-10 -57.61 -47.88 80.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.387 0.613 . . . . 0.0 110.894 -176.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -60.61 -43.03 97.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.766 -174.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.432 ' HB2' ' CG2' ' X' ' 30' ' ' THR . 3.0 pp20? -89.02 -34.04 16.95 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.566 -177.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . 0.517 ' HA ' HD23 ' X' ' 34' ' ' LEU . 39.2 t30 -60.04 -46.7 88.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.747 0.419 . . . . 0.0 111.798 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . 0.479 HG22 ' O ' ' X' ' 23' ' ' GLU . 31.2 m -79.55 0.6 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.164 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.37 0.19 12.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.239 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 44.95 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.067 1.747 . . . . 0.0 113.537 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' X' ' 25' ' ' GLU . 74.1 p -98.41 -24.38 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.493 . . . . 0.0 111.659 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 68.01 -59.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.245 1.418 . . . . 0.0 113.985 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.628 ' O ' HG23 ' X' ' 36' ' ' VAL . 26.1 t70 -58.88 -61.39 2.66 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 10.4 p -82.24 -25.03 9.1 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' X' ' 26' ' ' ASN . 2.9 tm? -58.64 -50.09 75.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.352 176.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.47 -33.8 76.51 Favored 'General case' 0 CA--C 1.483 -1.61 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.784 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.628 HG23 ' O ' ' X' ' 32' ' ' ASP . 40.2 t -65.75 -50.23 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.623 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 40.7 mt -69.04 -43.66 74.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 O-C-N 124.442 1.089 . . . . 0.0 111.379 -172.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.475 ' O ' HG12 ' X' ' 42' ' ' VAL . 34.1 mt -61.54 -45.29 94.78 Favored 'General case' 0 N--CA 1.421 -1.878 0 O-C-N 124.163 0.914 . . . . 0.0 111.571 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.49 -41.57 72.49 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.253 177.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.518 ' O ' HG12 ' X' ' 44' ' ' ILE . 16.0 t60 -62.3 -45.9 91.16 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.466 0.478 . . . . 0.0 109.92 -175.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.496 ' CD2' HD11 ' X' ' 54' ' ' ILE . 43.7 t80 -58.25 -53.18 61.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.295 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' X' ' 38' ' ' LEU 0.285 14.5 p -67.86 -31.62 52.94 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.891 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.8 pttp -69.14 -32.27 71.52 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.745 -0.597 . . . . 0.0 111.991 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.518 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.7 pt -85.17 -35.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.869 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 61.1 p -84.22 -35.43 23.47 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 58.25 30.73 19.91 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.195 1.398 . . . . 0.0 111.325 -176.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 36.4 t-80 -77.14 134.66 67.29 Favored Pre-proline 0 N--CA 1.423 -1.788 0 CA-C-N 114.024 -1.444 . . . . 0.0 107.862 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 17.1 Cg_exo -71.0 -2.27 10.8 Favored 'Trans proline' 0 CA--C 1.493 -1.541 0 C-N-CA 123.362 2.708 . . . . 0.0 112.805 -175.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 11.8 m-20 -138.21 29.84 2.47 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -173.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.485 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.99 -61.05 3.64 Favored Glycine 1 CA--C 1.45 -4.017 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.946 -176.48 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.46 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.05 -28.44 57.65 Favored 'General case' 0 C--N 1.248 -3.837 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.252 -172.5 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.587 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.76 -40.47 95.25 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.026 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 26.3 mt -56.32 -44.5 80.01 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.731 0.644 . . . . 0.0 112.087 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.496 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -66.63 -45.24 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.276 -177.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.423 ' HD2' ' O ' ' X' ' 51' ' ' THR . 29.7 m-85 -61.01 -49.31 77.93 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.74 -178.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.5 pt-20 -70.29 -36.28 74.25 Favored 'General case' 0 C--O 1.202 -1.432 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.638 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.19 -40.84 82.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.652 0.206 . . . . 0.0 111.319 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.25 92.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 178.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -43.52 62.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.88 178.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 63.7 mtp180 -61.0 -30.92 70.58 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.684 1.193 . . . . 0.0 111.363 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.91 -45.78 17.97 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.2 176.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.91 81.55 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.173 -177.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.37 75.24 0.95 Allowed 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 174.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 16.0 t-20 -72.94 118.67 70.3 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.257 -177.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -92.56 27.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.122 2.548 . . . . 0.0 111.759 -178.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 45.1 7.65 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -174.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.09 172.66 20.98 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -176.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -128.91 157.78 40.63 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.94 -3.24 31.77 Favored Glycine 0 CA--C 1.494 -1.249 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.613 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.74 83.82 1.61 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.59 170.06 22.0 Favored Glycine 0 N--CA 1.406 -3.307 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.489 ' O ' HG12 ' X' ' 76' ' ' VAL . 25.7 Cg_endo -65.0 -50.98 1.81 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 123.085 2.524 . . . . 0.0 110.956 -176.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.85 1.68 6.66 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -111.55 -29.16 3.48 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.065 174.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.614 HG13 HD13 ' X' ' 19' ' ' LEU . 5.2 pt -66.3 -32.98 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 118.248 1.024 . . . . 0.0 111.045 175.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.668 HG11 HG12 ' X' ' 16' ' ' VAL . 0.5 OUTLIER -59.6 -43.64 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-O 121.998 0.904 . . . . 0.0 110.327 173.177 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 54.4 tttp -58.42 -46.13 87.08 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.551 175.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -67.21 -30.71 70.72 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.463 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.4 mm -68.21 -45.99 81.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 175.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -64.02 -36.11 82.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.726 0.298 . . . . 0.0 110.699 -176.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.31 -32.31 70.02 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.837 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.497 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 76.2 t90 -72.16 -44.1 63.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.77 -43.08 98.49 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.775 -176.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.44 84.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.821 178.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.22 99.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.359 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.472 ' ND2' ' HE2' ' X' ' 88' ' ' LYS . 3.5 t30 -73.46 -34.1 65.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.59 47.73 2.91 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.472 ' HE2' ' ND2' ' X' ' 86' ' ' ASN . 60.1 mttm -118.77 147.94 43.35 Favored Pre-proline 0 N--CA 1.4 -2.942 0 C-N-CA 123.234 0.614 . . . . 0.0 109.863 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.1 130.83 28.44 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.309 2.006 . . . . 0.0 110.477 175.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.27 -126.59 5.58 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.465 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' X' ' 7' ' ' ILE . 36.8 m-85 -81.27 156.7 25.45 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.108 -174.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' X' ' 11' ' ' THR . 53.0 pttt -94.57 174.28 7.2 Favored 'General case' 0 N--CA 1.389 -3.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.08 141.73 35.71 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.775 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.236 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.552 HD22 HD13 ' X' ' 18' ' ' LEU . 22.6 mt -91.8 127.82 37.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.149 0.499 . . . . 0.0 110.6 -177.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.544 ' HE3' ' O ' ' X' ' 9' ' ' ASP . 37.7 mmtt -102.8 -179.96 4.11 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.203 -175.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.0 -24.79 16.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.325 0.583 . . . . 0.0 109.741 178.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.4 p -142.02 162.93 34.23 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.079 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -67.3 -17.92 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.24 1.016 . . . . 0.0 111.341 -176.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 75.8 m -86.6 -3.09 58.98 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.544 ' O ' ' HE3' ' X' ' 4' ' ' LYS . 25.6 t0 -103.56 4.44 35.78 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 9.7 m-85 -99.0 121.06 40.46 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.6 -177.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.444 HG22 ' HG3' ' X' ' 92' ' ' LYS . 73.7 p -79.18 167.08 21.48 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 169.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.631 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.4 pt-20 -56.52 -42.65 78.78 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.629 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -38.31 75.6 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' X' ' 11' ' ' THR . 22.3 mm-40 -59.0 -37.65 77.36 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.363 0.601 . . . . 0.0 110.12 174.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.701 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 25.0 t80 -73.42 -42.8 61.61 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.743 HG12 HG11 ' X' ' 76' ' ' VAL . 3.9 m -62.99 -29.05 46.28 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.447 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.978 178.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -61.01 -46.75 89.47 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.625 ' O ' HG13 ' X' ' 22' ' ' ILE . 30.1 tp -61.34 -47.23 86.82 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 175.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 41.1 mt -58.21 -38.54 76.99 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.158 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 68.3 mttm -71.55 -34.83 70.34 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.659 176.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.85 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.67 HG12 ' HB3' ' X' ' 37' ' ' LEU . 60.9 mt -62.92 -42.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.431 ' O ' HG22 ' X' ' 27' ' ' VAL . 1.6 tt0 -58.14 -44.45 87.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.242 174.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -59.11 -48.69 80.68 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.384 1.074 . . . . 0.0 109.567 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.8 -26.75 49.85 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.357 -178.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -80.01 -41.41 25.87 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 122.157 -0.34 . . . . 0.0 111.81 -179.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . 0.431 HG22 ' O ' ' X' ' 23' ' ' GLU . 33.0 m -70.52 -20.84 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.845 -179.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.93 -16.85 18.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.39 76.13 0.31 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.161 1.384 . . . . 0.0 111.969 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 67.8 p -96.37 -168.81 1.8 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.87 -43.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.943 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.516 ' O ' HG23 ' X' ' 36' ' ' VAL . 23.6 t70 -64.89 -53.02 53.19 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 79.4 t -87.15 -27.12 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.604 -178.106 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.04 -46.53 87.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.05 -20.6 61.65 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.516 HG23 ' O ' ' X' ' 32' ' ' ASP . 54.7 t -70.86 -49.77 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 C-N-CA 118.563 -1.255 . . . . 0.0 108.286 175.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 63.3 mt -68.29 -41.68 80.59 Favored 'General case' 0 CA--C 1.469 -2.166 0 CA-C-N 113.756 -1.565 . . . . 0.0 112.345 -170.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 13.5 mt -59.28 -44.57 92.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 124.151 0.907 . . . . 0.0 110.517 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.53 -45.0 63.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.71 177.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.58 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 20.2 t60 -59.33 -45.48 91.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.2 -175.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.586 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 39.6 t80 -60.49 -50.83 72.02 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.877 178.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.87 -32.19 55.38 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.538 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -179.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 20.8 ptmt -69.53 -33.77 73.27 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.998 -0.439 . . . . 0.0 111.925 -178.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.469 HG12 ' O ' ' X' ' 40' ' ' HIS . 11.7 pt -85.07 -31.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 -178.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 53.2 p -84.77 -32.26 23.51 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.255 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 58.45 31.89 21.49 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.652 1.181 . . . . 0.0 109.949 -177.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 33.8 t-80 -82.52 135.14 46.86 Favored Pre-proline 0 N--CA 1.424 -1.774 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.441 -178.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.51 -12.33 31.29 Favored 'Trans proline' 0 CA--C 1.501 -1.168 0 C-N-CA 123.068 2.512 . . . . 0.0 112.681 -176.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 9.0 m-20 -130.51 30.28 4.72 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.586 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.38 -58.69 5.69 Favored Glycine 0 CA--C 1.453 -3.805 0 CA-C-N 114.491 -1.231 . . . . 0.0 113.277 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.484 HG21 HD13 ' X' ' 38' ' ' LEU . 1.5 m -79.09 -23.3 44.23 Favored 'General case' 0 C--N 1.251 -3.707 0 C-N-CA 117.944 -1.502 . . . . 0.0 110.759 -172.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.53 67.15 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 175.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 28.3 mt -66.67 -37.28 84.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.627 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mt -66.37 -42.79 91.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.891 0.853 . . . . 0.0 108.827 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -62.72 -43.35 99.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.083 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.89 -40.09 75.88 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.048 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.67 81.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.97 99.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.595 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.02 68.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.408 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -60.75 -40.19 91.53 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.623 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.481 ' HB2' ' CA ' ' X' ' 71' ' ' GLY . . . -75.82 -32.18 59.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.637 0.256 . . . . 0.0 111.188 177.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.23 88.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.1 179.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.13 14.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 61.81 89.1 0.11 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 111.082 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.96 176.16 10.26 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 122.603 2.202 . . . . 0.0 112.048 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.01 72.15 2.65 Favored Glycine 0 CA--C 1.484 -1.875 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.76 172.17 13.24 Favored Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 t70 73.64 -53.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.951 1.3 . . . . 0.0 111.909 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.97 -46.16 1.21 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.72 -46.85 2.09 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.481 ' CA ' ' HB2' ' X' ' 61' ' ' ALA . . . -82.09 -134.93 1.99 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 -172.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.545 ' O ' HG13 ' X' ' 75' ' ' ILE . 12.8 Cg_endo -54.1 -45.44 41.0 Favored 'Trans proline' 0 C--O 1.212 -0.804 0 C-N-CA 123.959 3.106 . . . . 0.0 114.077 -171.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -74.15 1.35 11.41 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.64 -6.25 25.19 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 119.901 -1.142 . . . . 0.0 112.769 174.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.545 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.0 OUTLIER -77.04 -43.68 31.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.743 HG11 HG12 ' X' ' 16' ' ' VAL . 1.2 p -58.22 -43.18 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.989 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 87.8 tttt -58.58 -48.15 81.89 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.393 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.35 -39.46 90.68 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.791 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.408 HG12 ' O ' ' X' ' 75' ' ' ILE . 47.6 mm -66.5 -45.31 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.278 178.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.9 pttp -62.34 -36.24 81.6 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -177.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 45.3 mt-10 -70.78 -36.23 72.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.134 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -70.2 -47.86 59.66 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.768 0.794 . . . . 0.0 108.877 178.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 13.6 tpt180 -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.783 -175.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.25 -43.08 78.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.175 0.59 . . . . 0.0 111.723 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -30.85 71.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -78.06 -37.4 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.08 33.63 5.68 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.345 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 20.2 mtpp -113.95 143.34 29.43 Favored Pre-proline 0 N--CA 1.4 -2.957 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -176.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 128.12 22.59 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.972 2.448 . . . . 0.0 111.884 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.36 -112.0 3.64 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.45 -178.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.98 166.18 14.68 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.406 -173.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.444 ' HG3' HG22 ' X' ' 11' ' ' THR . 22.2 ptmt -99.76 170.72 8.35 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.27 141.14 30.74 Favored 'General case' 0 N--CA 1.391 -3.409 0 CA-C-O 121.678 0.751 . . . . 0.0 109.571 178.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.109 0 N-CA-C 107.374 -2.29 . . . . 0.0 107.374 178.987 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' X' ' 40' ' ' HIS . 85.0 mt -95.75 127.4 41.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 176.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 24.1 mmtt -104.14 142.33 34.68 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -75.12 -16.01 60.57 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.113 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 84.5 p -132.2 162.73 30.2 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.959 175.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.454 HD11 ' CE1' ' X' ' 91' ' ' PHE . 8.5 tp -69.27 -17.84 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.717 0.807 . . . . 0.0 109.679 -177.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -19.61 59.18 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.359 -172.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 17.6 t70 -101.82 5.0 40.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.974 0.892 . . . . 0.0 109.095 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' X' ' 3' ' ' LEU . 4.2 m-85 -95.01 114.95 26.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.085 -174.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.523 HG22 ' HG3' ' X' ' 92' ' ' LYS . 70.8 p -80.42 162.36 24.49 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.592 ' O ' HG13 ' X' ' 16' ' ' VAL . 7.5 pt-20 -56.56 -44.77 81.27 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.579 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.1 -39.05 75.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -58.61 -38.46 78.04 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.277 0.49 . . . . 0.0 110.023 175.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -73.49 -43.12 60.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.338 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.817 HG12 HG11 ' X' ' 76' ' ' VAL . 11.0 m -62.58 -36.39 74.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.082 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.513 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.418 ' HB3' HE21 ' X' ' 17' ' ' GLN . 6.0 tt0 -61.52 -49.46 76.63 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 109.649 177.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.508 ' O ' HG13 ' X' ' 22' ' ' ILE . 1.7 tm? -61.19 -43.32 99.07 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.546 HD23 HG13 ' X' ' 75' ' ' ILE . 3.0 mp -58.41 -36.94 74.35 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.553 -1.203 . . . . 0.0 114.046 176.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 91.4 mttt -66.26 -40.0 89.87 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.188 0.518 . . . . 0.0 109.643 176.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.78 -37.36 87.34 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.595 178.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' X' ' 37' ' ' LEU . 26.3 mt -61.0 -45.18 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.413 ' CD ' ' HD3' ' X' ' 72' ' ' PRO . 52.6 mt-10 -58.54 -46.22 87.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.551 0.691 . . . . 0.0 110.639 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.01 -49.83 76.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.069 -175.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -71.82 -27.63 63.04 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -70.59 -53.92 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.462 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.62 -20.65 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.38 -13.98 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.543 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.87 70.25 0.6 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.297 1.039 . . . . 0.0 111.071 -176.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p -88.9 -17.56 29.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 110.951 -176.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . 0.394 1.7 m-20 65.3 -59.55 0.27 Allowed 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 178.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.671 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.6 t70 -63.55 -57.01 11.51 Favored 'General case' 0 CA--C 1.478 -1.816 0 CA-C-N 119.817 1.19 . . . . 0.0 111.733 -176.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.73 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 44.0 t -76.42 -32.25 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.067 -177.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.628 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 1.8 tm? -58.35 -47.28 84.28 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 32.8 t70 -65.02 -41.84 94.93 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.671 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.6 t -56.53 -50.03 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 O-C-N 124.224 0.953 . . . . 0.0 110.079 179.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 73.2 mt -67.65 -39.92 84.58 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.603 -172.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 43.8 mt -63.21 -49.95 72.21 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 7.3 pt-20 -71.2 -34.45 70.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.889 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.564 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 59.3 t60 -60.21 -45.49 92.98 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.416 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 63.7 t80 -60.63 -52.98 62.83 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.781 178.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.526 HG12 ' O ' ' X' ' 38' ' ' LEU 0.291 2.7 p -67.49 -32.91 59.2 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.915 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 13.0 ptmm? -67.17 -33.39 75.3 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.924 -0.485 . . . . 0.0 111.876 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.487 HG12 ' O ' ' X' ' 40' ' ' HIS . 17.6 pt -86.23 -36.05 9.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.833 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -84.18 -33.45 24.18 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 120.891 0.377 . . . . 0.0 111.117 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 64.05 19.34 11.71 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.266 1.427 . . . . 0.0 111.392 -176.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.418 ' O ' HG23 ' X' ' 42' ' ' VAL . 47.8 t-80 -73.0 132.22 82.98 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.533 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -70.19 -17.05 35.88 Favored 'Trans proline' 0 CA--C 1.492 -1.613 0 C-N-CA 122.833 2.355 . . . . 0.0 112.662 -172.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' X' ' 52' ' ' ALA . 5.4 m-20 -127.14 36.19 4.46 Favored 'General case' 0 N--CA 1.389 -3.508 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -173.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.416 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -48.48 -53.52 16.15 Favored Glycine 0 CA--C 1.454 -3.731 0 CA-C-N 114.062 -1.426 . . . . 0.0 112.422 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.482 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -76.43 -31.56 57.96 Favored 'General case' 0 C--N 1.247 -3.874 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.731 -173.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -60.88 -38.08 84.38 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.058 177.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.8 -48.45 75.35 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.477 0.486 . . . . 0.0 112.136 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.454 HG12 HG21 ' X' ' 22' ' ' ILE . 5.1 mp -67.88 -42.17 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 118.272 -1.371 . . . . 0.0 110.079 -178.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.413 ' HD2' ' O ' ' X' ' 51' ' ' THR . 27.0 m-85 -62.55 -45.51 92.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.158 -178.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 9.8 pt-20 -68.66 -35.92 77.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.283 176.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . 0.434 ' O ' ' HA3' ' X' ' 70' ' ' GLY . . . -57.48 -39.28 76.05 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 122.482 0.313 . . . . 0.0 110.982 178.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.74 87.42 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 177.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.41 78.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.834 0.826 . . . . 0.0 110.113 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -64.92 -30.34 71.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.058 178.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.45 58.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.112 0.482 . . . . 0.0 109.746 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.09 94.06 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.94 72.45 0.78 Allowed 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.456 0.646 . . . . 0.0 109.39 174.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -72.02 117.86 61.9 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.498 -177.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -85.74 -14.48 5.37 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.13 1.887 . . . . 0.0 112.181 177.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.89 177.46 14.9 Favored Glycine 0 CA--C 1.485 -1.805 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -177.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.85 -133.52 17.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.52 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -80.05 -50.45 10.34 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 175.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.17 -134.65 20.1 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' X' ' 57' ' ' ALA . . . -103.83 128.08 9.37 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 176.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.464 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 168.96 165.77 26.91 Favored Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.69 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.562 ' O ' HG12 ' X' ' 76' ' ' VAL . 12.8 Cg_endo -61.09 -43.77 27.92 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.541 2.828 . . . . 0.0 112.564 -175.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.89 0.82 16.93 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.2 -40.31 1.41 Allowed Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.381 177.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.546 HG13 HD23 ' X' ' 19' ' ' LEU . 3.6 pt -60.52 -29.72 45.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.169 0.485 . . . . 0.0 111.771 176.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.817 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -65.51 -45.59 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 122.327 1.061 . . . . 0.0 111.088 175.12 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 40.7 ttmt -63.07 -37.72 88.31 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.584 -1.643 . . . . 0.0 109.761 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.91 -43.74 98.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.319 0.581 . . . . 0.0 111.124 174.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.469 HG12 ' O ' ' X' ' 75' ' ' ILE . 44.5 mm -61.24 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.912 176.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 22.3 ptmt -63.59 -36.3 83.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.963 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 43.6 mt-10 -64.55 -41.64 96.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.415 0.447 . . . . 0.0 110.752 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.533 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 64.3 t90 -68.12 -45.33 73.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.524 0.678 . . . . 0.0 109.769 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -60.91 -45.28 95.27 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.454 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.11 85.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.59 92.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.951 0.405 . . . . 0.0 110.738 178.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.469 ' OD1' ' HG3' ' X' ' 88' ' ' LYS . 21.7 t-20 -69.63 -41.34 75.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.726 0.774 . . . . 0.0 109.444 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.79 28.75 5.23 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' X' ' 86' ' ' ASN . 67.7 mttm -100.31 150.85 37.28 Favored Pre-proline 0 N--CA 1.402 -2.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.67 128.56 28.63 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.281 2.654 . . . . 0.0 112.152 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.21 -149.47 25.5 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.941 -177.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' X' ' 7' ' ' ILE . 42.2 m-85 -79.28 159.66 27.15 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -176.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' X' ' 11' ' ' THR . 21.3 ptmt -98.73 176.31 5.67 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-O 121.723 0.773 . . . . 0.0 110.126 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -112.34 141.84 45.58 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.554 174.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.569 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 -179.794 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 CA--C 1.517 -0.303 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -116.94 136.37 53.0 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.503 0.502 . . . . 0.0 110.121 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -111.68 -169.84 1.54 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -107.75 -29.18 9.25 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.628 0.727 . . . . 0.0 110.236 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -131.82 163.52 28.08 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.352 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -69.68 -13.4 17.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 CA-C-O 121.549 0.69 . . . . 0.0 110.668 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 10.8 m -72.82 -22.13 60.85 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.636 -174.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' X' ' 92' ' ' LYS . 21.9 t70 -100.57 3.4 42.67 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.165 0.983 . . . . 0.0 108.883 177.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -92.49 115.12 27.81 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.473 -176.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 65.2 p -76.53 159.18 30.58 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 171.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.636 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.7 pt-20 -61.13 -35.27 76.61 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.951 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.44 -38.45 74.53 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.802 177.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.2 -40.99 83.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.12 0.962 . . . . 0.0 109.243 173.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.562 ' HD2' HG12 ' X' ' 76' ' ' VAL . 41.4 t80 -69.27 -45.02 70.68 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.057 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.786 HG12 HG11 ' X' ' 76' ' ' VAL . 8.4 m -61.86 -38.75 81.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.46 -36.48 79.06 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 121.487 0.661 . . . . 0.0 111.544 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.487 ' O ' HG13 ' X' ' 22' ' ' ILE . 3.1 tm? -66.92 -46.18 75.61 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.702 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' X' ' 41' ' ' PHE . 7.3 mp -60.13 -36.97 78.66 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.081 177.28 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.649 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 62.5 mttm -63.11 -35.64 80.93 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.477 0.656 . . . . 0.0 109.964 176.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -69.38 -33.5 73.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.632 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' X' ' 37' ' ' LEU . 9.5 mt -67.46 -40.84 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.72 -46.75 84.0 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.55 -42.81 97.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.907 -176.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -77.16 -29.05 54.31 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.164 -0.335 . . . . 0.0 111.493 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -75.42 -46.37 33.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.131 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.44 -35.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.909 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.33 -10.07 56.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 177.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.07 74.51 0.29 Allowed 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.543 1.537 . . . . 0.0 113.431 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 56.6 p -99.24 -166.27 1.33 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.34 -61.84 1.01 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.59 ' O ' HG23 ' X' ' 36' ' ' VAL . 18.5 m-20 -56.96 -50.93 71.14 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.668 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 62.0 t -88.59 -29.16 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.52 -45.65 88.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.64 -30.4 67.02 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.267 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.59 HG23 ' O ' ' X' ' 32' ' ' ASP . 95.8 t -63.29 -49.73 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.493 176.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.669 ' HB3' HG12 ' X' ' 22' ' ' ILE . 77.0 mt -68.47 -43.78 76.25 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.486 -170.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 36.2 mt -61.14 -46.22 91.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 124.099 0.874 . . . . 0.0 110.428 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.44 -43.77 69.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.989 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.485 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.2 t60 -60.12 -45.71 92.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.607 -176.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.636 ' CD2' HD11 ' X' ' 54' ' ' ILE . 39.5 t80 -61.43 -51.49 68.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.224 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.432 HG12 ' O ' ' X' ' 38' ' ' LEU . 14.9 p -67.7 -32.59 57.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.8 pttt -72.63 -26.59 61.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.46 HG12 ' O ' ' X' ' 40' ' ' HIS . 26.6 pt -87.26 -34.87 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.779 179.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -84.3 -31.97 24.59 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 58.06 31.71 21.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.633 1.173 . . . . 0.0 109.877 -176.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 40.9 t-80 -82.43 138.52 44.74 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 113.514 -1.675 . . . . 0.0 108.117 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' X' ' 47' ' ' HIS . 15.6 Cg_exo -73.5 -6.42 18.73 Favored 'Trans proline' 0 CA--C 1.492 -1.593 0 C-N-CA 123.1 2.533 . . . . 0.0 112.599 -175.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.433 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 38.0 m-20 -135.63 32.19 3.04 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.583 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.73 -59.99 5.13 Favored Glycine 1 CA--C 1.445 -4.34 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.872 -176.842 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.469 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -75.18 -30.13 60.6 Favored 'General case' 1 C--N 1.242 -4.092 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.019 -172.641 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.15 -28.13 69.85 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' X' ' 56' ' ' GLU . 28.1 mt -65.13 -43.1 93.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 175.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.636 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.6 mp -67.2 -41.66 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.789 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -58.27 -47.28 84.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.685 178.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 3.6 pt-20 -67.67 -36.72 81.23 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.325 175.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.53 -45.14 85.38 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.125 0.421 . . . . 0.0 111.824 -178.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.9 97.84 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.91 70.56 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.923 179.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' X' ' 64' ' ' ASN . 52.0 mtp180 -64.85 -30.71 71.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.064 0.946 . . . . 0.0 111.517 177.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.18 16.21 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.174 175.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -45.34 88.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.233 0.54 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 80.23 1.52 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' X' ' 60' ' ' ARG . 5.1 t-20 -72.11 112.47 14.65 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.911 -176.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.98 -50.46 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.956 1.77 . . . . 0.0 110.518 178.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.16 172.54 31.42 Favored Glycine 0 CA--C 1.473 -2.575 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.27 52.58 4.54 Favored Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 115.384 -0.408 . . . . 0.0 112.909 -176.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -93.46 -8.81 40.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.153 0.501 . . . . 0.0 109.864 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.99 81.21 0.94 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -177.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.6 88.79 1.47 Allowed Glycine 0 N--CA 1.418 -2.508 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 177.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.492 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 147.09 -143.94 11.96 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 178.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.623 ' O ' HG13 ' X' ' 76' ' ' VAL . 12.7 Cg_endo -74.46 -46.24 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.353 2.702 . . . . 0.0 112.353 -172.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.483 ' C ' HG22 ' X' ' 76' ' ' VAL . 31.5 mt-10 -73.5 0.86 11.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -177.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.31 -34.3 2.95 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.518 172.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.52 HG13 ' O ' ' X' ' 72' ' ' PRO . 1.8 pt -66.89 -27.11 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-N 117.647 0.723 . . . . 0.0 110.633 172.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.786 HG11 HG12 ' X' ' 16' ' ' VAL . 27.6 m -62.16 -37.99 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.889 0 CA-C-O 121.689 0.757 . . . . 0.0 110.992 176.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' X' ' 81' ' ' GLU . 39.8 ttmt -65.74 -45.01 84.22 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.788 176.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -58.1 -38.05 75.71 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.57 -46.89 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.412 177.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 17.9 ptpt -66.82 -38.5 86.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.726 -175.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 46.2 mt-10 -69.69 -32.22 70.7 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.252 -178.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.403 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 81.2 t90 -72.19 -48.28 44.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.559 0.695 . . . . 0.0 109.354 177.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 14.9 tpt180 -61.39 -45.45 94.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.415 -174.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.42 84.3 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.04 84.26 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.862 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.58 -45.74 57.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.645 0.736 . . . . 0.0 109.061 177.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.35 37.5 1.94 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 93.0 mttt -112.51 143.47 29.0 Favored Pre-proline 0 N--CA 1.391 -3.387 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.51 131.23 27.27 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.43 2.086 . . . . 0.0 110.314 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -114.59 -115.71 3.12 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.818 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -79.18 145.93 33.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -174.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' X' ' 11' ' ' THR . 45.8 pttt -97.38 172.4 7.79 Favored 'General case' 0 N--CA 1.384 -3.771 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.97 148.64 22.11 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 177.86 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 CA--C 1.487 -1.467 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' X' ' 18' ' ' LEU . 35.0 mt -91.65 131.89 36.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 35.1 mmtt -93.09 -166.73 1.58 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -118.16 -0.08 11.65 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 174.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -153.44 158.89 42.08 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.212 176.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' X' ' 10' ' ' TYR . 11.3 tt -67.4 -24.43 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.488 0.661 . . . . 0.0 110.571 -178.422 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -85.44 0.09 53.31 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.951 -174.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 5.6 t70 -104.11 -1.28 27.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' X' ' 7' ' ' ILE . 8.0 m-85 -97.53 124.61 41.83 Favored 'General case' 0 CA--C 1.472 -2.025 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.804 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 47.9 p -78.75 159.4 27.94 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.014 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.63 ' O ' HG13 ' X' ' 16' ' ' VAL . 0.0 OUTLIER -56.21 -41.11 75.1 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 123.321 0.388 . . . . 0.0 110.383 -179.41 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.719 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.4 76.26 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.48 -38.9 82.05 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.737 0.779 . . . . 0.0 109.682 173.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.599 ' CD2' HG12 ' X' ' 76' ' ' VAL . 22.0 t80 -75.3 -41.73 56.28 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.73 -177.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.719 HG22 ' HA ' ' X' ' 13' ' ' ALA . 15.1 m -62.87 -32.79 57.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 176.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -64.24 -47.33 80.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 122.912 0.485 . . . . 0.0 109.966 178.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.679 ' O ' HG13 ' X' ' 22' ' ' ILE . 19.9 tp -57.23 -47.59 80.94 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 123.873 0.733 . . . . 0.0 109.292 177.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.94 -36.82 77.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.345 177.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.623 ' HG2' ' HG3' ' X' ' 72' ' ' PRO . 97.4 mttt -61.23 -46.47 90.29 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.518 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . 0.499 ' HA ' ' HE3' ' X' ' 24' ' ' LYS . 54.8 mt-10 -64.14 -37.81 88.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.627 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.701 HG12 ' HB3' ' X' ' 37' ' ' LEU . 27.4 mt -63.17 -44.61 99.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' X' ' 20' ' ' LYS . 4.8 pt-20 -65.68 -35.07 79.71 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.143 0.973 . . . . 0.0 109.423 -178.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' X' ' 21' ' ' GLU . 27.8 ttpp -72.29 -52.03 18.11 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.474 -174.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -17.33 64.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.947 0.403 . . . . 0.0 111.305 176.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -81.08 -51.38 8.54 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.524 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 m -73.09 -26.39 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -177.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.24 -22.01 33.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.31 78.82 0.27 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.171 1.388 . . . . 0.0 112.011 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -92.31 -28.04 17.2 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 67.79 -55.15 0.49 Allowed 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 126.297 1.839 . . . . 0.0 115.374 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.44 ' O ' HG23 ' X' ' 36' ' ' VAL . 9.5 p-10 -68.36 -47.4 67.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 7.4 p -85.95 -29.88 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.2 tm? -59.13 -41.27 87.84 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 177.309 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 27.0 t70 -62.0 -41.69 98.33 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 123.386 0.429 . . . . 0.0 110.02 178.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.44 HG23 ' O ' ' X' ' 32' ' ' ASP . 58.2 t -59.29 -48.74 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 O-C-N 124.622 1.201 . . . . 0.0 109.47 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 69.2 mt -64.64 -43.22 94.37 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.662 -173.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 17.3 mt -60.11 -50.69 72.68 Favored 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 124.119 0.887 . . . . 0.0 111.051 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 1.5 pt-20 -70.69 -37.5 73.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.697 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 11.5 t60 -59.75 -46.26 89.71 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.268 0.627 . . . . 0.0 109.644 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.556 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 44.9 t80 -61.8 -53.52 54.77 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.259 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.452 HG12 ' O ' ' X' ' 38' ' ' LEU . 8.2 p -67.09 -31.7 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 54.1 pttt -69.63 -38.88 77.35 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 122.089 -0.382 . . . . 0.0 111.948 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.48 HG12 ' O ' ' X' ' 40' ' ' HIS . 19.1 pt -79.63 -31.79 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.795 0.331 . . . . 0.0 110.747 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 54.7 p -84.04 -34.99 24.13 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.81 22.95 13.25 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.65 1.18 . . . . 0.0 109.929 -176.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -79.3 133.31 60.58 Favored Pre-proline 0 N--CA 1.433 -1.305 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.278 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.445 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 19.1 Cg_exo -71.69 -19.48 27.7 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.282 -173.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -118.5 30.37 7.24 Favored 'General case' 0 N--CA 1.4 -2.957 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -171.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.556 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -46.0 -57.33 6.25 Favored Glycine 0 CA--C 1.461 -3.34 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.9 -178.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.525 HG21 HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -82.26 -22.78 35.61 Favored 'General case' 0 C--N 1.247 -3.867 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.959 -172.206 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -62.84 -36.69 84.06 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.754 174.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.09 -40.44 97.66 Favored 'General case' 0 C--O 1.207 -1.142 0 O-C-N 123.609 0.568 . . . . 0.0 110.643 175.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.497 HD13 HG21 ' X' ' 22' ' ' ILE . 51.1 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.392 0.615 . . . . 0.0 109.864 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -62.17 -44.49 96.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.69 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.6 pt-20 -71.17 -38.38 72.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.924 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.13 96.46 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.57 -46.16 80.9 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.328 0.392 . . . . 0.0 110.595 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.17 -44.48 59.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.481 178.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -67.91 -31.31 70.99 Favored 'General case' 0 C--O 1.194 -1.845 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.72 -23.44 42.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.974 -0.454 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.02 69.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.866 178.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.52 85.61 2.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -87.74 112.07 46.36 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.21 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.19 -2.22 11.89 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.247 2.631 . . . . 0.0 113.513 -177.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.72 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.32 -168.06 38.53 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.083 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 64.78 25.42 12.94 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.743 1.217 . . . . 0.0 111.722 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.18 -30.22 0.1 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.86 61.3 4.54 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.81 170.14 23.05 Favored Glycine 0 N--CA 1.396 -3.979 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.755 ' HA ' HD11 ' X' ' 75' ' ' ILE . 24.1 Cg_endo -66.11 -24.64 51.74 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.472 . . . . 0.0 112.805 -175.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.479 ' HG2' HG11 ' X' ' 16' ' ' VAL . 35.7 mt-10 -85.68 1.96 47.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.964 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -105.44 -32.82 3.82 Favored Glycine 0 N--CA 1.419 -2.441 0 C-N-CA 118.377 -1.868 . . . . 0.0 114.322 176.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.755 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -69.95 -28.21 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-N 118.68 1.24 . . . . 0.0 110.204 175.128 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.599 HG12 ' CD2' ' X' ' 15' ' ' PHE . 27.5 m -63.61 -38.06 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-O 121.347 0.594 . . . . 0.0 110.489 177.225 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 44.2 tttm -61.28 -48.46 81.29 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.445 173.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.16 -37.45 82.95 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.741 -178.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.422 HG12 ' O ' ' X' ' 75' ' ' ILE . 31.4 mm -68.46 -46.36 80.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.571 177.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 20.2 pttp -65.09 -38.06 89.51 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.666 -174.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.23 -38.78 75.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.272 -178.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.445 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 71.2 t90 -66.69 -47.88 71.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 109.131 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' X' ' 88' ' ' LYS . 19.7 tpt180 -61.19 -46.33 90.92 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.071 -175.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.58 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.868 -178.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.05 75.02 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.923 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.419 ' ND2' ' HE2' ' X' ' 88' ' ' LYS . 3.1 t30 -72.82 -42.63 63.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.64 34.99 1.62 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.918 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' X' ' 83' ' ' ARG . 65.9 mttm -115.43 140.13 25.48 Favored Pre-proline 0 N--CA 1.385 -3.685 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -177.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -61.5 136.31 62.49 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.422 2.082 . . . . 0.0 110.899 176.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.0 -120.33 4.68 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.233 -174.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -86.87 166.42 15.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 124.202 0.59 . . . . 0.0 109.441 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' X' ' 11' ' ' THR . 18.0 ptmt -105.18 162.14 13.65 Favored 'General case' 1 N--CA 1.374 -4.265 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.176 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.83 134.44 49.98 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.489 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.265 -3.379 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.806 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 . . . . . 0 CA--C 1.509 -0.609 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.07 130.4 44.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.849 0.833 . . . . 0.0 112.623 -178.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' X' ' 9' ' ' ASP . 32.2 mmtt -101.76 -157.52 0.61 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -120.5 -20.37 7.19 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.222 171.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 66.4 p -141.01 165.7 26.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.464 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.09 -23.11 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.649 1.18 . . . . 0.0 110.393 -179.3 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.9 m -73.68 -16.33 61.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.798 -173.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 19.2 t70 -102.97 3.27 36.13 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.508 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.463 ' OH ' HD22 ' X' ' 18' ' ' LEU . 8.6 m-85 -97.04 118.4 33.35 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.39 -175.235 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 23.8 p -80.15 164.62 23.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.624 ' O ' HG13 ' X' ' 16' ' ' VAL . 5.8 pt-20 -59.08 -40.44 85.26 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.403 178.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.636 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.91 -38.63 76.32 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.42 -38.0 79.48 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.707 0.765 . . . . 0.0 110.261 174.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.575 ' HD2' HG12 ' X' ' 76' ' ' VAL . 36.3 t80 -72.87 -46.02 55.12 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.617 -179.054 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.741 HG12 HG11 ' X' ' 76' ' ' VAL . 10.4 m -62.34 -34.42 64.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.848 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.09 -49.69 76.3 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.657 ' O ' HG13 ' X' ' 22' ' ' ILE . 55.3 tp -60.0 -46.78 88.35 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.524 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.423 HD21 ' CD1' ' X' ' 41' ' ' PHE . 4.4 mm? -58.51 -36.86 74.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.619 178.224 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 88.5 mttt -63.83 -37.23 86.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.333 0.587 . . . . 0.0 110.568 175.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.31 -35.61 66.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.657 HG13 ' O ' ' X' ' 18' ' ' LEU . 17.3 mt -67.64 -42.09 86.2 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.176 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.405 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -42.8 84.75 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.917 1.287 . . . . 0.0 109.604 177.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.74 -47.62 74.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.619 -177.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.676 ' HG3' ' CG1' ' X' ' 33' ' ' VAL . 7.1 mm-40 -76.97 -15.4 59.66 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.319 178.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.53 -45.93 64.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.16 -26.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.383 179.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.42 50.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.061 176.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.8 77.27 0.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.166 1.386 . . . . 0.0 111.267 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 27.2 p -101.46 -168.73 1.59 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.73 -35.35 0.58 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.126 176.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.481 ' O ' HG23 ' X' ' 36' ' ' VAL . 37.7 m-20 -65.11 -53.02 51.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.742 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 4.8 p -88.52 -31.12 5.49 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.943 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.181 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.25 -45.02 92.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.322 -175.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.76 -29.71 63.54 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.887 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.481 HG23 ' O ' ' X' ' 32' ' ' ASP . 92.4 t -64.46 -48.78 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.063 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.457 176.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 85.9 mt -67.58 -43.57 80.26 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.121 -172.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 44.5 mt -61.81 -45.06 95.5 Favored 'General case' 0 N--CA 1.422 -1.837 0 O-C-N 124.194 0.934 . . . . 0.0 110.786 -179.575 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.24 -47.28 62.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 177.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.504 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 12.3 t60 -59.71 -44.2 93.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -175.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.593 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 30.9 t80 -59.95 -52.97 63.13 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.884 177.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.518 HG12 ' O ' ' X' ' 38' ' ' LEU . 13.8 p -67.71 -32.55 57.2 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.773 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 15.0 pttp -70.17 -28.59 65.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.454 HG12 ' O ' ' X' ' 40' ' ' HIS . 21.5 pt -84.38 -40.77 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.369 -177.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.573 HG22 ' O ' ' X' ' 41' ' ' PHE . 6.4 t -83.64 -32.11 25.85 Favored 'General case' 0 C--O 1.252 1.224 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.653 178.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.56 30.55 12.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 125.908 1.683 . . . . 0.0 111.342 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.514 ' H ' HG23 ' X' ' 45' ' ' THR . 48.0 t-80 -76.65 137.0 67.01 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.85 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 18.6 Cg_exo -70.99 -13.07 31.35 Favored 'Trans proline' 0 CA--C 1.502 -1.115 0 C-N-CA 123.099 2.533 . . . . 0.0 112.645 -174.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.55 31.45 4.78 Favored 'General case' 0 N--CA 1.398 -3.051 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -173.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -47.15 -56.88 7.49 Favored Glycine 0 CA--C 1.457 -3.584 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.921 -178.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.459 HG23 HD22 ' X' ' 38' ' ' LEU . 1.3 m -72.08 -32.55 67.14 Favored 'General case' 0 C--N 1.256 -3.479 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.271 -173.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -63.32 -37.21 86.39 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.996 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' X' ' 75' ' ' ILE . 27.6 mt -58.47 -39.02 78.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.766 0.666 . . . . 0.0 112.22 178.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.628 HD13 HG21 ' X' ' 22' ' ' ILE . 67.8 mt -65.89 -44.43 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.638 . . . . 0.0 109.304 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.56 -49.74 74.09 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.274 178.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 7.8 pt-20 -69.65 -42.43 74.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.22 92.73 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.187 -179.603 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.26 73.52 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.033 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.93 75.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.701 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.37 -31.07 71.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.521 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -74.71 -35.75 62.71 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.063 178.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.97 97.91 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.995 -179.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.53 -48.53 13.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.909 177.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 60.91 90.9 0.08 OUTLIER Pre-proline 0 C--O 1.241 0.612 0 C-N-CA 125.441 1.497 . . . . 0.0 113.158 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.28 2.99 4.44 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.771 2.314 . . . . 0.0 112.511 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.46 161.11 15.38 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.83 177.42 49.32 Favored Glycine 0 C--O 1.247 0.957 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -178.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -102.85 -169.57 1.67 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.75 -33.11 6.66 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -177.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.71 143.92 21.83 Favored Glycine 0 N--CA 1.414 -2.811 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 176.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.521 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 89.56 164.78 40.41 Favored Glycine 0 N--CA 1.424 -2.109 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.947 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.512 ' HA ' HD11 ' X' ' 75' ' ' ILE . 18.7 Cg_endo -55.98 -37.71 95.71 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 123.884 3.056 . . . . 0.0 114.126 -176.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.444 ' C ' HG22 ' X' ' 76' ' ' VAL . 35.7 mt-10 -86.37 2.39 47.68 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.76 -28.03 5.5 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 118.684 -1.722 . . . . 0.0 112.481 173.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' X' ' 72' ' ' PRO . 0.3 OUTLIER -61.12 -39.69 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 122.326 1.06 . . . . 0.0 108.277 176.349 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.741 HG11 HG12 ' X' ' 16' ' ' VAL . 29.2 m -59.46 -33.76 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 CA-C-N 113.314 -1.766 . . . . 0.0 112.686 -176.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -60.06 -51.64 68.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.773 172.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -59.32 -42.29 91.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.488 HD12 HG21 ' X' ' 45' ' ' THR . 29.0 mm -62.75 -46.29 96.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.014 177.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.49 -43.36 73.31 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.621 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -72.16 -32.21 66.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.156 -175.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.609 ' CZ3' ' HE3' ' X' ' 88' ' ' LYS . 62.0 t90 -66.11 -45.85 79.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.597 1.189 . . . . 0.0 109.133 175.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.438 ' HG2' ' HA2' ' X' ' 90' ' ' GLY . 9.2 tpt180 -66.24 -46.92 75.48 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.169 -177.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -38.35 81.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.489 0.716 . . . . 0.0 112.094 -176.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.24 70.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . 0.597 ' HB3' ' NZ ' ' X' ' 88' ' ' LYS . 56.4 t30 -101.4 6.16 42.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.075 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.43 42.32 49.19 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.004 175.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.609 ' HE3' ' CZ3' ' X' ' 82' ' ' TRP . 36.6 mtmm -105.19 139.44 20.13 Favored Pre-proline 1 N--CA 1.378 -4.042 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.849 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.08 114.7 2.12 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 111.788 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' X' ' 83' ' ' ARG . . . -94.0 -125.11 4.09 Favored Glycine 0 CA--C 1.489 -1.587 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.659 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.71 152.84 28.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.975 0.417 . . . . 0.0 110.285 -175.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.07 177.71 6.85 Favored 'General case' 0 N--CA 1.391 -3.375 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . 0.425 ' HA ' ' NE2' ' X' ' 93' ' ' GLN . 11.1 mm100 -117.59 143.37 46.18 Favored 'General case' 1 N--CA 1.377 -4.09 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 177.065 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.511 ' CD2' HD13 ' X' ' 18' ' ' LEU . 33.9 mt -103.01 134.32 46.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' X' ' 9' ' ' ASP . 34.3 mmtt -102.06 -162.45 0.93 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.52 -19.61 8.73 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.447 -0.783 . . . . 0.0 111.34 173.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 60.7 p -135.86 163.61 29.83 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.545 HG12 HH12 ' X' ' 83' ' ' ARG . 3.6 tp -69.81 -14.88 18.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.667 -177.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 44.5 m -71.87 -17.55 62.11 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.184 -174.036 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' X' ' 4' ' ' LYS . 17.2 t70 -106.83 5.06 28.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.791 0.805 . . . . 0.0 108.932 178.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.82 121.58 38.84 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.216 -176.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 43.6 p -88.61 179.51 6.25 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.665 ' O ' HG13 ' X' ' 16' ' ' VAL . 8.3 mm-40 -59.16 -52.36 66.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -69.22 -38.74 78.7 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.741 -171.244 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.56 -36.27 80.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 110.279 175.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.681 ' HD2' HG12 ' X' ' 76' ' ' VAL . 44.7 t80 -75.94 -44.66 39.02 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.354 -177.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.78 HG12 HG11 ' X' ' 76' ' ' VAL . 6.2 m -62.44 -33.25 58.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 116.939 -0.119 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -65.4 -47.84 74.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 123.024 0.53 . . . . 0.0 110.077 178.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.651 ' O ' HG13 ' X' ' 22' ' ' ILE . 17.9 tp -57.64 -47.44 82.22 Favored 'General case' 0 C--O 1.208 -1.09 0 CA-C-O 121.222 0.534 . . . . 0.0 109.789 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.515 HD13 ' O ' ' X' ' 15' ' ' PHE . 7.9 mp -59.48 -39.2 82.95 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.234 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 50.6 mttp -63.73 -38.5 91.33 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.174 0.511 . . . . 0.0 109.997 176.153 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' X' ' 24' ' ' LYS . 42.9 mt-10 -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.198 177.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.651 HG13 ' O ' ' X' ' 18' ' ' LEU . 31.0 mt -67.3 -40.89 85.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.351 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . 0.448 ' O ' HG22 ' X' ' 27' ' ' VAL . 52.3 mt-10 -57.89 -42.74 85.27 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.903 0.858 . . . . 0.0 109.728 177.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' X' ' 21' ' ' GLU . 80.1 tttt -60.23 -52.15 66.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.389 -176.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' X' ' 21' ' ' GLU . 1.2 pp20? -83.71 -32.93 25.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -58.3 -45.6 87.66 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.324 0.249 . . . . 0.0 111.503 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . 0.448 HG22 ' O ' ' X' ' 23' ' ' GLU . 31.7 m -76.22 -24.24 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.22 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -21.23 46.33 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.962 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.85 80.92 0.17 Allowed 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.878 1.671 . . . . 0.0 111.796 -178.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 0.7 OUTLIER -98.34 -175.2 3.04 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.139 174.433 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.71 -55.93 0.62 Allowed 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.724 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.67 ' O ' HG23 ' X' ' 36' ' ' VAL . 32.9 t70 -63.12 -57.42 10.65 Favored 'General case' 0 CA--C 1.484 -1.572 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.939 -179.177 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.687 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 9.8 p -73.08 -30.16 30.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -175.428 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.537 ' HB2' ' OG1' ' X' ' 30' ' ' THR . 3.4 tm? -61.21 -50.16 74.22 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.493 178.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.59 -24.5 62.77 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.835 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.67 HG23 ' O ' ' X' ' 32' ' ' ASP . 98.8 t -70.57 -51.34 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.98 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.118 177.084 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 44.7 mt -69.29 -43.13 74.46 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.87 -170.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.476 ' O ' HG12 ' X' ' 42' ' ' VAL . 25.7 mt -60.98 -43.51 98.72 Favored 'General case' 0 N--CA 1.419 -2.019 0 O-C-N 124.283 0.989 . . . . 0.0 111.226 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.82 -44.05 67.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.987 0.423 . . . . 0.0 111.128 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.516 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 7.8 t60 -59.52 -45.21 92.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.63 -175.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.617 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 60.5 t80 -60.16 -51.79 68.09 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.94 178.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.476 HG12 ' O ' ' X' ' 38' ' ' LEU 0.258 9.5 p -67.51 -32.28 56.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.494 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.716 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 19.0 ptmt -70.47 -37.49 74.27 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.99 -0.444 . . . . 0.0 112.073 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.511 HG12 ' O ' ' X' ' 40' ' ' HIS . 18.5 pt -78.75 -31.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.248 0.547 . . . . 0.0 110.776 -178.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.433 ' O ' ' HD2' ' X' ' 83' ' ' ARG . 53.7 p -84.36 -42.4 15.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.04 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.57 25.97 6.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.159 1.784 . . . . 0.0 110.446 -176.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' X' ' 49' ' ' ASP . 44.8 t-80 -80.35 135.66 53.63 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 114.286 -1.324 . . . . 0.0 107.797 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 23.2 Cg_exo -69.45 -15.56 38.31 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 122.933 2.422 . . . . 0.0 112.737 -173.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.427 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 20.7 m-20 -127.17 32.85 5.0 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.617 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.09 -59.23 4.04 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.966 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.474 ' O ' ' HD2' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -73.26 -32.39 64.66 Favored 'General case' 0 C--N 1.246 -3.933 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.537 -171.036 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -61.75 -36.0 79.75 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.494 178.165 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -59.82 -45.55 92.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 176.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.469 HD13 HG21 ' X' ' 22' ' ' ILE . 85.2 mt -67.62 -40.73 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.431 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.474 ' HD2' ' O ' ' X' ' 51' ' ' THR . 17.0 m-85 -59.34 -46.65 88.03 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.078 177.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 5.6 pt-20 -67.68 -36.13 80.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.24 176.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.45 79.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 122.947 0.155 . . . . 0.0 110.757 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.83 -48.05 82.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.747 0.654 . . . . 0.0 110.269 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.96 -40.86 78.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -65.67 -33.04 74.96 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.517 0.727 . . . . 0.0 111.817 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.1 39.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.134 0.493 . . . . 0.0 110.694 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.98 -46.78 56.05 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.43 78.03 1.81 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . 0.516 ' ND2' ' HA3' ' X' ' 69' ' ' GLY . 42.7 t-20 -66.45 116.04 30.05 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.684 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.73 -11.69 13.92 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.99 2.46 . . . . 0.0 114.469 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.74 -175.28 16.23 Favored Glycine 0 CA--C 1.489 -1.563 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.13 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.57 -80.47 1.83 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.9 -41.02 0.36 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . 0.516 ' HA3' ' ND2' ' X' ' 64' ' ' ASN . . . 107.48 -142.28 15.77 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.485 174.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.62 31.54 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.54 ' O ' HG12 ' X' ' 75' ' ' ILE . . . 158.39 -177.24 35.14 Favored Glycine 0 N--CA 1.404 -3.498 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 -179.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.623 ' O ' HG13 ' X' ' 76' ' ' VAL . 9.2 Cg_endo -58.3 -43.15 49.16 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.771 2.981 . . . . 0.0 112.403 -176.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.462 ' C ' HG22 ' X' ' 76' ' ' VAL . 37.0 mt-10 -85.5 1.87 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 123.771 0.828 . . . . 0.0 110.796 -176.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' X' ' 77' ' ' LYS . . . -107.98 -29.72 4.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 119.264 -1.446 . . . . 0.0 112.886 173.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.54 HG12 ' O ' ' X' ' 71' ' ' GLY . 1.6 pt -69.64 -28.5 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 CA-C-N 117.576 0.688 . . . . 0.0 110.762 173.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.78 HG11 HG12 ' X' ' 16' ' ' VAL . 31.4 m -59.89 -35.92 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 121.76 0.79 . . . . 0.0 110.787 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.549 ' HA ' ' HG2' ' X' ' 80' ' ' LYS . 40.4 tttp -62.38 -49.11 76.82 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.302 174.293 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.33 -41.2 84.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . . . . . . . . . 23.5 mm -63.0 -45.85 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.067 177.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' HA ' ' X' ' 77' ' ' LYS . 61.5 pttt -71.87 -38.58 70.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.993 -176.287 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' X' ' 77' ' ' LYS . 44.1 mt-10 -69.4 -32.32 71.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.839 -178.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.442 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 72.0 t90 -65.99 -46.15 79.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.228 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.545 HH12 HG12 ' X' ' 7' ' ' ILE . 0.9 OUTLIER -66.26 -39.74 89.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.274 177.205 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.27 86.51 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.817 0.698 . . . . 0.0 111.717 -179.065 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.786 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.23 -40.03 15.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.15 28.71 3.49 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -175.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -93.55 156.46 39.71 Favored Pre-proline 0 N--CA 1.412 -2.328 0 C-N-CA 124.225 1.01 . . . . 0.0 108.779 179.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -63.71 129.57 25.29 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.574 2.183 . . . . 0.0 112.979 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.99 -132.57 7.78 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.945 178.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' X' ' 80' ' ' LYS . 42.4 m-85 -96.21 152.75 18.27 Favored 'General case' 0 C--O 1.252 1.198 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -88.85 169.55 11.49 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.29 136.0 41.86 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.82 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.273 -2.926 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -177.695 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.545 HD22 HD13 ' X' ' 18' ' ' LEU . 40.4 mt -92.19 126.8 37.42 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.457 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 35.3 mmtt -95.62 -161.06 0.83 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.177 -173.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -108.79 -33.51 6.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -130.69 166.61 20.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.624 -176.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' X' ' 44' ' ' ILE . 10.2 tp -67.65 -25.15 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.595 0.712 . . . . 0.0 109.785 178.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -77.67 -11.54 59.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.261 -173.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' X' ' 4' ' ' LYS . 37.0 t0 -99.28 1.13 44.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.04 121.43 40.97 Favored 'General case' 0 CA--C 1.476 -1.899 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.855 -174.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' X' ' 92' ' ' LYS . 80.1 p -79.52 167.94 20.1 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 170.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.604 ' O ' HG13 ' X' ' 16' ' ' VAL . 6.0 pt-20 -59.96 -41.86 92.82 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.031 178.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.58 -38.5 74.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.47 177.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' X' ' 11' ' ' THR . 9.6 mm-40 -59.72 -36.17 76.0 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.403 0.62 . . . . 0.0 109.973 174.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.728 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 18.8 t80 -70.92 -46.17 62.97 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.867 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.74 HG12 HG11 ' X' ' 76' ' ' VAL . 4.9 m -62.57 -29.97 48.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.523 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -60.76 -49.41 77.61 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.969 0.907 . . . . 0.0 109.697 174.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.653 ' O ' HG13 ' X' ' 22' ' ' ILE . 22.7 tp -57.72 -46.79 83.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.577 0.704 . . . . 0.0 109.677 175.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 38.1 mt -58.23 -38.71 77.38 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.055 -178.761 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 97.6 mttt -70.3 -39.21 74.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.957 0.408 . . . . 0.0 110.157 176.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.41 -37.47 87.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 178.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.653 HG13 ' O ' ' X' ' 18' ' ' LEU . 27.5 mt -65.82 -46.74 87.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.98 -39.86 79.24 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.367 1.067 . . . . 0.0 113.053 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . 0.543 ' HG3' ' OE1' ' X' ' 25' ' ' GLU . 24.3 tptp -60.21 -48.67 80.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . 0.543 ' OE1' ' HG3' ' X' ' 24' ' ' LYS . 9.4 mm-40 -92.15 -1.83 56.93 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.484 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -70.84 -53.39 15.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.71 -28.31 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.962 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -23.36 33.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.959 0.409 . . . . 0.0 110.316 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.77 71.21 0.58 Allowed 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.57 1.548 . . . . 0.0 111.935 -176.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' X' ' 25' ' ' GLU . 68.9 p -91.25 -164.03 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.34 -38.71 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.716 177.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.525 ' O ' HG23 ' X' ' 36' ' ' VAL . 33.8 t70 -67.78 -55.09 14.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -172.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.675 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 1.4 p -84.86 -28.88 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 118.711 -1.195 . . . . 0.0 108.267 -177.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 3.0 tm? -59.07 -49.73 76.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.92 -176.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.52 -16.02 59.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.294 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.525 HG23 ' O ' ' X' ' 32' ' ' ASP . 57.3 t -71.69 -50.4 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 C-N-CA 118.599 -1.24 . . . . 0.0 107.815 172.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 82.3 mt -68.18 -42.44 79.94 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 113.457 -1.702 . . . . 0.0 112.059 -169.395 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.0 mt -59.12 -45.78 90.03 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.352 1.033 . . . . 0.0 110.524 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -70.55 -43.3 69.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.893 178.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.524 ' O ' ' HG2' ' X' ' 43' ' ' LYS . 19.6 t60 -59.89 -46.37 89.55 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.109 -176.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.611 ' HE2' ' O ' ' X' ' 50' ' ' GLY . 45.7 t80 -62.45 -50.54 71.07 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.095 -179.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.461 HG12 ' O ' ' X' ' 38' ' ' LEU . 12.5 p -67.08 -30.97 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.549 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 51.0 pttt -73.08 -35.41 66.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.364 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.517 HG12 ' O ' ' X' ' 40' ' ' HIS . 28.6 pt -81.21 -38.69 16.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.9 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 77.2 p -79.47 -36.15 39.19 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-O 121.227 0.537 . . . . 0.0 110.398 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 65.02 23.82 12.55 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -75.28 134.14 74.08 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.483 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 16.7 Cg_exo -72.17 -3.09 12.66 Favored 'Trans proline' 0 CA--C 1.493 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.549 -174.428 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' X' ' 52' ' ' ALA . 24.0 t70 -138.51 32.48 2.29 Favored 'General case' 0 N--CA 1.389 -3.507 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -174.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.611 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -45.44 -59.72 4.56 Favored Glycine 1 CA--C 1.45 -4.01 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.353 -179.152 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.452 ' CG2' HD13 ' X' ' 38' ' ' LEU . 0.2 OUTLIER -70.23 -32.4 70.25 Favored 'General case' 0 C--N 1.248 -3.81 0 CA-C-N 114.764 -0.718 . . . . 0.0 111.461 -173.149 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -75.08 -24.07 58.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.037 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.31 -40.48 94.36 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.435 173.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.58 HD13 HG21 ' X' ' 22' ' ' ILE . 11.7 mt -66.23 -46.11 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -57.45 -49.06 77.46 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.437 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 6.3 pt-20 -71.57 -36.11 70.79 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.148 177.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -39.26 76.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.159 0.436 . . . . 0.0 110.335 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.9 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.638 0.586 . . . . 0.0 110.465 175.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.22 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.424 0.631 . . . . 0.0 111.026 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -67.64 -32.71 73.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.869 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' X' ' 71' ' ' GLY . . . -76.9 -22.86 52.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.729 0.3 . . . . 0.0 111.024 177.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.23 77.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.955 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.48 -47.09 7.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 57.26 83.68 0.22 Allowed Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.602 1.561 . . . . 0.0 112.419 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.45 106.38 2.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.825 2.35 . . . . 0.0 111.58 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -49.43 4.23 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.904 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.08 -37.33 0.65 Allowed Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.275 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -100.89 172.66 6.9 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.932 0.396 . . . . 0.0 110.711 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.54 -68.72 0.25 Allowed Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.17 -178.24 28.93 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.529 ' N ' ' HB2' ' X' ' 61' ' ' ALA . . . 84.43 173.66 49.93 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.481 ' O ' HG13 ' X' ' 75' ' ' ILE . 11.6 Cg_endo -58.31 -44.4 38.61 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.899 -178.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.79 1.05 7.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.03 -22.78 6.72 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.739 176.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.505 ' O ' HG12 ' X' ' 79' ' ' ILE . 0.2 OUTLIER -65.63 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.703 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.74 HG11 HG12 ' X' ' 16' ' ' VAL . 0.7 OUTLIER -58.27 -47.2 88.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.291 178.653 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' X' ' 80' ' ' LYS . 23.9 ttmm -58.26 -44.66 88.45 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.72 -29.73 64.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.285 0.564 . . . . 0.0 110.664 -178.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.505 HG12 ' O ' ' X' ' 75' ' ' ILE . 40.3 mm -69.02 -45.92 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.028 175.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' X' ' 77' ' ' LYS . 18.2 pttp -63.07 -36.29 83.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.186 -174.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.21 -37.6 75.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.144 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.483 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 69.4 t90 -68.42 -47.38 67.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.192 0.52 . . . . 0.0 110.239 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.485 ' NH1' ' HD3' ' X' ' 88' ' ' LYS . 12.3 tpt180 -60.48 -45.66 92.94 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.26 -175.127 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.32 87.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.804 0.335 . . . . 0.0 111.457 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.46 -30.44 64.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.6 34.77 4.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.843 177.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . 0.485 ' HD3' ' NH1' ' X' ' 83' ' ' ARG . 58.7 mttm -111.91 148.27 38.62 Favored Pre-proline 0 N--CA 1.403 -2.802 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.01 126.54 14.65 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.512 2.142 . . . . 0.0 110.344 175.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.79 -114.61 3.13 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.096 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' X' ' 76' ' ' VAL . 18.0 m-85 -88.59 158.5 18.25 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 121.114 0.483 . . . . 0.0 110.273 -174.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' X' ' 11' ' ' THR . 20.6 ptmt -98.45 166.43 11.36 Favored 'General case' 0 N--CA 1.381 -3.881 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.03 136.46 44.46 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 173.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -3.119 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.39 -177.166 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' X' X ' 2' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' X' X ' 3' ' ' LEU . . . . . 0.49 HD22 HD13 ' X' ' 18' ' ' LEU . 67.8 mt -94.18 142.75 27.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.707 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 4' ' ' LYS . . . . . 0.472 ' O ' ' HE1' ' X' ' 40' ' ' HIS . 36.3 mmtt -101.66 -159.84 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 5' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.98 -22.55 6.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.134 0.492 . . . . 0.0 110.446 175.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . 0.489 ' HA ' HG22 ' X' ' 44' ' ' ILE . 23.1 p -140.0 165.95 25.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.559 179.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 7' ' ' ILE . . . . . 0.724 HG12 HH12 ' X' ' 83' ' ' ARG . 4.7 tp -70.38 -18.02 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.488 0.661 . . . . 0.0 110.317 -175.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -70.67 -18.89 62.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.851 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 9' ' ' ASP . . . . . 0.519 ' HA ' ' HD2' ' X' ' 92' ' ' LYS . 19.8 t0 -104.09 6.9 36.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.904 0.859 . . . . 0.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' X' ' 4' ' ' LYS . 15.4 m-85 -96.3 123.81 40.08 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.57 -176.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 11' ' ' THR . . . . . . . . . . . . . 67.3 p -86.29 172.73 10.24 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 171.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 12' ' ' GLU . . . . . 0.612 ' O ' HG13 ' X' ' 16' ' ' VAL . 4.1 mm-40 -56.05 -52.04 65.67 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.138 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 13' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' X' ' 16' ' ' VAL . . . -70.13 -38.55 75.58 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.82 -174.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' X' ' 17' ' ' GLN . 5.2 mm-40 -62.35 -33.47 74.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.899 175.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 15' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' X' ' 19' ' ' LEU . 27.1 t80 -71.94 -44.96 62.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 16' ' ' VAL . . . . . 0.779 HG12 HG11 ' X' ' 76' ' ' VAL . 3.6 m -62.51 -30.43 49.13 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.176 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.452 HE21 ' HB3' ' X' ' 17' ' ' GLN . 0.3 OUTLIER -59.22 -50.21 74.88 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.647 0.779 . . . . 0.0 109.023 174.788 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' X' X ' 18' ' ' LEU . . . . . 0.637 ' O ' HG13 ' X' ' 22' ' ' ILE . 26.0 tp -58.62 -45.91 88.2 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.042 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' X' ' 15' ' ' PHE . 22.3 mt -57.93 -40.96 81.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.937 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' X' ' 16' ' ' VAL . 99.4 mttt -65.22 -37.49 87.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.23 176.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' X' ' 24' ' ' LYS . 7.9 mm-40 -71.8 -37.37 70.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 22' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' X' ' 37' ' ' LEU . 18.5 mt -62.4 -39.61 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.738 178.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.73 -47.05 83.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.356 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 24' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' X' ' 21' ' ' GLU . 17.4 pttp -67.42 -36.26 80.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.497 -175.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 25' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -71.86 -31.64 66.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.269 0.557 . . . . 0.0 110.038 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -72.46 -50.79 23.59 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.473 177.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 27' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' X' ' 24' ' ' LYS . 32.8 m -68.82 -32.35 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.69 -10.06 49.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 109.92 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.62 80.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.701 1.6 . . . . 0.0 113.495 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 30' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' X' ' 34' ' ' LEU . 61.7 p -105.16 -168.53 1.48 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 31' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -143.01 -29.13 0.55 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.555 177.465 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 32' ' ' ASP . . . . . 0.583 ' O ' HG23 ' X' ' 36' ' ' VAL . 11.0 m-20 -67.87 -57.8 5.65 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.043 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 33' ' ' VAL . . . . . 0.677 ' O ' ' HG ' ' X' ' 37' ' ' LEU . 85.6 t -86.36 -29.02 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.472 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 34' ' ' LEU . . . . . 0.636 ' O ' ' HG ' ' X' ' 38' ' ' LEU . 2.4 tm? -58.01 -44.25 87.13 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 35' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' X' ' 39' ' ' GLU . 28.1 t70 -71.7 -35.2 70.15 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.287 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . 0.583 HG23 ' O ' ' X' ' 32' ' ' ASP . 80.9 t -57.76 -49.85 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.008 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 37' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' X' ' 33' ' ' VAL . 64.9 mt -68.12 -43.21 78.92 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.615 -172.179 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 38' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' X' ' 34' ' ' LEU . 21.5 mt -60.58 -49.09 78.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 124.154 0.909 . . . . 0.0 111.876 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 39' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' X' ' 35' ' ' ASP . 4.6 pt-20 -71.36 -36.39 71.47 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.8 178.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 40' ' ' HIS . . . . . 0.513 ' O ' HG12 ' X' ' 44' ' ' ILE . 13.6 t60 -62.72 -46.53 87.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 41' ' ' PHE . . . . . 0.644 ' O ' HG22 ' X' ' 45' ' ' THR . 54.8 t80 -58.02 -56.03 27.24 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 42' ' ' VAL . . . . . 0.435 HG12 ' O ' ' X' ' 38' ' ' LEU . 10.6 p -67.06 -32.87 59.83 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 43' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' X' ' 40' ' ' HIS . 9.2 pttp -70.3 -31.99 69.56 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.026 -179.068 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 44' ' ' ILE . . . . . 0.513 HG12 ' O ' ' X' ' 40' ' ' HIS . 25.9 pt -83.24 -37.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.164 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . 0.644 HG22 ' O ' ' X' ' 41' ' ' PHE . 7.3 t -84.78 -29.59 25.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.22 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 60.44 34.69 20.49 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.418 1.087 . . . . 0.0 111.549 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 47' ' ' HIS . . . . . 0.55 ' H ' HG23 ' X' ' 45' ' ' THR . 45.1 t-80 -85.3 134.26 40.94 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 114.542 -1.208 . . . . 0.0 107.742 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' CZ2' ' X' ' 82' ' ' TRP . 21.7 Cg_exo -69.63 -15.55 37.64 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.945 2.43 . . . . 0.0 113.146 -174.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' CE1' ' X' ' 47' ' ' HIS . 10.8 m-20 -124.29 29.29 6.41 Favored 'General case' 0 N--CA 1.402 -2.827 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -173.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 50' ' ' GLY . . . . . 0.525 ' O ' ' HE2' ' X' ' 41' ' ' PHE . . . -44.96 -58.05 5.12 Favored Glycine 1 CA--C 1.447 -4.186 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.473 -176.73 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' X' ' 55' ' ' TYR . 0.2 OUTLIER -75.66 -33.23 60.42 Favored 'General case' 1 C--N 1.242 -4.091 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.512 -171.876 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild full ' X' X ' 52' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' X' ' 56' ' ' GLU . . . -59.11 -37.03 76.21 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.527 177.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 53' ' ' LEU . . . . . . . . . . . . . 42.6 mt -57.82 -44.73 86.61 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.774 0.671 . . . . 0.0 112.007 177.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 54' ' ' ILE . . . . . 0.603 HD11 ' CD2' ' X' ' 41' ' ' PHE . 4.0 mp -67.38 -43.46 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.645 -179.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 55' ' ' TYR . . . . . 0.519 ' HD1' ' O ' ' X' ' 51' ' ' THR . 29.6 m-85 -55.03 -47.46 74.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.292 177.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 56' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' X' ' 52' ' ' ALA . 8.1 pt-20 -71.53 -36.74 71.1 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 176.079 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.03 83.49 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 118.184 0.447 . . . . 0.0 110.784 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.89 81.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.963 178.089 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.43 -43.52 85.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.188 0.518 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 60' ' ' ARG . . . . . 0.55 ' O ' ' HD3' ' X' ' 65' ' ' PRO . 63.3 mtm180 -66.53 -30.96 71.39 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.593 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.31 58.78 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.306 176.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.84 91.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.85 -48.29 59.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 64' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.87 85.72 0.15 Allowed Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 125.98 1.712 . . . . 0.0 112.441 178.209 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 65' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' X' ' 60' ' ' ARG . 47.9 Cg_endo -99.12 5.4 0.98 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.91 2.407 . . . . 0.0 111.937 177.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.82 -151.75 23.38 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -177.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 67' ' ' GLY . . . . . . . . . . . . . . . -93.16 -15.96 49.27 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.289 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 68' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -67.73 92.73 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.82 0.93 86.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.103 176.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.64 71.87 1.51 Allowed Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.78 173.93 13.11 Favored Glycine 0 N--CA 1.408 -3.204 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.931 178.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.521 ' O ' HG13 ' X' ' 75' ' ' ILE . 18.8 Cg_endo -62.87 -38.4 48.24 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.637 2.891 . . . . 0.0 111.845 -179.017 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.8 -0.2 12.69 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.16 -22.3 7.97 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.771 176.066 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 75' ' ' ILE . . . . . 0.521 HG13 ' O ' ' X' ' 72' ' ' PRO . 0.1 OUTLIER -67.19 -42.74 88.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.356 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' X' X ' 76' ' ' VAL . . . . . 0.779 HG11 HG12 ' X' ' 16' ' ' VAL . 0.9 OUTLIER -58.76 -41.3 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.785 177.487 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' X' X ' 77' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' X' ' 80' ' ' LYS . 26.1 ttpp -60.06 -48.61 80.99 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.809 177.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 78' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.42 -45.11 84.96 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.888 0.851 . . . . 0.0 110.053 176.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 79' ' ' ILE . . . . . 0.469 HG23 ' OG1' ' X' ' 45' ' ' THR . 31.1 mm -61.46 -40.81 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.881 176.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 80' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' X' ' 77' ' ' LYS . 0.4 OUTLIER -71.67 -39.97 69.92 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.458 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' X' X ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.11 -41.97 85.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 82' ' ' TRP . . . . . 0.401 ' CZ2' ' HD3' ' X' ' 48' ' ' PRO . 57.8 t90 -64.08 -46.85 82.44 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.65 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 83' ' ' ARG . . . . . 0.724 HH12 HG12 ' X' ' 7' ' ' ILE . 0.8 OUTLIER -66.28 -39.72 89.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.783 176.874 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' X' X ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.69 96.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.555 0.534 . . . . 0.0 110.864 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.03 83.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.857 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.31 -49.2 15.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.43 0.633 . . . . 0.0 110.381 -176.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.52 27.99 3.92 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 88' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -99.04 155.52 36.48 Favored Pre-proline 0 N--CA 1.406 -2.625 0 C-N-CA 123.342 0.657 . . . . 0.0 109.903 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.58 110.89 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.698 2.265 . . . . 0.0 111.947 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 90' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' X' ' 83' ' ' ARG . . . -85.28 -111.22 0.71 Allowed Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.468 -177.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 91' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -109.87 164.21 12.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.357 -179.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.519 ' HD2' ' HA ' ' X' ' 9' ' ' ASP . 21.1 ptmt -91.45 168.04 11.83 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.014 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' X' X ' 93' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.47 139.44 30.71 Favored 'General case' 0 C--N 1.266 -3.053 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' X' X ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.393 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.744 . . . . . . . . 0 0 . 1 stop_ save_